0001493152-24-017279.txt : 20240430 0001493152-24-017279.hdr.sgml : 20240430 20240430171304 ACCESSION NUMBER: 0001493152-24-017279 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 120 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SMX (Security Matters) Public Ltd Co CENTRAL INDEX KEY: 0001940674 STANDARD INDUSTRIAL CLASSIFICATION: MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-41639 FILM NUMBER: 24898509 BUSINESS ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 BUSINESS PHONE: 353 1 920 1000 MAIL ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 FORMER COMPANY: FORMER CONFORMED NAME: Empatan Public Ltd Co DATE OF NAME CHANGE: 20220801 20-F 1 form20-f.htm
false FY 0001940674 0001940674 2023-01-01 2023-12-31 0001940674 dei:BusinessContactMember 2023-01-01 2023-12-31 0001940674 SMX:OrdinarySharesWithNominalValueOf0.0022PerShareMember 2023-01-01 2023-12-31 0001940674 SMX:WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf253.00PerShareMember 2023-01-01 2023-12-31 0001940674 ifrs-full:OrdinarySharesMember 2023-12-31 0001940674 SMX:PublicWarrantsMember 2023-12-31 0001940674 SMX:DeferredSharesMember 2023-12-31 0001940674 2023-12-31 0001940674 2022-12-31 0001940674 2022-01-01 2022-12-31 0001940674 2021-01-01 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2020-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2020-12-31 0001940674 ifrs-full:RetainedEarningsMember 2020-12-31 0001940674 2020-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-12-31 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-01-01 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2023-12-31 0001940674 ifrs-full:RetainedEarningsMember 2023-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001940674 ifrs-full:OrdinarySharesMember SMX:SecurityMattersPTYLtdMember 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-10-03 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-12-31 0001940674 SMX:EquityPurchaseAgreementMember ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember 2024-04-01 0001940674 SMX:EquityLineAgreementMember 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001940674 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:NatoAgreementMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersSmxPlcMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-12-31 0001940674 SMX:SMXFashionAndLuxuryMember 2023-01-01 2023-12-31 0001940674 SMX:TrueSilverSMXPlatformLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MachineryMember 2023-01-01 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-02 2023-10-02 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-10-02 0001940674 SMX:SpecialPurposeAcquisitionCompanyMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001940674 ifrs-full:MachineryMember 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2021-12-23 2021-12-24 0001940674 SMX:SMXBeveragesPtyLtdMember 2021-12-23 2021-12-24 0001940674 SMX:SMXBeveragesPtyLtdMember 2021-12-24 0001940674 SMX:GlobalBevCoPtyLtdMember SMX:ConsultingAgreementMember 2021-12-23 2021-12-24 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2023-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 ifrs-full:LicencesMember 2023-12-31 0001940674 SMX:TechnologyLicenseMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 ifrs-full:LicencesMember 2022-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2023-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 ifrs-full:OrdinarySharesMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember ifrs-full:OrdinarySharesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:BonusWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-25 0001940674 SMX:RedeemableWarrantsMember 2023-01-24 2023-01-25 0001940674 2022-05-01 2022-05-31 0001940674 2022-05-31 0001940674 SMX:ConvertibleNotesAgreementsMember 2022-07-31 0001940674 ifrs-full:MajorOrdinaryShareTransactionsMember 2023-03-07 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-09-06 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember SMX:WarrantAMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember SMX:WarrantBMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember ifrs-full:OrdinarySharesMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember SMX:WarrantAMember ifrs-full:OrdinarySharesMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember SMX:PromissoryNoteMember 2023-12-31 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:ElevenLendersMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember 2022-01-01 2022-12-31 0001940674 SMX:ThreeValuationModelsMember 2023-01-01 2023-12-31 0001940674 SMX:ThreeValuationModelsMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-12-31 2023-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:FirstInstallmentMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:SecondInstallmentMember 2023-02-28 0001940674 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-01 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-12-31 2023-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:NonadjustingEventMember 2023-07-31 2023-07-31 0001940674 SMX:EquityPurchaseAgreementMember ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember 2024-04-19 0001940674 ifrs-full:OfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MotorVehiclesMember 2023-01-01 2023-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2021-12-31 0001940674 ifrs-full:MotorVehiclesMember 2021-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember 2022-01-01 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2023-12-31 0001940674 ifrs-full:MotorVehiclesMember 2023-12-31 0001940674 2015-01-01 2015-12-31 0001940674 SMX:LenderTwoMember 2023-01-01 2023-12-31 0001940674 2022-08-01 2022-08-31 0001940674 SMX:LoanAgreementMember 2023-09-19 0001940674 SMX:LoanAgreementsMember 2023-09-19 0001940674 ifrs-full:PreferenceSharesMember 2023-12-31 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 2023-03-07 0001940674 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:PrivateWarrantsMember 2023-03-07 0001940674 SMX:PublicWarrantsMember 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 2023-03-07 0001940674 SMX:BridgeLoansMember 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 0001940674 SMX:UnderwritingAgreementMember SMX:EFHuttonLLCMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember SMX:EFHuttonLLCMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember SMX:EFHuttonLLCMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:PublicOfferingMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:PrefundedWarrantMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:WarrantBMember 2022-06-27 0001940674 SMX:WarrantBMember 2023-12-08 0001940674 SMX:WarrantBMember 2023-12-08 2023-12-08 0001940674 2023-12-08 2023-12-08 0001940674 SMX:WarrantBMember 2023-12-31 0001940674 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001940674 SMX:UnderwriterWarrantMember 2023-12-31 0001940674 SMX:UnderwriterWarrantMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:EmployeesMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:EmployeesMember 2023-12-31 0001940674 SMX:EmployeesMember 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:BlackScholesPricingModelMember 2022-01-01 2022-12-31 0001940674 SMX:ServiceProviderAgreementsMember 2023-12-31 0001940674 SMX:IncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2021-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember 2023-01-01 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember 2023-01-01 2023-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2023-01-01 2023-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-12-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-12-31 0001940674 SMX:DirectorsMember 2023-12-31 0001940674 SMX:DirectorsMember 2022-12-31 0001940674 SMX:ShareholdersMember 2023-12-31 0001940674 SMX:ShareholdersMember 2022-12-31 0001940674 ifrs-full:JointVenturesMember 2023-12-31 0001940674 ifrs-full:JointVenturesMember 2022-12-31 0001940674 ifrs-full:RelatedPartiesMember 2023-12-31 0001940674 ifrs-full:RelatedPartiesMember 2022-12-31 0001940674 2023-10-25 2023-10-25 0001940674 2015-01-31 0001940674 2023-01-31 0001940674 2023-01-29 2023-01-31 0001940674 ifrs-full:CreditRiskMember 2023-12-31 0001940674 ifrs-full:CreditRiskMember 2022-12-31 0001940674 SMX:ConvertibleNotesMember 2023-12-31 0001940674 SMX:ConvertibleNotesMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember 2022-12-31 0001940674 ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:DerivativesMember 2022-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:BorrowingFromRelatedPartiesMember 2023-12-31 0001940674 SMX:BorrowingFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NISMember 2023-01-01 2023-12-31 0001940674 SMX:NISMember 2022-01-01 2022-12-31 0001940674 SMX:AUDMember 2023-01-01 2023-12-31 0001940674 SMX:AUDMember 2022-01-01 2022-12-31 0001940674 SMX:SGDMember 2023-01-01 2023-12-31 0001940674 SMX:SGDMember 2022-01-01 2022-12-31 0001940674 SMX:EURMember 2023-01-01 2023-12-31 0001940674 SMX:EURMember 2022-01-01 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:TradeAndOtherPayableMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:BridgeLoansMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:ConvertibleNoteMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:FinancialDerivativesMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:TradeAndOtherPayableMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:BridgeLoansMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:BorrowingsFromRelatedPartiesMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:DerivativesMember 2022-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:DerivativesMember 2022-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:DerivativesMember 2022-12-31 0001940674 ifrs-full:DerivativesMember 2022-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:UnderwritingAgreementMember SMX:NonadjustingEventMember 2024-01-12 0001940674 SMX:NonadjustingEventMember 2024-01-01 2024-01-31 0001940674 SMX:LetterAgreementMember SMX:NonadjustingEventMember 2024-02-29 0001940674 SMX:NonadjustingEventMember SMX:LetterAgreementMember 2024-02-01 2024-02-29 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember 2024-02-20 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember 2024-02-20 2024-02-20 0001940674 SMX:NonadjustingEventMember 2024-02-20 2024-02-20 0001940674 SMX:NonadjustingEventMember 2024-02-01 2024-02-29 0001940674 SMX:NonadjustingEventMember 2024-02-29 2024-02-29 0001940674 ifrs-full:OrdinarySharesMember SMX:BoardOfDirectorMember SMX:NonadjustingEventMember 2024-03-04 0001940674 ifrs-full:OrdinarySharesMember SMX:SecuritiesPurchaseAgreementMember SMX:NonadjustingEventMember 2024-04-11 0001940674 SMX:SecuritiesPurchaseAgreementMember SMX:NonadjustingEventMember ifrs-full:OrdinarySharesMember 2024-04-11 2024-04-11 0001940674 SMX:SecuritiesPurchaseAgreementMember ifrs-full:WarrantsMember 2023-09-06 0001940674 SMX:StockPurchaseAgreementMember ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember 2024-04-19 0001940674 SMX:StockPurchaseAgreementMember ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember 2024-04-19 2024-04-19 0001940674 SMX:NonadjustingEventMember 2024-04-19 0001940674 ifrs-full:OrdinarySharesMember ifrs-full:WarrantReserveMember SMX:NonadjustingEventMember 2024-01-12 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember 2024-01-12 0001940674 SMX:WarrantBMember SMX:NonadjustingEventMember 2024-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD xbrli:shares iso4217:EUR iso4217:EUR xbrli:shares iso4217:SGD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 20-F

 

(Mark One)

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the fiscal year ended December 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from __________ to __________

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  Date of event requiring this shell company report:

 

Commission File Number: 001-41639

 

SMX (Security Matters) Public Limited Company

(Exact name of Registrant as specified in its charter)

 

Not applicable   Ireland
(Translation of Registrant’s name into English)   (Jurisdiction of incorporation or organization)

 

Mespil Business Centre

Mespil House, Sussex Road

Dublin 4, Ireland, D04 T4A6

+353-1-920-1000

(Address of principal executive offices)

 

Haggai Alon

haggai@securitymattersltd.com

Mespil Business Centre

Mespil House, Sussex Road

Dublin 4, Ireland, D04 T4A6

Tel: +353-1-920-1000

(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, with a nominal value of $0.0022 per share   SMX   Nasdaq Stock Market LLC
Warrants, each exercisable for one Ordinary Share at an exercise price of $253.00 per share   SMXWW   Nasdaq Stock Market LLC

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: On December 31, 2023, the issuer had 10,242,706 Ordinary Shares, with a par value of $0.0022 per share, 284,091 public warrants, and 25,000 Deferred Shares, EURO 1 par value, outstanding.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.

 

†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting over Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

US GAAP ☐ International Financial Reporting Standards as issued ☒ Other ☐
  by the International Accounting Standards Board ®  

 

If “Other” has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow. Item 17 ☐ Item 18 ☐

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

 

 

 
 

 

TABLE OF CONTENTS

 

GENERAL INFORMATION 1
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 1
PART I 3
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 3
A. Directors and Senior Management 3
B. Advisors 3
C. Auditors 3
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3
A. Offer Statistics 3
B. Method and Expected Timetable 3
ITEM 3. KEY INFORMATION 3
A. [Reserved] 3
B. Capitalization and Indebtedness 3
C. Reasons for the Offer and Use of Proceeds 3
D. Risk Factors 3
ITEM 4. INFORMATION OF THE COMPANY 28
A. History and Development of the Company 28
B. Business Overview 29
C. Organizational Structure 44
D. Property, Plants and Equipment 44
ITEM 4A. UNRESOLVED STAFF COMMENTS 44
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 44
A. Operating Results 47
B. Liquidity and Capital Resources 52
C. Research and Development, Patents and Licenses, Etc. 59
D. Trend Information 71
E. Critical Accounting Policies and Estimates 71
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 72
A. Directors and Executive Officers 72
B. Compensation 79
C. Board Practices 80
D. Employees 82
E. Share Ownership 83
F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 83
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 83
A. Major Shareholders 83
B. Related Party Transactions 84

 

i
 

 

C. Interests of Experts and Counsel 88
ITEM 8. FINANCIAL INFORMATION 88
A. Consolidated Statements and Other Financial Information 88
B. Significant Changes 89
ITEM 9. THE OFFER AND LISTING 94
A. Offer and Listing Details 94
B. Plan of Distribution 94
C. Markets 94
D. Selling Shareholders 94
E. Dilution 95
F. Expenses of the Issue 95
ITEM 10. ADDITIONAL INFORMATION 95
A. Share Capital 95
B. Memorandum and Articles of Association 95
C. Material Contracts 95
D. Exchange Controls 95
E. Taxation 96
F. Dividends and Paying Agents 106
G. Statement by Experts 106
H. Documents on Display 106
I. Subsidiary Information 107
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 107
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 108
A. Debt Securities 108
B. Warrants and Rights 108
C. Other Securities 108
D. American Depositary Shares 108
PART II 108
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 108
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 108
ITEM 15. CONTROLS AND PROCEDURES 108
A. Disclosure Controls and Procedures 108
B. Management’s Annual Report on Internal Control Over Financial Reporting 108
C. Attestation Report of the Registered Public Accounting Firm 109
D. Changes in Internal Control Over Financial Reporting 109
ITEM 16. [RESERVED] 109
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 109
ITEM 16B. CODE OF ETHICS 109
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 109
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARD FOR AUDIT COMMITTEES 110
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASER 110
ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT 110
ITEM 16G. CORPORATE GOVERNANCE 110
ITEM 16H. MINE SAFETY DISCLOSURE 112
ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 112
ITEM 16J. INSIDER TRADING POLICIES 112
ITEM 16K. CYBERSECURITY 112
PART III 112
ITEM 17. FINANCIAL STATEMENTS 112
ITEM 18. FINANCIAL STATEMENTS 112
ITEM 19. EXHIBITS 113
EXHIBIT INDEX 113

 

ii
 

 

GENERAL INFORMATION

 

Unless context otherwise requires, all references in this Annual Report on Form 20-F to the “Company,” “we,” “us” and “our” refer to SMX (Security Matters) Public Limited Company and, where appropriate, its consolidated subsidiaries.

 

This Annual Report includes trademarks, tradenames and service marks, certain of which belong to us and others that are the property of other organizations. Solely for convenience, trademarks, tradenames and service marks referred to in this Annual Report appear without the ®, and SM symbols, but the absence of those symbols is not intended to indicate, in any way, that we will not assert our rights or that the applicable owner will not assert its rights to these trademarks, tradenames and service marks to the fullest extent under applicable law. We do not intend our use or display of other parties’ trademarks, trade names or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 20-F (including information incorporated by reference herein, the “Report”) contains or may contain forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve significant risks and uncertainties. All statements other than statements of historical facts are forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. Forward-looking statements reflect the Company’s current views with respect to, among other things, its capital resources, performance and results of operations. Likewise, all of the Company’s statements regarding anticipated growth in operations, anticipated market conditions, demographics and results of operations are forward-looking statements. Words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or variations of such words and similar expressions are intended to identify the forward-looking statements. Forward-looking statements in this Report and in any document incorporated by reference in this Report may include, for example, statements about:

 

the Company’s financial performance;

 

the ability to obtain or maintain the listing of the Ordinary Shares on Nasdaq;

 

changes in the Company’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;

 

the Company’s ability to develop and launch new products and services;

 

the Company’s ability to successfully and efficiently integrate future expansion plans and opportunities;

 

the Company’s ability to grow its business in a cost-effective manner;

 

the Company’s product development timeline and estimated research and development costs;

 

the implementation, market acceptance and success of the Company’s business model;

 

developments and projections relating to the Company’s competitors and industry;

 

the Company’s approach and goals with respect to technology;

 

1
 

 

the Company’s expectations regarding its ability to obtain and maintain intellectual property protection and not infringe on the rights of others;

 

the impact of war, terror threats, or adverse public health developments on the Company’s business;

 

changes in applicable laws or regulations; and

 

the outcome of any known and unknown litigation and regulatory proceedings.

 

These forward-looking statements are based on information available as of the date of this Report, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. The risk factors and cautionary language referred to or incorporated by reference in this Report provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations described in our forward-looking statements, including among other things, the items identified in the section entitled “Risk Factors”. You should, however, review the factors and risks that the Company describes in the reports it will file from time to time with the SEC.

 

As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:

 

the outcome of any legal proceedings that may be instituted against the Company;
   
the ability to  maintain the listing of the Ordinary Shares on Nasdaq;
   
changes in applicable laws or regulations;
   
the lingering effects of the COVID-19 pandemic on the Company’s business;

 

the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities;
   
the risk of downturns and the possibility of rapid change in the highly competitive industry in which the Company operates;
   
the risk that the Company and its current and future collaborators are unable to successfully develop and commercialize its products or services, or experience significant delays in doing so;
   
the risk that the Company may never achieve or sustain profitability;
   
the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all;
   
the risk that the Company experiences difficulties in managing its growth and expanding operations;

 

2
 

 

the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations;
   
the risk that the Company is unable to secure or protect its intellectual property;
   
the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and
   
other risks and uncertainties described in this Annual Report, including those under “Item 3.D Risk Factors.”

 

Public Warrant

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS

 

A. Directors and Senior Management

 

Not applicable.

 

B. Advisors

 

Not applicable.

 

C. Auditors

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

A. Offer Statistics

 

Not applicable.

 

B. Method and Expected Timetable

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

An investment in our securities is highly speculative, involves a high degree of risk and should be made only by investors who can afford a complete loss. If any of the following risks actually occurs, then our business, financial condition or results of operations could be materially adversely affected, the trading of our ordinary share and warrants could decline, and you may lose all or part of your investment therein. In addition to the risks outlined below, risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations. Potential risks and uncertainties that could affect our operating results and financial condition include, without limitation, the following:

 

3
 

 

Summary Risk Factors

 

Investing in our securities entails a high degree of risk as more fully described under “Risk Factors.” You should carefully consider such risks before deciding to invest in our securities. These risks include, among others:

 

Risks Related to Ownership of the Ordinary Shares

 

A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.
If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding the Ordinary Shares adversely, then the price and trading volume of the Ordinary Shares could decline.

 

Risks Related to Our Legal and Regulatory Environment

 

Changes in laws, regulations or rules, and a failure to comply with any laws, regulations and standards, may adversely affect our financial and operating performance and profitability.

 

Risks related to the business and operations of the Company

 

We are a rapidly growing company with a relatively limited operating history, which may result in increased risks, uncertainties, expenses and difficulties, and it may be difficult to evaluate our future prospects.
If we fail to effectively manage our growth, our business, financial condition, and results of operations could be adversely affected.
The industry in which we operate is competitive, and if we fail to compete effectively, we could experience price reductions, reduced margins or loss of revenues.
We will need in the future to raise additional funds, inter alia, by equity, debt, or convertible debt financings, to support our growth, and those funds may be unavailable on acceptable terms, or at all. As a result, we may be unable to meet our future capital needs, which may limit our ability to grow and jeopardize our ability to continue our business.

 

Risks Related to Technology, Intellectual Property and Data

 

We may be unable to, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights sufficiently.

 

Risks Related to Our Operations in Israel

 

Conditions in Israel and relations between Israel and other countries could adversely affect our business.

 

Risks related to Tax

 

The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or changes in tax legislation or policies could impact our future financial position and results of operations.
   
U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of “controlled foreign corporations.”

 

4
 

 

Our U.S. shareholders may suffer adverse tax consequences if we are classified as a “passive foreign investment company.”
   
The Internal Revenue Service may not agree that the Company should be treated as a non-U.S. corporation for U.S. federal income tax purposes.
   
Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.
   
Future changes in U.S. and foreign tax laws could adversely affect the Company.

 

Risks related to Irish Law

 

The Company does not intend to pay dividends in the foreseeable future.
   
Provisions in the Company’s Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”) and under Irish law could make an acquisition of the Company more difficult, may limit attempts by the Company shareholders to replace or remove the Company’s management, may limit shareholders’ ability to obtain a favorable judicial forum for disputes with the Company or the Company’s directors, officers, or employees, and may limit the market price of the Ordinary Shares, the warrants to acquire one Ordinary Share at an exercise price of $253.00 per share (the “Public Warrants”) and/or other securities issued by the Company.

 

General Risks

 

The Company will incur significant costs and devote substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.
   
The stock price of the Ordinary Shares may be volatile.
   
The Company may issue additional Ordinary Shares or other equity securities without seeking approval of its shareholders, which would dilute your ownership interests and may depress the market price of the Ordinary Shares.
   
The Company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses. This would subject the Company to generally accepted accounting principles, as in effect in the United States from time to time (“GAAP”), reporting requirements which may be difficult for it to comply with.
   
The Company is an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make the Ordinary Shares less attractive to investors.
   
The Company will incur significant costs and devote substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.
   
The Company’s management has limited experience in operating a public company in the United States.
   
There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq. If we are not able to comply with the applicable continued listing requirements or standards of the Nasdaq Capital Markets, Nasdaq could delist our Ordinary Shares and Public Warrants.

 

5
 

 

In addition, we face other risks and uncertainties that may materially affect our business prospects, financial condition, and results of operations. You should consider the risks discussed in “Risk Factors” and elsewhere in this Report before investing in our securities.

 

An investment in our securities is highly speculative, involves a high degree of risk and should be made only by investors who can afford a complete loss. If any of the following risks actually occurs, then our business, financial condition or results of operations could be materially adversely affected, the trading of our Ordinary Share and warrants could decline, and you may lose all or part of your investment therein. In addition to the risks outlined below, risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations. Potential risks and uncertainties that could affect our operating results and financial condition include, without limitation, the following:

 

Risks Related to Ownership of the Ordinary Shares

 

A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.

 

The price of our securities may fluctuate significantly due to the general market and economic conditions. An active trading market for our securities may never develop or, if developed, it may not be sustained. In addition, the price of our securities can vary due to general economic conditions and forecasts, our general business condition and the release of our financial reports. Additionally, if our securities become delisted from Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

 

The trading price of our securities could be volatile and subject to wide fluctuations.

 

The trading price of our securities could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment in our securities and our securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience a further decline.

 

Broad market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock market in general and Nasdaq have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities, may not be predictable. A loss of investor confidence in the market for the stocks of other companies that investors perceive to be similar to the Company could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the market price of our securities also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.

 

In the past, securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management’s attention and resources and could also require us to make substantial payments to satisfy judgments or to settle litigation.

 

If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding the Ordinary Shares adversely, then the price and trading volume of the Ordinary Shares could decline.

 

The trading market for our Ordinary Shares will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. Securities and industry analysts do not currently, and may never, publish research on the Company. If no securities or industry analysts commence coverage of the Company, our stock price and trading volume would likely be negatively impacted. If any of the analysts who may cover the Company change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our Ordinary Shares would likely decline. If any analyst who may cover the Company were to cease coverage or fail to regularly publish reports on it, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.

 

6
 

 

Risks related to the business and operations of the Company

 

We are a rapidly growing company with a relatively limited operating history, which may result in increased risks, uncertainties, expenses and difficulties, and it may be difficult to evaluate our future prospects.

 

We have experienced rapid growth in recent years in the markets we serve, including hiring additional employees, running multiple projects concurrently and expanding into new fields, and we plan to continue to expand into new markets. Our limited operating history may make it difficult to make accurate predictions about our future performance. Assessing our business and future prospects may also be difficult because of the risks and difficulties we face. These risks and difficulties include our ability to:

 

enter into new relationships and maintain existing relationships with clients and business partners;
   
maintain cost-effective access to capital;
   
expand the use and applicability of our technology;
   
successfully build our brand and protect our reputation from negative publicity;
   
successfully adjust our proprietary technology, products and services in a timely manner in response to changing market conditions;
   
successfully compete with companies that are currently in, or may in the future enter, the business of providing traceability solutions;
   
enter into new markets and introduce new products and services based on our technology;
   
comply with and successfully adapt to complex and evolving legal and regulatory environments in our existing markets and ones we may enter in the future;
   
attract, integrate and retain qualified employees and independent contractors; and
   
effectively manage, scale and expand the capabilities of our teams, outsourcing relationships, third-party service providers, operating infrastructure and other business operations.

 

If we are not able to timely and effectively address these risks and difficulties as well as those described elsewhere in this “Risk Factors” section, our business, financial condition and results of operations may be adversely affected.

 

If we fail to effectively manage our growth, our business, financial condition, and results of operations could be adversely affected.

 

As described above, over the last several years, we have experienced rapid growth in our business and number of employees, and we expect to continue to experience growth in the future. This rapid growth has placed, and may continue to place, significant demands on our management, processes, systems and operational, technological and financial resources. Our ability to manage our growth effectively, integrate new employees, independent contractors and technologies into our existing business and attract new business partners and maintain relationships with existing business partners will require us to continue to retain, attract, train, motivate and manage employees and independent contractors and expand our operational, technological and financial infrastructure. Continued growth could strain our ability to develop and improve our operational, technological, financial and management controls, reporting systems and procedures, recruit, train and retain highly skilled personnel and maintain business partners’ and their customers’ satisfaction.

 

7
 

 

We may not have sufficient manufacturing capabilities for our markers and readers to satisfy demand for our products, including due to the Eastern-European issues, world politics, post-COVID-19 related issues, international freight issues, costs of goods and other external financial or political issues. We may be unable to control the availability or cost of producing such products.

 

Our current manufacturing capabilities may not reach the required production levels necessary in order to meet growing demands for any products we may commission or future products we may develop. There can be no assurance that our commissioned products can be manufactured at the desired commercial quantities, in compliance with our requirements and at an acceptable cost. Any such failure could delay or prevent us from shipping said products and marketing the technologies in accordance with our target growth strategies.

 

While we were able to date to find new employees, when required, Israeli (and other) high-tech employment atmosphere (including due to the post-COVID-19 pandemic and lack of available professionals) is making it harder and harder to find and retain new employees. Thus, risk exists that we will not be able to hire all the employees we seek to hire, in the timeframe required and anticipated, which may slow down our growth, cause increased costs and reduced profits or hinder our ability to duly and timely fulfill all tasks and growth plans.

 

We note that due to such employment atmosphere we may need to extend additional resources, including issuance of shares and options, and financial measures in order to create retention plans for key personnel.

 

Part of our products are in the field of sustainability and circular economy and part of our growth engine is the upcoming world-wide legislation and regulations demanding sustainability and circular economy and carbon-free environment. While we are not relying on such upcoming legislation or regulations, slow legislation or promulgation process and changes in priorities (including due to lingering effects of the COVID-19 epidemic or the Eastern-European issues) may slow our growth.

 

Due to the fact that we aim our sales efforts at large international market-maker conglomerates, our sales cycle is relatively slow and there is a larger risk that at any time, due to many reasons that are beyond our control, the sales cycle will be broken and all efforts will be lost.

 

Any of the foregoing factors could negatively affect our business, financial condition and results of operations.

 

If the Isorad License Agreement is terminated, our business, financial condition and results of operations may be harmed.

 

In January 2015, SMX Israel entered a license agreement with Isorad Ltd (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Nuclear Research Center technology for civilian uses) (“Isorad”) to license the initial technology of tracking and tracing materials by observing and identifying markers (“Source IP”) and commercialize and develop the technology further (the “Isorad License Agreement”). Under the Isorad License Agreement, the Source IP can be utilized in almost any industry and with any product. The Source IP has been the cornerstone for our technological developments. Since entering into the Isorad License Agreement, we filed over a hundred additional patent applications worldwide (most of which are irrelated to the Source IP).

 

Specifically as to Yahaloma, the royalty rate on gross sales of Yahaloma, to be paid by Yahaloma, are 4.2% (and not 2.2% that applies solely to Security Matters PTY, its other affiliates and to other sublicensees). Upon the occurrence of an M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of Yahaloma and similar event), Isorad is entitled to a fee equal to 1% of the total consideration paid to, received by, or distributed to, Yahaloma and/or its shareholders and/or its affiliates in connection with the event, including, without limitation, all cash, securities or other property which is received by Yahaloma and/or its shareholders in connection with such event of two such events (i.e. twice) at its choice.

 

8
 

 

The Isorad License Agreement will continue in full force and effect in perpetuity unless terminated. If either party does not remedy a material breach of its obligations within 180 days of notice of the material breach, the non-defaulting party may terminate the Isorad License Agreement immediately. Isorad may terminate the agreement by providing 30 days prior written notice if the royalties payable to Isorad are nil in any semi-annual report or if we breach other certain obligations (such as a failure to maintain a patent or patent application in the previous semi-annual review period). If the Isorad License Agreement is terminated, our business, financial condition and results of operations may be harmed.

 

If we fail to penetrate the full value chain manufacturing eco-system effectively, our business, financial condition, and results of operations could be adversely affected.

 

Value based pricing may be necessary to enable roll-out across clients, creating challenges in full value capture and effective customer segmentation. Some end-markets (e.g. plastics) require high levels of penetration to support our full value proposition. A broad range of potential end-markets and clients with different value propositions and price sensitivities will require a substantial, high performing, commercial organization.

 

In order to maintain continuous growth there is a need to onboard more and more players from different parts of the value chain manufacturing eco-system with the final view of covering all links in the value chain manufacturing eco-system. This may be time and cost consuming and will require funding and personnel and we may not be able to achieve the full value chain penetration due to failure to attain funding or personnel or due to external circumstances, which may hinder our growth.

 

The COVID-19 pandemic has adversely affected, and its lingering effects may continue to affect, our business, financial condition, liquidity and results of operations.

 

The COVID-19 pandemic resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic volatility in the United States, Israel, Australia and international capital markets. We have followed guidance issued from time to time by the Australian and Israeli governments and the other local governments in territories in which we operate to protect our employees. As such, we have implemented work from home where possible, minimized face-to-face meetings and utilized video conference as much as possible and adhered to social distancing rules at our facilities while eliminating international travel, which required us to use local representatives to handle presentations and demonstrations for oversees customers. As a result, we have experienced some difficulties in employee ability to efficiently collaborate to meet our customer needs, a difficulty in our efforts to recruit and hire qualified personnel during this time, and have recorded a minor decrease in expected growth in 2020 and 2021, both due to the lockdown and restrictions, and our customers postponing or being hesitant of making future financial, or other, commitments due to the need to put response to the pandemic at the forefront, hesitations that may continue, or reoccur, in the future. Although many of these limitations have been lifted as the pandemic has receded, some of the resulting difficulties have remained in varying degrees.

 

We cannot predict the other future potential, direct or indirect, lingering impacts of the COVID-19 pandemic on our business or operations. Additional waves of infections, or any further lingering adverse impacts caused by the COVID-19 pandemic could further impact employment rates, supply chains, priorities and the economy, affecting our customer base and divert customers’ discretionary spend to other uses, including for essential items. These events could impact our cash flows, results of operations and financial conditions and heighten many of the other risks described in this Annual Report on Form 20-F.

 

Our operations in foreign jurisdictions will subject us to risks associated with operating in those jurisdictions and may adversely affect our business, cash flows, financial condition and results of operations.

 

As we operate in foreign jurisdictions (such as Ireland, Israel, Australia, Singapore, France and Canada), we will be subject to those risks associated with operating in foreign jurisdictions. Such risks may include economic, social or political instability or change, hyperinflation, currency non-convertibility or instability and changes of laws affecting foreign ownership, government participation, taxation, working conditions, rates of exchange, exchange control, licensing, repatriation of income or return of capital, consumer health and safety or labor relations. While the jurisdictions in which we currently operate are economically stable, there is no certainty that political and economic conditions will remain stable. Any deterioration in political or economic conditions, including hostilities or terrorist activity may adversely affect our operations and profitability. There is a risk that the government of any such jurisdiction may change its policies regarding foreign investment, apply new or different taxes and levies, or make any other change which may have an adverse impact on our profitability. See the risk factors under “Risks Related to Our Operations in Israel.”

 

9
 

 

Prior to the Russian-Ukrainian dispute, Security Matters PTY was cooperating with a Ukrainian entity in parallel with its activities in Israel and European entities for research and development for its readers. Security Matters PTY was also reviewing potential relationships with entities in Russia, Belarus and Ukraine. As a result of the dispute, Security Matters PTY put on hold its research and development in Ukraine while continuing its research and development activity in Israel and with European entities and undertook no business relationships with parties in those regions. It is yet unknown what other effects such dispute may have on other jurisdictions, mainly in Europe, and any such effect might affect our business and growth. We cannot predict the other future potential impacts of the dispute on our business or operations, especially if such dispute becomes more than a regional event. These events could impact our cash flows, business, results of operations and financial condition and heighten many of the other risks described in this Annual Report on Form 20-F.

 

Moreover, events may occur within or outside the jurisdictions in which we operate that could impact those economies, our operations and the price of the Ordinary Shares. These events include but are not limited to acts of terrorism, an outbreak of international hostilities, fires, floods, earthquakes, labor strikes, civil wars, natural disasters, outbreaks of disease or other natural or manmade events or occurrences that can have an adverse effect on the demand for our products and our ability to conduct business. While we seek to maintain insurance in accordance with industry practice to insure against the risks we consider appropriate after consideration of our needs and circumstances, no assurance can be given as to our ability to obtain such insurance coverage in the future at reasonable rates or that any coverage arranged will be adequate and available to cover any and all potential claims. The occurrence of an event that is not covered or fully covered by insurance could have a material adverse effect on our business, financial condition and results of operations.

 

If we are unable to successfully identify and integrate acquisitions, our results of operations could be adversely affected.

 

Acquisitions may be a significant component of our growth strategy and from time to time we may seek to identify and complete acquisitions. Our future acquisitions may not be successful or may not generate the financial benefits that we expected we would achieve at the time of acquisition. In addition, there can be no assurance that we will be able to locate suitable acquisition candidates in the future or acquire them on acceptable terms or, because of competition in the marketplace. Acquisitions involve special risks, including, without limitation, the potential assumption of unanticipated liabilities and contingencies, difficulty in assimilating the operations and personnel of the acquired businesses, disruption of our existing business, dissipation of our limited management resources and impairment of relationships with employees and customers of the acquired business as a result of changes in ownership. While we believe that strategic acquisitions can improve our competitiveness and profitability, these activities could have a material adverse effect on our business, financial condition and operating results.

 

We may incur significant costs such as transaction fees, professional service fees and other costs related to future acquisitions. We may also incur integration costs following the completion of any such acquisitions as we integrate the acquired business with the rest of our Company. Although we expect that the realization of efficiencies related to the integration of any acquired businesses will offset the incremental transaction and acquisition-related costs over time, this net financial benefit may not be achieved in the near term, or at all.

 

The industry in which we operate is competitive, and if we fail to compete effectively, we could experience price reductions, reduced margins or loss of revenues.

 

Generally, the track and trace and anti-counterfeit industry in which we operate is subject to global and domestic competition. We are unable to influence or control the conduct of our competitors and such conduct may detrimentally affect our financial and operating performance There are several competitors that operate in the anti-counterfeit and track-and-trace industries and if new competitors enter the market, or established companies develop new products and technologies that are superior to our current technology, our ability to exploit any technological advantage successfully may be affected. We may be unable to develop further products or keep pace with developments and may lose clients to competitors. If our competitors develop a more efficient business model or undertake a more aggressive marketing campaign, this is likely to affect our marketing strategies and results of operations adversely.

 

10
 

 

There is no guarantee that customers will adopt our products and we may be unable to compete successfully with more established track and trace and anti-counterfeit companies on price or quality or may be unsuited to the established preferences of potential customers.

 

Our continued growth, including our ability to manage our operations and meet our strategic objectives, depends on retaining our current employees upon whom we are dependent and attracting and retaining qualified personnel, and we may not be able to do so at a rate that will enable us to stand up to our expected growth or cope with specific demands that may arise.

 

Our success depends to a large extent upon the skills and experience of our executive officers, management and sales, marketing, operations and scientific staff. We may not be able to attract or retain qualified employees due to the intense competition for qualified personnel in the technology industry, as well as to geographic considerations, our ability to offer competitive compensation and benefits, and other reasons.

 

If we are not able to attract and retain the necessary qualified personnel to manage our operations and accomplish our business objectives, we may experience constraints that will adversely affect our ability to manufacture, sell and market our products or to support research and development programs effectively.

 

SMX Israel has entered into employment contracts with several of its executives including Haggai Alon, its founder and Chief Executive Officer, and Ofira Bar, its CFO. Due to the specific knowledge and experience of these executives regarding the industry, technology and market generally and to our company specifically, the loss of the services of any one of these executives could have a material adverse effect on us. We have not obtained a key person insurance policy on any officer.

 

Although our employment agreements contain non-compete clauses, Israeli law does not fully enforce employees’ non-compete obligations and may limit their application, including with regard to duration and scope.

 

Under Israeli case law an Israeli Court will usually only enforce non-compete provisions if the employee received specific consideration for it. While all of our employment agreements include specific provisions stipulating that special consideration was paid for the non-compete provision, a risk always exists that a Court will not enforce such.

 

We may not be able to anticipate or adapt to consumer preferences which may have an adverse effect on our business, cash flows, financial condition and results of operations.

 

Our success depends on our ability to develop and commercialize our technology. A failure to successfully develop and commercialize our technology could lead to a loss of opportunities and adversely impact on our business, cash flows, financial condition and results of operations.

 

The global market for our technology is ever changing due to new technologies, new products, changes in regulations and other factors influencing market acceptance or market rejection of our technologies. This market volatility and risks exists despite our best efforts in relation to market research, promotion and sales efforts.

 

Our business is dependent on consumer awareness and market acceptance of our products. We may not be able to anticipate and react to trends within the industries we target in a timely manner or accurately assess the impact that such trends may have on consumer preferences. Failure to respond to changes in consumer preferences or anticipate market trends may adversely affect our future revenues and performance. Although we have striven to establish market recognition for our products in the relevant industry, it is too early in the life cycle of our brand to determine whether markers, readers, blockchain technology and any further technology developed by us will achieve and maintain satisfactory levels of acceptance and sustained adoption by manufacturers and consumers. Our technology may not be accepted by the market or used in our proposed markets and industries. We may not be able to commercialize our products, which could adversely impact on business, cash flows, financial condition and results of operations.

 

11
 

 

We may not be able to adapt our markers to the needs of any customer or field which may have an adverse effect on our business, cash flows, financial condition and results of operations.

 

Research and development tailoring costs are required to adapt marker and scanning technology to different materials and industrial/commercial environments, potentially increasing the cost and time to market as we scale across customers and verticals. If we are unable to adapt our markers to the needs of any customer or field due to the costs of doing so, our business, cash flows, financial condition and results of operations could be adversely affected.

 

We will need in the future to raise additional funds, inter alia, by equity, debt, or convertible debt financings, to support our growth, and those funds may be unavailable on acceptable terms, or at all. As a result, we may be unable to meet our future capital needs, which may limit our ability to grow and jeopardize our ability to continue our business.

 

We plan to continue to make investments to support our growth and will require additional funds to respond to business challenges that may arise, including the need to develop new products and services, enhance our technology, scale and improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we will need to engage in equity, debt or convertible debt financings to secure additional funds. In raising additional funds by the issuance of equity securities or securities convertible into equity securities, our shareholders may experience dilution. Debt financing, such as credit facilities or corporate bonds, may involve covenants restricting our operations or our ability to incur additional debt. Debt financing may also require security arrangements including cash collateral agreements that restrict the availability of cash held as collateral which is the case for amounts we may borrow in the future. In addition, future equity financing or replacement or refinancing of any debt financings may not be available on terms favorable to us, or at all, and the fact that debt holders are repaid first may reduce our ability to raise a later equity financing and may limit the ability to distribute dividends.

 

If we are unable to obtain adequate financing or financing at terms satisfactory to us when we require it, we may be unable to pursue certain business opportunities, supply proper service to our customers, and our ability to continue to support our business growth and the then current business and to respond to business challenges may be impaired and our business may be harmed.

 

Legal proceedings, investigations or claims against us may be costly and time-consuming to defend and may harm our reputation and damage our business regardless of the outcome. In addition, our business and operations could be negatively affected if they become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of business and growth strategy and impact our share price.

 

We are currently not aware of any risk of litigation against us, but we may be involved in litigation disputes with third parties including suppliers, customers, employees, former employees and government bodies in the ordinary course of business. The occurrence of a litigation dispute may be costly and impact on our reputation which may have a material adverse effect on our business, cash flows, financial condition and results of operations. Insurance might not cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims and might not continue to be available at terms acceptable to us. A claim brought against us for which we are uninsured or underinsured could result in unanticipated costs, potentially harming our business, cash flows, financial position and results of operations.

 

Although not a director of that entity, Mr. Alon previously worked as the deputy general manager for business development of an Israeli public company, Plat Technologies International Ltd (“Plat”) which entered insolvency. In early 2017, an ILS 35.9 million shareholders claim was filed by the appointed court officers at the end of the seven year statute of limitation period against 18 defendants, including Mr. Alon, regarding the collapse of Plat (the “Claim”). The insurance policy covering directors and officers responded and are now handling the claim. Mr. Alon denies any wrongdoing and does not consider that he will be required to commit any significant time to the conduct of the Claim and therefore will not constrain his ability to perform his duties and obligations to Security Matters PTY. The parties agreed to try and amicably resolve the dispute in mediation under which the insurance company agreed to consider taking upon itself any compensation as to the liability of Mr. Alon, if any, in such mediation proceedings. Security Matters PTY is not a party to the Claim and the Claim does not relate to the business or the affairs of Security Matters PTY.

 

12
 

 

Our markers may contaminate or spoil the raw material into which our marker is inserted, which could damage our reputation, subject us to product liability claims and result in a loss of revenue.

 

While we follow production protocols and conduct quality assurance tests, our markers may contaminate the raw material or certain raw material ingredients may be spoiled, contaminated by chemicals, microorganisms or toxins, or include foreign materials or substances. The risk of contamination may lead to product recalls or other interventions, which may cause serious damage to our reputation as a marking solution which does not affect the characteristics of the materials or products, or result in product liability claims and loss of revenue.

 

Our markers may include hazardous materials which may put customers, employees and other parties in our supply chain at risk. If any person is harmed by hazardous materials in our markers, our reputation could be damaged and we could be subject to litigation which may adversely affect our business, cash flows, financial position and results of operations.

 

The markers used by us are produced from materials chosen specifically for a specific application. Markers may, in some cases, include low concentrations of materials that may be deemed hazardous materials and the production of the markers by our employees can include dealing with hazardous materials. While manufacturing is conducted according to the material’s Material Safety Data Sheets (MSDS) and other relevant safety guidelines, a risk of health, even if minimal, may arise. While the hazardous materials are sent to the customers at a low concentration (of the marker), the risk of misuse or error in production may cause damage to our employees or customers, which may affect our expenses and production abilities. While we take safety provisions with respect to the hazardous materials used in our markers, these safety precautions may not be sufficient to prevent harm to our employees or customers from the production of or use of, respectively, our markers. While we are in compliance with the requirements of ISO 9001:2015 standard for quality management and quality assurance as well as safety measures instructed by an external safety engineer, such safety provisions may not be sufficient to prevent human error or other causes of damage.

 

Our readers use x-rays and may be of danger if tampered with or otherwise not used in accordance with the user manual and safety rules.

 

Although we supply customers with strict instructions for the use of our readers, and although we take measures to avoid misuse of the readers and minimize the risk of damage from misuse of the readers, users and others may suffer damage from not following such user instructions and may seek legal actions against us, even if such users or others are at fault.

 

We may not be able to procure adequate insurance and any insurance we have or may have may not be of sufficient coverage

 

We and our subsidiaries seek to maintain appropriate policies of insurance consistent with those customarily carried by organizations in our industry sector, including product insurance, as well as cyber-risk and privacy-risk insurance. Any increase in the cost of insurance policies or the industry in which they operate could adversely affect our business, cash flows, financial condition and results of operations. Our insurance coverage may also be inadequate to cover losses we may sustain and the insurance company may refuse to provide coverage or demand excessive payment for such coverage. In particular, our insurance does not extend to any potential liability or claims made against us under our agreement with Isorad. Uninsured loss or a loss in excess of our insured limits could adversely affect our business, cash flows, financial condition and results of operations.

 

13
 

 

Our risk management policies and procedures, and those of our third-party vendors upon which we rely, may not be fully effective in identifying or mitigating risk exposure. If our policies and procedures do not adequately protect us from exposure to these risks, we may incur losses that would adversely affect our financial condition, reputation and market share.

 

We have developed risk management policies and procedures and we continue to refine such as we conduct our business. Our policies and procedures are meant to identify, monitor and manage risks may not be fully effective in mitigating our risk exposure. Further, as we are a research and development (“R&D”) company and expand into new fields of business, our risk management policies and procedures may not be able to keep up with our current rapid rate of expansion adequately, and may not be adequate or sufficient to mitigate risks. Moreover, we are subject to the risks of errors and misconduct, including by our officers, employees and independent contractors, including fraud and non-compliance with policies. These risks are difficult to detect in advance and prevent or avoid, and could harm our business, results of operations or financial condition. Although we seek to maintain insurance and use other traditional risk-shifting tools when possible, such as third-party indemnification, where possible, to manage certain exposures, they are subject to terms such as deductibles, coinsurance, limits and policy exclusions, as well as risk of counterparty denial of coverage, default or insolvency. If our policies and procedures do not adequately protect us from exposure, and our exposure is not adequately covered by insurance or other risk-shifting tools, we may incur losses that would adversely affect our business, cash flows, financial condition and results of operations.

 

Risks Related to Technology, Intellectual Property and Data

 

We may be unable to, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights sufficiently.

 

Our ability to operate our businesses depends, in part, upon our proprietary technology. We may be unable to protect our proprietary technology effectively, which would allow competitors to duplicate our technology and adversely affect our ability to compete with them.

 

We have applied for over a hundred patents. While we are not aware of any such patent applications or the technology infringing any third party’s patents, we have not undertaken an exhaustive assessment of existing patents to determine any overlapping technology or potential infringement, and we do not conduct a freedom to operate search or any other exhaustive search of patents that may limit our ability to supply solutions to specific customers or fields, as the costs of such would be prohibitive. Accordingly, there is a risk that a third party may claim that any patent application infringes that third party’s patent. Any event that would jeopardize our proprietary rights or any claims of infringement by third parties could have an adverse effect on our ability to market or exploit our technology.

 

There is no guarantee that our proposed patents that are the subject of the patent applications filed by us will provide adequate protection for our intellectual property, or that third parties will not infringe or misappropriate the patents or similar proprietary rights. In addition, there can be no assurance that we will not have to pursue litigation against other parties to assert our rights. There is no guarantee that any of the patents that have been applied for will be granted. If some or all of the patent applications are not granted, our ability to exploit our technology may be materially adversely affected.

 

If third parties claim that we infringe upon or otherwise violate their intellectual property rights, our business could be adversely affected.

 

Although we are not aware of any infringement on the rights of third parties, we may in the future be subject to claims that we have infringed or otherwise violated third parties’ intellectual property rights. There is patent, copyright, and other intellectual property development and enforcement activity in our industry and relating to the advanced technology we use in our business. Our future success depends in part on not infringing upon or otherwise violating the intellectual property rights of others. From time to time, our competitors or other third parties (including non-practicing entities and patent holding companies) may contend that we are infringing upon or otherwise violating their intellectual property rights, or attack our pending or approved patents, and we may be found to be infringing upon or otherwise violating such rights or otherwise in legal claims regarding patents or other intellectual property rights. We may be unaware of the intellectual property rights of others that may cover some or all of our current or future technology or conflict with our rights, and the patent and other intellectual property rights of others may limit our ability to improve our technology and compete effectively. Any claims of intellectual property infringement or other intellectual property violations, even those without merit, could cause the incurrence of costs and other direct, or indirect, damage to us, including:

 

be expensive and time consuming to defend;
   
cause us to cease making, licensing, or using any of our products that incorporate the challenged intellectual property;

 

14
 

 

require us to modify, redesign, reengineer or rebrand our products, if feasible;
   
damage our reputation;
   
hinder our ability to market or sell our products and services;
   
affect negotiations or executed agreements;
   
cause increase to our insurance policies premium or refusal of insurance companies to insure us;
   
divert management’s attention and resources; or
   
require us to enter into royalty or licensing agreements to obtain the right to use a third-party’s intellectual property.

 

Any royalty or licensing agreements, if required, may not be available to us on acceptable terms or at all. A successful claim of infringement against us could result in our being required to pay significant damages, enter into costly settlement agreements, or prevent us from offering our solutions, any of which could have a negative impact on our operating profits and harm our future prospects. We may also be obligated to indemnify our customers or business partners in connection with any such litigation and to obtain licenses, modify our solutions, or refund fees, which could further exhaust our resources. Such disputes could also disrupt our solutions, adversely affecting our customer satisfaction and ability to attract customers.

 

Under applicable employment laws, we may not be able to enforce covenants not to compete.

 

As part of our employment agreements with our employees we have confidentiality obligations. These agreements generally prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors from benefitting from the expertise our former employees or consultants developed while working for us. For example, Israeli labor Courts have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer which have been recognized by the courts, such as the protection of a company’s trade secrets or other proprietary knowhow.

 

Risks Related to Our Legal and Regulatory Environment

 

Litigation, regulatory actions, consumer complaints and compliance issues could subject us to significant fines, penalties, judgments, remediation costs and/or requirements resulting in increased expenses.

 

In the ordinary course of business, we may be named as a defendant in various legal actions, including litigation or regulatory enforcement actions. All such legal actions are inherently unpredictable and, regardless of the merits of the claims, are often expensive, time-consuming, disruptive to our operations and resources, and distracting to management.

 

Changes in laws, regulations and standards and failure to comply with laws, regulations and standards may adversely affect our financial and operating performance and profitability.

 

Any changes to the existing regulatory framework or the imposition of new legislation or regulations applicable to any of the industries in which Security Matters PTY operates may adversely affect the financial and operating performance of Security Matters PTY. This risk factor applies to government policy and legislative changes in the United States, Australia, Israel, as well as the other jurisdictions in which we currently operate, or will operate in the future, or jurisdictions in which our current or future customers may operate.

 

15
 

 

Additionally, while we currently do not anticipate this, as the markers used in materials or products are of minuscule quantities, the markers may in the future be required to comply with health and safety laws in certain jurisdictions, and failure to comply with such laws may lead to penalties and other liabilities being imposed on us. In such circumstances, we may be required to suspend production or cease operations, which may lead to a materially adverse effect on our financial performance and profitability.

 

While we are not aware of any regulation or similar restriction that currently materially limits our ability to use our markers, such regulation or similar restriction may in the future limit our ability to sell our products and may require us either to avoid marking certain material or require us to disclose data to certain entities for certification process that may be required in order for us to use our markers.

 

The readers use X-range ray technology, which may thus require in certain jurisdictions specific authorization in order to import, manufacture or use such readers. Such authorization process in each such jurisdiction may be time and resources consuming, but may also limit the ability of users to use the readers without proper qualifications, as well as may require, in certain jurisdictions the supervision of such use.

 

Obligations and changes in laws or regulations relating to privacy, cybersecurity, and data protection, or any actual or deemed failure by us to comply with such laws and regulations that could adversely affect our business.

 

We receive, collect, use, disclose, transmit, and store information, including certain sensitive data, relating to our customers and employees. Our collection and processing of such data in our business may subject us to certain state, federal, and international laws and regulations relating to privacy, cybersecurity, and data protection. These laws, rules, and regulations evolve frequently and their scope may continually change through new legislation, amendments to existing legislation, and changes in interpretation or enforcement, and may be inconsistent from one jurisdiction to another.

 

Changes in laws or regulations relating to privacy, cybersecurity, and data protection, particularly any new or modified laws or regulations that require enhanced protection of certain types of data or new obligations with regard to data retention, transfer, or disclosure, could greatly increase the cost of our operations or prevent us from providing certain services. Complying with these requirements through changing our policies and practices may be onerous and costly. These changes may in turn impair our ability to offer our existing or planned products and services or increase our cost of doing business. Further, we may become subject to privacy and data security laws from jurisdictions outside of our standard business operations in. Despite our efforts to comply with any applicable laws, regulations, and other obligations relating to privacy, cybersecurity, and data protection, it is possible that our interpretations of the law, practices, or our network could be inconsistent with, or fail or be alleged to fail to meet all requirements of, such laws, regulations, or obligations. Our failure, or the failure by our business partners or customers using our services to comply with applicable laws or regulations or any other obligations relating to privacy, cybersecurity, and data protection or any compromise of security that results in unauthorized access to, or use or release of personal information or other data relating to consumers or other individuals, or the perception that any of the foregoing types of failure or compromise has occurred, could damage our reputation, discourage new and existing business partners and customers from working with us, or result in fines, investigations, or proceedings by governmental agencies and private claims and litigation, any of which could adversely affect our business, cash flows, financial condition, and results of operations. Even if not subject to legal challenge, the perception of privacy concerns, whether or not valid, may harm our reputation and brand and adversely affect our business, cash flows, financial condition, and results of operations.

 

We invest significant resources in information technology protection and security measures. If these measures are targeted or breached, we may incur significant legal and financial exposure as a result of ransomware, loss of information, and related litigation. Moreover, we hold data of our employees and customers and we invest significant resources in information technology protection and security measures to ensure that such data is safe. If these measures are targeted or breached, we may incur significant reputational damage and related legal and financial exposure.

 

16
 

 

Risks Related to Our Operations in Israel

 

Conditions in Israel and relations between Israel and other countries could adversely affect our business.

 

Certain of our offices and R&D facilities are located in Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region directly affect our business and operations and could materially and adversely affect our ability to continue to operate from Israel. Recently, for example, the current political situation in Israel where the ruling parties are attempting to implement laws that essentially allow the parliament to enact laws that are preemptively immune to judicial review could adversely affect our business and results of operations. In addition, since the State of Israel was established in 1948, a number of armed conflicts have occurred between Israel and its Arab neighbors. In the event that our facilities are damaged as a result of hostile action or hostilities otherwise disrupt the ongoing operation of our facilities, our ability to continue our operations could be materially adversely affected.

 

In recent years, and most recently restarting in October 2023 Israel has been engaged in sporadic armed conflicts with terrorist groups, including those that control the Gaza Strip and other regions close to Israel. In addition, Iran has threatened to attack, and has attacked, Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being fired from the Gaza Strip, Lebanon, Syria and Iran against civilian targets in various parts of Israel, including areas in which our employees and independent contractors are located, which negatively affected business conditions in Israel. Any hostilities involving Israel, regional political instability or the interruption or curtailment of trade between Israel and its trading partners could materially and adversely affect our operations and results of operations.

 

Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of property damage and certain direct and indirect damages that are caused by terrorist attacks or acts of war, such coverage would likely be limited, may not be applicable to our business (either due to the geographic location of our offices or the type of business that we operate) and may not reinstate our loss of revenue or economic losses more generally. Furthermore, we cannot assure that this government coverage will be maintained or that it will sufficiently cover our potential damages, or whether such coverage would be timely provided. Any losses or damages incurred by us could have a material adverse effect on our business, cash flows, financial condition and results of operations.

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts and Israeli legal reforms initiatives may cause countries to limit activities with Israel or otherwise apply certain restrictions, or may otherwise adversely affect our activities. Several countries still restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in Israel or political instability in the region continues or increases. These restrictive laws and policies, or significant downturn in the economic or financial condition of Israel, could materially and adversely affect our operations and product development, and could cause our sales to decrease.

 

A large concentration of our staff resides in Israel and many of our employees and independent contractors in Israel are required to perform military reserve duty, which may disrupt their work for us.

 

Many of our employees and independent contractors, including certain of our founders and certain members of our management team, operate from our headquarters that are located in central Israel. In addition, a number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists, including since October 7, 2023. It is possible that there will be additional and continued military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, particularly if such call-ups include the call-up of members of our management, and given the current shortage of talent in Israel due to the recent acceleration of activity in startups, especially in the technology space. Such disruption could materially and adversely affect our business, financial condition and results of operations.

 

17
 

 

Risks Related to Tax

 

The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or changes in tax legislation or policies could impact the Company’s future financial position and results of operations.

 

Corporate tax reform, base-erosion efforts and tax transparency continue to be high priorities in many tax jurisdictions where we have business operations. As a result, policies regarding corporate income and other taxes in numerous jurisdictions are under heightened scrutiny and tax reform legislation is being proposed or enacted in a number of jurisdictions.

 

In 2015, the Organization for Economic Co-operation and Development (the “OECD”) published final recommendations on base erosion and profit shifting (“BEPS”). These recommendations proposed the development of rules directed at counteracting the effects of tax havens and preferential tax regimes in countries around the world. Several of the areas of tax law on which the BEPS project focused have led or will lead to changes in the domestic law of individual OECD jurisdictions. These changes include (amongst others) restrictions on interest and other deductions for tax purposes, the introduction of broad anti-hybrid regimes and reform of controlled foreign corporation rules. Changes are also expected to arise in the application of certain double tax treaties, which may restrict the ability of certain members of the Company to rely on the terms of relevant double tax treaties in certain circumstances.

 

On December 20, 2021, the OECD published the draft Global Anti-Base Erosion Model Rules which are aimed at ensuring that Multinational Enterprises (“MNEs”) will be subject to a global minimum 15% tax rate from 2023 (“GloBE Rules”). The GloBE Rules are part of the OECD/G20 Inclusive Framework on BEPS which currently has 141 participant countries. The EU Council adopted Council Directive 2022/25234 (the “GloBE Directive”) on 22 December 2022 to implement the GloBE Rules in the EU. The GloBE Directive provides for the introduction of rules designed to achieve a minimum effective taxation for MNEs and large-scale domestic groups with revenues of at least €750,000,000, operating in the EU’s internal market and beyond. It provides a common framework for implementing the GloBE Rules into EU Member States’ national laws by 31 December 2023. If the Company is regarded as part of an “MNE Group” (or large-scale domestic group) which has consolidated revenues of more than EUR 750,000,000 in at least two out of the previous four years, it may be within the scope of the GloBE Rules which may result in an increase in the Company’s tax costs and operational expenses.

 

Changes of law in individual jurisdictions which may arise as a result of the BEPS project or other tax measures may ultimately increase the tax base of individual members of the Company in certain jurisdictions or the worldwide tax exposure of the Company. Changes of law may also include revisions to the definition of a “permanent establishment” and the rules for attributing profit to a permanent establishment. Other changes may focus on the goal of ensuring that transfer pricing outcomes are in line with value creation.

 

Such changes to tax laws could increase their complexity and the burden and costs of compliance. Additionally, such changes could also result in significant modifications to existing transfer pricing rules and could potentially have an adverse impact on the Company’s taxable profits in various jurisdictions.

 

18
 

 

U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of “controlled foreign corporations.”

 

A non-U.S. corporation generally will be classified as a controlled foreign corporation for U.S. federal income tax purposes (a “CFC”), if “10% U.S. equityholders” (as defined below) own, directly, indirectly or constructively, more than 50% of either (i) the total combined voting power of all classes of stock of such corporation entitled to vote or (ii) the total value of the stock of such corporation. We do not believe that the Company would be classified as a CFC at the time of Closing, although CFC status is determined after taking into account complex constructive ownership rules and, accordingly, there can be no assurance in this regard. However, certain of the Company’s non-U.S. subsidiaries may be classified as CFCs (as a result of the application of certain constructive ownership rules which treat the Company’s U.S. subsidiaries as owning the equity of those non-U.S. subsidiaries), and it is possible that we may be classified as a CFC in the future. The U.S. federal income tax consequences for U.S. holders who at all times are not 10% U.S. equityholders would not be affected by the CFC rules. However, a U.S. holder that owns (or is treated as owning, directly, indirectly or constructively, including by applying certain attribution rules) 10% or more of the combined voting power of all classes of our stock entitled to vote or the total value of our equity interests (including equity interests attributable to a deemed exercise of options and convertible debt instruments), or a “10% U.S. equityholder,” if we were classified as a CFC, would generally be subject to current U.S. federal income taxation on a portion of our applicable subsidiaries’ earnings and profits (as determined for U.S. federal income tax purposes) and our earnings and profits, regardless of whether such 10% U.S. equityholder receives any actual distributions (with certain exceptions in the case of CFCs attributed through downward attribution). In addition, if we were classified as a CFC, a portion of any gains realized on the sale of our common shares by a 10% U.S. equityholder may be treated as ordinary income. A 10% U.S. equityholder will also be subject to additional U.S. federal income tax information reporting requirements with respect to our subsidiaries that are classified as CFCs and with respect to us (if we or any of our subsidiaries were classified as a CFC) and substantial penalties may be imposed for noncompliance. We cannot provide any assurances that the Company will assist U.S. holders in determining whether the Company or any of its subsidiaries are treated as a CFC for U.S. federal income tax purposes or whether any U.S. holder is treated as a 10% U.S. equityholder with respect to any of such CFC or furnish to any holder information that may be necessary to comply with reporting and tax paying obligations if the Company, or any of its subsidiaries, is treated as a CFC for U.S. federal income tax purposes. Each U.S. holder should consult its own tax advisor regarding the CFC rules and whether such U.S. holder may be a 10% U.S. equityholder for purposes of these rules.

 

There is a risk that we will be a passive foreign investment company for any taxable year, which could result in adverse U.S. federal income tax consequences to U.S. investors in our shares.

 

In general, a non-U.S. corporation is a passive foreign investment company, (“PFIC”), for any taxable year in which (i) 75% or more of its gross income consists of passive income or (ii) 50% or more of the average quarterly value of its assets consists of assets that produce, or are held for the production of, passive income. For purposes of the above calculations, a non-U.S. corporation that owns at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other corporation and received directly its proportionate share of the income of the other corporation. Passive income generally includes dividends, interest, rents, royalties and certain gains. Cash is a passive asset for these purposes.

 

Based on the expected composition of our income and assets and the value of our assets, including goodwill, we do not expect to be a PFIC for our current taxable year. However, the proper application of the PFIC rules to a company with a business such as ours is not entirely clear. Because the proper characterization of certain components of our income and assets is not entirely clear, because we will hold a substantial amount of cash following this offering, and because our PFIC status for any taxable year will depend on the composition of our income and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our shares, which could be volatile), there can be no assurance that we will not be a PFIC for our current taxable year or any future taxable year.

 

If we were a PFIC for any taxable year during which a U.S. investor holds shares, certain adverse U.S. federal income tax consequences could apply to such U.S. investor. See “Material Income Tax Considerations-U.S. Federal Income Taxation Considerations-Passive Foreign Investment Company Consequences” for additional information.

 

The Internal Revenue Service may not agree that the Company should be treated as a non-U.S. corporation for U.S. federal income tax purposes.

 

Although the Company is incorporated in Ireland, the Internal Revenue Service (“IRS”) may assert that it should be treated as a U.S. corporation (and therefore a U.S. tax resident) for U.S. federal income tax purposes pursuant to Section 7874 of the Internal Revenue Code of 1986, as amended (the “Code”). For U.S. federal income tax purposes, a corporation is generally considered a U.S. “domestic” corporation (or U.S. tax resident) if it is organized in the United States, and a corporation is generally considered a “foreign” corporation (or non-U.S. tax resident) if it is not a U.S. corporation. Because the Company is an entity incorporated in Ireland, it would generally be classified as a foreign corporation (or non-U.S. tax resident) under these rules. Section 7874 of the Code provides an exception under which a foreign incorporated and foreign tax resident entity may, in certain circumstances, be treated as a U.S. corporation for U.S. federal income tax purposes.

 

19
 

 

The Company is not currently expected to be treated as a U.S. corporation for U.S. federal income tax purposes under Section 7874 of the Code after the Business Combination. However, the application of Section 7874 of the Code is complex and is subject to detailed regulations (the application of which is uncertain in various respects and would be impacted by changes in such U.S. Treasury Regulations with possible retroactive effect) and is subject to certain factual uncertainties. Accordingly, there can be no assurance that the IRS will not challenge the status of the Company as a foreign corporation under Section 7874 of the Code or that such challenge would not be sustained by a court.

 

If the IRS were to successfully challenge under Section 7874 of the Code the Company’s status as a foreign corporation for U.S. federal income tax purposes, the Company and certain the Company shareholders would be subject to significant adverse tax consequences, including a higher effective corporate income tax rate on the Company and future withholding taxes on certain the Company shareholders, depending on the application of any income tax treaty that might apply to reduce such withholding taxes.

 

Investors in the Company should consult their own tax advisors regarding the application of Section 7874 of the Code to the Business Combination.

 

Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.

 

We are subject to federal and state income taxes in the United States and potentially in other jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including:

 

changes in the valuation of our deferred tax assets and liabilities;
   
expected timing and amount of the release of any tax valuation allowances;
   
tax effects of stock-based compensation;
   
changes in tax laws, regulations or interpretations thereof; or
   
lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates.

 

In addition, we may be subject to audits of our income, sales and other transaction taxes by taxing authorities. Outcomes from these audits could have an adverse effect on our financial condition and results of operations.

 

Future changes in U.S. and foreign tax laws could adversely affect the Company.

 

The U.S. Congress and the Organisation for Economic Co-operation and Development have focused on issues related to the taxation of multinational corporations. In particular, specific attention has been paid to “base erosion and profit shifting”, where payments are made between affiliates from a jurisdiction with high tax rates to a jurisdiction with lower tax rates. As a result, the tax laws in Ireland could change on a prospective or retroactive basis, and any such change could adversely affect the Company.

 

Risks Related to Irish Law

 

The Company does not intend to pay dividends for the foreseeable future.

 

The Company has never declared or paid any cash dividends on its capital stock and does not intend to pay any cash dividends in the foreseeable future. The Company expects to retain future earnings, if any, to fund the development and growth of its business. Any future determination to pay dividends on the Company’s capital stock will be at the discretion of the Board of Directors of the Company (the “Board”).

 

20
 

 

Irish taxes may apply to any dividends paid or transfers of the Company’s securities.

 

If the Company pays dividends, such dividends may be subject to Irish dividend withholding tax or Irish income tax. Certain transfers of Ordinary Shares, may be subject to Irish capital acquisitions tax or stamp duty. In particular, Irish stamp duty will apply to any future transfer of Ordinary Shares which are not listed and held through the Depository Trust Company (“DTC”) and generally the purchaser / transferee will be liable for the payment of the stamp duty arising.

 

Provisions in the Amended and Restated Memorandum and Articles of Association and under Irish law could make an acquisition of Lionheart more difficult, may limit attempts by the Company shareholders to replace or remove the Company’s management, may limit shareholders’ ability to obtain a favorable judicial forum for disputes with the Company or the Company’s directors, officers or employees, and may limit the market price of the Ordinary Shares, the Public Warrants and/or other securities issued by the Company.

 

Provisions in the Amended and Restated Memorandum and Articles of Association may have the effect of delaying or preventing a change of control or changes in the Company’s management. The Amended and Restated Memorandum and Articles of Association includes provisions that:

 

require that the Company’s Board be classified into three classes of directors with staggered three-year terms;
   
permit the Company’s Board to establish the number of directors and fill any vacancies and newly created directorships; and
   
prohibit shareholder action by written consent without unanimous approval of all holders of the Ordinary Shares.

 

General Risk Factors

 

The Company incurs significant costs and devotes substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.

 

As a company subject to reporting requirements in the United States, the Company incurs significant legal, accounting and other expenses that the Company would not have incurred as a private company. For example, the Company is subject to the reporting requirements of the Exchange Act and is required to comply with the applicable requirements of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as rules and regulations subsequently implemented by the SEC, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Compliance with these requirements increase the Company’s legal and financial compliance costs and make some activities more time consuming and costly, while also diverting management attention. In particular, the Company expects to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act, which will increase when it is no longer an emerging growth company as defined by the JOBS Act.

 

The Company’s management has limited experience in operating a public company in the United States.

 

While the Company’s executive officers have experience in the management of a public company in Australia, the Company’s executive officers have limited experience in the management of a public company in the United States. The Company’s management team may not successfully or effectively manage its transition to a U.S. public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to U.S. public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted to the management and growth of the Company. The Company may not have adequate personnel with the appropriate level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States. The development and implementation of the standards and controls necessary for the Company to achieve the level of accounting standards required of a public company in the United States may require costs greater than expected. It is possible that the Company will be required to expand its employee base and hire additional employees to support its operations as a public company, which will increase its operating costs in future periods.

 

21
 

 

The stock price of the Ordinary Shares may be volatile.

 

The market price of the Ordinary Shares may be volatile. In addition to factors discussed elsewhere in this Risk Factors section, the market price of the Ordinary Shares may fluctuate significantly in response to numerous factors, many of which are beyond the Company’s control, including:

 

overall performance of the equity markets;
   
actual or anticipated fluctuations in the Company’s revenue and other operating results;
   
changes in the financial projections the Company may provide to the public or the failure to meet these projections;
   
failure of securities analysts to initiate or maintain coverage of the Company, changes in financial estimates by any securities analysts who follow the Company or the Company’s failure to meet these estimates of the expectations of investors;
   
the issuance of reports from short sellers that may negatively impact the trading price of the Ordinary Shares;
   
the Company’s stock being targeted by “naked” short sellers or other manipulative acts;
   
recruitment or departure of key personnel;
   
the economy as a whole and market conditions in the Company’s industry;
   
new laws, regulations, subsidies, or credits or new interpretations of them applicable to the Company’s business;
   
negative publicity related to real or perceived quality of the Company’s products;
   
rumors and market speculation involving the Company or other companies in the Company’s industry;
announcements by the Company or its competitors of significant technical innovations, acquisitions, strategic partnerships, or capital commitments;
   
lawsuits threatened or filed against the Company;
   
other events or factors including those resulting from war, incidents of terrorism or responses to these events or events related to changes, attempted changes, or anticipated changes in the Israeli or other legal or governmental system in jurisdictions in which the Company is active;
   
the expiration of contractual lock-up or market standoff agreements; and
   
sales or anticipated sales of shares of the Ordinary Shares by the Company or the Company’s shareholders.

 

In addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. Stock prices of many companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility.

 

22
 

 

The Company may issue additional Ordinary Shares or other equity securities without seeking approval of the Company’s shareholders, which would dilute your ownership interests and may depress the market price of the Ordinary Shares.

 

The Company has warrants outstanding to purchase approximately 15 million Ordinary Shares and other convertible securities, compared to 38,334,442 Ordinary Shares issued and outstanding, as of April 29, 2024. Further, the Company may choose to seek third party or other financing to provide additional working capital, in which event the Company may issue additional equity securities. The Company may also issue additional Ordinary Shares or other equity securities of equal or senior rank in the future for any reason or in connection with, among other things, future acquisitions, the redemption of outstanding warrants, or repayment of outstanding indebtedness, without shareholder approval, in a number of circumstances.

 

The Company’s issuance of additional Ordinary Shares or other equity securities of equal or senior rank would have the following effects:

 

The Company’s existing shareholders’ proportionate ownership interest in the Company will decrease;
   
the amount of cash available per share, including for payment of dividends in the future, may decrease;
   
the relative voting strength of each previously outstanding Ordinary Share may be diminished; and
   
the market price of the Ordinary Shares may decline.

 

The Company is an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make the Ordinary Shares less attractive to investors.

 

The Company is an “emerging growth company” as defined in the JOBS Act. As an emerging growth company, the Company is only required to provide two years of audited financial statements and only two years of related selected financial data and management discussion and analysis of financial condition and results of operations disclosure. In addition, the Company is not required to obtain auditor attestation of its reporting on internal control over financial reporting, has reduced disclosure obligations regarding executive compensation and is not required to hold non-binding advisory votes on executive compensation. In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. The Company has elected to take advantage of such extended transition period. The Company cannot predict whether investors will find the Ordinary Shares to be less attractive as a result of its reliance on these exemptions. If some investors find the Ordinary Shares to be less attractive as a result, there may be a less active trading market for the Ordinary Shares and the price of the Ordinary Shares may be more volatile.

 

The Company will remain an emerging growth company until the earliest of: (i) the end of the fiscal year in which the Company has total annual gross revenue of $1.07 billion; (ii) the last day of the Company’s fiscal year following the fifth anniversary of the date on which Lionheart consummated its initial public offering; (iii) the date on which the Company issues more than $1.0 billion in non-convertible debt during the preceding three-year period; or (iv) the end of the fiscal year in which the market value of the Ordinary Shares held by non- affiliates exceeds $700 million as of the last business day of its most recently completed second fiscal quarter.

 

Further, there is no guarantee that the exemptions available to the Company under the JOBS Act will result in significant savings. To the extent that the Company chooses not to use exemptions from various reporting requirements under the JOBS Act, it will incur additional compliance costs, which may impact the Company’s financial condition.

 

23
 

 

The Company will need additional capital in the future to meet its financial obligations and to pursue its business objectives. Additional capital may not be available on favorable terms, or at all, which could compromise the Company’s ability to meet its financial obligations and grow its business.

 

The Company will need to raise additional capital to fund operations in the future, pay substantial existing liabilities and obligations, and possibly finance future growth of acquisitions.

 

If the Company seeks to raise additional capital in order to meet various objectives, including developing existing or future technologies and solutions, refinancing or repaying indebtedness or other liabilities or obligations, increasing working capital, acquiring new clients, expanding geographically and responding to competitive pressures, capital may not be available on favorable terms or may not be available at all, which could have a material adverse effect on the continued development or growth of the Company. Lack of sufficient capital resources could significantly limit the Company’s ability to take advantage of business and strategic opportunities. Any additional capital raised through the sale of equity or debt securities with an equity component would dilute stock ownership. If adequate additional funds are not available, the Company may be required to delay, reduce the scope of, or eliminate material part of its business strategy, including acquiring potential new clients or the continued development of new or existing technologies or solutions and geographic expansion.

 

There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq. If we are not able to comply with the applicable continued listing requirements or standards of the Nasdaq Capital Markets, Nasdaq could delist our Ordinary Shares and Public Warrants.

 

The Company’s Ordinary Shares and Public Warrants are currently listed on the Nasdaq Capital Market, after failing to meet all of the listing standards of the Nasdaq Global Market. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding minimum stockholders’ equity, minimum market value, minimum share price, and certain corporate governance requirements.

 

On January 26, 2024, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market, as the bid price of the Company’s ordinary shares on the Nasdaq Capital Market was below $1.00 for 30 consecutive business days, from December 11, 2023 to January 25, 2024.

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has a period of 180 calendar days, or until July 24, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time before the Compliance Date, the closing bid price of the Company’s ordinary shares is at least $1.00 for a minimum of ten consecutive business days, the Staff will provide a written confirmation to the Company that it has regained compliance with the Minimum Bid Price Requirement.

 

In addition, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii), if the Ordinary Shares trade below $0.10 per share for ten consecutive trading days, we could be subject to a Nasdaq delisting notification which could result in the delisting of our Ordinary Shares from Nasdaq unless we appeal or unless Nasdaq provides a compliance period in which to cure such bid price deficiency.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (the “Panel”) pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful.

 

Additionally, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, or will otherwise be compliant with other Nasdaq Listing Rules.

 

24
 

 

If Nasdaq delists the Ordinary Shares and/or the Public Warrants from trading on its exchange for failure to meet the listing standards, we and our stockholders could face significant material adverse consequences including:

 

a limited availability of market quotations for our securities;
   
reduced liquidity for our securities;
   
a determination that the Ordinary Shares is a “penny stock” which will require brokers trading in the Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
   
a limited amount of news and analyst coverage; and
   
a decreased ability to issue additional securities or obtain additional financing in the future.

 

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” To the extent the Ordinary Shares and Public Warrants are listed on Nasdaq, they are covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. Further, if we were no longer listed on Nasdaq, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities.

 

Upon delisting from Nasdaq, our Ordinary Shares may be traded, if at all in the over-the-counter inter-dealer quotation system, more commonly known as the OTC. OTC transactions involve risks in addition to those associated with transactions in securities traded on securities exchanges such as Nasdaq. Many OTC stocks trade less frequently and in smaller volumes than exchange-listed Stocks. Accordingly, our stock would be less liquid than it would be otherwise. Also, the values of OTC stocks are often more volatile than exchange-listed stocks. Additionally, institutional investors are often prohibited from investing in OTC stocks, and it might be more challenging to raise capital when needed.

 

In addition, if our Ordinary Shares are delisted, your ability to transfer or sell your Ordinary Shares may be limited and the value of those securities will be materially adversely affected.

 

If our Ordinary Shares becomes subject to the penny stock rules, it may be more difficult to sell our Ordinary Shares.

 

The Commission has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system). The OTC Bulletin Board does not meet such requirements and if the price of our Ordinary Shares is less than $5.00 and our Ordinary Shares are no longer listed on a national securities exchange such as Nasdaq, our stock may be deemed a penny stock. The penny stock rules require a broker-dealer, at least two business days prior to a transaction in a penny stock not otherwise exempt from those rules, to deliver to the customer a standardized risk disclosure document containing specified information and to obtain from the customer a signed and dated acknowledgment of receipt of that document. In addition, the penny stock rules require that prior to effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our Ordinary Shares, and therefore shareholders may have difficulty selling their shares.

 

25
 

 

Future issuances of debt securities and equity securities may adversely affect us, including the market price of our Ordinary Shares and may be dilutive to existing shareholders.

 

We expect that significant additional capital will be needed in the future to continue our planned research, development and business operations. In the future, we may incur debt or issue equity ranking senior to our Ordinary Shares. Those securities will generally have priority upon liquidation. Such securities also may be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of Ordinary Shares. Because our decision to issue debt or equity in the future will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts. As a result, recent and future capital raising efforts may reduce the market price of Ordinary Shares and be dilutive to existing shareholders. In addition, our ability to raise additional capital through the sale of equity or convertible debt securities could be significantly impacted by the resale of Ordinary Shares by selling shareholders pursuant to one or more prospectuses, which could result in a significant decline in the trading price of Ordinary Shares and potentially hinder our ability to raise capital at terms that are acceptable to us or at all.

 

The JOBS Act permits “emerging growth companies” like the Company to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, which may make our Ordinary Shares less attractive to investors.

 

The Company currently qualifies as an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Its Business Startups Act of 2012, which is referred to as the “JOBS Act.” As such, the Company takes advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as it continues to be an emerging growth company, including the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act. As a result, Company shareholders may not have access to certain information they deem important.

 

The Company cannot predict if investors will find Ordinary Shares less attractive because it relies on these exemptions. If some investors find Ordinary Shares less attractive as a result, there may be a less active trading market and share price for Ordinary Shares may be more volatile. The Company may incur increased legal, accounting and compliance costs associated with Section 404 of the Sarbanes-Oxley Act.

 

There is less publicly available information concerning the Company than there is for issuers that are not foreign private issuers because the Company is considered a foreign private issuer and is exempt from a number of rules under the Exchange Act, and is permitted to file less information with the SEC than issuers that are not foreign private issuers.

 

The Company is considered a “foreign private issuer” under the Exchange Act. A foreign private issuer under the Exchange Act is exempt from certain rules under the Exchange Act, and is not required to file periodic reports and financial statements with the SEC as frequently or as promptly as companies whose securities are registered under the Exchange Act but are not foreign private issuers, or to comply with Regulation FD, which restricts the selective disclosure of material non-public information. The Company is exempt from certain disclosure and procedural requirements applicable to proxy solicitations under Section 14 of the Exchange Act. SMX currently prepares its financial statements in accordance with IFRS. The Company will not be required to file financial statements prepared in accordance with or reconciled to U.S. GAAP so long as its financial statements are prepared in accordance with IFRS as issued by the International Accounting Standards Board. The Company is not required to comply with Regulation FD, which imposes restrictions on the selective disclosure of material information to shareholders. The members of the Company’s board of directors, officers and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions of Section 16 of the Exchange Act with respect to their purchases and sales of Company securities. Accordingly, there will likely be less publicly available information concerning the Company than there is for companies whose securities are registered under the Exchange Act but are not foreign private issuers, and such information may not be provided as promptly as it is provided by such companies.

 

26
 

 

In addition, certain information may be provided by the Company in accordance with Irish law, which may differ in substance or timing from such disclosure requirements under the Exchange Act. As a foreign private issuer, under Nasdaq rules the Company is subject to less stringent corporate governance requirements. Subject to certain exceptions, the rules of Nasdaq permit a foreign private issuer to follow its home country practice in lieu of the listing requirements of Nasdaq, including, for example, certain internal controls as well as board, committee and director independence requirements. The Company intends from time to time to follow Irish corporate governance practices in lieu of Nasdaq corporate governance rules and (a) followed Irish practices to amend its 2022 Incentive Equity Plan to increase the number of authorized shares under such plan without shareholder approval and (b) follows home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of its Ordinary Shares (or securities convertible into or exercisable for its Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, each as permitted under Irish law, and we cannot assure you that we will not avail ourselves of other such exceptions in the future. If the Company determines to follow Irish corporate governance practices in lieu of Nasdaq corporate governance standards, the Company will disclose each Nasdaq rule that it does not intend to follow and describe the Irish practice that the Company will follow in lieu thereof.

 

The Company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses. This would subject the Company to GAAP reporting requirements which may be difficult for it to comply with.

 

As a “foreign private issuer,” the Company would not be required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. Under those rules, the determination of foreign private issuer status is made annually on the last business day of an issuer’s most recently completed second fiscal quarter.

 

In the future, the Company could lose its foreign private issuer status if a majority of its Ordinary Shares are held by residents in the United States and it fails to meet any one of the additional “business contacts” requirements. Although the Company intends to follow certain practices that are consistent with U.S. regulatory provisions applicable to U.S. companies, the Company’s loss of foreign private issuer status would make such provisions mandatory. The regulatory and compliance costs to the Company under U.S. securities laws if it is deemed a U.S. domestic issuer may be significantly higher. If the Company is not a foreign private issuer, the Company will be required to file periodic reports and prospectuses on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. For example, the Company would become subject to the Regulation FD, aimed at preventing issuers from making selective disclosures of material information. The Company also may be required to modify certain of its policies to comply with good governance practices associated with U.S. domestic issuers. Such conversion and modifications will involve additional costs. In addition, the Company may lose its ability to rely upon exemptions from certain corporate governance requirements of Nasdaq that are available to foreign private issuers. For example, Nasdaq’s corporate governance rules require listed companies to have, among other things, a majority of independent board members and independent director oversight of executive compensation, nomination of directors, and corporate governance matters. As a foreign private issuer, the Company would be permitted to follow home country practice in lieu of the above requirements. As long as the Company relies on the foreign private issuer exemption to certain of Nasdaq’s corporate governance standards, a majority of the directors on its board of directors are not required to be independent directors, its compensation committee is not required to be comprised entirely of independent directors, and it will not be required to have a nominating committee. Also, the Company would be required to change its basis of accounting from IFRS as issued by the IASB to GAAP, and would have to obtain shareholder approval for certain issuances of its Ordinary Shares or equivalents, each of which may be difficult and costly for it to comply with. If the Company loses its foreign private issuer status and fails to comply with U.S. securities laws applicable to U.S. domestic issuers, the Company may have to de-list from Nasdaq and could be subject to investigation by the SEC, Nasdaq and other regulators, among other materially adverse consequences.

 

The sale of currently-restricted Ordinary Shares acquired by the Company’s stockholders, or the perception that such sales may occur, could cause the price of our Ordinary Shares to fall.

 

Depending on a number of factors, including market liquidity, sales of currently-restricted Ordinary Shares held by our stockholders may cause the trading price of our Ordinary Shares to fall. The stockholders may resell all, some, or none of those shares at its discretion upon registration or an exemption from registration. Therefore, sales by the stockholders could result in substantial dilution to the interests of other holders of our Ordinary Shares. Additionally, the sale of a substantial number of Ordinary Shares, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a desirable time and price. The resale of Ordinary Shares by stockholders in the public market or otherwise or the perception that such sales could occur, could also harm the prevailing market price of our Ordinary Shares.

 

27
 

 

ITEM 4. INFORMATION OF THE COMPANY

 

A. History and Development of the Company

 

General

 

The legal name of the Company is SMX (Security Matters) Public Limited Company (f/k/a Empatan Public Limited Company). The Company was formed on July 1, 2022 as a public limited company under the name Empatan Public Limited Company, incorporated in Ireland. The Company changed its name to SMX (Security Matters) Public Limited Company on February 17, 2023. Its affairs are governed by its Amended and Restated Memorandum and Articles of Association, the Irish Companies Act of 2014 (the “ICA”), and the laws of Ireland. The Company’s principal executive office is located at Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Ireland, D04 T4A6. The Company’s telephone number is +353 1 920 1000.

 

The Company was newly incorporated for the purposes of becoming a holding company following the Business Combination, described further below. Through the consummation of the Business Combination, the Company did not conduct any material activities other than those incident to its formation and the Business Combination and only had nominal assets consisting of cash and its interest in Merger Sub.

 

The Company is subject to certain of the informational filing requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Since the Company is a “foreign private issuer,” it is exempt from the rules and regulations under the Exchange Act prescribing the furnishing and content of proxy statements, and the officers, directors and principal shareholders of the Company are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act with respect to their purchase and sale of Parent Shares. In addition, the Company is not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. public companies whose securities are registered under the Exchange Act. However, the Company is required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent accounting firm. The SEC maintains a website at http://www.sec.gov that contains reports and other information that the Company files with or furnishes electronically to the SEC.

 

The website address of the Company is https://smx.tech. The information contained on the website does not form a part of, and is not incorporated by reference into, this Report.

 

SMX Israel

 

SMX Israel was incorporated in 2014 to provide brand protection and supply chain integrity solutions to businesses. It provides these solutions through the commercialization of the initial technology of tracking and tracing materials by observing and identifying markers (the “Source IP”). SMX Israel’s Source IP was initiated from the Soreq Nuclear Research Center, an Israeli government research and development institute for nuclear and photonic technologies under the Israeli Atomic Energy Commission (“Soreq”). In January 2015, SMX Israel entered into the Isorad License Agreement with Isorad Ltd. (an IP holding company of Soreq) to license the Source IP and develop and commercialize the technology (the “Isorad License Agreement”). Under the Isorad License Agreement, as amended, the Source IP can be utilized in almost any industry and with any product.

 

28
 

 

In 2018, SMX Israel merged into Security Matters Limited, an Australian company, to effect a listing on the Australian Securities Exchange under the symbol “ASX: SMX.” Security Matters Limited (“SMX”) was incorporated in May 2018 under Australian law. SMX’s registered address is Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. SMX has four wholly owned subsidiaries: Security Matters Ltd., an Israeli company, Security Matters France, a French company, Security Matters Canada Ltd., a Canadian company, and SMX Beverages Pty Ltd., an Australian company. It also holds 50% of Yahaloma Technologies Inc., a Canadian company and 44.4% of trueGold Consortium Pty Ltd., an Australian company.

 

Business Combination

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination pursuant to the BCA and its previously announced SID. Beginning on the day immediately prior to the Closing Date and finishing on the day immediately after the Closing Date, the following transactions occurred pursuant to the terms of the Business Combination Agreement (the “Business Combination”):

 

Under the SID, Security Matters Limited proposed a scheme of arrangement under Part 5.1 of the Corporations Act (“Scheme”) and Capital Reduction which resulted in all shares in Security Matters Limited being cancelled in return for the issuance of Ordinary Shares, with the Company being issued one share in Security Matters Limited (“Security Matters Shares”) (this resulted in Security Matters Limited becoming a wholly owned subsidiary of the Company);
   
Under the SID, Security Matters Limited proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters Limited options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for Security Matters Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;

 

Security Matters Limited shareholders received consideration under the Scheme of 1 Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters Limited and Lionheart, with Security Matters Limited being delisted from the Australian Stock Exchange;
   
Merger Sub merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company; and
   
Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares.

 

Other than in connection with the Business Combination, a 1:22 reverse stock split effected in 2023 as further described in our financial statements included in this Annual Report, and with respect to the trueGold Investment Agreement described below, since our incorporation, there have been no material changes to our share capital, mergers, amalgamations or consolidations of the Company or any of our significant subsidiaries, no acquisitions or dispositions of material assets other than in the ordinary course of business, no material changes in the mode of conducting our business, no material changes in the types of products produced or services rendered and no name changes. There have been no bankruptcy, receivership or similar proceedings with respect to the Company or its significant subsidiaries. There have been no public takeover offers by third parties for our shares nor any public takeover offers by us for the shares of another company which have occurred during the last or current financial years. 

 

true-Gold Investment Agreement

 

On October 3, 2023, Security Matters PTY entered into the Investment Agreement with trueGold. Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 trueGold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in trueGold shall be increased to 51.9% of the total issued and outstanding shares of trueGold, making Security Matters PTY the majority owner of trueGold. Additionally, the existing license agreement as between Security Matters PTY and trueGold was amended to include additional intellectual property of Security Matters PTY to be licensed to trueGold thereunder. Security Matters PTY shall further supply to trueGold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

B. Business Overview

 

Vision

 

The Company envisions itself as the next generation solution provider of brand protection, authentication and track and trace technology for the anti-counterfeit market. Its vision is to build confidence in the era of the digital economy, enabling parties to maintain trust in physical assets and processes. Its transformative solution aims at building on the principles of The United Nations’ Sustainability Development Goals, particularly Goal 12: “Ensure sustainable consumption and production patterns” that can create value for participants in the circular economy. As an increasing number of industries and sectors are committing to using recycled material and realizing the broader strategic vision of net zero carbon emissions, we believe our solution is the next generation for sustainability and the circular economy.

 

29
 

 

Overview

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

Business Model

 

The Company’s business model targets leading brands and manufacturers (as opposed to directly targeting consumers) in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Company offers both business-to-business sales and “white label” solutions, depending on the needs of customers and the ultimate end use based on either a fixed fee or volume-based revenue model (or both).

 

The Company may work directly with the manufacturer of the products or through the manufacturer’s raw material supplier so that the manufacturer is not required to change (or is required to make no more than minimal changes to) its manufacturing process in order to implement Security Matters PTY technology in the production process. Gaining the trust of raw material producers is the first stage, which in turn allows for credibility and trust when supplying solutions to brand owners, manufacturers and suppliers, which is a key step for its success.

 

Product and Applications

 

Product

 

The Company provides a solution comprised of three components: (1) a physical or chemical marker system coupled with (2) a reader and connected to (3) a blockchain digital platform.

 

Markers

 

Markers are embedded sub-molecular particles applied to a solid, liquid or gas. The Company uses various building blocks, comprised of a variety of molecules, to serve as markers for materials and products. For each project, its team selects a combination of molecules based on the specification of the customer and marked material (for example, the marked medium, the production process, the end use of the product and regulatory requirements, among others). The Company’s innovative reader can identify the marker and identify a response at a sub molecular building block level, designed to make the marker identification more accurate.

 

The ability to more accurately identify the concentration level of a marker allows Security Matters PTY to use numerous markings from a variety of different molecules. This enables it to not only identify the marker, but also identify the concentration within a product within a pre-defined range and “read” whether the marked material was diluted (authenticating not only the marked goods but also identifying the quantity).

 

30
 

 

Based on the specifications of the marked product, Security Matters PTY can mark materials based on several techniques, allowing its solution to be implemented across materials and processes. Markers can carry information denoting each origins of manufacture, product provenance, date of production and many other types of data, depending on customer needs.

 

The Company can produce either permanent or removable markers that can be applied either topically or internally to material in any state of matter (solid, liquid or gas) to form an “Intelligence on Things,” or “IOT2” marking system. The IOT2 concept involves marking products during or after the manufacturing process by inserting or applying materials to the products and encoding information through this process, namely by the treatment of materials or affixing and embedding product authentication security devices. The IOT2 concept allows for materials in a wide variety of products to be protected against counterfeiting, tampering, and diversion, and to help ensure the integrity of genuine products and manage the supply chain and logistics processes.

 

The marker supports invisible, indelible, and non-damaging tracking of distinctive molecules designed to ensure uniqueness and prevent duplication or counterfeiting. The marker is designed to not in any way affect the properties of the material it is applied to—it simply becomes a part of that material. The molecules are designed to be inert, inactive, and invisible to the human eye.

 

Readers

 

Markers are embedded in the material and can only be read by designated readers. A reader scans for the existence of markers. If the reading satisfies a pre-determined condition set by Security Matters PTY (which can be programmed), than the reader can identify the marked product and convey information about such product to the customer.

 

The Company currently utilizes an x-ray wave reader that is modified according to its specifications to allow it to scan its proprietary markers. The reader and Security Matters PTY’s algorithm are designed to make its detection method unique and prevent duplication or interference with its markers. The reader is available as hand-held device or industrial apparatus for large-scale applications, with the ability to read the embedded material data from a physical or chemical marker without requiring lengthy and expensive laboratory testing for confirmation.

 

Platform

 

Blockchain technology is a ledger of records, which are linked and designed to be secured using cryptography from third party infrastructure and Security Matters PTY’s architecture. The Company can record a marker manifestation on the blockchain and store this information in cloud computing data storage. It has developed an algorithm designed to securely connect its reader to an existing platform (licensed from a SaaS provider) and record changing ownership and other information to the blockchain. Once Security Matters PTY’s blockchain solution is implemented, a marked good or material is scanned in order to identify the marker, the results can be verified on the blockchain in order to confirm the data embedded in it, such as the identity of the producer, date of production, supplier and past owners. During the same scan, the reader can record to the blockchain a change of location or ownership of the marked product or material.

 

The IOT2 concept mentioned above also refers to the retrieving, analyzing and processing of encoded information embedded on products and product components and uploading such information to a cloud computing system or to a distributed blockchain system, creating a digital twin to a physical product for the purpose of product authentication, brand protection, tracking and tracing products and product components, supply chain management, and logistical processes.

 

Applications

 

The Company’s solution offers the following applications across industries:

 

31
 

 

Process Tracing

 

Process tracing involves the upstream marking of raw material and blockchain-backed scanning throughout processing stages to allow for full traceability of raw material across its life cycle. Manufacturers are under increasing consumer and regulatory pressure to prove material provenance in order to be able to certify compliance with environmental, social and governance (“ESG”), sourcing practices and carbon content of finished goods. Through upstream marking of raw material and blockchain-backed scanning throughout the processing stages, Security Matters PTY’s technology enables real tracking and tracing of materials, including the source of those materials. Additionally, Security Matters PTY’s technology enables manufacturers to know whether any used items are theirs and enables them to pay third parties to collect their used products, creating a market for collecting used products and selling them to other manufacturers.

 

Authentication

 

Growing concerns about component tampering along high security or critical infrastructure product supply chains and increasing counterfeit issues for high value density products are also issues that Security Matters PTY’s marking and authenticating process is designed to address. Manufacturers can validate product authenticity to their customers by marking final products or prime components and scanning the marker at a retail location or as part of the process of recycling their products.

 

Sustainability and Circular Economics

 

The end-to-end technology solution covers three product lifecycles to enhance the circular economy from raw material to manufacturing/production, packaging, and end-of-life, enabling it to re-enter the economy for recycling or reuse. By marking upstream raw material and later scanning recycled content at waste collection points, an advanced sorting of materials is enabled which can increase the value of recycled content and in turn help to increase global recycling rates and recycled content certification.

 

Business Strategy

 

The Company’s roadmap for entry into markets it identifies is as follows:

 

Market Leader Adoption. Adoption of the solution by a market leader that provides a “seal of approval” that the technology is valid for the industry and generates added value.
   
Becoming an Industry Standard. Leverage the market leader’s position in the market to increase adoption by other companies along the value chain.
   
Regulator Adoption. In the future, Security Matters PTY aims to become the preferred solution by regulators and professional associations in each industry.

 

Research and Development

 

Given the varied needs of different industries, the Company’s research and development processes are divided according to industry.

 

Plastics, Rubber and Other Materials

 

In 2022, Security Matters PTY completed a successful trial of marking recycled plastics by studying the impact of gravimetric and volumetric feeding methods on final Post Consumer Recyclat (“PCR”), readings. The compounding master batch and extrusion processes of these trials were performed on a pilot scale in a fully commercial and industrial facility. The Company’s team demonstrated its ability to manage the process remotely, indicating the viability of industrial scale adoption.

 

32
 

 

The successful trial provides plastic manufacturer and importing companies with a proof of concept, enabling them to more accurately identify and audit, via an automated transparent reporting system, the polymer type, number of loops and the amount of recycled content despite the size and color of the plastic. As a result, the Company is positioning itself to be able to offer plastic manufacturing and importing companies the ability to promote their operations as being sustainable and environmentally friendly. Combined with its ability to digitally certify the materials, the Company is also positioning itself to offer these companies the ability to avoid human/manual-paper auditing and use technology/automated auditing, which helps to reduce the potential for human errors and can provide for cost savings.

 

In March 2023, the Company announced that it succeeded for the first time in verifying a marker substance for natural rubber in a tire and so throughout the entire production process. The dedicated marker technology, which the Company and Continental optimized for use in natural rubber, is designed to create greater transparency along the entire value chain of tires and technical rubber products from Continental. Provided with special security features, the use of the marker substances enables the invisible marking of natural rubber with information on its geographical origin. This means, for example, that responsibly sourced natural rubber and its origin can be verified at every stage of the supply chain all the way through to the customer.

 

In the field test, the marker substance was added to responsibly grown latex during harvesting and withstood not only the intensive preparations involved in the production of natural rubber but also the tire manufacturing process itself. In the manufactured tire, the data was retrieved using special, purpose-built software and a reader and correctly interpreted. The appearance and performance of a bicycle tire containing the invisible marker remained unchanged.

 

The Company expects that Continental will use the new marker technology on a larger scale in the future during the process of sourcing its rubber and also to integrate it in other rubber products. As part of the industrialization of this technology, it is conceivable to link the markers with blockchain technology. This could provide additional support for tamper-free monitoring of compliance with quality standards and quality criteria along the complex supply chain of natural rubber.

 

On April 10, 2024, the Company announced that it has successfully completed the marking of 21 tons of natural rubber sourced in Latin America from tree to tire. The program covered the marking at the tree in Latin America through manufacturing and production in the region. The Company’s marker was added to the cup lump harvesting by the farmers prior to transfer to the manufacturing centre where the 42 tons of latex was converted to 21 tons of natural rubber. The bails were then transferred to tire manufacturing for commercial car, truck and lorry tires. The tires were then sent for evaluation. The results demonstrated 100% success rates on all marked tires to have a proven verification technology for origin authentication of the natural rubber and full traceability all along the entire supply chain data and integrity from tree to tire.

 

Plastic Cycle Token

 

On November 28, 2023, the Company announced the planned launch of a plastic cycle token, scheduled for release in the third quarter of 2024. The initiative is being designed to present a reliable, ethical digital credit platform, aiming to capitalize on billions of dollars in recyclable plastics credits in a newly created market.

 

The tradeable plastic cycle token is being designed to enable companies to transition towards sustainable practices, encouraging entities within and outside the plastic ecosystem, including oil producers and waste management firms, to increase recycled content utilization.

 

This initiative is also expected to position the SMX Plastic Cycle Token as a next-generation alternative to carbon credits, creating a new paradigm in the Impact ESG investment landscape. Each token is being designed to represent a quantifiable amount of recycled plastic using SMX’s technology to physically mark the plastics, potentially offering a tangible impact on environmental circularity.

 

33
 

 

Gold and Other Metals

 

Gold

 

Security Matters PTY formed a joint initiative with Perth Mint to develop a mine-to-marketplace ethical gold supply chain technology solution. Since the incorporation of trueGold Consortium Pty Ltd (“trueGold”) in June 2020, this research and development project aims to promote a ‘mine to product’ transparency solution dedicated to responsible mining of materials. Security Matters PTY’s track & trace technology provides information on the origin of the materials and how they move across production and distribution chains towards recycling and back to refining.

 

On July 29, 2020, Security Matters PTY signed a shareholders’ agreement with W.A. Mint Pty Ltd. (“Perth Mint”) and trueGold. The shareholders’ agreement and the ancillary agreements discuss the establishment of a new entity—trueGold—by Security Matters PTY and Perth Mint. Security Matters PTY granted to trueGold, subject to the terms of the license agreement, an exclusive, worldwide, perpetual license to use Security Matters PTY’s technology for the purpose of commercializing it within the industry comprising gold as a precious metal (as elaborated below). Security Matters PTY owns any development of its intellectual property and, while trueGold owns all generated data it creates, trueGold granted to Security Matters PTY a free non-exclusive, irrevocable, perpetual, royalty free license to use the generated data, subject to regulatory requirements and to the extent that it relates to the Isorad License Agreement technology or Security Matters PTY’s technology. The parties agreed that neither Perth Mint or Security Matters PTY are required to provide any funding to trueGold and that any investment by any of them in trueGold from time to time will be by way of in-kind contributions. Third party equity investors will contribute the working capital will fund R&D, development capital and other expenses in accordance with the business plan.

 

Other than with the consent of the other shareholders or between affiliates (defined, inter alia, as a related body corporate of a shareholder; a company in which the shareholder beneficially owns 50% or more of the issued shares) a transfer of shares will be done subject to a right of first refusal of the other shareholders, whom will also have tag-along rights and a drag-along (as elaborated below). Under the constitution (as amended in July, 2022, to add the specific right of Security Matters PTY to purchase shares before any other shareholders) any shareholder wishing to transfer shares must notify the board of directors and, before the board of directors authorize the transfer of any share or shares, the share or shares must first have been offered to Security Matters PTY (for its own benefit and unless Security Matters PTY is 50% owned by one entity), and if SMX does not notify within 30 days that it wishes to purchase, then to all other shareholders (including Security Matters PTY) at a price to be agreed on by the transferor and the directors of trueGold. If the transferor and the directors of trueGold are unable to agree on a price, the price of the relevant shares will be a price which: represents a fair market price; and is determined by expert determination administered by the Australian Disputes Centre (ADC) in accordance with the ADC Rules for Expert Determination which are operating at the time the matter is referred to ADC, which Rules are incorporated into the constitution of trueGold. The determination of such person in relation to the price of the relevant shares will be final and binding on all shareholders.

 

Subject to certain terms and conditions, a drag-along right is established under which where shareholders wish to dispose of all of their share to a third party that wishes to acquire 100% of trueGold and 75% or more of the aggregate number of shares on issue at that time agreed, the remaining shareholders may be forced to transfer to the third party all of the shares held by each of the remaining shareholders. In case of a deadlock (defined as a case where the board of directors disagrees on a material matter regarding the fundamental operation of trueGold or the business and cannot resolve the disagreement within 10 business days of the disagreement first arising), if the shareholders are unable to reach agreement on any matter, a dispute resolution mechanism was created.

 

The board of directors of trueGold was agreed to consist of not less than three and not more than seven. The board is comprised as follows: Security Matters PTY may appoint (remove or replace) up to two directors; Zeren Browne; Perth Mint may appoint (remove or replace) up to two directors; and Hugh Morgan, who is a non-executive, independent chair. A list of resolutions was set, which require a board majority including at least one Security Matters PTY appointed director and one Perth Mint appointed director. Another list of resolutions was set, which require a resolution carried by a majority of the shareholders including Security Matters PTY and Perth Mint. trueGold and Yahaloma (defined below) agreed to bear the payments to Soreq related thereto of 4.2% of its revenues. SMX’s CEO, Mr. Haggai Alon, provides CEO services to trueGold and reports to the board of directors of trueGold, and Zeren Browne provides General Manager services to trueGold.

 

34
 

 

On October 3, 2023, Security Matters PTY entered into the Investment Agreement with trueGold. Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 trueGold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in trueGold shall be increased to 51.9% of the total issued and outstanding shares of trueGold, making Security Matters PTY the majority owner of trueGold. Additionally, the existing license agreement as between Security Matters PTY and trueGold was amended to include additional intellectual property of Security Matters PTY to be licensed to trueGold thereunder. Security Matters PTY shall further supply to trueGold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

TrueSilver

 

On June 7, 2023, we announced that we are in the process of creating a new subsidiary, TrueSilver, and that we have entered into a 120 day exclusive agreement with Sunshine Minting Inc. (“Sunshine”), to create a path to full transparency and traceability for silver products from mine site to final products and recycling and the creation of an industry standard. During the 120-day exclusivity period, Sunshine shall evaluate our technology for its use, with possible further collaborations thereafter.

 

In July 2023, we transferred the ownership of our wholly owned granddaughter company “Security Matters Canada Ltd.” from ownership by our subsidiary Security Matters PTY to direct ownership by the Company and renamed it “TrueSilver SMX Platform Ltd.”

 

On April 15, 2024, the Company announced the successful completion of proof of concept for ethical sourcing and authentication of silver in cooperation with Sunshine.

 

The Company has now successfully completed the marking of 2.2 tons of silver within Sunshine’s operations. The program covered the marking of the silver raw material through continuous manufacturing processes to final products including recycling loops.

 

The Company’s technology was added at the melting stage and the marked silver material was processed into blank (from casting, extrusion, rolling, annealing, blank cutting & recycling), and the quality of the marked intermediate material and final products was evaluated (from billet to blank and recycled blank after several cycles).

 

The results demonstrated 100% success rates on all marked products all along the production process (from billet to finished product) ensuring the durability and irrefutable proof of quality and Brand authentication of the silver for credible ESG reporting for stakeholders, customers, auditors, and regulators.

 

Non-Ferrous Metals

 

On November 29, 2022, Security Matters PTY signed a products distribution and SAAS reseller agreement with Sumitomo Corporation, a Japanese corporation. Under such agreement, Security Matters PTY appointed Sumitomo to act as Security Matters PTY’s exclusive, worldwide distributor to market and sell markers, readers and Security Matters PTY services to customers for application in the Non-Ferrous Metals Market (as defined below) only, subject to the customer entering into with Security Matters PTY its standard product license agreement. The “Non-Ferrous Metals Market” is defined as all supply chain market segments of the industry for aluminum, copper, lead, nickel, zinc, molybdenum, cobalt, lithium and tin.

 

The price at which Security Matters PTY shall sell products to Sumitomo and the license fee at which Security Matters PTY shall license Security Matters PTY products and Security Matters PTY service to Sumitomo shall be a discount of the invoices issued to the customers.

 

Generally, the agreement shall remain in effect for an initial term of five years from the effective date of first commercial sale by Security Matters PTY to Sumitomo of any products. The companies have agreed that over the coming years there is a target to reach $35 million in sales.

 

Alcoholic Beverages

 

In December 2021, Security Matters PTY acquired all the holdings SMX Beverages Pty Ltd, a joint venture incorporated in February 2020 for the promotion of solutions in the alcoholic beverage industries including in relation to the prevention of counterfeit alcoholic beverages, circular economy concepts and packaging and supply chain within those industries.

 

35
 

 

Diamonds and Precious Stones

 

On April 30, 2019, Security Matters PTY signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters PTY’s trace technology in the diamonds and precious stone industry. Under the terms of the agreement, Security Matters PTY and Trifecta established a new entity—Yahaloma Technologies Inc., which is equally held by Security Matters PTY and Trifecta.

 

Both parties covenanted not to pursue the use of Security Matters PTY’s technology for diamonds and precious stones, or any other venture related to the testing of the origin of diamonds or precious stone, other than through the Yahaloma. Additionally, in agreement with Isorad, all rights in and to any intellectual property related to the diamonds and precious stones industry that is developed by or for Yahaloma is jointly owned in equal parts by the Security Matters PTY, Yahaloma and Soreq.

 

Security Matters PTY continues to develop the technology and will supply Yahaloma technical services. Security Matters PTY bears the cost of such R&D services but the agreed hourly costs of Security Matters PTY’s staff is recorded as a shareholders loan of Security Matters PTY to Yahaloma, once the first USD 250,000 to be paid by Trifecta are exhausted (which is yet to happen). Trifecta supplies Yahaloma diamonds and other raw materials, which remain in the ownership of Trifecta. If Security Matters PTY causes damage to such diamonds during the R&D process, this will be reported the Trifecta and the damage recorded as a shareholders loan of Trifecta to Yahaloma. Trifecta will supply Yahaloma services of business development. Trifecta bears the cost of such services but the agreed hourly costs of Trifecta’s staff is recorded as a shareholders loan of Trifecta to Yahaloma. Management of Yahaloma is agreed to be jointly, with certain special resolutions requiring agreement of both parties. Actual day-to-day management is in Canada.

 

In addition to the shareholders loan extended by man-hours as stipulated above, the parties covenanted to extend up to USD 1 million to Yahaloma (USD 350,000 by Security Matters PTY and USD 650,000 by Trifecta, with USD 250,000 extended by Trifecta registered as capital and all other funds as shareholders loans). Funds were agreed to be injected upon reaching certain milestones. The Security Matters PTY loan of USD 350,000 are to be injected only upon reaching future milestones and only if such funds will be required, which stage has not yet arrived. Such Security Matters PTY loan will bear an interest rate of 5% per annum. Upon Yahaloma being able to repay the shareholders loans, first a sum of USD 250,000 will be repaid to Trifecta and then all other shareholders loans will be repaid pro-rata. Only after repayment of all shareholders loans will Yahaloma distribute profits.

 

A party may not transfer its shares to others without the prior approval of the other party other than a transfer to an affiliate (defined as an entity directly or indirectly controlled by a party or directly or indirectly controls such party or is directly or indirectly controlled by a person which also, directly or indirectly, controls such person) done after 30 days’ notice to the other party, and after the affiliate agrees to adopt the agreement.

 

Yahaloma agreed to bear the payments to Soreq related thereto (as described in “Gold and Other Metals” above).

 

Electronics

 

Security Matters PTY has joined an alliance formed by six founding partners, among them the World Business Council for Sustainable Development, to set a shared vision for a circular economy for electronics, called the Circular Electronics Partnership. This group of global companies has been brought together to reduce e-waste and to commit to a roadmap for a circular economy for electronics by 2030.

 

36
 

 

Fashion

 

In December 2020, Security Matters PTY announced that it had launched a Fashion Sustainability Competence Centre to enable fashion brands globally, to transition successfully to a sustainable circular economy by being able to identify the origination of their raw materials and hence, recycle their own unsold and/or end-of-life merchandise (garments, footwear and accessories including sunglasses) back into new high-quality materials and new fashion merchandise Security Matters PTY’s technology is applicable across a range of materials including leather, silk, cotton, wool, coated canvas, vegan leather, polyesters, cashmere, metals (e.g., gold & metallic parts) and plastics; and its applications encompass finished leather goods, shoes, garments, and accessories. Security Matters PTY is also collaborating with several luxury fashion conglomerates on R&D projects to trace the origin of raw materials used in their supply chain and is in commercial negotiations regarding the implementation of its solution with partners in the industry.

 

In July 2023, we changed the name of the wholly owned subsidiary from “SMX France” to “SMX Fashion and Luxury” in anticipation for such company to be used for the fields of fashion and luxury.

 

Marketing and Sales

 

The Company intends to concentrate its market penetration efforts into the U.S. market, including recruitment of sales and marketing personnel, either located in the U.S. or with U.S. orientation, participation in various professional expos, conventions and exhibitions and entering into agreements or arrangements with distributors in the U.S. markets and commencing collaborative relationships with commercial entities for the development of new customized products. Moreover, the Company intends to continue to invest significant resources in research and development in order to improve and build on its array of existing solutions and strive to develop new innovative products in sync with new market technological developments. The Company plans to further advance its innovative technology and commercialization efforts by:

 

engaging with additional suppliers and service providers in order to improve and streamline its product development process and supply chain;
   
increasing marketing and sales activities, concentrating on specific target markets;
   
increasing participation in professional expos, conventions and exhibitions; and
   
establishing partnerships and collaborations with strategic customers and entities in the segments relevant to its technology.

 

The Company’s pricing is based on the perceived value proposition of its solution for its customers. The pricing model is expected to be comprised of three components:

 

set-up fee (for initial consultations);
   
marker implementation fee (typically on a per item or per kg basis) and sale or lease of readers; and
   
service fee (for reading, blockchain services and other support services).

 

Pricing may also include an annual license fee, payment of royalties, pay-per-read, or other models.

 

37
 

 

Target Industries

 

Fashion

 

For the fashion industry, the Company’s technology enables authentication from raw materials to retail stores and beyond:

 

 

Its technology targets the luxury fashion industry by enabling high-end brands to:

 

verify the origin of raw materials to prevent fraud;
   
control material usage during the manufacturing process;
   
track a product’s journey from the first point of manufacturing to delivery to customers.
   
share information on product traceability with customers to prevent fraud in returned products;
   
generate secondary and reseller demand by demonstrating product authenticity; and
   
improve upcycling and recycling processes through material recognition, grading, and recycled content certification.

 

38
 

 

Electronics

 

For the electronics industry, the Company’s technology enables end-to-end traceability and authentication from raw material to point of use.

 

 

Its technology targets semiconductor manufacturers enabling a manufacturer to:

 

verify the origin of raw material;
   
control material usage;
   
demonstrate product authenticity along its supply chain;
   
detect tampering during use (e.g., when giving products off-premises for maintenance or other reasons); and
   
implement upcycling and/or recycling programs through material recognition, grading, and recycled content certification.

 

39
 

 

Gold and Other Metals

 

The Company’s technology allows for the tracing of gold or other metals from mine to consumer.

 

 

Its technology enables gold refineries, mining companies, and bullion banks to:

 

prove the origin and mine location of the gold;
   
facilitate the sale or trading of gold from ESG-compliant mines; and
   
demonstrate that their products are ESG-compliant to customers and end-users.

 

40
 

 

Plastics, Rubber and Other Materials

 

Given the challenges around mechanical recycling, chemical recycling is emerging as a promising solution to help tackle the global challenge associated with single use plastic waste. An embedded chemical marker allows for better tracking, monitoring and sorting of post-consumer plastic with the Circular Value Chain Approach. The Company’s technology is applicable throughout the life cycle of the material or product, from raw material to production to recycling. Its technology enables plastic footprint transparency and traceability along the supply chain.

 

 

Its digital twin technology can address a key challenge of the first step to identify, track and trace commodities produced in emerging countries for use in the developed countries, such as rubber or food commodities (e.g., cocoa, soy, and palm oil). The creation of a digital twin for each physical good enables participants in the value chain to come together and form the global ledger for the goods. As a number of industries and sectors are increasing their commitments to recycling, many companies are realizing the need for sustainability and circular economies.

 

Competition

 

Armed with its various products and designs, the Company believes it possesses a unique combination of knowledge and features. It has established an innovative, cross- segment technology, developed over several years by an experienced and dedicated team of scientists, which it believes create a barrier to entry to its competitors.

 

The Company’s product is currently undergoing pilot projects with customers with strong international presence. The customizable nature of its technology allows SMX to embed the technology in multiple products, from silk to rubber to diamonds to gold to plastics, across multiple segments.

 

The Company is constantly striving to improve its competitive status in the market by:

 

entering into agreements or arrangements with large and high-profile customers in the industry, which it believes enhances its status and reputation in multiple markets and provides opportunities to enter into new agreements or arrangements with new customers;
   
entering into agreements or arrangements with strategic partners in order to strengthen its position to become the new industry standard; and
   
Providing high level development and support services to customers, to promote customer retention, and encourage its customers to rely on SMX to use its technologies for future projects.

 

41
 

 

Government Royalty Obligations and Regulations

 

Israeli R&D Law

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted by the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS).

 

Under Israeli laws with respect to research and development, which is referred to as R&D Law, a royalty of between 3% to 5% applies to the net sales of products developed from a project funded by the IIA, beginning with the commencement of sales of products developed with grant funds and ending when a dollar-linked amount equal to 100% of the grant plus interest at LIBOR has been repaid. The terms of the R&D Law also place restrictions on the location of the manufacturing of products developed with government grants, which, in general, must be performed in Israel, and on the transfer to third parties of technologies developed through projects in which the government participates. Security Matters PTY’s research and development team will remain in Israel and all funds previously received by way of a grant from IIA have been invested in Israel.

 

The IIA has published a directive incorporating most of the former provisions, including those with respect to transfer of manufacturing rights, transfer of know-how and others. These provisions include limitations and requirements for payment with respect to outsourcing or transferring development or manufacturing activities with respect to any product or technology outside of Israel, and change in control in companies which received government funding from the OCS or IIA, which may impair ability to sell technology assets outside of Israel or to outsource, transfer develop or manufacture with respect to any product or technology that received government funding under the R&D Law outside of Israel, or consummate a change in control in the Company, all without prior approval of the IIA.

 

In May 2017, the IIA published the Rules for Granting Authorization for Use of Know-How Outside of Israel, or the Licensing Rules. The Licensing Rules enable the approval of licensing arrangements and other arrangements for granting of an authorization to an entity outside of Israel to use know-how developed under research and development programs funded by the IIA. Subject to payment of a “License Fee” to the IIA, at a rate that will be determined by the IIA in accordance with the Licensing Rules, the IIA may now approve arrangements for the license of know-how outside of Israel. This allows companies that have received IIA support to commercialize know-how in a manner which was not previously available. In addition, the IIA has recently published a directive incorporating most of the former provisions, including those with respect to transfer of manufacturing rights, transfer of know-how and others.

 

Security Matters PTY had one approved project with the IIA (project number 55715, approved on November 23, 2015) of a 40% grant out of a project of up to approximately $400,000 under which it received $196,000 in prior years. Security Matters PTY passed a final review by the IIA and no additional funding is expected to be received under the project.

 

Security Matters PTY is obligated to pay 3% of our relevant revenues for the first three years, and 4% of the relevant revenues for further years, until repayment of the entire grant, being $196,000. To date we paid about $1,000 out of such amount.

 

Approved Enterprise

 

The Israeli Encouragement of Capital Investments Law, 1959, is intended to encourage investment in industry in Israel in national priority areas, to promote economic initiatives while giving preference to advanced and innovative industries, and to strengthen development areas. Based on the Investment Law, the Investment Center may, on application, grant the status of “Approved Enterprise” for Capital Investments in industry and tourism. Certificates of approval are issued and such approval entitles the project to receive substantial support from the State. The support may be in the form of reduced taxation, investment grants or other benefits specifically designed to encourage capital investment in Israel. Such State support is conditional on certain restrictions on the activities of a supported company, which restrictions may not easily be alleviated.

 

In December 2016, Security Matters PTY received approval as an Approved Enterprise (File 24638, Plan 429, Motion 120941) for the building of a factory for the marking of materials with an investment of ILS 3,700,000, provided that at least 24% of the investment will be financed by the issuance of new shares. Due to changes in our activity plans, we did not pursue such project and did not take any funds under such Approved Enterprise.

 

42
 

 

Isorad License Agreement

 

Under the Isorad License Agreement (as amended), Security Matters PTY received from Isorad an exclusive, worldwide, royalty-bearing license, to make use of (including, without limitation, to develop, manufacture, use, market, offer for sale, sell, export and import in the field of marking methods) US patent number 8158432 B2 and the technology derived from it can be utilized in almost any industry and with any product. Additionally, any uses for the Israeli Security Forces and/or its purposes will be conducted via us at a “cost plus” price to be agreed. While Isorad and Soreq reserve the right to freely continue to research and develop the technology, Security Matters PTY has a right of first offer to any newly developed technology. If the Source IP is developed further by Soreq and Soreq wishes to commercialize the new technology, then Soreq must offer the right to commercialize the new technology to Security Matters PTY in the first instance.

 

Security Matters PTY and its affiliate are to pay Isorad royalties for 25 years as of January 1, 2020 in the amount of 2.2% of all gross sales by the Company, our affiliates or sublicensees and after 25 years the license becomes royalty-free. Gross sales are defined under the Isorad License Agreement to include the total amount invoiced or received by Security Matters PTY and/or its affiliates, including, without limitation, for sale of products and provision of services. If Security Matters PTY charges a fee for sublicensing or an option for a sublicense, for which it does not pay the 2.2% royalty described above, such income will be subject to royalty payment of 15% of the amounts received. The royalties for revenues from sub-licensing the technology are payable as of January 1, 2020.

 

Upon the occurrence of the next M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of ours and similar event) Security Matters PTY is to pay a cash amount equal to 1.5% of the Exit Consideration (as such term is defined in such agreement). Additionally, Isorad was issued 864,000 options to purchase shares of Security Matters PTY and is entitled to receive 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and any amount actually received against equity or other funding during a period of 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof). This will not apply to any future offer of shares, merger or sale of assets thereafter. As of December 31, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $123 against a liability that reflects the due amount.

 

Under the Isorad Agreement, Isorad can only refuse to approve a sublicense based on governmental defense, security, governmental policy, political and other official State of Israel policy considerations. A sublicensee cannot further grant, directly or indirectly, to any third party any sublicense or rights to the technology and cannot further assign the sublicense agreement.

 

Specifically as to Yahaloma, the royalty rate on gross sales of Yahaloma, to be paid by Yahaloma, are 4.2% (and not 2.2% that applies solely to Security Matters PTY, its other affiliates and to other sublicensees). Upon the occurrence of an M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of Yahaloma and similar event), Isorad is entitled to a fee equal to 1% of the total consideration paid to, received by, or distributed to, Yahaloma and/or its shareholders and/or its affiliates in connection with the event, including, without limitation, all cash, securities or other property which is received by Yahaloma and/or its shareholders in connection with such event of two such events (i.e. twice) at its choice.

 

The Isorad License Agreement will continue in full force and effect until terminated pursuant to its terms. If either party does not remedy a material breach of its obligations within 180 days of notice of the material breach, the non-defaulting party may terminate the Isorad License Agreement immediately. Isorad may terminate the agreement by providing 30 days prior written notice if the royalties payable to Isorad are $nil in any semi-annual report and we have breached other certain obligations (such as a failure to maintain a patent or patent application in the previous semi-annual review period).

 

Security Matters PTY has provided broad indemnities to Isorad and Soreq and their related parties under the terms of the Isorad License Agreement. The Isorad License Agreement is governed by the laws of Israel.

 

43
 

 

Safety Certifications and Permits

 

Security Matters PTY is in compliance with the requirements of the ISO 9001:2015 standard for quality management and quality assurance. The ISO organization promotes worldwide proprietary, industrial and commercial standards. Security Matters PTY is examined annually to verify that we comply with the ISO standards of excellence, safety, quality, process management and risks management, and currently holds an ISO certificate as of the date of this Annual Report on Form 20-F.

 

Under the provisions of the Israeli Non Ionizing Radiation Law, and the Work Safety regulations (regarding employment safety and health of those working with non-ionizing radiation), the Company is required to hold a valid license for operations involving non ionizing radiation as well as employ a safety expert with qualifications as defined by the law. As of May 8, 2022, Security Matters PTY has a valid license for operations involving non ionizing radiation and employs a safety expert as required by law. Additionally, the import and use of its readers may be subject to a license requirement in certain jurisdictions, which requirement may change from one jurisdiction to another.

 

Legal Proceedings

 

From time to time, the Company may become involved in legal proceedings or may be subject to claims arising in the ordinary course of our business. Although the results of these proceedings and claims cannot be predicted with certainty, the Company currently believes that the final outcome of these ordinary course matters will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

C. Organizational Structure

 

The Company has six wholly owned subsidiaries: Lionheart, Security Matters PTY, SMX Circular Economy Platform PTE, Ltd. (Singapore), TrueSilver SMX Platform Ltd. (Canada) (“TrueSilver”), SMX Fashion and Luxury (France) and SMX (Security Matters) Ireland Limited (Ireland). Security Matters PTY has two wholly-owned subsidiaries: Security Matters Ltd. (Israel) and SMX Beverages Pty Ltd. (Australia), along with being the record holder of 50% of Yahaloma Technologies Inc. (Canada) (“Yahaloma”) and 51.9% of trueGold Consortium Pty Ltd. (Australia).

 

D. Property, Plants and Equipment

 

The Company’s main business activities are conducted at SMX Israel’s headquarters in central Israel. It leases 363 square meters of office space at this location under a lease until May 31, 2027, with an option to extend the lease with an additional rental fee of 10% for an additional five years. The Company also leases an additional adjacent building of 146 square meters where it conducts research and development activities. The lessor (who represented that he is not aware of any such impending circumstances) has the right to shorten the lease with 90 days-notice if it is demanded by a government entity to evacuate the premises, to change the agreement or to pay fines due to the agreement. The Company believes that its current facilities are suitable and sufficient to meet its anticipated needs for the foreseeable future.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

You should read the following discussion and analysis of our audited financial condition and results of operations together with our consolidated financial statements appearing elsewhere in this Annual Report on Form 20-F. This Annual Report on Form 20-F contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Exchange Act, including, without limitation, statements regarding our expectations, beliefs, intentions or future strategies that are signified by the words “expect,” “anticipate,” “intend,” “believe,” or similar language. All forward-looking statements included in this Annual Report on Form 20-F are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. In evaluating our business, you should carefully consider the information provided under “Item 3.D. Risk Factors.” Actual results could differ materially from those projected in the forward-looking statements. The terms “Company,” “we,” “our” or “us” as used herein refer to SMX (Security Matters) Public Limited Company and its consolidated subsidiaries unless otherwise stated or indicated by context.

 

44
 

 

All amounts discussed are in U.S. dollars, unless otherwise indicated.

 

Business

 

The Company integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, the Company’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. One reader can detect embedded data in various materials, from metals to fabrics to food and plastics, with all data logged onto the same digital platform. This versatility across materials sets the SMX tech apart from competitors. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

The potential of the SMX technology application extends beyond merely tracing raw materials from origination to finished product for recycling and reuse. It serves as a cornerstone for broader innovative markets, including the following:

 

In November 2023, SMX unveiled plans for the launch of the world’s first plastic cycle token. In response to the global plastic recycling rate of just 9% and an estimated market valued at over $40 billion, this initiative aims to establish a reliable, ethical digital credit platform, tapping into the vast potential of recyclable plastics credits in a new market. Collaborating with a range of partners and sponsors, each offering unique skills and expertise, SMX aims to create the Plastic Cycle Token, facilitating companies’ transition to sustainable practices. This token is poised to serve as a next-generation alternative to carbon credits, aligned with the European Union’s efforts to improve recycling rates. Leveraging its technology, which enables physical traceability of recycled materials, SMX seeks to incentivize genuine plastic recycling, promoting environmental circularity and supporting impactful ESG investments.

 

45
 

 

This was followed by another SMX announcement in January 2024, for a $5 million contract with R&I Trading of New York, deploying cutting-edge technology to enhance supply chain transparency for a NATO member state, with plans to expand to additional NATO members. This partnership aims to establish new standards in brand protection, authentication, and ethical sourcing, particularly in the FMCG sector. Through this initiative, SMX is committed to promoting transparency and security in global supply chains, reflecting its dedication to ethical business practices and technological innovation.

 

History

 

SMX Israel was incorporated in 2014 to provide brand protection and supply chain integrity solutions to businesses. It provides these solutions through the commercialization of the initial technology of tracking and tracing materials by observing and identifying markers (the “Source IP”). SMX Source IP was initiated from the Soreq Nuclear Research Center, an Israeli government research and development institute for nuclear and photonic technologies under the Israeli Atomic Energy Commission (“Soreq”). In January 2015, SMX Israel entered into the Isorad License Agreement with Isorad Ltd. (an IP holding company of Soreq) to license the Source IP and develop and commercialize the technology (the “Isorad License Agreement”). Under the Isorad License Agreement, as amended, the Source IP can be utilized in almost any industry and with any product.

 

SMX Israel merged into Security Matters PTY, an Australian company, to effect a listing on the Australian Securities Exchange under the symbol “ASX: SMX.” At that time, Security Matters PTY had three wholly-owned subsidiaries: Security Matters Ltd. (Israel), SMX Fashion and Luxury (France), and SMX Beverages Pty Ltd. (Australia). It was also the record holder of 50% of Yahaloma Technologies Inc., a Canadian company and, as of October 3, 2023, 51.9% of trueGold Consortium Pty Ltd., an Australian company.

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination pursuant to the BCA and its previously announced SID. Beginning on the day immediately prior to the Closing Date and finishing on the day immediately after the Closing Date, the following transactions occurred pursuant to the terms of the BCA:

 

Security Matters PTY proposed a scheme of arrangement under Part 5.1 of the Corporations Act (“Scheme”) and Capital Reduction which resulted in all shares in Security Matters Limited being cancelled in return for the issuance of the Company’s Ordinary Shares, with the Company being issued one share in Security Matters PTY (“Security Matters Shares”) (this resulted in Security Matters PTY becoming a wholly owned subsidiary of the Company);

 

Security Matters PTY proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters PTY options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for Security Matters Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;
   
Security Matters PTY shareholders received consideration under the Scheme of 1 Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters PTY and Lionheart, with Security Matters PTY being delisted from the Australian Stock Exchange;
   
Merger Sub merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company;
   
Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares; and
   
The Company’s Ordinary Shares were listed on NASDAQ under the ticker SMX and the Public Warrants were listed under the ticker SMXWW.

 

46
 

 

As a result of the Business Combination, the Company owns the entire share capital of Security Matters PTY. Accordingly, for financial reporting purposes, Security Matters PTY (the legal subsidiary) is the accounting acquirer and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the Business Combination, and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference between the fair value of the shares deemed to have been issued by Security Matters PTY and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

A. Operating Results

 

Key Factors Affecting Operating Results

 

The Company believes that its performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section of this Annual Report on Form 20-F titled “Risk Factors.

 

Commercial Agreements

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they can be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

Due to the fact that we aim our sales efforts at large multi-national market-leading conglomerates, our sale cycle is of several quarters and there is a risk associated with it that at any time, due to force majeure, or events like CoV 19, regional wars, global tension, global supply chain challenges and climate change, that are beyond our control, the sale cycle will be broken and all efforts will be lost.

 

The Company has received interest in its technology from several international market-makers conglomerates as well as parties interested in making such technology a market standard, which will greatly assist the creation of future income. Any delays in the successful completion of projects or the creation of a market standard, as well as the materialization of any of the risks described in the section entitled “Risk Factors” above may impact the ability to generate revenue.

 

47
 

 

Components of Operating Results

 

The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this Annual Report on Form 20-F.

 

Revenue

 

To date, we haven’t seen substantial revenue from our technology sales. This is partly because our focus has been on creating a seamless onboarding process for multinational clients, establishing a solid foundation to become an industry standard, and ensuring readiness for a full and rapid deployment as a global commercial service.

 

Operating Expenses

 

The Company’s current operating expenses consist of the following components: research and development expenses, general and administrative expenses and selling and marketing expenses. The Company is working to maintain discipline on expenses over time.

 

Research and Development Expenses, Net

 

The Company’s research and development expenses consist primarily of wage and salary related expenses, subcontractors and consultants, depreciation and amortization of equipment, research expenses and share-based compensation expenses. The Company expects that its research and development expenses will increase as the Company continues to develop its products and recruit additional research and development employees.

 

The Company is engaged in Proof of Concept (POC) agreements according to which it receives funds for financing research and development expenses from prospective customers. Those funds are reimbursements for expenses and therefore are offset against the related R&D expenses in profit or loss.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of professional services fees, wages and salary related expenses, share-based compensation, facility-related costs and other general and administrative expenses. In the year ended December 31, 2023, general and administrative expenses also include the costs that are related to the Business Combination and thereafter the cost related to being a public NASDAQ company.

 

Selling and Marketing Expenses

 

Selling and marketing expenses consist primarily of wages and salary related expenses, digital advertising and marketing expenses.

 

Finance Income and Expenses

 

Finance expenses, net consists primarily of revaluation of financial liabilities and warrants at fair value, interest on borrowings, inducement expenses, exchange rate difference, and fees and commissions to banks.

 

48
 

 

Gain from Remeasurement of investment in associated company

 

Gain from remeasurement of investment in associated company arises due to the agreement the Company signed with true-Gold Consortium Pty Ltd.’s (“true-Gold”) on October 3, 2023 to acquire an additional 7.5% which increased the Company’s holdings to 51.9% in true-Gold and resulted in the Company gaining control over true-Gold.

 

Foreign Currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of true-Gold Consortium PYT LTD. is Australian Dollar.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities - at the rate of exchange applicable at the reporting date;
Expense items - at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recorded in exchange losses arising on translation of foreign operations in the consolidated statement of comprehensive loss.

 

Comparison of the Years Ended December 31, 2023, December 31, 2022, and December 31, 2021

 

The following table summarizes our historical results of operations for the periods indicated:

 

   Year Ended
December 31,
 
U.S. dollars in thousands (except of per share data)  2023   2022   2021 
             
Research and development expenses   2,711    1,898    2,039 
Selling and marketing expenses   661    569    453 
General and administrative expenses   16,567    2,723    2,482 
Listing cost   16,802    -    - 
                
Operating Loss   (36,741)   (5,190)   (4,974)
Finance expenses   7,891    1,128    101 
Finance income   1,580    28    237 
Gain from remeasurement of investment in associated company   22,164    -    - 
Share of net profit (loss) of associate companies   (101)   106    101 
                
Loss before income tax   (20,989)   (6,184)   (4,939)
                
Income tax   -    -    - 
                
Net Loss   (20,989)   (6,184)   (4,939)
                
Net loss attributable to:               
Equity holders of the Company   (20,914)   (6,184)   (4,939)
Non- controlling interest   (75)   -    - 
                
Basic and diluted loss per share attributable to shareholders**   (7.82)   (8.47)   (7.41)

 

** Restated as a result of the Business Combination and after giving effect to the reverse stock split

 

49
 

 

Research and Development Expenses, Net

 

The Company’s research and development expenses for the year ended December 31, 2023, amounted to $2,711 thousand, representing an increase of $813 thousand, or 42.8%, compared to $1,898 thousand for the year ended December 31, 2022. The major changes in research and development expenses were an increase of $320 thousand in Share based compensation expenses and reimbursement from proof of concept projects that decreased by $568 thousand.

 

The Company’s research and development expenses for the year ended December 31, 2022, amounted to $1,898 thousand, representing a decrease of $141 thousand, or 7%, compared to $2,039 thousand for the year ended December 31, 2021. The major changes in research and development expenses were an increase of $371 thousand in salaries and related expenses that were offset against the reimbursement from paid pilots and proof of concept projects that increased in $335 thousand and Subcontractors and consultants’ expenses that decreased in $257 thousand.

 

General and Administrative Expenses

 

The Company’s general and administrative expenses amounted to $16,567 thousand for the year ended December 31, 2023, a net increase of $13,844 thousand, or 508.4%, compared to $2,723 for the year ended December 31, 2022. The net increase was primarily attributable to an increase of $7,278 thousand in Business Combination cost, an increase of $5,128 in public company expenses, an increase of $1,085 in Share based compensation, an increase of $413 in Wages and salaries related reflecting an increase in payroll expenses and in the number of employees and an increase of $388 thousand in travel expenses, due to returning to full operation after the COVID-19 pandemic which is offset by decrease of $438 thousand in Professional services expenses.

 

The Company’s general and administrative expenses totaled $2,723 thousand for the year ended December 31, 2022, a net increase of $241 thousand, or 10%, compared to $2,482 for the year ended December 31, 2021. The net increase was primarily attributable to an increase of $183 thousand in wages and salaries related expenses reflecting an increase in the number of employees and an increase of $223 thousand in travel expenses offset by decrease of $194 thousand in share-based compensation expenses.

 

Selling and Marketing Expenses

 

The Company’s selling and marketing expenses totaled $661 thousand for the year ended December 31, 2023, an increase of $92 thousand, or 16.1%, compared to $569 thousand for the year ended December 31, 2022, and was primarily due to an increase of $176 thousand in wages and salaries related due to hiring new professional senior selling and marketing team. This was offset by a decrease in marketing expenses and consulting.

 

The Company’s selling and marketing expenses totaled $569 thousand for the year ended December 31, 2022, an increase of $116 thousand, or 26%, compared to $453 thousand for the year ended December 31, 2021, and was primarily due to an increase in digital advertising cost associated with our marketing efforts.

 

50
 

 

Listing Cost

 

The Company’s listing cost for the year ended December 31, 2023, amounted to $16,802 thousand, which consisted of $11,599 thousand representing deemed issuance of shares at fair value at the closing of the Business Combination and $5,203 thousand, which represents the fair value of the Company’s identifiable net assets which represents a payment for the service of obtaining a stock exchange listing for its shares and it is therefore recorded to the consolidated statement of comprehensive loss.

 

Finance Income and Expenses

 

The Company’s finance income for the year ended December 31, 2023, totaled $1,580 thousand, an increase of $1,552 thousand, or 5,543%, compared to $28 thousand for the year ended December 31, 2022. The increase is due to $927 thousand revaluation of public warrants financial liabilities at fair value and $377 thousand revaluation of convertible note. The Company’s finance expenses for the year ended December 31, 2023, amounted to $7,891 thousand, an increase of $6,763 thousand, or 599.6%, compared to $1,128 thousand for the year ended December 31, 2022. The increase mainly attributed to a $3,704 thousand revaluation of the bridge loans and convertible notes, $2,005 thousand due to warrants revaluation, $1,000 thousand due to interest on borrowings, and $250 thousand from inducement expenses.

 

The Company’s finance income for the year ended December 31, 2022, totaled $28 thousand, a decrease of $209 thousand, or 88%, compared to $237 thousand for the year ended December 31, 2021. The Company’s finance expenses totaled $1,128 thousand for the year ended December 31, 2022, an increase of $1,027 thousand or 1,017%, compared to $101 thousand for the year ended December 31, 2021. The increase is mainly attributed to a revaluation of the bridge loans and redeemable warrants at fair value.

 

Gain from Remeasurement of Investment in Associated Company

 

Gain from remeasurement of investment in associated company amounted to $22,164 thousand and reflects the remeasurement of the investment in true-Gold at fair value following the Company obtaining control over true-Gold, since before the transaction’s completion the Company held 44.4% of the shares of true-Gold which were treated as a joint venture investment.

 

Share of Net Profit/Loss of Associated Companies

 

Shares of net loss of associated companies consists of equity loss from associated joint venture activity for the year ended on December 31, 2023 at the amount of $101 thousand and share of net profit of associated companies consists of equity profit from associated joint venture activity for the year ended on December 31, 2022 at the amount of $106 thousand. As of December 31, 2023 and December 31, 2022, the carrying amount of the investment in associated companies is $115 thousand and $221 thousand, respectively.

 

Shares of net profit of associated companies consists of equity profit from associated joint venture activity for the year ended on December 31, 2022 at the amount of $106 thousand and share of net loss of associated companies consists of equity loss from associated joint venture activity for the year ended on December 31, 2021 at the amount of $101 thousand. As of December 31, 2022 and December 31, 2021, the carrying amount of the investment in associated companies is $221 thousand and $147 thousand, respectively.

 

Income Tax

 

As of December 31, 2023, the Company estimated carry forward tax losses of approximately $45,095 thousand (December 31, 2022: $24,106 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company and its subsidiaries did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

As of December 31, 2022, the Company estimated carry forward tax losses of approximately $24,106 thousand (December 31, 2021: $17,659 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company and its subsidiaries did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

51
 

 

Operating Loss

 

As a result of the foregoing, our operating loss for year ended December 31, 2023 was $36,741 thousand compared to an operating loss of $5,190 thousand for year ended December 31, 2022, an increase of $31,551 thousand, or 608%.

 

Our operating loss for year ended December 31, 2022 was $5,190 thousand compared to an operating loss of $4,974 thousand for year ended December 31, 2021, an increase of $216 thousand, or 4.3%.

 

Net Loss Attributable to Shareholders

 

As a result of the foregoing, our net loss for the year ended December 31, 2023 was $20,989 thousand, compared to $6,184 thousand for the year ended December 31, 2022, an increase of $14,805 thousand, or 240%.

 

As a result of the forgoing, our net loss for the year ended December 31, 2022 was $6,184 thousand, compared to $4,939 thousand for the year ended December 31, 2021, an increase of $1,245 thousand, or 25%.

 

B. Liquidity and Capital Resources

 

Overview

 

Since our inception through December 31, 2023 and thereafter, the Company has funded its operations principally through the issuance of Ordinary Shares, warrants, convertible notes, loans from investors and related parties and reimbursement from prospected customers for paid pilots and proof-of-concept projects. As of December 31, 2023, the Company had $168 thousand in cash and cash equivalents. In addition, during February 2024, the Company raised gross proceeds of approximately $3,307 thousand, before deducting fees and other offering expenses payable by the Company, from the issuance of share, prefunded warrants and convertible security, and during April 2024, the Company raised gross proceeds of approximately $2,000 thousand before deducting fees and after offering expenses payable by the Company, from the issuance of a promissory note and warrants.

 

The table below presents our cash flows for the periods indicated:

 

   For
Year Ended
December 31,
 
U.S. dollars in thousands  2023   2022   2021 
Net cash used in operating activities   12,479    5,223    3,908 
Net cash used in investing activities   1,036    1,127    1,765 
Net cash provided by financing activities   11,954    3,846    6,118 
                
Net increase (decrease) in cash and cash equivalents   (1,561)   (2,504)   445 

 

Operating Activities

 

Net cash used in operating activities was $12,479 thousand during the year ended December 31, 2023, compared to net cash used in operating activities of $5,223 thousand during the year ended December 31, 2022. The increase is mainly attributed to the net loss for the period which amounted to $20,914 thousand and adjusted as non-cash, remeasurement of investment in associated company at the amount of $22,164 thousand due to the acquisition of additional 7.5% in true-Gold, Business Combination listing costs at the amount of $16,802 thousand, financial expenses due to bridge loans at the amount of $3,800 thousand and stock-based compensation expenses at the amount of $3,269 thousand. Net cash used in operating activities amounted to $3,908 thousand during the year ended December 31, 2021. The increase was primarily used for payment of salaries and related expenses, travel expenses, research and development, subcontractors, consultants and materials. In addition, the increase in cash used in operating activities derived from a material increase in prepaid expenses related to the BCA.

 

Investing Activities

 

Net cash used in investing activities was $1,036 thousand during the year ended December 31, 2023, consisted of capitalized development costs in the amount of $976 thousand and $60 thousand used for purchasing property, plant and equipment. Net cash used in investing activities was $1,127 thousand during the year ended December 31, 2022, consisted of capitalized development costs in the amounts of $975 thousand and $152 thousand, which were used for purchasing property and equipment. Net cash used in investing activities was $1,765 thousand during the year ended December 31, 2021, and consisted of cost of capitalized development expenses in the amounts of $1,468 thousand and $297 thousand, which were used for purchasing property and equipment.

 

52
 

 

Financing Activities

 

Net cash provided by financing activities was $11,954 thousand during the year ended December 31, 2023, consisted mainly of $2,679 thousand in advance payment for equity, $2,356 thousand in net proceeds from issuance of promissory note $2,919 thousand for net proceeds from issuance of shares in the Business Combination net , an aggregate of $2,630 thousand net proceeds from the issuance of shares and warrants, $642 thousand in exercise of warrants, $550 thousand in proceeds from issuance of bridge loans and warrants and $250 thousand in proceeds from the issuance of a convertible note. Net cash provided by financing activities was $3,846 thousand during the year ended December 31, 2022, consisted mainly of $3,310 thousand in proceeds from issuance of bridge loans and warrants and $581 thousand of proceeds from issuance of convertible notes and $182 thousand net issuance of shares, which was partially offset by payment of $172 thousand for loan repayment to related parties. Net cash provided by financing activities was $6,118 thousand during the year ended December 31, 2021, consisted mainly of $5,892 thousand in proceeds from net issuance of shares and warrants and $395 thousand of net proceeds from the exercise of warrants, which was partially offset by payment of $98 thousand for lease liabilities and loan repayment to related parties of $103 thousand.

 

Current Outlook

 

The Company has incurred and continues to incur losses and continues to generate negative cash flows from operations since inception in 2015. Since the Company’s inception, it has not generated significant revenue from the sale of technology.

 

As of December 31, 2023 and December 31, 2022, the Company had $168 thousand and $1,398 thousand, respectively, in cash and cash equivalents, which the Company has been using and continues to use for working capital and general corporate purposes since those dates. Since December 31, 2023, the Company has raised an additional approximately $5,557 thousand in funding from various investors. The Company expects that its existing cash and cash equivalents, along with amounts it may draw down under the Alpha SPA referred to below (during April 2024, the Company terminated its then-existing $25 million SEPA with Yorkville and entered into a similar agreement for $30 million with Alpha), and receivables from clients once paid, will be sufficient to fund its operations for the foreseeable future but perhaps at a delayed or reduced scope. In addition, the Company has outstanding approximately $13,000 thousand in existing payables and other liabilities related to expenses of the Business Combination. The Company expects to fund the payment of such amounts out of the Alpha SPA, referred to below, ongoing activities of the Company and possibly other capital raisings in 2024. Further, the Company’s operating plans may change as a result of many factors that may currently be unknown to it, and it may need to seek additional funds sooner than planned. The Company’s future capital requirements will depend on several factors, including:

 

Commercial scaling and initial deployment of the technology, along with the progress and costs of our research and development activities;
   
the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;
   
the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and
   
the magnitude of our general and administrative expenses.

 

When and until the Company starts to generate significant recurring revenues and profit, the Company expects to satisfy its future cash needs through capital raising and shareholders’ financial support. The Company cannot be certain that additional funding will be available when needed, on acceptable terms, if at all. The Company’s outstanding warrants are generally either out of money or have nominal exercise prices; accordingly, the Company does not expect to raise any material additional funds from the exercise of outstanding warrants in at least the short-term. If funds are not available, the Company may be required to delay or reduce the scope of research or development plans.

 

53
 

 

We can give no assurances that we will be able to secure additional sources of funds to support our operations on acceptable terms, or at all, or, if such funds are available to us, that such additional financing will be sufficient to meet our needs. If we raise additional funds by issuing equity or convertible debt securities, including pursuant to the Alpha SPA, it could result in dilution to our existing stockholders or increased fixed payment obligations. In addition, as a condition to providing additional funds to us, future investors may demand, and may be granted, rights superior to those of existing stockholders. If we incur additional indebtedness, we could become subject to covenants that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but may not be on terms that are favorable to us. Any of the foregoing could significantly harm our business, financial condition and results of operations. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may be required to reduce the scope of the commercialization of our planned products or delay, scale back or discontinue the development of one or more of our product candidates.

 

We may also need to take certain other actions to allow us to maintain our projected cash and projected financial position, including but not limited to additional reductions in general and administrative costs, sales and marketing costs, and other discretionary costs. Although we believe such plans, if executed and coupled with the above-described sources of liquidity, should provide us with financing to meet our needs, successful completion of such plans is dependent on factors outside of our control.

 

We anticipate that we will continue to incur net losses into the foreseeable future as we continue our development of our product candidates and expand our corporate infrastructure.

 

Contractual Obligations

 

Reciprocal Standby Equity Purchase Agreement

 

In February 2023, we entered into a SEPA with Yorkville, whereby we have the right, but not the obligation, to sell to Yorkville up to $25.0 million of our Ordinary Shares at our request, subject to the terms therein. We have received as loans Pre-Paid Advances of $3.5 million, all of which as of April 29, 2024, have been converted into our Ordinary Shares or repaid in cash.

 

On April 13, 2024, the Company exercised its right of termination under the SEPA and sent to Yorkville a termination notice, which became effective on or about April 19, 2024.

 

Alpha Stock Purchase Agreement

 

On April 19, 2024, the Company entered into a Stock Purchase Agreement (the “SPA”) with Generating Alpha Ltd. (“Alpha”), pursuant to which Alpha has committed to purchase from us up to $30,000,000 of our ordinary shares, subject to the terms and conditions specified in the SPA. The Company entering into the SPA was a condition of the Company’s previously announced note and warrant transaction with Alpha from April 11, 2024.

 

54
 

 

Subject to the terms and conditions of the SPA, the Company has the right from time to time at its discretion, any time after the three month anniversary of the shares underlying the SPA being registered for resale pursuant to the Registration Rights Agreement referred to below, to direct Alpha to purchase a specified amount of our ordinary shares (each such sale, a “Put”) by delivering written notice to Alpha (each, a “Put Notice”). There is a $20,000 mandatory minimum amount for any Put and it may not exceed $500,000, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to : (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20.

 

The Company will control the timing and amount of any sales of ordinary shares to Alpha. Actual sales of our ordinary shares to Alpha as a Put under the SPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company’s ordinary shares and determinations by the Company as to the appropriate sources of funding for its business and operations.

 

The obligations of Alpha to accept any Put pursuant to a Put Notice is subject to customary conditions, including that Alpha is not required to purchase any ordinary shares pursuant to a Put if it would result in Alpha beneficially owning in excess of 4.99% of the Company’s ordinary shares, and that the ordinary shares subject to the Put be registered for resale. The Company agreed to pay a commitment fee to Alpha equal to 1.5% of the commitment amount, payable in shares, or 2,725,621 ordinary shares and which shall be subject to a three month lock-up.

 

The net proceeds under the SPA to the Company will depend on the frequency and prices at which the Company sells ordinary shares to Alpha. The Company expects that any proceeds received by it from such sales to Alpha will be used for working capital and general corporate purposes; provided, however, that in the event the Company owes any indebtedness to Alpha, 50% of any such proceeds shall be applied to repayment of such indebtedness.

 

The SPA will automatically terminate on the earliest to occur of (a) the first day of the month next following the 36-month anniversary of the date of the SPA or (ii) the date on which Alpha shall have made payment of Puts pursuant to the SPA for ordinary shares equal to $30,000,000. The Company has the right to terminate the SPA at no cost or penalty upon five (5) trading days’ prior written notice to Alpha, provided that there are no outstanding Put Notices for which ordinary shares need to be issued and the Company has paid all amounts owed to Alpha pursuant to the SPA and any indebtedness the Company otherwise owes to Alpha or its affiliates. The Company and Alpha may also agree to terminate the SPA by mutual written consent. Neither the Company nor Alpha may assign or transfer its respective rights and obligations under the SPA, and no provision of the SPA may be modified or waived by the Company or Alpha other than by an instrument in writing signed by both parties.

 

The SPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.

 

The Company further entered into a Registration Rights Agreement with Alpha, pursuant to which the Company agreed to register for resale ordinary shares underlying the SPA.

 

Leases

 

SMX Israel is a party to a lease agreement dated January 14, 2020, and amended as of December 24, 2020 (the “Lease”). Under the Lease, it is obligated to pay ILS 253 thousand plus VAT per year. The Lease will expire on May 31, 2027, with an additional option of 5 years, unless terminated by the landlord due to a requirement of a governmental authority to modify or terminate the Lease, pursuant to the terms of the lease.

 

55
 

 

Borrowings

 

On September 19, 2023, the Company amended the loan agreements dated September 7, 2015, by and between SMX Israel, the Company’s shareholders and Kamea Fund. Pursuant to the amendment to the loan agreements, Kamea agreed to convert US$657 thousand of indebtedness under the loan agreements into 487,281 ordinary shares (post share reverse split) of the Company, as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the shares are not at least equal to the indebtedness amount, the Company will remain liable to Kamea for the balance of the indebtedness amount. In accordance with management estimation the FV of this Indebtedness is immaterial.

 

Additionally, Kibbutz Ketura provides administrative services for SMX Israel for which it was debited $34 thousand and $36 thousand for the year ended December 31, 2023 and December 31, 2022, respectively.

 

Security Matters PTY and the Company borrowed an aggregate of $3,860 thousand from private investors between September 2022 and February 2023, which loans are due no earlier than May 31, 2024. All of such loans have an interest rate of 10% per annum. Each such lender (except for one lender which lent an amount of $1,000 thousand which is not entitled to the redeemable warrants), further received 20% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share and a first priority security interest in the shares of Security Matters PTY’s interest in true-Gold Consortium Pty Ltd. In March 2023, the Company signed an addendum to the Bridge Loans agreements which converted $1,350 thousand into common shares and deferred the remaining cash payments during the first and second quarter of 2024.

 

On December 31, 2023, the Company issued an aggregate of 4,032,256 Ordinary Shares and warrants to purchase an aggregate of 4,032,256 ordinary shares, to the lenders, in exchange for the cancellation of an aggregate of (a) approximately $750 thousand in principal owed to the lenders and (b) $1,450 thousand cash value of Redeemable Warrants. The Company also issued 457,682 Ordinary Shares to a service provider (the “Service Provider”) as payment in full for $260 thousand worth of services previously provided to the Company by the Service Provider. Such transactions were evidenced by a series of substantially similar Conversion and Exchange Rights Agreements executed as of December 31, 2023.

 

In January 2023, the Company borrowed $250 thousand from a private investor, which loan is due December 31, 2024. Such loan has an interest rate of 15% per annum and is convertible at a conversion price of $10.00 per share, and the holder further received 5% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share.

 

On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 (the “September SPA”) and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to the Company of approximately $2,358 thousand, before deducting fees and other offering expenses payable by the Company. The note was issued in the principal amount of $4,290 thousand, all of which have been converted as of April 29, 2024 into an aggregate of 2,619,377 Ordinary Shares. The actual amount loaned by the investor pursuant to the Note was $2,574 thousand after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the effective date and is the date upon which any remaining accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into Ordinary Shares at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary adjustments and limitations set forth in the note, including for fundamental transactions. As of April 29, 2024, the investor has converted all of the principal of the note into an aggregate of 2,619,377 Ordinary Shares.

 

56
 

 

Additionally, as part of the transaction, we issued two warrants to the Investor, an “A” Warrant and a “B” Warrant. The A Warrant for 3,929,051 Ordinary Shares has an exercise price of $0.0022 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the A Warrant. As of April 29, 2024, the investor exercised the Warrant A for 3,789,264 Ordinary Shares. The B Warrant for 2,619,367 Ordinary Shares had, pursuant to the September SPA, an exercise price of $1.6378 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the B Warrant. On April 11, 2024, as an inducement of the Company for the Investor to enter into transactions pursuant to a Securities Purchase Agreement, whereby the Company issued and sold to the Investor a promissory note and warrants, for gross proceeds to the Company of approximately US$2.0 million, before deducting fees and other offering expenses payable by the Company, the Company entered into a Warrant Amendment and Inducement Letter with the Investor, with respect to the “B” warrants. Pursuant to the Warrant Amendment and Inducement Letter, the Investor exercised for cash the outstanding “B” warrants in full at a reduced exercise price of $0.0022 per share, or approximately $5,762. See Item 8.B. Significant Changes, elsewhere in this Annual Report on Form 20-F.

 

On October 3, 2023, Security Matters PTY entered into an Investment Agreement (the “Investment Agreement”) with True Gold Consortium Pty Ltd (“True Gold”), of which Security Matters PTY is a shareholder.

 

Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 True Gold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in True Gold shall be increased to 51.9% of the total issued and outstanding shares of True Gold, making Security Matters PTY the majority owner of True Gold. Additionally, the existing license agreement as between Security Matters PTY and True Gold was amended to include additional intellectual property of Security Matters PTY to be licensed to True Gold thereunder. Security Matters PTY shall further supply to True Gold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

Pursuant to the Investment Agreement, True Gold shall have the right, within 12 months of the issuance of the True Gold Shares to Security Matters PTY, to purchase the True Gold Shares from Security Matters PTY for a purchase price to be decided by an external valuator.

 

Government Grants

 

As of December 31, 2023 and December 31, 2022, the Company has a contingent liability of $153 thousand and $135 thousand, respectively, for government grant it received for the use of research and development activities from Israel Innovation Authority (IIA). The Company is subject to paying 3% of its relevant revenues for the first three years, and 4% of the relevant revenues for further years, until repayment of the entire grant.

 

Isorad License Agreement

 

In January 2015, the Company entered into the Isorad License Agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

In January 2023, the Company signed an amendment to the agreement that determine the following:

 

(1) for the BCA with Lionheart, Isorad was issued 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main assumptions which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%.

 

57
 

 

The fair value of these options was $33 thousand and recognized as a technology license intellectual property.

 

(2) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof).

 

As of December 31, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $123 thousand against a liability that reflects the due amount.

 

(3) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

Sales Cooperation Agreement

 

On July 25, 2023, the Company entered into a Sales Cooperation Agreement with Data Vault Holdings, Inc., which acts in the area of Web 3.0 technologies, crypto anchors and data software as a service, pursuant to which each party on a non-exclusive basis will effect introductions of potential clients to the other. Pursuant to the agreement, any transaction between a party and an introduced client shall entitle the introducing party to a commission on income received in the transaction for 48 months. In addition to entering into the Sales Cooperation Agreement, the companies intend to collaborate to advance Data Vault’s Web 3.0 strategies for data visualization, inventory tracking and laboratory automation, using the Company’s digital blockchain platform enhanced with a physical marker.

 

Warrant Reset Offer

 

On December 8, 2023, the Company consummated an inducement offer letter agreement with certain holders of the Company’s outstanding Warrant Bs to purchase Ordinary Shares of the Company. The Warrant Bs were issued on June 27, 2022 and had an exercise price of $5.28 per share (after taking into account the Company’s 1:22 reverse share split).

 

Pursuant to the inducement letter, the holders agreed to exercise for cash their Warrant Bs to purchase an aggregate of 606,060 Ordinary Shares at a reduced exercise price of $1.15 per share in consideration for the Company’s agreement to issue new warrants to purchase, in the aggregate, up to 909,090 of the Company’s Ordinary Shares at an exercise price of either (i) $0.0022 per share in an amount not to exceed 75% of the new warrant shares, or (ii) $1.15 per share, in the discretion of the warrantholders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of approximately $697,000 from the exercise of the Warrant Bs by the holders. In January 2024, the holders of such reset warrants exercised 454,544 warrants pursuant to the option described above under clause (i), and as a result we issued an aggregate of 454,544 ordinary shares.

 

Quantitative and Qualitative Disclosures about Market Risk

 

The Company is exposed to market risks in the ordinary course of business. Market risk represents the risk of loss that may impact on our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily with respect to the ILS, AUD, EUR and SGD, which is discussed in detail in the following paragraph.

 

Foreign Currency Exchange Risk

 

Currency Fluctuations

 

The Company’s operating expenses are denominated in ILS, AUD, EURO and SGD, and therefore are currently subject to foreign currency risk. We have been affected by changes in some of such rates compared to the U.S. dollar, as of December 31,2023, the ILS increased against the U.S. dollar by approximately 3%, the AUD increased against the U.S. dollar by approximately 0%, the EUR increased against the U.S. dollar by approximately 4% and the SGD increased against the U.S. dollar by approximately 1%.

 

58
 

 

The Company’s policy is not to enter into any currency hedging transactions, and we cannot assure you that we will not be adversely affected by currency fluctuations in the future.

 

Credit Risk

 

Credit risk is a risk of financial loss if a counterparty or customer fails to meet its contractual obligations. We closely monitor the activities of our counterparties and control the access to its intellectual property which enables it to ensure a prompt collection. Our main financial assets are cash and cash equivalents as well as other receivables and represent the Company’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Company holds cash with major and sound financial institutions in Israel and Australia.

 

Liquidity Risk

 

Liquidity risk is the risk that we will encounter in meeting our obligations associated with our financial liabilities that are settled by delivering cash or another financial asset. The Company seeks to minimize that risk by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. For more details, please refer to the section titled, “Liquidity and Capital Resources”.

 

C. Research and Development, Patents and Licenses, Etc.

 

Research and Development

 

Given the varied needs of different industries, the Company’s research and development processes are divided according to industry.

 

Plastics, Rubber and Other Materials

 

In 2022, Security Matters PTY completed a successful trial of marking recycled plastics by studying the impact of gravimetric and volumetric feeding methods on final Post Consumer Recyclat (“PCR”), readings. The compounding master batch and extrusion processes of these trials were performed on a pilot scale in a fully commercial and industrial facility. The Company’s team demonstrated its ability to manage the process remotely, indicating the viability of industrial scale adoption.

 

The successful trial provides plastic manufacturer and importing companies with a proof of concept, enabling them to more accurately identify and audit, via an automated transparent reporting system, the polymer type, number of loops and the amount of recycled content despite the size and color of the plastic. As a result, the Company is positioning itself to be able to offer plastic manufacturing and importing companies the ability to promote their operations as being sustainable and environmentally friendly. Combined with its ability to digitally certify the materials, the Company is also positioning itself to offer these companies the ability to avoid human/manual-paper auditing and use technology/automated auditing, which helps to reduce the potential for human errors and can provide for cost savings.

 

In March 2023, the Company announced that it succeeded for the first time in verifying a marker substance for natural rubber in a tire and so throughout the entire production process. The dedicated marker technology, which the Company and Continental optimized for use in natural rubber, is designed to create greater transparency along the entire value chain of tires and technical rubber products from Continental. Provided with special security features, the use of the marker substances enables the invisible marking of natural rubber with information on its geographical origin. This means, for example, that responsibly sourced natural rubber and its origin can be verified at every stage of the supply chain all the way through to the customer.

 

In the field test, the marker substance was added to responsibly grown latex during harvesting and withstood not only the intensive preparations involved in the production of natural rubber but also the tire manufacturing process itself. In the manufactured tire, the data was retrieved using special, purpose-built software and a reader and correctly interpreted. The appearance and performance of a bicycle tire containing the invisible marker remained unchanged.

 

59
 

 

The Company expects that Continental will use the new marker technology on a larger scale in the future during the process of sourcing its rubber and also to integrate it in other rubber products. As part of the industrialization of this technology, it is conceivable to link the markers with blockchain technology. This could provide additional support for tamper-free monitoring of compliance with quality standards and quality criteria along the complex supply chain of natural rubber.

 

On April 10, 2024, the Company announced that it has successfully completed the marking of 21 tons of natural rubber sourced in Latin America from tree to tire. The program covered the marking at the tree in Latin America through manufacturing and production in the region. The Company’s marker was added to the cup lump harvesting by the farmers prior to transfer to the manufacturing centre where the 42 tons of latex was converted to 21 tons of natural rubber. The bails were then transferred to tire manufacturing for commercial car, truck and lorry tires. The tires were then sent for evaluation. The results demonstrated 100% success rates on all marked tires to have a proven verification technology for origin authentication of the natural rubber and full traceability all along the entire supply chain data and integrity from tree to tire.

 

Plastic Cycle Token

 

On November 28, 2023, the Company announced the planned launch of a plastic cycle token, scheduled for release in the third quarter of 2024. The initiative is being designed to present a reliable, ethical digital credit platform, aiming to capitalize on billions of dollars in recyclable plastics credits in a newly created market.

 

The tradeable plastic cycle token is being designed to enable companies to transition towards sustainable practices, encouraging entities within and outside the plastic ecosystem, including oil producers and waste management firms, to increase recycled content utilization.

 

This initiative is also expected to position the SMX Plastic Cycle Token as a next-generation alternative to carbon credits, creating a new paradigm in the Impact ESG investment landscape. Each token is being designed to represent a quantifiable amount of recycled plastic using SMX’s technology to physically mark the plastics, potentially offering a tangible impact on environmental circularity.

 

Gold and Other Metals

 

Gold

 

Security Matters PTY formed a joint initiative with Perth Mint to develop a mine-to-marketplace ethical gold supply chain technology solution. Since the incorporation of trueGold Consortium Pty Ltd (“trueGold”) in June 2020, this research and development project aims to promote a ‘mine to product’ transparency solution dedicated to responsible mining of materials. Security Matters PTY’s track & trace technology provides information on the origin of the materials and how they move across production and distribution chains towards recycling and back to refining.

 

On July 29, 2020, Security Matters PTY signed a shareholders’ agreement with W.A. Mint Pty Ltd. (“Perth Mint”) and trueGold. The shareholders’ agreement and the ancillary agreements discuss the establishment of a new entity—trueGold—by Security Matters PTY and Perth Mint. Security Matters PTY granted to trueGold, subject to the terms of the license agreement, an exclusive, worldwide, perpetual license to use Security Matters PTY’s technology for the purpose of commercializing it within the industry comprising gold as a precious metal (as elaborated below). Security Matters PTY owns any development of its intellectual property and, while trueGold owns all generated data it creates, trueGold granted to Security Matters PTY a free non-exclusive, irrevocable, perpetual, royalty free license to use the generated data, subject to regulatory requirements and to the extent that it relates to the Isorad License Agreement technology or Security Matters PTY’s technology. The parties agreed that neither Perth Mint or Security Matters PTY are required to provide any funding to trueGold and that any investment by any of them in trueGold from time to time will be by way of in-kind contributions. Third party equity investors will contribute the working capital will fund R&D, development capital and other expenses in accordance with the business plan.

 

60
 

 

Other than with the consent of the other shareholders or between affiliates (defined, inter alia, as a related body corporate of a shareholder; a company in which the shareholder beneficially owns 50% or more of the issued shares) a transfer of shares will be done subject to a right of first refusal of the other shareholders, whom will also have tag-along rights and a drag-along (as elaborated below). Under the constitution (as amended in July, 2022, to add the specific right of Security Matters PTY to purchase shares before any other shareholders) any shareholder wishing to transfer shares must notify the board of directors and, before the board of directors authorize the transfer of any share or shares, the share or shares must first have been offered to Security Matters PTY (for its own benefit and unless Security Matters PTY is 50% owned by one entity), and if SMX does not notify within 30 days that it wishes to purchase, then to all other shareholders (including Security Matters PTY) at a price to be agreed on by the transferor and the directors of trueGold. If the transferor and the directors of trueGold are unable to agree on a price, the price of the relevant shares will be a price which: represents a fair market price; and is determined by expert determination administered by the Australian Disputes Centre (ADC) in accordance with the ADC Rules for Expert Determination which are operating at the time the matter is referred to ADC, which Rules are incorporated into the constitution of trueGold. The determination of such person in relation to the price of the relevant shares will be final and binding on all shareholders.

 

Subject to certain terms and conditions, a drag-along right is established under which where shareholders wish to dispose of all of their share to a third party that wishes to acquire 100% of trueGold and 75% or more of the aggregate number of shares on issue at that time agreed, the remaining shareholders may be forced to transfer to the third party all of the shares held by each of the remaining shareholders. In case of a deadlock (defined as a case where the board of directors disagrees on a material matter regarding the fundamental operation of trueGold or the business and cannot resolve the disagreement within 10 business days of the disagreement first arising), if the shareholders are unable to reach agreement on any matter, a dispute resolution mechanism was created.

 

The board of directors of trueGold was agreed to consist of not less than three and not more than seven. The board is comprised as follows: Security Matters PTY may appoint (remove or replace) up to two directors; Zeren Browne; Perth Mint may appoint (remove or replace) up to two directors; and Hugh Morgan, who is a non-executive, independent chair. A list of resolutions was set, which require a board majority including at least one Security Matters PTY appointed director and one Perth Mint appointed director. Another list of resolutions was set, which require a resolution carried by a majority of the shareholders including Security Matters PTY and Perth Mint. trueGold and Yahaloma (defined below) agreed to bear the payments to Soreq related thereto of 4.2% of its revenues. SMX’s CEO, Mr. Haggai Alon, provides CEO services to trueGold and reports to the board of directors of trueGold, and Zeren Browne provides General Manager services to trueGold.

 

On October 3, 2023, Security Matters PTY entered into the Investment Agreement with trueGold. Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 trueGold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in trueGold shall be increased to 51.9% of the total issued and outstanding shares of trueGold, making Security Matters PTY the majority owner of trueGold. Additionally, the existing license agreement as between Security Matters PTY and trueGold was amended to include additional intellectual property of Security Matters PTY to be licensed to trueGold thereunder. Security Matters PTY shall further supply to trueGold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

TrueSilver

 

On June 7, 2023, we announced that we are in the process of creating a new subsidiary, TrueSilver, and that we have entered into a 120 day exclusive agreement with Sunshine Minting Inc. (“Sunshine”), to create a path to full transparency and traceability for silver products from mine site to final products and recycling and the creation of an industry standard. During the 120-day exclusivity period, Sunshine shall evaluate our technology for its use, with possible further collaborations thereafter.

 

61
 

 

In July 2023, we transferred the ownership of our wholly owned granddaughter company “Security Matters Canada Ltd.” from ownership by our subsidiary Security Matters PTY to direct ownership by the Company and renamed it “TrueSilver SMX Platform Ltd.”

 

On April 15, 2024, the Company announced the successful completion of proof of concept for ethical sourcing and authentication of silver in cooperation with Sunshine.

 

The Company has now successfully completed the marking of 2.2 tons of silver within Sunshine’s operations. The program covered the marking of the silver raw material through continuous manufacturing processes to final products including recycling loops.

 

The Company’s technology was added at the melting stage and the marked silver material was processed into blank (from casting, extrusion, rolling, annealing, blank cutting & recycling), and the quality of the marked intermediate material and final products was evaluated (from billet to blank and recycled blank after several cycles).

 

The results demonstrated 100% success rates on all marked products all along the production process (from billet to finished product) ensuring the durability and irrefutable proof of quality and Brand authentication of the silver for credible ESG reporting for stakeholders, customers, auditors, and regulators.

 

Non-Ferrous Metals

 

On November 29, 2022, Security Matters PTY signed a products distribution and SAAS reseller agreement with Sumitomo Corporation, a Japanese corporation. Under such agreement, Security Matters PTY appointed Sumitomo to act as Security Matters PTY’s exclusive, worldwide distributor to market and sell markers, readers and Security Matters PTY services to customers for application in the Non-Ferrous Metals Market (as defined below) only, subject to the customer entering into with Security Matters PTY its standard product license agreement. The “Non-Ferrous Metals Market” is defined as all supply chain market segments of the industry for aluminum, copper, lead, nickel, zinc, molybdenum, cobalt, lithium and tin.

 

The price at which Security Matters PTY shall sell products to Sumitomo and the license fee at which Security Matters PTY shall license Security Matters PTY products and Security Matters PTY service to Sumitomo shall be a discount of the invoices issued to the customers.

 

Generally, the agreement shall remain in effect for an initial term of five years from the effective date of first commercial sale by Security Matters PTY to Sumitomo of any products. The companies have agreed that over the coming years there is a target to reach $35 million in sales.

 

Alcoholic Beverages

 

In December 2021, Security Matters PTY acquired all the holdings SMX Beverages Pty Ltd, a joint venture incorporated in February 2020 for the promotion of solutions in the alcoholic beverage industries including in relation to the prevention of counterfeit alcoholic beverages, circular economy concepts and packaging and supply chain within those industries.

 

Diamonds and Precious Stones

 

On April 30, 2019, Security Matters PTY signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters PTY’s trace technology in the diamonds and precious stone industry. Under the terms of the agreement, Security Matters PTY and Trifecta established a new entity—Yahaloma Technologies Inc., which is equally held by Security Matters PTY and Trifecta.

 

62
 

 

Both parties covenanted not to pursue the use of Security Matters PTY’s technology for diamonds and precious stones, or any other venture related to the testing of the origin of diamonds or precious stone, other than through the Yahaloma. Additionally, in agreement with Isorad, all rights in and to any intellectual property related to the diamonds and precious stones industry that is developed by or for Yahaloma is jointly owned in equal parts by the Security Matters PTY, Yahaloma and Soreq.

 

Security Matters PTY continues to develop the technology and will supply Yahaloma technical services. Security Matters PTY bears the cost of such R&D services but the agreed hourly costs of Security Matters PTY’s staff is recorded as a shareholders loan of Security Matters PTY to Yahaloma, once the first USD 250,000 to be paid by Trifecta are exhausted (which is yet to happen). Trifecta supplies Yahaloma diamonds and other raw materials, which remain in the ownership of Trifecta. If Security Matters PTY causes damage to such diamonds during the R&D process, this will be reported the Trifecta and the damage recorded as a shareholders loan of Trifecta to Yahaloma. Trifecta will supply Yahaloma services of business development. Trifecta bears the cost of such services but the agreed hourly costs of Trifecta’s staff is recorded as a shareholders loan of Trifecta to Yahaloma. Management of Yahaloma is agreed to be jointly, with certain special resolutions requiring agreement of both parties. Actual day-to-day management is in Canada.

 

In addition to the shareholders loan extended by man-hours as stipulated above, the parties covenanted to extend up to USD 1 million to Yahaloma (USD 350,000 by Security Matters PTY and USD 650,000 by Trifecta, with USD 250,000 extended by Trifecta registered as capital and all other funds as shareholders loans). Funds were agreed to be injected upon reaching certain milestones. The Security Matters PTY loan of USD 350,000 are to be injected only upon reaching future milestones and only if such funds will be required, which stage has not yet arrived. Such Security Matters PTY loan will bear an interest rate of 5% per annum. Upon Yahaloma being able to repay the shareholders loans, first a sum of USD 250,000 will be repaid to Trifecta and then all other shareholders loans will be repaid pro-rata. Only after repayment of all shareholders loans will Yahaloma distribute profits.

 

A party may not transfer its shares to others without the prior approval of the other party other than a transfer to an affiliate (defined as an entity directly or indirectly controlled by a party or directly or indirectly controls such party or is directly or indirectly controlled by a person which also, directly or indirectly, controls such person) done after 30 days’ notice to the other party, and after the affiliate agrees to adopt the agreement.

 

Yahaloma agreed to bear the payments to Soreq related thereto (as described in “Gold and Other Metals” above).

 

Electronics

 

Security Matters PTY has joined an alliance formed by six founding partners, among them the World Business Council for Sustainable Development, to set a shared vision for a circular economy for electronics, called the Circular Electronics Partnership. This group of global companies has been brought together to reduce e-waste and to commit to a roadmap for a circular economy for electronics by 2030.

 

Fashion

 

In December 2020, Security Matters PTY announced that it had launched a Fashion Sustainability Competence Centre to enable fashion brands globally, to transition successfully to a sustainable circular economy by being able to identify the origination of their raw materials and hence, recycle their own unsold and/or end-of-life merchandise (garments, footwear and accessories including sunglasses) back into new high-quality materials and new fashion merchandise Security Matters PTY’s technology is applicable across a range of materials including leather, silk, cotton, wool, coated canvas, vegan leather, polyesters, cashmere, metals (e.g., gold & metallic parts) and plastics; and its applications encompass finished leather goods, shoes, garments, and accessories. Security Matters PTY is also collaborating with several luxury fashion conglomerates on R&D projects to trace the origin of raw materials used in their supply chain and is in commercial negotiations regarding the implementation of its solution with partners in the industry.

 

63
 

 

In July 2023, we changed the name of the wholly owned subsidiary from “SMX France” to “SMX Fashion and Luxury” in anticipation for such company to be used for the fields of fashion and luxury.

 

Intellectual Property

 

The ability of Security Matters PTY to develop and maintain proprietary information technology is crucial to our success. Since 2015, Security Matters PTY technology has been protected by more than 20 patent families and more than 100 patents filed around the world in various stages with respect to our marking and reading technologies. The table below lists the 20 patent families. Under each patent family, we note the countries under which such patents have been filed.

 

The following table provides a list of Security Matters PTY’s patents that have passed the international phase (PCT) and may be publicly disclosed:

 

Patent
Family
  Countries   Type   Title and Type
of
Patent
Protection
  US Status   US App#’s   US
Filing
Date
  US Patent #   US
Publication
  US
Expiration
Date
1  

US

Taiwan

Japan

China

Europe

Israel

 

Republic of
Korea

  PCT   System and method for reading x-ray-fluorescence marking   Registered  

15/563,756

16/709,804

 

Mar 2016

 

Mar 2016

 

US10539521B2

US10969351B2

 

Jan.2020

Apr 2021

 

Jul 2036

Mar 2036

                   
2  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   Authentication of metallic objects   Registered   16/074,226   Feb 2017   US11446951B2   Sep 2022   Jan 2040
                   
3  

US

Australia

Europe

Israel

Korea

  PCT   Access control system and method thereof   Published/
Pending
  16/083,966   Mar 2017   US20200242865A1   Jul 2020    
                   
4  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   A method and a system for XRF marking and reading XRF marks of electronic systems  

Registered

Registered

 

16/091,222

16/834,732

  Apr 2017   US10607049B2   Mar 2020   Apr 2037
                   
5  

US

Australia

China

Europe

Austria

Germany

Estonia

Spain

Finland

France

Great Britain

Latvia

Sweden

Israel

Japan

Korea

  PCT   An XRF analyzer for identifying a plurality of solid objects, a sorting system and a sorting method thereof   Registered   US16/311,290   Jun 2021   US10967404B2   Apr 2021   Dec 2037
                   
6  

US

Australia

Canada

Europe

Israel

South Africa

  PCT   Method for marking and authenticating precious stones  

Registered

Pending

 

16/328,526

17/666,866

  Aug 2017   US11320384B   May 2022   Oct 2038

 

64
 

 

Patent
Family
  Countries   Type   Title and Type
of
Patent
Protection
  US Status   US App#’s   US
Filing
Date
  US Patent #   US
Publication
  US
Expiration
Date
7  

US

Australia

China

Europe

Israel

Korea

Taiwan

Japan

Ukraine

  PCT   X- ray fluorescence system and method for identifying samples   Registered   16/334,431   Sep 2017   US11112372B2   Sep 2021   Jun 2038
                   
8  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   Method for Detecting Mishandling and Misuse of Food Products   Pending   16/336,712   Sep 2017   US20210321649A1   Oct 2021    
                   
9  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   XRF-Identifiable Transparent Polymers   Registered   16/340,913   Oct 2017   US11193007B2   Dec2021   Apr 2038
                   
10  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   A System for Virtual Currency based on Blockchain Architecture and Physical Marking   Pending   16/609,686   May 2018   US20200184465A1   Jun 2020    
                   
11  

US

Australia

Europe

Israel

Korea -
Application
discontinuation

  PCT   An Object Marking System for Authentication and Verification   Registered   16/609,700   May 2018   US11221305B2   Jan 2022   Oct 2038
                   
12  

US

Australia

Canada

China

Europe

Israel

Japan

Korea

  PCT   Management of Recyclable Goods and Their Source Materials   Application
Filed
  17/766,874   Oct 2020   WO2021070182A1   Apr 2021    
                   
13  

US

Australia

China

Europe

Hong-Kong

Israel

Japan

Korea

  PCT  

Systems and Methods for Supply Chain Management and Integrity

 

Verification Via Blockchain

  Application
filed
  16/980,693   Mar 2019   WO2019175878A1   Sep 2019    

 

65
 

 

Patent
Family
  Countries   Type   Title and Type
of
Patent
Protection
  US Status   US App#’s   US
Filing
Date
  US Patent #   US
Publication
  US
Expiration
Date
14  

US

Australia

Azerbaijan

Brazil

Canada

China

Europe

Hong-Kong

Indonesia

Israel

Japan

Korea

Malaysia

Singapore

Uzbekistan

  PCT   System and Method for Detection and Identification of Foreign Elements in a Substance   Application
filed
  17/285,167   Oct 2019   US20210325323A1   Oct 2021    
                   
15  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Method and System for Classification of Samples   Application
filed
  17/594,406   Apr 2020   WO2020212969A1   Oct 2022    
                   
16  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency in Production Value Chains  

Pending

Pending

 

17/626,916

17/626,923

 

Jul 2020

Jul 2020

 

US20220251252A1

US20220259356A1

 

Aug 2022

Aug 2022

 

Pending

Pending

                   
17  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency in Production Value Chains  

Pending

Pending

 

17/626,916

17/626,923

 

Jul 2020

Jul 2020

 

US20220251252A1

US20220259356A1

 

Aug 2022

Aug 2022

   
                   
18  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite for Marking Seeds and Plants   Application
Filed
  17/639,397   Sep 2020   20220312711 A1   Oct 2022    
                   
19  

US

Australia

Canada

China

Europe

Israel

Japan

Korea

  PCT   Management of Recyclable Goods and Their Source Materials   Application
Filed
  17/769,175   Oct 2020   WO2021074919A1   Apr 2022    
                   
20   PCT/
IL2021/050325
  PCT   Device and Method for Detection of Viruses By XRF   Application
filed
      Mar 2021   WO2021191899A1   Sep 2021    

 

Abstracts

 

Patent Family 1:

 

System and method for reading x-ray-fluorescence marking (US10,539,521, granted, expires 13/07/2036; US10969351B2, granted, expires 31/03/2036). Abstract: Method and systems are presented for authentication of precious stones, according to their natural ID and/or predetermined markings created in the stones, based on unique characteristic radiation response of the stone to predetermined primary radiation.

 

66
 

 

Patent Family 2:

 

Authentication of metallic objects (US16/074,226, granted, expires 25/01/2040). Abstract: The present invention provides an anti-counterfeit marking technique for verifying authenticity of objects using x-ray fluorescence (XRF) analysis.

 

Patent Family 3:

 

Access control system and method thereof (US16/083,966, Pending, filed 21/03/2017). Abstract: The present invention relates to an access control system, an access object and a method for access control. The access control system comprises an access request receiving device being configured and operable for receiving an access object; the access request receiving device comprising an emitter configured and operable for irradiating the access object with a radiation having a wavelength in the range of about 10”12 and 10”9 m and a detector configured and operable for detecting a response signal from the irradiated access object; a control circuit being configured and operable to receive the response signal from the access request receiving device and process the response signal to identify spectral features indicative of an XRF signature of the access object; wherein the control circuit is adapted to generate an unlocking signal for switching a module device between a locked state and an unlocked state upon identification of the XRF signature.

 

Patent Family 4:

 

A method and a system for XRF marking and reading XRF marks of electronic systems (US10,607,049, granted, expires 04/042037, US16/834,732, granted, expires 04/12/2037). Abstract: Methods and systems for verifying compatibility of components (e.g. parts or devices) of an electronic system are disclosed. In certain embodiments the method includes: irradiating a first and second components presumably associated with the electronic system, with XRF exciting radiation, and detecting one or more XRF response signals indicative of a first and a second XRF signatures, emitted from the first and second components in response to the irradiation. Then the first and second XRF signatures are processed to determine whether they are associated with respectively a first and second XRF marking compositions on the first and second components, and the compatibility of the first and second components to the electronic system is determined/verified based on the correspondence between the first and a second XRF signatures/marking. Certain embodiments also disclose electronic systems including at least a first and a second electronic components/devices respectively having the first and second XRF marking compositions that enable verification of compatibility of the components. Certain embodiments disclose techniques for pairing the first and second components (e.g. devices) based a correspondence between the first and second XRF signatures/markings thereof. Certain embodiments disclose various calibration techniques for calibrating the XRF measurements of XRF markings applied to different substrate materials of the electronic components.

 

Patent Family 5:

 

An XRF analyzer for identifying a plurality of solid objects, a sorting system and a sorting method thereof (US10,967,404, granted, expires 04/12/2037). Abstract: The present invention discloses a novel XRF analyzer capable of simultaneously identifying the presence of a marking composition in a plurality of objects by modulating/varying the intensity of the excitation beam on the different objects and measuring the secondary radiation thereof. The XRF analyzer comprises a radiation emitter assembly adapted for emitting at least one X-Ray or Gamma-Ray excitation radiation beam having a spatial intensity distribution for simultaneously irradiating the plurality of objects; a radiation detector for detecting secondary radiation X-Ray signals arriving from a plurality of objects in response to irradiation of the objects by X-Ray or Gamma-Ray radiation, and providing data indicative of spatial intensity distribution of the detected data X-Ray signals on the plurality of objects; and a signal reading processor in communication with the detector, the processor being adapted for receiving and processing the detected response X-Ray signals to verify presence of the marking composition included at least one surface of each object of the plurality objects.

 

Patent Family 6:

 

Method for marking and authenticating precious stones (US16/091,222, granted, expires 20/10/2038, US Divisional 17/666,866, pending, filed 08/02/2022). Abstract: Method and systems are presented for authentication of precious stones, according to their natural ID and/or predetermined markings created in the stones, based on unique characteristic radiation response of the stone to predetermined primary radiation.

 

67
 

 

Patent Family 7:

 

X-ray fluorescence system and method for identifying samples (US11,112,372, granted, expires 03/06/2038). Abstract: A control system and method are presented for controlling operation of an X-ray Fluorescent (XRF) system for detecting at least one material carried by a sample, for example at least one marker carried by the sample. The control system comprises: data input utility for receiving input data comprising material/marker related data about said at least one material/marker; and data processor and analyzer utility. The data processor and analyzer utility is configured and operable for analyzing the input data and determining optimal geometrical characteristics of the XRF system for optimizing operational conditions of said XRF system to maximize amount of primary X-ray radiation that reaches a predetermined region of the sample and is absorbed by a volume of said region and to maximize a portion of secondary radiation emitted from said region that reaches a detector of the XRF system; and for generating operational data to the XRF system enabling adjustment of the geometrical characteristics of the XRF system.

 

Patent Family 8:

 

Method for Detecting Mishandling and Misuse of Food Products (US16/366,712, Pending, filed 25/09/2017). Abstract: The present invention provides a method of labeling a product for human or animal use with an XRF identifiable label, the method comprising forming a pattern of at least one FDA-grade material identifiable by XRF on at least an area of the product. Wherein the pattern is optionally at least partially invisible to the naked eye and has predefined identifiable properties, wherein the product is selected from foods, therapeutics and cosmetics.

 

Patent Family 9:

 

XRF-Identifiable Transparent Polymers (US11,193,007, granted, expires 02/03/2038). Abstract: The invention provides formulations and masterbatches of a polymeric material and XRF-identifiable markers, for producing transparent elements including a polymer and at least one XRF-identifiable marker for a variety of industrial uses.

 

Patent Family 10:

 

A System for Virtual Currency based on Blockchain Architecture and Physical Marking (US16/609,686, Pending, filed 08/05/2018). Abstract: Methods and system for management of transactions of marked objects are disclosed. In an embodiment, a method for recording a marked object includes: determining specific and unique marking of the object by a reader unit; and communicating encrypted data indicative of the marking and data indicative of the marked object to at least one server system, for generating at least one record of the object and its marking thereat. The at least one server system may be a distributed blockchain system including: at least one blockchain service module adapted for recording transactions of objects in a blockchain; and at least one management service module adapted for authorization of each transaction of an object based on authentication of the transaction by: providing a reader unit with a certain reading scheme/parameters that authorize/enable the reader unit to correctly read the specific marking on the object; and obtaining from the reader unit in response, a reading data indicative of the marking being read using the reading scheme, and authenticating the object based on a match between the reading data and stored data of the object’s marking which is stored by the at least one server. In turn, before carrying out a request for recordation of a transaction for the object in the blockchain, the blockchain service module is adapted to await authorization of the transaction from the management service.

 

68
 

 

Patent Family 11:

 

An Object Marking System for Authentication and Verification (US11,221,305, granted, expires 23/10/2038). Abstract: Systems and methods for marking of objects, such as keys/key-blanks, in a production line are disclosed. The objects are marked by applying a marking composition(s) to pre-selected areas on the surface thereof. The system includes a marking unit for dispensing a volume of marking composition in one or more localized pre-selected areas on the surface of an object to be marked; a holder/gripper for positioning the object to be marked in one or more positions relative to the marking unit so as to allow the marking unit to dispense the marking composition on the one or more pre-selected localized areas; a reading/verification unit for detecting the marking composition applied to the object thereby verifying that the objects are properly marked; an orientation sensing unit for identifying the orientation of the object to be marked relatively to the holder. The system also includes a controller configured for controlling the operation of the holder, orientation sensing unit, and the marking unit. The reading/verification unit is adapted to identify the marking composition in the one or more pre-selected areas on surface of the object by detecting an electromagnetic signal (such as XRF signal) emitted from the marking composition (e.g. in response to its illumination by X-ray or gamma-ray).

 

Patent Family 12:

 

Management of Recyclable Goods and Their Source Materials (US17/766,874, Pending, filed 07/10/2020). Abstract: Techniques for monitoring production and reuse of a recyclable material, and/or determining a currency or quality measure thereof, are disclosed. In the disclosed embodiments one or more markers are introduced into ingredient material components of the recyclable material, where the one or more markers being indicative of one or more properties of at least one of the ingredient material components. Information indicative of at least the one or more properties is recorded in a database comprising a plurality of records, each associated with at least one of the one or more markers. A signal obtained from a product comprising the recyclable material is processed for determining presence of at least one of the one or more markers, and based thereon the information recorded in at least one of the database records associated therewith, and a quality or currency measure of at least one of the ingredient material components of the recyclable material comprised in the product is determined based on the one or more properties indicative by the information.

 

Patent Family 13:

 

Systems and Methods for Supply Chain Management and Integrity Verification Via Blockchain (US16/980,693, Pending, filed 14/03/2019). Abstract: Systems and methods for managing transactions of physical objects are disclosed. The system is connectable to a first distributed ledger adapted to record object transactions associated with transactions of one or more physical objects between parties. The system includes a second distributed ledger adapted to record data indicative of object handling operations carried out with respect to the one or more physical objects; and an object handling management module adapted to authenticate handling operations carried out with respect to the one or more physical objects. The object handling management module is configured and operable for obtaining parameters of execution of the handling operations, authenticating the parameters of execution of the handling operations, and recording the authenticated handling operations in the second distributed ledger. The system thereby enables recordation of the object transactions associated with the one or more physical objects upon authenticating that the parameters of execution of the handling operations that are carried out with respect to the one or more physical objects satisfy one or more respective predetermined conditions.

 

Patent Family 14:

 

System and Method for Detection and Identification of Foreign Elements In A Substance (US17/285,167, Pending, filed 18/10/2019). Abstract: In one embodiment, a system and method for inspecting a substance to detect and identify predetermined foreign element(s) in the substance. The foreign element may carry X-ray responding material compositions, emitting X-ray signals in response to primary exciting X-ray or Gamma-ray radiation. The inspection is performed during a relative displacement between the substance and an inspection zone, defined by an overlap region between a solid angle of emission of an X-ray/Gamma-ray source and a solid angle of detection of X-ray radiation, along a predetermined movement path, as the substance moves along said path, the detected X-ray radiation includes X-ray response signals from successive portions of the substance propagating towards, through, and out of said overlap region. Measured data indicative of X-ray response signals is analyzed to identify a signal variation pattern over time indicative of a location of at least one foreign element carrying an X-ray responsive marker.

 

69
 

 

Patent Family 15:

 

Method and System for Classification of Samples (US17/594,406, Pending. filed 05/04/2020). Abstract: A method and system are provided for model-based analysis of samples of interest and management of sample classification. Predetermined modeled data is provided comprising data indicative of K models for respective K measurement schemes based on a predetermined function having a spectral line shape, data indicative of M characteristic vectors of M predetermined group to which different samples relate, and data indicative of a common vector of weights for the M groups. A data processor utilizes said data and operates to apply model-based processing to measured spectral data of a sample of interest using said predetermined modeled data, and generate classification data indicative of relation of said specific sample of interest to one of said M predetermined groups.

 

Patent Family 16:

 

Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency In Production Value Chains (US17/626,916, Pending, filed 15/07/2020). Abstract: The present invention is in the field of polymers comprising XRF identifiable tracers allowing information to be encoded by the polymers, and in particular polymers for conservation, restoration and retouching in artworks, electronics, coatings, plastics etc.

 

Patent Family 17:

 

Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency In Production Value Chains (US17/626,923, Pending, filed 15/07/2020). Abstract: The present invention is in the field of polymers comprising identifiable tracers by spectroscopic methods such as XRF, IR, NIR and XRD allowing information to be encoded by the polymers, and in particular polymers for conservation, restoration and retouching in artworks, electronics, coatings, plastics, packaging, 3D printing, rubber, and the like.

 

Patent Family 18:

 

Traceable Composite for Marking Seeds and Plants (US17/639,397, application filed, filed 02/09/2020). Abstract: The invention concerns compositions and methods for authenticating an agricultural product.

 

Patent Family 19:

 

Management of Recyclable Goods and Their Source Materials (US17/769,175, application filed, filed 15/10/2020). Abstract: Techniques for managing production and reuse of a recyclable material are disclosed. Combination of markers introduced into one or more ingredient material components of recyclable materials are used to indicate one or more properties of at least one of the ingredient material components e.g., a type of material used, percentage of the material type in the recyclable material, and suchlike. A signal obtained from a product comprising the recyclable material can be processed to detect presence or absence of the combination of markers therein. Based on the detection of the combination of markers, information indicative of the one or more properties of the at least one ingredient material component is determined, and based on the information it is decided either about a suitable recycling process for reusing the at least one ingredient material component, or a suitable disposal process for disposing the product.

 

Patent Family 20:

 

Device and Method for Detection of Viruses by XRF (PCT/IL2021/050325, National Phase due by September 26, 2022). Abstract: The invention provides methods and tools for the directed and indirect detection of infection with micro-organisms pathogens in biological and non- biological samples, and specifically applications of XRF (X-ray fluorescence) methodology for the detection of infections with viral and bacterial pathogens responsible for the widespread epidemics in mammals and humans, including COVID-19.

 

70
 

 

D. Trend Information

 

Other than as described elsewhere in this Annual Report on Form 20-F, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material adverse effect on our revenue, income from continuing operations, profitability, liquidity or capital resources, or that would cause our reported financial information not necessarily to be indicative of future operation results or financial condition.

 

E. Critical Accounting Policies and Estimates

 

Reverse Acquisition Transaction

 

The result of the merger between the Company and Security Matters PTY is that legally the Company owns the entire share capital of Security Matters PTY.

 

Accordingly, for financial reporting purposes, Security Matters PTY (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599 thousand), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802 thousand, between the fair value of the shares deemed to have been issued by Security Matters PTY and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921 thousand) and trade and other payables and warrants ($10,127 thousand) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY have been recognized and measured in the consolidated financial statements of the Company for the year ended December 31, 2023, at their pre-combination carrying amounts.
   
2. The retained earnings and other equity balances recognized in the consolidated financial statements of the Company for the year ended December 31, 2023, are the retained earnings and other equity balances of Security Matters PTY immediately before the Business Combination.
   
3. The amount recognized as issued equity instruments in the consolidated financial statements of the Company for the year ended December 31, 2023, has been determined by adding to the issued equity of Security Matters PTY immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
   
4. The statement of comprehensive loss in the consolidated financial statements of the Company for the year ended December 31, 2023, reflects that of Security Matters PTY for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

71
 

 

true-Gold Business Combination

 

On October 3, 2023 (acquisition date), the Company has signed an agreement with true-Gold Consortium Pty Ltd. (“true-Gold”) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in true-Gold and result in the Company’s gain control over true-Gold. true-Gold uses the Company’s advanced next-generation technology to invisibly mark and store multiple data types at a molecular level as well as its blockchain digital platform. This strategic transaction through gaining control of true-Gold diversifies the Company’s operations into true-Gold’s pioneering ventures in research and development and revenue commercialization.

 

The Company previously held 44.4% of the shares of true-Gold which, up to the acquisition date and the beginning of consolidation, were treated as an investment in a joint venture which accounted for under the equity method. At the time the transaction was completed, and control was obtained, the balance of the investment was remeasured at fair value of $22,164 thousand and a gain was recognized in the amount of $22,164 thousand, which was recorded in the statement of comprehensive loss (the carrying amount of the previous investment in true-Gold was approximately nil). This fair value amount was added to the consideration transferred for the calculation of goodwill, as described below.

 

The Company has elected to measure the non-controlling interests in true-Gold at full fair value which includes also the non-controlling interests’ share in the entire goodwill of true-Gold. The fair value of the non-controlling interests in true-Gold was based on the fair value of true-Gold as a whole, as described above, and was estimated using the discounted cash flow method of the income approach, as true-Gold is a private company and therefore quoted market prices of its share were unavailable. The fair value has been determined by management with the assistance of a valuation performed by an external and independent valuation specialist using valuation techniques and assumptions as to estimates of projected net future cash flows of true-Gold and estimate of the suitable discount rate for these cash flows. The significant assumptions used in estimating the fair value of true-Gold are:

 

  1. After-tax net cash flow discount rate (weighted average cost of capital) of 24.8%.
  2. Terminal value cash flow multiple of 4.59 and terminal growth rate of 3%.
  3. Discount for lack of marketability of 25.2% (or $11.17), resulting in a fair value of $33.12 per ordinary share of true-Gold).

 

The total cost of the business combination comprised a full forgiveness of the outstanding payables from true-Gold to the Company which amounted to AUD 475 thousand (approximately $307 thousand) at acquisition date. The calculating of any goodwill upon acquisition included also the fair value of the previous investment in true-Gold.

 

See Note 2 in the notes to our consolidated financial statements appearing elsewhere in this Annual Report for a description of critical accounting estimates.

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Executive Officers

 

The following sets forth certain information, as of April 29, 2024, concerning our executive officers and members of the Board.

 

Name   Age   Position
Director        
Ophir Sternberg   53   Chairman of the Board
Haggai Alon   50   Director
Amir Bader   61   Director
Pauline Khoo   64   Director
Roger Meltzer   73   Director
Thomas Hawkins   62   Director
Zeren Browne   44   Director
Executive Officers        
Haggai Alon   49   Chief Executive Officer
Ofira Bar   43   Chief Financial Officer
Zeren Browne   44   Executive Vice President, Chief Strategy Officer, Managing Director of trueGold

 

72
 

 

Information about Directors

 

Ophir Sternberg. Mr. Sternberg, our Chairman, was the Chairman, President and Chief Executive Officer of Lionheart since its inception through the Business Combination. He has been our Chairman since the Business Combination, and has over 28 years of experience acquiring, developing, repositioning and investing in all segments of the real estate industry, including office, industrial, retail, hospitality, ultra-luxury residential condominiums and land acquisitions. Mr. Sternberg is the Founder and Chief Executive Officer of Miami-based Lionheart Capital, founded in 2010. Lionheart Capital is a Miami-based diversified investment firm focused on building shareholder value in high-growth companies.

 

Mr. Sternberg began his career assembling, acquiring and developing properties in emerging neighborhoods in New York City, which established his reputation for identifying assets with unrealized potential and combining innovative partnerships with efficient financing structures to realize above average returns. Mr. Sternberg came to the United States in 1993 after completing three years of military service within an elite combat unit for the Israeli Defense Forces.

 

Under Mr. Sternberg’s leadership, Lionheart Capital executed numerous prominent real estate transactions and repositions, including The Ritz-Carlton Residences in Miami Beach, which resulted in a total sell-out value in excess of $550 million, as well as purchase of the development’s site, the former Miami Heart Institute. Additionally, Mr. Sternberg led the $120 million sale of The Seagull Hotel, making it the highest grossing hotel sale of 2020 in Miami Beach. Mr. Sternberg and Lionheart Capital are currently in development on a number of other projects, including retail properties in Miami’s fashion and culture epicenter, The Design District. In addition to The Ritz-Carlton Residences, Miami Beach, Lionheart Capital also developed The Ritz-Carlton Residences Singer Island, Palm Beach, cementing a reputation for developing high-end luxury branded properties.

 

In 2017, Mr. Sternberg founded Out of the Box Ventures, LLC, a Lionheart Capital subsidiary, to acquire and reposition distressed retail properties throughout the United States. With 19 properties in 14 states, Out of the Box Ventures currently controls over 5 million square feet of big box stores, shopping centers and enclosed regional mall properties with plans to improve and expand upon these acquisitions.

 

Mr. Sternberg and Lionheart Capital are dedicated to working with best-in-class operators and partners such as Marriot International. Lionheart Capital has been able to execute numerous, marquee transactions due largely in part to Mr. Sternberg’s extensive industry relationships particularly with key institutional investors.

 

In March 2020, Mr. Sternberg became Chairman of Nasdaq-listed OPES which on June 30, 2020, announced a definitive agreement to merge with BurgerFi International LLC. The OPES-BurgerFi merger closed on December 16, 2020 to form BurgerFi International Inc., or BurgerFi, a fast-causal “better burger” concept that consists of approximately 120 restaurants nationally and internationally. Mr. Sternberg is the Chairman of the Nasdaq-listed company, BurgerFi (NASDAQ: BFI). The OPES team, led by Mr. Sternberg, evaluated over 50 potential targets and negotiated business combination terms with multiple candidates in a span of a few months and acquired BurgerFi at what it believed was an attractive multiple relative to its peers.

 

In addition, in May 2021, Lionheart Capital led a partnership group to purchase the iconic American powerboat business, Cigarette Racing Team, from its longtime owner.

 

In addition, since its inception in December 2019, Mr. Sternberg has been the Chairman, President and Chief Executive Officer of Nasdaq-listed Lionheart Acquisition Corporation II (“Lionheart II”), a SPAC. Lionheart II completed its initial public offering in August 2020, in which it sold an aggregate of 23,000,000 units (including the exercise of the underwriters’ over-allotment option), each unit consisting of one share of Lionheart II Class A common stock and one-half of one redeemable warrant for one share of Lionheart II Class A common stock, for an offering price of $10.00 per unit, generating aggregate proceeds of $230,000,000. Lionheart II’s units, shares of Class A common stock and warrants currently trade on Nasdaq under the symbols “LIONU,” “LION” and “LIONW,” respectively. On July 12, 2021, Lionheart II announced a $32.6 billion business combination with MSP Recovery, Inc. (d/b/a LifeWallet) (NASDAQ” LIFW), a leader in data-driven solutions that recovers improperly paid benefits on behalf of Medicare, Medicaid and other commercial payers. The Lionheart II-MSP merger closed on May 23, 2022. Mr. Sternberg serves on the Board of Directors for MSP Recovery, Inc. Mr. Sternberg is qualified to serve as a director due to his extensive experience in acquiring, developing, repositioning and investing in all segments of the real estate industry.

 

73
 

 

Haggai “H” Alon. Haggai “H” Alon is the founder of Security Matters (SMX) and has served as the CEO of SMX Israel since 2015 and a director and CEO of SMX since July 2018. Mr. Alon is also the CEO and a board member of trueGold Consortium Pty Ltd since June 2020. Mr. Alon has over 25 years of experience in commercializing technology. Haggai Alon held several roles at the Ministry of Defense and was the CEO of an economic consulting firm focusing on M&A. He has a master’s degree from the Tel Aviv and Haifa Universities in international relations and political science. Out of a total of 27 patent families filed in the name of SMX, Haggai Alon is a named inventor on 26 of them. Most of the applications that are part of these patent families are under examination, many are still unpublished. In 7 of the 26 patent families Haggai Alon is a named inventor, the patents have been issued in a variety of jurisdictions. Presently, Haggai Alon is a named inventor on 19 patents, all of which are in the public domain. He has also published a White Paper—New Plastic Economic Order: To regulate the entire value chain, not just the product, which calls for a transition to a new regulatory approach by the EU over plastics. Mr. Alon’s founding of Security Matters and his experience as CEO of Security Matters since 2015 makes him a valuable asset to our board.

 

Amir Bader. Amir Bader is has served as the CEO of the Dairy Farm at the Golan Heights, currently the manager of one of Israel’s largest dairy farms, since April 2017. Previously, Mr. Bader served as the CEO of Degenya Cooperative Agricultural Association from 2012 through 2016. Mr. Bader has been a director of SMX since July 2018. Mr. Bader and has more than 38 years of experience at managerial positions in dairy farms and other agricultural projects in Israel and Europe. Amir Bader also served as Kibbutz Degania A’s business manager for five years, during that period he served as the board member of several subsidiaries and companies related to the Kibbutz. Amir Bader brings to the Company board extensive experience in the management of agricultural businesses.

 

Pauline Khoo. Ms. Khoo currently serves as the Wealth Planning Manager at Mishcon de Reya since January 2022 and was previously the Managing Director of Credit Suisse Trust Limited from August 2009 to December 2021. Ms. Khoo has more than forty years of financial and managerial experience in financial institutions, law firms and various companies. Ms. Khoo is a member of the Institute of Chartered Secretaries (by completing exams), the Society of Trust and Estate Practitioners, the Institute of Chartered Secretaries and Administrators Chartered Trustee of Singapore Trustees Association, Family Firm Institute-Business Advisory and Family Advisory and a senior member of the Global-Asia Family Office Circle. We believe Ms. Khoo is well qualified to serve on our board due to her more than forty years of experience in financial and managerial positions.

 

Thomas Hawkins. Thomas Hawkins, a director of Lionheart until the Business Combination, previously served as a Management Consultant for MEDNAX, Inc. from February 2014 to December 2017, after serving as General Counsel and Board Secretary from April 2003 to August 2012. Prior to that, Mr. Hawkins worked for New River Capital Partners as a Partner from January 2000 to March 2003; AutoNation, Inc. as Senior Vice President of Corporate Development from May 1996 to December 1999; Viacom, Inc. as Executive Vice President from September 1994 to May 1996; and Blockbuster Entertainment Corporation as Senior Vice President, General Counsel, and Secretary from October 1989 to September 1994. Mr. Hawkins currently serves on the board of directors of the Alumni Association of the University of Michigan and Jumptuit Inc., a data analytics technology company. Mr. Hawkins also serves on the board of directors of MSP Recovery. Mr. Hawkins received his Juris Doctor from Northwestern University in 1986 and his A.B. in Political Science from the University of Michigan in 1983. Mr. Hawkins is qualified to serve as a director due to his experience as a senior executive and chief legal officer at several public companies (including his experience acquiring companies) and with counseling and serving on boards of directors.

 

74
 

 

Roger Meltzer, Esq. Mr. Meltzer practiced law at DLA Piper LLP from 2007 and held various roles: Global Co-Chairman (2015 through 2020), and currently as Chairman Emeritus; Americas Co-Chairman (2013 through 2020); Member, Office of the Chair (2011 through 2020); Member, Global Board (2008 through 2020); Co-Chairman, U.S. Executive Committee (2013 through 2020); Member, U.S. Executive Committee (2007 through 2020); and Global Co-Chairman, Corporate Finance Practice (2007 through 2015). Prior to joining DLA Piper LLP, Mr. Meltzer practiced law at Cahill Gordon & Reindel LLP from 1977 to 2007 where he was a member of the Executive Committee from 1987 through 2007, Co-Administrative Partner and Hiring Partner from 1987 through 1999, and Partner from 1984 through 2007. Mr. Meltzer currently serves on the Advisory Board of Harvard Law School Center on the Legal Profession (May 2015—Present); and the Board of Trustees, New York University Law School (September 2011—Present); and previously served on the Corporate Advisory Board, John Hopkins, Carey Business School (January 2009—December 2012). He has previously served on the board of directors of: Lionheart II Corp (March 2021 to May 2022), Lionheart III Corp (March 2021 to August 2022), Haymaker Acquisition Corp. III (February 2021 to July 2022), certain subsidiaries of Nordic Aviation Capital (December 2021 to April 2022), The Legal Aid Society (November 2013 to January 2020), Hain Celestial Group, Inc. (December 2000 to February 2020), American Lawyer Media (January 2010 to July 2014) and The Coinmach Service Corporation (December 2009 to June 2013). Mr. Meltzer has also received several awards and honors and has been actively involved in philanthropic activity throughout his career. Mr. Meltzer received Juris Doctor degree in law from New York University School of Law and an A.B. from Harvard College. In February 2021, Mr. Meltzer joined the board of directors of Haymaker Acquisition Corp. 4, a special purpose acquisition company focused on identifying and implementing value creation initiatives within the consumer and consumer-related products and services industries. In May 2022, Mr. Meltzer joined the board of directors of MSP Recovery, Inc. following its business combination with Lionheart Acquisition Corp. II. In August 2022, Mr. Meltzer joined the board of directors of the Company following the Business Combination. In April 2023, Mr. Meltzer joined the board of directors of Cyxtera Technologies, Inc., a company specializing in colocation and interconnection services, with a footprint of more than 60 data centers in over 30 markets. In November 2023, Mr. Meltzer joined the board of directors of Audacy Inc., a leading multi-platform audit content and entertainment company. Mr. Meltzer also serves on the board of directors of various private companies as well.

 

Zeren Browne. Ms. Browne has previously held senior management roles and led the marketing and commercial business activities for brands under luxury & lifestyle conglomerates LVMH and Estee Lauder Companies. Ms. Browne has been the Executive Vice President and Chief Strategy Officer, of the Company and its predecessors since July 2018. She was formerly the Managing Director at Mulloway Pty Limited from October 2016 to July 2020 and is currently the Managing Director of trueGold Consortium Pty Limited since June 2020. Ms. Browne holds a Bachelor of Commerce Degree and an advanced MBA Degree from The University of Western Australia, where she was awarded the Dux and The Women in Management Scholarship. Ms. Browne brings more than 20 years’ experience in global marketing and strategic brand management to our board.

 

Information about Executive Officers

 

Haggai Alon. See “Information about Directors” above.

 

Ofira Bar. Prior to her appointment as Chief Executive Officer of the Company, from February 2018 through July 2021, Ms. Bar had been the CFO of Mer Telemanagement Solutions Ltd., an Israeli-based global provider of solutions for telecommunications expense management, enterprise mobility management, call usage and accounting software, then listed on Nasdaq. Thereafter, as a result of a reverse takeover which, among other things, resulted in Mer Telemanagement changing its name to SharpLink Gaming, Ltd. and acquiring a new line of business, from July 2021 until February 2024, Ms. Bar was CFO of the legacy business subsidiary of Mer Telemanagement. Prior to February 2018 and from February 2017, Ms. Bar was chief financial officer of H.T.S Market, Ltd., an internet marketing firm, and was corporate controller of EZTD Inc., a then-public company that engaged with software development and binary options online trading, from December 2014 to January 2017. In addition, from September 2005 to July 2013, Ms. Bar served as an audit team manager of public and private companies at Kesselman and Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited. Ms. Bar holds a B.A. degree in Accounting and Economics from Tel Aviv University and is licensed as a Certified Public Accountant in Israel.

 

75
 

 

Mr. Alon and Ms. Bar have employment agreements with Security Matters Ltd., an Israeli company and subsidiary of SMX, and as provided in their employment agreement will provide services to Security Matters Ltd., and its parent and any wholly owned subsidiary thereof. Pursuant to his employment agreement, Mr. Alon will receive a salary of approximately $295,000, and be entitled to other benefits such as receipt of options and bonus payments. Pursuant to her employment agreement, Ms. Bar will receive a salary of approximately ILS 740,000 in calendar year ending December 31, 2024, and be entitled to other benefits such as receipt of options and bonus payments.

 

Zeren Browne. See “Information about Directors” above.

 

Nasdaq Diversity Disclosure

 

The matrix below reflects our Board’s gender and racial characteristics and LGBTQ+ status, based on the self-identification of our directors. Each of the categories listed below has the meaning as it is used in Nasdaq Rule 5605(f).

 

Country of Principal Executive Offices   Ireland
Foreign Private Issuer   Yes

Disclosure Prohibited under Home

Country Law

  No
Total Number of Directors   7

 

Board Diversity Matrix (as of April 29, 2024)
Part I: Gender Identity:   Male   Female   Non-Binary  

Did Not

Disclose Gender

Directors   5   2        
Part II: Demographic Background:
Underrepresented individual in Home Country Jurisdiction   2
LGBTQ+   1
Did Not Disclose Demographic Background   1

 

Family Relationships

 

There are no family relationships among any of our executive officers or directors.

 

Family Relationships

 

There are no family relationships among any of our executive officers or directors.

 

Foreign Private Issuer Exemption

 

We are a “foreign private issuer,” as defined by the SEC. As a result, in accordance with Nasdaq rules, we may comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. While we expect to voluntarily follow most Nasdaq corporate governance rules, we may choose to take advantage of the following limited exemptions:

 

  Exemption from filing quarterly reports on Form 10-Q containing unaudited financial and other specified information or current reports on Form 8-K upon the occurrence of specified significant events;
     
  Exemption from Section 16 rules requiring insiders to file public reports of their securities ownership and trading activities and providing for liability for insiders who profit from trades in a short period of time;

 

76
 

 

  Exemption from quorum requirements for shareholder meetings;
     
  Exemption from the Nasdaq rules applicable to domestic issuers requiring disclosure within four business days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers;
     
  Exemption from the requirement to obtain shareholder approval for certain issuances of securities, including shareholder approval of share option plans;
     
  Exemption from the requirement that our audit committee have review and oversight responsibilities over all “related party transactions,” as defined in Item 7.B of Form 20-F;
     
  Exemption from the requirement that our board have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. We currently have only director who serves on the compensation committee who meets the heightened independence standards for members of a compensation committee; and
     
  Exemption from the requirements that director nominees are selected, or recommended for selection by our board, either by (1) independent directors constituting a majority of our board’s independent directors in a vote in which only independent directors participate, or (2) a committee comprised solely of independent directors, and that a formal written charter or board resolution, as applicable, addressing the nominations process is adopted.

 

Furthermore, Nasdaq Rule 5615(a)(3) provides that a foreign private issuer, such as we, may rely on home country corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that we nevertheless comply with Nasdaq’s Notification of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). Most recently, we have elected to (a) amend our 2022 Equity Incentive Plan to increase the number of shares authorized under the plan without stockholder approval, and (b) follow home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of our Ordinary Shares (or securities convertible into or exercisable for our Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, each as permitted under Irish law.

 

Accordingly, our shareholders will not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. We may utilize these exemptions for as long as we continue to qualify as a foreign private issuer.

 

Limitation on Liability and Indemnification of Directors and Officers

 

The Company is subject to the ICA. Subject to exceptions, the ICA does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection with any negligence, default, breach of duty or breach of trust by a director in relation to the company. The exceptions allow a company to (i) purchase and maintain director and officer insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company; and (ii) indemnify a director or other officer against any liability incurred in defending proceedings, whether civil or criminal (a) in which judgement is given in his or her favor or in which he or she is acquitted or (b) in respect of which an Irish court grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.

 

77
 

 

Under the Company’s Amended and Restated Memorandum and Articles of Association, subject to certain limitations and so far as may be permitted by the ICA, each director, officer or employee of the Company, and each person who is or was serving at the request of the Company as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Company, shall be entitled to be indemnified by the Company against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of the Company or such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or omission in which relief is granted to him or her by the court. However, any such indemnity shall not be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for fraud or dishonesty in the performance of his or her duty to the Company unless and only to the extent that the courts of Ireland or the court in which such action or suit was brought shall determine upon application that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper.

 

The Company on closing entered into indemnification agreements with each of its directors to provide contractual indemnification providing for indemnification and advancements by the Company of certain expenses and costs relating to claims, suits or proceedings arising from his or her service to the Company, and to Lionheart if applicable or, at Lionheart’s request, service to other entities, as officers or directors occurring at or prior to the Business Combination, to the maximum extent permitted by applicable law.

 

The Company maintains standard policies of insurance under which coverage is provided (1) to its directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act, while acting in their capacity as directors and officers of the Company, and (2) to the Company with respect to payments which may be made by the Company to such officers and directors pursuant to any indemnification provision contained in the Company’s Amended and Restated Memorandum and Articles of Association or otherwise as a matter of law.

 

Board Leadership Structure

 

It is not anticipated that a policy requiring the positions of the Chairperson of the Board and Chief Executive Officer to be separate or held by the same individual will be implemented by the Board, as the Board’s determination is expected to be based on circumstances existing from time to time, based on criteria that are in the Company’s best interests and the best interests of its stockholders, including the composition, skills and experience of the Board and its members, specific challenges faced by the Company or the industry in which it operates and governance efficiency. If the Board convenes for a meeting, it is expected that the non-management directors will meet in one or more executive sessions, if the circumstances warrant. The Board may consider appointing a lead independent director, if the circumstances warrant.

 

Risk Oversight

 

Upon the consummation of the Business Combination, the Board administered the risk oversight function directly through the Board as a whole, as well as through its committees, where applicable, monitoring and assessing strategic risk exposure, enterprise risk, and governance risks. The audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The allocation of risk oversight responsibility may change, from time to time, based on the evolving needs of the Company.

 

Code of Business Conduct and Ethics

 

The Board adopted a Code of Ethics applicable to our directors, executive officers and team members that complies with the rules and regulations of Nasdaq and the SEC. The Code of Ethics is available on the Company’s website. In addition, the Company intends to post on the Corporate Governance section of its website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the Code of Ethics. The reference to the Company’s website address in this Annual Report does not include or incorporate by reference the information on the Company’s website into this Annual Report.

 

78
 

 

B. Compensation

 

The aggregate compensation paid by Security Matters PTY to Security Matters PTY’s directors for the fiscal year ended December 31, 2022 was approximately $136,000. The compensation for the year ended December 31, 2022 amount included 322,317 shares that were granted to its directors as a group, with a value of $54,000.

 

The aggregate compensation paid by the Company to the Board for the fiscal year ended December 31, 2023 was approximately $684,000. The compensation for the year ended December 31, 2023 amount included 135,777 shares that were granted to its directors as a group, with a value of approximately $147,996.

 

The aggregate compensation paid by to our senior executive officers for the fiscal years ended December 31, 2023 and December 31, 2022 was approximately $1 million and $541,000. In fiscal years 2023 and 2022, our predecessor granted stock option awards to its executive officers to acquire an aggregate of 200,000 of Security Matters PTY’s ordinary shares, all of the options are subject to performance condition. In fiscal year 2023, we granted an aggregate of 81,551 restricted stock units to our executive officers, with a value of approximately $88,891.

 

The Company’s CEO, CFO and Executive Vice President are subject to the terms of their employment agreements with SMX Israel. It is expected that any executive compensation program beyond existing arrangements will include:

 

  annual base salaries;
     
  performance bonus opportunities, potentially in cash and/or equity awards;
     
  long term incentive compensation in the form of stock options, restricted stock and stock appreciation awards, among others, and
     
  with regard to key executive officers, formal employment arrangements to include change of control provisions.

 

Director Compensation

 

For the fiscal year ended December 31, 2023, each independent director was granted restricted stock units in an amount equal to $150,000 divided by the closing price on the last trading day of the fiscal year, generally to vest on the one-year anniversary of the date of grant and be settled in Ordinary Shares, subject to such director’s continuous services as a director until such time and earlier vesting due to a change of control. In addition, each committee chair is entitled to receive an additional grant annually of restricted stock units in an amount equal to $15,000 divided by the closing price on the last trading day of the fiscal year, subject to the same terms listed in the prior sentence. Mr. Alon and Ms. Browne will not receive any director compensation as their compensation is governed by their individual employment agreements. The Company’s directors, other than Mr. Alon and Ms. Browne, were granted an aggregate of 8,018 restricted stock units.

 

2022 Incentive Equity Plan and Other Plan Options

 

Our Board and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan (the “2022 Incentive Equity Plan”), which was subsequently amended by our board of directors, which reserved for grant and authorized 231,019 Ordinary Shares. Additionally, pursuant to the 2022 Incentive Equity Plan, the Ordinary Shares reserved for issuance thereunder will automatically increase annually by 5% on the first day of each fiscal year beginning with the 2023 fiscal year, by an amount equal to 5% of the number of outstanding shares of the Company as of the last day of the prior fiscal year. As April 29, 2024, an aggregate of 1,731,898 restricted stock units or stock options have been granted under the 2022 Incentive Equity Plan. The Company received stockholder approval at its 2023 annual general meeting of shareholders held on December 21, 2023, which increased the number of ordinary shares by 1,500,000 to a total of 1,731,019 ordinary shares.

 

79
 

 

The 2022 Incentive Equity Plan provides for the grant of options, restricted shares units, phantom shares or substitute awards or any combination of the foregoing including such other awards that may be denominated or payable in, value in whole or in part, by reference to or otherwise based upon, or related to, shares to our employees, directors, and consultants and any of our affiliates’ employees and consultants.

 

Our Board, or any person or persons or committee to whom decision-making authority with respect to the 2022 Incentive Equity Plan is delegated by our board of directors (the “Administrator”) will administer the 2022 Incentive Equity Plan.

 

Our Board and the Administrator have the authority to amend or suspend the 2022 Incentive Equity Plan at any time and from time to time, and our Board has the authority to terminate the 2022 Incentive Equity Plan provided that such action does not materially impair the existing rights of any participant without such participant’s written consent. Certain material amendments also require the approval of our shareholders.

 

In addition, as part of the Business Combination, we assumed an aggregate of 1,326,747 options originally granted under Security Matters PTY’s 2018 Share Option Plan.

 

C. Board Practices

 

Corporate Governance

 

The Company structured its corporate governance in a manner it believes closely aligns its interests with those of its shareholders. Notable features of this corporate governance include:

 

  The Company has four independent directors and independent director representation on our audit and compensation committees immediately. Furthermore, until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.
     
  The independent directors will meet regularly in executive sessions without the presence of our corporate officers or non-independent directors;
     
  The Company implemented a range of other corporate governance practices, including a robust director education program.

 

At this time, the Company does not have on its Audit Committee at least one member who qualifies as an “audit committee financial expert” as defined by the SEC; however, the Company believes that all of the audit committee members are able to read and understand fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement. Additionally, at least one member of the audit committee has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication, and accordingly believes that the audit committee can properly fulfill its functions and role as if at least one member was an “audit committee financial expert” as defined by the SEC.

 

Classified Board of Directors

 

In accordance with the Company’s Amended and Restated Memorandum and Articles of Association, its board of directors shall be divided into three classes of directors with staggered terms depending on the class. The Board has designated Amir Bader and Thomas Hawkins as Class I Directors with terms ending in 2026, Pauline Khoo, Roger Meltzer and Zeren Browne as Class II Directors with terms ending in 2024, and Haggai Alon and Ophir Sternberg as Class III Directors with terms ending in 2025.

 

80
 

 

Independence of our Board of Directors

 

Four of the Company’s seven directors are independent as defined in Nasdaq listing standards and applicable SEC rules and the Company’s Board has an independent audit committee and a compensation committee. Furthermore, until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.

 

Board Committees

 

Audit Committee

 

The audit committee is responsible for, among other things:

 

  appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;
  discussing with our independent registered public accounting firm their independence from management;
  reviewing, with our independent registered public accounting firm, the scope and results of their audit;
  approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
  overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the annual financial statements that we file with the SEC;
  overseeing our financial and accounting controls and compliance with legal and regulatory requirements;
  reviewing our policies on risk assessment and risk management;
  reviewing related person transactions; and
  establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.

 

The members of the Company’s audit committee are Pauline Khoo, Chairperson, Amir Bader and Thomas Hawkins.

 

Each member of the Company’s audit committee qualifies as an independent director according to the rules and regulations of the SEC and Nasdaq with respect to audit committee membership. In addition, all audit committee members meet the requirements for financial literacy under applicable SEC and Nasdaq rules. The audit committee’s charter is available on the Company’s website. The reference to the Company’s website address in this Annual Report on Form 20-F does not include or incorporate by reference the information on the Company’s website into this Annual Report on Form 20-F.

 

Compensation Committee

 

The compensation committee is responsible for, among other things:

 

  reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving, (either alone or, if directed by the board of directors, in conjunction with a majority of the independent members of the board of directors) the compensation of our Chief Executive Officer;
  overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our board of directors regarding the compensation of our other executive officers;
  reviewing and approving or making recommendations to our board of directors regarding our incentive compensation and equity-based plans, policies and programs;
  reviewing and approving all employment agreement and severance arrangements for our executive officers;
  making recommendations to our shareholders regarding the compensation of our directors; and
  retaining and overseeing any compensation consultants.

 

81
 

 

The members of the Company’s compensation committee are Roger Meltzer, Chairperson, Pauline Khoo and Amir Bader, all of whom qualify as independent directors according to the rules and regulations of the SEC and Nasdaq with respect to compensation committee membership, including the heightened independence standards for members of a compensation committee. The compensation committee’s charter is available on the Company’s website. The reference to the Company’s website address in this Annual Report on Form 20-F does not include or incorporate by reference the information on the Company’s website into this Annual Report on Form 20-F.

 

Nominating and Corporate Governance Committee

 

The Company has not yet appointed members of the Board to a nominating committee. Any nominating committee would be responsible for, among other things:

 

  identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors;
  overseeing succession planning for our Chief Executive Officer and other executive officers;
  periodically reviewing our board of directors’ leadership structure and recommending any proposed changes to our board of directors;
  overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and
  developing and recommending to our board of directors a set of corporate governance guidelines.

 

Until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.

 

Any nominating and corporate governance committee charter would be available on the Company’s website. The reference to the Company’s website address in this Annual Report on Form 20-F does not include or incorporate by reference the information on the Company website into this Annual Report on Form 20-F.

 

D. Employees

 

As of April 29, 2024, the Company had 36 employees, 27 full time employees and 9 part time employees located in Israel. The Company also has three employees in Singapore, one in Australia and one in the United Kingdom.

 

None of the Company’s employees are members of a union or subject to the terms of a collective bargaining agreement. In Israel, the Company is subject to certain Israeli labor laws, regulations and Labor Court precedent rulings, as well as certain provisions of collective bargaining agreements applicable to the Company by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Ministry of Economy and Industry, and which apply such agreement provisions to the Company’s employees even though they are not part of a union that has signed a collective bargaining agreement.

 

All of the Company’s employment and consulting agreements include standard non-compete and intellectual property assignment provisions, as well as strict confidentiality obligations. The enforceability of non-compete provisions may be limited by Israeli law.

 

The Company has a diversity policy in effect, last updated and approved by the board on February 7, 2021, according to which we are committed to gender diversity across its Board, senior management team and across its entire workforce, with a particular goal of increasing the representation of women in all areas.

 

82
 

 

E. Share Ownership

 

For information regarding the share ownership of our directors and executive officers, see “Item 7.A Major Shareholders” and “Item 6.B Compensation” for a discussion of the 2022 Incentive Equity Plan.

 

F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

 

Not applicable.

 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

Security Ownership of Certain Beneficial Owners and Management of the Company

 

The following table sets forth the information regarding the beneficial ownership of the Ordinary Shares as of April 29, 2024:

 

  each person known by the Company to be the beneficial owner of more than 5% of the Company’s Ordinary Shares; and
     
  each of the Company’s current executive officers and directors and all of the Company’s executive officers and directors as a group.

 

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, and includes shares underlying warrants and options, as applicable, that are currently exercisable or convertible or exercisable or convertible within 60 days. Ordinary Shares that may be acquired within 60 days of April 29, 2024 pursuant to the exercise of warrants or options are deemed to be outstanding for the purpose of computing the percentage ownership of such holder but are not deemed to be outstanding for computing the percentage ownership of any other person or entity shown in the table.

 

Unless otherwise indicated, we believe that all persons named in the table below have sole voting and investment power with respect to the Ordinary Shares beneficially owned by them.

 

The percentage of Ordinary Shares beneficially owned is computed on the basis of 38,334,442 Ordinary Shares outstanding on April 29, 2024.

 

Name and Address of Beneficial Owners  Number of Ordinary Shares   Percentage of Total Voting Power 
Haggai Alon(1)   159,375    * 
Ophir Sternberg(2)   223,009    * 
Amir Bader(3)   25,554    * 
Zeren Browne(4)   24,520    * 
Pauline Khoo(5)   25,886    * 
Thomas Hawkins(6)   26,973    * 
Roger Meltzer(7)   27,164    * 
Ofira Bar   -    - 
All executive officers and directors as a group (9 persons)   512,481    1.33%
Greater than 5% Holders          
Doron Afik(8)   1,887,459    4.92%

 

* Less than 1%

 

83
 

 

(1) Represents shares held by Benguy Escrow Company Ltd., a testamentary trust of which Mr. Alon is the beneficiary. Doron Afik is the trustee of Benguy Escrow Company Ltd. The amount of beneficial ownership includes 2,193 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable as a result of Security Matters PTY options held, that are currently exercisable or exercisable within 60 days. Also includes 55,802 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares granted to Mr. Alon, and an additional 53,850 (adjusted pursuant to the Reverse Stock Split) restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024. Does not include an additional 417,353 (adjusted pursuant to the Reverse Stock Split) restricted stock units that do not vest within 60 days of April 29, 2024.
(2) Ophir Sternberg, Lionheart’s Chairman, President and Chief Executive Officer, is the member of the Sponsor. Mr. Sternberg disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. Also includes 36,562 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares granted to Mr. Sternberg, and an additional 30,000 (adjusted pursuant to the Reverse Stock Split) restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024. Does not include an additional 249,642 (adjusted pursuant to the Reverse Stock Split) restricted stock units that do not vest within 60 days of April 29, 2024.
(3) Includes 7,466 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares and includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.
(4) Represents shares held by Sooperduper Pty Ltd., which is owned by Ms. Browne and Simon Browne. Ms. Browne is the control person of Sooperduper Pty Ltd. Includes 6,692 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares. Also includes 11,395 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.
(5) Represents shares held by in nominee by HSBC Bank Australia Limited. Includes 7,657 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares. Also includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.
(6) Includes 7,466 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares and includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.
(7) Includes 7,657 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares. Also includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.
(8) Includes 2,778 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares. Also includes 5,556 restricted stock units that settle into Ordinary Shares that vest within 60 days from April 29, 2024.

 

B. Related Party Transactions

 

trueGold

 

On July 29, 2020, Security Matters PTY signed a shareholders’ agreement with W.A. Mint Pty Ltd. (“Perth Mint”) and trueGold. The shareholders’ agreement and the ancillary agreements discuss the establishment of a new entity—trueGold—by Security Matters PTY and Perth Mint. Security Matters PTY granted to trueGold, subject to the terms of the license agreement, an exclusive, worldwide, perpetual license to use Security Matters PTY’s technology for the purpose of commercializing it within the industry comprising gold as a precious metal (as elaborated below). Security Matters PTY owns any development of its intellectual property and, while trueGold owns all generated data it creates, trueGold granted to Security Matters PTY a free non-exclusive, irrevocable, perpetual, royalty free license to use the generated data, subject to regulatory requirements and to the extent that it relates to the Isorad License Agreement technology or Security Matters PTY’s technology. The parties agreed that neither Perth Mint or Security Matters PTY are required to provide any funding to trueGold and that any investment by any of them in trueGold from time to time will be by way of in-kind contributions. Third party equity investors will contribute the working capital will fund R&D, development capital and other expenses in accordance with the business plan.

 

84
 

 

Other than with the consent of the other shareholders or between affiliates (defined, inter alia, as a related body corporate of a shareholder; a company in which the shareholder beneficially owns 50% or more of the issued shares) a transfer of shares will be done subject to a right of first refusal of the other shareholders, whom will also have tag-along rights and a drag-along (as elaborated below). Under the constitution (as amended in July, 2022, to add the specific right of Security Matters PTY to purchase shares before any other shareholders) any shareholder wishing to transfer shares must notify the board of directors and, before the board of directors authorize the transfer of any share or shares, the share or shares must first have been offered to Security Matters PTY (for its own benefit and unless Security Matters PTY is 50% owned by one entity), and if SMX does not notify within 30 days that it wishes to purchase, then to all other shareholders (including Security Matters PTY) at a price to be agreed on by the transferor and the directors of trueGold. If the transferor and the directors of trueGold are unable to agree on a price, the price of the relevant shares will be a price which: represents a fair market price; and is determined by expert determination administered by the Australian Disputes Centre (ADC) in accordance with the ADC Rules for Expert Determination which are operating at the time the matter is referred to ADC, which Rules are incorporated into the constitution of trueGold. The determination of such person in relation to the price of the relevant shares will be final and binding on all shareholders.

 

Subject to certain terms and conditions, a drag-along right is established under which where shareholders wish to dispose of all of their share to a third party that wishes to acquire 100% of trueGold and 75% or more of the aggregate number of shares on issue at that time agreed, the remaining shareholders may be forced to transfer to the third party all of the shares held by each of the remaining shareholders. In case of a deadlock (defined as a case where the board of directors disagrees on a material matter regarding the fundamental operation of trueGold or the business and cannot resolve the disagreement within 10 business days of the disagreement first arising), if the shareholders are unable to reach agreement on any matter, a dispute resolution mechanism was created.

 

The board of directors of trueGold was agreed to consist of not less than three and not more than seven. The board is comprised as follows: Security Matters PTY may appoint (remove or replace) up to two directors; Zeren Browne; Perth Mint may appoint (remove or replace) up to two directors; and Hugh Morgan, who is a non-executive, independent chair. A list of resolutions was set, which require a board majority including at least one Security Matters PTY appointed director and one Perth Mint appointed director. Another list of resolutions was set, which require a resolution carried by a majority of the shareholders including Security Matters PTY and Perth Mint. trueGold and Yahaloma (defined below) agreed to bear the payments to Soreq related thereto of 4.2% of its revenues. SMX’s CEO, Mr. Haggai Alon, provides CEO services to trueGold and reports to the board of directors of trueGold, and Zeren Browne provides General Manager services to trueGold.

 

On October 3, 2023, Security Matters PTY entered into the Investment Agreement with trueGold. Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 trueGold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in trueGold shall be increased to 51.9% of the total issued and outstanding shares of trueGold, making Security Matters PTY the majority owner of trueGold. Additionally, the existing license agreement as between Security Matters PTY and trueGold was amended to include additional intellectual property of Security Matters PTY to be licensed to trueGold thereunder. Security Matters PTY shall further supply to trueGold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

Business Combination

 

On March 7, 2023, we consummated the Business Combination. See Item 4. Information of the Company-History and Development of the Company-Business Combination, elsewhere in this Annual Report on Form 20-F, and Note 1.B. The SPAC Transaction, to the audited financial statements of the Company on page F-10, included in this Annual Report on Form 20-F for a discussion of the Business Combination and the related party transactions with respect to the Business Combination.

 

85
 

 

Bridge Loans

 

Between August 2022 to January 2023, Security Matters PTY entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, including Doron Afik and Jessica Wasserstrom, who lent Security Matters PTY an aggregate amount of $3,860,000. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum.

 

In March 2023, the Company signed an addendum to the Bridge Loans agreements which converted $1,350,000 of principal and $1,000,000 of redeemable warrants into 872,418 Ordinary Shares.

 

On December 31, 2023, the Company signed an addendum to the Bridge Loans, which converted $750,000 of principal and $1,450,000 redeemable warrants into 4,032,256 Ordinary Shares. According to the addendum, the Company issued to the lenders an aggregate of 4,032,256 warrants to purchase up to an aggregate of 4,032,256 Ordinary Shares at an exercise price of $1.17 per share. The warrants were exercisable immediately upon issuance and will expire three years following their issuance.

 

General Legal Counsel

 

On January 10, 2017, an affiliate of Lionheart’s Sponsor, Lionheart Equities, LLC (“Lionheart Equities”), engaged Jessica L. Wasserstrom, LLC (“Wasserstrom”), to represent Lionheart Capital and its affiliated companies, as corporate general counsel and otherwise in connection with any corporate and/or transactional matters as requested by Lionheart Equities. The engagement letter between Lionheart Equities and Wasserstrom is for an indefinite period only subject to termination rights of either party, of which no termination has occurred since the agreement was executed. Jessica Wasserstrom, the principal of Wasserstrom, currently holds the title of Chief Legal Officer of Lionheart Equities and its affiliated companies.

 

In connection therewith, Wasserstrom was specifically engaged by Lionheart to provide counsel for general corporate legal matters, including related to mergers and acquisitions activity and, as such, may be deemed to be a related party of Lionheart. For the year ended December 31, 2023, the Company paid to Wassertrom an aggregate of approximately $300,000, in the form of cash payments, issuance of Ordinary Shares and issuances of warrants to purchase Ordinary Shares, for legal services provided to Lionheart through the closing of the Business Combination in March 2023. As of April 29, 2024, an aggregate of $100,000 is remains unpaid and outstanding.

 

Chairman Agreement

 

Mr. Ophir Sternberg and the Company entered into a Chairman Agreement (the “Chairman Agreement”). Pursuant to the Chairman Agreement, beginning at the closing of the Business Combination, Mr. Sternberg will serve as the Chairman of the Board for so long as he serves as a member of the Board, unless he is earlier terminated. Mr. Sternberg will not receive any cash compensation for his service on the Board nor will he be entitled to participate in any employee benefit plans of the Company.

 

The Chairman Agreement provides that Mr. Sternberg will be granted restricted stock units of the Company representing 3% of the issued and outstanding Ordinary Shares as of the grant date in accordance with and subject to the terms and conditions of the Company’s 2022 Incentive Equity Plan. Mr. Sternberg’s restricted stock units are subject to time-based vesting, as follows: 20% vest on the grant date, and the remaining restricted stock units will vest in quarterly installments thereafter over a period of three years subject to his continued service on the Board as of each vesting date subject to earlier vesting as forth below.

 

In the event of the expiration or termination of the Chairman Agreement for any reason other than termination for Cause (as defined in the Chairman Agreement), any unvested outstanding equity awards held by Mr. Sternberg will immediately vest and become nonforfeitable. In the event of the termination of the Chairman Agreement by the Company for Cause, all unvested outstanding equity awards will be cancelled and forfeited, and Mr. Sternberg will not be entitled to any payment in connection therewith.

 

86
 

 

The Chairman Agreement states that Mr. Sternberg will honor his confidentiality obligations after the termination of his services.

 

Independent Contractor Agreement

 

Mr. Faquiry Diaz and the Company entered into an independent contractor agreement (the “Independent Contractor Agreement”). The Independent Contractor Agreement provides for an initial term of three years that automatically renews for one-year terms thereafter, so long as Ophir Sternberg is the Chairman of the Board. Notwithstanding the foregoing, the Independent Contractor Agreement is terminable by either party at any time, with or without Cause (as defined in the Independent Contractor Agreement), effective upon notice to the other party.

 

In exchange for his services, Mr. Diaz Cala will be compensated and reimbursed in the total amount of $84,000, annually, payable in twelve equal monthly payments. In addition, the Independent Contractor Agreement provides that Mr. Diaz Cala will be granted restricted stock units of the Company representing 1% of the issued and outstanding Ordinary Shares as of the grant date in accordance with and subject to the terms and conditions of the Company’s 2022 Incentive Equity Plan. Mr. Diaz Cala’s restricted stock units are subject to time-based vesting, as follows: 20% vest on the grant date, and the remaining restricted stock units will vest in quarterly installments thereafter over a period of three years subject to his continued service on the Board as of each vesting date subject to earlier vesting as set forth below.

 

In the event of the termination of the Independent Contractor Agreement by the Company without Cause or upon a Change in Control (each such term as defined in the Independent Contractor Agreement), any unvested outstanding equity awards held by Mr. Diaz Cala will immediately vest and become nonforfeitable. In the event of the termination of the Independent Contractor Agreement for Cause by the Company or for any reason by Mr. Diaz Cala, all unvested outstanding equity awards will be cancelled and forfeited without consideration.

 

The Independent Contractor Agreement also contains non-solicitation and non-competition covenants, generally prohibiting Mr. Diaz Cala from (i) soliciting or hiring employees or business contacts during the one-year period that follows the termination of the Independent Contractor Agreement and (ii) directly or indirectly competing with the Company during the term of the Independent Contractor Agreement. In addition, the Independent Contractor Agreement states that Mr. Diaz Cala will honor his confidentiality obligations after the termination of his services.

 

The only discussions involving continuing employment or involvement for any persons affiliated with Lionheart before the Business Combination were with Ophir Sternberg relating to the Chairman Agreement with The company and with Faquiry Diaz relating to an independent contractor agreement, with the Company, which provides for certain services to the Company. There has not been any formal or informal commitment to retain any financial advisors after the Business Combination, and there are no pre-existing relationships between Lionheart (or individuals affiliated with Lionheart) and additional investors.

 

Borrowings From Related Parties

 

In 2015, SMX Israel signed an agreement to receive a loan of ILS 2 Million ($512,558 at 2015) from Kibbutz Ketura, and Kibbutz Degania A, an entity associated with Mr. Bader on back-to-back terms from a third party (the Kamea Fund). The loan bears an interest at an annual rate of 4%. The loan was fully repaid in August 2022. The balance as of December 31, 2021 was $269,311 (including provision for bonus at the amount $87,311), and as of December 31, 2020 was $279,939. The balance includes interest and there was no change in the interest rate.

 

In consideration with providing the funding, SMX Israel agreed to provide, as additional consideration, a bonus payment on the occurrence of an exit or major liquidity event. The bonus payment is capped at ILS 3 Million (approximately $965,000) per each of Kibbutz Ketura and Kibbutz Degania A (together, the “Bonus Payments”). The Bonus Payments are intended to operate in one of the two trigger events: (i) dividend distributions by Security Matters Ltd.; or (ii) the sale of shares by either Kibbutz Ketura and Kibbutz Degania A in SMX Israel (either in the event of a takeover or otherwise). Only if the aggregate amounts of one of the two trigger events exceeds the investment of Kibbutz Ketura and Kibbutz Degania A in SMX Israel (by loan or shares), the either party would be entitled to the Bonus Payment.

 

87
 

 

We entered into an Amended and Restated Promissory Note dated as of March 7, 2023 in the principal amount of $549,000, in favor of Lionheart Management, LLC and Lionheart Equities, LLC, which are affiliates of Ophir Sternberg, our Chairman of the Board, Such note was amended in April 2023 to extend the maturity date thereunder to June 10, 2024; however, we prepaid the note in full in May 2023. Such note amended and restated a Promissory Note, executed by Lionheart in favor of the holders, in the original aggregate principal amount of $549,000, to reflect the assumption of all rights and responsibilities of Lionheart by the Company.

 

In August 2022, the Company signed an addendum to the Loan agreement that reduces the amount of the Bonus payment for both lenders to a total fixed amount of ILS 2.5 million ($710,000) that was to be paid upon the completion of the Business Combination. On March 2, 2023, the Bonus payment date was postponed to March 31, 2024 and on April 28, 2023, it was further postponed to June 1, 2024.

 

On September 19, 2023, the Company amended the loan agreements dated September 7, 2015, by and between SMX Israel, the Company’s shareholders and Kamea Fund. Pursuant to the amendment to the loan agreements, Kamea agreed to convert $657,000 of indebtedness under the loan agreements into 487,281 Ordinary Shares (post share reverse split) of the Company, as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the shares are not at least equal to the indebtedness amount, the Company will remain liable to Kamea for the balance of the indebtedness amount. In accordance with management estimation the fair value of this indebtedness is immaterial.

 

Additionally, Kibbutz Ketura provides administrative services for SMX Israel for which it was paid $34,000 in 2023 and $36,000 in 2022. Until 2020, SMX Israel’s lab was located in Kibbutz Ketura.

 

Proof Of Concept Projects Paid By Affiliated Companies

 

The Company is engaged in Proof of Concept (POC) agreements according to which it receives funds for financing research and development expenses from prospective customers and affiliated companies. Affiliated companies paid for reimbursement of POC projects the amount of $858,000 in 2023 and $1,426,000 in 2022.

 

Lock-Up Agreements

 

At the closing of the Business Combination, certain of our shareholders, executive officers and directors entered into lock-up agreements, as filed hereto as Exhibit 4.34 through 4.43, pursuant to which, among other things, they agreed not to offer, sell, contract to sell or otherwise transfer or dispose of any of their Ordinary Shares for six months after the Closing Date, subject to the exceptions described in the agreements.

 

Review, Approval or Ratification of Transactions with Related Persons

 

We have a related party transaction policy that requires the review and, if applicable, approval or ratification of any related party transaction by the Audit Committee.

 

C. Interests of Experts and Counsel

 

Not applicable.

 

ITEM 8. FINANCIAL INFORMATION

 

A. Consolidated Statements and Other Financial Information

 

Financial Statements

 

Our consolidated financial statements are appended at the end of this Annual Report, starting at page F-1.

 

Legal Proceedings

 

From time to time, the Company may become involved in legal proceedings or may be subject to claims arising in the ordinary course of our business. Although the results of these proceedings and claims cannot be predicted with certainty, the Company currently believes that the final outcome of these ordinary course matters will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. We were not a party to any material litigation and did not have material contingency reserves established for any liabilities as of December 31, 2023.

 

Dividends and Dividend Policy

 

We have never declared or paid cash dividends on our share capital. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our Board of Directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects and other factors our Board of Directors may deem relevant.

 

Under Irish law, among other things, we may only pay dividends if we have sufficient distributable reserves (on a non-consolidated basis), which are our accumulated realized profits that have not been previously distributed or capitalized, less our accumulated realized losses, so far as such losses have not been previously written off in a reduction or reorganization of capital. In addition, no distribution or dividend may be made if our net assets are not, or if making such distribution or dividend will cause our net assets to not be, equal to or in excess of the aggregate of our called up share capital plus undistributable reserves.

 

As we are an Irish company, Irish dividend withholding tax, or DWT, currently at a rate of 25%, will arise in respect of dividends or other distributions to our shareholders unless an exemption applies. There are exemptions that may be available to U.S. Holders; such shareholders should consult their respective tax advisors. Where DWT arises, we are responsible for deducting DWT at source and accounting for the relevant amount to the Revenue Commissioners of Ireland.

 

88
 

 

B. Significant Changes

 

Share Issuances to Debtholders

 

In April 2024, the Company issued an aggregate of 690,000 Ordinary Shares to certain former debtholders of the Company as further consideration relating to the December 2023 conversion of their indebtedness and related obligations. Furthermore, the Company issued an aggregate of an additional 891,069 Ordinary Shares to those same former debtholders, for the conversion and termination of an aggregate of 3,564,277 warrants held by them.

 

Alpha SEPA

 

On April 19, 2024, the Company entered into a Stock Purchase Agreement (the “SPA”) with Generating Alpha Ltd. (“Alpha”), pursuant to which Alpha has committed to purchase from us up to $30,000,000 of our ordinary shares, subject to the terms and conditions specified in the SPA. The Company entering into the SPA was a condition of the Company’s previously announced note and warrant transaction with Alpha from April 11, 2024.

 

Subject to the terms and conditions of the SPA, the Company has the right from time to time at its discretion, any time after the three month anniversary of the shares underlying the SPA being registered for resale pursuant to the Registration Rights Agreement referred to below, to direct Alpha to purchase a specified amount of our ordinary shares (each such sale, a “Put”) by delivering written notice to Alpha (each, a “Put Notice”). There is a $20,000 mandatory minimum amount for any Put and it may not exceed $500,000, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20.

 

The Company will control the timing and amount of any sales of ordinary shares to Alpha. Actual sales of our ordinary shares to Alpha as a Put under the SPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company’s ordinary shares and determinations by the Company as to the appropriate sources of funding for its business and operations.

 

The obligations of Alpha to accept any Put pursuant to a Put Notice is subject to customary conditions, including that Alpha is not required to purchase any ordinary shares pursuant to a Put if it would result in Alpha beneficially owning in excess of 4.99% of the Company’s ordinary shares, and that the ordinary shares subject to the Put be registered for resale. The Company agreed to pay a commitment fee to Alpha equal to 1.5% of the commitment amount, payable in shares, or 2,725,621 ordinary shares and which shall be subject to a three month lock-up.

 

The net proceeds under the SPA to the Company will depend on the frequency and prices at which the Company sells ordinary shares to Alpha. The Company expects that any proceeds received by it from such sales to Alpha will be used for working capital and general corporate purposes; provided, however, that in the event the Company owes any indebtedness to Alpha, 50% of any such proceeds shall be applied to repayment of such indebtedness.

 

The SPA will automatically terminate on the earliest to occur of (a) the first day of the month next following the 36-month anniversary of the date of the SPA or (ii) the date on which Alpha shall have made payment of Puts pursuant to the SPA for ordinary shares equal to $30,000,000. The Company has the right to terminate the SPA at no cost or penalty upon five (5) trading days’ prior written notice to Alpha, provided that there are no outstanding Put Notices for which ordinary shares need to be issued and the Company has paid all amounts owed to Alpha pursuant to the SPA and any indebtedness the Company otherwise owes to Alpha or its affiliates. The Company and Alpha may also agree to terminate the SPA by mutual written consent. Neither the Company nor Alpha may assign or transfer its respective rights and obligations under the SPA, and no provision of the SPA may be modified or waived by the Company or Alpha other than by an instrument in writing signed by both parties.

 

89
 

 

The SPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.

 

The Company further entered into a Registration Rights Agreement with Alpha, pursuant to which the Company agreed to register for resale ordinary shares underlying the SPA.

 

April 11, 2024 Securities Purchase Agreement

 

On April 11, 2024 (the “April Effective Date”), the Company consummated the transactions pursuant to a Securities Purchase Agreement (“April SPA”) and issued and sold to an institutional investor a promissory note and warrants, for gross proceeds to the Company of approximately US$2.0 million, before deducting fees and other offering expenses payable by the Company. Notwithstanding such consummation of the transactions, funding of the proceeds occurred on or about April 15, 2024.

 

The Company used the net proceeds from the sale of the note to repay approximately $425,000 of certain amounts owed by the Company, and for working capital and general corporate purposes.

 

The note is in the principal amount of $2,250,000. The actual amount loaned by the investor pursuant to the note is approximately $2.0 million after a 10% original issue discount. The maturity date of the note is the 12-month anniversary of the April Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year from the April Effective Date and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise.

 

The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s Ordinary Shares, at a fixed conversion price of $0.24 per share, subject to customary adjustments as provided in the note including for fundamental transactions. In addition, in the event that the Company is no longer subject to certain limitations on entering into variable rate transactions, the investor may instead convert the note at a 15% discount to the lowest volume weighted average price during the 15 trading days prior to the conversion notice. Any such conversion is subject to customary conversion limitations set forth in the note so the investor beneficially owns less than 4.99% of the Company’s Ordinary Shares. Additionally, the Company has the right to convert in whole or in part the note into Ordinary Shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of Ordinary Shares in excess of 4.99%. In the event of the Company’s failure to timely deliver Ordinary Shares upon conversion of the note, the Company would be obligated to pay a “Conversion Default Payment” of $2,000 per day, pursuant to the terms of the note.

 

Subject to exceptions described in the purchase agreement, the Company may not sell any equity or debt securities for a period of 90 business days after the April Effective Date without the investor’s consent.

 

The note contains customary Events of Default for transactions similar to the transactions contemplated by the purchase agreement and the note, which entitle the investor, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the note. Any principal amount or interest on the note which is not paid when due shall bear interest at the rate of the lesser of (i) 24.5% per annum and (ii) the maximum amount permitted by law during the Event of Default. Upon the occurrence of any Event of Default, the principal amount then outstanding plus accrued interest (including any costs, fees and charges) increases to 120% of such amount through the date of full repayment (or upon the occurrence of certain Events of Default, 500% tacked back to the April Effective Date), as well as all costs of collection.

 

90
 

 

The April SPA and the note contains restrictions on the Company’s ability to enter into any transaction with a Variable Security (as defined in the Note) component, as well as other restrictions on and covenants by the Company, all as described in the note and the purchase agreement.

 

The April SPA contains customary representations and warranties made by each of the Company and the investor. It further grants to the investor certain rights of participation and first refusal, and certain most-favored nation rights, all as set forth in the purchase agreement and the note.

 

The Company is subject to customary indemnification terms in favor of the Investor and its affiliates and certain other parties.

 

The warrant, for 11,825,508 Ordinary Shares, has an exercise price of $0.157 per share, subject to customary adjustments and certain price-based anti-dilution protections (in the event that the Company is no longer subject to certain limitations on entering into variable rate transactions), and may be exercised at any time until the five and one-half year anniversary of the warrant. The warrant also may be exercised pursuant to a cashless or net exercise provision. The exercise of the warrant is subject to a beneficial ownership limitation of 4.99% of the number of Ordinary Shares outstanding immediately after giving effect to such exercise. In the event of the Company’s failure to timely deliver Ordinary Shares upon exercise of the warrants, the Company would be obligated to pay a “Buy-In” amount pursuant to the terms of the warrant.

 

The Company further entered into a Registration Rights Agreement with the investor, pursuant to which the Company agreed to register for resale all of the Ordinary Shares underlying the note and the warrant.

 

Also on the April Effective Date, as a further inducement of the Company for the investor to enter into the transaction, the Company entered into a Warrant Amendment and Inducement Letter with the investor, with respect to its outstanding “B” warrants of the Company to purchase 2,619,367 Ordinary Shares. The outstanding “B” warrants were issued to the investor as of September 6, 2023 pursuant to a Securities Purchase Agreement dated as of September 5, 2023, and had a fixed exercise price of $1.6378 per share.

 

Pursuant to the Warrant Amendment and Inducement Letter, the investor exercised for cash the outstanding “B” warrants in full at a reduced exercise price of $0.0022 per share, or approximately $5,762.

 

The Company agreed to register for resale the shares underlying the outstanding “B” warrants.

 

The Company paid to EF Hutton LLC as placement agent, approximately $20,000 in cash fees in relation to the transactions contemplated by the purchase agreement.

 

Industrial Marking Process for Natural Rubber for Vehicle and Truck Tires

 

On April 10, 2024, the Company announced that it has successfully completed the marking of 21 tons of natural rubber sourced in Latin America from tree to tire. The program covered the marking at the tree in Latin America through manufacturing and production in the region. The Company’s marker was added to the cup lump harvesting by the farmers prior to transfer to the manufacturing centre where the 42 tons of latex was converted to 21 tons of natural rubber. The bails were then transferred to tire manufacturing for commercial car, truck and lorry tires. The tires were then sent for evaluation. The results demonstrated 100% success rates on all marked tires to have a proven verification technology for origin authentication of the natural rubber and full traceability all along the entire supply chain data and integrity from tree to tire.

 

91
 

 

Industrial Marking Process for the Steel Industry

 

On March 27, 2024, the Company announced that it finalized a solution to track and report the ethical sourcing of ores and can demonstrate a market-leading verification process for premium steel products spanning virgin and recycled steel.

 

The Company’s technology would enable customers to demonstrate with accurate data embedded within their steel products that they can track, authenticate and report origination and amount of recycled content in steel products, in an enhanced and compliant manner across their operations.

 

Appointment of Dr. Amnon Azoulay

 

On March 20, 2024, the Company announced its appointment of Dr. Amnon Azoulay as the new head of online and industrial detectors for the Company. Dr. Azoulay has a Ph.D. in condensed matter physics and has spent over 25 years transforming ideas into turnkey products, demonstrating ability to create vision and inspire teams towards achieving innovative outcomes.

 

Dr. Azoulay’s background includes work in additive manufacturing, particularly in 3D polymer printing, as well as non-destructive evaluation (NDE) and imaging systems, including ultrasound, X-Ray, Neutrons, and Terahertz technologies. His expertise extends to the development of nuclear sensors, gas-surface interaction analysis, and the creation of highly complex automated systems incorporating robotics, fast data acquisition, and diverse sensing technologies. The Company believes that this wide-ranging experience positions him to contribute to the Company’s endeavors in enhancing recycling processes and advancing circular economy initiatives through innovative scanning technology.

 

Throughout his career, Dr. Azoulay has held significant positions, including Head of the 3D Printing Lab at the National Research Center (NRC), where he established a center for developing new printing methods and polymers for additive manufacturing technologies. His role in leading the NDT Department and the Ultrasonic Section at NRC involved the management of large projects, budgeting, and the establishment of scientific infrastructures, highlighting his capability in leadership and business development in cutting-edge technological fields.

 

$2,910,000 Offering

 

On February 20, 2024, the Company closed an underwritten public offering of securities for gross proceeds of approximately $2.9 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The offering was pursuant to an underwriting agreement with EF Hutton LLC relating to the public offering of 12,124,666 Ordinary Shares at a subscription price per share of $0.24. Additionally, to the extent that the purchase of such shares would cause the beneficial ownership of a purchaser in the offering, together with its affiliates and certain related parties, to exceed 4.99% of the Ordinary Shares, the Company agrees to issue the underwriter, for delivery to such purchasers, at the election of the purchasers, a number of Pre-Funded Warrants which are initially convertible on a 1-for-1 basis into Ordinary Shares, at a price per Pre-Funded Warrant of $0.2378 (100% of the public offering price allocated to each firm share less $0.0022).

 

The net proceeds to the Company upon the closing of the offering, after deducting the underwriting commissions and estimated offering expenses payable by the Company, were approximately $2.66 million. The Company used the net proceeds from the Offering for (i) sales and marketing; (ii) payment of certain outstanding liabilities and working capital; and (iii) digital branding consulting services. The Company entered into various agreements with consultants to provide the marketing and digital branding consulting services, effective as of the closing of the Offering.

 

Pursuant to the underwriting agreement, the Company paid the underwriter a cash fee equal to 2.5% of the gross proceeds of the Offering, and also paid $100,000 of expenses of the underwriter in connection with the offering.

 

92
 

 

Letter Agreement with YA II PN, Ltd.

 

On February 2, 2024, the Company entered into a Letter Agreement with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”) dated February 1, 2024 (the “Letter Agreement”), which amends and supplements the Standby Equity Purchase Agreement dated February 23, 2023, by and between the Company and Yorkville (the “SEPA”) pursuant to which, among other things, Yorkville advanced to the Company pre-paid advances in the aggregate of $2,000,000 evidenced by a convertible promissory note issued to Yorkville dated May 23, 2023 as amended by that Letter Agreement dated July 27, 2023 (the “May Pre-Paid Advance”).

 

Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances (as defined in the SEPA) under the SEPA, to repay the amounts outstanding under the May Pre-Paid Advance plus Payment Premium (as defined in the SEPA), until all such amounts are fully repaid, and shall use commercially reasonable best efforts to do so by April 1, 2024. The Letter Agreement further provided that any proceeds from any capital raise after April 1, 2024, other than advances under the SEPA, will be utilized to pay down outstanding principal, outstanding default interest and Payment Premium under the May Pre-Paid Advance. As a result, subsequent to the effective date of the Letter Agreement, the Company issued an aggregate of 1,000,000 Ordinary Shares as advances, the proceeds of which were applied to pay the first $100,000 fee described below and the remainder to repay a portion of the principal and interest outstanding under the convertible promissory note evidencing the remaining Pre-paid Advance.

 

The Company agreed to pay a fee to Yorkville equal to $200,000, of which $100,000 shall be payable from the next Advance after the date of the Letter Agreement and $100,000 shall be payable by April 1, 2024 (the “Second Tranche Fee”); provided, that the Second Tranche Fee will not be due if the total amount due and outstanding under the May Pre-Paid Advance is paid in full by April 1, 2024.

 

The Company further agreed to issue to Yorkville a 5-year warrant to purchase 250,000 ordinary shares of the Company at an exercise price of $0.0022 per share (the “Yorkville Warrant”). Such ordinary shares issuable upon exercise of the Yorkville Warrant have demand registration rights, and the Company further agreed to register additional ordinary shares that may be issued pursuant to the SEPA as provided in the Letter Agreement.

 

The Company also agreed to file a registration statement to register additional Registrable Securities (defined in the SEPA) and the Ordinary Shares issuable upon exercise of the Yorkville Warrant no later than thirty (30) calendar days from the date of the Letter Agreement and to file a registration statement to register additional Registrable Securities any time the Registrable Securities are less than 500,000 Ordinary Shares.

 

On or about April 19, 2024, the Company terminated the SEPA in accordance with its terms.

 

Notice of Failure to Satisfy a Continued Listing Rule

 

On January 26, 2024, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of Nasdaq, notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market, as the bid price of the Company’s Ordinary Shares on the Nasdaq Capital Market was below $1.00 for 30 consecutive business days, from December 11, 2023 to January 25, 2024.

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has a period of 180 calendar days, or until July 24, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time before the Compliance Date, the closing bid price of the Company’s Ordinary Shares is at least $1.00 for a minimum of ten consecutive business days, the Staff will provide a written confirmation to the Company that it has regained compliance with the Minimum Bid Price Requirement.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (the “Panel”) pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful.

 

93
 

 

Additionally, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, or will otherwise be compliant with other Nasdaq Listing Rules.

 

Conversion and Exchange of Notes and Warrants

 

On or about January 12, 2024, the Company issued an aggregate of 4,032,256 Ordinary Shares and warrants to purchase an aggregate of 4,032,256 Ordinary Shares, to holders (the “Note Holders”) of existing convertible notes (the “Existing Notes”) and Redeemable Warrants (the “Redeemable Warrants”), in exchange for the cancellation of an aggregate of (a) approximately $750,000 owed to the Note Holders under the Existing Notes and (b) $1,450,000 cash value of Redeemable Warrants. The Company also issued 457,682 Ordinary Shares to a service provider (the “Service Provider”) as payment in full for $260,000 worth of services previously provided to the Company by the Service Provider. Such transactions were evidenced by a series of substantially similar Conversion and Exchange Rights Agreements executed as of December 31, 2023.

 

Agreement with R&I Trading of New York

 

On January 12, 2024, the Company announced that it entered into a $5 million contract with R&I Trading of New York (“R&I Trading”). The agreement with R&I Trading aims to set new standards in brand protection, authentication, ethical sourcing, and origination, specifically for the Fast-Moving Consumer Goods (FMCG) sector, including Beverage and Pharmaceutical industries.

 

Discussions of other significant changes since December 31, 2023, are provided under Item 4 of this Report and elsewhere in this Report and are incorporated herein by reference.

 

ITEM 9. THE OFFER AND LISTING

 

A. Offer and Listing Details

 

Our Ordinary Shares and Warrants are listed on The Nasdaq Stock Market LLC under the symbols “SMX” and “SMXWW,” respectively. Holders of our Ordinary Shares and Warrants should obtain current market quotations for their securities. There can be no assurance that our Ordinary Shares and/or Warrants will remain listed on Nasdaq. If we fail to comply with the Nasdaq listing requirements, our Ordinary Shares and/or Warrants could be delisted from Nasdaq. A delisting of our Ordinary Shares will likely affect the liquidity of our Ordinary Shares and could inhibit or restrict our ability to raise additional financing. See the sections entitled “Item 3. Key Information - D. Risk Factors v- General Risks - There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq” and “Item 8 Financial Information – B. Significant Changes - Notice of Failure to Satisfy a Continued Listing Rule.”

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

 

The Ordinary Shares are listed on the Nasdaq Capital Market under the symbol “SMX” and the Public Warrants are listed on the Nasdaq Capital Market under the symbol “SMXWW.” If the Company fails to comply with the Nasdaq listing requirements, the Ordinary Shares and/or Public Warrants could be delisted from Nasdaq. A delisting of the Ordinary Shares will likely affect the liquidity of the Ordinary Shares and could inhibit or restrict the ability of the Company to raise additional financing. See “Item 8 Financial Information – B. Significant Changes - Notice of Failure to Satisfy a Continued Listing Rule.”

 

D. Selling Shareholders

 

Not applicable.

 

94
 

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Not applicable.

 

B. Memorandum and Articles of Association

 

The Company is a public limited company organized and existing under the laws of Ireland. The Company was formed on July 1, 2022 as a public limited company incorporated in Ireland under the name “Empatan Public Limited Company”. The Company changed its name to SMX (Security Matters) Public Limited Company on February 17, 2023. Its affairs are governed by its Amended and Restated Memorandum and Articles of Association, the ICA, and the laws of Ireland.

 

A copy of our Amended and Restated Memorandum and Articles of Association are filed as Exhibit 1.5 to this Annual Report on Form 20-F, and is incorporated by reference into this Annual Report. Exhibit 2.1 to this Annual Report, which contains a description of our Ordinary Shares and our Constitution, is incorporated by reference into this Annual Report.

 

C. Material Contracts

 

Material Contracts Relating to the Company’s Operations

 

In addition to the contracts described elsewhere in this Annual Report, the following are summaries of each material contract, other than contracts entered into in the ordinary course of business, to which we are a party, for the two years preceding the date of this Annual Report. For additional information on our material contracts, please see “Item 4. Information on the Company,” “Item 5. Operating and Financial Review and Prospects,”Item 6. Directors, Senior Management and Employees,” and “Item 7.B Related Party Transactions” of this Annual Report.

 

A discussion of other material contracts, are provided under Item 8(b) of this Report and is incorporated herein by reference.

 

Material Contracts Relating to the Business Combination

 

The description of the Business Combination Agreement and Scheme Implementation Deed and related and ancillary agreements are included in this Annual Report in “Item 4. Information on the Company,”Item 5. Operating and Financial Review and Prospects” and “Item 7.B. Related Party Transactions”, which are incorporated herein by reference.

 

D. Exchange Controls

 

Under the laws of Ireland, except as indicated below, there are currently no Irish restrictions on the export or import of capital, including foreign exchange controls or restrictions that affect the remittance of dividends (other than dividend withholding tax where an exemption does not apply) to nonresident holders of our ordinary shares.

 

It is an offence under Irish law (pursuant to various statutory instruments) to transfer funds or make funds or economic resources available, directly or indirectly to any person or entity in contravention of Irish, EU or United Nations sanctions or to otherwise contravene Irish, EU or United Nations sanctions.

 

Under the Financial Transfers Act 1992 (the “1992 Act”), the Minister for Finance of Ireland may make provision for the restriction of financial transfers between Ireland and other countries. Financial transfers are broadly defined, and dividends would fall within this definition.

 

The 1992 Act and underlying EU regulations prohibit financial transfers with certain persons and entities listed in the EU Consolidated Financial Sanctions List and United Nations Security Council Consolidated List, each of which is updated on an ongoing basis.

 

95
 

 

E. Taxation

 

Certain Material U.S. Federal Income Tax Considerations

 

The following is a discussion of certain material U.S. federal income tax considerations generally applicable to the acquisition, ownership, and disposition of the Ordinary Shares by a “U.S. Holder.” This discussion applies only to the Ordinary Shares that are held by a U.S. Holder as “capital assets” within the meaning of Section 1221 of the Internal Revenue Code of 1986, as amended (the “Code”) (generally, property held for investment). This discussion does not describe all U.S. federal income tax considerations that may be relevant to a U.S. Holder in light of such U.S. Holder’s particular circumstances, nor does it address any state, local, or non-U.S. tax considerations, any non-income tax (such as gift or estate tax) considerations, the alternative minimum tax, the special tax accounting rules under Section 451(b) of the Code, the Medicare contribution tax on net investment income, or any tax consequences that may be relevant to U.S. holders that are subject to special tax rules, including, without limitation:

 

  banks or other financial institutions;

 

  insurance companies;
     
  mutual funds;
     
  pension or retirement plans;
     
  S corporations;
     
  broker or dealers in securities or currencies;
     
  traders in securities that elect mark-to-market treatment;
     
  regulated investment companies;
     
  real estate investment trusts;
     
  trusts or estates;
     
  tax-exempt organizations (including private foundations);
     
  persons that hold the Ordinary Shares as part of a “straddle,” “hedge,” “conversion,” “synthetic security,” “constructive ownership transaction,” “constructive sale,” or other integrated transaction for U.S. federal income tax purposes;
     
  persons that have a functional currency other than the U.S. dollar;
     
  certain U.S. expatriates or former long-term residents of the United States;
     
  persons owning (directly, indirectly, or constructively) 5% (by vote or value) or more of our stock;
     
  persons that acquired the Ordinary Shares pursuant to an exercise of employee stock options or otherwise as compensation;
     
  partnerships or other entities or arrangements treated as pass-through entities for U.S. federal income tax purposes and investors in such entities;
     
  “controlled foreign corporations” within the meaning of Section 957(a) of the Code;
     
  “passive foreign investment companies” within the meaning of Section 1297(a) of the Code; and
     
  corporations that accumulate earnings to avoid U.S. federal income tax.

 

If a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds the Ordinary Shares, the tax treatment of a partner in such partnership generally will depend on the status of the partner and the activities of the partnership and the partner. Partnerships holding the Ordinary Shares should consult their tax advisors regarding the tax consequences in their particular circumstances.

 

This discussion is based on the Code, the U.S. Treasury regulations promulgated thereunder, administrative rulings, and judicial decisions, all as currently in effect and all of which are subject to change or differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences described herein. Furthermore, there can be no assurance that the Internal Revenue Service (the “IRS”) will not challenge the tax considerations described herein and that a court will not sustain such challenge.

 

96
 

 

For purposes of this discussion, a “U.S. Holder” is a beneficial owner of the Ordinary Shares, that is, for U.S. federal income tax purposes:

 

  an individual who is a U.S. citizen or resident of the United States;
     
  a corporation (including an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;
     
  an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
     
  a trust (i) if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” within the meaning of Section 7701(a)(30) of the Code have the authority to control all substantial decisions of the trust or (B) that has in effect a valid election under applicable U.S. Treasury regulations to be treated as a United States person.

 

THIS DISCUSSION IS FOR GENERAL INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE PROSPECTIVE INVESTORS SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE TAX CONSEQUENCES OF THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF THE ORDINARY SHARES IN THEIR PARTICULAR CIRCUMSTANCES.

 

Distributions on the Ordinary Shares

 

Subject to the PFIC rules discussed below under “-Passive Foreign Investment Company Rules,” distributions on the Ordinary Shares generally will be taxable as a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Such distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the applicable U.S. Holder’s adjusted tax basis in its Ordinary Shares. Any remaining excess will be treated as gain realized on the sale or other taxable disposition of the Ordinary Shares and will be treated as described below under “-Sale or Other Taxable Disposition of the Ordinary Shares.” The amount of any such distributions will include any amounts required to be withheld by us (or another applicable withholding agent) in respect of any non-U.S. taxes. Any such amount treated as a dividend will be treated as foreign-source dividend income. Any such dividends received by a corporate U.S. Holder generally will not qualify for the dividends-received deduction generally allowed to U.S. corporations in respect of dividends received from other U.S. corporations. With respect to non-corporate U.S. Holders, any such dividends generally will be taxed at currently preferential long-term capital gains rates only if (i) the Ordinary Shares are readily tradable on an established securities market in the United States or we are eligible for benefits under an applicable tax treaty with the United States, (ii) we are not treated as a PFIC with respect to the applicable U.S. Holder at the time the dividend was paid or in the preceding year, and (iii) certain holding period and other requirements are met. Any such dividends paid in a currency other than the U.S. dollar generally will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.

 

As noted above and subject to applicable limitations, taxing jurisdictions other than the United States may withhold taxes from distributions on the Ordinary Shares, and a U.S. Holder may be eligible for a reduced rate of withholding to the extent there is an applicable tax treaty between the applicable taxing jurisdiction and the United States and/or may be eligible for a foreign tax credit against the U.S. Holder’s U.S. federal income tax liability. The foreign tax credit rules are complex and U.S. Holders should consult their tax advisers regarding the application of such rules, including the creditability of foreign taxes, in their particular circumstances.

 

97
 

 

Sale or Other Taxable Disposition of the Ordinary Shares

 

Subject to the PFIC rules discussed below under “-Passive Foreign Investment Company Rules,” upon any sale or other taxable disposition of the Ordinary Shares, a U.S. Holder generally will recognize gain or loss in an amount equal to the difference, if any, between (i) the sum of (A) the amount of cash and (B) the fair market value of any other property received in such sale or disposition and (ii) the U.S. Holder’s adjusted tax basis in the Ordinary Shares. Any such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the U.S. Holder’s holding period for such Ordinary Shares exceeds one year. Long-term capital gain recognized by non-corporate U.S. Holders generally will be taxed at currently preferential long-term capital gains rates. The deductibility of capital losses is subject to limitations. For foreign tax credit purposes, any such gain or loss generally will be treated as U.S. source gain or loss.

 

If the consideration received by a U.S. Holder upon a sale or other taxable disposition of the Ordinary Shares is not paid in U.S. dollars, the amount realized will be the U.S. dollar value of such payment calculated by reference to the exchange rate in effect on the date of such sale or disposition. A U.S. Holder may have foreign currency gain or loss to the extent of the difference, if any, between (i) the U.S. dollar value of such payment on the date of such sale or disposition and (ii) the U.S. dollar value of such payment calculated by reference to the exchange rate in effect on the date of settlement.

 

U.S. Holders should consult their tax advisors regarding the tax consequences of a sale or other taxable disposition of the Ordinary Shares, including the creditability of foreign taxes imposed on such sale or disposition by a taxing jurisdiction other than the United States, in their particular circumstances.

 

Information Reporting and Backup Withholding

 

Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries are subject to information reporting, and may be subject to backup withholding, unless (i) the U.S. Holder is a corporation or other exempt recipient or (ii) in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding.

 

Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder’s U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is timely furnished to the IRS.

 

THIS DISCUSSION IS FOR GENERAL INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE PROSPECTIVE INVESTORS SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE TAX CONSEQUENCES OF THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF THE ORDINARY SHARES, INCLUDING THE IMPACT OF ANY POTENTIAL CHANGE IN LAW, IN THEIR PARTICULAR CIRCUMSTANCES.

 

98

 

 

Possible Constructive Distributions

 

The terms of each Public Warrant provide for an adjustment to the number of Ordinary Shares for which the Public Warrant may be exercised or to the exercise price of the Public Warrant in certain events, as discussed in the Exhibit to this Annual Report entitled “Description of Securities.” An adjustment which has the effect of preventing dilution generally is not taxable. A U.S. holder of a Public Warrant would, however, be treated as receiving a constructive distribution from the Company if, for example, the adjustment increases the holder’s proportionate interest in the Company’s assets or earnings and profits (e.g., through an increase in the number of Ordinary Shares that would be obtained upon exercise of such warrant) as a result of a distribution of cash to the holders of the Ordinary Shares which is taxable to the U.S. holders of such shares as described under the section entitled “-Distributions on the Ordinary Shares” above. Such constructive distribution would be subject to tax as described under that section in the same manner as if the U.S. holder of such warrant received a cash distribution from the Company equal to the fair market value of such increased interest. The rules regarding constructive distributions are complex. U.S. holders should consult their own tax advisors regarding the application of the rules to them in light of their own circumstances.

 

Passive Foreign Investment Company Rules

 

Generally. The treatment of U.S. holders of the Ordinary Shares could be materially different from that described above if the Company is treated as a passive foreign investment company (a “PFIC”), for U.S. federal income tax purposes. A PFIC is any foreign corporation with respect to which either: (i) 75% or more of the gross income for a taxable year constitutes passive income for purposes of the PFIC rules, or (ii) 50% or more of such foreign corporation’s assets in any taxable year (generally based on the quarterly average of the value of its assets during such year) is attributable to assets, including cash, that produce passive income or are held for the production of passive income. Passive income generally includes dividends, interest, certain royalties and rents, annuities, net gains from the sale or exchange of property producing such income and net foreign currency gains. The determination of whether a foreign corporation is a PFIC is based upon the composition of such foreign corporation’s income and assets (including, among others, its proportionate share of the income and assets of any other corporation in which it owns, directly or indirectly, 25% (by value) of the stock), and the nature of such foreign corporation’s activities. A separate determination must be made after the close of each taxable year as to whether a foreign corporation was a PFIC for that year. Once a foreign corporation qualifies as a PFIC it is, with respect to a shareholder during the time it qualifies as a PFIC, and subject to certain exceptions, always treated as a PFIC with respect to such shareholder, regardless of whether it satisfied either of the qualification tests in subsequent years.

 

Based on the projected composition of the Company’s income and assets, including goodwill, the Company does not expect to be classified as a PFIC for its taxable year that includes the date of the Business Combination. The tests for determining PFIC status are applied annually after the close of the taxable year, and it is difficult to predict accurately future income and assets relevant to this determination. The fair market value of the assets of the Company is expected to depend, in part, upon (a) the market value of the Ordinary Shares, and (b) the composition of the assets and income of the Company. Further, because the Company may value its goodwill based on the market value of the Ordinary Shares, a decrease in the market value of the Ordinary Shares and/or an increase in cash or other passive assets (including as a result of the Business Combination) would increase the relative percentage of its passive assets. Moreover, any interest income that the Company earns on its cash deposits would generally be treated as passive income and increase the risk that the Company would be treated as a PFIC. The application of the PFIC rules is subject to uncertainty in several respects and, therefore, no assurances can be provided that the IRS will not assert that the Company is a PFIC for the taxable year that includes the date of the Business Combination, the Company’s current taxable year or in a future year.

 

99

 

 

If the Company is or becomes a PFIC during any year in which a U.S. holder holds Ordinary Shares, there are three separate taxation regimes that could apply to such U.S. holder under the PFIC rules, which are the (i) excess distribution regime (which is the default regime), (ii) mark-to-market regime and (iii) QEF regime (as defined below). A U.S. holder who holds (actually or constructively) stock in a foreign corporation during any year in which such corporation qualifies as a PFIC is subject to U.S. federal income taxation under one of these three regimes. The effect of the PFIC rules on a U.S. holder will depend upon which of these regimes applies to such U.S. holder. However, dividends paid by a PFIC are generally not eligible for the lower rates of taxation applicable to qualified dividend income (“QDI”) under any of the foregoing regimes.

 

Excess Distribution Regime. If a U.S. holder does not make a mark-to-market election, as described below, the U.S. holder will be subject to the default “excess distribution regime” under the PFIC rules with respect to (i) any gain realized on a sale or other disposition (including a pledge) of Ordinary Shares, and (ii) any “excess distribution” received on Ordinary Shares (generally, any distributions in excess of 125% of the average of the annual distributions on Ordinary Shares during the preceding three years or the U.S. holder’s holding period, whichever is shorter). Generally, under this excess distribution regime:

 

the gain or excess distribution will be allocated ratably over the period during which the U.S. holder held Ordinary Shares;
   
the amount allocated to the current taxable year, will be treated as ordinary income; and
   
the amount allocated to prior taxable years will be subject to the highest tax rate in effect for that taxable year, and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.

 

The tax liability for amounts allocated to years prior to the year of disposition or excess distribution will be payable generally without regard to offsets from deductions, losses and expenses. In addition, gains (but not losses) realized on the sale of Ordinary Shares cannot be treated as capital gains, even if you hold the shares as capital assets. Further, no portion of any distribution will be treated as QDI.

 

Mark-to-Market Regime. Alternatively, a U.S. holder may make an election to mark marketable shares in a PFIC to market on an annual basis. PFIC shares generally are marketable if: (i) they are “regularly traded” on a national securities exchange that is registered with the Securities and Exchange Commission or on the national market system established under Section 11A of the Securities Exchange Act of 1934; or (ii) they are “regularly traded” on any exchange or market that the Treasury Department determines to have rules sufficient to ensure that the market price accurately represents the fair market value of the stock. It is expected that Ordinary Shares, which are expected to be listed on Nasdaq, will qualify as marketable shares for the PFIC rules purposes, but there can be no assurance that Ordinary Shares will be “regularly traded” for purposes of these rules. Pursuant to such an election, a U.S. holder would include in each year as ordinary income the excess, if any, of the fair market value of such stock over its adjusted basis at the end of the taxable year. A U.S. holder may treat as ordinary loss any excess of the adjusted basis of the stock over its fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of the election in prior years. A U.S. holder’s adjusted tax basis in the PFIC shares will be increased to reflect any amounts included in income, and decreased to reflect any amounts deducted, as a result of a mark-to-market election. Any gain recognized on a disposition of Ordinary Shares will be treated as ordinary income and any loss will be treated as ordinary loss (but only to the extent of the net amount of income previously included as a result of a mark-to-market election). A mark-to-market election only applies for the taxable year in which the election was made, and for each subsequent taxable year, unless the PFIC shares ceased to be marketable or the IRS consents to the revocation of the election. U.S. holders should also be aware that the Code and the Treasury Regulations do not allow a mark-to-market election with respect to stock of lower-tier PFICs that is non-marketable. There is also no provision in the Code, Treasury Regulations or other published authority that specifically provides that a mark-to-market election with respect to the stock of a publicly traded holding company (such as the company) effectively exempts stock of any lower-tier PFICs from the negative tax consequences arising from the general PFIC rules. U.S. holders should consult their own tax advisors to determine whether the mark-to-market tax election is available to them and the consequences resulting from such election. In addition, U.S. holders of Public Warrants will not be able to make a mark-to-market election with respect to their Public Warrants.

 

100

 

 

QEF Regime. Alternatively, a U.S. holder of a PFIC may avoid the adverse PFIC tax consequences described above in respect of stock of the PFIC (but not warrants) by making and maintaining a timely and valid qualified electing fund (“QEF”) election (if eligible to do so) to include in income its pro rata share of the PFIC’s net capital gains (as long-term capital gain) and other earnings and profits (as ordinary income), on a current basis, in each case whether or not distributed, in the first taxable year of the U.S. Holder in which or with which the PFIC’s taxable year ends and each subsequent taxable year. In order to comply with the requirements of a QEF election, a U.S. Holder must receive a PFIC Annual Information Statement from the PFIC. The company does not presently intend to provide a PFIC Annual Information Statement in order for U.S. Holders to make or maintain a QEF election. However, as described above, the company does not expect to be classified as a PFIC for the taxable year that includes the Business Combination.

 

PFIC Reporting Requirements. A U.S. holder of Ordinary Shares will be required to file an annual report on IRS Form 8621 containing such information with respect to its interest in a PFIC as the IRS may require. Failure to file IRS Form 8621 for each applicable taxable year may result in substantial penalties and result in the U.S. holder’s taxable years being open to audit by the IRS until such Forms are properly filed.

 

Additional Reporting Requirements

 

Certain U.S. holders holding specified foreign financial assets with an aggregate value in excess of the applicable dollar thresholds are required to report information to the IRS relating to Ordinary Shares, subject to certain exceptions (including an exception for Ordinary Shares held in accounts maintained by U.S. financial institutions), by attaching a complete IRS Form 8938 to their tax return, for each year in which they hold Ordinary Shares. Substantial penalties apply to any failure to file IRS Form 8938, unless the failure is shown to be due to reasonable cause and not willful neglect. Also, in the event a U.S. holder does not file IRS Form 8938 or fails to report a specified foreign financial asset that is required to be reported, the statute of limitations on the assessment and collection of U.S. federal income taxes of such U.S. holder for the related taxable year may not close before the date which is three years after the date on which the required information is filed. U.S. holders should consult their tax advisors regarding the effect, if any, of these rules on the ownership and disposition of Ordinary Shares.

 

Certain U.S. holders may be required to file an IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) to report a transfer of property to the company. Substantial penalties may be imposed on a U.S. holder that fails to comply with this reporting requirement and the statute of limitations on the assessment and collection of U.S. federal income taxes will be extended in the event of any such failure to comply.

 

Non-U.S. Holders

 

This section applies to non-U.S. holders. For purposes of this discussion, a “non-U.S. holder” means a beneficial owner (other than a partnership or an entity or arrangement so characterized for U.S. federal income tax purposes) of Ordinary Shares or Public Warrants that is not a U.S. holder, including:

 

a nonresident alien individual, other than certain former citizens and residents of the United States;
   
a foreign corporation; or
   
a foreign estate or trust;

 

but, generally, does not include an individual who is present in the United States for 183 days or more in the taxable year of disposition.

 

101

 

 

Ownership and Disposition of Ordinary Shares and Public Warrants by Non-U.S. Holders. A non-U.S. holder of Ordinary Shares will generally not be subject to U.S. federal income tax or, subject to certain reporting or withholdings, U.S. federal withholding tax on any dividends received on Ordinary Shares or any gain recognized on a sale or other disposition of Ordinary Shares (including, any distribution to the extent it exceeds the adjusted basis in the non-U.S. holder’s Ordinary Shares) unless the dividend or gain is effectively connected with the non-U.S. holder’s conduct of a trade or business in the United States and, if required by an applicable tax treaty, is attributable to a permanent establishment maintained by the non-U.S. holder in the United States. In addition, special rules may apply to a non-U.S. holder that is an individual present in the United States for 183 days or more during the taxable year of the sale or disposition, and certain other requirements are met. Such holders should consult their own tax advisors regarding the U.S. federal income tax consequences of the sale or disposition of Ordinary Shares.

 

Dividends and gains that are effectively connected with a non-U.S. holder’s conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment or fixed base in the United States) generally will be subject to U.S. federal income tax at the same regular U.S. federal income tax rates applicable to a comparable U.S. holder and, in the case of a non-U.S. holder that is a corporation for U.S. federal income tax purposes, also may be subject to an additional branch profits tax at a 30% rate or a lower applicable tax treaty rate.

 

The U.S. federal income tax treatment of a non-U.S. holder’s exercise of a Public Warrant, or the lapse of a Public Warrant held by a non-U.S. holder generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrant by a U.S. holder, although to the extent a cashless exercise results in a taxable exchange, the consequences would be similar to those described in the preceding paragraphs above for a non-U.S. holder’s gain on the sale or other disposition of the Ordinary Shares and Public Warrants.

 

CERTAIN MATERIAL IRISH TAX CONSIDERATIONS TO NON-IRISH HOLDERS

 

Scope

 

The following is a summary of the anticipated material Irish tax consequences of the acquisition, ownership and disposal of Ordinary Shares and Public Warrants. The summary is based upon Irish tax laws and the practice of the Irish Revenue Commissioners in effect on the date of this Annual Report and submissions which will be made to the Irish Revenue Commissioners. Changes in law and/or administrative practice may result in a change in the tax consequences described below, possibly with retrospective effect.

 

A “Non-Irish Holder” is an individual who beneficially owns their Ordinary Shares and/or Public Warrants, that is neither a resident nor ordinarily resident in Ireland for Irish tax purposes and does not hold their Ordinary Shares and/or Public Warrants, in connection with a trade carried on by such person through an Irish branch or agency.

 

102

 

 

This summary does not constitute tax advice and is intended only as a general guide. The summary is not exhaustive and securityholders should consult their tax advisors about the Irish tax consequences (and tax consequences under the laws of other relevant jurisdictions) of the business combination and of the acquisition, ownership and disposal of Ordinary Shares and Public Warrants. The summary applies only to Non-Irish Holders who own their Ordinary Shares and/or Public Warrants, as capital assets and does not apply to other categories of Non-Irish Holders, such as dealers in securities, trustees, insurance companies, collective investment schemes and Non-Irish Holders who acquired, or are deemed to have acquired, their Ordinary Shares and/or Public Warrants by virtue of an Irish office or employment (performed or carried on to any extent in Ireland).

 

The summary does not, except where expressly stated, consider the position of Non-Irish Holders who hold their Ordinary Shares and/or Public Warrants directly (and not beneficially through a broker or custodian (through DTC)). The Irish tax consequences of transactions in Ordinary Shares and/or Public Warrants held directly are generally negative when compared with Ordinary Shares and/or Public Warrants held through DTC. Any Non-Irish Holder contemplating holding their Ordinary Shares and/or Public Warrants directly should consult their personal tax advisors as to the Irish tax consequences of acquiring, owning and disposing of such Ordinary Shares and/or Public Warrants.

 

Irish Tax on Chargeable Gains (Irish CGT)

 

The current rate of tax on chargeable gains (where applicable) in Ireland is 33%.

 

Non-Irish Holders will not be within the territorial scope of a charge to Irish CGT on a disposal of their Ordinary Shares and/or Public Warrants, provided that such Ordinary Shares and/or Public Warrants neither (a) were used in or for the purposes of a trade carried on by such Non-Irish Holder through an Irish branch or agency, nor (b) were used, held or acquired for use by or for the purposes of an Irish branch or agency.

 

Stamp Duty

 

The rate of stamp duty (where applicable) on transfers of shares or warrants of Irish incorporated companies is 1% of the greater of the price paid or market value of the shares or warrants acquired. Where Irish stamp duty arises it is generally a liability of the transferee. However, in the case of a gift or transfer at less than fair market value, all parties to the transfer are jointly and severally liable.

 

Irish stamp duty may be payable in respect of transfers of Ordinary Shares and Public Warrants, depending on the manner in which the Ordinary Shares and Public Warrants are held. The Company entered into arrangements with DTC to allow the Ordinary Shares and Public Warrants to be settled through the facilities of DTC. As such, the discussion below discusses separately the securityholders who hold their shares through DTC and those who do not.

 

Ordinary Shares or Public Warrants Held Through DTC

 

The Irish Revenue Commissioners have confirmed to the Company that transfers of Ordinary Shares and Public Warrants effected by means of the transfer of book entry interests in DTC will not be subject to Irish stamp duty.

 

Ordinary Shares or Public Warrants Held Outside of DTC or Transferred Into or Out of DTC

 

A transfer of Ordinary Shares or Public Warrants where any party to the transfer holds such Ordinary Shares or Public Warrants outside of DTC may be subject to Irish stamp duty.

 

Holders of Ordinary Shares or Public Warrants wishing to transfer their Ordinary Shares or Public Warrants into (or out of) DTC may do so without giving rise to Irish stamp duty provided that:

 

there is no change in the beneficial ownership of such shares as a result of the transfer; and
   
the transfer into (or out of) DTC is not effected in contemplation of a sale of such shares or warrants by a beneficial owner to a third party.

 

103

 

 

Withholding Tax on Dividends (DWT)

 

Distributions made by the Company will, in the absence of one of many exemptions, be subject to DWT, currently at a rate of 25%.

 

For DWT and Irish income tax purposes, a distribution includes any distribution that may be made by the Company to holders of Ordinary Shares, including cash dividends, non-cash dividends and additional stock taken in lieu of a cash dividend. Where an exemption from DWT does not apply in respect of a distribution made to a holder of Ordinary Shares, the Company is responsible for withholding DWT prior to making such distribution.

 

General Exemptions

 

Irish domestic law provides that a non-Irish resident holder of Ordinary Shares is not subject to DWT on distributions received from the Company if such holder of Ordinary Shares is beneficially entitled to the distribution and is either (for a List of Relevant Territories for DWT purposes see Exhibit 15.3 to this Annual Report):

 

a person (not being a company) resident for tax purposes in a Relevant Territory (including the United States) and is neither resident nor ordinarily resident in Ireland;
   
a company resident for tax purposes in a Relevant Territory, provided such company is not under the control, whether directly or indirectly, of a person or persons who is or are resident in Ireland;
   
a company that is controlled, directly or indirectly, by persons resident in a Relevant Territory and who is or are (as the case may be) not controlled by, directly or indirectly, persons who are not resident in a Relevant Territory;
   
a company whose principal class of shares (or those of its 75% direct or indirect parent) is substantially and regularly traded on a stock exchange in Ireland, on a recognized stock exchange either in a Relevant Territory or on such other stock exchange approved by the Irish Minister for Finance; or
   
a company that is wholly owned, directly or indirectly, by two or more companies where the principal class of shares of each of such companies is substantially and regularly traded on a stock exchange in Ireland, a recognized stock exchange in a Relevant Territory or on such other stock exchange approved by the Irish Minister for Finance;

 

and provided, in all cases noted above (but subject to “-Ordinary Shares Held by U.S. Resident Shareholders” below), the Company or, in respect of Ordinary Shares held through DTC, any qualifying intermediary appointed by the Company, has received from the holder of such Ordinary Shares, where required, the relevant DWT Forms prior to the payment of the distribution. In practice, in order to ensure sufficient time to process the receipt of relevant DWT Forms, the holders of Ordinary Shares, where required, should furnish the relevant DWT Form to:

 

its broker (and the relevant information is further transmitted to any qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to the holder of Ordinary Shares by the broker) if its Ordinary Shares are held through DTC; or
   
The Company’s transfer agent before the record date for the distribution if its Ordinary Shares are held outside of DTC.

 

Links to the various DWT Forms are available at: http://www.revenue.ie/en/tax/dwt/forms/index.html. The information on such website does not constitute a part of, and is not incorporated by reference into, this Annual Report.

 

For non-Irish resident holders of Ordinary Shares that cannot avail themselves of one of Ireland’s domestic law exemptions from DWT, it may be possible for such holder of Ordinary Shares to rely on the provisions of a double tax treaty to which Ireland is party to reduce the rate of DWT.

 

104

 

 

Ordinary Shares Held by U.S. Resident Shareholders

 

Distributions paid in respect of Ordinary Shares that are owned by a U.S. resident and held through DTC will not be subject to DWT provided the address of the beneficial owner of such Ordinary Shares in the records of the broker holding such Ordinary Shares is in the United States (and such broker has further transmitted the relevant information to a qualifying intermediary appointed by the Company). It is strongly recommended that such holders of Ordinary Shares ensure that their information is properly recorded by their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company).

 

If any holder of Ordinary Shares that is resident in the United States receives a distribution from which DWT has been withheld, the holder of Ordinary Shares should generally be entitled to apply for a refund of such DWT from the Irish Revenue Commissioners, provided the holder of Ordinary Shares is beneficially entitled to the distribution.

 

Ordinary Shares Held by Residents of Relevant Territories Other Than the United States

 

Holders of Ordinary Shares who are residents of Relevant Territories, other than the United States, must satisfy the conditions of one of the exemptions referred to above under the heading “-General Exemptions”, including the requirement to furnish valid DWT Forms, in order to receive distributions without suffering DWT. If such holders of Ordinary Shares hold their Ordinary Shares through DTC, they must provide the appropriate DWT Forms to their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to holder of Ordinary Shares by the broker). If such holders of Ordinary Shares hold their Ordinary Shares outside of DTC, they must provide the appropriate DWT Forms to the Company’s transfer agent before the record date for the distribution.

 

If any holder of Ordinary Shares who is resident in a Relevant Territory receives a distribution from which DWT has been withheld, the holder of Ordinary Shares may be entitled to a refund of DWT from the Irish Revenue Commissioners provided the holder of Ordinary Shares is beneficially entitled to the distribution.

 

Shares Held by Other Persons

 

Holders of Ordinary Shares that do not fall within any of the categories specifically referred to above may nonetheless fall within other exemptions from DWT. If any holders of Ordinary Shares are exempt from DWT, but receive distributions subject to DWT, such holders of Ordinary Shares may apply for refunds of such DWT from the Irish Revenue Commissioners.

 

Distributions paid in respect of Ordinary Shares held through DTC that are owned by a partnership formed under the laws of a Relevant Territory and where all the underlying partners are resident in a Relevant Territory will be entitled to exemption from DWT if all of the partners complete the appropriate DWT Forms and provide them to their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to the holder of Ordinary Shares by the broker). If any partner is not a resident of a Relevant Territory, no part of the partnership’s position is entitled to exemption from DWT.

 

Qualifying Intermediary

 

Prior to paying any distribution, the Company will put in place an agreement with an entity that is recognized by the Irish Revenue Commissioners as a “qualifying intermediary,” which will provide for certain arrangements relating to distributions in respect of Ordinary Shares that are held through DTC, which are referred to as the “Deposited Securities.” The agreement will provide that the qualifying intermediary shall distribute or otherwise make available to Cede & Co., as nominee for DTC, any cash dividend or other cash distribution with respect to the Deposited Securities after the Company delivers or causes to be delivered to the qualifying intermediary the cash to be distributed.

 

105

 

 

The Company will rely on information received directly or indirectly from its qualifying intermediary, brokers and its transfer agent in determining where holders of Ordinary Shares reside, whether they have provided the required U.S. tax information and whether they have provided the required DWT Forms. Holders of Ordinary Shares that are required to file DWT Forms in order to receive distributions free of DWT should note that such forms are generally valid, subject to a change in circumstances, until December 31 of the fifth year after the year in which such forms were completed.

 

Income Tax on Dividends Paid on Ordinary Shares

 

Irish income tax may arise for certain persons in respect of distributions received from Irish resident companies.

 

A Non-Irish Holder that is entitled to an exemption from DWT will generally have no Irish income tax or universal social charge liability on a distribution from the Company. A Non-Irish Holder that is not entitled to an exemption from DWT, and therefore is subject to DWT, generally will have no additional Irish income tax liability or liability to universal social charge. The DWT deducted by the Company discharges the Irish income tax liability and liability to universal social charge.

 

Capital Acquisitions Tax (CAT)

 

CAT comprises principally gift tax and inheritance tax on property situated in Ireland for CAT purposes or otherwise within the territorial scope of CAT. CAT could apply to a gift or inheritance of Ordinary Shares and Public Warrants because Ordinary Shares and Public Warrants are regarded as property situated in Ireland for CAT purposes. The person who receives the gift or inheritance has primary liability for CAT.

 

CAT is currently levied at a rate of 33% on the value of any taxable gift or inheritance above certain tax-free thresholds. The appropriate tax-free threshold depends upon (1) the relationship between the donor and the donee and (2) the aggregation of the values of previous taxable gifts and inheritances received by the donee from persons within the same group threshold. Gifts and inheritances passing between spouses are exempt from CAT, as are gifts to certain charities. Children have a lifetime tax-free threshold of €335,000 in respect of taxable gifts or inheritances received from their parents. There is also a “small gift exemption” from CAT whereby the first €3,000 of the taxable value of all taxable gifts taken by a donee from any one donor, in each calendar year, is exempt from CAT and is also excluded from any future aggregation. This exemption does not apply to an inheritance.

 

THE IRISH TAX CONSIDERATIONS SUMMARIZED ABOVE ARE FOR GENERAL INFORMATION ONLY AND ARE NOT INTENDED TO PROVIDE ANY DEFINITIVE TAX REPRESENTATIONS TO HOLDERS. EACH SECURITYHOLDER SHOULD CONSULT HIS OR HER TAX ADVISOR AS TO THE PARTICULAR CONSEQUENCES THAT MAY APPLY TO SUCH SECURITYHOLDER.

 

F. Dividends and Paying Agents

 

Not applicable.

 

G. Statement by Experts

 

Not applicable.

 

H. Documents on Display

 

Documents concerning the Company referred to in this Report may be inspected at the principal executive offices of the Company at Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Ireland, D04 T4A6.

 

106

 

 

We are subject to certain of the informational filing requirements of the Exchange Act. Since we are a “foreign private issuer,” our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act, with respect to their purchase and sale of our equity securities. In addition, we are not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we are required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent registered public accounting firm. We will also furnish to the SEC, on Form 6-K, unaudited financial information with respect to our first six-month period of our fiscal year. The SEC also maintains a website at http://www.sec.gov that contains reports and other information that we file with or furnish electronically with the SEC.

 

I. Subsidiary Information

 

Not applicable.

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is exposed to market risks in the ordinary course of business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of U.S. dollar/ILS Israeli Shekels exchange rates, which is discussed in detail in the following paragraph.

 

Foreign Currency Exchange Risk

 

Currency Fluctuations

 

The Company’s operating expenses are denominated in ILS, AUD, EURO and SGD, and therefore are currently subject to foreign currency risk. We have been affected by changes in some of such rates compared to the U.S. dollar, as of December 31, 2023, the ILS increased against the U.S. dollar by approximately 3%, the AUD increased against the U.S. dollar by approximately 0%, the EUR increased against the U.S. dollar by approximately 4% and the SGD increased against the U.S. dollar by approximately 1%.

 

The Company’s policy is not to enter into any currency hedging transactions, and we cannot assure you that we will not be adversely affected by currency fluctuations in the future.

 

Credit Risk

 

Credit risk is a risk of financial loss if a counterparty or customer fails to meet its contractual obligations. We closely monitor the activities of our counterparties and control the access to its intellectual property which enables it to ensure a prompt collection. Our main financial assets are cash and cash equivalents as well as other receivables and represent the Company’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Company holds cash with major and sound financial institutions in Israel and Australia.

 

Liquidity Risk

 

Liquidity risk is the risk that we will encounter in meeting our obligations associated with our financial liabilities that are settled by delivering cash or another financial asset. The Company seeks to minimize that risk by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. For more details, please refer to the section titled, “Liquidity and Capital Resources”.

 

107

 

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A. Debt Securities

 

Not applicable.

 

B. Warrants and Rights

 

Not applicable.

 

C. Other Securities

 

Not applicable.

 

D. American Depositary Shares

 

Not applicable.

 

PART II

 

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

 

Not applicable.

 

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

 

Not applicable.

 

ITEM 15. CONTROLS AND PROCEDURES

 

A. Disclosure Controls and Procedures

 

As required by Rule 13a-15 under the Exchange Act, management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report (the “Evaluation Date”). Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitations, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding our required disclosures. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be included in periodic filings under the Exchange Act and that such information is accumulated and communicated to management, including our principal executive and financial officers, as appropriate to allow timely decisions regarding required disclosure.

 

B. Management’s Annual Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with international financial reporting standards. Our internal control over financial reporting includes those policies and procedures that:

 

  Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
     
  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with international financial reporting standards, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
     
  Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies and procedures may deteriorate. Under the supervision of our Chief Executive Officer and Chief Financial Officer, our management assessed the design and effectiveness of our internal control over financial reporting as of December 31, 2023. In making its assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in Internal Control — Integrated Framework (2013).

 

Based on our assessment and those criteria, our management has concluded that our Company maintained effective internal control over financial reporting as of December 31, 2023.

 

This Annual Report on Form 20-F does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this Annual Report on Form 20-F.

 

108

 

 

C. Attestation Report of the Registered Public Accounting Firm

 

This Annual Report does not include an attestation report of the Company’s registered public accounting firm on management’s assessment of the Company’s internal control over financial reporting since we are an emerging growth company.

 

D. Changes in Internal Control Over Financial Reporting

 

During the year ended December 31, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 16. [RESERVED]

 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

 

At this time, the Company does not have on its Audit Committee at least one member who qualifies as an “audit committee financial expert” as defined by the SEC; however, the Company believes that all of the audit committee members are able to read and understand fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement. Additionally, at least one member of the audit committee meets the criteria of having past employment experience in finance or accounting, requisite professional certification in accounting, or other comparable experience or background which results in the individual’s financial sophistication, and accordingly believes that the audit committee can properly fulfill its functions and role as if at least one member was an “audit committee financial expert” as defined by the SEC.

 

ITEM 16B. CODE OF ETHICS

 

The Board adopted a Code of Ethics applicable to our directors, executive officers and team members that complies with the rules and regulations of Nasdaq and the SEC. The Code of Ethics is available on the Company’s website. In addition, the Company intends to post on the Corporate Governance section of its website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the Code of Ethics. The reference to the Company’s website address in this Annual Report does not include or incorporate by reference the information on the Company’s website into this Annual Report.

 

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

BDO Ziv Haft has served as our independent registered public accountant since 2023 and has audited our consolidated financial statements for the years ended December 31, 2023, 2022 and 2021.

 

The following table shows the aggregate fees for services rendered by BDO Ziv Haft to us and our subsidiaries, in the fiscal year ended December 31, 2023 and 2022.

 

   Year Ended December 31, 
(in USD)  2023   2022 
Audit Fees  $215,250   $188,500 
Audit-Related Fees   71,250    25,000 
Tax Fees   -    - 
All Other Fees   -   $- 
           
Total  $286,500   $213,500 

 

Auditor Name   Auditor Location   Auditor Firm ID
Ziv Haft   Tel Aviv, Israel   03-6386868

 

109

 

 

Audit fees. Audit fees consisted of fees for the audit of our annual financial statements and other professional services provided in connection with the statutory and regulatory filings or engagements, including fees for the review of our interim financial information.

 

Audit-related fees. Audit-related fees included fees for assurance reporting on our current and historical financial information included in our SEC registration statements, including services that generally only the independent accountant can reasonably provide.

 

Tax Fees. Tax fees included fees for tax compliance, tax advice, and tax planning.

 

All Other Fees. All Other Fees are any additional amounts billed for products and services provided by Ziv Haft.

 

Audit and Risk Committee Pre-Approval Policies and Procedures

 

Our audit committee reviews and pre-approves the scope and the cost of audit services related to us and permissible non-audit services performed by the independent auditors. All of the services related to us provided by Ziv Haft during the last fiscal year have been pre-approved by our audit committee.

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARD FOR AUDIT COMMITTEES

 

Not applicable.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASER

 

Not applicable.

 

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

Not applicable.

 

ITEM 16G. CORPORATE GOVERNANCE

 

We are a “foreign private issuer,” as defined by the SEC. As a result, in accordance with Nasdaq rules, we will comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. While we expect to voluntarily follow most Nasdaq corporate governance rules, we may choose to take advantage of the following limited exemptions:

 

Exemption from filing quarterly reports on Form 10-Q containing unaudited financial and other specified information or current reports on Form 8-K upon the occurrence of specified significant events;

 

110

 

 

Exemption from Section 16 rules requiring insiders to file public reports of their securities ownership and trading activities and providing for liability for insiders who profit from trades in a short period of time;
   
Exemption from quorum requirements for shareholder meetings;
   
Exemption from the Nasdaq rules applicable to domestic issuers requiring disclosure within four business days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers;
   
Exemption from the requirement to obtain shareholder approval for certain issuances of securities, including shareholder approval of share option plans;

 

Exemption from the requirement that our audit committee have review and oversight responsibilities over all “related party transactions,” as defined in Item 7.B of Form 20-F;
   
Exemption from the requirement that our board have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. We currently have only director who serves on the compensation committee who meets the heightened independence standards for members of a compensation committee; and
   
Exemption from the requirements that director nominees are selected, or recommended for selection by our board, either by (1) independent directors constituting a majority of our board’s independent directors in a vote in which only independent directors participate, or (2) a committee comprised solely of independent directors, and that a formal written charter or board resolution, as applicable, addressing the nominations process is adopted.

 

Furthermore, Nasdaq Rule 5615(a)(3) provides that a foreign private issuer, such as we, may rely on home country corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that we nevertheless comply with Nasdaq’s Notification of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). Most recently, we have elected to (a) amend our 2022 Equity Incentive Plan to increase the number of shares authorized under the plan without stockholder approval, and (b) follow home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of our Ordinary Shares (or securities convertible into or exercisable for our Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, each as permitted under Irish law.

 

Accordingly, our shareholders will not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. We may utilize these and possibly other future exemptions for as long as we continue to qualify as a foreign private issuer.

 

The Company structured its corporate governance in a manner it believes closely aligns its interests with those of its shareholders. Notable features of this corporate governance include:

 

The Company has four independent directors and independent director representation on our audit and compensation committees immediately. Furthermore, until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.

 

111

 

 

The independent directors will meet regularly in executive sessions without the presence of our corporate officers or non-independent directors;
   
The Company implemented a range of other corporate governance practices, including a robust director education program.

 

At this time, the Company does not have on its Audit Committee at least one member who qualifies as an “audit committee financial expert” as defined by the SEC; however, the Company believes that all of the audit committee members are able to read and understand fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement. Additionally, at least one member of the audit committee has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication, and accordingly believes that the audit committee can properly fulfill its functions and role as if at least one member was an “audit committee financial expert” as defined by the SEC.

 

ITEM 16H. MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

ITEM 16J. INSIDER TRADING POLICIES

 

We have adopted insider trading policies and procedures governing the purchase, sale, and other dispositions of our securities by directors, senior management, and employees that are reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and any listing standards applicable to our company. The insider trading policy is filed as an exhibit to this Annual report on Form 20-F.

 

ITEM 16K. CYBERSECURITY

 

Since our formation, our business focus has primarily been on identifying brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity, using our proprietary technology. We have 41 full and part time employees and also use third-party vendors and service providers for certain activities.

 

We use a third-party sub-contractor to manage all Information Technology (IT) issues, including protection against, detection, and response to cyberattacks.

 

The measures that are taken to ensure proper protection include:

 

All computers are protected using a cloud-powered endpoint security solution that helps enterprises prevent, detect, investigate, and respond to advanced threats on their networks. It offers endpoint protection, endpoint detection and response, mobile threat defense, and integrated vulnerability management. It also provides, among other things, malware and spyware detection and remediation, rootkit detection and remediation and network vulnerability detection.
   
All Company e-mails are protected by a cloud-based email filtering service designed to protect the Company against advanced threats related to email and collaboration tools.
   
Periodically, all users on the Company’s computer network are required to perform multi-factor authentication.
   
The Company uses a cloud-based identity and access management service that enables access to external resources, which use two-factor authentication.
   
Backup is performed using a secure, automatic cloud-based backup and restore service.

 

Additionally, we believe that our third-party vendors and service providers have their own respective cybersecurity protocols which our management believes to be adequate for protecting any of the Company’s data that might be in their possession from time to time; however, having such protocols is not necessarily a condition for us using or not using the services of any such vendors or providers.

 

Our senior management and part-time chief technology officer is responsible for assessing and managing cybersecurity risks, through oversight of our IT service provider that manages our IT, but our management does not have specific cybersecurity expertise. The Company has an Information Technology Policy that, among other things, governs and provides for cybersecurity policies and processes, including to define safety measures to protect the Company’s confidentiality, integrity and availability of data and other intellectual property, as well as to define the manner in which information is stored, saved and routed in the Company’s network. Additionally, the Board and management believe cybersecurity represents an important component of the Company’s overall approach to risk management and oversight. The Company also has cybersecurity insurance in effect as of the date of this Annual Report on Form 20-F.

 

Cybersecurity threats have not materially affected, and are not reasonably likely to affect, the Company, including its business strategy, results of operations or financial condition while we are strategically focused on pursuing brands and manufacturers. The Company is not aware of any material security breach to date. Accordingly, the Company has not incurred any expenses over the last two years relating to information security breaches. The occurrence of cyber-incidents, or a deficiency in our cybersecurity or in those of any of our third-party service providers could negatively impact our business by causing a disruption to our operations, a compromise or corruption of our confidential information and systems, or damage to our business relationships or reputation, all of which could negatively impact our business and results of operations. There can be no assurance that the Company’s third-party vendors’ and service providers’ cybersecurity risk management processes, including their policies, controls or procedures, will be fully implemented, complied with or effective in protecting the Company’s systems and information.

 

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

See pages F-1 though F-43 of this Annual Report.

 

ITEM 18. FINANCIAL STATEMENTS

 

Not applicable.

 

112

 

 

ITEM 19. EXHIBITS

 

EXHIBIT INDEX

 

Exhibit

No.

  Description
1.1   Articles of Association of the Company (incorporated by reference to Exhibit 3.2 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
1.2   Form of Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Annex C to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
1.3   Certificate of Incorporation on Change of Name (incorporated by reference to Exhibit 3.5 to the Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
1.4  

Amended Public Limited Company Constitution of SMX (Security Matters) Public Limited Company Memorandum of Association (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 6-K filed with the SEC on August 18, 2023).

     
1.5  

Further Amended Public Limited Company Constitution of SMX (Security Matters) Public Limited Company Memorandum of Association (incorporated by reference to Exhibit 3.7 to the Registration Statement on Form F-1 (Reg. No. 333-274774), as amended, initially filed with the SEC on September 29, 2023).

     
2.1*   Description of Securities
     
2.2   Promissory Note between the Company and EF Hutton, dated March 7, 2023 (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
2.3  

Warrant Agreement, dated November 3, 2021, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K filed by Lionheart III Corp with the SEC on November 9, 2021)

     
2.4  

Form of Warrant A (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)

     
2.5  

Form of Warrant B (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)

     
2.6  

Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)

     
2.7   Form of Underwriter’s Warrant (incorporated by reference to Exhibit 4.6 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
2.8  

Form of Warrant Agent Agreement with Respect to Warrant A, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.7 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)

     
2.9   Form of Warrant Agent Agreement with Respect to Warrant B, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     

2.10

 

Form of A Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023)

     

2.11

 

Form of B Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023)

     
2.12  

Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).

     
2.13  

Warrant to YAII PN, Ltd. (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on February 2, 2024).

     

2.14

 

Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).

     
2.15  

Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.14 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-276760), as amended, initially filed with the SEC on February 8, 2024).

     
2.16  

Form of Ordinary Share Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on April 12, 2024).

     
2.17  

Form of Warrant.

 

113

 

 

Exhibit No.   Description
4.1   Registration Rights Agreement, dated November 3, 2021, by and between Lionheart III Corp, Lionheart Equities, LLC and certain securityholders (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
4.2  

Private Placement Securities Subscription Agreement, dated November 3, 2021, by and between Lionheart III Corp and Lionheart Equities, LLC (incorporated by reference to Exhibit 10.5 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).

     

4.3

 

Form of Indemnity Agreement (incorporated by reference to Exhibit 10.6 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).

     

4.4

 

Amended and Restated Sponsor Agreement, dated July 26, 2022, by and among Lionheart III Corp, Lionheart Equities, LLC, and certain insiders (incorporated by reference herein to Exhibit 10.9 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).

     
4.5  

Amended and Restated Registration Rights Agreement, by and between the Company, Lionheart Equities, LLC and Holders, dated February 23, 2023 (incorporated by reference to Exhibit 4.10 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     

4.6

 

Employment Agreement, dated June 1, 2021, by and between Security Matters Ltd. and Haggai Alon (incorporated by reference to Exhibit 10.12 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.7  

Employment Agreement, dated April 25, 2021, by and between Security Matters Ltd. and Limor Moshe Lotker (incorporated by reference to Exhibit 10.13 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     

4.8

 

Amendment I, dated June 9, 2022, to Employment Agreement dated June 1, 2021, by and between Security Matters Ltd. and Haggai Alon (incorporated by reference to Exhibit 10.14 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     

4.9

 

Amendment I, dated June 9, 2022, to Employment Agreement dated April 25, 2021, by and between Security Matters Ltd. and Limor Moshe Lotker (incorporated by reference to Exhibit 10.15 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.10  

License Agreement, dated January 1, 2015, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.16 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     

4.11

  Amendment to License Agreement, dated July 10, 2018, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.17 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
4.12  

Addendum to License Agreement, dated April 30, 2019, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.18 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.13  

TrueGold Licensing Agreement dated July 26, 2020, by and between Security Matters Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.20 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     

4.14

 

Shareholders Agreement dated July 27, 2020 by and among Security Matters PTY, W.A. Mint Pty Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.21 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.15  

True Gold R&D Services Agreement dated November 16, 2022, by and between Security Matters Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.22 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.16  

Services Agreement dated June 16, 2021, by and between Security Matters PTY and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.23 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.17  

Amendment, dated May 26, 2022, to True Gold R&D Services Agreement, by and between Security Matters, Ltd. and True Gold Consortium Pty. Ltd. (incorporated by reference to Exhibit 10.24 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.18   Shareholders Agreement dated April 30, 2019, by and among Security Matters Ltd., Trifecta Industries Ltd. and Newco (incorporated by reference to Exhibit 10.25 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
4.19  

Chairman Agreement dated July 26, 2022, by and among Ophir Sternberg and the Company (incorporated by reference to Exhibit 10.26 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.20  

Independent Contractor Agreement dated July 26, 2022, by and among Faquiry Diaz and the Company (incorporated by reference to Exhibit 10.27 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

     
4.21  

Form of Assignment, Assumption and Amendment Agreement with respect to the Warrant Agreement (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

 

114

 

 

Exhibit No.   Description
4.22  

Reciprocal Standby Equity Purchase Agreement with YA II PN, LTD., dated February 23, 2023 (incorporated by reference to Exhibit 4.27 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.23  

Convertible Promissory Note with YA II PN, LTD., dated March 9, 2023 (incorporated by reference to Exhibit 4.28 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.24  

Form of Senior Secured Promissory Note (incorporated by reference to Exhibit 4.29 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.25  

Form of Specific Security Deed (incorporated by reference to Exhibit 4.30 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.26  

Form of 15% Senior Convertible Note due 2024 Growth Financing Termsheet (incorporated by reference to Exhibit 4.31 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.27  

Amended and Restated Promissory Note with Lionheart Management, LLC and Lionheart Equities, LLC, dated March 7, 2023 (incorporated by reference to Exhibit 4.32 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).

     
4.28  

2022 Incentive Equity Plan (incorporated by reference to Exhibit 4.33 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.29  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Ophir Sternberg (incorporated by reference to Exhibit 4.34 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.30  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Thomas Hawkins (incorporated by reference to Exhibit 4.35 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.31  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Faquiry Diaz Cala (incorporated by reference to Exhibit 4.36 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.32  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Haggai Alon (incorporated by reference to Exhibit 4.37 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.33  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and James Anderson (incorporated by reference to Exhibit 4.38 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.34  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Lionheart Equities, LLC (incorporated by reference to Exhibit 4.39 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.35  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Roger Meltzer (incorporated by reference to Exhibit 4.40 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     

4.36

 

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Thomas Byrne (incorporated by reference to Exhibit 4.41 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

 

115

 

 

Exhibit No.   Description
4.37  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Benguy Escrow Co. Ltd. A/C. (incorporated by reference to Exhibit 4.42 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.38  

Lock-Up Agreement, dated February 23, 2023, by and between the Company and Paul Rapisarda (incorporated by reference to Exhibit 4.43 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     

4.39

 

Form of 2022 Incentive Equity Plan, Option Award Agreement (incorporated by reference to Exhibit 4.44 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.40  

Form of 2022 Incentive Equity Plan, RSU Award Agreement (incorporated by reference to Exhibit 4.45 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.41  

Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.46 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.42   Amendment to 10% Secured Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.47 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.43  

Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.48 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.44  

Amendment to Senior Secured Promissory Note Due August 24, 2024, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.49 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.45  

Amendment to Senior Secured Promissory Note, dated March 2, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.50 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022 filed with the SEC on April 28, 2023).

     

4.46

 

Amendment to 10% Secured Notes Due July 1st, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.51 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.47  

Amendment to 10% Secured Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.52 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.48  

Amendment to 10% Secured Bridge Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.53 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.49  

Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.54 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

     
4.50  

Amendment to Loan Agreement, dated March 2, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.55 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

 

116

 

 

Exhibit No.   Description
4.51   Amendment to Senior Secured Promissory Note Due July 31, 2023, dated March 5, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.56 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
     
4.52   Amendment to Senior Secured Promissory Note Due December 19, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.57 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.53   Conversion and Exchange Rights Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.58 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.54   Conversion and Exchange Rights Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.59 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.55   Amendment to Senior Secured Promissory Note Due December 19, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.60 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.56   Amendment to Senior Secured Promissory Note Due July 31, 2023, dated March 5, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.61 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.57   Amended and Restated Promissory Note dated as of March 7, 2023, in favor of Lionheart Management, LLC and Lionheart Equities, LLC (incorporated by reference to Exhibit 4.62 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
4.58   Amendment dated April 27, 2023 to Amended and Restated Promissory Note dated as of March 7, 2023 (incorporated by reference to Exhibit 4.63 to the Company’s Annual Report on Form 20-F filed with the SEC on April 28, 2023),
     
4.59   Convertible Promissory Note with YA II PN, LTD., dated May 22, 2023 (incorporated by reference to Exhibit 10.59 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023).
     
4.60   Letter Agreement by and between the Company and YA II PN, Ltd., dated July 27, 2023 (incorporated by reference to Exhibit 10.60 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-274378), as amended, initially filed with the SEC on September 6, 2023).
     
4.61   Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
4.62   Form of Promissory Note (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
4.63   Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
4.64   Employment Agreement by and between Security Matters Pty and Zeren Browne, dated July 21, 2022 (incorporated by reference to Exhibit 10.64 to the Company’s Registration Statement on Form F-1 (Reg No. 333-276258), as amended, initially filed with the SEC on December 22, 2023).
     
4.65   Form of Conversion and Exchange Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on January 25, 2024).

 

117

 

 

Exhibit No.   Description
4.66   Form of Conversion and Exchange Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 6-K filed with the SEC on January 25, 2024).
     
4.67   Letter Agreement with YAII PN, Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on February 2, 2024).
     
4.68   Form of Inducement Letter (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).
     
4.69   Investment Agreement dated as of October 3, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on October 10, 2023).
     
4.70   Employment Agreement by and between Security Matters Ltd. and Ofira Bar dated December 23, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on March 1, 2024).
     
4.71   Private Placement Binding Term Sheet by and between the Company and Steve Wallitt, dated February 25, 2024 (incorporated by reference to Exhibit 10.71 the Company’s Registration Statement on Form F-1 (Reg. No. 333-277482), as amended, filed with the SEC on March 7, 2024).
     
4.72   Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on April 12, 2024).
     
4.73   Form of Promissory Note (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 6-K filed with the SEC on April 12, 2024).
     
4.74   Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 6-K filed with the SEC on April 12, 2024).
     
4.75   Form of Warrant Amendment and Inducement Letter (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 6-K filed with the SEC on April 12, 2024).
     
4.76   Stock Purchase Agreement, by and between Generating Alpha Ltd. and the Company, dated April 19, 2024 (incorporated by reference to Exhibit 10.76 to the Company’s Registration Statement on Form F-1 (File No. 333-376257), as amended, initially filed with the SEC on December 22, 2023).
     
4.77*   Form of Conversion and Exchange Rights Agreement
     
8.1  

List of Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023).

11.1   Company’s Code of Conduct and Business Ethics (incorporated by reference to Exhibit 11.1 to the Company’s Annual Report on Form 20-F filed with the SEC on May 1, 2023).
     
11.2   Company’s Insider Trading Policy (incorporated by reference to Exhibit 11.2 to the Company’s Annual Report on Form 20-F filed with the SEC on May 1, 2023).
     
12.1*   Certification by Principal Executive Officer pursuant to Securities Exchange Act Rules 13-a-12(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
12.2*   Certification by Principal Financial Officer pursuant to Securities Exchange Act Rules 13-a-12(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
13.1*   Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
13.2*   Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
15.1   Relevant Territories for withholding Tax on Dividends (incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

# Indicates a management contract or any compensatory plan, contract or arrangement
* Filed herewith

 

118

 

 

SIGNATURES

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Report on its behalf.

 

  SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY
   
April 30, 2024 By: /s/ Haggai Alon
  Name: Haggai Alon
  Title: CEO

 

119

 

 

INDEX TO FINANCIAL STATEMENTS

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2023 and 2022

 

TABLE OF CONTENTS

 

  Page
   
Report of independent registered public accounting firm PCAOB #1185 F-2
Consolidated statements of financial position F-3
Consolidated statements of comprehensive loss F-4
Consolidated statements of changes in equity F-5 - F-7
Consolidated statements of cash flows F-8 - F-9
Notes to the consolidated financial statements F-10 - F-43

 

The amounts are stated in thousands of U.S. Dollars

 

F-1
 

 

Report of Independent Registered Public Accounting Firm

 

to the Shareholders of

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of SMX (Security Matters) Public Limited Company and subsidiaries (the “Company”) as of December 31, 2023, and 2022, the related consolidated statements of comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively, the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Tel-Aviv, Israel /s/ Ziv Haft

April 19, 2024

We have served as the Company’s auditor since 2023 Certified Public Accountants (Isr.)
  BDO Member Firm

 

F-2
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

     December 31, 2023   December 31, 2022 
  Note  US$ in thousands 
Current assets            
Cash and cash equivalents     168    1,398 
Other current receivables 4   634    3,673 
Total current assets     802    5,071 
Non-current assets            
Intangible assets, net 3,7   16,486    5,027 
Goodwill 3   32,957    - 
Property, plant and equipment, net 5   411    555 
Right of use assets 11   389    414 
Investment in associated companies 6   115    221 
Total non-current assets     50,358    6,217 
             
Total assets     51,160    11,288 
Current liabilities            
Trade payables     10,515    2,972 
Other payables 12   2,483    650 
Convertible notes 8   377    563 
Warrants - derivative financial liability 9   1,143    - 
Pre-paid advance 10   700    - 
Bridge loans liabilities 9   1,750    - 
Convertible promissory note 8   1,013    - 
Borrowings from related parties 13   -    710 
Lease liabilities 11   41    30 
Total current liabilities     18,022    4,925 
Non-current liabilities            
Lease liabilities 11   411    440 
Bridge loans liabilities 9   483    3,682 
Long term payables     -    85 
Total non-current liabilities     894    4,207 
             
Total liabilities     18,916    9,132 
Equity            
Issued capital and additional paid-in capital 14   62,901    32,713 
Foreign currency translation reserve     (491)   (537)
Accumulated losses     (50,934)   (30,020)
Total equity attributable to owners of the parent     11,476    2,156 
Non- controlling interest     20,768    - 
Total equity     32,244    2,156 
Total liabilities and shareholders’ equity     51,160    11,288 

 

/s/ Ofira Bar   /s/ Haggai Alon   /s/ Pauline Khoo  

April 19, 2024

Ofira Bar

Chief Financial Officer

 

Haggai Alon

Chief Executive Officer

 

Pauline Khoo

Audit Committee Chairperson

  Date of approval of financial statements

 

The accompanying notes are an integral part of the financial statements.

 

F-3
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

     December 31, 2023   December 31, 2022   December 31, 2021 
     Year ended 
     December 31, 2023   December 31, 2022   December 31, 2021 
  Note  US$ in thousands 
Research and development expenses 15   2,711    1,898    2,039 
Selling and marketing expenses     661    569    453 
General and administrative expenses 16   16,567    2,723    2,482 
Listing expenses     16,802    -    - 
Operating loss     (36,741)   (5,190)   (4,974)
Finance expenses     7,891    1,128    101 
Finance income     1,580    28    237 
Gain from remeasurement of investment in associated company     22,164    -    - 
Share of net profit (loss) of associated companies 6   (101)   106    (101)
Loss before income tax     (20,989)   (6,184)   (4,939)
Income tax 17   -    -    - 
Net loss     (20,989)   (6,184)   (4,939)
                  
Other comprehensive loss:                 
Items that will not be reclassified to profit or loss:                 
Adjustments arising from translating financial statements from functional currency to presentation currency     (224)   (522)   (7)
                  
Items that will or may be reclassified to profit or loss:                 
Exchange losses arising on translation of foreign operations     (59)   (238)   (375)
Total other comprehensive loss     (283)   (760)   (382)
                  
Total comprehensive loss     (21,272)   (6,944)   (5,321)
                  
Net loss attributable to:                 
Equity holders of the Company     (20,914)   -    - 
Non- controlling interest     (75)   -    - 
                  
Basic and diluted loss per share attributable to shareholders 18   (7.82)   *(8.47)   *(7.41)

 

*Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1.B)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-4
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

                         
   Issued capital and Additional paid-in capital   Foreign currency translation reserve   Accumulated loss   Total equity attributable to owners of the parent   Non- controlling interests   Total equity 
                         
Balance as of January 1, 2023   32,713    (537)   (30,020)   2,156    -    2,156 
Comprehensive loss                              
Net loss   -    -    (20,914)   (20,914)   (75)   (20,989)
Other comprehensive income   -    46    -    46    17    63 
Total comprehensive loss   -    46    (20,914)   (20,868)   (58)   (20,926)
                               
Issuance of shares, net   4,896    -    -    4,896    -    4,896 
Recapitalization due to issuance of shares following the SPAC transaction, net   11,460    -    -    11,460    -    11,460 
Share-based compensation   3,269    -    -    3,269    -    3,269 
Conversion of financial liabilities to shares   5,955    -    -    5,955    -    5,955 
Exercise of options into shares   10    -    -    10    -    10 
Issuance of shares and warrants B, net (See note 14.B.3)   1,837    -    -    1,837    -    1,837 
Conversion of warrants A to ordinary shares (See note 14.B.3)   1,008    -    -    1,008    -    1,008 
Exercise of warrants B, net (See note 14 B.3)   888    -    -    888    -    888 
Issuance of warrants B after reset (See note 14 B.3)   865    -    -    865    -    865 
Non-controlling interests arising from initially consolidated companies   -    -    -    -    20,826    20,826 
Balance as of December 31, 2023   62,901    (491)   (50,934)   11,476    20,768    32,244 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-5
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

                 
  

Issued capital and

Additional paid-in capital

  

Foreign currency translation

reserve

   Accumulated loss  

Total equity

 
                 
Balance as of January 1, 2022   31,504    223    (23,836)   7,891 
Comprehensive loss                    
Loss after income tax for the year   -    -    (6,184)   (6,184)
Other comprehensive loss for the year   -    (760)   -    (760)
Total comprehensive loss for the year   -    (760)   (6,184)   (6,944)
                     
Issuance of shares, net   182    -    -    182 
Share-based compensation   306    -    -    306 
Issuance of options to acquire intangible asset   721    -    -    721 
                     
Balance as of December 31, 2022   32,713    (537)   (30,020)   2,156 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-6
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

                 
  

Issued capital and

Additional paid-in capital

  

Foreign currency translation

reserve

   Accumulated loss  

Total equity

 
                 
Balance as of January 1, 2021   24,733    605    (18,897)   6,441 
Comprehensive loss                    
Loss after income tax for the year   -    -    (4,939)   (4,939)
Other comprehensive loss for the year   -    (382)   -    (382)
Total comprehensive loss for the year   -    (382)   (4,939)   (5,321)
                     
Issuance of shares, net   5,892    -    -    5,892 
Exercise of warrants   395    -    -    395 
Share-based compensation   484    -    -    484 
                     
Balance as of December 31, 2021   31,504    223    (23,836)   7,891 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-7
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Year ended December 31, 2023   Year ended December 31, 2022   Year ended December 31, 2021 
   US$ in thousands 
Cash flows from operating activities:               
Loss before tax for the year   (20,914)   (6,184)   (4,939)
Share based compensation   3,269    306    484 
Depreciation and amortization   225    290    315 
Decrease (increase) in other current receivables   2,938    (2,936)   (463)
Increase in trade payables   2,074    2,217    401 
Increase (decrease) in other payables   (235)   114    60 
Increase (decrease) in other liabilities   19    17    (3)
Revaluation of financial liabilities at fair value   1,496    387    - 
Interest expenses   4,281    51    47 
Revaluation of convertible notes   (382)   -    - 
Remeasurement of investment in associated company   (22,164)   -    - 
Provision of borrowing to related parties   -    621    89 
Share in (earnings) losses of associated companies, net   101    (106)   101 
Issuance of options to underwriters   11    -    - 
SPAC transaction - listing costs   16,802    -    - 
Net cash flow used in operating activities   (12,479)   (5,223)   (3,908)
                
Cash flows from investing activities:               
Purchase of property, plant and equipment   (60)   (152)   (297)
Capitalized development cost   (976)   (975)   (1,468)
Net cash flow used in investing activities   (1,036)   (1,127)   (1,765)
                
Cash flows from financing activities:               
Payments of borrowings to related parties   -    (172)   (103)
Payment of lease liabilities   (42)   (55)   (98)
Proceeds from issuance of shares, warrants A and B, net (see note 14 B.3)   2,630    -    - 
Exercise of warrants B (see note 14 B.3)   642    -    395 
Proceeds from issuance of convertible notes (see note 8.A)   250    581    - 
Advance payment for equity, net (see note 10)   2,679    -    - 
Repayment of bridge loans (see note 9)   (30)   -    - 
Proceeds from issuance of shares, net   -    182    5,892 
Proceeds from issuance of bridge loans and warrants (see note 9)   550    3,310    32 
Proceeds from issuance of promissory note (see note 8.C)   2,356    -    - 
Issuance of shares in the SPAC transaction, net   2,919    -    - 
Net cash flow from financing activities   11,954    3,846    6,118 
                
Increase (decrease) in cash and cash equivalents   (1,561)   (2,504)   445 
Cash and cash equivalents at beginning of year   1,398    4,171    4,341 
Exchange rate differences on cash and cash equivalent   331    (269)   (615)
Cash and cash equivalents at end of year   168    1,398    4,171 

 

F-8
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Year ended December 31, 2023   Year ended December 31, 2022   Year ended December 31, 2021 
   US$ in thousands     
Appendix A – Non-cash transactions during the year:        -    - 
Conversion of liability to ordinary shares (see note 10)   2,300    -    - 
Conversion of warrants A to ordinary shares (see note 14.B.3)   1,008    -    - 
Conversion of bridge loans and derivative financial liability to ordinary shares   5,192    -    - 
Exercise of options and warrants into ordinary shares   2,925    -    - 
Conversion of convertible notes to ordinary shares   175    -    - 
Conversion of liability to ordinary shares (see note 14)   3,030         -        - 
Remeasurement of investment in associated company (see note 3)   (22,164)   -    - 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-9
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 1 - GENERAL:

 

A.SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Company integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, SMX’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. One reader can detect embedded data in various materials, from metals to fabrics to food and plastics, with all data logged onto the same digital platform.

 

Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B.The SPAC transaction:

 

On March 7, 2023 (the “Closing Date”) the Company completed its SPAC transaction (the “Business Combination”) with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd. were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange. The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account.

 

C.On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd.’s (“TrueGold”) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold, See also Note 3.

 

D.During the 12 months ended December 31, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 10, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). Furthermore, and as described in note 10 and note 24(10), in April 2024, the Company terminated the equity line agreement with Yorkville and entered into a similar agreement for $30,000 with an institutional investor. The Company is continuing with additional capital raising and as described in note 24(5), post balance sheet date it received an additional $3 million in funding. The Company also plans to secure a convertible note between $500 and $1,000 in addition to second round funding to raise approximately $5,800 after balance sheet date. The Company has also the ability to decrease its expenses and capitalize debt in order to meet its existing cash flow streams. Furthermore, the Company expect that the $5,000 NATO government agreement describe in note 24 (2), shall continue in the second half of 2024. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

F-10
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 1 - GENERAL (CONT.):

 

E.The Company operates primarily through 9 wholly owned subsidiaries and one majority owned all of which have been consolidated in these consolidated financial statements.
  

Controlled entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters (SMX) PLC  Ireland   100%   - 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
  Australia   100%   - 
Lionheart III Corp  USA   100%   ** 
SMX Circular Economy Platform PTE, Ltd.  Singapore   100%   * 
SMX (Security Matters) Ireland Limited  Ireland   100%   * 
SMX Fashion and Luxury
  France   100%   - 
TrueSilver SMX Platform Ltd.
  Canada   100%   - 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
  Israel   100%   100%***
Security Matters Canada Ltd.  Canada   100%   100%***
SMX Beverages Pty Ltd.  Australia   100%   100%***
True Gold Consortium Pty Ltd.  Australia   51.9%***   See note 6 

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

  *Incorporated in 2023.
  **Merger occurred in March 2023 as part of the Business Combination.
  ***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.

 

F-11
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:

 

  The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value.

 

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of SMX (Security Matters) Public Limited Company as of December 31, 2023 and 2022 and the results of all subsidiaries for the three years in the period then ended. SMX (Security Matters) Public Limited Company, a public limited company and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

F-12
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

The Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.
2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.
3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True Gold consortium PYT LTD. is Australian Dollar.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date.
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

F-13
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at fair value through profit or loss.

 

F-14
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for financial liabilities which are measured at fair value through profit or loss.

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

Impairment of non-financial assets

 

Intangible assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   8 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be successful, are offset in profit or loss against the related expenses (research and development expenses). Any intellectual property generated from this activity remains at the ownership of the Group.

 

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

 

F-15
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee;
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option; and
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Capitalized technology development costs

 

Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when a milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

 

F-16
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Capitalized technology development costs (Cont.) 

 

Currently, the Group’s capitalized development activities focus on:

 

  1. Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.
  2. Semi Industrial scale – technology implementation in semi-industrial production.
  3. Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.

 

The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.

 

The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.

 

The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.

 

Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.

 

The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.

 

Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.

 

Subsequent measurement

 

In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.

 

An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.

 

F-17
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Capitalized technology development costs (Cont.) 

 

Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.

 

The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.

 

All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.

 

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments adopted from January 1, 2023

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements);

 

In February 2021, the IASB issued amendments to IAS 1 and IFRS Practice Statement 2. The amendments aim to make accounting policy disclosures more informative by replacing the requirement to disclose ‘significant accounting policies’ with ‘material accounting policy information’. The amendments also provide guidance under what circumstance, the accounting policy information is likely to be considered material and therefore requiring disclosure.

 

These amendments have no effect on the measurement or presentation of any items in the consolidated financial statements of the Group but affect the disclosure of accounting policies of the Group.

 

Definition of Accounting Estimates (Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors);

 

The amendments to IAS 8, which added the definition of accounting estimates, clarify that the effects of a change in an input or measurement technique are changes in accounting estimates, unless resulting from the correction of prior period errors. These amendments clarify how entities make the distinction between changes in accounting estimate, changes in accounting policy and prior period errors. These amendments had no effect on the consolidated financial statements of the Group.

 

F-18
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

 

There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2024:

 

  IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback);
  IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current);
  Non-current Liabilities with Covenants (Amendments to IAS 1 Presentation of Financial Statements); and
  Supplier Finance Arrangements (Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures).

 

The following amendments are effective for the period beginning January 1, 2025:

 

Lack of Exchangeability (Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates).

 

The Group is currently assessing the impact of these new accounting standards and amendments. The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

 

F-19
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

H.The significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent basis, are:

 

In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.

 

The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.

 

Share based compensation

 

The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.

 

Intangible assets

 

The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.

 

This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 7.

 

The management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.

 

F-20
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liability at fair value

 

The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions of the financial liability, which are described in Note 22 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.

 

NOTE 3 – TRUE GOLD BUSINESS COMBINATION

 

On October 3, 2023 (acquisition date), the Company signed an agreement with True Gold Consortium Pty Ltd. (“TrueGold”) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. TrueGold uses the Company’s advanced next-generation technology to invisibly mark and store multiple data types at a molecular level as well as its blockchain digital platform. This strategic transaction through gaining control of TrueGold diversifies the Company’s operations into TrueGold’s pioneering ventures in research and development and revenue commercialization.

 

The Company previously held 44.4% of the shares of TrueGold which, up to the acquisition date and the beginning of consolidation, were treated as an investment in a joint venture which accounted for under the equity method. At the time the transaction was completed and control was obtained, the balance of the investment was remeasured at fair value of $22,164 and a gain was recognized in the amount of $22,164, which was recorded in the statement of comprehensive loss (the carrying amount of the previous investment in TrueGold was approximately nil). This fair value amount was added to the consideration transferred for the calculation of goodwill, as described below.

 

The Company has elected to measure the non-controlling interests in TrueGold at full fair value which includes also the non-controlling interests’ share in the entire goodwill of TrueGold. The fair value of the non-controlling interests in TrueGold was based on the fair value of TrueGold as a whole, as described above, and was estimated using the discounted cash flow method of the income approach, as TrueGold is a private company and therefore quoted market prices of its share were unavailable. The fair value has been determined by management with the assistance of a valuation performed by an external and independent valuation specialist using valuation techniques and assumptions as to estimates of projected net future cash flows of TrueGold and estimate of the suitable discount rate for these cash flows. The significant assumptions used in estimating the fair value of TrueGold are:

 

1.After-tax net cash flow discount rate (weighted average cost of capital) of 24.8%.
2.Terminal value cash flow multiple of 4.59 and terminal growth rate of 3%.
3.Discount for lack of marketability of 25.2% (or $11.17), resulting in a fair value of $33.12 per ordinary share of TrueGold).

 

The total cost of the business combination comprised a full forgiveness of the outstanding payables from TrueGold to the Company which amounted to AUD 475 (approximately $307) at acquisition date. The calculating of any goodwill upon acquisition included also the fair value of the previous investment in TrueGold.

 

F-21
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 3 – TRUE GOLD BUSINESS COMBINATION (CONT.):

 

The fair value of the identifiable assets and liabilities of TrueGold on the acquisition date:

           
   US$ in thousands 
Cash and cash equivalents       13 
Other current receivables        155 
Intangible asset (core technology license)        10,449 
Trade payables        277 
           
Net identifiable assets        10,340 
Non-controlling interests        (20,826)
Goodwill        32,957 
           
Loan to TrueGold   307      
           
Fair value of previous investment   22,164      
Fair value of identifiable assets and liabilities        22,471 

 

The only intangible asset identified in the purchase price allocation, and recognized as shown in the table above, represents a core technology license that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). As mentioned above, this licensee represents the current right of TrueGold to use the Company’s intellectual property of technology under a license agreement signed in 2020. For the purpose of the purchase price allocation, this right was treated as a reacquired right and accordingly was recognized separately from goodwill and valued on the basis of the remaining contractual term of the related contract, regardless of whether market participants would consider potential contractual renewals. After acquisition, this intangible asset should be amortized in according to its economic useful life. The Company has not yet began amortizing the asset and is assessing the economic useful life of it. See also Note 7.

 

The goodwill arising from acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Company and TrueGold. The goodwill recognized is not expected to be deductible for income tax purposes.

 

From the acquisition date, TrueGold has contributed $155 to the consolidated net loss. If the business combination had taken place at the beginning of the year 2023, the consolidated net loss would have been increased by $692 after elimination the Company’s’ share of TrueGold’s net loss until acquisition date.

 

NOTE 4 - OTHER CURRENT ASSETS:

SCHEDULE OF OTHER CURRENT ASSETS

   December 31, 2023   December 31, 2022 
Prepaid expenses   142    *3,157
Tax authorities   257    358 
Proof of concept receivables   148    86 
Other   87    72 
Total   634    3,673 

 

*Includes $3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).

 

F-22
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 5 - PROPERTY, PLANT AND EQUIPMENT, NET:

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2023   63    1,147    65    102    1,377 
Additions   15    5    7    4    31 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (3)   (6)   (3)   (4)   (16)
At December 31, 2023   75    1,146    69    102    1,392 
                          
Accumulated depreciation                         
At January 1, 2023   18    699    31    74    822 
Depreciation   6    151    7    16    180 
Currency translation adjustments   -    (18)   (1)   (2)   (21)
At December 31, 2023   24    832    37    88    981 
Net book value at December 31, 2023   51    314    32    14    411 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2022   81    1,233    83    99    1,496 
Additions   -    135    -    17    152 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (18)   (221)   (18)   (14)   (271)
At December 31, 2022   63    1,147    65    102    1,377 
                          
Accumulated depreciation                         
At January 1, 2022   20    645    33    72    770 
Depreciation   4    202    7    19    232 
Currency translation adjustments   (6)   (148)   (9)   (17)   (180)
At December 31, 2022   18    699    31    74    822 
Net book value at December 31, 2022   45    448    34    28    555 

 

F-23
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 6 - INVESTMENTS IN ASSOCIATED COMPANIES:

 

SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%
True Gold Consortium Pty Ltd.  Australia   51.9%   44.4%

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

Yahaloma Technologies Inc.

 

On April 30, 2019, Security Matters Ltd. signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.

 

Under the terms of the agreement, Security Matters Ltd. and Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.

 

Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

True Gold Consortium Pty Ltd

 

On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. and TrueGold. The purpose of the agreement is to set the framework for TrueGold’s activity. TrueGold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, TrueGold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.

 

The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement.

 

The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting. During 2023 the Company acquired an additional 7.5% and gained control in TrueGold. See also note 3.

 

SMX Beverages Pty Ltd

 

On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.

 

The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.

 

On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining 50% shares in SMX-B in exchange for 8,000,001 options of the Company at exercise price of AUD 0.4, with an expiration date of March 25, 2027. Total fair value is AUD 960,000 (USD 721,424), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black-Scholes model, free rate interest of 2.5%, expected life 5 years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD 13,500 per month and a 5% revenue share for referred clients.

 

F-24
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 7 - INTANGIBLE ASSETS, NET:

 

SUMMARY OF INTANGIBLE ASSETS NET

   Capitalization of development cost   Purchased license   Core Technology License   Total 
   US$ in thousands   US$ in thousands   US$ in thousands   US$ in thousands 
COST                    
As of January 1, 2023   4,372    655    -    5,027 
Capitalized development cost   977    157    10,449    11,583 
Currency translation adjustments   (7)   7    -    - 
As of December 31, 2023   5,342    819    10,449    16,610 
                     
Accumulated amortization                    
As of January 1, 2023   127    -    -    127 
Amortization   -    -    -    - 
Currency translation adjustments   (3)   -    -    (3)
As of December 31, 2023   124    -    -    124 
                     
Net book value as of December 31, 2023   5,218    819    10,449    16,486 

 

F-25
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 7 - Intangible assets, NET (CONT.):

 

   Capitalization of development cost   Purchased license   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 

 

An intangible asset at the amount of 145 is being amortized. The rest of the intangible assets have not yet commenced amortization.

 

Intangible assets as of December 31, 2023, consist of capitalized development costs of the Group’s technology as well as the cost of the exclusive license intellectual property (662) which includes the addition amount as a result of the acquisition of additional 50% interest in SMX Beverages Pty Ltd. The acquired rights have not yet commenced amortization as the license was not yet commenced usage.

 

In addition, intangible asset as of December 31, 2023, consist also of core technology license raised from the TrueGold business combination that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). See also Note 3.

 

NOTE 8 - CONVERTIBLE NOTES:

 

A.On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i) Bonus Warrants - 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants have a term of five years commencing upon the closing of the Business Combination.

 

(ii) Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants have a term of five years commencing upon the closing of the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

  

F-26
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 8 - CONVERTIBLE NOTES (CONT.):

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 32.2%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 73.74% and the risk-free interest rate used is 3.91%. As of December 31, 2023, the fair value of the Convertible Notes was $304 and the fair value of the Redeemable Warrants was $73.

 

B.In May 2022, Security Matters PTY Ltd. issued 828,240 convertible notes (the “2022 Convertible Notes”), with a face value of AUD 1 (USD 0.7) per each 2022 Convertible Note, for an aggregate amount of AUD 828 thousand (USD 569). The 2022 Convertible Notes have a maturity date of six months from issuance date. The conversion price is as follows: (i) if Security Matters PTY Ltd. executes a binding agreement for an M&A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share.. As of December 31, 2022, the 2022 Convertible Note amounted to 563. In July 2022, an amendment to the 2022 Convertible Notes agreements was signed between Security Matters PTY Ltd. and the investors which prescribes a cancellation of the 2022 Convertible Notes and replacing them with the issuance of 1,000,000 ordinary shares of Security Matters PTY Ltd. (with the occurrence of the Business Combination as described in Note 1.B). On March 7, 2023, the 2022 Convertible Notes were converted to 1,000,000 ordinary shares of Security Matters PTY Ltd.

 

C.On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a convertible promissory note with a fixed conversion price of $1.6378, 3,929,051 warrant As and 2,619,367 warrant Bs, for gross proceeds to SMX of approximately $2,358, before deducting fees and other offering expenses payable by the Company to their service providers. The warrant As are exercisable into 3,929,051 ordinary shares at an exercise price of $0.0022 per, share subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant As. The warrant Bs are exercisable into 2,619,367 ordinary shares at an exercise price of $1.6378 per share, subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant Bs. The warrant As and the warrant Bs meet the fixed-for-fixed criterion of IAS 32, resulting in being classified as equity. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

 

F-27
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 8 - CONVERTIBLE NOTES (CONT.):

 

The promissory note was recognized base on the amortized cost method.

 

As of December 31, 2023, the note principle amounted to $1 million and during the period $2.1 million of promissory note was converted to shares. As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of 2,619,377 Ordinary Shares and exercised the Warrant A and Warrant B for 3,789,264 and 2,619,367 Ordinary Shares, respectively. See note 24(11).

 

NOTE 9 - BRIDGE LOANS LIABILITIES:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As of December 31, 2023, the principal and the accumulated interest of the bridge loans were $1,739.

 

As part of the Bridge Loans agreements, some of the lenders were granted two types of warrants:

 

(i)Bonus Warrants - 11,045 (after reverse stock split) warrants to purchase ordinary shares of the Company at an exercise price of USD 253 per share and a first priority security interest in the shares of Security Matters PTY’s interest in trueGold Consortium Pty Ltd.
   
  The Bonus Warrants term is five years commencing upon the closing of the Business Combination.
   
  Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants The fair value of the Bonus Warrants was calculated using the Black and Scholes model.
   
  As of December 31, 2023, and as of December 31, 2022, the fair value of the Bonus Warrants was nil and $24 respectively.

 

(i)Redeemable Warrants Type 1 - 15,545 (after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD 253 per share. The Redeemable Warrants Type 1 term is five years commencing upon the BCA (see to Note 1B).

 

50.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD 110 per warrant.

 

25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for
   
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD 110 per warrant.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model.

 

As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was $72 and $1,973 respectively.

 

F-28
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 9 - BRIDGE LOANS LIABILITIES (CONT.):

 

(ii)Redeemable Warrants Type 2 – 10,454 (after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD 253 per share. The Redeemable Warrants Type 2 term is five years commencing upon the SPAC transaction (see also Note 1B).

 

50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD 110 per warrant.
50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD 110 per warrant.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model.

 

As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 2 was $421 and $696 respectively.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The main assumptions used in the three valuation models as of December 31, 2023 described above were: (1) risk free rate 3.91%; (2) volatility of assets 73.74%; and (3) excepted terms of the warrants 4.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

The main assumptions used in the three valuation models as of December 31, 2022 described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

On March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares.

 

On December 31, 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $750 and redeemable warrants at the amount of $1,450 into 4,032,256 ordinary shares. According to the addendum the company has issued to the lenders an aggregate of fully paid 4,032,256 warrants to purchase up to an aggregate of 4,032,256 ordinary shares at an exercise price of $1.17 per share. The Warrants were exercisable immediately upon issuance and will expire three years following their issuance.

 

The warrants include a cashless exercise mechanism, according to the terms specified in the addendum and it’s according to the lender election (the “Cashless Warrants”).

 

Therefore, the Company accounts for the Cashless Warrants as financial liability instruments that measured at fair value and recognized financial expenses or income through profit and loss.

 

The Company valued each Cashless Warrants at $0.25 per warrant by using the Black-Scholes option-pricing model The key inputs that were used in the Cashless Warrants fair value as of December 31, 2023 were:

 

  risk-free interest rate 4.13%
  expected volatility 70.39%
  expected dividend yield of 0%
  expected term of warrants – 3 years

 

As of December 31, 2023 the Cashless Warrants fair value was $1,023

 

F-29
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 10 - PRE-PAID ADVANCE:

 

In February 2023, the Company entered into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period or (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of a registration statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the ordinary shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 14.4), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The Company made additional change to the Yorkville agreement which effectively eliminates the floor price - see also note 24(4). The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500 and as of December 31, 2023 the Company repaid the second Pre-Paid Advance in the amount of $1,300. In the period, the Company issued ordinary shares in net consideration of $1,979 in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $377 as of the date of the authorization of these financial statements. On April 13, 2024, the Company exercised its right of termination under the SEPA and sent Yorkville a written termination letter, which is effective upon five trading days thereafter. On April 19, 2024, the Company entered into a similar agreement with an institutional investor, which will enable the Company to raise up to $30,000. See also note 24(10).

 

NOTE 11 - LEASES:

 

The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of 12 years, motor vehicles generally have lease terms of 3 years.

 

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

  

Office and lab

facilities

   Motor vehicles   Total 
At January 1, 2022   446    20    466 
Additions   49    -    49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)   -    (39)
As at December 31, 2022   414    -    414 
Additions   -    26    26 
Foreign currency translation   (6)   -    (6)
Deductions   -    -    - 
Depreciation expense   (42)   (3)   (45)
As at December 31, 2023   366    23    389 

 

F-30
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 11 - LEASES (CONT.):

 

Information on leases:

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
         
Interest expense on lease liabilities   32    51 
Total cash outflow for leases   45    39 

 

For an analysis of maturity dates of lease liabilities, see Note 22 on liquidity risk.

 

NOTE 12 - OTHER PAYABLES:

 

SCHEDULE OF OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
         
Employees, salaries and related liabilities   726    392 
Related party   4    56 
Liabilities for grants received (see also note 20)   153    50 
Excise Tax   1,569    - 
Other   31    152 
Total   2,483    650 

 

NOTE 13 - BORROWINGS FROM RELATED PARTIES:

 

In 2015, the Group signed an agreement to receive a loan of ILS 2 million (approximately 513) from its shareholders. These loan bears interest at an annual rate of 4%.

 

   December 31, 2023   December 31, 2022 
Balance at January 1,   710    270 
Payment of borrowings   (657)   (172)
Provision for bonus (include interest)   -    621 
Exchange rate differences   (53)   (9)
Balance at December 31,   -    710 

 

In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS 3 million (approximately 965) per each of the two lenders.

 

The Bonus Payments are intended to operate in one of the two trigger events:

 

(i)dividend distributions paid by the Company; or
(ii)the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise).

 

Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.

 

The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.

 

F-31
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 13 - BORROWINGS FROM RELATED PARTIES (CONT.):

 

There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS 3 million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of 87 to profit and loss in 2021.

 

In August 2022 the loan from related party has been fully repaid and the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS 2.5 million (approximately 710), to be paid upon the completion of the business combination. As of December 31, 2022, the liability was 710.

 

On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount. In accordance with management estimation the FV of this Indebtedness is immaterial.

 

NOTE 14 - SHAREHOLDERS’ EQUITY

 

A.Share capital:

SCHEDULE OF SHARE CAPITAL

   Number of shares 
   December 31, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0022
par value
   36,363,636,364    10,185,909    22,727,272    - 
Preferred shares
USD 0.0001
par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1
par value
   25,000    25,000    25,000    25,000 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0022 and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

Preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

F-32
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

B.Changes in Share capital

 

1.On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination as described in Note 1B. Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

  a) The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.
  b) Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.
  c) 32,211,716 warrants and options have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.
  d) 848,784 (post reverse stock split) ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.
  e) The Company issued 160,227 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.
  f) The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.
  g) The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

2.During 2023, the Company issued 1,237,751 ordinary shares (4,196 shares as commitment fees) to Yorkville post reverse stock split, for an aggregate of $1,979 net proceeds (see also Note 10).
   
3.On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 606,061 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 606,061 warrants in the form of Warrant A to subscribe for 606,061 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 606,061 warrants in the form of Warrant B to subscribe for 606,061 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 90,909 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 90,909 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0 001 per share, and/or (b) 90,909 warrants in the form of Warrant A to subscribe for an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 90,909 warrants in the form of Warrant B to purchase an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 681,818 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of the authorization of these financial statements, an aggregate of 690,096 Warrant A warrants were cashless exercised into an aggregate of 345,349 ordinary shares. The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028.

 

F-33
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

On December 8, 2023, the Company consummated an inducement offer letter agreement with certain holders of the Company’s outstanding Warrant Bs to purchase Ordinary Shares of the Company. The Warrant Bs were issued on June 27, 2022 and had an exercise price of $5.28 per share (after taking into account the Company’s 1:22 reverse share split).

 

Pursuant to the inducement letter, the holders agreed to exercise for cash their Warrant Bs to purchase an aggregate of 606,060 shares of the Company’s Ordinary Shares at a reduced exercise price of $1.15 per share in consideration for the Company’s agreement to issue new warrants to purchase, in the aggregate, up to 909,090 of the Company’s Ordinary Shares at an exercise price of either (i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrant holders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of $697 from the exercise of the Warrant Bs by the holders, and the carrying amount of those warrants, was classified to ordinary shares and premium together with the proceeds the Company received from the exercise price. See also note 24(3).

 

In accordance with IAS 32, the Company measured the difference between the fair value of the consideration the holder receives on conversion of the instrument under the revised terms and the fair value of the consideration the holder would have received under the original terms, was recognized as a loss in profit or loss.

 

The Company utilized Black-Scholes valuation model to calculate the fair values of the repriced warrants both before and after the repricing and recognized the incremental fair value of $209 as finance expense in the statement of comprehensive income against an increase in the carrying amount of the warrants (presented within issued capital and additional paid-in capital). In addition, fair value was also calculated for the new 909,090 issued warrants at the amount of $865, which was recognized as finance expense against an increase in equity. Warrant Bs are classified as equity instruments according to IAS 32.

 

Warrant A was valued at $0.067 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of the Warrant Bs specify that each warrant has a cash exercise price of $0.24. The Warrant Bs were valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrant As and Bs expire in June 2028. The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660. The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

4.On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

5.On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount (see also note 13).

 

F-34
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

   
6.On December 31,2023 The Company also issued 457,682 Ordinary Shares to a service provider as payment in full for $260 worth of legal services which previously provided to the Company.

 

C.Options granted to employees and service providers:

 

1.In June 2018, Security Matters PTY Ltd. has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Plan include employees, directors and consultants of Security Matters PTY Ltd. or any subsidiary. On March 7, 2023 as part of the SPAC transaction. These options were exercised on a cashless basis and then after replaced to the Company’s shares. See also note 14B1(c-d).
   
 2.In March 7, 2023 Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.
   
3.In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

4.During the period ended December 31, 2023, the Company granted 197,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. Related share-based expenses recognized for the period totaled $2,820.

 

RSUs granted to employees, directors and service providers:

  

Year ended

December 31, 2023 (in thousands)

  

Year ended

December 31, 2022 (in thousands)

 
Outstanding at beginning of period   -    - 
Granted   197    - 
Vested   (57)   - 
Forfeited   (4)   - 
           
Outstanding at December 31, 2023   136    - 

 

 

F-35
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

5.

During the year ended December 31, 2023, the Company granted 38,656 options to employees and service providers. These grants carry an exercise price of between $22.71 - $88, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $219. The related share-based expenses that were recognized in the year ended December 31, 2023, amounted to $184.


A summary of the status of the Company’s Share Option Plan granted to employees and service providers (including performance-based awards) and changes during the relevant period ended on that date is presented below:

   Year ended
December 31, 2023
   Year ended
December 31, 2022
 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (USD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (USD)

 
Outstanding at beginning of year   57    44.22    73    41.85 
Issue of options   38    82.04    17    41.85 
Expired   (30)   31.02    (33)   34.10 
                   
Outstanding at end of year   65     69.92     57    54.25 
Exercisable options   58    68.67    38    43.40 

 

The options to employees and service providers outstanding as of December 31, 2023, are comprised, as follows:

Exercise price (USD) 

Outstanding as of

December 31, 2023

  

Weighted average remaining

contractual term

   Exercisable as of December 31, 2023  

Weighted average remaining

contractual term

 
       (years)       (years) 
18.70-23.32   5    2.46    5    2.46 
29.48-31.02   3    3.21    3    3.21 
40.48-48.18   6    1.41    6    1.41 
52.80-56.10   9    2.26    9    2.26 
78.54-88.00   35    4.40    28    4.38 
93.28-108.90   7    3.03    7    3.03 
    65         58      

 

1.The options issued in 2023, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.58-3.42%; (2) expected volatility: 78.35-73.01%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.
   
2.The options issued in 2022, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.09-4.68%; (2) expected volatility: 62.06-85.03%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.

 

F-36
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 15 - RESEARCH AND DEVELOPMENT EXPENSES, NET:

 

   December 31, 2023   December 31, 2022   December 31, 2021 
Salaries and related expenses   2,228    2,166    1,795 
Subcontractors and consultants   344    374    631 
Materials and laboratory expenses   223    316    252 
Depreciation and amortization   197    255    287 
Share based compensation   447    127    100 
Travel expenses   87    50    42 
Freight   33    30    23 
Other   10    6    - 
Reimbursement from paid pilots and proof of concept projects   (858)   (1,426)   (1,091)
Total   2,711    1,898    2,039 

 

NOTE 16 - GENERAL AND ADMINISTRATIVE EXPENSES:

 

   December 31, 2023   December 31, 2022   December 31, 2021 
BCA transaction cost   7,278    -    - 
Professional services   667    1,105    1,089 
Public company expenses   5,128    -    - 
Wages and salaries related   1,348    935    752 
Travel expenses   611    223    - 
Office and maintenance   170    145    116 
Share based compensation   1,222    137    331 
Insurance   50    60    102 
Depreciation and amortization   30    35    28 
Other   63    83    64 
Total   16,567    2,723    2,482 

 

NOTE 17 - TAXES ON INCOME:

 

1.The Company is incorporated and domiciled in Ireland where the applicable tax rate is 12.5%.
2.Theoretical tax:

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

   December 31, 2023   December 31, 2022   December 31, 2021 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (20,989)   (6,184)   (4,939)
                
Theoretical tax rate of 12.5%   (2,624)   (1,701)   (1,358)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   3254    335    118 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   (630)   1,366    1,240 
Income tax / (benefit)            

 

3.As of December 31, 2023, the Group has estimated carry forward tax losses of approximately $45,095 (2022: $24,106 2021:$17,659) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

F-37
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 18 - LOSS PER SHARE

 

   December 31, 2023   December 31, 2022   December 31, 2021 
             
Net loss attributable to the owners of the company   (20,914)   (6,184)   (4,939)
                
Basic and diluted loss per share   (7.82)   *(8.47)   *(7.41)
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   2,676    730    666 

 

*Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

NOTE 19 - RELATED PARTIES:

 

Key Management Personnel Compensation and other related party transactions and balances:

 

The key management personnel, among others includes board members, CEO and CFO.

 

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

1. Transactions with related parties:  December 31, 2023   December 31, 2022 
Issuance of options to related party   -    721 
Short-term salary and fees   803    508 
Short-term salary until deletion   22    - 
Loan repayment   -    172 
Conversion of loan to ordinary shares   657    - 
Share based payments   2,084    98 
Post-employment retirement benefits   98    94 
Payment for Administrative services   34    36 
Non-monetary benefits   49    29 
Payments for legal services   287     - 
Revaluation of financial liabilities at fair value   1,204    - 
Proof of Concept projects paid by affiliated companies   -   (1,064)
Key management personnel compensation   5,238    594 

 

2. Balance with related parties:     December 31, 2023   December 31, 2022 
Key management  Salary and related   (219)   (99)
Directors  Salary and related   -    (82)
Shareholders  Borrowings from related parties   -    (710)
Shareholders  Other accounts payable   (3)   (56)
Shareholders  Trade payables   (58)   -  
Shareholders  Derivatives   (476)   - 
Joint Ventures  Other receivables   15    59 
Joint Ventures  Investment in subsidiary   115    221 
       (626)   (667)

 

F-38
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 20 - GOVERNMENT GRANTS

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS). The Group has an approved project with the IIA under which it received a total of $162 in prior years. The Group is subject to paying 3% of its relevant revenues until repayment of the entire grant. As of December 31, 2023, the Group paid an amount of 0. The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.

 

Until October 25, 2023, the interest was calculated at a rate based on 12-month London Interbank Offered Rate, or LIBOR applicable to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual interest will be calculated at a rate based on 12-month Secured Overnight Financing Rate, the SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest will be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.

 

   December 31, 2023   December 31, 2022 
Short term liability at year end   153    50 
Long term liability at year end   -    85 
Total   153    135 

 

NOTE 21 - COMMITMENTS AND CONTINGENT LIABILITIES:

 

As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.

 

1.In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

On January 2023, the Company signed an amendment to the agreement that determine the following:

 

(1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main assumptions which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%;

 

The fair value of these options was $33 and recognized as a technology license intellectual property.

 

F-39
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 21 - COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):

 

(2) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof).

 

As of December 31, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $123 against a liability that reflects the due amount.

 

(3) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

Composition of the Group’s financial assets and financial liabilities:

 

   2023   2022 
   December 31, 
   2023   2022 
Financial assets at amortized cost:          
Cash and cash equivalents   168    1,398 
Other current receivables   424    3,673 
Total financial assets   592    5,071 

 

 

   2023   2022 
   December 31, 
   2023   2022 
Financial liabilities at fair value through profit or loss:          
Convertible notes   377    563 
Trade and other payables   12,487    3,622 
Bridge loans   2,233    3,682 
Pre-paid advance   700    - 
Derivatives   1,143    - 
Total financial liabilities at fair value through profit or loss   16,940    7,867 
           
Financial liabilities at amortized cost:          
Convertible promissory note   1,013    - 
Lease liabilities   649    - 
Government grants   153    - 
Borrowing from related parties   -    - 
Total financial liabilities at amortized cost   1,815    - 
Total financial liabilities   18,755    7,867 

 

F-40
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Financial risk management objectives

 

The Group’s activities expose it to a variety of financial risks such as market risks (foreign currency risk), credit risk and liquidity risk. The Company’s management oversees the management of these risks, focusing on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to monitor different types of risk to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange, ageing analysis for credit risk and maturity analysis in respect of liquidity risk.

 

Market risk

 

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices, which in the group’s case refers only to foreign currency risk. Financial instruments affected by this risk include, loans and borrowings and short-term payables and receivables.

 

Foreign currency risk

 

Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the NIS and Euro.

 

As of December 31, 2023, the Group has excess financial liabilities over financial assets in foreign currencies in relation to the NIS , AUD ,SGD and EUR totaling approximately $1,651, $185 $142 and $101, respectively (December 31, 2022: approximately $729 ,$1265 $0 and $34, respectively).

 

Foreign currency sensitivity analysis

 

The following table demonstrates the sensitivity test to a reasonably possible change of 10% in EUR and NIS exchange rates against the USD, with all other variables held constant. The impact on the Group’s net loss (tax effect is not relevant) and equity is due to changes in the fair value of monetary assets and liabilities including non-designated foreign currency derivatives and embedded derivatives. The Company’s exposure to foreign currency changes for all other currencies is immaterial.

 

   Change in NIS rate   Effect on net loss 
December 31, 2023   10%   165 
December 31, 2022   10%   73 

 

   Change in AUD rate   Effect on net loss 
December 31, 2023   10%   19 
December 31, 2022   10%   127 

 

   Change in SGD rate   Effect on net loss 
December 31, 2023   10%   14 
December 31, 2022   10%   - 

 

   Change in EUR rate   Effect on net loss 
December 31, 2023   10%   10 
December 31, 2022   10%   3 

 

F-41
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Credit risk

 

Credit risk is the risk that a counterparty will not meet its obligations as a customer or under a financial instrument leading to a loss to the Group. The Group is exposed to credit risk from its operating activity (other receivables and cash balances). The Group’s main financial assets are cash and cash equivalents as well as other receivables and their carrying amounts represent the Group’s maximum exposure to credit risk. Credit risk from balances with banks and financial institutions is managed by the Group’s management in accordance with the Group’s policy. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia which the Company’s management regards as financially solid.

 

Liquidity risk

 

Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.

 

The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.

 

As of December 31, 2023

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   12,487    -    -    -    -    -    12,487 
Bridge loans   1,750    453    15    15    -    -    2,233 
Government grants   153    -     -     -     -    -    153 
Lease liability   81    81    74    74    74    265    649 
Convertible promissory note   1,013    -    -    -    -    -    1,013 
Pre-paid advance   700    - 

-

   -    

-

    

-

    

-

    700 
Convertible note   377    -    -    -    -    -    377 
Financial derivatives   1,143    -    -    -    -    -    1,143 
    17,704    534    89    89    74    265    18,755 

 

As of December 31, 2022

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   3,622    -    -    -    -    -    3,622 
Bridge loans   -    1,031    -    -    -    -    1,031 
Government grants   75    84     -     -     -     -    159 
Lease liability   72    72    72    72    72    353    713 
Borrowings from related parties   710    -     -     -     -     -    710 
    4,479    1,187    72    72    72    353    6,235 

 

F-42
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 23 - FAIR VALUE MEASUREMENT:

 

Fair value hierarchy

 

The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:

 

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

 

Level 3: Unobservable inputs for the asset or liability.

 

 

As of December 31, 2023  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,707    1,707 
Tradable warrants   2    -    -    2 
Total   2    -    1,707    1,709 

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,031    1,031 
Total   -    -    1,031    1,031 

 

NOTE 24 - SUBSEQUENT EVENTS:

 

Since the reporting date the following significant events have occurred:

 

1.The financial statements were authorized for issuance on April 19, 2024.
  
2.On January 12, 2024, the Company announced that it entered into a $5 million contract with R&I Trading of New York. This project, spearheaded by the SMX team, will deploy SMX’s technology to enhance supply chain transparency with respect to a NATO government member state and with the expectation of expanding to further NATO government member states.
  
3.In January 2024, pursuant to the inducement letter described in note 14(3), the holders of the new 909,090 warrants exercised 454,544 warrants for an aggregate of 454,544 Ordinary Shares.
  
4.In February 2024, the Company entered into a Letter Agreement with Yorkville dated February 1, 2024 (the “Letter Agreement”), which amends the SEPA. Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances under the SEPA, to repay the amounts outstanding under the Pre-Paid Advance plus payment premium. The Company agreed to pay a fee to Yorkville equal to $200.
  
 The Company further agreed to issue to Yorkville a 5-year warrant to purchase 250,000 ordinary shares of the Company at an exercise price of $0.0022 per share.
  
5.On February 20, 2024, the Company closed an underwritten public offering of 12,124,666 Ordinary Shares at a subscription price per share of $0.24 and Pre-Funded Warrants convertible on a 1-for-1 basis into Ordinary Shares, at a price per Pre-Funded Warrant of $0.2378. The gross proceeds was approximately $2.9 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The net proceeds to the Company upon the closing of the offering, after deducting the underwriting commissions and estimated offering expenses payable by the Company, were approximately $2.66 million.
  
6.On February 28, 2024, in connection with a private placement binding term sheet, the Company issued (i) a convertible security to an investor relating to a loan in the principal amount of $407 and (ii) 100,000 warrants to the investor. The warrants have an exercise price of $0.5 per share. The net proceeds to the Company upon the closing of the private placement was $350.
  
7.On February 29, 2024, the Company’s Board of Directors approved a grant of 1,500,000 RSUs to an officer, directors and service providers under the 2022 Incentive Equity Plan. As of the date of these Financial Statements 166,667 of the RSUs are vested.
  
8.On March 4, 2024, the Company’s Board of Directors approved the issuance of 100,000 ordinary shares to a service provider in connection with certain investor relations services.
  
9.On April 11, 2024 the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor a promissory note and warrants, for gross proceeds of approximately US$2.0 million, before deducting fees and other offering expenses payable by the Company. The Note is in the principal amount of $2,250. The actual amount loaned by the Investor pursuant to the Note is approximately $2.0 million after a 10% original issue discount. The maturity date of the Note is the 12-month anniversary of the Effective Date, and is the date upon which the Principal Amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year. In addition, the Warrant, for 5 years period and for 11,825,508 Ordinary Shares, has an exercise price of $$0.157 per share, subject to customary adjustments and limitations as described in the agreement. Furthermore, as a further inducement of the Company for the Investor to enter into the transaction, the Company entered into a Warrant Amendment and Inducement Letter with the Investor, with respect to its outstanding “B” warrants of the Company (the “Existing Warrant”) to purchase 2,619,367 Ordinary Shares. The Existing Warrant was issued to the Investor as of September 6, 2023 and had a fixed exercise price of $1.6378 per share. Pursuant to the Inducement Letter, the Investor agreed to exercise for cash the Existing Warrant in full at a reduced exercise price of $0.0022 per share, or approximately $6, see also note 8(c).
  
10.

On April 19, 2024, the Company entered into a Stock Purchase Agreement (the “SPA”) with an institutional investor, pursuant to which the investor has committed to purchase from time to time from the Company, up to $30,000 of the Company’s ordinary shares, subject to the terms and conditions specified in the SPA. Subject to the terms and conditions of the SPA, the Company has the right from time to time at its discretion, any time after the three month anniversary of the shares underlying the SPA being registered for resale pursuant to the Registration Rights Agreement referred to below, to direct Alpha to purchase a specified amount of the Company’s ordinary shares (each such sale, a “Put”) by delivering written notice to Alpha (each, a “Put Notice”). There is a $20 mandatory minimum amount for any Put and it may not exceed $500 in any consecutive 30-day period, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.

 

The obligations of the investor to accept any Put pursuant to a Put Notice is subject to customary conditions, including that it is not required to purchase any ordinary shares pursuant to a Put if it would result in it beneficially owning in excess of 4.99% of the Company’s ordinary shares, and that the ordinary shares subject to the Put be registered for resale. The Company agreed to pay a commitment fee to the investor equal to 1.5% of the commitment amount, payable in shares, or 2,725,621 ordinary shares (the “Commitment Shares”) and which are subject to a three month lock-up.

 

The SPA will automatically terminate on the earliest to occur of (a) the first day of the month next following the 36-month anniversary of the date of the SPA or (ii) the date on which the investor shall have made payment of Puts pursuant to the SPA for ordinary shares equal to $30,000. The Company has the right to terminate the SPA at no cost or penalty upon five (5) trading days’ prior written notice to the investor, provided that there are no outstanding Put Notices for which ordinary shares need to be issued and the Company has paid all amounts owed to the investor pursuant to the SPA and any indebtedness the Company otherwise owes to the investor or its affiliates. The Company and the investor may also agree to terminate the SPA by mutual written consent.

  
11.As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of 2,619,377 Ordinary Shares and exercised the Warrant A and Warrant B for 3,789,264 and 2,619,367 Ordinary Shares, respectively, see also note 8(c).

 

F-43

 

EX-2.1 2 ex2-1.htm

 

Exhibit 2.1

 

DESCRIPTION OF RIGHTS OF SECURITIES

 

Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”)

 

As of April 30, 2024, SMX (Security Matters) Public Limited Company (the “Company,” “we,” “us,” and “our”) has the following securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, with a nominal value of $0.0022 per share   SMX   Nasdaq Stock Market LLC
Warrants, each exercisable for one Ordinary Share at an exercise price of $253.00 per share   SMXWW   Nasdaq Stock Market LLC

 

General

 

The Company is a public limited company organized and existing under the laws of Ireland. The Company was formed on July 1, 2022 as a public limited company incorporated in Ireland under the name “Empatan Public Limited Company” and underwent a change of name to SMX (Security Matters) Public Limited Company on February 17, 2023. The Company’s affairs are governed by the Company’s Amended and Restated Memorandum and Articles of Association, the ICA, and the laws of Ireland.

 

The following are summaries of material provisions of the Company’s Amended and Restated Memorandum and Articles of Association and the ICA, insofar as they relate to the material terms of the Ordinary Shares.

 

Description of Ordinary Shares

 

The following are summaries of material provisions of the Company’s Amended and Restated Memorandum and Articles of Association, and the ICA, insofar as they relate to the material terms of the Ordinary Shares.

 

General. The authorized share capital of the Company is $100,000,000 divided into 36,363,636,364 Ordinary Shares with a nominal value of $0.0022 each, 200,000,000,000 preferred shares with a nominal value of $0.0001 each and €25,000 divided into 25,000 deferred Ordinary Shares with a nominal value each of €1.00 each.

 

Immediately prior to consummation of the Business Combination, the Company had issued and paid-up share capital of (i) €25,000 representing 25,000 deferred shares of €1.00 each and (ii) $0.0001 representing one Ordinary Share of $0.0001 each in the capital of the Company, in order to satisfy statutory capitalization requirements for all Irish public limited companies.

 

Dividends. The holders of Ordinary Shares are entitled to such dividends as may be declared by the Company’s board of directors. Dividends may be declared and paid out of the funds legally available therefor, or any other fund or account which can be authorized for this purpose in accordance with the ICA.

 

Voting Rights. Each Ordinary Share shall be entitled to one vote on all matters subject to the vote at general meetings of the Company. Voting at any meeting of shareholders is by way of a poll, which shall be taken in such manner as the chairperson of the meeting directs.

 

An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the Ordinary Shares cast at a meeting, while a special resolution requires the affirmative vote of no less than 75% of the votes cast attaching to the outstanding Ordinary Shares at a meeting. Where the shareholders wish to act by way of written resolution in lieu of holding a meeting, unanimous consent of the holders of the Ordinary Shares shall be required. A special resolution will be required for important matters such as a change of name, reducing the share capital or making changes to the Company’s Amended and Restated Memorandum and Articles of Association.

 

 
 

 

Transfer of Ordinary Shares. Subject to the restrictions contained in the BCA with respect to the Ordinary Shares, and subject to any further restrictions contained in the Amended and Restated Memorandum and Articles of Association, any shareholder may transfer all or any of his or her Ordinary Shares by an instrument of transfer in the usual or common form or any other form approved by the Company’s Board.

 

Liquidation. On a return of capital on winding-up or otherwise (other than on conversion, redemption or purchase of Ordinary Shares), assets available for distribution among the holders of Ordinary Shares shall be distributed among the holders thereof on a pro rata basis. If the Company’s assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by the Company’s shareholders proportionately.

 

General Meetings of Shareholders. Shareholders’ meetings may be convened by the board of directors on the requisition of the shareholders or, if the Board fails to so convene a meeting, such extraordinary general meeting may be convened by the requisitioning shareholders where the requisitioning shareholders hold not less than 10% of the paid up share capital of the Company. Any action required or permitted to be taken at any annual or extraordinary general meetings may be taken only upon the vote of the shareholders at an annual or extraordinary general meeting duly noticed and convened in accordance with the Company’s Amended and Restated Memorandum and Articles of Association and the ICA. Unanimous consent of the holders of the Ordinary Shares shall be required before the shareholders may act by way of written resolution without a meeting.

 

Description of Public Warrants

 

Each whole Public Warrant shall entitle the holder thereof to purchase one Ordinary Share at an exercise price of $253.00 per share.

 

Subject to the terms of the BCA, on the consummation of the Business Combination, each Lionheart Public Warrant remained outstanding but was automatically adjusted to become one Public Warrant. Each such Public Warrant continues to have, and be subject to, the same terms and conditions set forth in the warrant agreement pursuant to which such Lionheart Public Warrant was issued immediately prior to the consummation of the Business Combination, except that each Public Warrant is exercisable (or will become exercisable in accordance with its terms) for that number of whole Ordinary Shares equal to the number of Lionheart Private Shares that were issuable upon exercise of such Lionheart Public Warrant that was outstanding immediately prior to the consummation of the Business Combination, and subject to adjustment pursuant to the subsequent reverse stock split. In addition, each Lionheart Private Warrant remains outstanding but is automatically adjusted to become one Public Warrant, subject to adjustment pursuant to the subsequent reverse stock split (each a “Parent Founder Warrant”). Each such Parent Founder Warrant continues to have, and be subject to the same terms and conditions set forth in the warrant agreement pursuant to which such Lionheart Private Warrant was issued immediately prior to the consummation of the Business Combination, except that each Parent Founder Warrant is exercisable (or will become exercisable in accordance with its terms) for that number of whole Ordinary Shares equal to the number of Lionheart Private Shares that were issuable upon exercise of such Lionheart Private Warrant that was outstanding immediately prior to the consummation of the Business Combination, subject to adjustment pursuant to the subsequent reverse stock split. As used herein: (1) “Lionheart Private Shares” shall mean the 400,000 shares of Lionheart Class A Common Stock, included in the units (“Lionheart Private Units”) issued in private placements at the time of the consummation of the initial public offering by Lionheart, which closed on November 8, 2021 (“IPO”), including (a) one Lionheart Class A Common Stock and (b) one-half of a warrant, with whole warrants entitling the holder thereof to purchase one Lionheart Class A Common Stock at an exercise price of $11.50 per share; (2) “Lionheart Private Warrants” shall mean (a) each warrant issued in private placements at the time of the consummation of the IPO, entitling the holder thereof to purchase one Lionheart Class A Common Stock at an exercise price of $11.50 per share and (b) each warrant issued as a component of Lionheart Private Units; and (3) “Lionheart Public Warrants” shall mean each warrant issued as a component of the Lionheart Public Units.

 

 
 

 

The Company is not obligated to deliver any Ordinary Shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Ordinary Shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration. No Public Warrant will be exercisable, and the Company will not be obligated to issue Ordinary Shares upon exercise of a Public Warrant unless the Ordinary Shares issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Public Warrant.

 

The Company has agreed that as soon as practicable, but in no event later than 30 days after the closing of the Business Combination, the Company would use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the Ordinary Shares issuable upon exercise of the Public Warrants and thereafter will use its best efforts to cause the same to become effective within 60 business days following the closing of the Transactions and to maintain a current prospectus relating to the Ordinary Shares issuable upon exercise of the Public Warrants, until the expiration of the Public Warrants in accordance with the provisions of that certain warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and Lionheart (the “Warrant Agreement”). As a registration statement covering the Ordinary Shares issuable upon exercise of the Public Warrants was not effective by the 60th business day after the closing of the Transactions, holders of the Public Warrants may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders of the Public Warrants will not be able to exercise their Public Warrants on a cashless basis. Once the Public Warrants become exercisable, the Company may call the Public Warrants for redemption:

 

● in whole and not in part;

 

● at a price of $0.22 per warrant;

 

● upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and

 

● if, and only if, the reported last reported sale price of the Ordinary Shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

 

If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of Ordinary Shares upon exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares under the blue sky laws of the state of residence in those states in which the Public Warrants were offered.

 

The Company has established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each holder of the Public Warrants will be entitled to exercise its Public Warrant prior to the scheduled redemption date. However, the price of the Ordinary Shares may fall below the $396 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $253 warrant exercise price after the redemption notice is issued.

 

 
 

 

If the Company calls the Public Warrants for redemption as described above, the Company’s management will have the option to require any holder that wishes to exercise its Public Warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their Public Warrants on a “cashless basis,” the Company’s management will consider, among other factors, the Company’s cash position, the number of Public Warrants that are outstanding and the dilutive effect on the Company’s shareholders of issuing the maximum number of Ordinary Shares issuable upon the exercise of Public Warrants. If the Company’s management takes advantage of this option, all holders of Public Warrants would pay the exercise price by surrendering their Public Warrants for that number of Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Public Warrants, multiplied by the difference between the exercise price of the Public Warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the average last reported sale price of the Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Public Warrants.

 

If the Company’s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Ordinary Shares to be received upon exercise of the Public Warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. The Company believes this feature is an attractive option to the Company if they do not need the cash from the exercise of the Public Warrants after the closing of the transactions contemplated by the BCA, the SID and the Ancillary Agreements.

 

A holder of a Public Warrant may notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the Ordinary Shares outstanding immediately after giving effect to such exercise.

 

If the number of outstanding Ordinary Shares is increased by a stock dividend payable in Ordinary Shares, or by a split-up of Ordinary Shares or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of Ordinary Shares issuable on exercise of each Public Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights offering to holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the fair market value will be deemed a stock dividend of a number of Ordinary Shares equal to the product of (i) the number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Ordinary Shares) and (ii) one (1) minus the quotient of (x) the price per share of Ordinary Shares paid in such rights offering divided by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price payable for the Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of the Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

In addition, if the Company, at any time while the Public Warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the holders of the Ordinary Shares on account of such Ordinary Shares (or other shares of the Company’s capital stock into which the Public Warrants are convertible), other than (a) as described above or (b) certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each Ordinary Share in respect of such event.

 

If the number of outstanding Ordinary Shares is decreased by a consolidation, combination, reverse stock split or reclassification of Ordinary Shares or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of Ordinary Shares issuable on exercise of each Public Warrant will be decreased in proportion to such decrease in outstanding Ordinary Shares.

 

Whenever the number of Ordinary Shares purchasable upon the exercise of the Public Warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Ordinary Shares purchasable upon the exercise of the Public Warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of Ordinary Shares so purchasable immediately thereafter.

 

 
 

 

In case of any reclassification or reorganization of the outstanding Ordinary Shares (other than those described above or that solely affects the par value of such Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Public Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Public Warrants and in lieu of the Ordinary Shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Public Warrants would have received if such holder had exercised their Public Warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of Ordinary Shares in such a transaction is payable in the form of Ordinary Shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the Public Warrant properly exercises the Public Warrant within thirty days following public disclosure of such transaction, the Public Warrant exercise price will be reduced as specified in the Warrant Agreement based on the Black-Scholes value (as defined in the Warrant Agreement) of the Public Warrant. The purpose of such exercise price reduction is to provide additional value to holders of the Public Warrants when an extraordinary transaction occurs during the exercise period of the Public Warrants pursuant to which the holders of the Public Warrants otherwise do not receive the full potential value of the Public Warrants in order to determine and realize the option value component of the Public Warrant. This formula is to compensate the warrant holder for the loss of the option value portion of the Public Warrant due to the requirement that the warrant holder exercise the warrant within 30 days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available.

 

The Warrant Agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of the Public Warrants.

 

The Public Warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to the Company, for the number of Public Warrants being exercised. The warrant holders do not have the rights or privileges of holders of Ordinary Share and any voting rights until they exercise their Public Warrants and receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise of the Public Warrants, each holder will be entitled to one (1) vote for each share held of record on all matters to be voted on by Company shareholders.

 

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to the warrant holder.

 

The Company has agreed that, subject to applicable law, any action, proceeding or claim against the Company arising out of or relating in any way to the Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and the Company irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.

 

Transfer Agent

 

The transfer agent for the Ordinary Shares is Continental Stock Transfer & Trust Company.

 

 
 

 

Comparison of Irish and Delaware Corporate Governance And Shareholder Rights

 

As holders of Ordinary Shares may be unfamiliar with corporate governance and shareholder rights of Irish public limited company when compared to a Delaware corporation, the below summarizes and compares certain corporate governance and shareholder rights of the Company, an Irish Public Limited Company, and Lionheart III Corp, a Delaware corporation and special purpose acquisition company, from immediately prior to its March 2023 business combination with Security Matters PTY Ltd., an Australian corporation and predecessor to the Company.

 

    Ireland   Delaware
PRINCIPAL APPLICABLE LEGISLATION   The ICA   Delaware General Corporation Law, as amended from time to time (“DGCL”)
     
CORPORATE PURPOSE   The objects for which the Company was established are very broad and allow the Company to engage in a wide range of activities for which a company may be incorporated under the ICA.   The purpose of Lionheart is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware
     
SHAREHOLDER VOTING  

Except where a greater majority is required by the Irish Companies Act or otherwise prescribed by the Company’s Amended Memorandum and Articles of Association, any question, business or resolution proposed at any general meeting shall be decided by a resolution approved by a simple majority of votes cast, in person or by proxy, at a general meeting of the Company shareholders at which a quorum is present (referred to under Irish law as an “ordinary resolution”).

 

An ordinary resolution is needed, among other matters, to appoint a Company director (where the appointment is by shareholders), to remove a Company director and to provide, vary or renew the Company’s directors’ authority to allot relevant securities.

 

Irish law requires approval of certain matters by a resolution approved by not less than 75% of the votes cast, in person or by proxy, at a general meeting of shareholders at which a quorum is present (referred to under Irish law as a “special resolution”).

 

A special resolution is needed, among other matters, to amend the Company’s Amended Memorandum and Articles of Association, to disapply statutory pre-emption rights on the issuance of equity securities of the Company and to reduce the Company’s company capital.

 

Additionally, the rights attaching to a particular class of shares may only be varied if (a) the holders of seventy five percent (75%) of the nominal value of the issued shares of that class consent in writing to the variation, or (b) a special resolution, passed at a separate general meeting of the holders of that class, sanctions the variation.

  Generally, approval of routine corporate matters that are put to a stockholder vote require the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter.

 

 
 

 

SPECIAL VOTE REQUIRED FOR COMBINATIONS WITH INTERESTED SHAREHOLDERS       A corporation may not engage in a business combination with an interested stockholder for a period of three years after the time of the transaction in which the person became an interested stockholder.
     
SHAREHOLDER RIGHTS PLAN   Subject to applicable law, the Company’s Amended Memorandum and Articles of Association provides the Board with the power to adopt a shareholder rights’ plan upon such terms as the Board deems expedient in the best interests of the Company, and to exercise any power of the Company to grant rights (including approving the execution of any documents relating to the grant of such rights) to subscribe for ordinary Shares or preference shares in the capital of the Company in accordance with the terms of such rights’ plan. The Company’s ability to adopt a rights’ plan or to take other anti-takeover measures after the Board has received an approach which may lead to an offer or has reason to believe an offer is, or may be, imminent would be restricted by the frustrating actions’ prohibition of the Irish Takeover Rules. A number of Irish companies have pre-existing rights’ plans, which automatically trigger in specified circumstances without the need for a target board decision (other than a decision to disarm), although the validity of these plans has not been tested with the Irish Takeover Panel or in the Irish courts.    
         
APPRAISAL RIGHTS       Stockholders have appraisal rights in certain circumstances as provided for under the DGCL.
         
SHAREHOLDER CONSENT TO ACTION WITHOUT MEETING   As set out in the Company’s Amended Memorandum and Articles of Association, for so long as the Company has more than one shareholder, any action required or permitted to be taken by the holders of shares of the Company requires the unanimous consent of the holders of the Ordinary Shares before the shareholders may act by way of written resolution in lieu of holding a duly called annual or extraordinary general meeting of such shareholders.   As set out in the charter, except as may be otherwise provided for any action required or permitted to be taken by the stockholders of Lionheart must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent of the stockholders other than with respect to Lionheart’s Class B Common Stock with respect to which action may be taken by written consent.

 

 
 

 

MEETINGS OF SHAREHOLDERS   The quorum is set in the Company’s Amended Memorandum and Articles of Association. Two members present in person or by proxy and having the right to attend and vote at the meeting and together holding shares representing more than 50% of the votes that may be cast by all members at the relevant time shall be a quorum at a general meeting; provided, however, that at any time when the Company is a single-member company, one member of the Company present in person or by proxy, at a general meeting of it shall be a quorum.   The quorum is set in Lionheart’s Bylaws. The holders of a majority of the shares of capital stock issued and outstanding and entitled to vote, represented in person or by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except as otherwise provided by statute or by the charter. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders present in person or represented by proxy shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented any business may be transacted which might have been transacted at the meeting as originally notified.
         
DISTRIBUTIONS AND DIVIDENDS; REPURCHASES AND REDEMPTIONS  

Under Irish law, the Company may only pay dividends and make other distributions (and, generally, make share repurchases and redemptions) out of distributable profits. In addition, no dividend may be paid or other distribution, share repurchase or redemption made by the Company unless the net assets of the Company are equal to, or exceed, the aggregate of the Company’s called-up share capital plus its un-distributable reserves and the dividend or other distribution, share repurchase or redemption does not reduce the Company’s net assets below such aggregate

 

The Company’s Amended Memorandum and Articles of Association authorizes the Board to pay such dividends as appears to the Board to be justified by the profits of the Company.

 

The Board may also recommend a dividend to be approved and declared by the Company’s shareholders at a general meeting, provided that no such dividend may exceed the amount recommended by the Board.

  Stockholders have the right to receive dividends to the extent declared by the board of directors.

 

 
 

 

NUMBER OF DIRECTORS  

Under the Company’s Amended and Restated Memorandum and Articles of Association, the number of directors shall from time to time be not less than two nor more than seven.

 

Under the Company’s Amended and Restated Memorandum and Articles of Association, the Board will be divided into three classes designated as Class I, Class II and Class III. The term of the initial Class I directors shall terminate at the conclusion of the Company’s 2023 annual general meeting; the term of the initial Class II directors shall terminate on the conclusion of the Company’s 2024 annual general meeting; and the term of the initial Class III directors shall terminate on the conclusion of the Company’s 2025 annual general meeting. Directors are eligible to stand for re-election at the relevant annual general meeting. Directors shall be re-elected for a three-year term.

 

Size of Board: Under Lionheart’s charter, the number of directors, other than those who may be elected by the holders of one or more series of the Preferred Stock voting separately by class or series, shall be fixed from time to time exclusively by Lionheart’s board of directors pursuant to a resolution adopted by a majority of Lionheart’s board of directors.

 

Election of Directors: Under Lionneart’s charter, the board of directors is divided into three classes, as nearly equal in number as possible and designated Class I, Class II and Class III. Lionheart’s board of directors is authorized to assign members of the board already in office to Class I, Class II or Class III. Each of the successors elected to replace the class of directors whose term expires at that annual meeting shall be elected for a three-year term or until the election and qualification of their respective successors in office, subject to their earlier death, resignation or removal.

 

 
 

 

VACANCIES ON BOARD OF DIRECTORS  

Any vacancy on the Board, including a vacancy that results from an increase in the number of directors or a vacancy that results from the removal of a director in accordance with the Company’s Amended and Restated Memorandum and Articles of Association, may be filled by a majority of the directors then in office or by ordinary resolution of the shareholders (i.e., a simple majority of the members attending and voting). The replacement director will hold office until the next annual general meeting at which the director he replaces would have been subject to retirement by rotation.

 

In the event of a contested election (i.e., where the number of the Company director nominees exceeds the number of the Company directors to be elected), each of those nominees shall be voted upon as a separate resolution and the directors of the Company shall be elected by a plurality of the votes cast in person or by proxy at any such meeting. “Elected by a plurality” means the election of those of the Company director nominees equaling in number the number of positions to be filled at the relevant general meeting that receive the highest number of votes.

  Under Lionheart’s charter, newly created directorships resulting from an increase in the number of directors and any vacancies on the board of directors resulting from death, resignation, retirement, disqualification, removal or other cause may be filled solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by the stockholders), and any director so chosen will hold office for the remainder of the full term of the class of directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has been elected and qualified, subject, however, to such director’s earlier death, resignation, retirement, disqualification or removal.
         
REMOVAL OF DIRECTORS; STAGGERED TERM OF DIRECTORS   Under Irish law, the Company shareholders may remove a director without cause by ordinary resolution, before the expiration of his or her period of office by way of ordinary resolution, provided that at least 28 clear days’ notice of the resolution is given to the Company, and the shareholders comply with the relevant procedural requirements of the ICA. Under Irish law, one or more Company shareholders representing not less than 10% of the paid-up share capital of the Company carrying voting rights may requisition the holding of an extraordinary general meeting at which a resolution to remove a director and appoint another person in his or her place may be proposed.  

Lionheart’s charter, whenever the holders of one or more series of the preferred stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling of vacancies, the removal from office and other features of such directorships shall be governed by the terms of such series of the preferred stock as set forth in Lionheart’s charter and such directors shall not be included in any of the classes created pursuant to Lionheart’s charter unless expressly provided by such terms.

 

Any or all of the other directors may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of a majority of the voting power of all then outstanding shares of the capital stock entitled to vote generally in the election of directors, voting together as a single class.

 

 
 

 

COMMITTEES   Under the Amended and Restated Memorandum and Articles of Association, the directors of the Company may establish one or more committees consisting in whole or in part of members of the Board. The composition, function, power and obligations of any such committee will be determined by the Board from time to time.    
         
CUMULATIVE VOTING       Under the charter the holders of shares of Ordinary Shares shall not have cumulative voting rights with regard to election of directors.
         
AMENDMENT OF GOVERNING DOCUMENTS   The Amended and Restated Memorandum and Articles of Association may only be amended by a special resolution of the shareholders.   Pursuant to the DGCL, the affirmative vote of the holders of a majority of the voting power of the Ordinary Shares entitled to vote thereon is required to amend, alter, or repeal provisions of the charter, subject to any additional vote required therein. In addition, for so long as any shares of Class B Stock shall remain outstanding, the, affirmative vote of the holders of a majority of the shares of Class B Stock outstanding, voting separately as a single class, shall be required to amend, alter or repeal any provision of the charter, in a manner that would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B Stock; and the affirmative vote of the holders of at least 65% of all outstanding shares of the Ordinary Shares, shall be required to amend Article IX regarding business combinations and redemption rights.
         
INDEMNIFICATION OF DIRECTORS AND OFFICERS  

Subject to exceptions, the ICA does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection with any negligence, default, breach of duty or breach of trust by a director in relation to the company.

 

The exceptions allow a company to (i) purchase and maintain director and officer insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company and (ii) indemnify a director or other officer against any liability incurred in defending proceedings, whether civil or criminal (a) in which judgement is given in his or her favor or in which he or she is acquitted or (b) in respect of which an Irish court grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.

 

Under the Amended and Restated Memorandum and Articles of Association, subject to certain limitations and so far as may be permitted by the ICA, each director, officer or employee of the Company, and each person who is or was serving at the request of the Company as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Company shall be entitled to be indemnified by the Company against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties or in relation thereto, as more particularly described in the section titled “Indemnification of Directors and Officers.”

 

It is expected that the Company will purchase and maintain directors and officers insurance on behalf of its directors, secretary, and employees.

 

Under the charter, the Lionheart, to the fullest extent permitted by Section 145 of DGCL, shall indemnify and hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was a director or officer of Lionheart or, while a director or officer of Lionheart, is or was serving at the request of Lionheart as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan, each of whom is an “indemnitee,” whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys’ fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred by such indemnitee in connection with such proceeding.

 

Expenses (including attorneys’ fees) incurred by an indemnitee in defending any civil, criminal, administrative, or investigative action, suit or proceeding for which such officer or director may be entitled to indemnification under the charter shall be paid by Lionheart in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall finally be determined that he is not entitled to be indemnified by Lionheart.

 

 
 

 

LIMITED LIABILITY OF DIRECTORS   Under the ICA, a director of the Company may be liable to the Company where such director acts in breach of certain of his or her fiduciary duties.   Under the charter, a director shall not be personally liable to Lionheart or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under DGCL unless a director violated his or her duty of loyalty to Lionheart or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived improper personal benefit from his or her actions as a director.
         
LIMITED LIABILITY OF DIRECTORS   Under the ICA, a director of the Company may be liable to the Company where such director acts in breach of certain of his or her fiduciary duties.   Under the charter, a director shall not be personally liable to Lionheart or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under DGCL unless a director violated his or her duty of loyalty to Lionheart or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived improper personal benefit from his or her actions as a director.
         
ADVANCE NOTIFICATION REQUIREMENTS FOR PROPOSALS OF SHAREHOLDERS  

The Company’s Amended and Restated Memorandum and Articles of Association requires that an annual general meeting shall be convened by not less than twenty-one clear days’.

 

The Company’s Amended and Restated Memorandum and Articles of Association requires that, subject to the ICA, all extraordinary general meetings shall be convened by not less than 21 clear days’ notice except that they may be called by not less than 14 clear days’ notice where (i) all members, who hold shares that carry rights to vote at the meeting, are permitted to vote by electronic means at the meeting; and (ii) a special resolution reducing the period of notice to 14 days has been passed at the immediately preceding annual general meeting, or at a general meeting held since that meeting.

 

“clear days” means calendar days and excludes: the day when the notice is given or deemed to be given and the day for which it is given or on which it is to take effect.

  A Lionheart stockholder must (i) give timely notice thereof in proper written form to the Secretary, and (ii) the business must be a proper matter for stockholder action. To be timely, a stockholder’s notice must be received by the Secretary at the principal executive offices of Lionheart not less than 90 or more than 120 days before the anniversary date of the immediately preceding meeting. The public announcement of an adjournment or postponement of an annual meeting shall not commence a new time period (or extend any time period) for the giving of a stockholder’s notice. Additionally, the stockholder must provide information pursuant to the advance notice provisions in Lionheart’s bylaws.

 

 
 

 

SHAREHOLDERS’ SUITS  

The Company’s Amended and Restated Memorandum and Articles of Association provides that any dispute or claim arising out of or in connection with the Company’sAmended and Restated Memorandum and Articles of Association will be governed by, and construed in accordance with, the laws of Ireland and that the courts of Ireland will have exclusive jurisdiction to settle any dispute arising out of or in connection with the Company’s Amended and Restated Memorandum and Articles of Association.

 

The Company’s Amended and Restated Memorandum and Articles of Association separately provides that unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Exchange Act or the Securities Act.

  The charter provides that unless Lionheart consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of Lionheart, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, employee or agent of Lionheart to Lionheart or Lionheart’s stockholders, or any claim for aiding and abetting such alleged breach, (iii) any action asserting a claim against the Lionheart, its directors, officers or employees arising pursuant to any provision of the DGCL or the Bylaws, or (iv) any action asserting a claim against Lionheart, its directors, officers or employees governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or arising under the federal securities laws, including the Securities Act of 1933, as amended, and the rules and regulations thereunder as to which the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum, unless Lionheart consents in writing to the selection of an alternative forum.

 

 
 

 

RIGHT TO INSPECT CORPORATE BOOKS AND RECORDS       Any stockholder may inspect the corporation’s books and records for a proper purpose during the usual hours for business.
         
RIGHTS TO INSPECT SHAREHOLDER LIST       Under Section 220 of the DGCL, a stockholder or its agent has a right to inspect Lionheart’s stock ledger, a list of all of its stockholders and its other books and records during the usual hours of business upon written demand stating his purpose (which must be reasonably related to such person’s interest as a stockholder). If Lionheart refuses to permit such inspection or refuses to reply to the request within five business days of the demand, the stockholder may apply to the Delaware Court of Chancery for an order to compel such inspection.
         
CLASS ACTION SUITS       Generally, Lionheart is subject to potential liability under the federal securities laws and under Delaware law. Under the DGCL, a stockholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation. Generally, a person may institute and maintain such a suit only if such person was a stockholder at the time of the transaction that is the subject of the suit or his or her shares thereafter devolved upon him or her by operation of law. The DGCL also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile. In certain circumstances, class action lawsuits are available to stockholders.

 

 

 

 

 

EX-4.77 3 ex4-77.htm

 

Exhibit 4.77

 

CONVERSION AND EXCHANGE RIGHTS AGREEMENT

 

CONVERSION AND EXCHANGE RIGHTS AGREEMENT (this “Agreement”) dated [___], 2024, with respect to those certain warrants described in Annex A hereto (“Warrants”) receive under that certain Conversion and Exchange Rights Agreement executed December 31, 2023 (“2023 Agreement”), by and between Security Matters Limited, SMX (Security Matters) PLC (formerly Empatan PLC) , and the person stipulated in Annex A as “Subscriber”. Unless and until Annex A is further executed and delivered by the parties hereto, this Agreement and the Annex A shall be of no force or effect on the parties.

 

W I T N E S S E T H:

 

 WHEREAS, pursuant to the 2023 Agreement the Subscriber was issued the Warrants and certain issues arose with regard to the consummation of the 2023 Agreement; and

 

 WHEREAS, SMX (Security Matters) PLC is hereby offering the Subscriber the right to convert the Warrants to shares on the terms and conditions set forth herein as full and final compensation for any claim or right that may have arose due to any issue that arose with regard to the consummation of the 2023 Agreement damage;

 

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

Section 1. Conversion of Warrants. Subject to the terms and conditions of this Agreement and notwithstanding anything to the contrary in the 2023 Agreement, the Warrants are hereby converted into to that number of shares (“Conversion Shares”) stipulated in Annex A.

 

Section 2. Result of Conversion. Upon the conversion, the Subscriber shall not have any interest in or title to the Warrants and all obligations under the Warrants or the 2023 Agreement shall cease and be of no further force or effect.

 

Section 3. Issuance of Shares. As soon as practical after March 31, 2024: (a) the Warrants will be cancelled on the books and records of SMX (Security Matters) PLC, and the Subscriber shall only have the right to receive the Conversion Shares pursuant to Section 1 above, and (b) SMX (Security Matters) PLC shall promptly file a registration statement to cause the Conversion Shares to be fully tradeable, subject to section 4 below, and deliver to Subscriber details of the shares issued.

 

Section 4. Representations and Warranties. The Subscriber represents and warrants that the Subscriber is the record and beneficial owner of the Note and of the Warrants, free and clear of all liens, charges, pledges, security interests, claims, mortgages, options, encumbrances, rights of first refusal, conditions, covenants and other restrictions (other than any restrictions under the U.S. Securities Act of 1933, as amended or other securities laws), and has the full right and power to enter into this Agreement and perform the terms and conditions specified herein.

 

Section 5. Miscellaneous. The parties shall execute such documents and other instruments and take such further actions as may be reasonably required or desirable to carry out the provisions of this Agreement. This Agreement constitutes the entire agreement between the parties and supersedes any prior understandings, agreements, or representations by or between the parties, written or oral, to the extent they related in any way to the subject matter hereof. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors, assigns, personal representatives, heirs, executors and administrators. Notwithstanding the foregoing, neither party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. This Agreement shall be governed by and construed in accordance with the laws of the State of Israel without giving effect to any choice or conflict of law provision or rule (whether of the State of Israel or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Israel. No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and signed by the parties. No waiver by any party of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of [___], 2024.

 

[_____] SMX (Security Matters) PLC
     
  By:         
  Name:  
  Title:  

 

 
 

 

Annex A

 

Details of the Conversion Shares:

 

Conversion of [___] warrants into [___] shares.

 

[_____] SMX (Security Matters) PLC
     
  By:         
  Name:  
  Title:  

 

 

 

EX-12.1 4 ex12-1.htm

 

Exhibit 12.1

 

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934)

 

I, Haggai Alon, certify that:

 

1. I have reviewed this Annual Report on Form 20-F of SMX (Security Matters) Public Limited Company.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

April 30, 2024 By: /s/ Haggai Alon
  Name: Haggai Alon
  Title:

Chief Executive Officer

(principal executive officer)

 

 

EX-12.2 5 ex12-2.htm

 

Exhibit 12.2

 

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934)

 

I, Ofira Bar, certify that:

 

1. I have reviewed this Annual Report on Form 20-F of SMX (Security Matters) Public Limited Company.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

April 30, 2024 By: /s/ Ofira Bar
  Name: Ofira Bar
  Title:

Chief Financial Officer

(principal financial and accounting officer)

 

 

 

EX-13.1 6 ex13-1.htm

 

Exhibit 13.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Annual Report on Form 20-F of SMX (Security Matters) Public Limited Company (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of such officer’s knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

April 30, 2024 By: /s/ Haggai Alon
  Name: Haggai Alon
  Title:

Chief Executive Officer

(principal executive officer)

 

 

EX-13.2 7 ex13-2.htm

 

Exhibit 13.2

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Annual Report on Form 20-F of SMX (Security Matters) Public Limited Company (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of such officer’s knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

April 30, 2024 By: /s/ Ofira Bar
  Name: Ofira Bar
  Title:

Chief Financial Officer

(principal financial and accounting officer)

 

 

GRAPHIC 8 fin_001.jpg begin 644 fin_001.jpg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end GRAPHIC 9 form20-f_001.jpg begin 644 form20-f_001.jpg M_]C_X 02D9)1@ ! 0$ E "4 #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" (& Y4# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* &,I)SG![5%),$5\-C9RQ;@ >M2/D9)/2OF;]O[XU7'PA^!MX--F,&KZQFU MMF7@XQ\^/P- 'G?[47_!1K3OACJ%SX;\!VL6O:["=L]](,M-TNYU4:6+]OWNH7)RH4 M_P!XUV7C3X+3> _BK9>'&$^NZ#--'F\LXR5E0]=I[4%'N7PF_P""G7Q"\*WD M:^*EM?%&BEP)9>?M2]CC'&*_2KX1_&+P_P#&SPG;^(O#=^LUA*H$D.?WL,G= M6%?DM^T]'X7T.2WT+2[31X-3M?+\M]'A\O,.WD2G^*3/>KW[ OQMO?A-\<+# M39;EO[!UYOLUW&S?)$<\.!ZYXJ9 ?KC\2?&0\ ^"]4UXP^=]BC\SR_[U>1:1 M\=/B5K>EVNJ67PSN;O3KJ/SHY(YE!9>Q&?6NS_:88_\ "D/$K*H=3!D ^F:\ MY^''Q'^*-K\._#]II/PV-S!'8QB"Z>^15D7'!QVKIBKQ,FCUGX3_ !:T_P"* M^@RWUO;36-Y:RFWN[*?_ %D$@X(-=RD@^91(K./[IYKYAN?!WB7X:_!KQKK] M_%!'?WJ?6M)O?A7\+[+7K+7=2OM=UF&&W\V\GW1QF0 M EP.QYJO9IF7,XGTH)(V4".97?IPPW4Y[AHR 3A5',F>,^E> ^+?AY-X/^'@ MUS2]>U$ZQ81)=^9--E9&."P;VZT2:]>_%+Q?H6FI?W.E6"Z3'J-RMJ^QG=CM M(S0J.NA,J^CN>HW'CAK?Q]8>'64R?:XFE$J]!@9-=W%W9R6;B,W!WN&QSSVK?^#6J75_HVNO>3-*T.H7$:%CT /%7*CI M=&%/$W=F>FS7#1,6$BD=U;I38[Q9G^1\GTSS_P#JKP33_%&J?\*ON)5NI9+^ MZU=[02OSL!;CZ"NP;X<75C)I<^G:[=C45*R2O-)NC<8Y&*CV23-57DWH=A:> M,[>Y\1W6C*&\^VC\R27(V\G&!73V^?)!+;@> [C+?8TO90_8!BM?H+-D9/&/ZUX=^V)\"/^%] M?!O4='MA_P 3>S!N;$]:BMOAI_L:ER@ M_O<=J^O_ #XD\;?#?P[\.+K2K?2-8>U,K:MI>J2+YXB)^4-GE#CI7DGPV\= M:-X!\/W'AKQ/=:KX1UO1+XS/+90GS;E@>(9A_M M<7\-;6XO?B-X:M[,%KUM0A$>WO\ ."?TKV[P+\4H-6\#^'M+O-5TVX-F)+?4 MSKD2O,Z')"PR'G/2NQ_X)Z_L[W?Q!^+S>-KZ!X?#&@W$DELTB8^TR[CA1Z@" MD^P,_3+XJ>#[GQQ\,]1T"UD$=W>6ZQJS= 0!6G\/]#G\*^!=$TBY*O=6-JD+ MD=R!C(KH5SMRIR.W'04FW=P?SH^ M2T2QD6.ZG PQX&*A\ M8?#)?&7PR@\,S2BVNH;6)([G;N\N5% W =^E=ZR[E&>#G-1N"\FWK7K&XXYX/84!25([^M:*H^AFZ4>IY-H/@GQ1=?$:T M\4:W<*D<=NT+6*I59=3-X>/0\@T[X37L7P]N=&N[HK>O.UPEQ$,X;.:RTZ\GCL=-MROF7EN<23*!T [=*]1'R_*&\L]!SU]Z=@%@0=V MTXX/\Z'4=[D1PU-.Z/-X?"^MZ;\1VU>R8/I\]NMO*DG4 'KFO3H&#+@'/K2> M7N8Y7 ^M0E6A^5!A1VK)RYF;TJ2I)ZEOTI:IK(^X(7&[L?6I/,8KG)&#@Y%( MV6I8HJ"!G..E!1)2U&N5ZT;G/2@1 M)14<;%FJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BBDS[4 +129H M_&@!:*3'O10 M%%-YS0 ZBD/(IB[AU(Q0!)13>>QIK;_ %% B2BHU;'6G"OV@YO[5F']A>)@-K:E:*,S+Z.O0GWKXZUS_@E M3\2HKV9--\2:)/9DD1RW)=9-O;.!7Z>Z]XET[PY:-<7L\<$*C)9VQ7E>J_M. M^&;&Z*6T=U?'.-T.,?K6T,-5K*Z1R5,71I.TY'RW\*?^"4MI;WUM>?$/7%U" M*%P[:;8#]U.1_>8\C\*^\?!WA72O!?AZTT?1-/CTW3+50D,$2@<#N?4UQ7A? M]H#POXBD\I9GL;@G'ES\$FO2[>Y66-70AT/0J:F5&I3TD:4\13J_ [F-XX\9 M6'P]\,76NZH62QML&0KU ->9_P##5WA2*>S:ZLM2LM&NE!CUJ>'%MD] 3ZU> M_:P6-O@9KZR%A&YB!V_[XKB/C;IUE'^S+X:@$,9M3N-@ &7_K5PC%_$:2 M.XT[]I#P_J'B:WTF>PU*P2\;R[._N8ML%RQZ;#[UH^,/C;H_A'6#H4-EJ&OZ MW&-TMCID6^2,'D$UQ'[0EK;P:7\,0%6'R==LQ'*H _V1[5%=^*=<\4?%_Q1 MI7AJ7W%S*Q&<)[5JJ<7J9ML]$\'_&G0_&VGZI=1175C>:2";S M3KI-L\0 SR*YZ3]J/PX=-AU.RTS5=1TMFV3WMO#F.W.<'>:\P^'UY/\ \)I\ M5+6?6$U>XBLI/-ECQAWVGY@1VKOOA/9VT?[*RM!9QH9-+N&D$B@EVP^6/J:) M4XQ%&39Z-JGQ0T;3[71;KS6FAU8C[+)&.&S5OQ)XYL/"]WIMO?E@U_*(8BHX MW'H#7S8M]!:_"'X27,UPTUM'<*IG;C;ECC<:] ^-6N6%YXX\!V,%W#<7+7RR MA8Y 0%!ZGW]*7L^A/.C7' MQLTVSN)K;3]*U/6K:Q_=S75G'E$QZD_2LC3Y O[0WB.,%9/]!#LH'S#"_P!: MP_"_B37/&NEZG>:?=Z5X MI>$3XE6Z$>EH,N\G!7V/OFN>L_C;I%]J%M!-8ZCI5M=OLM[ZZCQ%(>V/K7BN MFLUU\%;QDF^WV<.L*94Q@A _0X_.O=?&'B3PY;^%[.:Y$&H6S/$D$,#*S%B0 M 5 YX-1*FHLT59R1SFB_$.]O_C%K6E/;7DFG11QB! HQ&P^^Q/H:]#T'Q99^ M,M+GN+#=L@F:)MW!RIP:\\\-7D5K\;_$4$K('DL8-AR%W<=.>])\$]4M=*\/ MZS# M@6U^%FG[0L7SVX147 ZKVJ_9QBTC/VU22;1U&L_$K3/#E]'ILR337WE*T448 MR\BXJQX:^(UEXGO9[-;:>POX0&>WN1AMIZ&N2EMXI?C?I\<@5I8]-5EW+G)J M#6%N/^%L7T-I)Y-S+I[!0N/O8X)]A2=.+:L*-:HE>1TUQ\6]+CO9HH+6ZO+> M!BDU[ N8HV'4$UTOA3Q1:>+=/6_L79K5B0&/?%>=_#G5=-MO \D%Q)%"\%/IBG M.#VI]<1Z84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !2%@.M+3&Z']* !9 :=N ZUB:YXHT[0-WVF4> M<$#>4.I7/6FZ+XPTS7!BVF57_NN<4 ;H8'I2TQ<]_P!*?0 4F:6FM0 N:;OY M H[5"TN%8] .,TK78-V5R9F^7)IGG+P0>"<#WKB;WXN>%[2ZDM9-5'VB-MDB M1QL2#[\5?T3Q_HNOW+VUA?QW%SU6-E*_EFM/9NQE[6-['6;J3=UID>#2 M7#^7"S @8&23Z5-M;&G,K7'K(&4$=*#(%!)X'K56UO(+Z,/#*LD9X!4\9J=L M*PSP<=.U*SN/H.,@(P#DXS3%0[NI/]*RY-(?B=J$\T?G?8D.(H;$+69HGU^S613@H2GEM7P'- M$L;,AB"O'P^\9:MKP_-X@\/2)JVCBX1%.=N3LQZXKV*F4*,;IGA4\Z]Z]5'//;%?-U*;IRY6?64JJ MJQYD'6EI*6LS8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BDS1F@!:*3<..:-PH 6BFAP<E=&&I^VJ*)RXJI[&FVCPC5M6USXT>(9P;A8X$) M?[(SX0**Y74=/&DW3V4TD:/'\P,(W #TXIVBWD\/G?8GBMI)5:&57^4_@U$> MCW,/'G1 $;3\XSGW-??4J2HM11^:UINNVT]2[X>\&WWBN%I[.2&.<9*!G"L< M5['^S[\5KK^U(_#>L3-)O)2"23EBXZC/I7BUC8W^EW<5Q%/;I\/V/BS29= M.U.!+JRD()1AP<52UCP;I6N>'X='OK1+C3X61HX''RG8*]9.K7FG!=1D&V2XA8JTH_VL=:[A M9 QPIR1U'I3MH7H>O'6I4Y%"S6[A-O.J#B53UW5K: M7X7TW1O#ZZ'96J0Z5%&T2P#H%.M0.R^80>,+NSFJYI!RHYJ MY^&OAZ^\,IH,^F1/I2CY+?'"'U%9VE_!+PCH]Q!<1Z1'->0L'2\F)9U*_=P< M]JUO$GC[3/"^K:/8WQ<7.IL4A '&171B5&P"01C/-/FG8CEB9,/A?3H=:N-7 M6W1=0F01R3@?,Z^AKFV^"7@][^:Y&EK$TS;Y8U)"N?4C-=PP'\;#':L;6/&5 MCH>JZ;87+,)M0E\J'C()QZT1E)["DH1W(+#X>Z%I.G7=C9Z=%'8W3;YK8#Y& M)&#Q69I/P?\ "VAZE%?6NF)YT)S"')(C_P!T5VOF[L@?>') --SN8G/(_AI< M\KV'R0.:O_A]HFI:Y'J]Q: W\9!$ZG!&.U4]2^$_AC5-0:_GL%29SEQ&Q <^ MIKKUVKO7()[T+L"B,,H[Y]:7/,/9TWT.=7P)H-GH+Z1#8QK8.V_R<<9ZYJWK M7A^QUC3X+6[B\VW4KL3Z8Q_*G:]X@M]#NK 7"82YE\D2?PKGN:TOO,%'<\,. M>*N[W%RQV2*,WA^S34UU40YOHX_+5O\ 9]*JWWARSFOQJ26Z+J>PJLQ'('I7 M12+N0@\Y%1[-B@8SQW[5/.XNXW24E8\)NK&;[7--JG@M;W7Y'95F@;:C*.$) M]\5WWPQ\-7'A7PO:VLZ;)M[221YSY>XYQ7:F%3N)'WN,@QQ3=_P V"PYZ#O2LP"Y_*N=\;:U-H/A/ M4+^W4-=1Q'R^/XCTHL!T&]N1M.?TH63+ 9[7R(L,.E 'Q MY^UYXLU/P+\4=&U.""?C/I7B"*.*YE&FZ@OW6!P#69 M_P % HP?$V@DM_RPP%!YZ]:^5[.^DADVAFFV\AE^\*Z(VL92O<_3+PK\3YK. M.**\_P!*MB.)E.37I.DZ]::Y;B6UD#>JYYK\V? /QLU/PW,LWD66)AD,IK*Q1.QQ5.Y^5D('(R=H[YJVV&YS5:=?,7 MGE>O':G'1D5-8.QX!X0\7:!X=\3>*CJRO).UT,[;J^L:3>?#GQU M8:CI\$DF@:JPAN;.&/<8Y3T?CM7==-GEC*!O[@'K5:'Q]JVL:7XBTB=K6/6K.V:42("8VCP><>MA6FB_$;6I] M:LKR:PU(B>"XLU+*IQT8#O6MX/M5U)O$%[IFCW%K!]E:WANKM2))VP>-I[57 M+"UR.:KL-^%NL>(M)^')N/LJ7[/\]K$GWV8GDL?2IM4\>^,O#-O;ZAJ<^CSV MSNJR6L((EC!ZC/M7,6NK:K#\,Y=/TRWU"#4K69%NV$)4A"?F\OUXJEXNT_3K MCPRD>C:5JVHWI=7;[1&V>.I)I\M.Y7/5/2[KQ)--XZL+5;.W>*YTR2X6?'[U M/;/I3/@9;)_PCNHK@C-X['GODUF"QO7^(&A3?99A NB-&[;"%5B/NY]:W/@K MI\]AH-]'>/ MZ5X7I?B"\TG2[^UM(6#7&W;<0CG [5[O^U5HTUQH^FZG"AS Y$LG94([U\_: M997S:/-?V4S):6I"F/'S$GO7TV6M.AIN?+9IIB+2V*S6MQ)([2),[RBY[UD-J%TN UZZY/?K5^P34]4CNQ%<-MAA,KLW M?':O9][E]YGAQY%>QT7P0UJ71?B+I=O W[FX;R9!^N37V\OIVQ7Q+\"M%EUK MXCV#0*2EHWG3-BOML#'-?&9GR^U7+V/N["@"2BH_,/)'(]J MBFO$MX6EDD2.)>2[G"@?6@"9L\XX]Z867:7;*JO4L<"O#?BA^UAH/@F9K/3( M3JUXK;689\H?\"%?//BK]K+Q=X@UN*0-#9Z+(6MV(L+ MWJ8)>A/J#WK3\3ZWI[1M:26T=\[= %&0?\*.4.9'N>A_%KPQX@T8ZE#J"0Q@ M@^*M+\36YDTZZCN"!]S/(KXJU31[G1-/:[L;50TC$O"SDLH]A M7T=\"OA[9:+I-IXBMKJ>6:_A#2POP$8]>*3T&G<]=7MT#=\5)44>.W0'&:EI M#"BBB@ HHHH 2D8CK2L-PQ3/+XQVHZ@)@*=Q/%>9_'+PC)XE\#7ZVH_TJ%O, M3/H.37IOEY4@TRXA62!U< J5(;BM:,W2FI(QKTU6IN+/@;PMX7_X2BYO+<._ MFI$Y:-4S\P'%9-U8S6=PR74!M[E$P59N6QWQ7T#\3O@'J"WTNL^$Y9(IY1EX MU.T'UZ5XKJ7A;Q':7,GV[3;D72@*964LI_&OM\/BZ=6TFS\\Q.%JT6XZL[-N7DWE8_"P52I*,IK1#?C5XFG\$_"/7+ZU8+)_[K.-N?PKS;5)-9^%/ MP"\*ZKHDJ+-"]O-J) _UV\_O7->C?'KPS<^)_A)KVG66/M'D^>BG^(1G<1]> M*H^$X[7XI? &UM8=K?;-+-N5(_U^-VMZ/\ M$+P;#X>EC;1'>-]8V\L4DYC_ $KH?%OQ=OM+\=>()8#YGAOP[I)FO+?^*:=\ M&/![<&N#^'OP<\5W'P]\<#7[1H])XGM/$>O1>5/YGWE,8PAS^%=35)+0RNRS8VOQ6\0^$QXO7Q;#I]TT9N[;1O MLBE#$!N\MV]2.]5/%WQD\2:YX1^'^H^&I8]-OM;NGM[V(QB4+@8.,^AYJQI? MC?QMH_@E?";>"-4EUZ& VD.H+&#:%<;0Y;/I0WPDUCPSH_PMTRVMWNY=*O)+ MC49H1E!N&3S]36:48O4B7,UH9/Q,N[WP+>^!Y_%^KC4Q!=S2-=)'M8+C/ KT M#X?^,-;\<27?B?S$3PV@9+&QB7,EQC^)CV/M4?Q>\#WGBCQ)X)DBL#?V-K=/ M) MIR.D^/->\4?:Y_\ A-+32M?\UU@T.YB"[55L $GN16O\4)-7FNO B)+'#KLE MXI\Y1NC5MO/%9VO+J.H6]]9:[X"FO]>,CQV^I6$ $6TGY69QR#BMFU\"ZWI] MG\.;:XCDN[G3+PRW4K'.Q".N>^.E/W8[&=IRW+ZZAXF\%^,M'M-3UI-3L=3E M97Q$$96QGCVI8=8\3?$/Q)J(TW6%T72-/E-NNR(.\SCKGT%;/C_PU>ZMXJ\& MW-M TD5I>O).V/NKMZUA6?\ :_PM\2:LBZ-<:WINH3MM6-KXOTK4YX9=8TJW,T$ZC D4C(R/:JVGWGC6;P2GB*37%65H MUG%G';!LKW&?>F-H^IR:'XV\3ZG8_8)]1LV2*U3 M_*NA^'6O'Q%X+TC4'^5I(MN#W*\9_2N ML/Q7XKLO ^GK=7A=UD;8N!WKGW/0Z'0G.!@4?-6-X;\5V/BBW\RTDW,!ED/: MMK;2M8 &<\TZFM\JDCK2!R6(Z8&: %##.,53U;>FFW;0MMF$;%68X ./6N8\ M>_%C0OA[I\UQ?W'G2HN1;6_S2,?0"OC+Q[^TQXN^,E[/8Z/-_P (WI,;;3 I M_?N/4U:BR>9'I_A?XJ7GC;5/$^G7YN([;39/L[2QL60Y[UUOPFTSQ%X=\1:E M='6(]2T3;NM[:27&!["O%_@;#%X7AU?R9]\]X=UP+@Y\QO7FO1-%UJ[N=4:& MR#FYB&9%VX51UXJN4:=SZ$TSQ9:7\%PTI^R-&Q\SS#_*O$?'OQTU:\\0R:5I MMO%;Z/%Q--<+GS/3&:Z[P_X\MM;T^:WEM4:9#@.PPC)U(KWOX#^,H/%W@/3D,PEU M#3X5MKCUW*,?TKYD^:1L1RGS\>6I[I27J!+692W!_B/-* M0'T=113>=V*S*'45'YGKQ3\\9[4 +12 YI: "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ J-OO<^G%24QL[NV.](#X;_ ."@2J_B7P\7RGEP9,B]LFOE MC3VW:IIX;!_?K&#'_&,]Z^OOVR9 /B+IT5[;+=V4EEC;_=YKYIG\$KNBNM G M6=XI-ZVLG#)]*ZH[&,MSK/BKX5L;/Q!+&;<6L:V221M&<'>17!*VK>&6T^ZN M1) DL9:&!OB0MQ!%=:-J"M$ M3_QYNU?(/C#P&FCW=J8$\I[EE%OM.8Y0>^?7-9L6MZQX$UO[/=E[.[MV!)0G M;CMFLW$K4_33P_\ $2RU1A#=@6MSWSTKK499%5@P9,9#*>*^#?!OQ^MKIUL] M<3,A V7$9XQ]:]\\(_$:XL[=+BVN1J5C_#&&R0*QE%WT*B]+,]S6,*>.?TIL MR!FR1TZY/;VK&T'QI8>(8T$3B*32NPTV17V*RRKM#IC M_5CDFK"_NE&WE?[OI[4Z.!=S.I(SUXJ39PA9(UZ+ MA<]<=34K0]"&P?6G>6OI2'9$ D1^,'+'\J>?O D\=@:>\*L,?=^E"QA>^?K3 M"VJ,#Q9H-OXDTJZL[J-9(;B/RV#'@>AKY2\1^#?%'PCO+E+..*\TJ=O]?(NX M>RXK[*,*LVIFL9PY5$\2EDLH.[D>?? M!WX9VWP\T4,[>??SKA[@CG'I7JH^[US56'3HX0!DD>AJWM'I7SLYN;NSZBC2 M5&"B@I:**@V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*3H>34-Y,E MK;RRR'9'&I9F]A0!,TB(NYF"CIECBF.5?@C!7QA^US^T5=V.KZ;X<\ M,73-;/@7KDN0./F^M7RL3=CZ[ M^)OQZ\,?#2W9+B[CO-3 PEE V6_&OFF^^)_BO]HG6)-,.HKX>T0'F")B'/UK MQ77[.[M=]_?3"Z63]X-2W%R??/:NZ^&,4E[IZZA9V(/%>IR+;VJ7,D<+GYESZ>]2?"VX^T>)+YS\KLA ;MQ_6F2.B^%NB>'M86X MM#,EZL8WO*>%^E:ZR);K((1NN2,&[8\8JOKNMQ_;I5,YED!PD=N/F)_VO:LN M2QO-4C::_E2WM@A)A@XR ,X-5'<3)+G7"TY^Q1O?7I&P,02N?ZU]9?!VRN[+ MP'8)>\7+#+*1C'MBOS4U?QIXFF>X\3:5=OHVGZ7<^58V\9!$Y!Y)]:_2GX0^ M,H?'?P^T/4&NXIK^:T1KA8F&5?'/%3)%1.VC4)P, 5)D5E76L6]KJ"6+NJRR M(6#2-Z>M7X7$B;E=9 1U4Y%9&A/124M !1110 4444 )3)E+1L!W%24UONT M5$CD50,J5';-1S6%K.I+6T;LW_/10:LK:H&)R2:7RAZ4[R7PLEQ4]9%>.!85 MVJ%7 ^ZHPM6 I.W))VG-'D(.:?MZ5+[6#M&[=0/:NMXI157L@]2NR'HI,#L*6H617^?<"68;3T7O2MOXX92>Z]OK5C\*:6;TH APQ&-I Z<4%2H M/&3TPO2IPQ[C%&[UH&0E-HW#=D=%SQ4;1X "@E>Z"K0[THQVHU%9$!^Z1T]3 M5=H2UP'"CR@/O9^:KW(SQ2*OR\BEJAV3,C7-$B\0:/>:=+(\:7$31-*OW@#Z M5!H7AM/#VEVUE#(TZ6T8C5V^^P [UNE0.V::K=>FX=35\SV(<(MWL3$19XME.*:NQJ*1O2?&Y5UB6(Z>T>FQR;3=,.OO6-\:/&>EZ M]HL%G;2[]Q$HDQQ]*\W\2>*6OK6YM88F9E'[M85R*W+ZQ>/X3V-W<6ACNI)0 MHWCG&>:+6!G8_L\,S+J)8Y5B"GK7M8KQ7]G=@5U' [_E7M=2QH:W>HYH_.C= M,[=PQFI:*0SX/^(7A3Q/:>.O$D(BDU^RM9#<;D.9(E/\(%>=WFBV'B)FGM]] MO> J3)#\LD1]&%?9G@,;OCEXQ5XRP,4960?=QW!%'Q2_9Y\,>,EDU2!QX;U0 M9Q=Q$(C^S#O6J9/*?*7@C49_#=YG7H?[9T_=S-9\-&/4U]6_#_7O!=YHTMWH M4R/$R[IO._UJ-C[IKY;\7Z1J_@FX:TO85N+=#B.^M8SY<@_VAVKJ?AEXBT1H M?(39IU])_K@S@K(?5:LG8[WQ1JD>AW5QJFA6[37,IVO'_ !GJ:U=.T'1)/#\ M5[JW[V]F?S_*3H/85 D8CC1E3R4;ER_(8>M8.N>,;+2ED1$$[J,;B>!4L-SJ M[/3/";R+?3P/8A7WF*3OCO7J_P -[B'5+>\U.SD#V-RX$8]-O%?%'B;XD3ZE M?1V\4DD\H&UHX.44=B3[5]@?!'P?J'A'P1:QWLQFFN=LXCC/" C.*ECU/2]P M]:9*X4,6.U5&XMVQ3 "[#S..^WTKQGXG?M&^%-!37/#_ /:&W54MY(E;'RB0 MJ1MJ$KE7.CE_:#\!+KW]CR:] M[O\L#DC=TQD5Z+#,DT2R1L'1AD,O((K\?[ M>ZO6)6 R)<32-E1R\C$GZH?!^WO;7X9^'(K_S!=K:)YJR_>!QT-.2L"=S MM :6FK],4ZI&%%%% !1110 4444 %%%% !1110 4444 %%%% !3&SD=*?2?Q M4 ?'7[8I/_"PM)XX^QC/O\U>077AV&\C6YMO]!N>^WAC7L'[8@S\0=)_Z]!_ MZ%7G*X\M6^E=4-C![G#ZYIZ72K!KEF/)7_5W\8_>*?4UC1V>J^$K>YETZ==8 MT+S%:6WZ[I,?*2*]5^S_ &R58!";KS2%, &=Q/2KFM? +QAH=BNL65B+9%^> M6,<@K[CUHYAGE-CXO@U73[729(&,AOHY+2"0\VJY&[GTS7>:OI.GZ[X]\PU75_AVVH^? MVIVE[ 8'O(^0XIIW&9%]X8N-#\+Z?KUO/YEM=NT2V_4_05J^#?B9JGA*^18) M)4"CF&7('TYKJ?#?B#1+C2?!%L[I+)9W;R2PO_!N^[D?6LEO#X\=:EXZ\\D2 MZ?+Y\3QC 51R1^-2T![;X&^-.G>)!&EVYL+X'B13@#ZU[WX9^)=Q8I&EY)]O MM",+/'R/QK\\-8T'4/#,.GW<(;@!W ;UI@=G<>*-/L[":]N[A+:WA)#M(<8(ZX]:\\T/XI:/ M\7]>U71=!N))(;)!YTWW1)GJ!7E7[6%QIWA;P;8>'UNKE;F4F3>9"2V>QKYY M\ _&J^^#MQ>"P6.>>[@">4G+KGO]:U42.8]A_:5\(:!XD\1V.EZ>D-AJEC'\ MZD@&5NV6[D5\M:UX=UIO&0_MNV:.WC.QYHSC(3868 MCDTF,D&"110/.)(L?*V,E370QVWA_X:://>S,/,4%G8MDG\*^8_AU\5-7\'Z%]HU.6 M6YT^4_+YC9D![X/>NQU/Q-:>.O#+W6CN\Y9&WPSG]Y^5(9Q_C#XH:UKD-[J6 M@6G]FZ7;SY>Z'+R\],^E:FH?$;4M<\+6\<G,T.'DSC.1WKRZWDUM$;PXB MM%%YOFR1XX;GH:Z"3PQ)<7&R[P54 "W9MHQCM5@2!WKTOP!XF\0?#2\_M#1]1NH;LC^U:]K_93^%FA>/;O4)=5 MA%V+-!Y470#![UG_ +5_B#1O^$HL])MK2UTR'2X\/-;XY/H<=:D#Z:\*QVE] MX&M/%.I7)GN[NU#O-IMXR/AJ^N[N]TW89%268D(5Z@BH M:'<^TO#_ (NM?$$*R1H\(8L%\P8S@XR*V5=N!C/XUYS9^//#;>,O[%DUBU6Z MM3L2+(4?2NXUC5H=$T^2]N& A3!W#IS61H7O,)Z#ZTY6++S6;I>N6NL+NMW_ M (0WYUI#OF@!U%)2T %(PR*6B@"/:32>6V[.[ J6DH ;M]3FG;?>BEH ;MI: M6B@!,48I:* $Q[T8]Z6B@!I%)MI]% Q-M&VEI&^[Z4"$Q[U%)(8QDX"Y^9B< M!:K6^L65U<-;17"-,G50W(KR[]HS7-:TO1],M]$.9KF;9(NK6_W' M1MR[*YOQ%XYDN&"6[FX/0A3P*M1)N=IK/C2WL8Y"'^;M(W)/TKSC5_&%WK#, MD(8G^_TS^-95Q'/=XFOY]L?41CM65JWC"VTF$QQ%54#@]ZVBB)-H[_P;XM;P M?>12,L-R#@R)+@GDUZAX\\6WWB'PW9W*6<:Z7YH",AX%?-OPY\,:Y\8-2O+F MQEBBAL]JE2<%^:^E?%'@^Z\*_"VPLKP_OS,"40\#-9RW*6QN?L\Y%QK)+ [F M! %>U]17BG[.YC_XFL>/GC8 U[6.E9LI#6?:1WST%(TP7$?'GC/6K6 W*^4?+ MRWR,1WQWKC_#OQ@UCXD7WG:D-MMM_=HPQ$&'?;ZUS/B#Q!;Z7\-]7NIIIKNZ M6.01O'T&X=_6O-?V<]:U;7=6LK-I3- B,RQXYYZYK96,[L^C7)DEG=AYY<;6 MCEY1Q]*X/Q5\'=,UIFDT;_B4ZCCS%C7_ %.?1?[M>@S02P74\;C;M]NE1'?( M-K-B,K_JU'WN>_I0(\0U/Q=JG@:QFL?$=]+:K$F2)&W!@.FUJX67QM/XFU;2 M;*!FM[74)E5G<&=5NHYKQ)(YI67[L6TYV4/8$?7WC#X1>&_AE\&9!H]N&N+B:)GO91F1L M]>>PKYR_:6_:&\7-XRA\.Z!K-QH^FZ=:P &T;8SMLYW&OLO]HG"?#&<(J[1< M1 8Z8YK\\[?P+?\ QJ^*VJ0VLACBA5?.E[*%XJ$5K<^E_P!EOXV>._'7@IK& MYD74;N*7RQ#2KS2$NKW6%-T=35L&&3OGUKZ3^ /P M7L?A)X4%I'\\DN)#+W/%>#_MQVLKBSC5I[*59%=Q\K%3D'%?<'PV_;AM9XH[7Q=9&*1 ,W]LO[O_ +YKX\AM MSN60HL4G\8]5]JN?#[X2>,/BUJ&K)X0@2?[ PREQ+L!!]16\TC-;GZL>&?$V MG^+-+BU+2[N.]M)5#*R'ID=#6O7@/['GPE\3?";P)>VWBB;=?7=QYBP*VY8@ M.PKWT BN4U'4444 %%%% !1110 4444 %%%% !1110 4444 %)_%2TW^(4@/ MCW]L/_DH.D_]>@_]"KSF-0+<'/R\5Z+^V+_R4#2%1;)&WF9Z;<=*^ M _"_Q4N/"/Q/TJ+3K4WYKZJ^-'BM+SX<3S!FAM9E'[Q3]]_P"[ M4-:FNA\MZ[9V^J7ES')"LD!E=HS_ '02<8KF+C1;W25]7>3MR,,.AIH3V/+KWPGI^KR/CZEH-IJJ#SX\2_\]4X85@ZEI]W8 MQ^5=6\>J::5P7?\ UJ#V;^E60+X-D76='E\-3SQW,MJBW=I+Z$#)C/UKR>^, MMQ>:C*R!9S*4..!&0>E=B?"YANO[1\+7D@N5Y6VFX#6-XH\5Z M;X9L3)?7L5J\G[N+>W5SP!CZT :?VR);K[-N7?MW8)YQ7*^*/B'HNCWT&D_V MK#%JMXXBB4-G:3W-)]0D;4YK682[;ANH'05:BV2V?7'[0TT'A'X=ZG/=7LR:UJ+!()HY"H8XZ<5 M\F?#GXH/\)/$IUP1"XD=<;9O7USUJ3XQ_'?6_BWJV88B;8',4)'R0CU%97PG M^%)^('C&VTLW0\Z9N9&/[OU(Y[U5K",[QU\0M?\ BEK4NJ71^S0M)_$Q9PO; M:#VKNOV=_@K9_$CQ7FEPE MVO7CG&/2O+?A#\7A\']6U#45LDO+VZBVH^?7N15:DV1WG[37A/PGX!BTC2]% MM'M]3A&YIF/)'O7"?#WXYZC\*_#&LV&E6@N9[YN9HQE@Q':N*\4>+M9^)FKS MZOK,Y,LCM\AZ*N>!7UK\#?@EX3\/_#VR\5WR1W]R\+2R-/\ ZM>.@]Z8K(^2 M++6="3WK[G_X0OPOX-^'C:[JME;7EU/8[9[R50QR MRX^4'H:^)?&FN:<_BJ_U"U']GV4ET3%;\=CG(]N*T/B!\7D^\866@B_D@M[DDR32'.".RCTKZ,^.'PP\&>&_" ML6G0Z=;0ZU>\0:@_#^9V:JN@/*/VE?%+Q9<:7KEJ)9+&(,)(N"Q'J:ZK M]K*WT#POI^C>&[#3K:"^4>(/&?B":X\4--%>&0XMIB0ZIG/%0!V7PV^)WBGP[9^(=,\%V MSW5Q<1A&=$R5/?!KBET&YOO$"2:YYU_=O*HN+>=B#NSR#7W5\)]-\,?#3X-Z M5K"6D&G7,UHTKR3*"\KX.*^(_%OBB/5/$&H:M=R8N[B8R)".&4YXZ4P/M_QK MX@T;X5?!^V:P:ST2_>R'E6L:C=(2.A]J^%K7QY>^']6:_L;Q[?49F+2M;GAL M]LUE/!FVGGVR*>7//(YH M%U,E?#_B?Q--/X@O;>ZCMXSNFD@R'0YR#FOJ[]E/Q7J?CD:CIGB*Z>]LM-BW M6[2-G(_VL^U=3^T1XDT;X8_#E]'TJ*UL[C4 (A'@%NG\5?&?AKXB:UX;NIX? M#3SSW-_'Y>1E9G91PN.U?FG+X;\:?#_5H-;U*2\TN_E/GP1[BHDSR*^Y_#_C MC1M!^%NC:QKVJ1Z=?7D0>1YL%V<]14V+/7=.OHM0MQ/"^]'./H1U%6\G=BN= M\(:IIFJZ%;3:3=1W5NXW[H7!.3UR*WO.7KGCO[5+ EHIJMNZ=*=2 ***3- " MT4E+0 4444 %%%% !1110 4444 %(W2EI#SP: /E;4M4N['XBZHMM/)$QO"J M\]L=*]%U/PC:+HAU'Q7JK_-'B) W<]#7F>N-M^).J[UX6]/)Z#CK75_&V]T[ MQ%X:Y('W8&,D$UO%&3D M=9XD^(DKJ\<3;B3VKBI9+K6&+7,CJGIFFR^1I\8=V#-WR:P]6\6;5"QE0!6L M27J>L> OBY>^"M9TI+>:."UWB)E3@O\ 7WKZK\3>(KOQ!X?M=4GU,,20JVA_ MC_\ U5\,_!U=&UC6[BZUY9GCA(>!E7*!_>OJJ/Q9:WFFVP%K^X3&)NH!]1BL MIQ-([6/V$?\ :B@^6,AG3N3]:]I^]]>HKYS^%_C"+P?Y\\D;2P7!!P!E MF'M7L6H>/["/P[/J5D_VF15R(01N4^AK%IE$/CSXC:1X1LYDNYE,I0YCSSC' M6OEAM<@US3;]H+^*U^U2/Y<[MC:37?+;7?CO5&O)XT?[Q>-AD!<=#57POX%^ M'EU=-%+IJQW 8F5HY"54_2FHL+GF^AVCV^@M9QWD%W>.3#YR@/'(3_LFH?@G M\!?'/AWXAV]_=6']GVT] _9Q\'Z?JQU2VEEDB+B58R_P"[ M+5Z??:A::?")KF7REQB..1\; O?GM3)L5-4\+V&M0@/$$P^?-48)/O7E7B/P M^WAW5#:B3S$D7(=?K6EX@^/%JVM?9]%BEU6$2+#-- ,11D]22:GU"%?'DB1Z M+=PR3HG)+9Y[BIU"QY5K-FLOBBWCVHTBK\K,,X/K]:Q_!OP)LO"?B+5O$DVI M7%SJ-XVX>8@WIZ8]*]$T7X8^);[QA'/+I1BCB4YGNC^Z/N,5[-X<^&MCI;17 M%Z3J%XG/F2?=7V [CZT7T&D>9:EH.L^(/ MU'J#R)IEK"UPTEP<;MHR,5\X_ MLMZ/J5Q>ZY=VK\7T\@1L=4!]:^[O'&CMKG@O6M.C(07-I)$H7C&17QQ\+8YO MA9##:A TT+NC9/5<\T1&SZ>^%/B#4/)NO#^KOOO[/F*4])8__K5Y!^W9;QWG MA7PQ/&?](%XV%/7;MKM]#\5V>K745W93F'4+= MF7T$:0Z3IEJTMT[-A=_/ %"W'T/DC?(TW[W/S$[:^U_V!/#JVOP[U36V5?M- M]=-&S=\(:^+89#-AQM8QY++GE0>E?.>,=:. MB>'&E0$SR?*-IKJCL<[6IR'AG4%M?B8+O&9"?F;=C:O>MWQ-\3KW_A"K711< MRSVXGN)(F=R027XKAY$GLX;#5,!9;G=&0>^:J>(7VM;:> 3]E0R*?0GFM!FI MX3U V+6S!L?/NE^M>O6L@N[<2J?E;D5Y'X7TCSO#M[>;\ #.6]:] \$WZWF@ MJ%8DQ'8WUJ6!T'.WY::R^8K!P#'U(/0T?PU:TNQ-]JMA;."!),J^QR:@+&-= M>#VU96NK.TN;>=1\LT:G KEM4LQ<;8/$%BIV<1WD(P0?[S5^CVA^%]/TO1X; M-+2'RO) ERH^;BOC?XC6=E#XRU6"W@1K7>0.^.:<7J/H?)GB73(M/^(6@P6M MW]O N83O5<[?G'6OV1T?G3+-B M>U??6D'=I=HQ&#Y2\#Z5E/>,^]?(VK?$36O$GB*'6M;U&74C;NLQM\D1K@YP!4G_!0US#\=K)P M_E2O8JD4A4@ Y]:\"L_&5\R1V]U,\JPL59H_[M=$4C-MGTY\<_VE[CXE65EI M.FP.+)(T)LXSU<#N:\T\*^#;WQSXFT_3[R57-S*J&(';LSVK+\/W6FW5JITT MH),Y93USZUUW@O6+;PWXKTO5KJ*3[-:SJ[$MU]:ULEL0F>_^,_V>/"_PO^'- M_=ZI>/)JNW;:;>%#>GO7CGPF\=6O@7QM9ZO-WO6K^S7\ 8/B5 7L:XO] MH_2/#7AWQJ-)\-VOV9K6$))_J/AO\ :2O_ '\-[OPQIT"BZSN%U"> M/F[&D!D_&RXT,_$#5)-&MUTW2[4A!!#_ *LD=D)#%#" M=IGB4J-O^U7FHT^_UJ[:?4)POVAMTB;N,L:^RO"/[.OA;P/\/9M7UE1=126? MG#/W58KP:8'R-X;\'_VSKUA;WLPEFGF5<9^4Y-?87CKX-^"OA7\,;N;4-/\ M[1N)(ML<^<8?':OE/3]9MO#7B"+4%AVPVESYBK,?DP&R *ZKXU?'[Q!\8+BU MMK6V>RTE8PJ^:I$98=6H YOP3\0!\.?%FGZXD4E2_%+XC>+O MBEXF-YKGF:3#"-]NFTKM'M7LO['7PA\/>(;?5M:URV&I7]LP\MKH9B3'\0KF M?VF?%UMK_C^:ULEMTM=-B$?GPJ C?_JH ]>_91^'_A72/AW_ ,)7<6:RW\9= MVU*^YSWXS7SE\9/&@\5^-M4U:Y=!&7**D( R < BLG3OBQK_ /PCMQX:TFXE MN[!/O1YPG/48KE8M'E^T-+J!D>3/^J<$(N?04 =*?B-XL\4:"OARQDN+RRMQ MB)5!)05C:?X?MX]4CBOMUU-<.@=R#E&)Z5]R?"7P/X8^'OPGL?$,5M"E\ULT M\DUR!F1L$[1FOB[Q5XJANM>O-:?;8QSW!G2",8;=F@#[DUJ+1OA-\)!?V-K: MQ76.=Y.<5N>+O%GCSXC:1IMW M?QWD.B0CRX[Q\[5'I7H'['_@W2;[XER)J5DMY)!;NZ-+RF<_>H \T\=:;XU\ M32Q^(?%:W"V5P?+MG<'!:O??V+="T>-M>NKZVMW2&(,)I0"8\'GK47[7GCZS MGN=,\-6-Q"MO;L7D:/&Q2/[OO7S78^-M6M8KJ'P[/+9VUU^XGD8X^4=Z-P/6 M_P!IWXF6/B[QSLAOO.TBP'EIMZEO05X_?:QKOBVQBL7N9(]*@.8]S'?].:BL MM&C1_M-TQO)5..:]\51J&K M)"\\MU.S;?)3E4]^*KE%<^F P.#G(/3%/KQ;PWX]NM,D\N*PK MTW0_%5EKT:^1*J2_\\W."?I2:L!N44WZ\&@'CCFD,=1110 4444 %%%% !2& MEI* /E'6I!_PL;5PXWQ/>E?TKU3Q)JN@?"_PA;2S6<4ZT=O MQ(UI>/>"=3 MH=X[/$T0^6/_ &37C^I>)H=/CV1*&XQNKV;XL:DEGX6UZVGABT^)V'DV>?\ M5N.H%?+.)[[:^UB>CJ*Z(['/+NWUJW#:E650 MWS,..,GZ#WKW7X,?LD^+OBQ<)=?8YM(T0XW75X-KN.Y4&E*5BHIGIW_!/;PK MI7B;_A-;'5;&&\@,$9%O(N2F3C(->S>+OV:]:\$SR:GX"N1,YZ?2N=R9O8^.M"^(4- MU=#2]0MV\/ZJIVM#<)M7/HI-:UYJEK#)%:JTDCS9++;G.<>M?07COX7>'_B# M9M%JEE&9L?+=(,2*?8UG>&_A)HG@?29S;0_:[E(6"33(C-:3L;62YRR[NJ[J]E\)S/)9>)49OO12 M_*>F?3::[NX_L#X=PZVL5O;V,T<'GI';_ZQN,DCWJ7N,X[1?A;K&J3QKK=Q%H5F MY$B6&FC;YV!_&:])^'D.A^'[VVL=,CM[2ZCD/VI ^2%]>M>67'C#Q1\2-+L+ M_P )VDD%K%,L5S- MJ/HG@;7K^+B2VLY)%^H%?GYI/QLL9[=9M3A9YG8[\=>:_1;6M,AUK2+O3[Q< MV]W&T+J/0C%?E1\0O"[^"/'.L:3D.EM.RHY[ D[1^55$F1]R_LDZM9>*/#>K MZA;A71;GRAN7D#&:\>_;BL=9TOQ; ^EK='2;O3BD\%N"4W DACCO7J_[#^E_ M8/A/<3@8^U77F'\L5Z]?6D&J>-IH+RWCN+2*Q#A9%# DMCI4O1EK5'Y&^"]0 M:\C(E1HYF'S1R*592#WS7Z'_ +".CM8_!V6\<_\ 'W?2XY]#BJ5]^RWX0^(O MCC5;N[$EEY;!C'9,$')]*]^\$^"]+\!^';?1=(A\JP@)*(W4L>IJI.Y"5CH5 MI:9&?EYZ^].%9EBT444 %%%% !1110 4444 %%%% !1110 4444 %(>U+2'M M2 ^._P!L/CXB:4>G^B+_ .A5D^#/ ^A>-?"FO?VO:B:YMXO-MR& YK5_;%_Y M*'I7./\ 1!S_ ,"K@8;J:UAS!*81(NP[3UKICL9/<\R^)F+--)MX8UA5 QV# MMBO/[BZ-Y(UQ)D;AC=7>?&BX&GKIW;_6AQ7(GS!)()2"['.%Z >E1T&AC?=-03: MV=)OK%HT:2:.57"#ZU.%"MSR*H-'YFIR, PE4 *W]STJ2C[?M_$T^H>#XFMX M6%_):A@I^E?'FJF1=7NWF.9#.WF9]>:] 7]H+55\-16-K9*EPL7DFX[KCC/X MU\[_ !"\375CK=JT,Q9KA_-FSW.>:$)GK/AQ3&(P>3YZX_.ON#21C2[0?],E M_E7PUX1N/M5C:S#_ ):2H?U%?YNV:1QAG.-N3BO=_V-;C7H M/&YMG>==*\ILQ,Q*YQ6CCH),^W:*;Z''-.K,H**** "BBB@ HHHH **** "B MBB@ HHHH \U^+OP'\+?&;3&MM=LDDN5&(;Q%_>1?CWKX!^-W[$/C'X8R7%]H M(DU_1E)FJ?EOH5+*1_2ME)&?+V-O3VMFB2:Q8%9 M/OJIR$]_>O6/A+\?(/A!X?UZP>VS=7WS0W:OR&[<5\BZ;KMUI%8?$NOLTME9>+(M*M/%-^VDKG3X+D_NY&[ \%_AEX$TOPQI>E6BW+OE) !YNT<$DTT,\L_9C^#NG?%# MQSJ$/B=I+BWM[9;E;3=\@8, !FNV_:ROM%L+K2O#>DZ=;P-;IOFCMP/E&,#D M5Y'X%^*NH?!Z]N+C3Y%-S<1^4RR=E/I7*:]JVM^*M6N[J=I(6FR/WG^LQU(% M'4#I=!^-&J_#W3[O2=+NL0ZA"4:%>>H]>U<+)9WVK-'-?O)9PAO]43GS?J:^ MC_V3_@5X:\:6]WJ5ZAN'LW7;'-SEL\@UB_M+:AI4OQ"_L_3K."QM[5-A6/&S M/K0!ZK^RS\'O"O\ PA:^)[NT6XNU9F99/]6H'KZU\_?&3Q-9Z]\1=3U"T@2V ML8Y#&@7B+BG6?QVU[2_ ,GA#2Q)=P*Q(^QJ3)^..U<5X6\*MXP\8:?'JDDD] MM>72HUI&:59-\L\:%53\>XH^!'@BR\3 M?$[2$U4-J:/(1);D9 KZT^,TOAWX,_"N73=&LK6VENH5BCA(&[D?>KXILO&D MO@G6H;^UN=FIQDX>TY SV-+4>A]=_M4>*-*\&^!X/".C+:HEPWSPH ?+QTSZ M5\@:7X^U#PAJ+3>'KN2/4?+\DHIRI4]>:9KFL:QXXO#=ZG.T*,2SES\\E,MK M>"RA_P!'A"*IR96ZU2BR&]2O-I]SK5XUSJDSW+3-O=2?]6>X%6Y7@M82),)% M&-JHO!(]:H:EX@2!7^SOYDA^\W85SMS?3WC[YF^?HN*O1#Z&Q?>(6.8X!MD( MXR,<5CQQW5]>10J)+FYD/[N)4W$GT KU7X0_LS^+OBM)&UO;R:7I2G<^H7:X M+^RU]O\ PA_9M\)_"6$/!9KJ.JD O>72AL-WVYZ5$IKH"1\M?"#]B?Q%XT$& MI>*I&TK3Y"&^S])"/<=J^VO ?PTT#X:Z:EAH=BEL-H#2 8+8[DUU"_,P)!4# MUJIKTTEOHM](APZQ$J1UK!RN:1V*&N>,-.T$'SIQ),WW$4]Z\<\??%K8CQ7% MT(E;GR(VR2/3-9,>M)<-.)PT@2'EHV.<"FEH! MJ^$]+U/XY>))K.UO6T32H4(;R!G/XU[Y\-?@SH_P]T^6)@-3F9N;B9=S5#\! M]'TK3?!=NUC;+!?,/]('\6ZO2&PN.#@CE12N!YOK'PG6^U*>^L[Q;=).5AV_ M*3Z5Y\U\^DZC]D?]<7XU^ M%>FZ'J,FHV=[<2W4SDO;LV0,TM6Q'5>'?B;-;QJM_P#OX%PIF3D_C7HVG:I: MZI;^=:2"6//5:^:K[7-.\&QEKNZ5CM/^BQG))]Z?\%?B!?\ B3XFV=I#NM-. M:&1GMNQ('!JI*P[GT]2T@Z4M04%%%% !1110 W?R1BFM,JD;B%!X&3C)KAOB MA\4-+^&-G!-?OMGNFV0[ON9]Z\BU+XD2^([M9FUV$LO(2V?Y5_\ KT(5S*UQ MRWQ"U20./+^W$%6ZFOIO0;>*UTBV$<:Q1F,$J!_%7RG:RKJ&O+=EO/<7&YF[ MGWKZE\-ZE;:EH]O+:2"?:H4\]#WS5N]A'Y&_'I)Y?C#XGAEGDFM/M\TJQL_" M'/:E^&?P5\5?%*^AMM"T^8QR'YKB12L9'UK[5T;]B.S\1?$K6?%?B^X^T137 MTD\-K"?E*D\ U]/>'?#.E^%=/BL=*L(;&VC&%6)1T^M4I-$\J/GWX'_L1^&/ MAW]GU+7%76M87#&.8;HHV] .]?2L-K%;Q+%$BI$O"HHP%'H*?'WI]0VRR,QG M(PW3I3_I2TE2,9MY.!@U#J'S6-R"<#RFR?3@T76H06<;/+*JA1DYKS3QM\6+ M2UM9X+9]P=2N1],4TA7/$O!HW1^(;91NEN(Y5B/7G<:RO!/Q>NO %I'X7\2Z M6R6<3?\ +1,Y!/4>M:GP^W*^JJA^=H7*^IY)KE1XF&K6_P#9VL6D=_;2.W,Q MPT6.ZOU)]JTU1F=-X9U^QOM6OYK%8UL%G+1)T&/Z&NEUWPSX;TOQM:>)-=UA M_P#3(T2*SD/WCCH/6O//"^BV7AR^G>RU..[TFX3?MF #1GT/O7KT/@G0/B!H M^E7FJY>33VS%*3R#VI:C.3CUCQ3X]&J^'-*TYO#MI&2UO(J[0_/'/O70:/\ M!_2]%-CJVNW?V[Q#;0F/S'/3WKL+[Q1Y2B#3T69(TVF3;C&.!S7/ZEI\OV.X MN[F1YY9E'EH#TYI#.CTAO^)9;H0PPOWF'4^E:$$S0ON0E6'7%5-/D,MC!YC* MVQ0OR_WZL=/KWJ2C9T_Q5+8\W!\Z/EF)/W5'>OS5^+NM)XD^(WB.]+/Y4UT< M''<' Q7W]XJD>'PSJ\BKR+5PFWJ#CBOS3\274T,=VLOF7%QYYDW(N=O/>K6Q M+U/TZ_9IT%/"_P %= B> >I M%>*? ?\ :>TS6/#ND>"KS0=5AF%L(1>K$?+8^N:[J.'4O"=U+!)$_D5;'H.U=/X7\8+KEU+8W$?E7 M4/0J>&'K7E4?Q :YC>.U/GN,C&P@YKJ_AIX;U5M6_M:[0VT6W C;JV:3 ]44 M?,>:?3(FW+G&.U*[!%))V@=2:0PW>V:-W.,5AWWB:U@945)+DYY,/(%:-EJE MM?$"*8%L>?''3S<>&X+E1N:*0*?Q[UY+I:Z7_ (3#18XEE%YT8[AFNO\ V>M3T+XF_$A=$O=. M2ZM%!F_><@XJGH(B^&&]*?\ A9UQGKG/2OO32LKIMH#U\I?Y5\B>)--L M-)\<:C9Z=!Y%E#=JL,2]!R*^N]+YTVV/7,:_R%55EC;/EDC/?I7TM^SS)!#XNGS+%;KY>$CZ%C7SEX;O%\.0L; M6$.K#=ANQK7T_P 3SZ?XDT_4;9VBV2*[[3QC/-:RV,T]3]#2V 2>,4J_=&*S MM"U)-:T6RO4.8[B%7_,5HKPH'6L346BBB@ HHHH **** "BBB@ HHHH **** M $'THI:0T &1VJAJNEV6M6TEGJ%O#=P2C:T,R!@1^-7MM 4CW- 'QK\I^!YH])U5E+_87_P!6Y]!7PQX^^'/B'X7:T^F>(]-GL;M6^5Y$/EM[ MJ>F*_:T0MN.6XZ@]ZYWQU\-?#OQ(T633/$&FP:A;R#!,B#<..H/6M%*Q+BF? MC/8>+-1T^$0&?,*G/7/U&:[GPKJFF7D(:"2/[21\V_KFO>?CA_P3[U'P_'/J MG@.;[9;1@N--)^91U.,]:^0+^SOO#^J26]W;/IU[$V)(Y4*'(],]:V33,N5H M^C/!'CNY^'/B*#6[95>=%P7?^E4/'GQ,U#XD^)IKN*-I99CEI9#Q']*\:T_Q M8[31I?R//;GTX(KT;2[VPU"U4V4P*(<_+PWXU5A7/4_V:/@KI/Q2\8WBZU>3 M3O:Q>=)%C@X/ %=A^U-I^@Z'>Z/H&C:=':7T*^9+)GY\= *\_P#A?\8[KX07 M5]>1)&ZW<1@9S]X#U%<)XL\7:SX[U*YNFF=U9R1>3']X%ZX%9EGH'@7XW:M\ M-=!UC2=,C:5[@9D"KF2,^HQ7F=PVH>(KYI[Z9XDNY,LA)+GGJ<]*^S?V>_@W MX/\ !_PYA\8WB#4+Z>-I)9[_ 5!QTYKY=\9ZS9ZIXRU;4+...SA\YMI480C M/:@#[ T;P)X3^!?P@EU73=-M7G>P\^62Z ,CDKSMS]:^*W\1?V?JC:U;,;:2 M.4S1[>",G/2MCQE\;M?\>:+8:3)(\\MHGEJRG"%1T%<>FBJTD8SF/ M_5J?0BJ462V;WC+XF>(/B=-;W%S<2M$J[&N)1RH]A6-8Z/;6!+* Q_Y[-R6J M:^NH[6'_ $AE5S]U5XS^%<_>ZU)=JP4[5'5E_AJK$ZFM?:M;VJOC<[DC&.3_ M /JK!U#5KFX9E9<#'S;3\N/\:71=%U+Q#>+;Z9;S7L[\ PC)/U/:OI+X4?LB MLUO;ZGXQF:/^*/3X3S_P*DY)%)'@7@WX=Z]X_O$M-#L9KE"?FN70B-?J:^U/ M@=^R%X3\,QVU_KUPNOZN#N,Q\-V"66EVD%C:!<-%&@&_ZF MKL+-"Z[< +RH]/I6#ET-3TJULH+&WB@MXEMX(QA8T 'X5.%^49YKD=+\6&$ MB*YY']]JZ>TOH;Z/?"X8=.*@9,P&TUF^(LC0;_ Q^Z./RK2+;:H:UJUGI.GR MW%ZX6#'*M_%2L,^8A)O9\GY@2",8QS5B&=K=_P!W+N.,X[5/XTUFUOKZ?4-, MLFBMEZQ\9;W^E86D^(+35HUCC98Y^ZG@UJB#NM#\57&FR)-%B!P>5]:]+T;X MC0W:YNHO* '+>M>&;0) 6+%^WI4.L:Y>:9I=R\38F491CT%/E3%='JWC'XP6 MVDVUPT4@1>@W'D?2O"?$GQDO-0\U;+=$6ZS$YS7GNI:M61N?E.% M%5'V\J7$4:C[^>#5QB)M%BZFDU*1I)I//F)R1G]:]._9D"S?%6)U#N8[>0,V M/E!QTKRWP5_Q77C;3O#6F1^8\TG[^2/G"#J"?AQHO@&P6+3K=1+_'.1 M\['OS6=0I'6 [@".E.IJX51QBEK(L6BBB@ HHHH YWQ?X+T;QQI\FGZW8I?P M,.%8H MH3%8^(_!/B#1I-4:UD:YTO68>);2Z7: >X4GK7HMGK%YHMT+JPN#:SD\*6.& M'KCI7K?Q(^"?AOXF6FS4;;[/=KRE[; )*#]1UKQZP^!7CS2=2DT<:G#>Z2?] M7?2@[HT[+]:TO<5CUKP+\4H?$.J_V)=[4U54WG9R& [UZ+D?6N!^'OPCTWP3 M*EZW^E:L5VO='^('TKOZAC#IVXI"?RH+!5)8X K'U3Q+!9?+'^]?T!I :LD@ MAC+.0%7DDFN,\5?$JRT2-DCE5I,?>K \5:IJNHZ7=_8G)G8?+$#S7S;XB\1: MO'H6\D$Z_P 4@.#^-4D#._\ &_Q:GO':..9BC=0M>6W^O7&I3[1*R)Z5 M59G^5GD)/?TIK,-PQP2?2M4B&>B^ &*QZF/[UHPSW[UYPORGCD(2#GZUZ+\/ M5_=ZCECN^S-UKSMF^9\^O]:NQ!)%GSE4\)_#C^M>K_#>_2_N/[(N'8'89^#Q M\O:O)X6^^>-;G6/$EG MIL4RZ?9LWS%N,Y[9K.S+.UT&UE@TM99(V2.9RZL>W-:>,KP-_P#TT%=QHNEP MPZ#;61-4R(ZOGEHW&0?PK)\/>'=-\+6*6.E6B6EDJX"QU?^6.0M&,D^M CJ]' MU72[G[]E;V\N<<1*,_I72 *VUE(('<=*\PW[FRP.[L5[5>AUB>QL9;=9&<-_ M%GD5)1V&H:_;:?E ?-E[(M8%SLC=:TU5 M3RA+G^\U%@&PQBW7;%P*C>W!821L891TD6I>6)S2G<%&,!>_J: +FG^(KBWQ M'?@,O07"_P!:Z.WN([F(/'()1_>%:P=-\31RLL5TC0R8^^?NFMP2!EW*0P[8H&/HI P/UHI +1110 44 M44 %%)N%&X4 +3<_-[TNX5'+(L>78@*O4GM0!\@_MB _\+ TH@K_ ,>@X/\ MO5Y[IMI-?A8K968]R1P*^A?B]\/=-\?_ ! L;V\D;[%%;!6D'3(.<52U;X70 MQV9?0W5HD7F-/O&MD]#)K4\%\66UGIWAW58)F-S=R6S[8DZ*<=:\.^&=UL\% M^+[,@2>:@_X!@5ZS\5O">OJLMO:;K)Y#M>20'[IZUP.J>";CP]X;-EHD;3W= MPO[^3/#&KZ$6-G]FN\M+?0]8L[J$LTLP*R=NE>M7WA@KMDMI ZM7FGP[\*W. MBZ/;687_ $B7YI2!T/UKWL>%]1T70[:YN+:1;:0 K+C(J64CB=/\0W&AZ7?Z M9)&VR[^7<*\7^,B[FTR+^Z,?&;P'J1^S7=@DEW$G M+",9(%4FAV/%RPD\U\%C@@+7T;^P_P"';V;XC7>K1X%G8V;^;]2#7SR]O/'* M$E@EC&_'*$'Z5[%\"/&WB3X?PZA'9Z;M?;)+_7+ MJXE.7:]S^&^OM'23NTVU(Z>4O\J^(=!RTD3D[G:=(/A;I4C MN&>WS E)RO%?/O[+MXFBPZCX>D8@JWG+&W4'^(5]!KRH/:N8Z1:*** M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 5IE4R$$;FZC=T%>9 M?%[]G?P;\8[ KK>F*E_M(34+90LJGMSWKU1E#+@C(I-GN0*$VA'Y6_'+]C'Q MA\)VFO;*-O$NC8)2:!3OB'N/7WKP/3]2O=,NLP3F*Z3_ %D+##\=F-?N9)#' M)$\4BAT<896&01[U\Y_'3]BSP;\4H9+G2XD\/:\02D]NN(W/^TO]:VC/N92B M?G7H/BBUO;D_VF"9CS@=*] ADBO+53;%#$IW?*:Y/XN? 'QC\&=1\K7-,D^S M*"4O+4>9'(/4L/N_2N'TW6KNQ4^1.Q$@P8=V/UK969&J/I35?CQJEQX-C\-# M=/;P@A;>'@-]:\\ATVZU"-#J-QM@)W"TCZ)]367X7\3::RQ6LK_8+SKN8[L_ MC6MJ7B"&UW+&I)[LO*M[XJK(+LO1^1:Q%5"JJ_=QUK)O/$1BSY)* ?>D') K M'NK^6Z4LT@*YR%/R&O1/A3^S]XQ^*UY"NGV+VFFLHOO M7U?\(?V6?!_PMCCG-JNM:RO6\NESM/\ L ]*]H5%X/IP*YY3[&JB>'^#_A'H MWPILQ::;I4<&.&N'7'7@#\*]-N+>*YCV2H'3T(KF=8\* MG:9+1O?RS6=[C.:?)/.VF\9YZ]J=<126\F)8_+'J13.%7NP/<4" L3P5#58T M^ZN+60_9Y/*8<_,?EJOC=TX^M(R>%?%SPK)X%\6R/ '%O='?&T?1/ M:OK$J?E4G!'8=JS/$WANR\1:>UM=VJW"L.X^8?0TQ:GRIH/CJ6':E^OFQ=%< M=JZ/4[R.]\/7AAG1TV$C/6K'CCX'76D;KK2'+P9R;V".-\FTY'K7G&O>,KS6LQ%_+@08CAB'+&NO^&'P/ M\3?%G4C(D4MKIJ\O=W'3WQ7UU\/_ -G7PCX#L2&L(]4O9,;IKA=P!]5]*IL+ M'+_L7_#U?!'AV?Q-JEF!?7WRHS#YHUZY_&OJZUFBN[=9("&C;YNM>>W>IZ=H M.V.3RD2--OD)PI';(KG_ /A9$%OG5P M_@WXFV?B0_99R+:]4XVGH_TKLU8K(03NS^E9FA-124M !1110 E%+2&@ YII M^]W],=J7GMR*KWE]#8QEI'"]]OX+C^&N M!DM!Y:#@ENM8,F7^>5_,DSWH U-2\23ZIE(R84[>]9&%=BKY+?WJ>[%L<8(I M'828'W1ZU1(HRK1#&R53]\=Q6;K_ (?T[Q(DL.H6B3!AC#_ ]C M CU-LY'V9AGUZUYS)C<[>Y_G7KM]X&U_X3/.MU:MJ6C3*8OM< R8QZD>E??TK12#E.(9F;/\..17=^$[6*&Q358+A4OXSY8!/8] M:Y;4M%N]/NMDD> ..1PU;WAWPK=-#NG;R(F.0GJ*+@D:4VJ3ZDT,<4;3W/F$ M&Y/0#VJW9Z#$TCW-VQN0.!&IP0:OV\=MI=B #]GAC/\ ']Y_I5O0-+U7Q==( MFD6#B#.'N9/E4>_O2YBK%_1_'E_X&6,Q3-/$Y %HQW-BO?=#U1M:TFWO#"T) ME3+1-P17&^#?@[I_AR87E\_]J:@3DO(/E7Z"O0A'A0%&S'2LY;C*5]I%KJ4. MUTQD8#+UKE]5\.W&GC,'[V+'S?2NY50O08[TC*&4J0"#V-2,\N^1G!P8UQT/ M>D;)QQBNZU3PW;7T>57RW'0+TKDM0TFZTUOWB%T[%:L@I'/%(RE8WQS4FTM@ MJPS_ "IA^6*1OO1]_6@"JF-J@?>S5J&]E@;KD>E5%):,,!M'IWI_"X*\F@#= MM]0CN<+]UJL=.,Y%-OO4;OFZ4F1NW8PWK0!T.EZ]; M:EE4_=2CJC]:U%_,5P\\:7#9?=%+_#(G!/UJW9ZY=Z8$2X7S4Z<=:@LZ^BJ= MCJ,.H(9+>42*.H[BK:G(H 6BDI%^N: %YI#P"3P*I:AJUOIL9:5\GLO>N2U+ MQ-/J&1%F&+T[F@#HM2\16MBI5^EB?H:M!CU!P:%RS;67/_32J M),G4H]+\31M::Q:"-^GF!>M>?^(?A#'II-Q86WVJV/.%/:O59+=+CY7VR=@J MCFKNG^%]4M4::%\VY&?)?T]J+A8\)T'0XKK4K:SA@\IY)@GE,.=OUOKV*3=_9FI1*1'+C"YS6-XN\0>)H?"M[HM MTAF2X3RQ?1_PT;A:QP>MB*;4KF:*12F\B-5Z8JO:R>7>P%V6%=P 7&[=]:Q] M-T&*P$2M=R321#N>":AU#Q9%IMY!!!%ON!)EG/\ #[50M3T/XA>&=$FLM.N' MTFV:[217#*@4TSXM74&H>"--$2A4BE4 1QA0!CFLOXM:Y>:?8Z)-"H"RQAG\ MP<_A1K6K.GPVTB6^7Y99L$8X-:=">IPOAQCM@.1M%PN3^-?;NDRI-I=JR'(\ MM?Y5\:R6T$>U[4 6SN&VKUKWOP;XPCDL;;[)<$R*H5HI#UK&1JCUVBL33/$T M-\!'(?)G[ANE; ;Y,M;U.2+8]I% M-/YA_O9(S7TYJ"^98W*GH8V_D:^7_#MY_P (_P##[QOK.0NT/; =R2QJXDL\ M#U;4)-6U&\NB CRS.Q/K\QJ7PM<):>)-)N)%^2*ZC9L].#6?&HD16)Z\X/O3 MHVV,"3C!R#FM5L9'U+XJM7\ ?$C2_$]K@:5J&TOLZ*#]ZOH2UF2ZMXYHVW1R M*&4CT(R*^,]#^-%]\1_"MYX8UV"TL#8*K0W>\#**/ZU]&?!74;^\\'6Z78,9[53:'RU&QAO;1Q MAHIE##\J^./CW_P3]L=::?6_ ;"QU 9=M/D;$;?0U]LU&?O=#GUJDVB>5,_$ MSQ+X'\0_#W6%L=:TF:QN Y!>9#@X[J?2NZ\#_#W7OB-J$%GX!M+ATW0K"#3;6,8V M1H 6^I[U?.PY4?.WP9_8CTCPRT&J>+F76M17#I:_\LU^I[_2OIRWT^*QM8K> MT@CMK>,;5AA 55^F*N>N/QIR_I47N40>6S8#-N []*GYI:*0#=I]:-O?J?6G M44 4[S3;>_CVS1@GUQ7*:IX5EM-TMN=T7]T=J[>D..AIW%8\L;*\-][T/6H- M2D=-/N' (:%=PKT;4/#]K?*S; DO9A7(:MHEQ8Y5T\R!^&QZ47"QX_HM@-2U M*.WQD32_,WUZU[I8V8L;"*VCPBQ_*/>O-])T/^P/%R7"Y:QF? 3'0U@_$#XG M>.OA3XSN;K6=(;7? [X:.XLUR]M]<5:V$>V+_K#G@KUS4C2;>H.T]ZY_P?XV MTSQQI<%_ILS21S)O,,PVO],5NC;NPJE6/2-J8AAS]W8K*>KD9KD_$WPVT'Q- MM^V6BF0-N4JOWOK78=>IP?2D9Q"K3/A8X^2321)AV>F6^AZ;%;P0Q6%K%P8E MX4^YKB?$WCUF/D:?'L*G:9 >*9XX\7'6+Q[6V?$"_>QWKC+JYBL;423LL42\ MY)JG<1+<%[AY)IY6FG;DEC@"L36/&.G:+ RRR(?]T\UY/\3OCK#I[/9Z;)NE M!YVU\]^(O'%W?/+->WCQ[CGY3TJXQN*Y]>6?QIMH=4M;BT\N2XA;Y%4\_C7U M1\*?BIIGQ&TUI8"8M0C&)X7&#D=Q[5^4OP@NM2\0?$;1XK0,V^=2ZMT:/^\: M^[OV<+-X/BUJPBSY$<#JW]W=FLYQY36+;W/JCS%]:7>,D Y-5-0O(-/L9;NY MD6&WB!=V/ KPRY_:BMX/%$MHNGF328Q@W"]6]Q611[]N!;&>:6N;\(>.-'\< M62W&E7:R;0"\?\2^QKHRWO@#KF@!)K?3T(0[WZ8%PZ4PQLRXSM(_&I:*0R"2U29&5U$BL,,C\J?PK MRKQM\!;35)I+_P /S_V-??>,2#]U*?0CM7K9]: :8'R3JTU_X7U".R\4Z>8B M#A;G;F//L:M0W#ZQEQ2ZAM6MC#9PK#;PI#$/X8Q@5*&SD9Y[XI](!A4[AQGL33\4M% !2'FEHH :JE> MIR*CFMUGC*.,K4U)3 Y?5/!ZR[GM6\H]<>M5^&?$VC^,M.2_P!' MOXKM&'*QMG;BM7<%P6&PGG#5YK\1OV>KOX7>"[6X^%D,ZWMI+OD@5LF1.IXK MD_AO^TU%JEX=%\6VT^D:]:G$AFB(A^A)%7H(]V7]X,K\PI5YSFH[.YAU2(7% MM*+B(C<)(""M/\POSA1_NU-F Z-VA^Z2*T[752<*U9>31M)Y!I@=&&##<.7C%.P%S.\@;N>P]*9<:E!I?-PZ[N@R>M<]J MWC".&/R[6/=+_>KEIKB:^F#RNTLVX,L=*R'^*\3T;1+MIH[E9%LY%D\P!AD 5US>,M0TN-A-&M_Z3(, 5+0SNI[ MJ.VCW2R*@]ZYK5O%2MF&VX/]ZN8;5GUO][)-NY_U>>E)@#Y2N#ZTK#'W$CW$ MNZ5R[TQF,A&[&1WI#Q2\;AFG8FX#G@T<\CK0P"$,3QZ"K-E8RWTV($8#NQ%& MP]RH5^7/Z5I:;H=UJ,84;ECSR2*Z#2_"L=K\]Q^\;^[6^D8C4+&-JCM2N%C- MTW0;734&R,/+W8UIC*]>?;%.%+2&4=1T>VU*$I/$KGJ#WKE=8\/W6FQR,@^V MV/\ %;D<@>U=Q3&ZX'6GL!X3K/P]L=2?.GG[-(_S*C\,&KRJUT6/P+XHN[OQ M'I\MW$02A5@);P\0(@X51V-7+[Q-K'B[1[+2?(VVUN0RL!W'%>P^(/A3 M:R;KG2HE,6NY#5.^W-<(2H4U8498?,0<=NM2[#.RT7XA30R1V]\AD"GF=.H^M>I M>'?&6^%)8YA>VC<#:#?!M]9SF[EN6A4CFV0\ M >M18+GNBZU;ZA8W.Q@D@1AL8\]#7Q)XKUZ]@TF_T_YDL[F[:21>V03Q7U#$ M3YBI"^PXP';O7E_QL\'OK'A5)=+M41XKDSS!!RW&-O\ 6KBD)GSAN+,S]F/ M%*R_O IQCOWIS1M')]GD#6[QC!+#&321]@H:29>0 .M:Z6,CD=6)COKCRW.& M^\JGJH[5UF@_&7Q/X=CT>#3;Z2R.FHP11RDBDYP:YG7+B.>Z.R0,V?WT07#1 MU0EDW0DJQGC[(6 _&OO:L)*S-(A1114%!1110 4444 %%%% !1110!\0_\%&/ MVI+WX6Z3:>!O"UW]F\0ZI&9;N93@PVYXR#ZDU^8^E^%]<\5?VA?V%CP@A:XNKA1ND50 M.1MZ\>U1^*=%OO@U\1MF@:HS7]GY=U;ZG;,4)5AD#'TZU]1^ ]#^&^@ZA\56 M\#:O=Z1\2])BF\J*_.Z-HP/WP0=ACUKXSU/6+SQ%>&_U&[DNKZ9L^8W/X"@3 M/V?_ &*/VB!^T1\*8KV]9?[>TMA:WZK_ !,!PWZ5]#5^5G_!*+7[NW^,GB71 M8Y,:=/I?VEXQT\T.!G\J_5*@1\Z_MI>/_%'@7PCX>7PIJSZ/J.IZI%9&>)07 M"N0,@'TS535O@Y\9='TZXO;3XMW5U-:PF5(;F-1'(P&<.<=*P_\ @H1;37W@ M[P7:V]PVGW$^N11QZA'P]N2R@,OO7%_M#_!7XG?#WPB=;MOB=XJ\4^&;8K_; M.EK.!Y_LV_':?XD_!IO$_BN2UT^[T^XGM;VXC;$#>4V"RD M^M;V@_M/?#/Q+XBAT33_ !7:RZG.=L44B.@<^@9@%/YUY#XJU3X3^%/V3-#? M3[:XU#P;?3PI96=G)B6YNW)(C=O4MG->3?M)_P#"77'PGT2?4/A]IG@;2[6_ MM?LV^1&N@^1M 9>Y';VH ^Z]*\<:/K6L:CI%G?1W.I::P2\@C/,.1D$YIN@^ M.]!\3-J/]DZI;WZZ+YPT&D^*O#"V4TS M-A%O0OR$>I.!^=>3^#=4O/V9=-\11ZC2X@W$[I-1GD93M]]I% 'Z M#^&?$VE>+[&6]TB[2\M5D:$R1G(W+U%:PC78%QQ7G?[//@8_#OX0^&]'DC\N M\6U66[+=6F;EB?>O1N: %P.E+110 4444 %%%% !1110 E->-9 0RAE/7-/I M,8Z4 <13J RRCU(- M?3S_ '#GIBOD/P?X'M_%W[0WC:UO;F2TN53=!) <'\:I"9J^&9KZ3[1=/<_9 M%MCN,ZC8./X146F_M9V&E:Z^F>(;"X^R%MB:G&N47_>(KH?$'P;\8W$;:2DL M%QIL@_UZ\8^H[FN3NO@.NF:E:G[8;6!1Y=S9W2[X;@'@D>AJM"3Z#T76].\0 M6,=[IE[#>VD@4[XFSC-"Q\K1[$JL4-V/O(/;N:]9AM8+=ED,:R M$L713]V,>@%<\WS,UB0_%#Q4->^&/B&..RN;>00_+N[\CI7R&K+"$;#Q^6<* M".17V%=722J()5\R%1G+<@^QKQ3XS:?:Z>8GM[2-6NCN:51@"DH@S'^"/C:3 MP3XZB/SG3[[]W-$O=NQ%>Y^,/C3IVGZL-->3W=^US,?])N7YRG^';C4&4\K'ZT@,V-=S;%!9CZ5O:7X3EN6 M$ER?+BZA:Z&PT&VT]5(0.X_B-:.1FBXR"QLH+2,+$@ '\6.35G:#UI%SWH]Z MDH7O2T4@H 6BBB@ HHHH :8U(((XI0H7@"EHH 3:/2EHHH **** "BBB@ HH MHH 0\C%)MI:0 T@&!55C@8/Z&O ?VO/APGB+X8WEYIEE;)?02K+/<+&%?9TZ MCZBO?V&>.A[&J6K:5#K6EW5A>1K-;W*&.12.H(JDQ'YW?;/'G[/-KIM^E\^J MZ%6ZM^R2OA_QKJ6CC6&6YBMEGLKF+*[6_J:VT M9-CZP^]R/E&.IZ4BDHO0E3T-?%/A/]I;Q!\(]:?P]XF+ZQ:02['E89D(!Z@= M:^LO"/Q"T;QQI\%W8N]J\@#+;7 V,0?8T-6"QTJE]WWL"J]WS;RY/:K,@W,I M*E/7BJUYQ!,!R0,XJ0L8=CI4E]EHQN1>"5ZUUOA_1;6&X:*5=LH'RR2=>:I^ M!T61+A$XD;G]:N7FJ:4VL/8RW@BOB!L60[=WTH V6C:UWJ,!>FX#K5:Z=6A> M-N2!T&!5*\OY;&+9,0 O/?$SX^:'X*W6WG?;]17_ )9P-G:>V:=@N>@Z MU=6VDVK7@FCA6/YF+'"_C6QI]Y!JUG#=P;I(77=O7[I'J*^"O''Q:\1>/+B5 MKZZ^S6><)!"<*1VW5Z]^R_\ $77M8UY_#ES*PTVQME5%/.XD]J+ ?3>W=ALY M0\@TZ&&2X?:B%R> 5K7TWPO<7;_/^YMQQ@]ZZNQTFWTU0L" >N:@9@:7X1)5 M7NG*MU""NHM[6*U3;'&J?2I,=QUI5&T8J1AM!ZTM%%(84444 %-92W2G4E " M;>3 OVB0C.!T_.JLT-TR'[1"EQ"1DQ>E.XCYC\9>'?[! MURVMUF\]9/N]R:U-)\ ZO?8DGA:T@)_UC#J/:O=K7PKH%YJ279@66Y3F-9NH M^@-=)-:QS1>7*BE,=.PIW"QY!I/A_3]%B'V:/?,/O3.,UI\]1\Q/6NIU+P>N M3):/C_IFW>N;N(9K639+$8FH$1.Q:-@1\V,?2E^125V_NL9*'D$TASC],U'J M%XNG6UB3Q!K5S=.IEW$[$7DA?7%5]'5CK.GX!+M,F#GIS6E]"+:GM?Q M5_99\-^.5ENM&5=$U9AD20CY)#[U\A?$#X.^)_AO>&WU33)3;GA;R$;D;Z5] MX:;K%WI6T12;HL_.9N0/I71+?:7XDA"75O%*I/RB=01^%0I,JR/DG]C[P'K] MMXV/B"?3)H=,:/RUF<8XK[8-5K6UBLX5AMX5AA4858P M6D\21PNNE>(D$CW;_ .K$^<%< M^H'.*Q$\!^%OAOH>GZ[#I9FN[*PBU&UUQ[@-%)='L8_K_#VK]1OCE\$?#WQ^ M\"7?A?Q#!O@;+P3C[UO+CAQ7Y1_&O]C?XN?"62333;ZAXH\-QRF2WFLR74C_ M &E[<4%&;X;_ &I-7N_$[S:IX;\/R2:H6M-1N8+01SS1R\/\_P!.]4_B]\&O M#WA31=3O] NKY!831>>L\)$.V090(W0$#CWKS.W^'_BV2X$$'AK4I+X/^[A$ M!W#V-?5_P)_8O^*WQGMX(O'5U?\ A[P@TJ2RVMYGS;@)T5E/3V/84"9Z9_P2 MG^%=Y!%XA\?7EO\ 9TN0+.W;9@3)UW*:_1/O6#X(\'Z5X!\,Z?H&AVRV>EV$ M0ABA0<<=_K6_0(\\^,/P>TGXQ6>CV>JRR1KI]ZE[%Y?=T((!_*NVO;6"^MYK M6ZA$\,T;1O"_*NI&"#]:GF^5BV=N*A5O,9U0C=D$C=T'8T >%6G['7@VS\ Z MOX02[U!-$O-0&JVMLLW_ !XS@YS%Z &LKQ!^QKI'C+0X-.\4^+O$&NQPLILO M.NB8X9%(*L5[D8QFOHIL>.U@7EY97PH';GUIXNUF5)5;S877*,A^_0!9A4 MJ%') &,GFI:BBD!50 0",CCI3?.VXX)!.!CK_P#JH GHK!T;QII/B#5=4TW3 M[Z*ZO=+D6*]BC.3 S#(#>Y%:YF90HP7+="!Q0!/16'J'C31])UO3M'O+^&WU M/4'9+6VD;#S$#)VCO6Y0 4444 %%%% !1110 C#<,&N'\/\ PMT[P_XUO_$T M3$WUX-K_ $KN:3:#Q0 Q5VY"DU3U/1K35H]EQ&&S[5?HQ0!Y_?\ AK4=!F>: MQ8R69ZPCDUY!XDWPZM-+.OV5I#G+#GBOI_%8>N>#]-UU6%Q;QEV'WBO-6I$V M/B7XMZ>=4@$&,JT15RIYY[UXIX?^#VMVM\TT%_;VUO)PS(0"!_M5]#^&O"O] MN?M$>+]%U7S9=,M8,I"C5Z$OP)\,[Y'\FY:/KY0D(S['UK3G)L>1_#?X+V$E MU%M5M8N!]^0+F ^WUKZ!T?X=6&FM&^H1_:KA1^ZMO^6,0KHO"=C8Z#H-M%:1 MQ6T:L?,1< K]14^K$^69&9@K]:K7-YA6X#,HR54\_6LZ:_P#LZN6;YNL('/F>U0!:FN]I9W;8BGG/I7EW MQ:UJVU73TMHV#20/N##^Z:Z7Q1JQ71;PRMY,SP[E3_:SC%>1V&GWVI72P>3) MBM\!==DLX[R22-'4%1 M"3R<=ZJ>&_A#KWB"_P!LT?V"VA.',W&\>U.XK'"[Q(\6274MO:0'[N*T_$'B MC4/$_6/P;\,6=FD4T,DTO\3D[1^5><^,_@ZVEW,\]E M-FS&66-CTI7N!3^'7Q6N_#/B&Q@G?[;IWF"-XY#\JJ>,BOLZUDCDMXWB*^4R M@KM]*_/"2 ^7/ QVM&>&7VYK[F^$MU+>?#G0I9G\R0VRY8]ZAHI'6O\ =P.A M[U6>\MX9!#--%'(W 1G 9JM,VU2<9X[5^>_[1'C_ %NS_:D&FPW=P((9(4C5 M)"JC=UXJ2C]!H^AI]5=+8MIMHSGF3R30!-15:.Y+ @!NASVI_V@;]N&SZXIV8KIDU%,W'Z M4K,1C S0,=12<^E)NZCI2 =129HH */PI:0F@!H4;L8P%Z5POQ.^%\7Q M8W MM[Q]+U2#/E7<8Z9'?UKN,EEY%*S<\4Q'S]\-_P!D/PYX3UF37?$LH\5:\S$K M M6ZNP/$@XIKHK?4K+6-+-Q92 MAX7&!!NQ,#_M>GTJ]JGPXU'1M0N+BP_?6?WD4'# ^_K7))\)]9UF2:_M6;2Y M)L^;(G?_ (#3YA'6>!2(TG.X*P?;C.6_+M7C?[0&I2Z7XWB>2VD6U6,8N!]X M'V-:6H>/-%_9S\16MK??:KB+54 FO9&,CK)W.T]!7HJS:%\5_LD]E?6FIZ6( MR;B'@ON(^7GM51W"1\[^+O%VNZI\*IA9:WY\4,P9MIVW*I[GTKYU:9[J0M-( M)9ICE)L8;_@5?1MO\,]5'Q(\8Z)96$D>CS6;+$\HR Y'4'VKFF^#6D?#?2(] M6\7W,EVP8*NGVHRTOXBM#%[GF/A'P7J_C74/LNE6DDC!\22./W8]P:^Z/V:O MA/IW@#1[DO&EWJ+-NDNY!ED/H/:OFOPU\4KZPURVEBL[?2-%B.*/E2HY!![BIGL:1/?44K&!GW6HIKE+="\AV+^IK/:^NKZ1% MM8]D&?WDK>GM0!=N;Z.V7KN/H*H^5=:@P,C"&V/\/=JDM;&*S;>6,\C DEN_ MT%&HZM;Z79F[N?DMU R?[OU% $RVT5K"8XX]J'J1UJMK5\=%TBZOI&#+"F0I MX'XURWB_XI6FBVL$UG']NAFX%S%RJ^X]:YC1]!U7QS)_JB>HKZ);"K6'KWABVUJ!MT:[V&U_1A[T MQ,\$^'_A6P7PW+JJ.EQN!\(VJR>(+!"&W+)G:W7@]:]VC\ MR>%I)DT^)OL%RS$Q_P#//CDUY!X)A'_"R=B@S112.I?Z5IT)/;F[XZ'G%-56 M9PL>5)Z&E)#9?.$/ H'S# R*D#8TOQ)<:>WDR_O%6NLL-6M]04>5( _=37G? M(&%/XTZ.9[5E>W8H_6TJD. 4/5&&.V37GOB#]H+XM_#'QWHOA_P 4>$=)OI_$^Z/2?[,F9O+E M4 XE]%&:W_VNM/NM0\1_"I;:W>=4ULO*RJ2$7"\G%'[0NGWEQ^T5\$KJ"WDE MMX)[SSI%4E8P47!/I0!:^'WQD\?VGQBC^'7Q&TG2K>^U"RDU#3KO1YF=61/O M(^>AJE=?$[XW>+FU?4?#OA;1M T:QDD2UBURX,=S=%.I*]%4XX/O4?Q(M=47 M]L/PA?6-D\[P^'+Y87C0[=Y' 8]*\+\'ZMX1\7V&LR?%>\U[7OB-]JG1/#,? MG1*K!B(Q$5PN,8ZF@#I_CS\:O$?QD_8YG\0:79VNDW"WT=MK"1S$F)UE Q$> MX+8_"O4-8^.'B[X;>!? V@3Z/INI_$7Q$@BTZSBF*VH14!+R.>G%>#>%/#NJ MR?L*^.M._L>XMM4L]2\^;3_+8RA%E5L8QR=N.GI70_&:UT?XGV/PL^)#:5?Z M_P""M,@^R:S! )(KFS^0+OP,'@]<4 >PZ'\;?'/@KQYX?\.?$VPT.VT[Q"7B ML]3TF[,GE3@9\IP>@.< UBP_'[XJ^./BQXE\(^#/#&DFW\.W$:7=U>3LH*GH MOU(KSWPKX?\ A+XQ^*/A2U^''A2_\3/;3>?=:Q?23B&QV\C(?O7J/[,MK<6_ MQL^-,LL';308-LUQH\MV1:+75O+Z_$C7+;QE\>OV=M?M(2'OVGG&[HB& M')7Z]:^LJ^,+#3]2G\5?LORBUF5((9OM#",XB_=$8/I^-?9_7I0 M%(,\YI: M "BBB@ HHHH **** "D/2EHH 04AZ^].IC$9P>>* /FKX7V8_P"&JO',C8D7 M[,/YU[CJWA6.YWRPNT;$\J*32_A]H^D>*KWQ!;6^W4+L;9'%=+M[&D!\W3?# M'5M(^*5YJ=WK$Z:->JNRV8G:K9KTO7&CM=,:W>8%-@\L@Y/%=YJ%A;:A$8KB M)9HSU![>^:\N\26.E^'[ETL6>^F)YC9LB.M4!S$U]+YBX00LCJDLS=U-5XM] MS;Q6MO&9!'*Q%P?[N>U:UKHMQK5S]IE^YT=5Z&NCM[.TT] H 1@.%Q18@YR+ MP'#J%C<07K^<9AS)Z#.>*W=#\-V?AN!AI<*+,QRTL@S^ K5M5%S&NYN/]FDO M&^P]%RIZ46 :WDQ@"3+N3N+,>AIEQ>F1C&X^4#Y6;C\JSYIP5.3[DGM56XO' M7.?F0#@T6 LSWI?*D[L\?/P?PKF/&4R3:!>E5;Y(\%B>E1ZYXJL=,A+37*)_ MLL<-^%>9>*/&ESXBC:*"-K>W'&Y3RWN13Y0.1GTT2PR^62K@,S'\*^R/@K-# M-\-=$"2K+M@ .#7R!!#<7S_9E!$MP2$EA&1C'>O08?BN/!>CZ?H]J!-K"QB) M5M3EV]L=*);#1]1:IXDTS1Y MY>16['H';K7YX?%WP_-XI^/S^*(M1L_L\=R MI(\P@X4^E>KCPGXX\7>(;75-8\ZVM89%G%E%DR.!S\V:X7XC>%[#5_C4VJRW ML&ES;X@]BQ*CIP<5FE<=S[7\&^.M+U?1]-Q?VYG:)5**W<#%=>K!N0U VPS<#YOR]*U?"/QWD\.ZE%HVO%H+I1AH&!" MHWH&-.PSZ-I:P-"\56'B")9K6?)QDPY''^-;<0^$/&WCSQ@9Y+*PTVWCMYS;S^9*;_ M?] UP[<_\323GTK"\*^$;;Q1X[\2R:QYUW#9W>ZU@:1E5,'J, M&NAQ4GV3W]M9QCSIXTS]W,FI)KZ"U3=-*D:^K-BO!M>\ Z?9_"6/6X MQ,=7C@CF2Z,S9!R/>K'C*QU+6E\-ZFUI+J]O';JT]G#(5+MCMZU$:*XPW4-U'OAE62/U5@:8^J6L;JK7,(+< %QS7C?@"\T6+4/$":;->:== MRV[;]*NF)$; =1FH/A[\,])U[PG+-JX MM(B9Y8KB.4CJ$8$U\\6_B"]U[P_HOAZ:[FC@N-1>TEN0 MQW-&K8VYKH/'GA"R^'MO8ZWH7G6ES%<)%(GFEA,AXP033=!1T;U#ZUI=(]DG MO8(5&^>.(*<';]S913A@Y."3C!SVI^SC%;DK$.?0 M]MB8-SSDCFG_ *BH8%VQXQM&?SJPO2N1GHQV(S_>(/THV^F%/;'2I*.!2&?) M?[:WP=UOQQ-HVK::-UE"1#=+&OS(&.-WTKYX\4>$_%_[-NI:9J.C:N192* C M1G=&[?W6]Z_2G5+&'4[*XM9_FMYE*L#7S-\3?V:O&7CXQ:%'J6G0^'8Y/-21 MMQE3!XJXLEZG,?#O]LW1O$&GW%GKVGSV6N/'Y<;J@Q+)]:\5_:3_ &@M;'D: M9:Z;!'(O,9;!>/W:JGQ0_9'\?_#_ %.&'0].N-9,UP#'<6YSU/7VKU;X8_L! M7.OQK>>-KZZM&E =X]VZ8G^Z<]JUDTMB>5,^4OA;X-\8_&3QJT6ES75[>R* M\V#Y4&>O-?J!^SC\%U^!/@,:$)VN[JXF:XNY230!<8@8S5"ZU4*QBMQYDOMVJ%8[G4-IN3Y$)'$ M:_>/UJ]#;16ZXC3:!^= %.#39)9!->-YLHZ(/NBKT@\M4.T* ><=!5.^U6&Q M$AED7>HR%4Y<\9Z5YEK_ ,1KO7K"VMK%);.6\E,228RHQ_ST] : .M\7>-AX M?U"TLK:W_M">8EGBC/SHOM7*ZAH=OX^MKFYT'4Y$"L!=:9,QP[=U<_P_A5O0 M_AG%>-!/J4;!HSAK9G. ?[Z-UQ]:[_3]'L]'A$-G;*B,?F*C!)]2>] '/:#\ M.].TU8'^R) 3'B6S5B\1;L1GI760QQV\(2)!'$O\*\ 4R6ZBMXR6E^[7 ^-O MBMIOANW9Y[I8V'2)3R:KE8KG;WVM6MBIWON(Z@'I]:\>^(WQVL-$CFMXG%W< M?\LTB.2*\9\>?&C5/$JO!9.;'3Y#RRGYWKSV%9;Z58XDDEF'+* M/'^C 9,X_P!H5]36QW0(3R2/O>M0]!DK?=Q3.>W&.*DHVBI&1LB[2"/E(P17 MS)XCT34/ ?CJXU2*'.FRSG"J,XW=37T\W Z<51NM)M[BX29XDD(XVR#(JKBL M>=6\RWEE%.= MM%PLF>*HKG;'/^[8]S6_&P905(([$5Y?][@_*S=#Z5?L- >HI#%I:;_%3J0!1110 4444 M %%%% !1110!3O(TFDC5XDF4')\Q0=OH12K%')('*+)(IX9E'R^N/2O(OVG_ M (W2_!;P3%:CI*ZE MO(DN;5Q';[>W/3- '9K$-S.R_.IR&(&<>@/I44FGVC2>:]I;M(W\7EC=GZXJ MOINM:?XB@,VE7]MJ-M]UY;699 A^H-0'Q1H\:VZ'5;-))F*1)),H9V!P0!GF M@#2^R1LK*L:1[N"50<_XTHLH(X_*2&-(C]^-4 5OJ*HWGBS1;".)KK5[&W$C M;8S)<*H8^@R>M2:AXDTC29H8KW4K2TFN,"-)IE5GSZ GF@"U;V-O:!A!;Q0; MCD^4@7/Y4JK"DDA$:J:I:6Z1'8TDDRKM)['TH NR0Q^6YXC,G5D49/ MU]:BATVTAR\-M;QLW4I$H+?7BI+&[MM2@2ZL[A;J!Q\LD;!E/T-4D\7:')>R MV:ZQ8M=P']Y +A-Z_49R* +ZVL8VE8HU9?11Q]/2K"#:N*BBGAF3S(I%E1OX MD.14RT %+110 4444 %%%% !1244 +124M !28^;-+10 W:%Z5G:WKEIH-F; MF[D"*.@_O'T%:3=*PO%/A>U\7:4UI7#NL[4G M.$.'(]#'*C:G9YPLJCD+[UAWS6M]"K MP1^9*O5&[&M$!VWAWQ9I$>FK')>PP32J66)F 8XK:U"(7=D;RV&X*HW"O#X_ M .F:CXKTO6-42='C) CC8A>O>O<+[4-.M=-+1.%A";<*W?MFF0<'XJ^+"_#^ M/34;3[B]-]+Y:- N0GN:[K1;QM?TDW#QL@VY!88_2O/;K5@LB@HC+#RH9=WS M9ZBNGC\>J]GLDBVRE<;T& ?PH S;J^:&:9)#M4'\:IR:D;A< X [>M9\LQNY M9'<$ G.#4D4);YT'"T"L8?B3X=6WC*:.XDF=9(S\O/W#["N.U#1;?PS>>7K- MRL4><0B-AYDQ]#Z5<\:>.O%%QJ\FA^$],'VV/ ?4)N$4'T]:N^&?A8MOFZUZ M9M3UB;!:61LJ#WVCM5A8XIO$&NZM;R6VD6::)IR,VYIN9I%QV/:O1/AG\+K! M='L]6M[B'[=(GF;[L[F4^H-4/%G@G556;^QPC1M\OE_A7;_"V'0KH67A?4I@ M-82(96)NGM4R*1OV>F^(9&'E^)+5#G ;<-WT^E?/WCZWTQ?BO+'JFFW&IZEY MT:G4(C^ZSVKZON/@SX>+%V:X1NN[><#%?*_Q$U230?BM-I>FS02:+#,F96(9 MCGKS6<09]1:;9>(%M(1%KUKY7EKLPPX&!Q6)XY^$PKN/AQ^T5IFMKY&HNR7*X#+(,2*?<=_PKTAO M&G+&V9[S:W7,FGZG;ZG"DUM(L ML;#(8'^E66;TZU\FV^J>/O@KJR6VMP-J%@Q_=W\/*M[MZ5],^$=8?Q!X>L[^ M1@^M)X3\%S:#KVN7DMR ML\=]-YJKCE/:NI#^7'D #'8=JE3YE!'4]>.M/F9G[.,M^AY?!\-]>\/:GJ!T M;4[%-+OI&EDCN8RTJ,>ZD4S1_A/=6&@>*K"74OM+ZSM99Y!RI'7/M7J9PHP. M,=Z1N0Q()&. :OVLK6,GAXH-Y<6L6Y?.,%P,UHHU$N:QG*=._(VPFGD\Q+E"9$YYVGM7MTDL5Q"=I5XI%QN]0: MKZ38PZ7:+;0HL4();;CO0JDHH7U>,F<3=?".V_X16VTZQNFAO+.7[5#ZA<$[T'(Q7>;>I''8^]."X[<5GS,T]G"VB(X<80 Y'O4U,.>!W MJ2H-!*6BB@9$8=W6FK$ZKMW;QW+5/2>E("(H5W8Q@#Y0>U*8BZ\D@D=13_P[ MTZF!#';B-@5)5N>)O%EEX1C@-P&DGN&V1+G <^['@5RFO\ Q6VV M4::7 1J[OL6SG'Z@]#^%=7YNB^-K)8)8X;V+(8P3#(%9^F_#72M.U*.];S;B M6-BT*W#[EA]E':@#D_#?A_7_ !%JG]LW;?8+]D*.K9VCZ"N\T#PG::#8I%L% MQ.3^\F89+'.:WL#&0,9ZFL[4M;MK%3E\N.E<[XA\ M:6/A^S+RRK#$O/F,>*\M^(7QZL='>6WMI/-NA_RS4Y%?//BKQOJGBR\,U]=R M+;GGR4S@5I%"/6?B!^T(U])+;:0,OT$O\)^E>)ZGJ5SJT[3ZA\?W2S6MNUI9D_\?,JD K[5]-^"OA)X<^&%C]NN3$]Y&NY[NXQ M\GKBH?'GQJ\.?#>U^Q6@2ZO$&Q+.V POUQ7SIXF\>^+_ (M:M]FA24Q2-M2U MM\D+G^]BHW"Y].^'_B9I'CC6+G3])O8REN 6=B!Y@/\ "HKOXT"QJ!D#'2OG M'X<_LTW'A^ZAUS6KZ2+4+<;DBMFPA'H:^C+5M]M$V,94?RJ)%(DI:**@8E&T M'K2T4P$V\8HQ2T4 4K[2;>^C*NF#ZK7):OX;N+-2\*^:O8+UKN3T]*3\,4Q, M\M;VT^]=YJ7A^WO%8HH24_Q5R.I:3+I;;7._P!#5"*38;J: M;N*L"#2;?7BCF@0[S"LF]?E;U%;VF>*I+55BGP\?][O7/TX*&XQQ4LI'I%GJ M4%\JF-QD]JM9KS*&XFMI 8'*OVYXKIM,\7!F6&Y7$G0MVI#.GW"BFQLLB@CD M&B@!]%%% !1110 4444 ?)G[?7@O2]:T'PCJ%Q;>9>+K-M!N+8'ELX!%,^/V MF_#[POXN\-Z5K>H:YJME90LT'@O0XFF>=B.)) .WUKV'X_?!N3XS:/HUA'?? M8#I^H17P?KG8P.,?A7)?$GX!^);SXTV?Q.\%ZY%8ZQ]C^P7=G=Q!HWC P""> MAH \9^!.J0Z;^V!9V/AW0]5\)^&=5T2>X;3-29H]\B#AO)/W-/$=U>ZKJNFZW=_8%:X81P*&88"=*]6\&_LY^*-,^.VF_%+Q%XI_MO M5%L);">R\H)%$K<*8\>@KL_@5\&Y_A!X6UK29[\7YU"^GNE=5QL$A)Q^M 'S M-^S[\&-&^)WPQ\>>(/$LUYJ,HN[O^SEDNF'V94#E<#L0PS5+X;?!_3_''['^ MJ>+?$&IZCJ?B:.TN+BWU&6Z9F@,9;9M],8KZ@^#OP6F^&?@'7/#TMVMS)J,M MQ() /NF0,,_K5#P'\ KCP?\ L]W7PX;4EGGN+6>$W6W !D)[>@S0!X8=>U/7 M--_99N[F\F>:Y5S^. M=?>]$Z>(KB.=(?\ GGM!!'XYH ^5M%\8:M\'OAG^T'I^@7E[/:Z)J,-MIXN) M"QLEE&&8,>@&:[#XF?LT^&/#?[,MUK=EJ=];^)8-/COSKWV@^9+(^UCN/=>3 MQ7H&K?!G2/ ?AWXUZMXMN)M0\->*"EW<0VZ9DCC1<$ #J02#^%?/GQ&6ZG_9 M[O;&/XQ1:SX8\J./2M+6W O+CY@%MW YR 1^5 'V1^S](\WP7\'2S2O/-)8H MSRMU=N>37HZUPOP6TFY\/_"?PGI]V-ES#81JZ,,=LX_(UW*L,#% #J*** (W M8]NG?UIK95?EY] 32,P$O0DGC_Z]?(_[6'[>FD? ^[D\,^&HDUWQ5C]X<_N; M?V)'\7M0!]<-YC!2/E/<#FG$E5R1QWYK\2?%'[;WQE\;WSS7/BEH(=Q\JUM( MQ$$'U'6MKX>?\%"/B]X'U"%KC6(]?T]6^>SNH_O+ZAJ!V/V8\S]XJ!CSSG'' MYU/^'XUX7^S3^U1X9_:4\-^?IW^@ZU;C-WI4APZ^K+ZBO@?>I>GO3 ^=[Z/4O#=TMEJ]OMW' N%& M4-5I[>*:,[)"5SC"G*M7T%J&FV>I6[074230MD%7&?U[5YGKWPBDL2TN@2_N M2=SVTIX_ UHI$\IP8MCN&X8;J/2IEC#>]+]L:WN/LFH6[VKAMA\T8'U%6I(4 MC0O&RR(.ZT)B(54!@"O%2+\H91QFEVDJA'1ONGM5?5+^UT>S>[O)XX+>,?-( M[8_*J E^SHQ.$"YZ%1S63XF\9:)X+MM^I7J0R 9VJFZKIW@MO[6AEMI)) 8HYCDA<5ZDOICI35A"]./Z4[;UYH 7OFD[G] M:=32OH<&@""\L;?4+=H;F&.YA/5)%!%.M[:*UA2*&-8HT&%C08 J;%)M!ZT M**6D%+0 4A^F:6B@!N/:EQ[444 -91W6HV.U@ ,"I6Z4Q_X?6A:!W&2+EL'C M(XQ7@7QR^,\_A^Z;0=&=FOF&V213RH/<>]>Y:Q="RL;BV!7P3K6K M3ZEKE[?S.'F6Z8JS=9%W=*]?+L*JKX_6M+UG(O-;M[I\G*2 MW65WY]^]4[/3;J\GC2SM)+BYZHEL(O%$_B2^%Q-<3"U!416[DL!@ M8Z5G07DMC*DUO--8W7(69"5P/8BOL%2C[*W4^)9+RV65#N1QN!'I7P3XBUZ3Q1<6=U-N:XMK=8 M3,2()=>^'6G33,S/&S0,S=RM?,9CAE37,CZW*<5*4^0]"VL M=ASP.U32'!&!R>]*OW6) S[4UFP@[U\_%W1]2E9%@=!2TB\J*6@ HHHH *** M* "BBB@ HHHH **** "BBB@ J.1-^.U25#*P1DR&)8X&* /G_P#:Z\421^#W M\/0VDD[W8#[DZC!KXTL[BXL[O=9NUM/'U.<'Z5]Q_'JQEAFM=8E>(6$ F'G%PO(Q4?A_Q%?\ A^Z$VG73 M+)_?4\#\*IQ$F?>WCCXL:?X;M2TMPL8QE8@?G>OF_P ;?&G5/%C3PV>^ULL? M>4X?/I7 WFHW&N7?VN^N)+N7;]]NF?:NT\ _!C7_ (B3))'']BLUY>:7Y05] MO6LG'EU'Q MKV3P?\*?"GPQLQ=R^69U&3=7&!S[5PWQ&_:;ALO-L?#,0N) 2KW4IPJ^XI;@ M>EW%YX3^#F@MA;>Q2-.(TQYCFOG_ .('[1VL^+\V6BPO86DQV1M&V7O+DE45?11WKZ+\#_!#PQ\/81?W.RZO N3=7!^1#[4;# M/&OA_P#L[Z]XPGCOM=DDT^T)WEW_ -<]>_66G^#_ (-Z*6\RWT\8R\TA'FR& MN#^)'[2EGH$J0'>DS':$(]*]JM6\RWB8# *@\5,@1/13=U.J"@HHI*8"T4F:-PP3Z4 ! MZ>M-9@OS,P4>]9VI:_;6"??W-Z+S7':EKESJ3EE=D3L*:$SH]6\41VQ,_C/\5.W8JA"-\U(M.3YL\@>@--'WL#K^E A: M-WEJ#G(]#4D,+W$GEQ#>WM72:9X1^[)=D,?[M2RD8%II=Q?L/)0\]ST%=7IO MA6&V9))SYLH'0]*VH;>.W4)&@51Z5(5S]*0QJ*L:[5&!Z"BG8HH 6BBB@ HH MHH **** &'KZTG/;D^]244 1M][//IB@G(QC/8U)10 SG;ZD>E(OZU)10!'R MPR>#2!>G8=R>M2T4 49[5;NW:&Y5)8VXE210R.OH0:XBQ^ _@#2]9_M>W\,V M2W@;S 2F54^H7IFO1*"H- %=5VJ!]U?X,=A4Z_='&*-HIU "4M%% 'D_[37Q M6'P9^#7B/Q+&V;^&%DLX_P"_*1@#^OX5^&TUY<^*O$#7.IW;O=ZG= W=U*V0 MKN_W\^P/Z5^MG_!2ZQN+S]G.Y>%6:."[5I64XVKZFOR,T_2KS5K@6MI:37=P MHR8X4+L1CKQ0,])^.?P/N_A9]BFLKMO$5E?0@0:E9J7",!DD!<_+]:])^,VE M>$O!OPHTC2DBL8=1N]-M+F Q#_3Q(PS*6'9#VSS6E\&4^(GA7X1Z=<>$TM7\ M0#5GEN=,U:1$9H%Y"JLO0&L#]M2&[UKXC:1XEDT.'3K[4;",S6UF=]L'4?,N MX<<>@H*/+_@/\3M0^#7Q0T'Q/I]XMND-RL=Q$K'=) 3A@1WK]X-'U2+6=)L- M0AXBO($N$/\ O*"!^M?SQ7#A]AA#&1G4,K+T^8<"OWZ^$MG)8_"_PG#.Q:5= M.@R6Z@E 10]$2R[XR^(>A?#W2X[_ ,2:A#I5I,_EI))_>]*U-)U*SU33[?4+ M&9;FSN4#QW"GAU/0UX#^VMH]MX@\(^%]+O/WD=WJGE#/J1@?J:V?@/XNDT'X M;:UI>J/LN_")DMVB/4PQKN4_C6ZIWBI&;E8]*M?B9X7O?%C^&H=;MY]="%CI MZY\P8ZUT2;4C (YZ&OC_P"#.DRC]HK2]?NSNN]?M;C4$!',<#C*"O6[OQ)\ M2M:U2^:VET'P[I-G*1!_:C'S;@#^+V%6Z5F9^TT/9;J^AT^U:XN)!%#&,L[' M %3P7$=U#'+$WF(XRK"OF;Q/\1-?^)'P#U?4$%K8SPRM%J"N2P,:N!NA([DU MV$OQ"UWP1X'\/VUT+&ZUO4EC@L_(.R)/E&&DS[5/L9,S^L16Y[=FES7B%=4T^#Q!?:/JMK>R"%6TQOF1O?/:GR>//&&K>.-4T'1%L%M[%5D>>Z4DJ MK=N*/8R%]9B>GV.MV=]J5W96\_G36O\ K8R.F:TRAVL5Y&/E6O+/"?B2_EU[ MQ:DUM"]S:11D20##S,5Z?2LN^\9>-M/T0ZO<7FDV,*G@>,+/0M0DM;/5%47-X?*@..=W6O/->^'^J^&%DN[#_2[-#S$.3BGZ_KG M_"2:]\.KYN%FN=^8^@;;7M4<8"=!SUJ)Q<+7-:-55;V/EGQ)XV?19([:STBX MOM4N!B*W53A6]347A7]F/7_'VIQZY\0M3D$&=\6D6S811Z-7T_\ V'IZWWVL M647VGM)L&:O\=>YZUED^)-1MI$\B[ANRD8QGY<\''TK[^F7*?8\#U2XU;1;Z2WO(U M!R#&_E#'(S5*'7+YF&)%'OAOID;J4D<-.R-ZM7BWP[^%^L_$#7K76_$P\O3X=OD1E2 MK<'H1Z5]4VUK%:PK%'&(XE C'0"OF,RKJ;4$?5Y3A73_>28N[&#_>HE7:HQ MWJ8HN/NTNT>E?/+L?4 OW13J2EI@%%%% !1110 4444 %%%% !1110 4444 M%12$[P!]?_K5+43?>V]2?Y4 ?//[5^I:I=Z*GA[3[96@FC$SMWSGH*^6?#_C M;5_"ER+>3S)8E^]#-V^E?8W[06F_V; GB2679:6T8C<]QDUX?JF@:1XXLS,D M<6[;Q<1XW5O!D2(M)\8:1XNM3$SHTK !K=N@K%\0_"**_OE31R(YG(^1>G-< M?XA\ :IX;;S[1FEMUY#1_?'UK6\$_%R?0=0MFU96GA0@$G[]7(@^G?AG^S7I M^B6]M=^("E](/&/C#XPZLML[3/"[?N;.W! 4>Y%>N?#?]F"VLUBOO$V+B8 ,+5#\ MOT:O2X[?PA\&]$WD06,2KS(V#(Y_G7@_Q(_:7U37))+/P\&L+(G:)NLCBCT& M>S^-/BQX:^%M@+2#RI+I%VQ6-MCG\J^;_%_Q3\4?%34%LD::*TD;$=E:@Y'^ M\16C\/?@/KWQ O%U#4VDM-/=M[SS9WR?3/2OHK0_"?A'X/Z.TP6&U"+F2[G M,C^P_P#K4 >4?#C]E\W"1WGBAB$R'%DIY/\ O5ZIXF\;>$OA#I"P$06VT?N[ M6WQDGMG%>0_$3]IJ\U 367AB%H(\E6NB?FQ[5X3>7ES?74MQ//+=RS',C3MG M'TJK$W/K3X8?$&^^*4VHZA+;&!+<[8;7/# ]S7I]GJR;4BN5^S2@8QVKPC]D M]S_9>MJ#G#K_ #KWJ[M8+I=MPN].S=P:SD4C0W;AZCL13ZP3'?Z6N8&%U!_< M/4"KMCJT-X!AO+D[I)P:FPS1I#[5')((HR2X4#NQKFM5\7*NZ*SR95_B[&F% MSH+J_ALHRTD@SZ9KE-4\47%XQBMOW2+]YO6L2XN)[QBT[>8?KTIF\X+C MMQ\QG.3G^]3.>=QX/:E9FXSP*0[MP(^84]@W%HY[=:&PHR>N?NU=T_2KG49/ MEC*)TW4KA8HM\K*?+,C^U;&G^&[C4L/(/)B)Z5TFE^'8-/4,Z^;+_>-:RC&> M>*+A8H6.DV^FJ$AC^;NQ%7]H]*=10,09I:**0!1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 <1\8/AS9?%OX;^(/"5\BFWU. MV:,,P^ZW4'\Q7Y#>%U;]G3Q)XO\ !/C%+CPW>7BB&UUF)-SVX5\AD]21CI7[ M5MG/3GH#7DOQR_9D\$_M :.+;Q'8;;R,?N=0A^65#ZYH&?C'\8/'G_"P/%\= M\EW<3I:PK:I=32$//M_C8#&,UWGP?^)45G\/-6\-7FHVBWWVN*:R&K1F>*./ M/[TKW&:^B?%?_!)W7[:ZFD\/>,+6ZMG?Y(+B *ZK[MW-;7P__P""3RPWD%=.ATW3X0H M/E@;WQW8]S77;O\ ]5*UQ,\'_:LTV]O[/P5]BL9;YXM81W\E"QC7CYN.U<3\ M8?#.O:=\4!9:#:SRV'BR*W@NYHP=L80@N6/;(KZI9P& !^;U-0Q@,S':I&-V MW' ]3FNB%;E5C-QN>$R:#=:9^TAHL6FV+IIMAH[PQ3F,["=G"[NE=NS MJ?7-/V[,Y4SY?\&Z'J;? ?QMI:Z/+97L&?"TTJ&3S+B>Y@:)8<_>O56V@8X('8#%&[J !CH6[BH==LE8:)XE:V>JV>J?$R> MP@<74L<9MF92,D*>1]*YHPZ1>>$GM([*_P!5\2M""ZW,;!3)WPQX]>*^AGC3 MS@A)PW)=>_L:ECA7'RA%0GY5V?=/K5K$&/U-'B5II]Y)#\.91:RPF.ZQ.NP_ MNP!TQ7O:CH.U49PBX)&]\?*0, ?CVJY;MNA0^U8U*OM#KHT%1O;J/7]*-OIT MI1WI:R.D**** "BBB@ HHHH **2EH **** "BBB@ HHHH **** "BBB@!#2; M:6D% #=N..HJ*2WW9('S$\U/NHI*Z%H]SG-6\":+KF?M^EP7A/4RKFJFE_"_ MPQI,RRVFA6MO(IR&5*Z[FC<:U56:5N8Q]C3;ORE5(1&H01@#UQTJTJXZ'M32 MW:GUGKU9LK=$ ''7-&.E+10,*04M% !1110 4444 %%%% !1110 4444 %%% M% !43)ND]#CJ/Y5+3&^\/:@#YX_:HM]4\00Q:';7 BM)H1(\?=B#7RC#>:WX M%OMBF2W(.-KY*$?6OM']HJSMM-\,R^)Y&;-J%7:._->(6UYH_CBSVR>5*OA1+9?OM-7S ,D6X_A_&LGPS\0M8\&:E;BP@O[@)=WZ*&:]NN=G'\/I7*?$[]IJST-I].\/*EY=*"&N''[M3[5 MXUXD^)'BOXI:A%;$W @ZIY>IZA&-[-+_ M *J,^H!K9\4_$/PM\(]-^RIY,'K=M;U5E*I]G7Y(S[XKAM0^%/B_P ;>'[[7_&. ML2Q1P1&:VL8V^[QTKV?X?_"/0?A_;@6D N+TCY[F4;B?7Z5M^.U_XHW6551_ MQ[-@"IZ@? @)/WN2&(W1CKCUILF,YE2"&]NE5[JQBG;,B[I?X9$X MQ5H\=\TWZ4D,Y+7]-U2%2YG-W;=2J]5%8,-PMQC8V%!P5Q@UZ6J'#'^''(/0 MUS/BC3M.DM&ER()E&X"/C)IB, ?O'(YRIQCI1RV.13+622XM4>3'MM[U/$ S M HA9V[4 -VLW&/SJ2WAEO'$,2EF]16OIOA6>^;S+DF)/3O766.FP:?&%B0 _ MWCUJ64C#TSPBL>V2Y;2N\L H!R3TKY7^+'Q6U3QEK M;:#H#2+&I*N83\TN.PKKPV%>(E;H>?C,8L+&_4]ZU?XP^%M%NO(N=5C:8?PK MSBETGXI>'M>N!%9ZM T\G"HS8-?%.H:5=:?=!+N!H[AN-UP]OI#_9 M]NSR X=XFPZ_2OH/['BH73/FEGCY[-'W^)OWL0&!N^]MZ'\:M'.!QSFOF'X) M_%ZZTG5HO#GB"20IO\NWFD.6!]&KZ>60-'NSD=8V-Y')'Y52TOQ/H^M7U?.FF_#71OB1^TEX\@UR.XN]+LK6U9+- MYV6/S&'+8!KG;+5&\0_%KQ6NH>$=6\5Z=HRQV=C969S%;*!CG)ZFM%15R.<^ ML[/4K34-/BN;>\AFM6Y6>-@5;\:JR>+-'6^AM6U:U6XEY2'S!EJ^;O!]EK^D M6_Q @&BZAX:\*7EBT]A:7K@FVD Y'7()/.*U_AU\&_#^J_ I;W4%FN=6N+66 MZEU1IF\P2+DJ0<\#@<4G123)]H?14EU';PEYY%A2/YC))@**S].\4:3K4TD6 MEZA;7DJ']XL;Y(_"OG%?$6G>*O@OX&N/%=[J<]SYA1+&Q)\_4F5B #[8%5M2 MNEL?B9X*N]-\,ZAX+EGG:(FXX-P@ ^4KTIQHZ&?MCZ4N->TVS5GN;Z&VV.%V MRN%&X]!5G5/$>EZ+!%-J-[#9K+]QI&&#GTKP?P[X'TWQY\8/'?\ ;4U%I"&.6_>X./2MG144CF6(QTO3X9H;,.0KEQ@DCO4,6 MGIX-^*%M8:;-)'I^H6LS-8[B<%1U%9JC*Y3UZ[\3:?9NAGU"")7.$RPPW MM5]+II%8(<\9W=J\+^'O@#2]8^']Y>WRR7UY=7,^9)9#\@#' 7TKL/@)>/>? M#FUWO)*4ED56F8DX5B ":SE3Y5H;4ZG-*/F>A7&H1V(:2XE6.+&=S' !]*I6 M/B.TOUD,%W'*X,D>FVI_>7/'3Z5RMK<"T^ M*/ANYL=$N]"%PK1RQ7C%PPPCG M]XP!%36VH_;E^TP31RV;KF-E/6O&/!_A73O$7BCQ<^IB6[C$PVI)(=H/L*R; M6]N?#7A;QO:VUS*(;>5%A!)_<@]A2]CJ+ZTTKGK/C+QU%I?A_4;FPO;>2]M8 M]WE%N^>E;OA/59M:\-Z??3@)-/&'8#UKR3Q)\.],A^%]U,B-]K>U29KEG.68 MX/->G^ F'_"'Z40,#[.H^G%1.*2*HUW.J[]CH(Y&;'>IJJVA&SKDYJTM4#/ELW-2Z/XDT[7HRVGWT5Y@\B,\BOFGXDZ7J%WXPU.>0&X$U24>0?M587X M-ZKT RO\Z^#;&^N=+D6XLV9) 7[50!^#>K$C(!4_K7P0,1CS%)S_= M[5M3(D>G^$_BY'YB0:L"N1CS!V^M=I)X3T;QQ-;QLL;Q.P(N83@CFOGSB1LA M05Q\RMWK5\-^*=1\+WD=Q83L!&V?+<_+6\C)'W_HFA^$/@[X=BDS!8H(PS2S M$&1SCM7E?B;XX>(/B)>-I?@C2YHX,[)+Z1?FQTRMJ?'[4GU77=3<6 M%O@.@/)_V=O05]-^%?">D>#[%;+2[);:-1C=CEO?-6^ /V=;:QO(M7\ M573ZSJA^=1,<[2>Q]:]JAAALX5BAC6&(<*B+@4YF"AF)5%[N37D_Q'_:$T3P MBSV.GRKJ6J\ M6:8WA73H;+R'14RZ@ .A]ZNQ-QGP[_9[T?PJHN]5?^T[\'%-A<"H!4AL8Z 4<;LX( M]:3*9Y;YJ7^Z=PPQ[UG\?>J.H:]#:^:L9!=.#7F M'B_XH1V3F"S_ -+O&XVQ\D5:V [W7O%<5C;LS2K;0KR78UY#XB^)S7UVMKIW MS;YT0RMR&4G!Q5'3])O?&DTEUK%TT5@K&-H6.,,!G!JGKFDVFE>-]%M;--MN MS0'!Z=:;"Y[1H_A^6ZC58D:"$\,S<_E78Z;H-MIP4A-T@XR>:T4B$:@( H]! M3U7:,"LBQ,YW ]*^U/B=H&-)N]3UI-+M7^SW6]T2;;D@J#UKZC*>3V1RP1RPS0LK':#MD]JL75_J=A,RSS31R0DHT>S M[WN*?ILVK:Q)':6E?< MWAG3/[)T.PMP.8X%5\]FP,U\UFTHZ+J?4Y-&INSP[]L;37UB'X>V"7$EFMQK M6TW$*DM$=N0P].<5O:=\%=<\0:YH][XU\2-K>GZ0_G6UHHPLSX&&?UQ7KNJ: M3:ZGY7VRUCNO);?%YBYVGU%6"BKM"?,R\]?N^U?/JHU"R/J4KR.%\)_"\^&O MB7XH\4_:!-_;,42>6?X=E8&O_!_5;;QM>>*O!>NC0Y]00+?VLH/E3.HPK'W% M>M+(>#G#=LC@5)MW9WX /:HC.2W&XH\4D^&-UX3\$^--6UC7;K6M;U"W9II) M&RD.!@+&.F*XSX0_#3Q7K7PCT2RM_%O0[3*1_I$:%B"B'I@^_K7TS=6 M<%Y&\4T:S0RKLDB;[K#W%0Z?IMGIMK#:64"VEI""!#&,*!Z5?M78S]FF>8>) M/@;;W&F^&$\/7_\ 96H>'2?LLSC(D!'(:JEQ\'?$&O>(M#U_5_$0N;_2IB4M ME'[@*>O7G.*]?:%(X2-F],Y _I3PH9B67;[^M'M&D+V:O8XGPK\.W\+^,/$^ MMK<+,NL-&?+[IM&,5ST'PJU[P_XDUF_\/ZU#;V>KRJ\L%PO*X&"5([UZQYBR M*0.'SCKS0TBG&1NQU^M)5&-TXL\S\)?!MO"__"0QRZG+J"ZP2TDLY_>@D8X] MJSX?@OJ2^"1X9GUPW%C%,LD#RCYD56W;:]::96QELE>XXQ4,*?AS=:EKUMXBTC4?[/U2. 0-(>CH!WIOAWX:7.F MZY-K.J:F-2U65#'#)CY44]34.;V9K[.*::Z'!>./AOJ6A^5FY0BJ M*_#74+CQ)I6N:GJK7ES9$_N1]WGTKTL;MTF0-OI3[7#*6/WCQFKC5E'0QEAX M2E=G*>&_!(T'4M7O//\ -;47W!!_#65:_#>&T_X2)+VX^V0ZPRAD ^Y@=:] MCM45FPS)&-APJ!>NT=!^ M5>C>&[(:5H-I9@EA!$$W'OBM22WCF4KC ZFDCMDC7;DFB4^;<<*483YD,L\^ M7T'6K=11PK']WI3MW.,-& MLI""W,SJ>GM3%BKG-<'L6 M%U@4[6;^+M4EO,(]S1'V>&O%UKX@38#Y-R/O1GO6^ %;C\J\ M)CG>.87%M)Y4T?3:?O5ZWX4UY?$&FI*6VSQ_+*OO4@;U%-]>U.H **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $:H;BY2UADGE.V) M%W%OI4K9VG'6N+^+>K'1_!.H.&VM(HC3ZFC<#RG6-/XCZ?(1D-K+KFAV=ZK;A+&"<>O>M7TXK,L\B_:J_Y(GK?_ /YU\"@84#V MK[\_:H4'X)Z[GT3_ -"KX%_N_2MJ>Y$A,\<=:$^5N.,4>M"_*V>^:Z)&2/LC M]D$G^S=;P^^,R)A/PKV+QA\1M"\"V[2:C>JKC[L*G+'VKX]^'7Q0UCX>6%]: MZ5#$9KQ0QFD'^KX[5G6-CX@^)FK VXN-7G9^;DYV(WI7+;74VZ';?$;]H#6_ M&QDMM+8V&FY(!!PS"LOX?_!7Q!X_*,R&SL"X=KB8'R_#3]FFRTJ:/9ZU:R6U MY"EQ&PQAUSBIYN@['S]X<^+#0M''?G!'_+5>AKOK#XB6=VF^"]7;W5C7"?%# MX3V_A*%[[3Y_]#.+<0[GNX5^C"N= MUGXH:=9J6FO&E91AA$>@[5X2,]"68>Y-*N%S@?+D,1]*=D!Z0MSX@\?3QPVD M)L=/R2)F.&<8K0\(Z19^&]/M)(K=;F_E+;YYN>C8XK=TQMNLZ5$ORQ>4IVCI MDI63;L38Z4&.>7_]#-( 4[]/U+/(;469@/7':N;\6D?\+$T'MQ!A?3FND7<; M/4 J$I_:+@GT^6N9\8*?^%AZ*R=%6WSGOS0,^H12TGI0/SK(H6BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** $(S24-32VUA2OT$RM<*6W#&6Q@#L:^>/BI\%]1TO6F\3>%BZS E MIK>,>W85]'D9.X&DDX4MGGZ5TT:\J#T.3%86&*C9GY^>(-2U:ZU""?6HYK2Z MC!7:Z[\QHB2W%RQX:%-P.>QK[@OO#FCZLV^[TRWN'(Y,T0)H MTOP_I&D O8V%M:X/_+&,*:]S^V)) )- M2E??' R_ZKW^M>^[>@QNR?I4>[:Q:Z#'\/M1O%\RVM];#.@&21MZ@=\=:R_CIX MVT7XGV_AGPQX5U"'7M8N-1ANE6S&[[+&C EG].*TC%A^%+G7=6L%2255EVKL;OFK6J?&Z]N-<'A_PMX8D\1:Y% L]]";@116 MI(SL,AXS[5E?#':_[2?Q';<7F6RM%>4I@' [5B_#?Q-IGPS^*7CK1_$URFC3 MZA<+=VMU<<)<1\Y&?:BT3+4]&\#_ !CL?%EIJ2ZG;-H6KZ2";VPN#\T8 ^\# MW'O7.K^T!J][8MK=MX*N9O"BR;3J)N LF <;A'C)%<+J-O/\4O%OQ(U+PZ?. ML/[,^PQW"I\L\G#95N_ KL/!_P 8/"VA_"VQ6ZN87U.VMQ ^CO\ ZUY <;=N M.35)/C$NF_P!G6ND:7+KFKZ@GFVUBK;,(1U8GH/>IO#/Q3DU+ M6FT/7='?0-9$?G+;O*)%=>Y5AUQ7COBB03?%/2/$&L7-SX4TK4=+2)9MI5(F MSQ&3V-=%X1L_#[?$BP>SU>^\27EG#(6N&4M$FX?=W=L^E:>SC8YW4G64X;"=36QX@^*R:?8Z6]IIDEU>ZBP6&RD/E ML6/J3TKR61?#EHFJ:KX?\43^&KR&:5Y-*G8E6ESSA3ZFMV]UC3_%/@KPY-XQ M@GM+R:3(OKL'3_B1IOACPSK6K6FDM';V]WLGA23DL3@L*Y[PKX@N]'\86^AVNNCQ M/I$\3-*57Y[;@X);O6/=-M^%?BQ6C8O_ &JA7"\L-XJ?9P1/MJC:U/0I/C!= MZ>UM?7?AN:#0KEEC34#+E\GIE.H%;&O?$QM.U&'3]-TM]3U6==PM@^U0OKFL M'XJW5N?AC&-[(2UN5VK[^E9,>J6_AGQY%JFIEH]/U"QC2*Z88$+*.1^-)0BR MYUIQ>YUWA7XG2:UXPD\.WVF2:;J$4!FDC9]Z>V&KO2_F;"1C/:O%_#OB2Q\3 M?&Z.73]LMO#ISHEPA^67GG\17M/#J>>5&,5A5BHLZ<+4=6-V+\NUL_C6>OB2 MPMMT3LP93C[M:D:@QC/XUY_J&/[3O,'A9#7/>[._H=?_ ,)5I_\ SU;_ +YI MK>+=.49\QC_P"N*;'!(R/2AL'[ORB@#L5\9Z86P'D'_ #5E/$E@PXE./I7#% M@@/(?/\ ".M5XXY;R3;%:SH%/S'!H ]'AUNSFD$:2?.>BXYJV[!<'H*Y72[G M2M)C#SQ/;2@X:5Y6WO*=[OGD5?U_5KGQ!K$UY*RCRGV)%V(KF-ZL=WEVJ;9U'5_?%= M'\-?!*>"]"4R*K7THW2R=S[5UMQ MU;R1/\ =E4J>.@-!1\^Z;-MF5,9'WE8 M],5V/@751I>O",$B"XX.?[W85RFL:<^DZM\AMS CI3ZS-!U!-7TFWN4.=ZX/^]W_6M*I 6BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@!K=J\=_: OB]KIMBO*[C(X'TK MV&5@L;$G: ,DUXGK#KXT\2:I>'C3K.!U+-TZ''ZTX[B9XZIW*,#H,YIZJ6QM M7?QN('I3(<>7%CGJ"*[7X9:7'K&N:A:RH &LW"$^N*U>Q)Z;\ ]9%YX3>R)R MUG(1^!YKT[TKQCX(VHT?5;VTC;<)%+,/=3BO90W08K)EGD_[4RY^">N@>B?^ MA5\!_P!WZ5]__M2?\D3U[_=3_P!"KX /:M:>Y$@]:%Z\^M&*%PS8/Z5T2,4> M]_!WX0GXES1SW-X;;3K7!EPW+^U?7OA;PGH_@W3TM-)LTMX1_$HY8^M?'/PG M^(5]X0O(K**)?LM\5C.>O85]7VOB@6-\VGO*I\L#*L?F (S7-(W1V/(/3 _O M4_>/6J5CJ$%Y#N@?,8/+/1?7T.GKOF8+QGKUQ611<+ J3V[UCZAX@B@=H8/W MDO3Y?6O//B-\8+'PS;D7#M',2-L*]>>A^E>7^!_B'J?C+QGIQN9/L]I]JQ&L M?\7^]5J(CHOBWXT34FFT:16-RKY;T!]*\OW.SDN #C'%=-\4N?'VJ=MLG]*Y MGN:T,A>HI&W?+@<'_&E'W:8[991\S[?\:&4CW;32%\0:6I[0KG_OBLNUYL]* MSQDOC_OLUK6,L6%RRB*%8%+2.>%&SK7'-XVTS1]'A1$:[O8VD(D_@'S'& M*D9O0QI-8:H\TZVT46HLQW-C/ KC->UBSUSX@:3+:,2(I88^.AP:C\/>&/$/ MQ(O&DB#P6MPYDDE8?*I^E>X^#?A-HW@^.*>2);J_4GKFE%, M_P#9J>O2LRA:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH 1ANIK1[L9I]% #0N.!TI#'N&.U/HH M C,0.,\XI/)4'/ /TJ6DYH 9Y8ZC&?I3MHI>:* /)_CG\-M1^(%SX-6QCADB MT[4_M-P9N@3&*[;1_!.@Z%=23Z9I%E87,K?O98(51V^A Z5N2J6;:>5/WL^G MI2D%EP!@@\57,[6 JPZ'96]]G6M_FCFCF861G:AX=TW5K4VU]9PWD!.?+G0. ?49Z5 M'I/A?2M#B>/3[*&T5_O>6@&?K6K2T^9]R>2/8PKCP/H-W=&YFTFTDG)R7:)< MD^IXJY>>']/U"U-MP+&%XKS>\C,.IWYD8@F8X%>DKG)KSW4A/+K-U%'"S M.93@XJ#8JLQ/7"]AFI$L[F\7R[2$O+W9ONULV_@M[R,F\D*D]EJRWA:WTVWV M?VA-!#^M C+T_P +ZC;S"X9(7D'0%NE;J+K<>"%MR.XSBLQ;?3MI_P")M*@_ MO$]:/L^F@<:U)D>_6F,Y?X@:3K7FB]N&CGLUY:)6Z5R'VJ.2/=Y81 0%*\8/ M>NY\776GV.CLL.HO/WI5(AE'6M?M[74)$BB+ MR*O+9KU'X6_#W3H[&VUV=S>7=PN]2XX6O$]?B\G4';(W8ZU[9\&?$ULO@M;: MZO$9[5L,?[H/-)@CTY?WBYQ@'L:=C\:AM;Z"\4&&59!UX-3U)1Y9\5])-O>V MFJ1@M&_[N1<<#TKC["0-&\98;@2%/KFNR^*GC2"%)-#C@9[AB'R1Z5Y_;N\, MPWIY9C7?^)JT(].^&>L#R[C3W;8J\Q9[>OZUW\;DKR58CK@UX';WDS7/F0,8 M#ZCT[UZ7\.8[C[#:O? M:6PWOM M_@'K0!1^(.NS:3H>V!-TUR3$#G&WCK7EOB;6+/P;\!=9U263*,X\QT^\/F&: MY[QG^T=X+NX5G?4)=1!3*6]OPP;\:^8/C]\=K_QQX8DTBVLUTW26Z+N.]P/4 M=,UI&#,W(]4TOQKX?UF$-8ZS:3,_.P/AE]C73>"?B+H_A_QQI5K-J,,=Q>2B MV$>_AMW%?GI&TL:IY,K0@C.V,X8UI^&]6ET_Q-I6HL\TLMI MPRRI"N^1U1![URM:FR/+OVHOF^">O_[J'_QZO@ $,HXYK[M_:-UC^VOA3KUG M8Q-U_%&[FL?'MQ-"[1R;$(<'V':O$/#Q*ZOHV>!YL?\Q7M M/Q<9_P#A-KA54,&1 ?8;1S64K7&=+\//B!>ZMJL>E7 R[G"2J<5!XV^)-U'? MSZ7;KLD1_+>:;H".N*P?A'932>-;$VR,\*,2\Q!VC\:]/TOX76DGB"]U)E^W MSRSLZF3_ %4>>_UK-V'J>(_'#3[O6OB)8165O)=7LEE$J*JY5OEY(KK?A_\ M!OQ#X-O='U&\BB1#*'DC!R4^M?0-CX=LK.\>],$:LSE@?,' '#<5S01HQN>:M^S_ *W8L%L9X;V/J-_45HIIJQFXN]SR]3N!(=2/ M041R9\Q5+!@.6QP*] 7X(^*92%\J&$UT&@?L]WE)M#U. M&;Q!XA\8/%9:>LGS*L.R,9' QS[5Z9X&^ \%OMO=>/FSGYA:K]T?6O2O#OA+ M3?"]N(K"U2+;PTF/F:MGG=C)49X/K[5FRQEE8P6,"PV\*01+P%08%2^6HXQD M'GFE7N#Q2C'3O4@+M%+110,***3I Q7*> =>@TG5%M;RW MMKB*0_+-(F0*]]M6UJ2UC:V%H(?X50#!':B0(AMM)%?[MN5J"AGBKP?:^*+;#J([K&([ MH#YA[&O'M8TFZT.Z:TNT8MRJ3$<./>O9E_M[SD=A"4_B4&I]]O=H MJ,>C@\@TTP/%+&,QKY9*B1OE4ISUKV_PUI[:3H5G;.V7C3YCZYK T?P5I7A> M$/=R1O(IRKR'%=!;^(+&ZN1;Q3I(YX&T_I3>I)IKU-.J,,=^,<>M25)04444 M %%%% !1110 44F>:0-VZF@!U%9>K>(K+182UQ*H?&0@/)KBYOBQ(X+0:>P1 M3U;O3 ](HKSRU^*A9E\^Q(0_Q*W2MVW^(>C75Q;V\5QOFF. H'0^]/E8'344 MQ7RQ4C&*<34@+1110 5Y;^TE="T^#_B ]/-A*5ZE7BW[65T+?X0WV]MHDE51 M[TUN)GY]PJ(T5MH; P,USOCS3[F\M[:*W#,?O?+S^%=0-L-JA<$8/S;QC'O7 M2>"? 7B'Q=>1?V+I\EU# V^2:1#MP.:ZHO0Q<3YVN8Y+5C%N:F4[Z"4+'8Z+#I_@G2;6RM88S M?0V\<4KK_&57!JC?ZE<:@^90H'95/2JBMF/("F3=G<>N*-HWEL#)ZUB;"*BY M)<@_[.,@_6O./'WP.T+QL9+FWB^Q:G,.=HP*])8E>%XS2\2("_WEZ,>M%Q-' MQ%XV^&>O> Y&CO[:26T1L)<1J2"/>N81T&FC( M\SH>1TKZMUGX9CQ)XH:_NY@8&CCVQ0]6&!QFN9^&/[,,<$<5YXFE:21#N6V3 MC:17T)::;#9PB.)%55 49ZX%*4KC2.6;P_;^&='VV86Q@C(S&JYS]?>NBT/: MVG*<;58DCWJ#Q)^YTMR/O,PSFK.A+_Q+4+#'?%9E6+VT<\W2D9@K*)&)X7DY^F*\ZUS3]?\ M6^)Y=/>YDTC0X%#-+ _[RX;^ZI[8JXJ[,YRL>A[@V?G;)YVGBD#?Q$?+WKR* MQ\2:KX4UKQ+H<]Z=8DM;/[7;2.>4XSM8U?T_QKKMG#IEYJ\L$VGWEMYS1V\6 M&B.. 3WK3V+;T,G745J>FM=0HR(750YVKN/4^E3[AP>>3VKQO4+[7[K4/"UW M>30BSFU10EO&N&"X.,MWXKUR28+U^4J2<"E*FXNPXUE)7)]RYP3GMFGKVKQO MPS\3K;0[_P 31:U<3/)#J++''%&7;R\<' Z#WKT?3/&&FZII3:G;74?K\;O#4>E+DEV#VL.YTM1.-V&(^;'%+KF:VT^65;B,9,= MS&8F;Z ]:J:I\5-&TG4);*6626X3E_(0N(O]['2A0DQNI%';0D^6-V-W?%.K MSSX-^(IO$.E:S)>)/VJK.WF:'1M.:\7.%N&8!3^%=%'#5:[2@CE MK8JC0^-GT%Y@/0TX?,M?+^F_M8:A#=#[;I"30YP5A8 BO8O /QBT?Q\I2Q+) M=J/FMY."*TJX.M1^-&5''T,0[09W]%0+U M?1/'6L/Q1X9M?$UFT,J@3X_=RXY6FG81\N7WAZ:')4LJIT*U;T+QIK&@R*RW MDS6GW7@).2/:N[U[P7J'AL,9XVN;5>3,O.?PKEKW1[?4E)A^2<\JW3%7N(]0 M\-^,-$\0VZ!M6DM+@CF&1L$5TGV6PC4;M7>3=TP]?,E]ILUC)Y6^F7T"WULQVIQE_P Z7*%SVE;.P0\:NYSVW5'=65F87\O6 M'1E&X'=FHDGL(V^72)$W]=PX_.LBZ\;>&]/U".P:U8W#MC9&-U*P'#WVKW%] M<7,=Y__P"JI?&D"P:LDZVTEO!(.!LX MSVS5.Q8R0-&DF74[2/4>M/H(]UT^ZCOK6"XC^XZY%6Z\_P# 'B;*OI3P/^Y/ MR2>J^M=ZH^52#D5!1)135IU PHHI/>@!:*CFFCAC+2.L:]GE M[;3W%W>=-W\*TQ'8ZAJ%MIT)ENI5B0=V.*\V\3?%28\XYQ5AKM-+MQ) M=786",] TE" MWG399_>M]=RR-@%?[N#5M!<^_;.ZBO(4F@E6:%AE74Y%3\5\S_!/XL2Z=-%H M^HRD6Y/#L>GM7TG#(LT:21G*,,CWK!HHFHHI*0Q:X;XN_#2W^*GA.71[B=K; MYM\-0">*;=7D]Y(7N7);L!TJE< MINM)5R?FC(_.DVQ'G$,DKVL4<:YDDZ_XUIZ+J0TO5U7;MD>M4(].5D9?,7IG%!;Y M0>E8O@LW[>&[4ZK%Y-W(O[N,_P S71Z?87-\QCB3<_1FQQ0QHK]>G)K4T_0+ MG4MI8;$K>TGPO#9@/<8DDZ[>U;RJ%P%4!:DHS]/T6VTU1LC4R_W\A,O'/"]Z\]U[X.Z)KVNMJ4YNEO&&/,AF9./3BM8-'-6C*2T(_"_P -DMM' MU6*_F-YJFJ1M'>76?F (^ZOM6TW@NW2UT^WW-]GL+<0&/KYB@8%-\)_#73O" M=T]S:SWDK-_#/.SC]:[#9W(YIRFT]!TZ:Y?>//X?AT([BQ9KR22VL9_M,$+' MHW8$^@ID-SX];6HEN+"Q73=Y+L)1OVY]*]#V+TQ4;1[MS,HQC'%+VFNH>QTL MCQ[X8Z3;3:[XQN_*5IY-3:'S&.[Y<#@>U8>B:Q8^'O#?C)KJS4V46IO$MM&? ME=R< >P)KV31?"6G^'FO6M5;-S,;B3_>-9C?#G1GT[4+3[.TEOJ4IGFSU#'O M6ZJJ^IS.A+H>4>.Y?$)^%\SWMG8:/IVQ3';0R!B<_= /K6MJFGPZEX^^'7GP M^:\>EAU20\=!UKJ9/@SH-S;M:737%Y:^68P))20I]<>M;'1?$$=DL:VJZM,(_+Z$<5ZH>%/-<[X( M\':;X+TZ:STN!K:WDE,QC8Y.X]3FM^X8K$Y R:YI>]+0ZX^[3/D;]H/X@3:W MX@GT6S;R[*R<;RO)D8GH17$>)/#%AX86&)-3:XU+8KF%8L1QAAG!/K69XE=I MO%&K]2S7),M727UL? .H:?J>C:I<3HRK/&VW;O'=36&-%8')O+ M<_\ J2YBD1DCFO%FV+^Z53E5%=$HJL_>.6G5>'CS0/N#X>^*H_&7AVRU-&! M,R#<\[.BFN\INW/U'2G=H#YXUG1[S1U:#4+"?(D9?O<]J^M-0T^VU2!H;J%98SUW"N<\4>"[6^T'R M+2!87MP7C51@-BJN2>8>(/'VN:M9SJLWV.V(QB,J)/:/$%G?>*/#OFQ7 MMK.87\UA$?6DWES;I"1SL)'6N+T_5=1T*8+;7LGXTK#.JT.^N],UBW%M(!YAV%FZ;.U>E^3K2RAOM$)7^Z#7D;JDD M<"EF"[U^8=1S7IS6^D!1_P 3*92XS_O'_"M&QU#3K ;/[1>3_>I#.@W?E6#X@\::?X?0B659)N@1""1 M7F/Q/^,$OFOI6A2+NZ27&?NUXY+>322R.]Y-@-&H>.-3URS;^SX? MLSQCG;U>M4D0SL]8\4Z=X?M\R.DCKQP:\N\2?$2ZUJ1D@L?1]/:^N0Y!$><^U:EY M#+?1!%Y458M%^QVXC&!D\FK$:4;+"N(^ !@TGF@Q'Y@&S5)K@PMY4?S2-VK< MTKPS>ZD%EF411]#QBAB*EK--YR-;!II5.1MKZC^%?Q,>:SL=+U%2;ACL1NPX M[UX =2TCPRIB@'VBY49.WUKT[X"V-KX@MY/$FK3&*XAG(@@7[N,=ZB211]); M_EW'@>]9FH>(K6Q0X<._917-:AXHN+Y2L:[%Z5C-&&?>6+/Z&LBS2U#7I]2R M7_=Q]@M9Q;"X''OWI#ZDX;TI: $4,QP#D]J)G587E=U2)#\SGI]*7)'1%'K7N.G MZ9!8;EC3YUY,C#K2*,/3_"+R;7NY#L)W>7Z5TUM:16J!8D"#VJ1@&X/>G4A@ M% I:** $HI:* "BBB@!*6BB@!&;:*B8_,*E(SQ36QUH]1-7&-G@C@=P:9)(% M0'^(_G3F8G.1E?6O+=<\6>([[X@7/AW1Q! %M%E%U."0N35PCS*Z,ZE10T/3 M8[@,6(4[13Q.PY(X]:\?T7Q9XV\0:EJ6A(MC:WFGE=]Y@XD';BM3PO\ $+7= M6T#5C+9P2ZUI\C1LD8(5\'@UI[-LQ]LNIZ@9-V!V(ZU%YGEMRI4'@'->+:WX MX\7>&K-=:N[[1KE4 \W38WQ,%)Y YZUH^+?'VM_VYH6CZ+#;J^I6PF\R[!(A M)YYQ1[&6X?68['HMUXFL;77+?27F'VZ92T:'^(=ZT/M"HC.1L4C;CTKQ35M6 MG\/^/-(O/$EW:^?:V;,TD0VJ>.@SWKK_ KXNO\ 4-*OO$.HP)::4(3-;QK] MYT )R:N=%V5C.GBDV[GR6,SS+"LC",,QP"Q["O* M(?'GBK4M+FUJ&[T2"!OWD-E*^7,8Z'KUQ63\1O$E[XX\-^$[[39K>."34HP. MOS3CMQ_#UI?5Y%?68O8]WC(8#:/E;K[TLF-KLZL0#P._X5Y9KWCSQ!:ZWI_A MZ.YTVQNW@\RYO9P5B],)[UTO@75-;O+FZAU>*&:*%L6]_"V5F%1*DXJY<,1& M3Y3LD=5^[\PQBG?>C/O20L'7CG/)J7;\OI6"=MSI:Z'Q7\&/',URJ[- M.OB6W8.%.>,?#ME:2QW>GW5N;1XUVPJV6''/ZU]D^,/".F^,M)FL=2@$ MJ2@H"!ROOFOFSQ1^S+X@TNZD&C2G4+,G*HS8?V'-?58/,(N*51['QF89=.$N M:DKGD-I;+>7BVN](MW'FR?=%='XF\/VFGC2=.L)$OK^X"JWD'//M70:;^S]X MUOW$%QI;68!XFDD!'Z5[3\*_@+9>!W6^U B]U=OF\UN5C]A75B,?!+]VS@PV M JU7RU861UGPA\)/X/\ !-I8,NR8L99%/4%J[9H'\Q&W [:+>,)CWYSZU,<8 MSC-?(5)\\W)GWE&FJ5-1[#UZ44B]**S-QU%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 44F:.] "T4UG"]:1) ] #Z*2@T +12"EH **** " MBBB@!K8[T<9]Z5EW4FV@#QGXJ:'_ &'>R:E"#Y,V2^>@8UPWAR\NM98P163R M[ 6$L8^7\:^C]8T2V\06,ME>Q^;;O_#WJ/1?#MEX?LDMK"W2&)>O')JKBL> M-:PW 82PJ64Y<-P?^'=,NYKRVEETV5[-3E@P_*N]74(?,"G0I,]SBMW4+6Z M:,+:S+$!T3&,UC^3XB6,AYX5.>#D5+*(UU*+<<:"X/T%9_B'6HK/1+^89$L3?\"%87CQ=;C\(:LTTD9@$!+_,,XI"/EG0]'DTJ;4# M+=R7DM[,92KG.Q2YKH-+L[>\T]+C1KK[7:1C.Z M(_O ?>N4OF5=/NHI65%$+9.>.E>(?"'7=8T/X@/#9ZA+';2DXC^\AK01]!>( M-'&LPEXT1=0'W%Q@O]:Y2U\.OYQ%R=C(?F0>M>C)JEOJDD401%/4MP M/KGUKL%\/VUK;K+?R@-U*]?PK/U/QE';YL]/A\N$K@R8[U8BU#I^F>%X1)=D M75T/Y^F*Q]:\77=VX6!_(B[(M8;23R2/'*[2(W\;'YOSJNL8CR"=Y'0TA,GW M?O7D'^M9?F/K7T/\!0J^"P2.KG/UKYU##83MPV.M?2_P9A6/P+:D<;_G-1(H M[?U9%V$8A>*3/EG+?,>V*GL;*>_FPD9;^5=7I/A6*V M'F7 W/\ W: L@TUM['SI3ZBM:.)8EVH J^U.5= MM%PL"KTXQ[4I&:,'UI:DH3[M%+10 4444 %%%% !1110 4444 (:1N]#9["F MD$G- $>SYG';%>9Z7IMTGQ>U:]D@D6V-A'&CGH2&KU J2.F*:;<,^[H>]7"3 M@K&-2FJC3/+_ =IUQ:_$7Q3I."Q/7%-,;,.>N>H-:QK-=#%X9,^:=>T[2]6\(W TKP]< MWNMK&JSW5U"R,IR-S#/7FNVFTBY;QCX2E\F0QQ6*J[;3C.!U/:O7I(G?J%(S MT([4+;[8]N-P]#5RQ#:(CA4GJ>4>./!L'B;XDZ4E]:_:K"*W8.-IP"1C.:I> M']%U&TT_Q!X$OEFGB^SL=/N\$*T; X3/J*]>6UE,R.2!MX/J14D=NRL0>5ZA MCU%)UW9(/JRNSYVTFUTC2M&CL;OPG-+KUFGD*@A8I(>@8MTK>\5:+O)Z9Q33"WF*0QQBJ>)DQ+!Q1XWXJU6U MU3[!<:MX>DU#P]<0X600'SX9/<=13_A#IES:^*-0N+$W4?AMH0+>&ZS\CYZ@ M&O8&63<0 NWOQUI(K=H$";5;/H,5$JO,BH8?EEXP.&P*M1*&C!J)K)&ZKFIT7 M8H 7BE9KJ+7J&W\*=C(%( 23G@4Z@L6BBBF(**** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHICG\^M #Z*JJS;68N54_FMJ_"O]K7X:_& M">*ST+Q);Q:K( QTV\;9*H]NU ['M7>E_BJ"-BR\Y4]MW6G-)A2(K83:?=KXLO38?>EC;E(&/. :49V\\F@!<9S45Q; MKU[19K"UF:&Y2/%OQ@9 XKYFU;2+GPW>K M:3Q-'.C%2W][WK[;U*V@M<(NGK(AY# ->@S:?^ M[_=D)NZAQFN#IY>>16I".WANI8;@M"JX/\ "U%YXB73 MH6>&(_:?TJL"& (R*I:Q_P >Y% S%U/4I]6+-/(ROUPIJBK-@(QSCN:7=\N/ M>DVC<2:L@DQNY;-1]S2[CP!Q1C,A8#<,8H 1>< ]37U3\,;<6O@G3!V9,U\I MQDLRJXVD,, ]Z^R_AGX9NIO".E*5\N#RP2S?>_"LF:HLK')(X2"/<:Z'2_"; M2LDET<#J5]:Z#3])M=/4>6FX_P!\U?ZX-8ED-O:0VJ;8D"+].:F[>M.HH :. MN>].HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@! :2 MG44 )12T4 %)BEHH 3\*0-\N33J* $%+110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4R7[O^>*?3))-A&>_&* /-/CY\9M/^!7 MPRU7Q5J*>=);H5MK=" T\A' &?S_ K\4_B3\5/%_P =/%D^N:W?W>I7R8Z,0=N*^"? /CJ_^%?C M/3_%.G16\NH6*L85N$\R(J1@@KZT#1EV?A^]U#Q!;:3':!M5NYE@2.92I#,< M#BNW^)'PGO\ X0BQU"V\1QW\TKLC3::K1-:7$?WD)/)P:^@M%\#^ /B7\5O! M6KZYXA?PAXEUN&*^BLY!B-I0*[HS>(M/@WPW,I^:YB''Z5]I[N MG SC\*_#/]E/Q/<>$?VC/ L]A+($N+](+KU*=Q]*_NZA8KJ^I(9X9OWOG2R^->J2ZM\4M:#GF<[6]*J_%?XEV?PI\'3^(=0LKB^MHV53#;X MWY)P/UKRW]DW4/+T_5M..=GF^:!Z5J_MB2E/@CJ953*WVB$I&#C<0X('YU\- M6H\F(<.A^B82LZN'C/J54_:*)/%7AV#4Y] M+N-&>3K9W7,B?7%>1:)\6OB9'H^G(OPJN)0($S)]MC&>!S5OXZ^,O$VE_";3 M-4M$?P_K]QJ%O"8@P;RU9L$$UBZ?O61V\Q[CYRL"1G'KBF?:%(.TYQU.*^G^)/A5;Z!XH/BV^U&2ZU"&VNK&<[K<^9_=7M6[XBOM6^)'Q$OM MM5NM$T M31X%DN)]/DVRM*PR 1Z8HC2N9SJJ*/3;'Q]:WWCJ\\,B"5+JUMA]>C/\3?#UQ;WT MMC?07@%>7Z%H?B/QIH\7B&7Q'>6=W= RVMO;MMB1?X0P[USWBS5M0\;?#F MQNK^[FBO;34OL'_M7?$*'P7X'M[(*OV[5IOL\+L, M[,OTI&8E?,VXY.%QUJQ"$U#:EE%),8K2.21XQD!C]ZHH MV5I&*L08^BM6S(L(RJO*G<" 3]:H:P?]'ST&*O;BT9+<-GD52U8C['@^E-$L MY;JK''0TC,%4DY'X4N&:0L3A!VJ6$37$WEPHV#P=HR35.Q*(=Q !QD'O222/ M;VLLH5O)B&^20*2JKWYKUWX=_L]ZMXN=+B^4V&F=07X8U[_%\$_#L/@R]\/P MPYBNX6B:X;DY(K&4GT-5%'RGX$L=.FUSPW?SQ?VGI]]=I I^Z2,Y(]*^ZK> M**%4BB0(D2!5 & *\&^%/[+J> ==-U?:HFH6=NX>UMPI&P^M>_[=V.R@_G4< MS*L/53QSCV'2EI:*D8AI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "FMU&.M.J.569EP< '- 'PC_ M ,%4_A[I:LW@IM0U'P1?;B/[/D):-2>0ZCI]:!HXOQ1\=-*TW7 M[?3K[PO;ZXOA9DMM+O(W"LD2'Y-Q_CJQ\0/ GA;XF1V_C6WUV31-1\0(S6V@ MR0&422I_K#O_ ( 37SW,S0R%9(YF>,E6CD1E93W)XYKVKX(^'OB]\0K>S\/^ M#M%-];-(RP7U[:_N[=6^\Q<_=H*-/]BGX97GCS]I+P];+$SPZ'2@/I7ND<3KD M@%>.E"]U7)G:3L?'?[0^@3:'\0+NZ5@1J'[U6 X/J/K7)ZKH%]8V]E-$L\EK M- )1,HXCSV-?77Q*^'-KX^T=K6:#9/DF*8#E#BOESQ1X%\8>#VDT^\BN[NTB M^Y,A(3;7U^7XR,J:IR9\)F. DJKG%:'(I=7+XC3?-*WR[.C'Z>]:^I^'K[3M M%@U&\>6)IOD2.48*8]:R;6.YNK@&VBD:<, BHISN^M>J> _@[XD\=7=M)KBW M5MHBG<5N&.\L#[]J]/$8BG17/&1YM#"5*DN5K0]$_98\-R6/AV^U6;)%U(!% M)G[R@<\?6MW]I+P7K/C[X8WFE:);I#'=GC_>KXBK7=2LYGW^'HJA0C \*T[XA?&'3]/MK9OAG;N8 M80O.HK\^!C/M5CQUI7C+XK?"_38[W0HM&UF/5;>XEL_.$@$:-D\]Z]KR4/R\ M[CP6/\J/ED.0V\]&P<&L.=WO8Z[(\W^-G@W5/%WA/2;+2XU:XMM0@N65FQ\B M?>%8.L^%?$/@WQY+XHT/3%UFVU&V6*\M?,".L@& V>XKV<1GH?\ '(I/+.WD MY/0$#'X4XUG%&4J*EN>/^ _#/B/4OB=J/B'Q!IT-MIUUIGV:*-6#%!NR58]Z M[>;X8Z!'9W4=IIMM82SQM%YT28;##&?UKJ8E(9B5QGH!T%0?8Y/,W>8Q/O1* MHY.XXT8I6/(])/CKP7I9\/0:-%?+"#':WQE &WMD4Z;X9ZG:?#^STH,K:B=0 M6]GP7P?IFJPVW] MIZ;;7TT:CYYT#%?I716=K!:6\<%O$L,"#"H@P!]*5E.[*C'K3UX4>MU24%BT4E% "UP'Q<^#^B_(+#6%D46[^;'+$VUE M/L:[[FFL.N>GM0!POP[^$>A?#?1WL+&(SB88D>Y.]B/2N=\=_ 73M;\VXT9O ML%^>=I^XWX5ZR$.XD?3FI-OH,GM5-B/BOQ!X1U?PW?#/PA>S">Y\,:1+*#][[ M%'D_7CFMC3M(LM)A:&PL[6P3.-MK$J#'T K0V@=*&4=Q0 1KM7KFE_6A5"]! M10 GYBJ=U9I=,P=5D3'*R#(J]367=UIW:V)DE+1HR8=#T^-LIIMHK+WCB4?T MK150F% 7L*D"A3_ #HV@=*5W+J"C&.R(F!QSSQWKR?]HCQ5JGA7P78WVD78 MM;DWL4;<=07 (KUF3[Z@=*\3_:NRO@'3@,C_ (F4(X_WQ3I+WK,F;9TMUX@@ MTOXC2FYUU]L6FI*VCJN0,_\ +3-OW(%KA&$ M91\SSZU2<7='KO\ PN+PS]J:$7_ ;8)%!*,WIFNVBN%E6.13OCD 8$?2OG73 MM-\12^!+>S2+PZFE36J 7 !W+D5^&OV9_!?A;Q2^N MVEK()V;>(7/R*<]<5ZXR;@0>AHV]NU ./IV%+1M'I2T %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 (3BCK110 M%%% !2444 )NHZT44R4W< M:W;TS7,>.O .F_$;2H=/U)IE@BF6<>4V#N4@BBBG'38IC5^'>FIXZ'BP/-_: M7V1;,+N^38.G'K1H'P[TKPWI^I65NK30:C/)/.LYW E_O#Z444^9D.*>YS7_ M HG1/,,4=]J$6G,VXZ>DV(3[8]*]$LK[2*&W010QJ%2,= !Q113G)N.K M,:,8QV1:48:I***QCL=(44450!1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '%%%% '__V0$! end GRAPHIC 10 form20-f_002.jpg begin 644 form20-f_002.jpg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end GRAPHIC 11 form20-f_003.jpg begin 644 form20-f_003.jpg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end GRAPHIC 12 form20-f_004.jpg begin 644 form20-f_004.jpg M_]C_X 02D9)1@ ! 0$ E "4 #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" 'J Z(# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH *3:*6F;\-CK0 ZC-&332P^E #68)G)J MM<7L=JA=Y$"*,DL<5C>,/&-GX1T^2ZNG5 .%S_$:^5_'7Q3-%.;*QW M;0%.=U=^%PDL0]3R\5CH8=6CN?4%]\3?#^GMB:_C!Z<,*73_ (DZ#J3;8+^, MG.,,P%?$[2^U3PSJ*P7<[7UFQP%)Y4>N:^I/"OB:T\2:>EW;R+ M+&1RPKPZV$='4]W#X^->T9(W4WKW$ERCE84^HMRKUSU]*<9 M/?Z4M"AQI.*"P[TU90S, ""#@YH#47)[4+G-(9EP>^.#2[ANQG!%+0-1W<4M M1[ATYS1Y@XZ@FGH ]J3!I-_RY'-1M=(O4X[ =Z!ZDO)H P:;YHSBE60-T(SZ M9I63#4?24;J V:H0FVG4E+0 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !3%7YLT^HF8KD8H$QS<\"J\TFW'/>I58[,^]9/B"XD MMM/N9XB T43,,_2KC'FE8SJ/ECS'R]\OI]K>3O-M*R$9 KC]6N&DU*_GRIEEF9L,W(+ MW3O$'P];45L(-.NQ<%56'&2OK6Q\!/&3:+KPTFXE9[6=/W2^]<9K'@>^T73# M,^HV;QH?EBCESU]JK>#KN2S\5:8478WG*-W7OVKDJ4XU*#;.BAB)QQ"1]N-( M4\G)SQR:\;^(WC;6-!^)>FVUO*JZ-%'YMWG^Z3BO7^98[9N@P":\B\1:/%XA M^+NJ6$XW(VCM\ON#D?K7R-)13:9]I7G.4%RGH?C+Q&FA>$;W4D/2 >6/=N!^ MIKE/@GXGU/5/"M_-X@FCDN;>Z96R>$4I4G&":Z/91Y;-G"J]5S3/:+/XC:+->"U2_5 MW=N)#]WZ9J_JWBRQT6+S+N>.!#T4GEOI7CVI:-KS^#4MWT[1;&V,0,=W]HP4 M ^ZV?6M*WMUOO'&@6FJRQW-LFG@IN^Z\@'WAZYK-THK4Z8UYL[FZ\=66IZ'? MSZ9&]*.L7ZM?S!M\@^Z#DBF>)M)\-VUJ*3U/3KWQ)9 M:99K=W$\*6[='!_UGTJAI/Q TG5[X6EM.K3D$HCG!;'7%>875Y;)X#\"QW-H M=0U.L7_Q M TG3I)8)[E%EC&70-R*@D\4V6M>&[R^TS4(TCV8:X#;O+_"N)\#:3;:E\1/% M_P!KA2Y:%XU7S%R I%8RPI9-\1;.T1(;2,H0JC 7CTJ?9QO8OV\[7L>HVOB" MVTOP[;37^I).@7(N"=GF>V*?H_CG2->8BUG22X RL;'#8Z9%>6Q1P75[X"M+ MPB6RD7>%;[K28Z&NYU+3O"FG:[;74\:V^HK$ZPI"=N5 )/3KQ3E3C'1$PKSD M][&GJ'Q'T#2IC!)>J'4[&<'(!]":QO'7C">SLM'FTJ6,-=7\,9D4YW1L>:XN MWFFU#0KV72/#NGKI$GF,9[F;,C>YSWK'L6EF\$^'/-"NZ:O&BKGA1NZ ^U:* MC'EN9_6IN=CZ2W$Y"\'WIR_+T%,7.WU.:?V%>>SV(_#-IM"T5M,N-+2YC23_ ):'OZU]M1KJO221^?8C"_5ZTFV7Y;,_4?;K@="/NBO*Q5 M?V5)Q/9PF']K54CUR./=&BG) Z5E6_A6V/BN77-I^U-#Y/X5OQ)Y>3G(J1< M=1WKX_FUNC[E4URI,Y'3? .FZ'XIO-:MHR+J\&)/2IM,\!Z9IMEJ=H$$L-_* MTTD<@XRW6NH8!N2>:CEC\SSR%[."//A\&=.VQP->W,EC'()!9L>W&V*:(8*+V KKE7;QD&EX[4^=D^QCT.%T3X7V.F->R32 M2WUU=1F)[B;[P0]0*T;3PG:V/A6;1+="EIM*#/)P>M=,V[!(-,9ACK2]I):# M]E'EV:HZ'3QBVD4X:,GN*;:_"?3EU*TO;J:>_O;= M?,IDS_L],55;P#I[7&M!$TTQE=$LQB&9.'0^H-5M-^&-GI]Q)=3RS:A=-&8O-FY.P]0/2N\QMSS3=P M7GDTY596,GAX7YCS^U^$.G6]O/:1W,\>FR?=M W">HS5VW^%6E0:7:6&UC;V MUR+F-2>C Y%==(^!N/ J!;EY&&T\4.K.PUAJ:U+QZXSS3O:HO-);!7GUI-PC MR7>L]S?R)Z6F(RR $'(I] PHHHH **** "BBB@!***0L%7)X% "23)"NYV"K MZFLU_$FG+-Y37*@^N>*XSQQXL/FFWB.(AU85Q1L[Z\LYKY$ M(;J*XC#QR*ZGNIJ3->(>$/&$VE7R.\[26I^4QMVKV:RNDNK=9HVWJPW?2D,M M44BXZBEI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ I*6B@!K*",'I31&%[U)10!5N+=9U9&CWH MPPV>XKR/QY\ =)\03275D?LL^/N?PU[&V?X>M,:/1\AZM\!?$UA,4MK1;E.S*^*DTWX!^)M0=$N$2S /S$MN.*^LI-JMDA0N M.F*I7!!;?"FU@,8]:]+^UJLERGDO**2=T>=^ _@7I/AN1;FZ_P!,N=HZ] ?I M7J<%FD*A5+;0, =JBM9AQO4(WM5W'OG\:\RI6E5?O,]:CAXT5[J(6#+QGCWK MR_7/''B23QQ/X>T5;5!#%YK2W"D]Z]2?!#U86GV+*S% M."<],TJ?*MS/$\[MRD&H_$#6[CQ$OAZPN;"VNH8!))O'. MMZ&/$%A]A2Q8&6.QDC)ED0= &]36I#\1M0M_%NC6%_#';6FIVQD1<9=)!U4G MZUS&A^-K[PWX7@\/2:/>?VY:Q>1$5A)A9AT);TJWX_M[V3PGIVN7*1P:KIH$ MTGE]!ZC-0HQ;-93E"#E%[&] M/]7TW^V;6WL!9R?O([!E_>E,]-W3.*9X3\+W/B#X9W1N04U36@9I)/[_ '4$ M_2JNE^.-2T'P_%HQT.^DUR(>4D:PGRBAU%Q\8-1;P,VL6\$#7T,_D2P9W!B#@D8KK_!5[XDO(/.UR:S: M.9!)&ENA4J",@'/>O/M6\.WDG@&%ET8:;=2WL*)I+?2Y'A_U MBD9^E<;H?C6RU*ZDMH+M8KR,G*R],^E=7XSN/LNC22*>=R@@^F:\JU3PK97P MFFLT\F[D))=3T/K6JV)/5_[8EEA<^3Y>U,B1C\K,.PK@O$GQ-1K>XM] !U.] MC<*5'0'N/SK"T[POXAU233H)]6QT3P?:RSE([0/DM(/ MOLQ/I3%<['P7<7]QH4$NI1^3=R1;O)UVC->8>,O%BZH MT=NHVJOWN<4"9S5YYFJWRP %C,W0'I7L6CZ/#8Z+%9O&"I3#*>]>9> 7LYM; MWS95T/ ->OC.TL#P>138SQ3QKX-E\*WS7D"F;2YCE@.JFMOX<^*9+=OLT[%H M&Y4L>0.U>C:HD36-P98UD0(258<5\VV.L7#:]?)!\L"N1N!Z4Q,^C[77+.XE M$<D2_G2-YG:-:%)DV0P-%D;9G!]ZNPZ@ MD+ %RU51YG>-:/+E//EK0]0N;,-TL^"H'/ %."C)Y+#/'M6,K3P@E5 S5JUO M7QAEP?K18J_H>1I#9%S:[/]:/3-=_% L*X!W?A39K59U*EL C'2A. MQ$J<9;F=80+IMG%#AD6-?+51T4#@?I6B&,F'4Y&,8Z?C4<.GB#HY;_>.:LA0 M.0?:ANY:6EBI+<)&P7) S^M3*PDP5/'<=J=]G1F)[T]8UZ#I4W86&+&J].YR M>:D&/2EV@]JC9BO44%$F*6HFD"YS\OH352ZU'R85/RB3&6C)YQ0D(H^,K>.Y MT619.FX8KR^:UN+"28PONCX.*[[5M4^UVK>8#'$^ I;U]:\.D^*C:+XWUG2[ M^)?L=M&)3+[&MK:$G5WWCXZ3;B""'-U(,;/2N,NKJ^U:Y4SS":Y9LI"W1:ZB MZ\'Q^.M)@UK2;M[>8C=$C 8DKDK>*\T'7X(M6B6SN-^/._@_.E<5S7T3Q1J? MA&YD\MY5D)^:%_N_A7KOA7XI:?KBK%,?)N<8.>A->1P^)H-:U*^T_6$MXHXU MW17$1X;\:9?>&9X8UN=.?[5;=?W)^=?K4VN4F?2D;"10ZE7SZ'M4E?/GAOXF M:CH-PD%PWGQKQM;J*]B\/^-=.\11*8)E2;H8G.#FERCN=%14>\]#]X_E3UZ< M]:@8M%)2%C3 210R%3T88Q7E_BSP3>S:@&MX08I#C(GTFW6"([97 MYWCM6+X(\5ZEJ%\UK,GVF(W/4UUHSC!&*1FV]! MDFJ]]J5MIL9DNIDA11G+&@8S6;)]2TRXMHVV-(-NZOGGQ-X5N_AZDYEFCEEN M&RF#SS7>>*OC9;6_F6VEQ?:9>@<5YO-'J7C'4$N-3+LZG*1C)%/8-SK?AD\M MSK5DZ9\U?]9CTKW.N)^'/A-M#MFN9D"2R#@>U=MBD #I2T44AA1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-Z MT%L?2@!U,DE6,M B/=%_SW-.6-9. M5E8CZ5>M;%F^:1!5^.%(E.!Q]*!F$80O64BD+*O'G&MV6W29>E9UQ9LK96/. M*!6*?RJ>9N*-J'I-@TKJ=P)@R:/G?<%MUJ@'K.;=A^]S6A;Z@C<%]QK-\Q^, MVR\4NZ3M H^E#&;RL&Y%.YK%M[J:$_ZKBM*WO!,.1@U([ECZ4(([68Q6L+ZA=@9$,1 M&!^-<)XV^)D?A>-GU^WETO32A\L(VYG8?[0KRG7_ !%X@U[5+9? 8N)M-EC\ M]FD;:5/A:I\5-&:\:QU;4)K?568I]DCZQ$#(S7%>%?B!XB@U;4-? M\16VS'3<,X'%9MGX790S GS!PQ'8#M3$>?\ CCXM:YXDN62VF:PB4G$+#! '2N$O-0N& M_M&[NV%S-=6_E[O7VKTOXG> [YKZ76[4+/;S';LAY*X^E>;*H\X1R@8[K(,5 MJA'N/@[XH:%X'^&VG"ZN6FU!8QY=O_WECAA[T))ZCT-=MXV\0Z;KW@?2]1\/6[6^VX:)9R,%MH_E4L9WD>K:%XF8(ZFR MNSRHF&U@U4KO2=1\-W/G(6PW(G7. *X33?$,NI6:MKMEE!@"ZCX=6'W<5Z/X M-U2XO_#E]%J-W]MG4?N\=5C[9I!J=7X1^+DUFJ6^JD21#@2]Z]9T?6K/6+<2 MVDJNI[9YKY89%5WC:/@_=.>E:6CZYJ&B7*/:W+1,.!SP?:IY1IGU)D4QV6-' M/91NKSKP?\5HM5N8M-U",17IX&WHU=_?1M-9SQ(<,4XJ6K%'D7C'5FU#4I'# M8"MM'O74^#[-?#GAZ[OYG59F4L-Q]JX'7HI[.^V.-K@[@6Z&N?U"XUC7IPDM MTRVX&"D9IDGH?@OXPC4)WM[] D:N1YYZ=:Y7XH7%_K7B6,VK2RZ:_&$SBJ'A M_289K^*QM$\V1A\_L:]VT'0;?3-+@ADC5G R6(R:!GE7AGX7S7)B=8?+B/)= MJ]/T/P98Z+\PC$TIX+,*WEPN%4 */:G+WI#0@7:,#IVI]%%(84444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %(QQ2U%<2"./)5F&<87K0!X7\5?VE] M1\#_ !3T_P !:!X-N/%6L7=J;K,-RL2*H&3DD5S^H?M>:YX+DM+OQS\-=2\. M:!+,L$NII.LZPDG +*!T]ZXCXRZ]XH\._MK:#-X-T*+7]7.CN#9W$WDQ["OS M'=ZU@?$[XC_$SX]^)+?X)^*?"NG_ Z&J.D]Q?27_F"Z@4Y,]?(7[37Q$N?!_B[X??"J#6-0T M70IM/66_OM,C+7+PQ )L&.5) SFL7X8^/U\$?&KPOHO@>^\3ZUX-UPM;7L7B M!6E-M(!D2"1N0,]J /MH9^EQ\/76N_;+M+>06I_P!0C'!D M;V%?%?BC7;23QYXOM?B]XB\8^$]92^D70]1L7DATU;?_ )9LVWACGK7HGQ<\ M6ZWHGPG^%DNG^+SK4TVNVEJ^N6$NU9XBX!1P.N1UH ^OF9AC:N[U-"2,<[QM M/I7R!K7AG6_BQ^V!XZ\*W7B?5--\)VFE6]=+^S5<: MMX+^+_Q"^&ESK%[K>B:,89M.GU"0R3*KKDJSGDX- 'TVK;L=O:GU&K?, >N* MDH **** "BBB@ HHHH **2B@!:*3-% "T444 %%%% !1110 444E "T444 ) M12,P7DG JG>7!VX2@"Q-=)".2/SK,FO2QXE"BH))I#]^$M4?_; U1(\L3R)E M_*F%=[9\[!IOS=H34@;O]G/Y4F-#2H&,W!IVU#P)F-/5F9L"VS]15RVL]S9: M()2&5([-IC\KG%:5O8^6N&8M5A(43HN*?0 BKM7% 7&>:4\TM "8HI:* *T] MFLN<'!K+ETZ6%B1(U;G?I2,H/8&@#GUC3IYY&.M! 7D3?G6G=6$;#*1C<:S[ MBW9%&Z$Y''% #&;Y0?.I/-9'"K.%D W%2/X:3=M7'DG(]J\G^*_Q/6Q9M&TE MQYCC$US_ !*?2J)-SQ/\?[+PU=M;P6IU'8<.RMC!]*Y:3]KBWCO%B;1'CC/5 MF>O'69G9R3YA>-VS^$+_6MSPKXF.GZK;_ M &J9K:,G:TD0^Z#WHL%SOAIXDOF5V=;>-_D.>@/O73Z!H,^N6][ M'I]RVEV0PEO;1G.![FM_0]%\*:]"#87C7B(F]YY&SENXK,771:WT@L5CC4-@ M01GL.]%ABQZ3#X/OHD,CW-U&F*T_%FI/KRPO9MB$)^]C/5S63J4;Z[ M-]N@N5@N6^0QR<&JTQGT>XBM;O\ =RMR'[&J2 98Z@;?$3(UKQCRF'R&LWQ- MX=\-ZIH\UQ?1_P!G7<8)$P/!/TJIX^^( L[=K'REDN H=)5'(KE-8?5/%&@V MEZ 1 I"NW;-4(S;>U5?,?3I \T:YCF]_I6IKGC#Q')X6:WU_5(G$D1$:+'DX MK+NM&>Q9)+&1DN-OSO\ PG\*S9C#JC;+SS(KI5VQR2?<-,1@1_#\ZQI<-M$A MU&ZE?<%V$D#/2NWFFD\/Z.FFZC:265I9KEE:,@(WMZU3L6U#0O/OK*>07T*@ M1_9QN4G-:GQ \9ZUXE\,F/Q UNM\JILCC4!FR<;C4L#)\/\ BS3[SQ!;QZC* M+33$ 82,?O\ IQ[UO?%O7CHOBZS30U:V#0J^^+[DX(Z$5YU)X!::2S;8^I3) M(KL8>5/MCVKN_$&O6][(]+:XM[A[^"&!F!!)&*]9AG2XC62-UDC895E.0:B12,O6O"UAK8'G MQC=V8=:J:7X#TO3&)6$/_O5T6X9QD9^M+]VD,Q;7PAIMCJC7\$ BF;KMZ5L; M?FSGBG9!Z4>U Q I[\BEQBBEI %%%% !1110 4444 %%%% !1110 4444 %% M%% "$T9XH:D_AH 02 \8H9MJDT#VHE*X#5EWX&,4N['_ .NJ]Q=Q6<9> M=UC0#[Q.*YJZ^)GAVU8HVJV^5X(W=*TC"4EHC&5:$':3.N9FQD#/XTGFGN,& MN;T_XA:#JHVVVIPS.>R,,UMPS),@96R/6ATYQU:*C4A)V3+#2[:&F(P0O%)L MW _I3=SK@=JS^(O9D_I11W%%,8M%%% !1110 4444 %%%% !1110 4444 %% M%% !3'&[ [=Z?3)#CVH \0U#X2^(;K]J72_B&C6G]@V^FR63KO/FY*XSBIOV MF_@?_P +H\)6YTFXCTWQ?H\JWFDZI)\HBD4YVLPYVFO8RS?-@#_ (SZ3=>(=$32?#/CO0K^>1]-O->?]]:HPQL9<$?+ M6.O[)'B#2_A#X+\+V%Q8W%[8>(TUW43+(1''\^YDB]AV%?6*J(_N'++P/)YK8:)K-C:VML%;,H>--K9'UI? _PI MUCPW^T'XY\9730MI6MQ0I:K&V6&Q<'<.W->QG9N8 9/6FR2JB'/W1U/]V@!R M+^\!4=L'TJ:H8Y!M)SD>O:E^T+P?X3T- $M%,\P$9'3ZTC3 8P-V?2@"2BD^ ME&: %HHHH :W-<9\5[K5[7PC-_8MTMK?NP1)7Z#-=HPSVS7$_%9]OAVW!YW7 M48/ZT 9?PGO-Y)/&!2K7F/PA^)VL_$"6_75M$?2%A;$7F?QCUKTY/I@4 .HI,TM !112 M$X&: %I*BCN4DD*J>12R7"1#)H$25!-=1Q=7^:J=UJ0. B,#_P L,#WJ M6*$NPQ!CZU0K$>UNGVFK-O9RS?\ +0U9@TT*P9D7Z5>2-4Z#%)C1##:^5@EB M34]&VBD,6BBB@ HHHH **0T9H 6BFYZTN[UZT +44T0D49]:EI#Z4 8VJ6+K M%.ZL1\M?.'B[PSI]QXBGM(_.M-3F&]&8920_6OIS5I/+T^<[&?Y#PM>3QW%I MJTC,&61XR5974!E_&F(\$U32;W1Y#!?6[0RQ\$KRK^^:J,I."F-O< U[++X5 M>$WTL]Q)J&GD%Q;N!O\ H*\^?PF-2TN75-)@DAMU?:]K,<.#[5H0TZ#VLLEJ/XDS\K5Z/X7^(&D>))EAUE/[-O1]V>/A3]:Y)XA(C))&&4]&?M6- M?:&1@P ,GQ-K]E:WS*;V.X"C,3+ZBO/]<\5:MXEUJ6.)VFVC#5.XFDNV#2.1CL*B&2WW0N!B@ M18L]2NM.D#P/E3U3L:?<0PZYI>"6CN[-([B7>JF"3^//3%3?%KQ'=>+[:W^T:7:Z5JC.%6&,_=S_& M:R+/69K%D=E65$Z9&6!]13;JUBOIS>7-[)7&]8ES),/\ 5_A3O%6FQZMXLU:^M8A+:>?]]>,GUK2NO-O-/C,2&.SC MY0]R?"M6U"_O/(N[%[=K5[N6*VBZ5\:K*.*+^T%?S)#MRHZ5 MX?\ V>]M'YT3K;P+G

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end EX-101.SCH 13 smx-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Changes In Equity link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995511 - Disclosure - GENERAL link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - TRUE GOLD BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET: link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - BRIDGE LOANS LIABILITIES link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - PRE-PAID ADVANCE link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - OTHER PAYABLES link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - BORROWINGS FROM RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - TAXES ON INCOME link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - GOVERNMENT GRANTS link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - GENERAL (Tables) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET: (Tables) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - OTHER PAYABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - SHAREHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - TAXES ON INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995551 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995552 - Disclosure - GOVERNMENT GRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995554 - Disclosure - FAIR VALUE MEASUREMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) link:presentationLink link:calculationLink link:definitionLink 995556 - Disclosure - GENERAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995557 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995558 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995559 - Disclosure - SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995560 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995561 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995562 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995563 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995564 - Disclosure - SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995566 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details) link:presentationLink link:calculationLink link:definitionLink 995567 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995568 - Disclosure - CONVERTIBLE NOTES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995569 - Disclosure - BRIDGE LOANS LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995570 - Disclosure - PRE-PAID ADVANCE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995571 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995572 - Disclosure - SCHEDULE OF INFORMATION ON LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 995573 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 995574 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995576 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995577 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) link:presentationLink link:calculationLink link:definitionLink 995578 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995579 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details) link:presentationLink link:calculationLink link:definitionLink 995580 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 995581 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995582 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 995583 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995584 - Disclosure - SHAREHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 995586 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995587 - Disclosure - TAXES ON INCOME (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995588 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995589 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) link:presentationLink link:calculationLink link:definitionLink 995590 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995591 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995592 - Disclosure - GOVERNMENT GRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995593 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995594 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 995596 - Disclosure - SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details) link:presentationLink link:calculationLink link:definitionLink 995597 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995598 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995599 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 995600 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 smx-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 15 smx-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 16 smx-20231231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Classes of share capital [axis] Ordinary Shares With Nominal Value Of 0. 0022 Per Share [Member] Warrants Each Exercisable For One Ordinary Share At Exercise Price Of 253. 00 Per Share [Member] Ordinary shares [member] Public Warrants [member] Deferred Shares [Member] Components of equity [axis] Issued and Additional paid in capital [member] Foreign Currency Translation [Member] Retained earnings [member] Equity attributable to owners of parent [member] Non-controlling interests [member] Consolidated Entities [Axis] Security matters pty ltd [member] Business combinations [axis] Lionheart [Member] Types of contracts [axis] Business Combination Agreement [Member] Categories of related parties [axis] True gold consortium pty ltd [member] Equity line agreement [member] Equity Purchase Agreement [Member] Non-adjusting events after reporting period [axis] Entering into significant commitments or contingent liabilities [member] Statistical Measurement [Axis] Bottom of range [member] Top of range [member] Nato Agreement [Member] Subsidiaries [axis] Security Matters Smx Plc [Member] Lion heart III corp [member] SMX circular economy platform pte ltd [member] SMX ireland limited [member] S M X Fashion And Luxury [Member] True Silver SMX Platform Ltd [Member] SMX israel ltd [member] Security matters canada ltd [member] SMX beverages pty ltd [member] Yahaloma technologies inc [member] Classes of property, plant and equipment [axis] Computer equipment [member] Machinery [member] Furniture and office equipment [member] Leasehold improvements [member] SPAC [member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Accumulated depreciation [member] Associates [axis] Joint ventures [axis] Global BevCo Pty Ltd. [member] Consulting agreement [member] Classes of intangible assets other than goodwill [axis] Capitalised development expenditure [member] Licences [member] Technology License [Member] Accumulated Depreciation Amortisation [Member] Other intangible assets [member] Classes of financial liabilities [axis] Convertible notes [member] Convertible Note Agreements [Member] Bonus warrants [member] Redeemable warrants [member] Convertible Notes Agreements [Member] Major ordinary share transactions [member] Securities purchase agreement [member] Warrant A [member] Warrant B [member] Promissory Note [Member] Bridge loan agreements [member] Eleven lenders [member] Range [axis] Nonadjusting event [member] Redeemable warrants type 1 [member] Creation date [axis] Third anniversary [member] Fourth anniversary [member] Measurement [axis] Monte carlo simulation model [member] Redeemable warrants type 2 [member] First anniversary [member] Second anniversary [member] Three valuation models [member] Standby equity purchase agreement [member] Borrowings by name [axis] First installment [member] Second installment [member] Office equipment [member] Motor vehicles [member] Lender two [member] Loan agreement [member] Loan agreements [member] Preference shares [member] Warrants [member] Types of antidilutive instruments [axis] Private warrants [member] Ordinary Shares Two [Member] Bridge loans [member] Underwriting agreement [member] Counterparties [axis] EF hutton llc [member] Public offering [member] Prefunded warrant [member] Underwriter warrant [member] Employees [member] Black scholes pricing model [member] Service Provider Agreements [Member] Incentive equity plan [member] Employees directors and service [member] Restricted share units [member] Ranges of exercise prices for outstanding share options [axis] Exercise price two [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Options Outstanding Six [Member] Options Outstanding Seven [Member] Attribution of expenses by nature to their function [axis] Research and development expenses [member] General and administrative expenses [member] Key management personnel of entity or parent [member] Directors [member] Shareholders [member] Joint ventures [member] Related parties [member] Types of risks [axis] Credit risk [member] Trade and other payables [member] Pre paid Advance [member] Derivatives [member] Convertible promissory note [member] Lease liabilities [member] Government grants [member] Borrowing from related parties [member] NIS [member] AUD [member] SGD [member] EUR [member] Maturity [axis] Not later than one year [member] Not Later Than One To Two Year [Member] Not Later Than Two To Three Year [Member] Not Later Than Three To Four Year [Member] Not Later Than Four To Five Year [Member] Later than five years [member] Trade And Other Payable [Member] Later than five years and not later than seven years [member] Convertible Promissory [Member] Convertible Note [Member] Financial Derivatives [Member] Borrowings from related parties [member] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Classes of liabilities [axis] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Letter Agreement [member] Board of director [member] Stock Purchase Agreement [Member] Warrant reserve [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Location Auditor Name Statement of financial position [abstract] Current assets Cash and cash equivalents Other current receivables Total current assets Non-current assets Intangible assets, net Goodwill Property, plant and equipment, net Right of use assets Investment in associated companies Total non-current assets Total assets Current liabilities Trade payables Other payables Convertible notes Warrants - derivative financial liability Pre-paid advance Bridge loans liabilities Convertible promissory note Borrowings from related parties Lease liabilities Total current liabilities Non-current liabilities Lease liabilities Bridge loans liabilities Long term payables Total non-current liabilities Total liabilities Equity Issued capital and additional paid-in capital Foreign currency translation reserve Accumulated losses Total equity attributable to owners of the parent Non- controlling interest Total equity Total liabilities and shareholders’ equity Profit or loss [abstract] Research and development expenses Selling and marketing expenses General and administrative expenses Listing expenses Operating loss Finance expenses Finance income Gain from remeasurement of investment in associated company Share of net profit (loss) of associated companies Loss before income tax Income tax Net loss Other comprehensive loss: Items that will not be reclassified to profit or loss: Adjustments arising from translating financial statements from functional currency to presentation currency Items that will or may be reclassified to profit or loss: Exchange losses arising on translation of foreign operations Total other comprehensive loss Total comprehensive loss Net loss attributable to: Equity holders of the Company Non- controlling interest Diluted earnings (loss) per share Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance, value Loss after income tax for the year Other comprehensive loss for the year Total comprehensive loss for the year Issuance of shares, net Recapitalization due to issuance of shares following the SPAC transaction, net Share-based compensation Conversion of financial liabilities to shares Exercise of options into shares Issuance of shares and warrants B, net (See note 14.B.3) Conversion of warrants A to ordinary shares (See note 14.B.3) Exercise of warrants B, net (See note 14 B.3) Issuance of warrants B after reset (See note 14 B.3) Non-controlling interests arising from initially consolidated companies Issuance of options to acquire intangible asset Exercise of warrants Ending balance, value Statement of cash flows [abstract] Cash flows from operating activities: Loss before tax for the year Share based compensation Depreciation and amortization Decrease (increase) in other current receivables Increase in trade payables Increase (decrease) in other payables Increase (decrease) in other liabilities Revaluation of financial liabilities at fair value Interest expenses Revaluation of convertible notes Remeasurement of investment in associated company Provision of borrowing to related parties Share in (earnings) losses of associated companies, net Issuance of options to underwriters SPAC transaction - listing costs Net cash flow used in operating activities Cash flows from investing activities: Purchase of property, plant and equipment Capitalized development cost Net cash flow used in investing activities Cash flows from financing activities: Payments of borrowings to related parties Payment of lease liabilities Proceeds from issuance of shares, warrants A and B, net (see note 14 B.3) Exercise of warrants B (see note 14 B.3) Proceeds from issuance of convertible notes (see note 8.A) Advance payment for equity, net (see note 10) Repayment of bridge loans (see note 9) Proceeds from issuance of shares, net Proceeds from issuance of bridge loans and warrants (see note 9) Proceeds from issuance of promissory note (see note 8.C) Issuance of shares in the SPAC transaction, net Net cash flow from financing activities Increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Exchange rate differences on cash and cash equivalent Cash and cash equivalents at end of year Appendix A – Non-cash transactions during the year: Conversion of liability to ordinary shares (see note 10) Conversion of warrants A to ordinary shares (see note 14.B.3) Conversion of bridge loans and derivative financial liability to ordinary shares Exercise of options and warrants into ordinary shares Conversion of convertible notes to ordinary shares Conversion of liability to ordinary shares (see note 14) Remeasurement of investment in associated company (see note 3) Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Notes and other explanatory information [abstract] GENERAL Significant Accounting Policies Accounting Judgments Estimates And Assumptions SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: Disclosure of material accounting policy information [text block] TRUE GOLD BUSINESS COMBINATION OTHER CURRENT ASSETS PROPERTY, PLANT AND EQUIPMENT, NET: Investments In Associated Companies INVESTMENTS IN ASSOCIATED COMPANIES INTANGIBLE ASSETS, NET CONVERTIBLE NOTES BRIDGE LOANS LIABILITIES PRE-PAID ADVANCE LEASES OTHER PAYABLES BORROWINGS FROM RELATED PARTIES SHAREHOLDERS’ EQUITY RESEARCH AND DEVELOPMENT EXPENSES, NET GENERAL AND ADMINISTRATIVE EXPENSES TAXES ON INCOME LOSS PER SHARE RELATED PARTIES GOVERNMENT GRANTS COMMITMENTS AND CONTINGENT LIABILITIES Financial Instruments And Risk Management FINANCIAL INSTRUMENTS AND RISK MANAGEMENT FAIR VALUE MEASUREMENT Disclosure of events after reporting period [text block] SUBSEQUENT EVENTS Basis of preparation Principles of consolidation Investments in associated companies Reverse acquisition transaction Foreign currency Issue of a unit of financial instruments Governmental grants Fair value measurement Classification of financial instruments by fair value hierarchy Financial assets Financial liabilities Impairment of non-financial assets Property, plant and equipment Reimbursement of research and development expenses Right-of-use assets Lease liabilities Capitalized technology development costs Share-based compensation New standards, interpretations and amendments adopted from January 1, 2023 New standards, interpretations and amendments not yet effective Share based compensation Intangible assets Financial liability at fair value SCHEDULE OF COMPANIES SUBSIDIARIES SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES SCHEDULE OF OTHER CURRENT ASSETS SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES SUMMARY OF INTANGIBLE ASSETS NET SCHEDULE OF RIGHT OF USE ASSETS SCHEDULE OF INFORMATION ON LEASE SCHEDULE OF OTHER PAYABLES SCHEDULE OF BORROWINGS FROM RELATED PARTIES SCHEDULE OF SHARE CAPITAL SCHEDULE OF RESTRICTED STOCK UNIT SCHEDULE OF RESTRICTED STOCK UNIT SCHEDULE OF SHARE OPTION GRANTED SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE SCHEDULE OF LOSS PER SHARE SCHEDULE OF KEY MANAGEMENT PERSONNEL SCHEDULE OF BALANCE WITH RELATED PARTIES SCHEDULE OF GOVERNMENT GRANTS SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY Disclosure of subsidiaries [table] Country of incorporation of subsidiary Proportion of ownership interest in subsidiary Statement [Table] Number of shares issued Share price Par value per share Redemption percentage of business combination Remaining funds in trust account Percentage of voting equity interests acquired Number of shares Notional amount Other receivables Issue of convertible instruments Proceeds from borrowings, classified as financing activities Decrease increase in expenses snd capitalize Disclosure of detailed information about property, plant and equipment [table] Depreciation rate, property, plant and equipment Fair value based on quoted opening share price Fair value of equity transaction Marketable securities held in trust account Trade and other payables Disclosure of detailed information about business combination [table] Cash and cash equivalents Other current receivables Intangible asset (core technology license) Trade payables Net identifiable assets Non-controlling interests Goodwill Total purchase cost Fair value of previous investment Fair value of identifiable assets and liabilities Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination Weighted average cost of capital percentage Terminal per shares Terminal growth rate percentage Discount for lack of marketability percentage Discount for lack of marketability value Forgiveness of outstanding payables Profit (loss) of acquiree since acquisition date Current prepayments and other current assets Tax authorities Proof of concept receivables Other Total Anticipated transaction costs Property and equipment, beginning balance Additions Deductions Depreciation Currency translation adjustments Property and equipment, ending balance Disclosure of associates [table] Country of incorporation Proportion of ownership interest in associate Disclosure of joint ventures [table] Proportion of ownership interest in joint venture Shares issued for exercise of stock options, shares Exercise price of outstanding share options Weighted average remaining contractual life of outstanding share options Consideration transferred, acquisition-date fair value Risk free interest rate, share options granted Options expected life Consulting fees Percentage of entity's revenue Disclosure of reconciliation of changes in goodwill [table] Cost, beginning balance Capitalized development cost Currency translation adjustments Cost, ending balance Accumulated amortization, beginning balance Amortization Accumulated amortization, ending balance Net book value Cost, ending balance Disclosure of detailed information about intangible assets [table] Amortisation, intangible assets other than goodwill Intangible assets under development Borrowings, maturity Borrowings, interest rate Fixed conversion price Discount rate Warrants to purchase ordinary shares Exercise price of warrants Warrants term Share purchase price Description of approach used to determine discount rates Expected volatility, share options granted Fair value of convertible notes Fair value of redeemable warrants Number of convertible notes issued Face value of convertible notes Convertible notes maturity period Convertible note conversion price description Convertible note Convertible notes convered into ordinary shares Conversion price Proceeds from issuing shares Warrants exercise price per share Net debt Borrowing costs incurred Original issue discount Interest accrued percent Description of conversion of debt to equity Number of value converted Exercised the warrant Exercised the warrant Disclosure of disaggregation of revenue from contracts with customers [table] Proceeds from loans and warrants Accumulated interest Warrants to purchase shares Exercise price, share options granted Fair value of bonus warrants Weighted average share price, share options granted Fair value of warrants Expected term of warrants Redeemable warrants Warrant per share Expected dividend as percentage, share options granted Proceeds from warrants Issued capital, ordinary shares Description of share-based payment arrangement Prepaid advance percentage Purchase price Floor price Repayments of borrowings, classified as financing activities Right-of-use assets, beginning balance Additions Foreign currency translation Deductions Depreciation expense Right-of-use assets, ending balance Interest expense on lease liabilities Total cash outflow for leases Employees, salaries and related liabilities Related party Liabilities for grants received (see also note 20) Excise Tax Other Total Lease expiration Borrowings from related parties, beginning balance Payment of borrowings Provision for bonus (include interest) Exchange rate differences Borrowings from related parties, ending balance Number of shares authorized Number of shares issued and outstanding Disclosure of transactions between related parties [table] Cash advances and loans from related parties Bonus payments Increase in the carrying amount of the liability Debt instruments issued Payment for service Share issue related cost Number of ordinary shares, percentage Number of shares authorised Number of outstanding, Granted Weighted average exercise price of other equity instruments granted in share-based payment arrangement Expense from share-based payment transactions Number of outstanding, Beginning Number of outstanding, Vested Number of outstanding, Forfeited Number of outstanding, Ending Number of options outstanding Beginning balance Weighted average exercise price, outstanding beginning balance Number of issue of options Weighted average exercise price, issued of options Number of options, Expired Weighted average exercise price, Expired Number of options outstanding Ending balance Weighted average exercise price, outstanding beginning balance Number of options, Exercisable Weighted average exercise price, Exercisable Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Number of outstanding shares Weighted average remaining contractual life of outstanding share options Number of exercisable shares Weighted average remaining contractual life of exercisable share options Disclosure of attribution of expenses by nature to their function [table] Salaries and related expenses Subcontractors and consultants Materials and laboratory expenses Depreciation and amortization Travel expenses Freight Other Reimbursement from paid pilots and proof of concept projects Total BCA transaction cost Professional services Public company expenses Wages and salaries related Office and maintenance Share based compensation Insurance Total Par value per share post reverse split. Notes and debentures issued Number of other equity instruments exercised or vested in share-based payment arrangement Number of instruments granted in share-based payment arrangement Number of share options forfeited in share-based payment arrangement Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Proceeds from issue of ordinary shares Debt instruments held Warrant price per share Number of shares commitment fees Warrants price per share Warrant term description Warrant cashless exercised Gross proceeds of warrants Incremental fair value granted, modified share-based payment arrangements Warrants to purchase ordinary amount Warrant exercise description Warrant cash exercise price Warrant exercise price Expected volatility Risk-free interest rate Net proceeds from offering Capital raise fee Warrants issued Option life, share options granted Stock option vesting period Weighted average fair value at measurement date, share options granted Expected term Loss before income tax Theoretical tax rate of 12.5% Tax effect amounts which are not deductible/(taxable) in calculating taxable income: Non-deductible expenditure and others Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized Income tax / (benefit) Applicable tax rate Tax effect of tax losses Net loss attributable to the owners of the company Weighted average number of ordinary shares used in calculating diluted earnings per share Issuance of options to related party Short-term salary and fees Short-term salary until deletion Loan repayment Conversion of loan to ordinary shares Share based payments Post-employment retirement benefits Payment for Administrative services Non-monetary benefits Payments for legal services Revaluation of financial liabilities at fair value Proof of Concept projects paid by affiliated companies Key management personnel compensation Salary and related Borrowings from related parties Other accounts payable Trade payables Trade payables Derivatives Investment in subsidiary Total Short term liability at year end Long term liability at year end Total Proceeds from government grants received Percentage of revenue Payments for government grants Descriptiont of government grants Percentage of royalty Contingent of consideration percentage Expected term Expected dividend yield License intellectual property Addtional equity fund of convertible percent Consideration paid (received) Increase (decrease) in investment property Payment of cash percent Disclosure of risk management strategy related to hedge accounting [table] Financial assets at amortized cost: Disclosure of financial liabilities [table] Financial liabilities at fair value through profit or loss: Total financial liabilities Total financial liabilities at fair value through profit or loss Financial liabilities at amortized cost: Total financial liabilities at amortized cost Tax rate effect from change in tax rate Net foreign exchange loss Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Financial liabilities at amortized cost Increase (decrease) in financial assets Disclosure of fair value measurement of assets [table] Derivative financial liabilities Disclosure of non-adjusting events after reporting period [table] Contractual capital commitments Number of warrants Warrants exercised Aggregate ordinary shares Payment for fee Warrant shares Exercise price of share Pre funded warrants convertible description Warrant exercise price share Fee and commission income Offering expenses payable Convertible security to investor, description Aggregate amount of convertible instruments issued Restricted stock unit shares Restricted stock unit vested shares Promissory note Principal amount Warrant term Stock purchase agreement description Purchase price, percentage Commitment fee, percentage Number of shares Ordinary shares Number of shares issued and outstanding. Deferred Shares [Member] Issued capital and additional paid in capital. Par value per share post reverse split. Proceeds from government grants received. Percentage of revenue. Payments for government grants. Private warrants [member] Public Warrants [member] Warrants exercise price per share. Ordinary shares two [member] Bridge loans [member] Warrant price per share. Redeemable warrants [member] Warrants term. Subcontractors and consultants. Research expense. Freight expense. Reimbursement from paid pilots and proof of concept projects. Percentage of royalty. Contingent of consideration percentage. Nonadjusting event [member] Description of expected expected term options granted. Addtional equity fund of convertible percent. Payment of cash percent. Disclosure O fInvestment In Associated Companies Explanatory. Yahaloma technologies inc [member] True gold consortium pty ltd [member] Underwriting agreement [member] EF hutton llc [member] SMX beverages pty ltd [member] Warrant A [member] Warrant B [member] Increase in carrying amount of liability. Bonus payments. Public offering [member] Prefunded warrant [member] Warrants price per share. Disclosure of financial instrument and risk management explanatory. Shares issued for exercise of stock options, shares. Warrant term description. Warrant cashless exercised. Weighted average remaining contractual life of outstanding share options. Options expected life. Consulting fees. Global BevCo Pty Ltd. [member] Consulting agreement [member] Standby equity purchase agreement [member] Transaction cost. Warrant exercise description. Warrant cash exercise price. Warrants exercise price. First installment [member] Second installment [member] Prepaid advance percentage. Capital raise fee. Warrants issued. Underwriter warrant [member] Purchase price of per share. Floor price per share. Intangible assets other than goodwill, gross. Loan agreement [member] Loan agreements [member] Issued and Additional paid in capital [member] Foreign Currency Translation [Member] Tax effect amounts which are not deductible taxable in calculating taxable income [Abstract] Conversion of warrants to ordinary shares. Lease expiration. Shares issued and outstanding period. Incentive equity plan [member] Disclosure of detailed information about right of use assets text block. Employees directors and service [member] Right-of-use assets effect of foreign exchange. Deductions to right of use assets. Accumulated Depreciation Amortisation [Member] Accumulated depreciation of intangible assets other than goodwill. Employees [member] Stock option vesting period. Capitalized development cost classified as investing activities. Repayment of bridge loans. Adjustments for increase decrease in interest expenses Remeasurement of investment in associated company Advance payment for equity net Proceeds from issuance of bridge loans and warrants Proceeds from issuance of promissory note Exercise price two [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Options Outstanding Six [Member] Options Outstanding Seven [Member] Issuance of options to underwriters Non cash transactions during period abstract. Conversion of liability to ordinary shares. Conversion of bridge loans and derivative financial liability to ordinary shares. Exercise of options and warrants to ordinary shares. Fixed conversion price. Conversion of convertible notes to ordinary shares. Discount rate. Security matters pty ltd [member] Share issued price per share. Lion heart III corp [member] SMX circular economy platform pte ltd [member] Warrants to purchase ordinary shares. Convertible Note Agreements [Member] Bonus warrants [member] SMX ireland limited [member] Exercise price of warrants. Share purchase price. SMX Fashion And Luxury [Member] Security Matters Smx Plc [Member] Security matters canada ltd [member] True Silver SMX Platform Ltd [Member] SMX israel ltd [member] Weighted average remaining contractual life of exercisable share options 2019. Disclosure of detailed information about trade and other payables explanatory. Not Later Than Four To Five Year [Member] Fair value of convertible notes. Fair value of redeemable warrants. Not Later Than Three To Four Year [Member] Not Later Than Two To Three Year [Member] Not Later Than One To Two Year [Member] Number of convertible notes issued. Face value of convertible notes. Convertible notes maturity period. Convertible note conversion price description. Black scholes pricing model [member] Description of expected term warrants. Convertible Notes Agreements [Member] Government grants [member] Convertible notes convered into ordinary shares. Stock issued during period value consideration of issuance of common stock. Equity line agreement [member] Conversion price. Securities purchase agreement [member] Convertible Note [Member] Issuance of options to related party. Financial Derivatives [Member] Key management personnel compensation loan repayment. Key management personnel compensation payment for administrative services. Key management personnel compensation non monetary benefits. Proof of concept projects paid by affiliated companies. Adjustments for decrease increase in expenses and capitalize Nato Agreement [Member] Interest accrued percent. Original issue discount. Liabilities for grants received. Trade And Other Payable [Member] Borrowings from related parties [member] Key management personnel compensation short term employee benefits deletion. Key management personnel compensation payments for legal services. Disclosure of detailed information about balance with related parties explanatory Directors [member] Shareholders [member] Proceeds from loans and warrants. Bridge loan agreements [member] Eleven lenders [member] Lender two [member] Balance with related parties. Warrants to purchase shares. Fair value of bonus warrants. Redeemable warrants type 1 [member] Third anniversary [member] Fourth anniversary [member] Fair value of warrants. Monte carlo simulation model [member] Redeemable warrants type 2 [member] First anniversary [member] Second anniversary [member] Three valuation models [member] Redeemable warrants. Convertible note. Prepaid advance Bridge loans liabilities. Convertible promissory note Listing expenses. Disclosure of detailed information about government grants explanatory. Descriptiont of government grants. Disclosure of detailed information about research and development expense explanatory. Number of shares commitment fees. Redemption percentage of business combination. Lionheart [Member] Business Combination Agreement [Member] Remaining funds in trust account. Technology License [Member] Disclosure of weighted average loss per share explanatory. General and administrative expenses [member] Trade and other payables [member] Disclosure of detailed information about components of income tax expense explanatory. Convertible notes [member] Financial liabilities amortised cost abstract Convertible promissory note [member] Service Provider Agreements [Member] Disclosure of restricted stock unit explanatory. Issuance of options to acquire intangible asset. Revaluation of convertible notes. Provision of borrowing to related parties. Listing costs. Payment for service Disclosure of detailed information about general and administrative expense explanatory Warrants to purchase ordinary amount Offering expenses payable Warrant exercise price share Disclosure of sensitivity analysis for actuarial assumption explanatory Promissory Note [Member] Disclosure of summary of significant accounting policies explanatory. Principles of consolidation explanatory. Disclosure of detailed information about property plant and equipment depreciation rate explanatory. Description of accounting policy for right of use assets explanatory. Description of accounting policy for basis of preparation explanatory. Description of accounting policy new standards interpretations and amendments not yet effective [Explanatory] Description of accounting policy for share based compensation explanatory Description of accounting policy for financial liabilities at fair value explanatory. Weighted average cost of capital percentage Terminal per shares. Terminal growth rate percentage. Discount for lack of marketability percentage Discount for lack of marketability value Forgiveness of outstanding payables Disclosure of detailed information about other current assets explanatory. Proof of concept receivables current. Deductions other than through business combinations property plant and equipment. Furniture and office equipment [member] Conversion of liability to ordinary shares one. Fair value based on quoted opening share price. Fair value of equity transaction. Marketable securities held in trust account. Description of accounting policy new standards interpretations and amendments adopted explanatory. Prefunded warrants convertible description. Disclosure of Financial Liabilities Risk Management Explanatory Convertible Promissory [Member] Convertible security to an investor description. NIS [member] AUD [member] SGD [member] EUR [member] Tax expense benefit arising from previously unrecognised tax loss tax credit or temporary difference of prior period used to reduce current tax expense. Research and development expenses [member] Accumulated depreciation [member] SPAC [member] Number of value converted. Bridge loans l liabilities current Issuance of warrants A after reset. Exercise of warrants net Increase decrease issuance of shares and warrants Proceeds from issuance of shares. Remeasurement of investment. Accumulated interest Warrant per share Conversion of loan to ordinary shares Revaluation of financial liabilities at fair value. Derivatives License intellectual property Pre paid Advance [member] Borrowing from related parties [member] Payment for fee Letter Agreement [member] Warrant shares. Board of director [member] Proceeds from warrants Payment of borrowings Principal amount Restricted stock unit shares Promissory note. Restricted stock unit vested shares. Current assets [Default Label] Non-current assets [Default Label] Assets Current liabilities [Default Label] Non-current lease liabilities Bridge loans l liabilities current Non-current liabilities [Default Label] Liabilities Equity attributable to owners of parent Equity [Default Label] Equity and liabilities Profit (loss) from operating activities OtherComprehensiveIncomeLoss ComprehensiveIncomeLoss Profit (loss), attributable to non-controlling interests RevaluationOfConvertibleNotes RemeasurementOfInvestmentInAssociatedCompany Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities CapitalizedDevelopmentCostClassifiedAsInvestingActivities Cash flows from (used in) investing activities Cash repayments of advances and loans from related parties Payments of lease liabilities, classified as financing activities RepaymentOfBridgeLoans Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Description of accounting policy for leases [text block] Description of accounting policy for share-based payment transactions [text block] DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory DisclosureOfRestrictedStockUnitExplanatory Cash and cash equivalents recognised as of acquisition date Current assets recognised as of acquisition date Trade and other payables recognised as of acquisition date Non-controlling interest in acquiree recognised at acquisition date Goodwill recognised as of acquisition date IntangibleAssetsOtherThanGoodwillGross Increase (decrease) through net exchange differences, intangible assets other than goodwill AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill IntangibleAssetsGross NumberOfSharesExercisedWarrantsClassB Additions to right-of-use assets RightofuseAssetsEffectofForeignExchange DeductionsToRightofuseAssets Depreciation, right-of-use assets Other payables [Default Label] Payment of borrowings Number of other equity instruments outstanding in share-based payment arrangement Number of other equity instruments forfeited in share-based payment arrangement Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options expired in share-based payment arrangement Weighted average exercise price of share options exercisable in share-based payment arrangement Weighted average remaining contractual life of outstanding share options [Default Label] Depreciation and amortisation expense Other expenses, by nature Revaluation of financial liabilities at fair value [Default Label] Key management personnel compensation Amounts payable, related party transactions Receivables due from related parties Government grants ShareIssued EX-101.PRE 17 smx-20231231_pre.xml XBRL PRESENTATION FILE XML 19 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
12 Months Ended
Dec. 31, 2023
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2023
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-41639
Entity Registrant Name SMX (Security Matters) Public Limited Company
Entity Central Index Key 0001940674
Entity Incorporation, State or Country Code L2
Entity Address, Address Line One Mespil Business Centre
Entity Address, Address Line Two Mespil House
Entity Address, Address Line Three Sussex Road
Entity Address, City or Town Dublin 4
Entity Address, Country IE
Entity Address, Postal Zip Code D04 T4A6
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] false
Auditor Firm ID 1185
Auditor Location Tel-Aviv, Israel
Auditor Name Ziv Haft
Ordinary Shares With Nominal Value Of 0. 0022 Per Share [Member]  
Entity Addresses [Line Items]  
Title of 12(b) Security Ordinary Shares, with a nominal value of $0.0022 per share
Trading Symbol SMX
Security Exchange Name NASDAQ
Warrants Each Exercisable For One Ordinary Share At Exercise Price Of 253. 00 Per Share [Member]  
Entity Addresses [Line Items]  
Title of 12(b) Security Warrants, each exercisable for one Ordinary Share at an exercise price of $253.00 per share
Trading Symbol SMXWW
Security Exchange Name NASDAQ
Ordinary shares [member]  
Entity Addresses [Line Items]  
Entity Common Stock, Shares Outstanding 10,242,706
Public Warrants [member]  
Entity Addresses [Line Items]  
Entity Common Stock, Shares Outstanding 284,091
Deferred Shares [Member]  
Entity Addresses [Line Items]  
Entity Common Stock, Shares Outstanding 25,000
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One Mespil Business Centre
Entity Address, Address Line Two Mespil House
Entity Address, Address Line Three Sussex Road
Entity Address, City or Town Dublin 4
Entity Address, Country IE
Entity Address, Postal Zip Code D04 T4A6
City Area Code +353-1
Local Phone Number 920-1000
Contact Personnel Name Haggai Alon

XML 20 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 168 $ 1,398
Other current receivables 634 3,673
Total current assets 802 5,071
Non-current assets    
Intangible assets, net 16,486 5,027
Goodwill 32,957
Property, plant and equipment, net 411 555
Right of use assets 389 414
Investment in associated companies 115 221
Total non-current assets 50,358 6,217
Total assets 51,160 11,288
Current liabilities    
Trade payables 10,515 2,972
Other payables 2,483 650
Convertible notes 377 563
Warrants - derivative financial liability 1,143
Pre-paid advance 700
Bridge loans liabilities 1,750
Convertible promissory note 1,013
Borrowings from related parties 710
Lease liabilities 41 30
Total current liabilities 18,022 4,925
Non-current liabilities    
Lease liabilities 411 440
Bridge loans liabilities 483 3,682
Long term payables 85
Total non-current liabilities 894 4,207
Total liabilities 18,916 9,132
Equity    
Issued capital and additional paid-in capital 62,901 32,713
Foreign currency translation reserve (491) (537)
Accumulated losses (50,934) (30,020)
Total equity attributable to owners of the parent 11,476 2,156
Non- controlling interest 20,768
Total equity 32,244 2,156
Total liabilities and shareholders’ equity $ 51,160 $ 11,288
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Research and development expenses $ 2,711 $ 1,898 $ 2,039
Selling and marketing expenses 661 569 453
General and administrative expenses 16,567 2,723 2,482
Listing expenses 16,802
Operating loss (36,741) (5,190) (4,974)
Finance expenses 7,891 1,128 101
Finance income 1,580 28 237
Gain from remeasurement of investment in associated company 22,164
Share of net profit (loss) of associated companies (101) 106 (101)
Loss before income tax (20,989) (6,184) (4,939)
Income tax
Net loss (20,989) (6,184) (4,939)
Items that will not be reclassified to profit or loss:      
Adjustments arising from translating financial statements from functional currency to presentation currency (224) (522) (7)
Items that will or may be reclassified to profit or loss:      
Exchange losses arising on translation of foreign operations (59) (238) (375)
Total other comprehensive loss (283) (760) (382)
Total comprehensive loss (21,272) (6,944) (5,321)
Net loss attributable to:      
Equity holders of the Company (20,914)
Non- controlling interest $ (75)
Diluted earnings (loss) per share $ (7.82) $ (8.47) [1],[2] $ (7.41) [1],[2]
[1] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1.B)
[2] Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes In Equity - USD ($)
$ in Thousands
Issued and Additional paid in capital [member]
Foreign Currency Translation [Member]
Retained earnings [member]
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Total
Beginning balance, value at Dec. 31, 2020 $ 24,733 $ 605 $ (18,897)     $ 6,441
IfrsStatementLineItems [Line Items]            
Loss after income tax for the year (4,939)     (4,939)
Other comprehensive loss for the year (382)     (382)
Total comprehensive loss for the year (382) (4,939)     (5,321)
Issuance of shares, net 5,892     5,892
Share-based compensation 484     484
Conversion of warrants A to ordinary shares (See note 14.B.3)          
Exercise of warrants 395     395
Ending balance, value at Dec. 31, 2021 31,504 223 (23,836)     7,891
IfrsStatementLineItems [Line Items]            
Loss after income tax for the year (6,184)     (6,184)
Other comprehensive loss for the year (760)     (760)
Total comprehensive loss for the year (760) (6,184)     (6,944)
Issuance of shares, net 182     182
Share-based compensation 306     306
Conversion of warrants A to ordinary shares (See note 14.B.3)          
Issuance of options to acquire intangible asset 721     721
Ending balance, value at Dec. 31, 2022 32,713 (537) (30,020) $ 2,156 2,156
IfrsStatementLineItems [Line Items]            
Loss after income tax for the year (20,914) (20,914) (75) (20,989)
Other comprehensive loss for the year 46 46 17 63
Total comprehensive loss for the year 46 (20,914) (20,868) (58) (20,926)
Issuance of shares, net 4,896 4,896 4,896
Recapitalization due to issuance of shares following the SPAC transaction, net 11,460 11,460 11,460
Share-based compensation 3,269 3,269 3,269
Conversion of financial liabilities to shares 5,955 5,955 5,955
Exercise of options into shares 10 10 10
Issuance of shares and warrants B, net (See note 14.B.3) 1,837 1,837 1,837
Conversion of warrants A to ordinary shares (See note 14.B.3) 1,008 1,008 1,008
Exercise of warrants B, net (See note 14 B.3) 888 888 888
Issuance of warrants B after reset (See note 14 B.3) 865 865 865
Non-controlling interests arising from initially consolidated companies 20,826 20,826
Ending balance, value at Dec. 31, 2023 $ 62,901 $ (491) $ (50,934) $ 11,476 $ 20,768 $ 32,244
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Loss before tax for the year $ (20,914) $ (6,184) $ (4,939)
Share based compensation 3,269 306 484
Depreciation and amortization 225 290 315
Decrease (increase) in other current receivables 2,938 (2,936) (463)
Increase in trade payables 2,074 2,217 401
Increase (decrease) in other payables (235) 114 60
Increase (decrease) in other liabilities 19 17 (3)
Revaluation of financial liabilities at fair value 1,496 387
Interest expenses 4,281 51 47
Revaluation of convertible notes (382)
Remeasurement of investment in associated company (22,164)
Provision of borrowing to related parties 621 89
Share in (earnings) losses of associated companies, net 101 (106) 101
Issuance of options to underwriters 11
SPAC transaction - listing costs 16,802
Net cash flow used in operating activities (12,479) (5,223) (3,908)
Cash flows from investing activities:      
Purchase of property, plant and equipment (60) (152) (297)
Capitalized development cost (976) (975) (1,468)
Net cash flow used in investing activities (1,036) (1,127) (1,765)
Cash flows from financing activities:      
Payments of borrowings to related parties (172) (103)
Payment of lease liabilities (42) (55) (98)
Proceeds from issuance of shares, warrants A and B, net (see note 14 B.3) 2,630
Exercise of warrants B (see note 14 B.3) 642 395
Proceeds from issuance of convertible notes (see note 8.A) 250 581
Advance payment for equity, net (see note 10) 2,679
Repayment of bridge loans (see note 9) (30)
Proceeds from issuance of shares, net 182 5,892
Proceeds from issuance of bridge loans and warrants (see note 9) 550 3,310 32
Proceeds from issuance of promissory note (see note 8.C) 2,356
Issuance of shares in the SPAC transaction, net 2,919
Net cash flow from financing activities 11,954 3,846 6,118
Increase (decrease) in cash and cash equivalents (1,561) (2,504) 445
Cash and cash equivalents at beginning of year 1,398 4,171 4,341
Exchange rate differences on cash and cash equivalent 331 (269) (615)
Cash and cash equivalents at end of year 168 1,398 4,171
Appendix A – Non-cash transactions during the year:      
Conversion of liability to ordinary shares (see note 10) 2,300
Conversion of warrants A to ordinary shares (see note 14.B.3) 1,008
Conversion of bridge loans and derivative financial liability to ordinary shares 5,192
Exercise of options and warrants into ordinary shares 2,925
Conversion of convertible notes to ordinary shares 175
Conversion of liability to ordinary shares (see note 14) 3,030
Remeasurement of investment in associated company (see note 3) $ (22,164)
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GENERAL
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
GENERAL

NOTE 1 - GENERAL:

 

A.SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Company integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, SMX’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. One reader can detect embedded data in various materials, from metals to fabrics to food and plastics, with all data logged onto the same digital platform.

 

Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B.The SPAC transaction:

 

On March 7, 2023 (the “Closing Date”) the Company completed its SPAC transaction (the “Business Combination”) with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd. were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange. The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account.

 

C.On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd.’s (“TrueGold”) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold, See also Note 3.

 

D.During the 12 months ended December 31, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 10, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). Furthermore, and as described in note 10 and note 24(10), in April 2024, the Company terminated the equity line agreement with Yorkville and entered into a similar agreement for $30,000 with an institutional investor. The Company is continuing with additional capital raising and as described in note 24(5), post balance sheet date it received an additional $3 million in funding. The Company also plans to secure a convertible note between $500 and $1,000 in addition to second round funding to raise approximately $5,800 after balance sheet date. The Company has also the ability to decrease its expenses and capitalize debt in order to meet its existing cash flow streams. Furthermore, the Company expect that the $5,000 NATO government agreement describe in note 24 (2), shall continue in the second half of 2024. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 1 - GENERAL (CONT.):

 

E.The Company operates primarily through 9 wholly owned subsidiaries and one majority owned all of which have been consolidated in these consolidated financial statements.
  

Controlled entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters (SMX) PLC  Ireland   100%   - 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
  Australia   100%   - 
Lionheart III Corp  USA   100%   ** 
SMX Circular Economy Platform PTE, Ltd.  Singapore   100%   * 
SMX (Security Matters) Ireland Limited  Ireland   100%   * 
SMX Fashion and Luxury
  France   100%   - 
TrueSilver SMX Platform Ltd.
  Canada   100%   - 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
  Israel   100%   100%***
Security Matters Canada Ltd.  Canada   100%   100%***
SMX Beverages Pty Ltd.  Australia   100%   100%***
True Gold Consortium Pty Ltd.  Australia   51.9%***   See note 6 

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

  *Incorporated in 2023.
  **Merger occurred in March 2023 as part of the Business Combination.
  ***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:
12 Months Ended
Dec. 31, 2023
Significant Accounting Policies Accounting Judgments Estimates And Assumptions  
SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:

 

  The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value.

 

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of SMX (Security Matters) Public Limited Company as of December 31, 2023 and 2022 and the results of all subsidiaries for the three years in the period then ended. SMX (Security Matters) Public Limited Company, a public limited company and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

The Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.
2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.
3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True Gold consortium PYT LTD. is Australian Dollar.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date.
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at fair value through profit or loss.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for financial liabilities which are measured at fair value through profit or loss.

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

Impairment of non-financial assets

 

Intangible assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   8 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be successful, are offset in profit or loss against the related expenses (research and development expenses). Any intellectual property generated from this activity remains at the ownership of the Group.

 

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee;
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option; and
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Capitalized technology development costs

 

Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when a milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Capitalized technology development costs (Cont.) 

 

Currently, the Group’s capitalized development activities focus on:

 

  1. Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.
  2. Semi Industrial scale – technology implementation in semi-industrial production.
  3. Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.

 

The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.

 

The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.

 

The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.

 

Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.

 

The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.

 

Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.

 

Subsequent measurement

 

In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.

 

An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Capitalized technology development costs (Cont.) 

 

Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.

 

The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.

 

All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.

 

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments adopted from January 1, 2023

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements);

 

In February 2021, the IASB issued amendments to IAS 1 and IFRS Practice Statement 2. The amendments aim to make accounting policy disclosures more informative by replacing the requirement to disclose ‘significant accounting policies’ with ‘material accounting policy information’. The amendments also provide guidance under what circumstance, the accounting policy information is likely to be considered material and therefore requiring disclosure.

 

These amendments have no effect on the measurement or presentation of any items in the consolidated financial statements of the Group but affect the disclosure of accounting policies of the Group.

 

Definition of Accounting Estimates (Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors);

 

The amendments to IAS 8, which added the definition of accounting estimates, clarify that the effects of a change in an input or measurement technique are changes in accounting estimates, unless resulting from the correction of prior period errors. These amendments clarify how entities make the distinction between changes in accounting estimate, changes in accounting policy and prior period errors. These amendments had no effect on the consolidated financial statements of the Group.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

 

There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2024:

 

  IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback);
  IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current);
  Non-current Liabilities with Covenants (Amendments to IAS 1 Presentation of Financial Statements); and
  Supplier Finance Arrangements (Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures).

 

The following amendments are effective for the period beginning January 1, 2025:

 

Lack of Exchangeability (Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates).

 

The Group is currently assessing the impact of these new accounting standards and amendments. The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

H.The significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent basis, are:

 

In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.

 

The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.

 

Share based compensation

 

The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.

 

Intangible assets

 

The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.

 

This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 7.

 

The management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liability at fair value

 

The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions of the financial liability, which are described in Note 22 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.

 

XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TRUE GOLD BUSINESS COMBINATION
12 Months Ended
Dec. 31, 2023
TRUE GOLD BUSINESS COMBINATION

NOTE 3 – TRUE GOLD BUSINESS COMBINATION

 

On October 3, 2023 (acquisition date), the Company signed an agreement with True Gold Consortium Pty Ltd. (“TrueGold”) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. TrueGold uses the Company’s advanced next-generation technology to invisibly mark and store multiple data types at a molecular level as well as its blockchain digital platform. This strategic transaction through gaining control of TrueGold diversifies the Company’s operations into TrueGold’s pioneering ventures in research and development and revenue commercialization.

 

The Company previously held 44.4% of the shares of TrueGold which, up to the acquisition date and the beginning of consolidation, were treated as an investment in a joint venture which accounted for under the equity method. At the time the transaction was completed and control was obtained, the balance of the investment was remeasured at fair value of $22,164 and a gain was recognized in the amount of $22,164, which was recorded in the statement of comprehensive loss (the carrying amount of the previous investment in TrueGold was approximately nil). This fair value amount was added to the consideration transferred for the calculation of goodwill, as described below.

 

The Company has elected to measure the non-controlling interests in TrueGold at full fair value which includes also the non-controlling interests’ share in the entire goodwill of TrueGold. The fair value of the non-controlling interests in TrueGold was based on the fair value of TrueGold as a whole, as described above, and was estimated using the discounted cash flow method of the income approach, as TrueGold is a private company and therefore quoted market prices of its share were unavailable. The fair value has been determined by management with the assistance of a valuation performed by an external and independent valuation specialist using valuation techniques and assumptions as to estimates of projected net future cash flows of TrueGold and estimate of the suitable discount rate for these cash flows. The significant assumptions used in estimating the fair value of TrueGold are:

 

1.After-tax net cash flow discount rate (weighted average cost of capital) of 24.8%.
2.Terminal value cash flow multiple of 4.59 and terminal growth rate of 3%.
3.Discount for lack of marketability of 25.2% (or $11.17), resulting in a fair value of $33.12 per ordinary share of TrueGold).

 

The total cost of the business combination comprised a full forgiveness of the outstanding payables from TrueGold to the Company which amounted to AUD 475 (approximately $307) at acquisition date. The calculating of any goodwill upon acquisition included also the fair value of the previous investment in TrueGold.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 3 – TRUE GOLD BUSINESS COMBINATION (CONT.):

 

The fair value of the identifiable assets and liabilities of TrueGold on the acquisition date:

           
   US$ in thousands 
Cash and cash equivalents       13 
Other current receivables        155 
Intangible asset (core technology license)        10,449 
Trade payables        277 
           
Net identifiable assets        10,340 
Non-controlling interests        (20,826)
Goodwill        32,957 
           
Loan to TrueGold   307      
           
Fair value of previous investment   22,164      
Fair value of identifiable assets and liabilities        22,471 

 

The only intangible asset identified in the purchase price allocation, and recognized as shown in the table above, represents a core technology license that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). As mentioned above, this licensee represents the current right of TrueGold to use the Company’s intellectual property of technology under a license agreement signed in 2020. For the purpose of the purchase price allocation, this right was treated as a reacquired right and accordingly was recognized separately from goodwill and valued on the basis of the remaining contractual term of the related contract, regardless of whether market participants would consider potential contractual renewals. After acquisition, this intangible asset should be amortized in according to its economic useful life. The Company has not yet began amortizing the asset and is assessing the economic useful life of it. See also Note 7.

 

The goodwill arising from acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Company and TrueGold. The goodwill recognized is not expected to be deductible for income tax purposes.

 

From the acquisition date, TrueGold has contributed $155 to the consolidated net loss. If the business combination had taken place at the beginning of the year 2023, the consolidated net loss would have been increased by $692 after elimination the Company’s’ share of TrueGold’s net loss until acquisition date.

 

XML 27 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER CURRENT ASSETS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
OTHER CURRENT ASSETS

NOTE 4 - OTHER CURRENT ASSETS:

SCHEDULE OF OTHER CURRENT ASSETS

   December 31, 2023   December 31, 2022 
Prepaid expenses   142    *3,157
Tax authorities   257    358 
Proof of concept receivables   148    86 
Other   87    72 
Total   634    3,673 

 

*Includes $3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 28 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PROPERTY, PLANT AND EQUIPMENT, NET:
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
PROPERTY, PLANT AND EQUIPMENT, NET:

NOTE 5 - PROPERTY, PLANT AND EQUIPMENT, NET:

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2023   63    1,147    65    102    1,377 
Additions   15    5    7    4    31 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (3)   (6)   (3)   (4)   (16)
At December 31, 2023   75    1,146    69    102    1,392 
                          
Accumulated depreciation                         
At January 1, 2023   18    699    31    74    822 
Depreciation   6    151    7    16    180 
Currency translation adjustments   -    (18)   (1)   (2)   (21)
At December 31, 2023   24    832    37    88    981 
Net book value at December 31, 2023   51    314    32    14    411 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2022   81    1,233    83    99    1,496 
Additions   -    135    -    17    152 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (18)   (221)   (18)   (14)   (271)
At December 31, 2022   63    1,147    65    102    1,377 
                          
Accumulated depreciation                         
At January 1, 2022   20    645    33    72    770 
Depreciation   4    202    7    19    232 
Currency translation adjustments   (6)   (148)   (9)   (17)   (180)
At December 31, 2022   18    699    31    74    822 
Net book value at December 31, 2022   45    448    34    28    555 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 29 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS IN ASSOCIATED COMPANIES
12 Months Ended
Dec. 31, 2023
Investments In Associated Companies  
INVESTMENTS IN ASSOCIATED COMPANIES

NOTE 6 - INVESTMENTS IN ASSOCIATED COMPANIES:

 

SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%
True Gold Consortium Pty Ltd.  Australia   51.9%   44.4%

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

Yahaloma Technologies Inc.

 

On April 30, 2019, Security Matters Ltd. signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.

 

Under the terms of the agreement, Security Matters Ltd. and Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.

 

Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

True Gold Consortium Pty Ltd

 

On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. and TrueGold. The purpose of the agreement is to set the framework for TrueGold’s activity. TrueGold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, TrueGold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.

 

The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement.

 

The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting. During 2023 the Company acquired an additional 7.5% and gained control in TrueGold. See also note 3.

 

SMX Beverages Pty Ltd

 

On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.

 

The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.

 

On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining 50% shares in SMX-B in exchange for 8,000,001 options of the Company at exercise price of AUD 0.4, with an expiration date of March 25, 2027. Total fair value is AUD 960,000 (USD 721,424), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black-Scholes model, free rate interest of 2.5%, expected life 5 years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD 13,500 per month and a 5% revenue share for referred clients.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 30 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INTANGIBLE ASSETS, NET
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
INTANGIBLE ASSETS, NET

NOTE 7 - INTANGIBLE ASSETS, NET:

 

SUMMARY OF INTANGIBLE ASSETS NET

   Capitalization of development cost   Purchased license   Core Technology License   Total 
   US$ in thousands   US$ in thousands   US$ in thousands   US$ in thousands 
COST                    
As of January 1, 2023   4,372    655    -    5,027 
Capitalized development cost   977    157    10,449    11,583 
Currency translation adjustments   (7)   7    -    - 
As of December 31, 2023   5,342    819    10,449    16,610 
                     
Accumulated amortization                    
As of January 1, 2023   127    -    -    127 
Amortization   -    -    -    - 
Currency translation adjustments   (3)   -    -    (3)
As of December 31, 2023   124    -    -    124 
                     
Net book value as of December 31, 2023   5,218    819    10,449    16,486 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 7 - Intangible assets, NET (CONT.):

 

   Capitalization of development cost   Purchased license   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 

 

An intangible asset at the amount of 145 is being amortized. The rest of the intangible assets have not yet commenced amortization.

 

Intangible assets as of December 31, 2023, consist of capitalized development costs of the Group’s technology as well as the cost of the exclusive license intellectual property (662) which includes the addition amount as a result of the acquisition of additional 50% interest in SMX Beverages Pty Ltd. The acquired rights have not yet commenced amortization as the license was not yet commenced usage.

 

In addition, intangible asset as of December 31, 2023, consist also of core technology license raised from the TrueGold business combination that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). See also Note 3.

 

XML 31 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONVERTIBLE NOTES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
CONVERTIBLE NOTES

NOTE 8 - CONVERTIBLE NOTES:

 

A.On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i) Bonus Warrants - 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants have a term of five years commencing upon the closing of the Business Combination.

 

(ii) Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants have a term of five years commencing upon the closing of the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

  

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 8 - CONVERTIBLE NOTES (CONT.):

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 32.2%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 73.74% and the risk-free interest rate used is 3.91%. As of December 31, 2023, the fair value of the Convertible Notes was $304 and the fair value of the Redeemable Warrants was $73.

 

B.In May 2022, Security Matters PTY Ltd. issued 828,240 convertible notes (the “2022 Convertible Notes”), with a face value of AUD 1 (USD 0.7) per each 2022 Convertible Note, for an aggregate amount of AUD 828 thousand (USD 569). The 2022 Convertible Notes have a maturity date of six months from issuance date. The conversion price is as follows: (i) if Security Matters PTY Ltd. executes a binding agreement for an M&A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share.. As of December 31, 2022, the 2022 Convertible Note amounted to 563. In July 2022, an amendment to the 2022 Convertible Notes agreements was signed between Security Matters PTY Ltd. and the investors which prescribes a cancellation of the 2022 Convertible Notes and replacing them with the issuance of 1,000,000 ordinary shares of Security Matters PTY Ltd. (with the occurrence of the Business Combination as described in Note 1.B). On March 7, 2023, the 2022 Convertible Notes were converted to 1,000,000 ordinary shares of Security Matters PTY Ltd.

 

C.On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a convertible promissory note with a fixed conversion price of $1.6378, 3,929,051 warrant As and 2,619,367 warrant Bs, for gross proceeds to SMX of approximately $2,358, before deducting fees and other offering expenses payable by the Company to their service providers. The warrant As are exercisable into 3,929,051 ordinary shares at an exercise price of $0.0022 per, share subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant As. The warrant Bs are exercisable into 2,619,367 ordinary shares at an exercise price of $1.6378 per share, subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant Bs. The warrant As and the warrant Bs meet the fixed-for-fixed criterion of IAS 32, resulting in being classified as equity. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 8 - CONVERTIBLE NOTES (CONT.):

 

The promissory note was recognized base on the amortized cost method.

 

As of December 31, 2023, the note principle amounted to $1 million and during the period $2.1 million of promissory note was converted to shares. As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of 2,619,377 Ordinary Shares and exercised the Warrant A and Warrant B for 3,789,264 and 2,619,367 Ordinary Shares, respectively. See note 24(11).

 

XML 32 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BRIDGE LOANS LIABILITIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
BRIDGE LOANS LIABILITIES

NOTE 9 - BRIDGE LOANS LIABILITIES:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As of December 31, 2023, the principal and the accumulated interest of the bridge loans were $1,739.

 

As part of the Bridge Loans agreements, some of the lenders were granted two types of warrants:

 

(i)Bonus Warrants - 11,045 (after reverse stock split) warrants to purchase ordinary shares of the Company at an exercise price of USD 253 per share and a first priority security interest in the shares of Security Matters PTY’s interest in trueGold Consortium Pty Ltd.
   
  The Bonus Warrants term is five years commencing upon the closing of the Business Combination.
   
  Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants The fair value of the Bonus Warrants was calculated using the Black and Scholes model.
   
  As of December 31, 2023, and as of December 31, 2022, the fair value of the Bonus Warrants was nil and $24 respectively.

 

(i)Redeemable Warrants Type 1 - 15,545 (after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD 253 per share. The Redeemable Warrants Type 1 term is five years commencing upon the BCA (see to Note 1B).

 

50.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD 110 per warrant.

 

25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for
   
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD 110 per warrant.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model.

 

As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was $72 and $1,973 respectively.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 9 - BRIDGE LOANS LIABILITIES (CONT.):

 

(ii)Redeemable Warrants Type 2 – 10,454 (after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD 253 per share. The Redeemable Warrants Type 2 term is five years commencing upon the SPAC transaction (see also Note 1B).

 

50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD 110 per warrant.
50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD 110 per warrant.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model.

 

As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 2 was $421 and $696 respectively.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The main assumptions used in the three valuation models as of December 31, 2023 described above were: (1) risk free rate 3.91%; (2) volatility of assets 73.74%; and (3) excepted terms of the warrants 4.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

The main assumptions used in the three valuation models as of December 31, 2022 described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

On March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares.

 

On December 31, 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $750 and redeemable warrants at the amount of $1,450 into 4,032,256 ordinary shares. According to the addendum the company has issued to the lenders an aggregate of fully paid 4,032,256 warrants to purchase up to an aggregate of 4,032,256 ordinary shares at an exercise price of $1.17 per share. The Warrants were exercisable immediately upon issuance and will expire three years following their issuance.

 

The warrants include a cashless exercise mechanism, according to the terms specified in the addendum and it’s according to the lender election (the “Cashless Warrants”).

 

Therefore, the Company accounts for the Cashless Warrants as financial liability instruments that measured at fair value and recognized financial expenses or income through profit and loss.

 

The Company valued each Cashless Warrants at $0.25 per warrant by using the Black-Scholes option-pricing model The key inputs that were used in the Cashless Warrants fair value as of December 31, 2023 were:

 

  risk-free interest rate 4.13%
  expected volatility 70.39%
  expected dividend yield of 0%
  expected term of warrants – 3 years

 

As of December 31, 2023 the Cashless Warrants fair value was $1,023

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 33 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PRE-PAID ADVANCE
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
PRE-PAID ADVANCE

NOTE 10 - PRE-PAID ADVANCE:

 

In February 2023, the Company entered into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period or (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of a registration statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the ordinary shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 14.4), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The Company made additional change to the Yorkville agreement which effectively eliminates the floor price - see also note 24(4). The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500 and as of December 31, 2023 the Company repaid the second Pre-Paid Advance in the amount of $1,300. In the period, the Company issued ordinary shares in net consideration of $1,979 in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $377 as of the date of the authorization of these financial statements. On April 13, 2024, the Company exercised its right of termination under the SEPA and sent Yorkville a written termination letter, which is effective upon five trading days thereafter. On April 19, 2024, the Company entered into a similar agreement with an institutional investor, which will enable the Company to raise up to $30,000. See also note 24(10).

 

XML 34 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
LEASES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
LEASES

NOTE 11 - LEASES:

 

The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of 12 years, motor vehicles generally have lease terms of 3 years.

 

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

  

Office and lab

facilities

   Motor vehicles   Total 
At January 1, 2022   446    20    466 
Additions   49    -    49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)   -    (39)
As at December 31, 2022   414    -    414 
Additions   -    26    26 
Foreign currency translation   (6)   -    (6)
Deductions   -    -    - 
Depreciation expense   (42)   (3)   (45)
As at December 31, 2023   366    23    389 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 11 - LEASES (CONT.):

 

Information on leases:

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
         
Interest expense on lease liabilities   32    51 
Total cash outflow for leases   45    39 

 

For an analysis of maturity dates of lease liabilities, see Note 22 on liquidity risk.

 

XML 35 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER PAYABLES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
OTHER PAYABLES

NOTE 12 - OTHER PAYABLES:

 

SCHEDULE OF OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
         
Employees, salaries and related liabilities   726    392 
Related party   4    56 
Liabilities for grants received (see also note 20)   153    50 
Excise Tax   1,569    - 
Other   31    152 
Total   2,483    650 

 

XML 36 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BORROWINGS FROM RELATED PARTIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
BORROWINGS FROM RELATED PARTIES

NOTE 13 - BORROWINGS FROM RELATED PARTIES:

 

In 2015, the Group signed an agreement to receive a loan of ILS 2 million (approximately 513) from its shareholders. These loan bears interest at an annual rate of 4%.

 

   December 31, 2023   December 31, 2022 
Balance at January 1,   710    270 
Payment of borrowings   (657)   (172)
Provision for bonus (include interest)   -    621 
Exchange rate differences   (53)   (9)
Balance at December 31,   -    710 

 

In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS 3 million (approximately 965) per each of the two lenders.

 

The Bonus Payments are intended to operate in one of the two trigger events:

 

(i)dividend distributions paid by the Company; or
(ii)the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise).

 

Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.

 

The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 13 - BORROWINGS FROM RELATED PARTIES (CONT.):

 

There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS 3 million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of 87 to profit and loss in 2021.

 

In August 2022 the loan from related party has been fully repaid and the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS 2.5 million (approximately 710), to be paid upon the completion of the business combination. As of December 31, 2022, the liability was 710.

 

On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount. In accordance with management estimation the FV of this Indebtedness is immaterial.

 

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHAREHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SHAREHOLDERS’ EQUITY

NOTE 14 - SHAREHOLDERS’ EQUITY

 

A.Share capital:

SCHEDULE OF SHARE CAPITAL

   Number of shares 
   December 31, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0022
par value
   36,363,636,364    10,185,909    22,727,272    - 
Preferred shares
USD 0.0001
par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1
par value
   25,000    25,000    25,000    25,000 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0022 and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

Preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

B.Changes in Share capital

 

1.On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination as described in Note 1B. Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

  a) The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.
  b) Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.
  c) 32,211,716 warrants and options have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.
  d) 848,784 (post reverse stock split) ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.
  e) The Company issued 160,227 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.
  f) The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.
  g) The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

2.During 2023, the Company issued 1,237,751 ordinary shares (4,196 shares as commitment fees) to Yorkville post reverse stock split, for an aggregate of $1,979 net proceeds (see also Note 10).
   
3.On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 606,061 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 606,061 warrants in the form of Warrant A to subscribe for 606,061 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 606,061 warrants in the form of Warrant B to subscribe for 606,061 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 90,909 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 90,909 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0 001 per share, and/or (b) 90,909 warrants in the form of Warrant A to subscribe for an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 90,909 warrants in the form of Warrant B to purchase an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 681,818 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of the authorization of these financial statements, an aggregate of 690,096 Warrant A warrants were cashless exercised into an aggregate of 345,349 ordinary shares. The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

On December 8, 2023, the Company consummated an inducement offer letter agreement with certain holders of the Company’s outstanding Warrant Bs to purchase Ordinary Shares of the Company. The Warrant Bs were issued on June 27, 2022 and had an exercise price of $5.28 per share (after taking into account the Company’s 1:22 reverse share split).

 

Pursuant to the inducement letter, the holders agreed to exercise for cash their Warrant Bs to purchase an aggregate of 606,060 shares of the Company’s Ordinary Shares at a reduced exercise price of $1.15 per share in consideration for the Company’s agreement to issue new warrants to purchase, in the aggregate, up to 909,090 of the Company’s Ordinary Shares at an exercise price of either (i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrant holders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of $697 from the exercise of the Warrant Bs by the holders, and the carrying amount of those warrants, was classified to ordinary shares and premium together with the proceeds the Company received from the exercise price. See also note 24(3).

 

In accordance with IAS 32, the Company measured the difference between the fair value of the consideration the holder receives on conversion of the instrument under the revised terms and the fair value of the consideration the holder would have received under the original terms, was recognized as a loss in profit or loss.

 

The Company utilized Black-Scholes valuation model to calculate the fair values of the repriced warrants both before and after the repricing and recognized the incremental fair value of $209 as finance expense in the statement of comprehensive income against an increase in the carrying amount of the warrants (presented within issued capital and additional paid-in capital). In addition, fair value was also calculated for the new 909,090 issued warrants at the amount of $865, which was recognized as finance expense against an increase in equity. Warrant Bs are classified as equity instruments according to IAS 32.

 

Warrant A was valued at $0.067 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of the Warrant Bs specify that each warrant has a cash exercise price of $0.24. The Warrant Bs were valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrant As and Bs expire in June 2028. The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660. The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

4.On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

5.On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount (see also note 13).

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

   
6.On December 31,2023 The Company also issued 457,682 Ordinary Shares to a service provider as payment in full for $260 worth of legal services which previously provided to the Company.

 

C.Options granted to employees and service providers:

 

1.In June 2018, Security Matters PTY Ltd. has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Plan include employees, directors and consultants of Security Matters PTY Ltd. or any subsidiary. On March 7, 2023 as part of the SPAC transaction. These options were exercised on a cashless basis and then after replaced to the Company’s shares. See also note 14B1(c-d).
   
 2.In March 7, 2023 Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.
   
3.In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

4.During the period ended December 31, 2023, the Company granted 197,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. Related share-based expenses recognized for the period totaled $2,820.

 

RSUs granted to employees, directors and service providers:

  

Year ended

December 31, 2023 (in thousands)

  

Year ended

December 31, 2022 (in thousands)

 
Outstanding at beginning of period   -    - 
Granted   197    - 
Vested   (57)   - 
Forfeited   (4)   - 
           
Outstanding at December 31, 2023   136    - 

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

 

5.

During the year ended December 31, 2023, the Company granted 38,656 options to employees and service providers. These grants carry an exercise price of between $22.71 - $88, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $219. The related share-based expenses that were recognized in the year ended December 31, 2023, amounted to $184.


A summary of the status of the Company’s Share Option Plan granted to employees and service providers (including performance-based awards) and changes during the relevant period ended on that date is presented below:

   Year ended
December 31, 2023
   Year ended
December 31, 2022
 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (USD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (USD)

 
Outstanding at beginning of year   57    44.22    73    41.85 
Issue of options   38    82.04    17    41.85 
Expired   (30)   31.02    (33)   34.10 
                   
Outstanding at end of year   65     69.92     57    54.25 
Exercisable options   58    68.67    38    43.40 

 

The options to employees and service providers outstanding as of December 31, 2023, are comprised, as follows:

Exercise price (USD) 

Outstanding as of

December 31, 2023

  

Weighted average remaining

contractual term

   Exercisable as of December 31, 2023  

Weighted average remaining

contractual term

 
       (years)       (years) 
18.70-23.32   5    2.46    5    2.46 
29.48-31.02   3    3.21    3    3.21 
40.48-48.18   6    1.41    6    1.41 
52.80-56.10   9    2.26    9    2.26 
78.54-88.00   35    4.40    28    4.38 
93.28-108.90   7    3.03    7    3.03 
    65         58      

 

1.The options issued in 2023, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.58-3.42%; (2) expected volatility: 78.35-73.01%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.
   
2.The options issued in 2022, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.09-4.68%; (2) expected volatility: 62.06-85.03%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 38 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RESEARCH AND DEVELOPMENT EXPENSES, NET
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
RESEARCH AND DEVELOPMENT EXPENSES, NET

NOTE 15 - RESEARCH AND DEVELOPMENT EXPENSES, NET:

 

   December 31, 2023   December 31, 2022   December 31, 2021 
Salaries and related expenses   2,228    2,166    1,795 
Subcontractors and consultants   344    374    631 
Materials and laboratory expenses   223    316    252 
Depreciation and amortization   197    255    287 
Share based compensation   447    127    100 
Travel expenses   87    50    42 
Freight   33    30    23 
Other   10    6    - 
Reimbursement from paid pilots and proof of concept projects   (858)   (1,426)   (1,091)
Total   2,711    1,898    2,039 

 

XML 39 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GENERAL AND ADMINISTRATIVE EXPENSES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
GENERAL AND ADMINISTRATIVE EXPENSES

NOTE 16 - GENERAL AND ADMINISTRATIVE EXPENSES:

 

   December 31, 2023   December 31, 2022   December 31, 2021 
BCA transaction cost   7,278    -    - 
Professional services   667    1,105    1,089 
Public company expenses   5,128    -    - 
Wages and salaries related   1,348    935    752 
Travel expenses   611    223    - 
Office and maintenance   170    145    116 
Share based compensation   1,222    137    331 
Insurance   50    60    102 
Depreciation and amortization   30    35    28 
Other   63    83    64 
Total   16,567    2,723    2,482 

 

XML 40 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TAXES ON INCOME
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
TAXES ON INCOME

NOTE 17 - TAXES ON INCOME:

 

1.The Company is incorporated and domiciled in Ireland where the applicable tax rate is 12.5%.
2.Theoretical tax:

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

   December 31, 2023   December 31, 2022   December 31, 2021 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (20,989)   (6,184)   (4,939)
                
Theoretical tax rate of 12.5%   (2,624)   (1,701)   (1,358)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   3254    335    118 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   (630)   1,366    1,240 
Income tax / (benefit)            

 

3.As of December 31, 2023, the Group has estimated carry forward tax losses of approximately $45,095 (2022: $24,106 2021:$17,659) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 41 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
LOSS PER SHARE
12 Months Ended
Dec. 31, 2023
Profit or loss [abstract]  
LOSS PER SHARE

NOTE 18 - LOSS PER SHARE

 

   December 31, 2023   December 31, 2022   December 31, 2021 
             
Net loss attributable to the owners of the company   (20,914)   (6,184)   (4,939)
                
Basic and diluted loss per share   (7.82)   *(8.47)   *(7.41)
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   2,676    730    666 

 

*Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

XML 42 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RELATED PARTIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
RELATED PARTIES

NOTE 19 - RELATED PARTIES:

 

Key Management Personnel Compensation and other related party transactions and balances:

 

The key management personnel, among others includes board members, CEO and CFO.

 

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

1. Transactions with related parties:  December 31, 2023   December 31, 2022 
Issuance of options to related party   -    721 
Short-term salary and fees   803    508 
Short-term salary until deletion   22    - 
Loan repayment   -    172 
Conversion of loan to ordinary shares   657    - 
Share based payments   2,084    98 
Post-employment retirement benefits   98    94 
Payment for Administrative services   34    36 
Non-monetary benefits   49    29 
Payments for legal services   287     - 
Revaluation of financial liabilities at fair value   1,204    - 
Proof of Concept projects paid by affiliated companies   -   (1,064)
Key management personnel compensation   5,238    594 

 

2. Balance with related parties:     December 31, 2023   December 31, 2022 
Key management  Salary and related   (219)   (99)
Directors  Salary and related   -    (82)
Shareholders  Borrowings from related parties   -    (710)
Shareholders  Other accounts payable   (3)   (56)
Shareholders  Trade payables   (58)   -  
Shareholders  Derivatives   (476)   - 
Joint Ventures  Other receivables   15    59 
Joint Ventures  Investment in subsidiary   115    221 
       (626)   (667)

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 43 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GOVERNMENT GRANTS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
GOVERNMENT GRANTS

NOTE 20 - GOVERNMENT GRANTS

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS). The Group has an approved project with the IIA under which it received a total of $162 in prior years. The Group is subject to paying 3% of its relevant revenues until repayment of the entire grant. As of December 31, 2023, the Group paid an amount of 0. The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.

 

Until October 25, 2023, the interest was calculated at a rate based on 12-month London Interbank Offered Rate, or LIBOR applicable to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual interest will be calculated at a rate based on 12-month Secured Overnight Financing Rate, the SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest will be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.

 

   December 31, 2023   December 31, 2022 
Short term liability at year end   153    50 
Long term liability at year end   -    85 
Total   153    135 

 

XML 44 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMITMENTS AND CONTINGENT LIABILITIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 21 - COMMITMENTS AND CONTINGENT LIABILITIES:

 

As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.

 

1.In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

On January 2023, the Company signed an amendment to the agreement that determine the following:

 

(1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main assumptions which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%;

 

The fair value of these options was $33 and recognized as a technology license intellectual property.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 21 - COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):

 

(2) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof).

 

As of December 31, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $123 against a liability that reflects the due amount.

 

(3) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

XML 45 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
12 Months Ended
Dec. 31, 2023
Financial Instruments And Risk Management  
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

Composition of the Group’s financial assets and financial liabilities:

 

   2023   2022 
   December 31, 
   2023   2022 
Financial assets at amortized cost:          
Cash and cash equivalents   168    1,398 
Other current receivables   424    3,673 
Total financial assets   592    5,071 

 

 

   2023   2022 
   December 31, 
   2023   2022 
Financial liabilities at fair value through profit or loss:          
Convertible notes   377    563 
Trade and other payables   12,487    3,622 
Bridge loans   2,233    3,682 
Pre-paid advance   700    - 
Derivatives   1,143    - 
Total financial liabilities at fair value through profit or loss   16,940    7,867 
           
Financial liabilities at amortized cost:          
Convertible promissory note   1,013    - 
Lease liabilities   649    - 
Government grants   153    - 
Borrowing from related parties   -    - 
Total financial liabilities at amortized cost   1,815    - 
Total financial liabilities   18,755    7,867 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Financial risk management objectives

 

The Group’s activities expose it to a variety of financial risks such as market risks (foreign currency risk), credit risk and liquidity risk. The Company’s management oversees the management of these risks, focusing on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to monitor different types of risk to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange, ageing analysis for credit risk and maturity analysis in respect of liquidity risk.

 

Market risk

 

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices, which in the group’s case refers only to foreign currency risk. Financial instruments affected by this risk include, loans and borrowings and short-term payables and receivables.

 

Foreign currency risk

 

Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the NIS and Euro.

 

As of December 31, 2023, the Group has excess financial liabilities over financial assets in foreign currencies in relation to the NIS , AUD ,SGD and EUR totaling approximately $1,651, $185 $142 and $101, respectively (December 31, 2022: approximately $729 ,$1265 $0 and $34, respectively).

 

Foreign currency sensitivity analysis

 

The following table demonstrates the sensitivity test to a reasonably possible change of 10% in EUR and NIS exchange rates against the USD, with all other variables held constant. The impact on the Group’s net loss (tax effect is not relevant) and equity is due to changes in the fair value of monetary assets and liabilities including non-designated foreign currency derivatives and embedded derivatives. The Company’s exposure to foreign currency changes for all other currencies is immaterial.

 

   Change in NIS rate   Effect on net loss 
December 31, 2023   10%   165 
December 31, 2022   10%   73 

 

   Change in AUD rate   Effect on net loss 
December 31, 2023   10%   19 
December 31, 2022   10%   127 

 

   Change in SGD rate   Effect on net loss 
December 31, 2023   10%   14 
December 31, 2022   10%   - 

 

   Change in EUR rate   Effect on net loss 
December 31, 2023   10%   10 
December 31, 2022   10%   3 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Credit risk

 

Credit risk is the risk that a counterparty will not meet its obligations as a customer or under a financial instrument leading to a loss to the Group. The Group is exposed to credit risk from its operating activity (other receivables and cash balances). The Group’s main financial assets are cash and cash equivalents as well as other receivables and their carrying amounts represent the Group’s maximum exposure to credit risk. Credit risk from balances with banks and financial institutions is managed by the Group’s management in accordance with the Group’s policy. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia which the Company’s management regards as financially solid.

 

Liquidity risk

 

Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.

 

The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.

 

As of December 31, 2023

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   12,487    -    -    -    -    -    12,487 
Bridge loans   1,750    453    15    15    -    -    2,233 
Government grants   153    -     -     -     -    -    153 
Lease liability   81    81    74    74    74    265    649 
Convertible promissory note   1,013    -    -    -    -    -    1,013 
Pre-paid advance   700    - 

-

   -    

-

    

-

    

-

    700 
Convertible note   377    -    -    -    -    -    377 
Financial derivatives   1,143    -    -    -    -    -    1,143 
    17,704    534    89    89    74    265    18,755 

 

As of December 31, 2022

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   3,622    -    -    -    -    -    3,622 
Bridge loans   -    1,031    -    -    -    -    1,031 
Government grants   75    84     -     -     -     -    159 
Lease liability   72    72    72    72    72    353    713 
Borrowings from related parties   710    -     -     -     -     -    710 
    4,479    1,187    72    72    72    353    6,235 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 46 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENT
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
FAIR VALUE MEASUREMENT

NOTE 23 - FAIR VALUE MEASUREMENT:

 

Fair value hierarchy

 

The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:

 

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

 

Level 3: Unobservable inputs for the asset or liability.

 

 

As of December 31, 2023  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,707    1,707 
Tradable warrants   2    -    -    2 
Total   2    -    1,707    1,709 

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,031    1,031 
Total   -    -    1,031    1,031 

 

XML 47 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2023
SUBSEQUENT EVENTS

NOTE 24 - SUBSEQUENT EVENTS:

 

Since the reporting date the following significant events have occurred:

 

1.The financial statements were authorized for issuance on April 19, 2024.
  
2.On January 12, 2024, the Company announced that it entered into a $5 million contract with R&I Trading of New York. This project, spearheaded by the SMX team, will deploy SMX’s technology to enhance supply chain transparency with respect to a NATO government member state and with the expectation of expanding to further NATO government member states.
  
3.In January 2024, pursuant to the inducement letter described in note 14(3), the holders of the new 909,090 warrants exercised 454,544 warrants for an aggregate of 454,544 Ordinary Shares.
  
4.In February 2024, the Company entered into a Letter Agreement with Yorkville dated February 1, 2024 (the “Letter Agreement”), which amends the SEPA. Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances under the SEPA, to repay the amounts outstanding under the Pre-Paid Advance plus payment premium. The Company agreed to pay a fee to Yorkville equal to $200.
  
 The Company further agreed to issue to Yorkville a 5-year warrant to purchase 250,000 ordinary shares of the Company at an exercise price of $0.0022 per share.
  
5.On February 20, 2024, the Company closed an underwritten public offering of 12,124,666 Ordinary Shares at a subscription price per share of $0.24 and Pre-Funded Warrants convertible on a 1-for-1 basis into Ordinary Shares, at a price per Pre-Funded Warrant of $0.2378. The gross proceeds was approximately $2.9 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The net proceeds to the Company upon the closing of the offering, after deducting the underwriting commissions and estimated offering expenses payable by the Company, were approximately $2.66 million.
  
6.On February 28, 2024, in connection with a private placement binding term sheet, the Company issued (i) a convertible security to an investor relating to a loan in the principal amount of $407 and (ii) 100,000 warrants to the investor. The warrants have an exercise price of $0.5 per share. The net proceeds to the Company upon the closing of the private placement was $350.
  
7.On February 29, 2024, the Company’s Board of Directors approved a grant of 1,500,000 RSUs to an officer, directors and service providers under the 2022 Incentive Equity Plan. As of the date of these Financial Statements 166,667 of the RSUs are vested.
  
8.On March 4, 2024, the Company’s Board of Directors approved the issuance of 100,000 ordinary shares to a service provider in connection with certain investor relations services.
  
9.On April 11, 2024 the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor a promissory note and warrants, for gross proceeds of approximately US$2.0 million, before deducting fees and other offering expenses payable by the Company. The Note is in the principal amount of $2,250. The actual amount loaned by the Investor pursuant to the Note is approximately $2.0 million after a 10% original issue discount. The maturity date of the Note is the 12-month anniversary of the Effective Date, and is the date upon which the Principal Amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year. In addition, the Warrant, for 5 years period and for 11,825,508 Ordinary Shares, has an exercise price of $$0.157 per share, subject to customary adjustments and limitations as described in the agreement. Furthermore, as a further inducement of the Company for the Investor to enter into the transaction, the Company entered into a Warrant Amendment and Inducement Letter with the Investor, with respect to its outstanding “B” warrants of the Company (the “Existing Warrant”) to purchase 2,619,367 Ordinary Shares. The Existing Warrant was issued to the Investor as of September 6, 2023 and had a fixed exercise price of $1.6378 per share. Pursuant to the Inducement Letter, the Investor agreed to exercise for cash the Existing Warrant in full at a reduced exercise price of $0.0022 per share, or approximately $6, see also note 8(c).
  
10.

On April 19, 2024, the Company entered into a Stock Purchase Agreement (the “SPA”) with an institutional investor, pursuant to which the investor has committed to purchase from time to time from the Company, up to $30,000 of the Company’s ordinary shares, subject to the terms and conditions specified in the SPA. Subject to the terms and conditions of the SPA, the Company has the right from time to time at its discretion, any time after the three month anniversary of the shares underlying the SPA being registered for resale pursuant to the Registration Rights Agreement referred to below, to direct Alpha to purchase a specified amount of the Company’s ordinary shares (each such sale, a “Put”) by delivering written notice to Alpha (each, a “Put Notice”). There is a $20 mandatory minimum amount for any Put and it may not exceed $500 in any consecutive 30-day period, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.

 

The obligations of the investor to accept any Put pursuant to a Put Notice is subject to customary conditions, including that it is not required to purchase any ordinary shares pursuant to a Put if it would result in it beneficially owning in excess of 4.99% of the Company’s ordinary shares, and that the ordinary shares subject to the Put be registered for resale. The Company agreed to pay a commitment fee to the investor equal to 1.5% of the commitment amount, payable in shares, or 2,725,621 ordinary shares (the “Commitment Shares”) and which are subject to a three month lock-up.

 

The SPA will automatically terminate on the earliest to occur of (a) the first day of the month next following the 36-month anniversary of the date of the SPA or (ii) the date on which the investor shall have made payment of Puts pursuant to the SPA for ordinary shares equal to $30,000. The Company has the right to terminate the SPA at no cost or penalty upon five (5) trading days’ prior written notice to the investor, provided that there are no outstanding Put Notices for which ordinary shares need to be issued and the Company has paid all amounts owed to the investor pursuant to the SPA and any indebtedness the Company otherwise owes to the investor or its affiliates. The Company and the investor may also agree to terminate the SPA by mutual written consent.

  
11.As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of 2,619,377 Ordinary Shares and exercised the Warrant A and Warrant B for 3,789,264 and 2,619,367 Ordinary Shares, respectively, see also note 8(c).
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies)
12 Months Ended
Dec. 31, 2023
Significant Accounting Policies Accounting Judgments Estimates And Assumptions  
Basis of preparation

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value.

 

Principles of consolidation

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of SMX (Security Matters) Public Limited Company as of December 31, 2023 and 2022 and the results of all subsidiaries for the three years in the period then ended. SMX (Security Matters) Public Limited Company, a public limited company and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Investments in associated companies

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Reverse acquisition transaction

Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

The Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.
2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.
3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.
Foreign currency

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True Gold consortium PYT LTD. is Australian Dollar.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date.
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Issue of a unit of financial instruments

Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

Governmental grants

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

Fair value measurement

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at fair value through profit or loss.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liabilities

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for financial liabilities which are measured at fair value through profit or loss.

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

Impairment of non-financial assets

Impairment of non-financial assets

 

Intangible assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   8 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be successful, are offset in profit or loss against the related expenses (research and development expenses). Any intellectual property generated from this activity remains at the ownership of the Group.

 

Right-of-use assets

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

Lease liabilities

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee;
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option; and
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Capitalized technology development costs

Capitalized technology development costs

 

Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when a milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

Share-based compensation

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments adopted from January 1, 2023

New standards, interpretations and amendments adopted from January 1, 2023

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements);

 

In February 2021, the IASB issued amendments to IAS 1 and IFRS Practice Statement 2. The amendments aim to make accounting policy disclosures more informative by replacing the requirement to disclose ‘significant accounting policies’ with ‘material accounting policy information’. The amendments also provide guidance under what circumstance, the accounting policy information is likely to be considered material and therefore requiring disclosure.

 

These amendments have no effect on the measurement or presentation of any items in the consolidated financial statements of the Group but affect the disclosure of accounting policies of the Group.

 

Definition of Accounting Estimates (Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors);

 

The amendments to IAS 8, which added the definition of accounting estimates, clarify that the effects of a change in an input or measurement technique are changes in accounting estimates, unless resulting from the correction of prior period errors. These amendments clarify how entities make the distinction between changes in accounting estimate, changes in accounting policy and prior period errors. These amendments had no effect on the consolidated financial statements of the Group.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

New standards, interpretations and amendments not yet effective

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

 

There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2024:

 

  IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback);
  IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current);
  Non-current Liabilities with Covenants (Amendments to IAS 1 Presentation of Financial Statements); and
  Supplier Finance Arrangements (Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures).

 

The following amendments are effective for the period beginning January 1, 2025:

 

Lack of Exchangeability (Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates).

 

The Group is currently assessing the impact of these new accounting standards and amendments. The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

H.The significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent basis, are:

 

In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.

 

The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.

 

Share based compensation

Share based compensation

 

The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.

 

Intangible assets

Intangible assets

 

The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.

 

This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 7.

 

The management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):

 

Financial liability at fair value

Financial liability at fair value

 

The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions of the financial liability, which are described in Note 22 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.

XML 49 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GENERAL (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF COMPANIES SUBSIDIARIES

Controlled entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters (SMX) PLC  Ireland   100%   - 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
  Australia   100%   - 
Lionheart III Corp  USA   100%   ** 
SMX Circular Economy Platform PTE, Ltd.  Singapore   100%   * 
SMX (Security Matters) Ireland Limited  Ireland   100%   * 
SMX Fashion and Luxury
  France   100%   - 
TrueSilver SMX Platform Ltd.
  Canada   100%   - 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
  Israel   100%   100%***
Security Matters Canada Ltd.  Canada   100%   100%***
SMX Beverages Pty Ltd.  Australia   100%   100%***
True Gold Consortium Pty Ltd.  Australia   51.9%***   See note 6 

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

  *Incorporated in 2023.
  **Merger occurred in March 2023 as part of the Business Combination.
  ***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables)
12 Months Ended
Dec. 31, 2023
Significant Accounting Policies Accounting Judgments Estimates And Assumptions  
SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   8 
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TRUE GOLD BUSINESS COMBINATION (Tables)
12 Months Ended
Dec. 31, 2023
SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES

The fair value of the identifiable assets and liabilities of TrueGold on the acquisition date:

           
   US$ in thousands 
Cash and cash equivalents       13 
Other current receivables        155 
Intangible asset (core technology license)        10,449 
Trade payables        277 
           
Net identifiable assets        10,340 
Non-controlling interests        (20,826)
Goodwill        32,957 
           
Loan to TrueGold   307      
           
Fair value of previous investment   22,164      
Fair value of identifiable assets and liabilities        22,471 
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER CURRENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

SCHEDULE OF OTHER CURRENT ASSETS

   December 31, 2023   December 31, 2022 
Prepaid expenses   142    *3,157
Tax authorities   257    358 
Proof of concept receivables   148    86 
Other   87    72 
Total   634    3,673 

 

*Includes $3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PROPERTY, PLANT AND EQUIPMENT, NET: (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2023   63    1,147    65    102    1,377 
Additions   15    5    7    4    31 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (3)   (6)   (3)   (4)   (16)
At December 31, 2023   75    1,146    69    102    1,392 
                          
Accumulated depreciation                         
At January 1, 2023   18    699    31    74    822 
Depreciation   6    151    7    16    180 
Currency translation adjustments   -    (18)   (1)   (2)   (21)
At December 31, 2023   24    832    37    88    981 
Net book value at December 31, 2023   51    314    32    14    411 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Total 
                     
Cost                         
At January 1, 2022   81    1,233    83    99    1,496 
Additions   -    135    -    17    152 
Deductions   -    -    -    -    - 
Depreciation   -    -    -    -    - 
Currency translation adjustments   (18)   (221)   (18)   (14)   (271)
At December 31, 2022   63    1,147    65    102    1,377 
                          
Accumulated depreciation                         
At January 1, 2022   20    645    33    72    770 
Depreciation   4    202    7    19    232 
Currency translation adjustments   (6)   (148)   (9)   (17)   (180)
At December 31, 2022   18    699    31    74    822 
Net book value at December 31, 2022   45    448    34    28    555 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

XML 54 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS IN ASSOCIATED COMPANIES (Tables)
12 Months Ended
Dec. 31, 2023
Investments In Associated Companies  
SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

Entity 

Country of

Incorporation

 

Percentage Owned

December 31, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.  Canada   50%   50%
True Gold Consortium Pty Ltd.  Australia   51.9%   44.4%
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INTANGIBLE ASSETS, NET (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SUMMARY OF INTANGIBLE ASSETS NET

SUMMARY OF INTANGIBLE ASSETS NET

   Capitalization of development cost   Purchased license   Core Technology License   Total 
   US$ in thousands   US$ in thousands   US$ in thousands   US$ in thousands 
COST                    
As of January 1, 2023   4,372    655    -    5,027 
Capitalized development cost   977    157    10,449    11,583 
Currency translation adjustments   (7)   7    -    - 
As of December 31, 2023   5,342    819    10,449    16,610 
                     
Accumulated amortization                    
As of January 1, 2023   127    -    -    127 
Amortization   -    -    -    - 
Currency translation adjustments   (3)   -    -    (3)
As of December 31, 2023   124    -    -    124 
                     
Net book value as of December 31, 2023   5,218    819    10,449    16,486 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 7 - Intangible assets, NET (CONT.):

 

   Capitalization of development cost   Purchased license   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
LEASES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF RIGHT OF USE ASSETS

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

  

Office and lab

facilities

   Motor vehicles   Total 
At January 1, 2022   446    20    466 
Additions   49    -    49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)   -    (39)
As at December 31, 2022   414    -    414 
Additions   -    26    26 
Foreign currency translation   (6)   -    (6)
Deductions   -    -    - 
Depreciation expense   (42)   (3)   (45)
As at December 31, 2023   366    23    389 
SCHEDULE OF INFORMATION ON LEASE

Information on leases:

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
         
Interest expense on lease liabilities   32    51 
Total cash outflow for leases   45    39 
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
OTHER PAYABLES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF OTHER PAYABLES

SCHEDULE OF OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
         
Employees, salaries and related liabilities   726    392 
Related party   4    56 
Liabilities for grants received (see also note 20)   153    50 
Excise Tax   1,569    - 
Other   31    152 
Total   2,483    650 
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BORROWINGS FROM RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF BORROWINGS FROM RELATED PARTIES

   December 31, 2023   December 31, 2022 
Balance at January 1,   710    270 
Payment of borrowings   (657)   (172)
Provision for bonus (include interest)   -    621 
Exchange rate differences   (53)   (9)
Balance at December 31,   -    710 
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHAREHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF SHARE CAPITAL

SCHEDULE OF SHARE CAPITAL

   Number of shares 
   December 31, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0022
par value
   36,363,636,364    10,185,909    22,727,272    - 
Preferred shares
USD 0.0001
par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1
par value
   25,000    25,000    25,000    25,000 
SCHEDULE OF RESTRICTED STOCK UNIT

 

5.On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount (see also note 13).

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

 

NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):

   
6.On December 31,2023 The Company also issued 457,682 Ordinary Shares to a service provider as payment in full for $260 worth of legal services which previously provided to the Company.

 

C.Options granted to employees and service providers:

 

1.In June 2018, Security Matters PTY Ltd. has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Plan include employees, directors and consultants of Security Matters PTY Ltd. or any subsidiary. On March 7, 2023 as part of the SPAC transaction. These options were exercised on a cashless basis and then after replaced to the Company’s shares. See also note 14B1(c-d).
   
 2.In March 7, 2023 Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.
   
3.In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

4.During the period ended December 31, 2023, the Company granted 197,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. Related share-based expenses recognized for the period totaled $2,820.

 

RSUs granted to employees, directors and service providers:

  

Year ended

December 31, 2023 (in thousands)

  

Year ended

December 31, 2022 (in thousands)

 
Outstanding at beginning of period   -    - 
Granted   197    - 
Vested   (57)   - 
Forfeited   (4)   - 
           
Outstanding at December 31, 2023   136    - 
SCHEDULE OF RESTRICTED STOCK UNIT

  

Year ended

December 31, 2023 (in thousands)

  

Year ended

December 31, 2022 (in thousands)

 
Outstanding at beginning of period   -    - 
Granted   197    - 
Vested   (57)   - 
Forfeited   (4)   - 
           
Outstanding at December 31, 2023   136    - 
SCHEDULE OF SHARE OPTION GRANTED

   Year ended
December 31, 2023
   Year ended
December 31, 2022
 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (USD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (USD)

 
Outstanding at beginning of year   57    44.22    73    41.85 
Issue of options   38    82.04    17    41.85 
Expired   (30)   31.02    (33)   34.10 
                   
Outstanding at end of year   65     69.92     57    54.25 
Exercisable options   58    68.67    38    43.40 
SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

The options to employees and service providers outstanding as of December 31, 2023, are comprised, as follows:

Exercise price (USD) 

Outstanding as of

December 31, 2023

  

Weighted average remaining

contractual term

   Exercisable as of December 31, 2023  

Weighted average remaining

contractual term

 
       (years)       (years) 
18.70-23.32   5    2.46    5    2.46 
29.48-31.02   3    3.21    3    3.21 
40.48-48.18   6    1.41    6    1.41 
52.80-56.10   9    2.26    9    2.26 
78.54-88.00   35    4.40    28    4.38 
93.28-108.90   7    3.03    7    3.03 
    65         58      
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE

 

   December 31, 2023   December 31, 2022   December 31, 2021 
Salaries and related expenses   2,228    2,166    1,795 
Subcontractors and consultants   344    374    631 
Materials and laboratory expenses   223    316    252 
Depreciation and amortization   197    255    287 
Share based compensation   447    127    100 
Travel expenses   87    50    42 
Freight   33    30    23 
Other   10    6    - 
Reimbursement from paid pilots and proof of concept projects   (858)   (1,426)   (1,091)
Total   2,711    1,898    2,039 
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GENERAL AND ADMINISTRATIVE EXPENSES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

 

   December 31, 2023   December 31, 2022   December 31, 2021 
BCA transaction cost   7,278    -    - 
Professional services   667    1,105    1,089 
Public company expenses   5,128    -    - 
Wages and salaries related   1,348    935    752 
Travel expenses   611    223    - 
Office and maintenance   170    145    116 
Share based compensation   1,222    137    331 
Insurance   50    60    102 
Depreciation and amortization   30    35    28 
Other   63    83    64 
Total   16,567    2,723    2,482 

 

XML 62 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TAXES ON INCOME (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

   December 31, 2023   December 31, 2022   December 31, 2021 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (20,989)   (6,184)   (4,939)
                
Theoretical tax rate of 12.5%   (2,624)   (1,701)   (1,358)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   3254    335    118 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   (630)   1,366    1,240 
Income tax / (benefit)            
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
LOSS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Profit or loss [abstract]  
SCHEDULE OF LOSS PER SHARE

 

   December 31, 2023   December 31, 2022   December 31, 2021 
             
Net loss attributable to the owners of the company   (20,914)   (6,184)   (4,939)
                
Basic and diluted loss per share   (7.82)   *(8.47)   *(7.41)
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   2,676    730    666 

 

*Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF KEY MANAGEMENT PERSONNEL

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

1. Transactions with related parties:  December 31, 2023   December 31, 2022 
Issuance of options to related party   -    721 
Short-term salary and fees   803    508 
Short-term salary until deletion   22    - 
Loan repayment   -    172 
Conversion of loan to ordinary shares   657    - 
Share based payments   2,084    98 
Post-employment retirement benefits   98    94 
Payment for Administrative services   34    36 
Non-monetary benefits   49    29 
Payments for legal services   287     - 
Revaluation of financial liabilities at fair value   1,204    - 
Proof of Concept projects paid by affiliated companies   -   (1,064)
Key management personnel compensation   5,238    594 
SCHEDULE OF BALANCE WITH RELATED PARTIES

2. Balance with related parties:     December 31, 2023   December 31, 2022 
Key management  Salary and related   (219)   (99)
Directors  Salary and related   -    (82)
Shareholders  Borrowings from related parties   -    (710)
Shareholders  Other accounts payable   (3)   (56)
Shareholders  Trade payables   (58)   -  
Shareholders  Derivatives   (476)   - 
Joint Ventures  Other receivables   15    59 
Joint Ventures  Investment in subsidiary   115    221 
       (626)   (667)
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GOVERNMENT GRANTS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF GOVERNMENT GRANTS

 

   December 31, 2023   December 31, 2022 
Short term liability at year end   153    50 
Long term liability at year end   -    85 
Total   153    135 
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2023
Financial Instruments And Risk Management  
SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE

Composition of the Group’s financial assets and financial liabilities:

 

   2023   2022 
   December 31, 
   2023   2022 
Financial assets at amortized cost:          
Cash and cash equivalents   168    1,398 
Other current receivables   424    3,673 
Total financial assets   592    5,071 
SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS

 

   2023   2022 
   December 31, 
   2023   2022 
Financial liabilities at fair value through profit or loss:          
Convertible notes   377    563 
Trade and other payables   12,487    3,622 
Bridge loans   2,233    3,682 
Pre-paid advance   700    - 
Derivatives   1,143    - 
Total financial liabilities at fair value through profit or loss   16,940    7,867 
           
Financial liabilities at amortized cost:          
Convertible promissory note   1,013    - 
Lease liabilities   649    - 
Government grants   153    - 
Borrowing from related parties   -    - 
Total financial liabilities at amortized cost   1,815    - 
Total financial liabilities   18,755    7,867 
SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS

 

   Change in NIS rate   Effect on net loss 
December 31, 2023   10%   165 
December 31, 2022   10%   73 

 

   Change in AUD rate   Effect on net loss 
December 31, 2023   10%   19 
December 31, 2022   10%   127 

 

   Change in SGD rate   Effect on net loss 
December 31, 2023   10%   14 
December 31, 2022   10%   - 

 

   Change in EUR rate   Effect on net loss 
December 31, 2023   10%   10 
December 31, 2022   10%   3 
SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   12,487    -    -    -    -    -    12,487 
Bridge loans   1,750    453    15    15    -    -    2,233 
Government grants   153    -     -     -     -    -    153 
Lease liability   81    81    74    74    74    265    649 
Convertible promissory note   1,013    -    -    -    -    -    1,013 
Pre-paid advance   700    - 

-

   -    

-

    

-

    

-

    700 
Convertible note   377    -    -    -    -    -    377 
Financial derivatives   1,143    -    -    -    -    -    1,143 
    17,704    534    89    89    74    265    18,755 

 

As of December 31, 2022

 

   Less than one year   1 to 2 years  

2 to 3

years

   3 to 4 years   4 to 5 years  

>5

years

   Total 
                             
Trade and other payables   3,622    -    -    -    -    -    3,622 
Bridge loans   -    1,031    -    -    -    -    1,031 
Government grants   75    84     -     -     -     -    159 
Lease liability   72    72    72    72    72    353    713 
Borrowings from related parties   710    -     -     -     -     -    710 
    4,479    1,187    72    72    72    353    6,235 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands)

XML 67 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENT (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY

 

As of December 31, 2023  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,707    1,707 
Tradable warrants   2    -    -    2 
Total   2    -    1,707    1,709 

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities   -    -    1,031    1,031 
Total   -    -    1,031    1,031 
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF COMPANIES SUBSIDIARIES (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Security Matters Smx Plc [Member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary [1] Ireland  
Proportion of ownership interest in subsidiary [1] 100.00%  
Security matters pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Australia  
Proportion of ownership interest in subsidiary 100.00%
Lion heart III corp [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary [2] USA  
Proportion of ownership interest in subsidiary [2] 100.00%  
SMX circular economy platform pte ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary [1] Singapore  
Proportion of ownership interest in subsidiary [1] 100.00%  
SMX ireland limited [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary [1] Ireland  
Proportion of ownership interest in subsidiary [1] 100.00%  
S M X Fashion And Luxury [Member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary France  
Proportion of ownership interest in subsidiary 100.00%  
True Silver SMX Platform Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Canada  
Proportion of ownership interest in subsidiary 100.00%  
SMX israel ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Israel  
Proportion of ownership interest in subsidiary 100.00% 100.00% [3]
Security matters canada ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Canada  
Proportion of ownership interest in subsidiary 100.00% 100.00% [3]
SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Australia  
Proportion of ownership interest in subsidiary 100.00% 100.00% [3]
True gold consortium pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Australia  
Proportion of ownership interest in subsidiary [3] 51.90%  
Yahaloma technologies inc [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation of subsidiary Canada  
Proportion of ownership interest in subsidiary 50.00% 50.00% [3]
[1] Incorporated in 2023.
[2] Merger occurred in March 2023 as part of the Business Combination.
[3] Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GENERAL (Details Narrative)
$ / shares in Units, $ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Oct. 03, 2023
Jul. 26, 2022
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
May 31, 2022
AUD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Apr. 19, 2024
USD ($)
Apr. 01, 2024
USD ($)
Dec. 31, 2023
€ / shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
Jan. 31, 2015
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares         1,237,751       1,000,000 864,000  
Par value per share | € / shares               € 1      
Percentage of voting equity interests acquired                     2.00%
Issue of convertible instruments     $ 569 $ 828              
Proceeds from borrowings, classified as financing activities         $ 5,800            
Bottom of range [member]                      
IfrsStatementLineItems [Line Items]                      
Issue of convertible instruments         500            
Top of range [member]                      
IfrsStatementLineItems [Line Items]                      
Issue of convertible instruments         1,000            
True gold consortium pty ltd [member]                      
IfrsStatementLineItems [Line Items]                      
Percentage of voting equity interests acquired 7.50%                    
Proportion of ownership interest in subsidiary 51.90%                    
Equity line agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares         25,000            
Other receivables         3,000            
Equity Purchase Agreement [Member] | Entering into significant commitments or contingent liabilities [member]                      
IfrsStatementLineItems [Line Items]                      
Notional amount           $ 30,000 $ 30,000        
Nato Agreement [Member]                      
IfrsStatementLineItems [Line Items]                      
Decrease increase in expenses snd capitalize         $ 5,000            
Lionheart [Member] | Business Combination Agreement [Member]                      
IfrsStatementLineItems [Line Items]                      
Redemption percentage of business combination   97.58%                  
Remaining funds in trust account   $ 3,061                  
Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares                 160,227    
Par value per share | $ / shares         $ 0.0022            
Ordinary shares [member] | Security matters pty ltd [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   1                  
Share price | $ / shares   $ 10.3624                  
Par value per share | $ / shares   $ 10.00                  
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details)
12 Months Ended
Dec. 31, 2023
Computer equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 33.00%
Machinery [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 20.00%
Furniture and office equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 10.00%
Leasehold improvements [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 8.00%
XML 71 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative)
12 Months Ended
Dec. 31, 2023
USD ($)
Significant Accounting Policies Accounting Judgments Estimates And Assumptions  
Fair value based on quoted opening share price $ 11,599
Fair value of equity transaction 16,802
Marketable securities held in trust account 4,921
Trade and other payables $ 10,127
XML 72 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details) - True gold consortium pty ltd [member]
$ in Thousands
Oct. 03, 2023
USD ($)
IfrsStatementLineItems [Line Items]  
Cash and cash equivalents $ 13
Other current receivables 155
Intangible asset (core technology license) 10,449
Trade payables 277
Net identifiable assets 10,340
Non-controlling interests (20,826)
Goodwill 32,957
Total purchase cost 307
Fair value of previous investment 22,164
Fair value of identifiable assets and liabilities $ 22,471
XML 73 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TRUE GOLD BUSINESS COMBINATION (Details Narrative)
3 Months Ended 9 Months Ended
Oct. 03, 2023
USD ($)
$ / shares
Oct. 03, 2023
AUD ($)
Oct. 02, 2023
Dec. 31, 2023
USD ($)
Oct. 02, 2023
USD ($)
Dec. 31, 2023
€ / shares
Jan. 31, 2015
IfrsStatementLineItems [Line Items]              
Percentage of voting equity interests acquired             2.00%
Par value per share | € / shares           € 1  
True gold consortium pty ltd [member]              
IfrsStatementLineItems [Line Items]              
Percentage of voting equity interests acquired 7.50%            
Proportion of ownership interest in subsidiary 51.90% 51.90% 44.40%        
Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date | $ $ 22,164,000            
Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination | $ $ 22,164,000            
Weighted average cost of capital percentage 24.80%            
Terminal per shares | $ / shares $ 4.59            
Terminal growth rate percentage 3.00%            
Discount for lack of marketability percentage 25.20%            
Discount for lack of marketability value | $ / shares $ 11.17            
Par value per share | $ / shares $ 33.12            
Forgiveness of outstanding payables $ 307 $ 475          
Profit (loss) of acquiree since acquisition date | $       $ 155 $ 692    
XML 74 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF OTHER CURRENT ASSETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Current prepayments and other current assets $ 142 $ 3,157 [1]
Tax authorities 257 358
Proof of concept receivables 148 86
Other 87 72
Total $ 634 $ 3,673
[1] Includes $3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).
XML 75 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)
$ in Thousands
Dec. 31, 2022
USD ($)
SPAC [member]  
IfrsStatementLineItems [Line Items]  
Anticipated transaction costs $ 3,123
XML 76 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance $ 555  
Property and equipment, ending balance 411 $ 555
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 1,377 1,496
Additions 31 152
Deductions
Depreciation
Currency translation adjustments (16) (271)
Property and equipment, ending balance 1,392 1,377
Accumulated depreciation [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 822 770
Depreciation 180 232
Currency translation adjustments (21) (180)
Property and equipment, ending balance 981 822
Leasehold improvements [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 45  
Property and equipment, ending balance 51 45
Leasehold improvements [member] | Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 63 81
Additions 15
Deductions
Depreciation
Currency translation adjustments (3) (18)
Property and equipment, ending balance 75 63
Leasehold improvements [member] | Accumulated depreciation [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 18 20
Depreciation 6 4
Currency translation adjustments (6)
Property and equipment, ending balance 24 18
Machinery [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 448  
Property and equipment, ending balance 314 448
Machinery [member] | Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 1,147 1,233
Additions 5 135
Deductions
Depreciation
Currency translation adjustments (6) (221)
Property and equipment, ending balance 1,146 1,147
Machinery [member] | Accumulated depreciation [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 699 645
Depreciation 151 202
Currency translation adjustments (18) (148)
Property and equipment, ending balance 832 699
Furniture and office equipment [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 34  
Property and equipment, ending balance 32 34
Furniture and office equipment [member] | Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 65 83
Additions 7
Deductions
Depreciation
Currency translation adjustments (3) (18)
Property and equipment, ending balance 69 65
Furniture and office equipment [member] | Accumulated depreciation [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 31 33
Depreciation 7 7
Currency translation adjustments (1) (9)
Property and equipment, ending balance 37 31
Computer equipment [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 28  
Property and equipment, ending balance 14 28
Computer equipment [member] | Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 102 99
Additions 4 17
Deductions
Depreciation
Currency translation adjustments (4) (14)
Property and equipment, ending balance 102 102
Computer equipment [member] | Accumulated depreciation [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 74 72
Depreciation 16 19
Currency translation adjustments (2) (17)
Property and equipment, ending balance $ 88 $ 74
XML 77 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Yahaloma technologies inc [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation Canada  
Proportion of ownership interest in associate 50.00% 50.00%
True gold consortium pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation Australia  
Proportion of ownership interest in associate 51.90% 44.40%
XML 78 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)
Jan. 31, 2023
Dec. 24, 2021
AUD ($)
shares
Dec. 24, 2021
USD ($)
Dec. 24, 2021
AUD ($)
$ / shares
IfrsStatementLineItems [Line Items]        
Risk free interest rate, share options granted 3.42%      
True gold consortium pty ltd [member]        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest in joint venture   7.50%    
SMX beverages pty ltd [member]        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest in joint venture   50.00%    
Shares issued for exercise of stock options, shares | shares   8,000,001    
Exercise price of outstanding share options | $ / shares       $ 0.4
Weighted average remaining contractual life of outstanding share options   Mar. 25, 2027    
Consideration transferred, acquisition-date fair value     $ 721,424 $ 960,000
Risk free interest rate, share options granted   2.50%    
Options expected life   5 years    
Global BevCo Pty Ltd. [member] | Consulting agreement [member]        
IfrsStatementLineItems [Line Items]        
Consulting fees | $   $ 13,500    
Percentage of entity's revenue   5.00%    
XML 79 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUMMARY OF INTANGIBLE ASSETS NET (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Amortization $ 145  
Net book value 16,486 $ 5,027
Capitalised development expenditure [member]    
IfrsStatementLineItems [Line Items]    
Net book value 5,218 4,372
Licences [member]    
IfrsStatementLineItems [Line Items]    
Net book value 819 655
Technology License [Member]    
IfrsStatementLineItems [Line Items]    
Net book value 10,449  
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance 5,027 4,024
Capitalized development cost 11,583 1,696
Currency translation adjustments (566)
Cost, ending balance 16,610 5,027
Cost, ending balance   5,154
Gross carrying amount [member] | Capitalised development expenditure [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance 4,372 4,024
Capitalized development cost 977 975
Currency translation adjustments (7) (500)
Cost, ending balance 5,342 4,372
Cost, ending balance   4,499
Gross carrying amount [member] | Licences [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance 655
Capitalized development cost 157 721
Currency translation adjustments 7 (66)
Cost, ending balance 819 655
Cost, ending balance   655
Gross carrying amount [member] | Technology License [Member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance  
Capitalized development cost 10,449  
Currency translation adjustments  
Cost, ending balance 10,449
Accumulated Depreciation Amortisation [Member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments (3) (3)
Accumulated amortization, beginning balance 127 116
Amortization 14
Accumulated amortization, ending balance 124 127
Accumulated Depreciation Amortisation [Member] | Capitalised development expenditure [member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments (3) (3)
Accumulated amortization, beginning balance 127 116
Amortization 14
Accumulated amortization, ending balance 124 127
Accumulated Depreciation Amortisation [Member] | Licences [member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments
Accumulated amortization, beginning balance
Amortization
Accumulated amortization, ending balance
Accumulated Depreciation Amortisation [Member] | Technology License [Member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments  
Accumulated amortization, beginning balance  
Amortization  
Accumulated amortization, ending balance
XML 80 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 24, 2021
Dec. 31, 2023
IfrsStatementLineItems [Line Items]    
Amortisation, intangible assets other than goodwill   $ 145
SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Proportion of ownership interest in joint venture 50.00%  
Other intangible assets [member] | SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets under development   $ 662
Proportion of ownership interest in joint venture   50.00%
XML 81 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONVERTIBLE NOTES (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 08, 2023
USD ($)
$ / shares
shares
Sep. 06, 2023
USD ($)
$ / shares
shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
Jan. 25, 2023
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
shares
May 31, 2022
AUD ($)
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
€ / shares
Jul. 31, 2022
shares
Jun. 27, 2022
$ / shares
May 31, 2022
AUD ($)
IfrsStatementLineItems [Line Items]                            
Issue of convertible instruments           $ 569,000 $ 828              
Borrowings, interest rate               4.00%            
Par value per share | € / shares                     € 1      
Expected volatility, share options granted       81.92%                    
Risk free interest rate, share options granted       3.42%                    
Fair value of convertible notes | $               $ 304,000            
Fair value of redeemable warrants | $               73,000            
Number of convertible notes issued           828,240 828,240              
Face value of convertible notes           $ 700               $ 1
Convertible notes maturity period           6 months 6 months              
Convertible note conversion price description           (i) if Security Matters PTY Ltd. executes a binding agreement for an M&A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share (i) if Security Matters PTY Ltd. executes a binding agreement for an M&A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share              
Convertible note | $               $ 377,000 $ 563,000          
Number of shares issued     1,000,000 864,000       1,237,751            
Proceeds from issuing shares | $               $ 182,000 $ 5,892,000        
Description of conversion of debt to equity     shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares                      
Major ordinary share transactions [member]                            
IfrsStatementLineItems [Line Items]                            
Convertible notes convered into ordinary shares     1,000,000                      
Redeemable warrants [member]                            
IfrsStatementLineItems [Line Items]                            
Warrants term     5 years                      
Expected volatility, share options granted         73.74%                  
Risk free interest rate, share options granted         3.91%                  
Warrant B [member]                            
IfrsStatementLineItems [Line Items]                            
Warrants to purchase ordinary shares 909,090                          
Number of shares issued 606,060                          
Proceeds from issuing shares | $ $ 697                          
Warrants exercise price per share | $ / shares $ 1.15                       $ 5.28  
Convertible Note Agreements [Member] | Bonus warrants [member]                            
IfrsStatementLineItems [Line Items]                            
Warrants to purchase ordinary shares         12,500                  
Exercise price of warrants | $ / shares         $ 11.50                  
Warrants term         5 years                  
Convertible Note Agreements [Member] | Redeemable warrants [member]                            
IfrsStatementLineItems [Line Items]                            
Discount rate         20.00%                  
Warrants to purchase ordinary shares         12,500                  
Warrants term         5 years                  
Share purchase price | $ / shares         $ 11.50                  
Par value per share | $ / shares         $ 5.00                  
Description of approach used to determine discount rates         The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary                  
Convertible Notes Agreements [Member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued                       1,000,000    
Securities purchase agreement [member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued               2,619,377            
Conversion price | $ / shares   $ 1.6378                        
Proceeds from issuing shares | $   $ 2,358,000                        
Net debt | $   4,290,000                        
Borrowing costs incurred | $   $ 2,574,000                        
Original issue discount   40.00%                        
Interest accrued percent   12.00%                        
Description of conversion of debt to equity   Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%                        
Exercised the warrant               3,789,264            
Exercised the warrant               2,619,367            
Securities purchase agreement [member] | Warrant A [member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued   3,929,051                        
Warrants exercise price per share | $ / shares   $ 0.0022                        
Securities purchase agreement [member] | Warrant B [member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued   2,619,367                        
Warrants exercise price per share | $ / shares   $ 1.6378                        
Ordinary shares [member]                            
IfrsStatementLineItems [Line Items]                            
Fixed conversion price | $ / shares         $ 10                  
Par value per share | $ / shares               $ 0.0022            
Number of shares issued     160,227                      
Ordinary shares [member] | Securities purchase agreement [member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued   3,929,051                        
Ordinary shares [member] | Securities purchase agreement [member] | Warrant A [member]                            
IfrsStatementLineItems [Line Items]                            
Number of shares issued   2,619,367                        
Convertible notes [member]                            
IfrsStatementLineItems [Line Items]                            
Issue of convertible instruments | $         $ 250,000                  
Notional amount | $         $ 250,000                  
Borrowings, maturity         December 31, 2024                  
Borrowings, interest rate         15.00%                  
Discount rate         32.20%                  
Convertible notes [member] | Ordinary shares [member]                            
IfrsStatementLineItems [Line Items]                            
Discount rate         20.00%                  
Promissory Note [Member] | Securities purchase agreement [member]                            
IfrsStatementLineItems [Line Items]                            
Notional amount | $               $ 1,000,000            
Number of value converted | $               $ 2,100,000            
XML 82 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BRIDGE LOANS LIABILITIES (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
Jan. 31, 2023
shares
Feb. 29, 2024
USD ($)
$ / shares
Mar. 31, 2023
USD ($)
shares
May 31, 2022
USD ($)
May 31, 2022
AUD ($)
Jan. 31, 2023
USD ($)
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Mar. 07, 2023
shares
Jan. 31, 2015
IfrsStatementLineItems [Line Items]                      
Borrowings, interest rate 4.00%             4.00%      
Percentage of voting equity interests acquired                     2.00%
Risk free interest rate, share options granted   3.42%                  
Expected volatility, share options granted   81.92%                  
Issue of convertible instruments         $ 569,000 $ 828          
Number of shares issued | shares 1,237,751 864,000         864,000 1,237,751   1,000,000  
Warrant per share $ 0.25             $ 0.25      
Expected dividend as percentage, share options granted   0.00%                  
Proceeds from warrants | $               $ 1,023      
Three valuation models [member]                      
IfrsStatementLineItems [Line Items]                      
Risk free interest rate, share options granted               3.91% 3.99%    
Expected volatility, share options granted               73.74% 81.03%    
Expected term of warrants               4 years 2 months 4 days 5 years 2 months 4 days    
Nonadjusting event [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price, share options granted     $ 0.5                
Issue of convertible instruments | $     $ 407,000                
Bridge loan agreements [member]                      
IfrsStatementLineItems [Line Items]                      
Borrowings, interest rate   10.00%         10.00%        
Accumulated interest | $               $ 1,739,000      
Fair value of bonus warrants | $             $ 24,000    
Risk free interest rate, share options granted               4.13%      
Expected volatility, share options granted               70.39%      
Expected term of warrants               3 years      
Issue of convertible instruments | $ 750,000     $ 1,350,000              
Redeemable warrants | $ $ 1,450,000     $ 1,000,000       $ 1,450,000      
Number of shares issued | shares 4,032,256     872,418       4,032,256      
Share purchase price $ 1.17                    
Expected dividend as percentage, share options granted               0.00%      
Bridge loan agreements [member] | Bonus warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Warrants to purchase shares | shares               11,045      
Exercise price, share options granted               $ 253      
Bridge loan agreements [member] | Redeemable warrants [member] | Nonadjusting event [member]                      
IfrsStatementLineItems [Line Items]                      
Borrowings, maturity               five years      
Bridge loan agreements [member] | Redeemable warrants type 1 [member]                      
IfrsStatementLineItems [Line Items]                      
Borrowings, maturity               five years      
Warrants to purchase shares | shares               15,545      
Exercise price, share options granted               $ 110      
Weighted average share price, share options granted               $ 253      
Percentage of voting equity interests acquired 50.00%             50.00%      
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Monte carlo simulation model [member]                      
IfrsStatementLineItems [Line Items]                      
Fair value of warrants | $               $ 72,000 1,973,000    
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Third anniversary [member]                      
IfrsStatementLineItems [Line Items]                      
Percentage of voting equity interests acquired 25.00%             25.00%      
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Fourth anniversary [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price, share options granted               $ 110      
Percentage of voting equity interests acquired 25.00%             25.00%      
Bridge loan agreements [member] | Redeemable warrants type 2 [member]                      
IfrsStatementLineItems [Line Items]                      
Borrowings, maturity               five years      
Warrants to purchase shares | shares               10,454      
Weighted average share price, share options granted               $ 253      
Description of approach used to determine discount rates               Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary      
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Monte carlo simulation model [member]                      
IfrsStatementLineItems [Line Items]                      
Fair value of warrants | $               $ 421,000 $ 696,000    
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | First anniversary [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price, share options granted               $ 110      
Percentage of voting equity interests acquired 50.00%             50.00%      
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Second anniversary [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price, share options granted               $ 110      
Percentage of voting equity interests acquired 50.00%             50.00%      
Bridge loan agreements [member] | Top of range [member]                      
IfrsStatementLineItems [Line Items]                      
Borrowings, maturity             two years        
Bridge loan agreements [member] | Eleven lenders [member]                      
IfrsStatementLineItems [Line Items]                      
Proceeds from loans and warrants | $             $ 3,860,000        
XML 83 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PRE-PAID ADVANCE (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended
Dec. 31, 2023
USD ($)
Jul. 31, 2023
USD ($)
Jul. 27, 2023
USD ($)
$ / shares
Jul. 31, 2023
USD ($)
Feb. 28, 2023
USD ($)
$ / shares
Apr. 19, 2024
USD ($)
Apr. 01, 2024
USD ($)
Dec. 31, 2023
€ / shares
IfrsStatementLineItems [Line Items]                
Par value per share | € / shares               € 1
Floor price | $ / shares     $ 1.10          
Standby equity purchase agreement [member]                
IfrsStatementLineItems [Line Items]                
Issued capital, ordinary shares   $ 1,979   $ 1,979 $ 25,000      
Description of share-based payment arrangement         (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period or (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.      
Notional amount         $ 3,500      
Par value per share | $ / shares         $ 3.65      
Purchase price | $ / shares         $ 1.10      
Repayments of borrowings, classified as financing activities $ 1,300   $ 500 $ 1,500        
Standby equity purchase agreement [member] | Nonadjusting event [member]                
IfrsStatementLineItems [Line Items]                
Repayments of borrowings, classified as financing activities   $ 377            
Standby equity purchase agreement [member] | First installment [member]                
IfrsStatementLineItems [Line Items]                
Notional amount         $ 1,500      
Standby equity purchase agreement [member] | Second installment [member]                
IfrsStatementLineItems [Line Items]                
Notional amount         $ 2,000      
Prepaid advance percentage         92.00%      
Equity Purchase Agreement [Member] | Entering into significant commitments or contingent liabilities [member]                
IfrsStatementLineItems [Line Items]                
Notional amount           $ 30,000 $ 30,000  
XML 84 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF RIGHT OF USE ASSETS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance $ 414 $ 466
Additions 26 49
Foreign currency translation (6) (41)
Deductions (21)
Depreciation expense (45) (39)
Right-of-use assets, ending balance 389 414
Office equipment [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 414 446
Additions 49
Foreign currency translation (6) (35)
Deductions (7)
Depreciation expense (42) (39)
Right-of-use assets, ending balance 366 414
Motor vehicles [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 20
Additions 26
Foreign currency translation (6)
Deductions (14)
Depreciation expense (3)
Right-of-use assets, ending balance $ 23
XML 85 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF INFORMATION ON LEASE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Interest expense on lease liabilities $ 32 $ 51
Total cash outflow for leases $ 45 $ 39
XML 86 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF OTHER PAYABLES (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Employees, salaries and related liabilities $ 726 $ 392
Related party 4 56
Liabilities for grants received (see also note 20) 153 50
Excise Tax 1,569
Other 31 152
Total $ 2,483 $ 650
XML 87 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
LEASES (Details Narrative)
12 Months Ended
Dec. 31, 2023
Office equipment [member]  
IfrsStatementLineItems [Line Items]  
Lease expiration 12 years
Motor vehicles [member]  
IfrsStatementLineItems [Line Items]  
Lease expiration 3 years
XML 88 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Borrowings from related parties, beginning balance $ 710 $ 270  
Payment of borrowings (657) (172)  
Provision for bonus (include interest) 621 $ 89
Exchange rate differences (53) (9)  
Borrowings from related parties, ending balance $ 710 $ 270
XML 89 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) - Dec. 31, 2023
$ / shares
€ / shares
IfrsStatementLineItems [Line Items]    
Par value per share | € / shares   € 1
Ordinary shares [member]    
IfrsStatementLineItems [Line Items]    
Par value per share $ 0.0022  
Preference shares [member]    
IfrsStatementLineItems [Line Items]    
Par value per share $ 0.0001  
XML 90 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF SHARE CAPITAL (Details) - shares
Dec. 31, 2023
Dec. 31, 2022
Ordinary shares [member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 36,363,636,364 22,727,272
Number of shares issued and outstanding 10,185,909
Preference shares [member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 200,000,000,000
Number of shares issued and outstanding
Deferred Shares [Member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 25,000 25,000
Number of shares issued and outstanding 25,000 25,000
XML 91 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BORROWINGS FROM RELATED PARTIES (Details Narrative)
$ in Thousands, ₪ in Millions
1 Months Ended 12 Months Ended
Aug. 31, 2022
USD ($)
Aug. 31, 2022
ILS (₪)
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2023
ILS (₪)
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2015
ILS (₪)
Sep. 19, 2023
USD ($)
shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
IfrsStatementLineItems [Line Items]                    
Cash advances and loans from related parties           $ 513 ₪ 2.0      
Borrowings, interest rate     4.00% 4.00%            
Bonus payments $ 710 ₪ 2.5                
Increase in the carrying amount of the liability | $         $ 87          
Number of shares issued | shares     1,237,751 1,237,751         1,000,000 864,000
Loan agreement [member]                    
IfrsStatementLineItems [Line Items]                    
Debt instruments issued | $               $ 657    
Loan agreements [member]                    
IfrsStatementLineItems [Line Items]                    
Number of shares issued | shares               487,281    
Lender two [member]                    
IfrsStatementLineItems [Line Items]                    
Bonus payments     $ 965 ₪ 3.0            
XML 92 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF RESTRICTED STOCK UNIT (Details)
12 Months Ended
Mar. 07, 2023
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
$ / shares
Dec. 31, 2022
shares
Sep. 19, 2023
USD ($)
shares
Apr. 25, 2023
shares
Jan. 31, 2023
shares
IfrsStatementLineItems [Line Items]            
Number of shares issued 1,000,000 1,237,751       864,000
Share issue related cost | $ $ 186,000 $ 11,460,000        
Employees directors and service [member] | Restricted share units [member]            
IfrsStatementLineItems [Line Items]            
Number of outstanding, Granted   197,000      
Expense from share-based payment transactions | $   $ 2,820,000        
Number of outstanding, Beginning        
Number of outstanding, Vested   (57,000)      
Number of outstanding, Forfeited   (4,000)      
Number of outstanding, Ending   136,000      
Employees directors and service [member] | Restricted share units [member] | Bottom of range [member]            
IfrsStatementLineItems [Line Items]            
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares   $ 1        
Employees directors and service [member] | Restricted share units [member] | Top of range [member]            
IfrsStatementLineItems [Line Items]            
Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares   $ 1.09        
Incentive equity plan [member]            
IfrsStatementLineItems [Line Items]            
Number of ordinary shares, percentage         15.00%  
Number of shares authorised         5,082,417  
Loan agreement [member]            
IfrsStatementLineItems [Line Items]            
Debt instruments issued | $       $ 657,000    
Loan agreements [member]            
IfrsStatementLineItems [Line Items]            
Number of shares issued       487,281    
Service Provider Agreements [Member]            
IfrsStatementLineItems [Line Items]            
Number of shares issued   457,682        
Payment for service | $   $ 260        
XML 93 R75.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF SHARE OPTION GRANTED (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Notes and other explanatory information [abstract]        
Number of options outstanding Beginning balance 57 57 73 73
Weighted average exercise price, outstanding beginning balance | (per share) $ 44.22 $ 54.25   $ 41.85
Number of issue of options 38 38 17 17
Weighted average exercise price, issued of options | (per share) $ 82.04     $ 41.85
Number of options, Expired (30) (30) (33) (33)
Weighted average exercise price, Expired | (per share) $ 31.02     $ 34.10
Number of options outstanding Ending balance 65 65 57 57
Weighted average exercise price, outstanding beginning balance | (per share) $ 69.92   $ 44.22 $ 54.25
Number of options, Exercisable 58 58 38 38
Weighted average exercise price, Exercisable | (per share) $ 68.67     $ 43.40
XML 94 R76.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 65 57 73
Weighted average remaining contractual life of outstanding share options 5 years    
Number of exercisable shares 58 38  
Exercise price two [member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 5    
Weighted average remaining contractual life of outstanding share options 2 years 5 months 15 days    
Number of exercisable shares 5    
Weighted average remaining contractual life of exercisable share options 2 years 5 months 15 days    
Exercise price two [member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 18.70    
Exercise price two [member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 23.32    
Exercise price three [member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 3    
Weighted average remaining contractual life of outstanding share options 3 years 2 months 15 days    
Number of exercisable shares 3    
Weighted average remaining contractual life of exercisable share options 3 years 2 months 15 days    
Exercise price three [member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 29.48    
Exercise price three [member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 31.02    
Exercise price four [member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 6    
Weighted average remaining contractual life of outstanding share options 1 year 4 months 28 days    
Number of exercisable shares 6    
Weighted average remaining contractual life of exercisable share options 1 year 4 months 28 days    
Exercise price four [member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 40.48    
Exercise price four [member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 48.18    
Exercise price five [member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 9    
Weighted average remaining contractual life of outstanding share options 2 years 3 months 3 days    
Number of exercisable shares 9    
Weighted average remaining contractual life of exercisable share options 2 years 3 months 3 days    
Exercise price five [member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 52.80    
Exercise price five [member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 56.10    
Options Outstanding Six [Member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 35    
Weighted average remaining contractual life of outstanding share options 4 years 4 months 24 days    
Number of exercisable shares 28    
Weighted average remaining contractual life of exercisable share options 4 years 4 months 17 days    
Options Outstanding Six [Member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 78.54    
Options Outstanding Six [Member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 88.00    
Options Outstanding Seven [Member]      
IfrsStatementLineItems [Line Items]      
Number of outstanding shares 7    
Weighted average remaining contractual life of outstanding share options 3 years 10 days    
Number of exercisable shares 7    
Weighted average remaining contractual life of exercisable share options 3 years 10 days    
Options Outstanding Seven [Member] | Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 93.28    
Options Outstanding Seven [Member] | Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise price of outstanding share options | $ / shares $ 108.90    
XML 95 R77.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Share based compensation $ 3,269 $ 306 $ 484
Total 2,711 1,898 2,039
Research and development expenses [member]      
IfrsStatementLineItems [Line Items]      
Salaries and related expenses 2,228 2,166 1,795
Subcontractors and consultants 344 374 631
Materials and laboratory expenses 223 316 252
Depreciation and amortization 197 255 287
Share based compensation 447 127 100
Travel expenses 87 50 42
Freight 33 30 23
Other 10 6
Reimbursement from paid pilots and proof of concept projects (858) (1,426) (1,091)
Total $ 2,711 $ 1,898 $ 2,039
XML 96 R78.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Total $ 16,567 $ 2,723 $ 2,482
General and administrative expenses [member]      
IfrsStatementLineItems [Line Items]      
BCA transaction cost 7,278
Professional services 667 1,105 1,089
Public company expenses 5,128
Wages and salaries related 1,348 935 752
Travel expenses 611 223
Office and maintenance 170 145 116
Share based compensation 1,222 137 331
Insurance 50 60 102
Depreciation and amortization 30 35 28
Other 63 83 64
Total $ 16,567 $ 2,723 $ 2,482
XML 97 R79.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHAREHOLDERS’ EQUITY (Details Narrative)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 08, 2023
USD ($)
$ / shares
shares
Jun. 22, 2023
$ / shares
shares
Mar. 07, 2023
USD ($)
shares
$ / shares
Jan. 31, 2023
shares
Jan. 25, 2023
Dec. 31, 2023
USD ($)
shares
$ / shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
€ / shares
Mar. 07, 2023
AUD ($)
shares
Jun. 27, 2022
$ / shares
IfrsStatementLineItems [Line Items]                      
Par value per share post reverse split. | $ / shares           $ 0.0022          
Notes and debentures issued | $                   $ 828,240  
Number of shares issued     1,000,000 864,000   1,237,751       1,000,000  
Share issue related cost | $     $ 186,000     $ 11,460,000          
Number of instruments granted in share-based payment arrangement     848,784                
Number of share options forfeited in share-based payment arrangement     193,500,379                
Description of conversion of debt to equity     shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares                
Proceeds from issue of ordinary shares | $           $ 1,979,000          
Number of shares commitment fees           4,196          
Par value per share | € / shares                 € 1    
Warrant term description (i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrant holders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of $697 from the exercise of the Warrant Bs by the holders, and the carrying amount of those warrants, was classified to ordinary shares and premium together with the proceeds the Company received from the exercise price                    
Gross proceeds of warrants | $           $ 182,000 $ 5,892,000      
Incremental fair value granted, modified share-based payment arrangements | $ $ 209                    
Warrant exercise description           Warrant A was valued at $0.067 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of the Warrant Bs specify that each warrant has a cash exercise price of $0.24. The Warrant Bs were valued at $0.0602 by using the Black-Scholes option-pricing          
Expected volatility       81.92%              
Risk-free interest rate       3.42%              
Net proceeds from offering | $           $ 2,580,000          
Capital raise fee | $           $ 660,000          
Weighted average remaining contractual life of outstanding share options           5 years          
Expected dividend as percentage, share options granted       0.00%              
Black scholes pricing model [member]                      
IfrsStatementLineItems [Line Items]                      
Risk-free interest rate           0.00%          
Expected term           5 years 5 years        
Expected dividend as percentage, share options granted             0.00%        
Bottom of range [member] | Black scholes pricing model [member]                      
IfrsStatementLineItems [Line Items]                      
Expected volatility           73.01% 62.06%        
Risk-free interest rate           3.42% 4.68%        
Top of range [member] | Black scholes pricing model [member]                      
IfrsStatementLineItems [Line Items]                      
Expected volatility           78.35% 85.03%        
Risk-free interest rate           3.58% 3.09%        
Employees [member]                      
IfrsStatementLineItems [Line Items]                      
Option life, share options granted           38,656          
Stock option vesting period           4 years          
Weighted average fair value at measurement date, share options granted | $           $ 219,000          
Expense from share-based payment transactions | $           $ 184,000          
Employees [member] | Bottom of range [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price of outstanding share options | $ / shares           $ 22.71          
Employees [member] | Top of range [member]                      
IfrsStatementLineItems [Line Items]                      
Exercise price of outstanding share options | $ / shares           $ 88          
Bridge loans [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     872,418             872,418  
Debt instruments held | $     $ 1,350,000                
Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Warrant term description   (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 681,818 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of the authorization of these financial statements, an aggregate of 690,096 Warrant A warrants were cashless exercised into an aggregate of 345,349 ordinary shares.                  
Private warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     2,200,000             2,200,000  
Public Warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     6,250,000             6,250,000  
Warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Warrants exercise price per share | $ / shares     $ 0.0204                
Expected volatility           70.39%          
Risk-free interest rate           4.13%          
Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     160,227             160,227  
Par value per share | $ / shares           $ 0.0022          
Ordinary shares [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   345,349                  
Ordinary shares [member] | Underwriting agreement [member] | EF hutton llc [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   606,061                  
Par value per share | $ / shares   $ 0.24                  
Ordinary Shares Two [Member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     303,053             303,053  
Proceeds from issue of ordinary shares | $     $ 3,110,000                
Warrant A [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Warrant cashless exercised   690,096                  
Warrant B [member]                      
IfrsStatementLineItems [Line Items]                      
Warrant cash exercise price | $ / shares           0.24          
Warrant exercise price | $ / shares           0.0602          
Underwriter warrant [member]                      
IfrsStatementLineItems [Line Items]                      
Warrants price per share | $ / shares           0.0575          
Warrant exercise price | $ / shares           $ 0.264          
Expected volatility           70.39%          
Risk-free interest rate           4.13%          
Warrants issued           666,667          
Warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued     24,568,773             24,568,773  
Number of other equity instruments exercised or vested in share-based payment arrangement     32,211,716                
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement | $ / shares     $ 11.5                
Redeemable warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Number of other equity instruments exercised or vested in share-based payment arrangement     200,000                
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement | $ / shares     $ 11.5                
Warrant price per share | $ / shares     $ 5                
Warrants term     5 years                
Expected volatility         73.74%            
Risk-free interest rate         3.91%            
Warrant A [member] | Underwriting agreement [member] | EF hutton llc [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   606,061                  
Warrants exercise price per share | $ / shares   $ 0.24                  
Warrant A [member] | Ordinary shares [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   606,061                  
Warrant B [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued 606,060                    
Warrants exercise price per share | $ / shares $ 1.15                   $ 5.28
Warrants to purchase ordinary shares 909,090                    
Gross proceeds of warrants | $ $ 697                    
Warrants to purchase ordinary amount | $ $ 865                    
Warrant B [member] | Underwriting agreement [member] | EF hutton llc [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   606,061                  
Warrants exercise price per share | $ / shares   $ 0.24                  
Public offering [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Description of share-based payment arrangement   (a) up to 90,909 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 90,909 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0 001 per share, and/or (b) 90,909 warrants in the form of Warrant A to subscribe for an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 90,909 warrants in the form of Warrant B to purchase an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants                  
Public offering [member] | Ordinary shares [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   90,909                  
Par value per share | $ / shares   $ 0.24                  
Public offering [member] | Prefunded warrant [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   90,909                  
Warrants exercise price per share | $ / shares   $ 0.0                  
Warrants price per share | $ / shares   $ 0.2399                  
Public offering [member] | Warrant A [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   90,909                  
Warrants exercise price per share | $ / shares   $ 0.24                  
Public offering [member] | Warrant B [member] | Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued   90,909                  
Warrants price per share | $ / shares   $ 0.24                  
XML 98 R80.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Loss before income tax $ (20,989) $ (6,184) $ (4,939)
Theoretical tax rate of 12.5% (2,624) (1,701) (1,358)
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:      
Non-deductible expenditure and others 3,254 335 118
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized (630) 1,366 1,240
Income tax / (benefit)
XML 99 R81.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Applicable tax rate 12.50%
XML 100 R82.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TAXES ON INCOME (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Applicable tax rate 12.50%    
Tax effect of tax losses $ 45,095 $ 24,106 $ 17,659
XML 101 R83.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Net loss attributable to the owners of the company $ (20,914) $ (6,184) $ (4,939)
Diluted earnings (loss) per share $ (7.82) $ (8.47) [1],[2] $ (7.41) [1],[2]
Weighted average number of ordinary shares used in calculating diluted earnings per share 2,676 730 666
[1] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1.B)
[2] Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.
XML 102 R84.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Issuance of options to related party $ 721
Short-term salary and fees 803 508
Short-term salary until deletion 22
Loan repayment 172
Conversion of loan to ordinary shares 657
Share based payments 2,084 98
Post-employment retirement benefits 98 94
Payment for Administrative services 34 36
Non-monetary benefits 49 29
Payments for legal services 287
Revaluation of financial liabilities at fair value 1,204
Proof of Concept projects paid by affiliated companies (1,064)
Key management personnel compensation $ 5,238 $ 594
XML 103 R85.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Other accounts payable $ (31,000) $ (152,000)
Trade payables (10,127)  
Trade payables 10,127  
Key management personnel of entity or parent [member]    
IfrsStatementLineItems [Line Items]    
Salary and related (219,000) (99,000)
Directors [member]    
IfrsStatementLineItems [Line Items]    
Salary and related (82,000)
Shareholders [member]    
IfrsStatementLineItems [Line Items]    
Borrowings from related parties (710,000)
Other accounts payable (3,000) (56,000)
Trade payables (58,000)
Trade payables 58,000
Derivatives (476,000)
Joint ventures [member]    
IfrsStatementLineItems [Line Items]    
Other receivables 15,000 59,000
Investment in subsidiary 115,000 221,000
Related parties [member]    
IfrsStatementLineItems [Line Items]    
Total $ (626,000) $ (667,000)
XML 104 R86.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF GOVERNMENT GRANTS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Short term liability at year end $ 153 $ 50
Long term liability at year end 85
Total $ 153 $ 135
XML 105 R87.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GOVERNMENT GRANTS (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Oct. 25, 2023
Dec. 31, 2023
Notes and other explanatory information [abstract]    
Proceeds from government grants received   $ 162
Percentage of revenue   3.00%
Payments for government grants   $ 0
Descriptiont of government grants IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual interest will be calculated at a rate based on 12-month Secured Overnight Financing Rate, the SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest will be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%  
XML 106 R88.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Dec. 31, 2023
Mar. 07, 2023
Jan. 31, 2015
Notes and other explanatory information [abstract]        
Percentage of royalty       2.20%
Contingent of consideration percentage       1.00%
Percentage of voting equity interests acquired       2.00%
Number of shares issued 864,000 1,237,751 1,000,000  
Risk free interest rate, share options granted 3.42%      
Expected volatility, share options granted 81.92%      
Expected term 3 years      
Expected dividend yield 0.00%      
License intellectual property   $ 33    
Addtional equity fund of convertible percent 1.00%      
Consideration paid (received) $ 27,000      
Increase (decrease) in investment property   $ 123    
Payment of cash percent 1.50%      
XML 107 R89.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Financial assets at amortized cost:        
Cash and cash equivalents $ 168 $ 1,398 $ 4,171 $ 4,341
Other current receivables 634 3,673    
Total current assets 802 5,071    
Credit risk [member]        
Financial assets at amortized cost:        
Cash and cash equivalents 168 1,398    
Other current receivables 424 3,673    
Total current assets $ 592 $ 5,071    
XML 108 R90.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Financial liabilities at fair value through profit or loss:    
Total financial liabilities $ 18,755 $ 7,867
Total financial liabilities at fair value through profit or loss 16,940 7,867
Financial liabilities at amortized cost:    
Total financial liabilities at amortized cost 1,815
Convertible notes [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 377 563
Trade and other payables [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 12,487 3,622
Bridge loans [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 2,233 3,682
Pre paid Advance [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 700
Derivatives [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 1,143
Convertible promissory note [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 1,013
Lease liabilities [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 649
Government grants [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities 153
Borrowing from related parties [member]    
Financial liabilities at fair value through profit or loss:    
Total financial liabilities
XML 109 R91.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details)
€ in Thousands, ₪ in Thousands, $ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
AUD ($)
Dec. 31, 2023
ILS (₪)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
SGD ($)
Dec. 31, 2022
AUD ($)
Dec. 31, 2022
ILS (₪)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
SGD ($)
IfrsStatementLineItems [Line Items]                
Net foreign exchange loss $ 19 ₪ 165 € 10 $ 14 $ 127 ₪ 73 € 3
NIS [member]                
IfrsStatementLineItems [Line Items]                
Tax rate effect from change in tax rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
AUD [member]                
IfrsStatementLineItems [Line Items]                
Tax rate effect from change in tax rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
SGD [member]                
IfrsStatementLineItems [Line Items]                
Tax rate effect from change in tax rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
EUR [member]                
IfrsStatementLineItems [Line Items]                
Tax rate effect from change in tax rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
XML 110 R92.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost $ 18,755 $ 7,867
Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 12,487 3,622
Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 2,233 3,682
Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 153
Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 649
Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,013
Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 700
Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 17,704 4,479
Not later than one year [member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 12,487 3,622
Not later than one year [member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,750
Not later than one year [member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 153 75
Not later than one year [member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 81 72
Not later than one year [member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,013  
Not later than one year [member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 700  
Not later than one year [member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 377  
Not later than one year [member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,143  
Not later than one year [member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost   710
Not Later Than One To Two Year [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 534 1,187
Not Later Than One To Two Year [Member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than One To Two Year [Member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 453 1,031
Not Later Than One To Two Year [Member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 84
Not Later Than One To Two Year [Member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 81 72
Not Later Than One To Two Year [Member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than One To Two Year [Member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than One To Two Year [Member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than One To Two Year [Member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than One To Two Year [Member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Two To Three Year [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 89 72
Not Later Than Two To Three Year [Member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Two To Three Year [Member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 15
Not Later Than Two To Three Year [Member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Two To Three Year [Member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 74 72
Not Later Than Two To Three Year [Member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Two To Three Year [Member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Two To Three Year [Member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Two To Three Year [Member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Two To Three Year [Member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Three To Four Year [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 89 72
Not Later Than Three To Four Year [Member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Three To Four Year [Member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 15
Not Later Than Three To Four Year [Member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Three To Four Year [Member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 74 72
Not Later Than Three To Four Year [Member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Three To Four Year [Member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Three To Four Year [Member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Three To Four Year [Member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Three To Four Year [Member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Four To Five Year [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 74 72
Not Later Than Four To Five Year [Member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Four To Five Year [Member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Four To Five Year [Member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Not Later Than Four To Five Year [Member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 74 72
Not Later Than Four To Five Year [Member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Four To Five Year [Member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Four To Five Year [Member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Four To Five Year [Member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Not Later Than Four To Five Year [Member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 265 353
Later than five years [member] | Trade and other payables [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Later than five years [member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Later than five years [member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Later than five years [member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 265 353
Later than five years [member] | Convertible promissory note [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years [member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years [member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years [member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years [member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Later than five years and not later than seven years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 18,755 6,235
Later than five years and not later than seven years [member] | Trade And Other Payable [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 12,487 3,622
Later than five years and not later than seven years [member] | Bridge loans [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 2,233 1,031
Later than five years and not later than seven years [member] | Government grants [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 153 159
Later than five years and not later than seven years [member] | Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 649 713
Later than five years and not later than seven years [member] | Convertible Promissory [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,013  
Later than five years and not later than seven years [member] | Pre paid Advance [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 700  
Later than five years and not later than seven years [member] | Convertible Note [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 377  
Later than five years and not later than seven years [member] | Financial Derivatives [Member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost $ 1,143  
Later than five years and not later than seven years [member] | Borrowings from related parties [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost   $ 710
XML 111 R93.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative)
12 Months Ended
Dec. 31, 2023
AUD ($)
Dec. 31, 2023
ILS (₪)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
SGD ($)
Dec. 31, 2022
AUD ($)
Dec. 31, 2022
ILS (₪)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
SGD ($)
Financial Instruments And Risk Management                
Increase (decrease) in financial assets $ 185 ₪ 1,651 € 101 $ 142 $ 1,265 ₪ 729 € 34 $ 0
XML 112 R94.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities $ 1,709 $ 1,031
Convertible promissory note 1,013
Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 1,707 1,031
Convertible promissory note 2  
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 2
Level 1 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities
Convertible promissory note 2  
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities
Level 2 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities
Convertible promissory note  
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 1,707 1,031
Level 3 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 1,707 $ 1,031
Convertible promissory note  
XML 113 R95.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SUBSEQUENT EVENTS (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 19, 2024
USD ($)
shares
Apr. 11, 2024
USD ($)
$ / shares
shares
Feb. 29, 2024
USD ($)
shares
Feb. 20, 2024
USD ($)
$ / shares
shares
Dec. 08, 2023
USD ($)
$ / shares
shares
Sep. 06, 2023
USD ($)
$ / shares
shares
Feb. 29, 2024
USD ($)
$ / shares
shares
Jan. 31, 2024
shares
May 31, 2022
USD ($)
May 31, 2022
AUD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Mar. 04, 2024
shares
Jan. 12, 2024
USD ($)
shares
Dec. 31, 2023
€ / shares
shares
Jun. 22, 2023
shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
Jun. 27, 2022
$ / shares
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                     1,237,751         1,237,751   1,000,000 864,000  
Par value per share | € / shares                               € 1        
Aggregate amount of convertible instruments issued                 $ 569,000 $ 828                    
Proceeds from issuance of shares, net | $                     $ 182,000 $ 5,892,000              
Warrant B [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued         606,060                              
Proceeds from issuance of shares, net | $         $ 697                              
Warrants exercise price per share | $ / shares         $ 1.15                             $ 5.28
Warrants [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                                   24,568,773    
Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                                   160,227    
Par value per share | $ / shares                     $ 0.0022                  
Nonadjusting event [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of warrants               909,090,000                        
Warrants exercised               454,544,000                        
Aggregate ordinary shares               454,544,000                        
Exercise price of share | $ / shares             $ 0.5                          
Warrant exercise price share | $ / shares       $ 0.2378                                
Fee and commission income | $       $ 2,900,000                                
Offering expenses payable | $       $ 2,660,000                                
Convertible security to investor, description             (i) a convertible security to an investor relating to a loan in the principal amount of $407 and (ii) 100,000 warrants to the investor.                          
Aggregate amount of convertible instruments issued | $             $ 407,000                          
Proceeds from issuance of shares, net | $             350,000                          
Restricted stock unit shares     1,500,000                                  
Restricted stock unit vested shares     166,667                                  
Ordinary shares 30,000                                      
Nonadjusting event [member] | Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Convertible notes convered into ordinary shares                             3,789,264          
Nonadjusting event [member] | Ordinary shares [member] | Warrant reserve [member]                                        
IfrsStatementLineItems [Line Items]                                        
Convertible notes convered into ordinary shares                             2,619,377          
Nonadjusting event [member] | Ordinary shares [member] | Board of director [member]                                        
IfrsStatementLineItems [Line Items]                                        
Convertible notes convered into ordinary shares                           100,000            
Nonadjusting event [member] | Warrant B [member]                                        
IfrsStatementLineItems [Line Items]                                        
Convertible notes convered into ordinary shares                             2,619,367          
Underwriting agreement [member] | Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                                 345,349      
Underwriting agreement [member] | Ordinary shares [member] | Warrant A [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                                 606,061      
Underwriting agreement [member] | Nonadjusting event [member]                                        
IfrsStatementLineItems [Line Items]                                        
Contractual capital commitments | $                             $ 5,000,000          
Underwriting agreement [member] | Nonadjusting event [member] | Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued       12,124,666                                
Par value per share | $ / shares       $ 0.24                                
Pre funded warrants convertible description       1-for-1 basis                                
Letter Agreement [member] | Nonadjusting event [member]                                        
IfrsStatementLineItems [Line Items]                                        
Payment for fee | $     $ 200,000,000       $ 200,000,000                          
Warrant shares     250,000       250,000                          
Exercise price of share | $ / shares             $ 0.0022                          
Securities purchase agreement [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued                     2,619,377         2,619,377        
Proceeds from issuance of shares, net | $           $ 2,358,000                            
Borrowing costs incurred | $           $ 2,574,000                            
Original issue discount           40.00%                            
Interest accrued percent           12.00%                            
Conversion price | $ / shares           $ 1.6378                            
Securities purchase agreement [member] | Warrant B [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued           2,619,367                            
Warrants exercise price per share | $ / shares           $ 1.6378                            
Securities purchase agreement [member] | Warrant A [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued           3,929,051                            
Warrants exercise price per share | $ / shares           $ 0.0022                            
Securities purchase agreement [member] | Warrants [member]                                        
IfrsStatementLineItems [Line Items]                                        
Warrants exercise price per share | $ / shares           $ 6                            
Securities purchase agreement [member] | Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued           3,929,051                            
Securities purchase agreement [member] | Ordinary shares [member] | Warrant A [member]                                        
IfrsStatementLineItems [Line Items]                                        
Number of shares issued           2,619,367                            
Securities purchase agreement [member] | Nonadjusting event [member] | Ordinary shares [member]                                        
IfrsStatementLineItems [Line Items]                                        
Convertible notes convered into ordinary shares   11,825,508                                    
Promissory note | $   $ 2,000,000.0                                    
Principal amount | $   2,250,000                                    
Borrowing costs incurred | $   $ 2,000.0                                    
Original issue discount   10.00%                                    
Interest accrued percent   12.00%                                    
Warrant term   5 years                                    
Exercise price of outstanding share options | $ / shares   $ 0.157                                    
Stock Purchase Agreement [Member] | Entering into significant commitments or contingent liabilities [member]                                        
IfrsStatementLineItems [Line Items]                                        
Notional amount | $ $ 30,000,000                                      
Stock purchase agreement description There is a $20 mandatory minimum amount for any Put and it may not exceed $500 in any consecutive 30-day period, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.                                      
Purchase price, percentage 4.99%                                      
Commitment fee, percentage 1.50%                                      
Number of shares 2,725,621,000                                      
EXCEL 114 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 115 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 116 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 118 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 520 470 1 true 151 0 false 11 false false R1.htm 00000001 - Document - Cover Sheet http://smxpublicltd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Statements of Financial Position Sheet http://smxpublicltd.com/role/StatementsOfFinancialPosition Consolidated Statements of Financial Position Statements 2 false false R3.htm 00000003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://smxpublicltd.com/role/StatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Changes In Equity Sheet http://smxpublicltd.com/role/StatementsOfChangesInEquity Consolidated Statements of Changes In Equity Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://smxpublicltd.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 995511 - Disclosure - GENERAL Sheet http://smxpublicltd.com/role/General GENERAL Notes 6 false false R7.htm 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptions SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: Notes 7 false false R8.htm 995513 - Disclosure - TRUE GOLD BUSINESS COMBINATION Sheet http://smxpublicltd.com/role/TrueGoldBusinessCombination TRUE GOLD BUSINESS COMBINATION Notes 8 false false R9.htm 995514 - Disclosure - OTHER CURRENT ASSETS Sheet http://smxpublicltd.com/role/OtherCurrentAssets OTHER CURRENT ASSETS Notes 9 false false R10.htm 995515 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET: Sheet http://smxpublicltd.com/role/PropertyPlantAndEquipmentNet PROPERTY, PLANT AND EQUIPMENT, NET: Notes 10 false false R11.htm 995516 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies INVESTMENTS IN ASSOCIATED COMPANIES Notes 11 false false R12.htm 995517 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://smxpublicltd.com/role/IntangibleAssetsNet INTANGIBLE ASSETS, NET Notes 12 false false R13.htm 995518 - Disclosure - CONVERTIBLE NOTES Notes http://smxpublicltd.com/role/ConvertibleNotes CONVERTIBLE NOTES Notes 13 false false R14.htm 995519 - Disclosure - BRIDGE LOANS LIABILITIES Sheet http://smxpublicltd.com/role/BridgeLoansLiabilities BRIDGE LOANS LIABILITIES Notes 14 false false R15.htm 995520 - Disclosure - PRE-PAID ADVANCE Sheet http://smxpublicltd.com/role/Pre-paidAdvance PRE-PAID ADVANCE Notes 15 false false R16.htm 995521 - Disclosure - LEASES Sheet http://smxpublicltd.com/role/Leases LEASES Notes 16 false false R17.htm 995522 - Disclosure - OTHER PAYABLES Sheet http://smxpublicltd.com/role/OtherPayables OTHER PAYABLES Notes 17 false false R18.htm 995523 - Disclosure - BORROWINGS FROM RELATED PARTIES Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedParties BORROWINGS FROM RELATED PARTIES Notes 18 false false R19.htm 995524 - Disclosure - SHAREHOLDERS??? EQUITY Sheet http://smxpublicltd.com/role/ShareholdersEquity SHAREHOLDERS??? EQUITY Notes 19 false false R20.htm 995525 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET Sheet http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet RESEARCH AND DEVELOPMENT EXPENSES, NET Notes 20 false false R21.htm 995526 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES Sheet http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses GENERAL AND ADMINISTRATIVE EXPENSES Notes 21 false false R22.htm 995527 - Disclosure - TAXES ON INCOME Sheet http://smxpublicltd.com/role/TaxesOnIncome TAXES ON INCOME Notes 22 false false R23.htm 995528 - Disclosure - LOSS PER SHARE Sheet http://smxpublicltd.com/role/LossPerShare LOSS PER SHARE Notes 23 false false R24.htm 995529 - Disclosure - RELATED PARTIES Sheet http://smxpublicltd.com/role/RelatedParties RELATED PARTIES Notes 24 false false R25.htm 995530 - Disclosure - GOVERNMENT GRANTS Sheet http://smxpublicltd.com/role/GovernmentGrants GOVERNMENT GRANTS Notes 25 false false R26.htm 995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities COMMITMENTS AND CONTINGENT LIABILITIES Notes 26 false false R27.htm 995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Sheet http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Notes 27 false false R28.htm 995533 - Disclosure - FAIR VALUE MEASUREMENT Sheet http://smxpublicltd.com/role/FairValueMeasurement FAIR VALUE MEASUREMENT Notes 28 false false R29.htm 995534 - Disclosure - SUBSEQUENT EVENTS Sheet http://smxpublicltd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 29 false false R30.htm 995535 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies) Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies) Policies 30 false false R31.htm 995536 - Disclosure - GENERAL (Tables) Sheet http://smxpublicltd.com/role/GeneralTables GENERAL (Tables) Tables http://smxpublicltd.com/role/General 31 false false R32.htm 995537 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables) Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsTables SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables) Tables http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptions 32 false false R33.htm 995538 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Tables) Sheet http://smxpublicltd.com/role/TrueGoldBusinessCombinationTables TRUE GOLD BUSINESS COMBINATION (Tables) Tables http://smxpublicltd.com/role/TrueGoldBusinessCombination 33 false false R34.htm 995539 - Disclosure - OTHER CURRENT ASSETS (Tables) Sheet http://smxpublicltd.com/role/OtherCurrentAssetsTables OTHER CURRENT ASSETS (Tables) Tables http://smxpublicltd.com/role/OtherCurrentAssets 34 false false R35.htm 995540 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET: (Tables) Sheet http://smxpublicltd.com/role/PropertyPlantAndEquipmentNetTables PROPERTY, PLANT AND EQUIPMENT, NET: (Tables) Tables http://smxpublicltd.com/role/PropertyPlantAndEquipmentNet 35 false false R36.htm 995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables) Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables INVESTMENTS IN ASSOCIATED COMPANIES (Tables) Tables http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies 36 false false R37.htm 995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://smxpublicltd.com/role/IntangibleAssetsNetTables INTANGIBLE ASSETS, NET (Tables) Tables http://smxpublicltd.com/role/IntangibleAssetsNet 37 false false R38.htm 995543 - Disclosure - LEASES (Tables) Sheet http://smxpublicltd.com/role/LeasesTables LEASES (Tables) Tables http://smxpublicltd.com/role/Leases 38 false false R39.htm 995544 - Disclosure - OTHER PAYABLES (Tables) Sheet http://smxpublicltd.com/role/OtherPayablesTables OTHER PAYABLES (Tables) Tables http://smxpublicltd.com/role/OtherPayables 39 false false R40.htm 995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables) Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables BORROWINGS FROM RELATED PARTIES (Tables) Tables http://smxpublicltd.com/role/BorrowingsFromRelatedParties 40 false false R41.htm 995546 - Disclosure - SHAREHOLDERS??? EQUITY (Tables) Sheet http://smxpublicltd.com/role/ShareholdersEquityTables SHAREHOLDERS??? EQUITY (Tables) Tables http://smxpublicltd.com/role/ShareholdersEquity 41 false false R42.htm 995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) Sheet http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) Tables http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet 42 false false R43.htm 995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Sheet http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Tables http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses 43 false false R44.htm 995549 - Disclosure - TAXES ON INCOME (Tables) Sheet http://smxpublicltd.com/role/TaxesOnIncomeTables TAXES ON INCOME (Tables) Tables http://smxpublicltd.com/role/TaxesOnIncome 44 false false R45.htm 995550 - Disclosure - LOSS PER SHARE (Tables) Sheet http://smxpublicltd.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://smxpublicltd.com/role/LossPerShare 45 false false R46.htm 995551 - Disclosure - RELATED PARTIES (Tables) Sheet http://smxpublicltd.com/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://smxpublicltd.com/role/RelatedParties 46 false false R47.htm 995552 - Disclosure - GOVERNMENT GRANTS (Tables) Sheet http://smxpublicltd.com/role/GovernmentGrantsTables GOVERNMENT GRANTS (Tables) Tables http://smxpublicltd.com/role/GovernmentGrants 47 false false R48.htm 995553 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Sheet http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Tables http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement 48 false false R49.htm 995554 - Disclosure - FAIR VALUE MEASUREMENT (Tables) Sheet http://smxpublicltd.com/role/FairValueMeasurementTables FAIR VALUE MEASUREMENT (Tables) Tables http://smxpublicltd.com/role/FairValueMeasurement 49 false false R50.htm 995555 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Details 50 false false R51.htm 995556 - Disclosure - GENERAL (Details Narrative) Sheet http://smxpublicltd.com/role/GeneralDetailsNarrative GENERAL (Details Narrative) Details http://smxpublicltd.com/role/GeneralTables 51 false false R52.htm 995557 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 52 false false R53.htm 995558 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative) Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative) Details http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsTables 53 false false R54.htm 995559 - Disclosure - SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details) Details 54 false false R55.htm 995560 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Details Narrative) Sheet http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative TRUE GOLD BUSINESS COMBINATION (Details Narrative) Details http://smxpublicltd.com/role/TrueGoldBusinessCombinationTables 55 false false R56.htm 995561 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails SCHEDULE OF OTHER CURRENT ASSETS (Details) Details 56 false false R57.htm 995562 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) Details 57 false false R58.htm 995563 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 58 false false R59.htm 995564 - Disclosure - SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details) Details 59 false false R60.htm 995565 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) Details http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables 60 false false R61.htm 995566 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details) Sheet http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails SUMMARY OF INTANGIBLE ASSETS NET (Details) Details 61 false false R62.htm 995567 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) Sheet http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative INTANGIBLE ASSETS, NET (Details Narrative) Details http://smxpublicltd.com/role/IntangibleAssetsNetTables 62 false false R63.htm 995568 - Disclosure - CONVERTIBLE NOTES (Details Narrative) Notes http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative CONVERTIBLE NOTES (Details Narrative) Details http://smxpublicltd.com/role/ConvertibleNotes 63 false false R64.htm 995569 - Disclosure - BRIDGE LOANS LIABILITIES (Details Narrative) Sheet http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative BRIDGE LOANS LIABILITIES (Details Narrative) Details http://smxpublicltd.com/role/BridgeLoansLiabilities 64 false false R65.htm 995570 - Disclosure - PRE-PAID ADVANCE (Details Narrative) Sheet http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative PRE-PAID ADVANCE (Details Narrative) Details http://smxpublicltd.com/role/Pre-paidAdvance 65 false false R66.htm 995571 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails SCHEDULE OF RIGHT OF USE ASSETS (Details) Details 66 false false R67.htm 995572 - Disclosure - SCHEDULE OF INFORMATION ON LEASE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfInformationOnLeaseDetails SCHEDULE OF INFORMATION ON LEASE (Details) Details 67 false false R68.htm 995573 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails SCHEDULE OF OTHER PAYABLES (Details) Details 68 false false R69.htm 995574 - Disclosure - LEASES (Details Narrative) Sheet http://smxpublicltd.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://smxpublicltd.com/role/LeasesTables 69 false false R70.htm 995575 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) Details 70 false false R71.htm 995576 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Details 71 false false R72.htm 995577 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) Sheet http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails SCHEDULE OF SHARE CAPITAL (Details) Details 72 false false R73.htm 995578 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative) Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative BORROWINGS FROM RELATED PARTIES (Details Narrative) Details http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables 73 false false R74.htm 995579 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails SCHEDULE OF RESTRICTED STOCK UNIT (Details) Details 74 false false R75.htm 995580 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) Sheet http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails SCHEDULE OF SHARE OPTION GRANTED (Details) Details 75 false false R76.htm 995581 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) Details 76 false false R77.htm 995582 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) Details 77 false false R78.htm 995583 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Details 78 false false R79.htm 995584 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative) Sheet http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS??? EQUITY (Details Narrative) Details http://smxpublicltd.com/role/ShareholdersEquityTables 79 false false R80.htm 995585 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Details 80 false false R81.htm 995586 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) Details 81 false false R82.htm 995587 - Disclosure - TAXES ON INCOME (Details Narrative) Sheet http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative TAXES ON INCOME (Details Narrative) Details http://smxpublicltd.com/role/TaxesOnIncomeTables 82 false false R83.htm 995588 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails SCHEDULE OF LOSS PER SHARE (Details) Details 83 false false R84.htm 995589 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) Sheet http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) Details 84 false false R85.htm 995590 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Details 85 false false R86.htm 995591 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails SCHEDULE OF GOVERNMENT GRANTS (Details) Details 86 false false R87.htm 995592 - Disclosure - GOVERNMENT GRANTS (Details Narrative) Sheet http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative GOVERNMENT GRANTS (Details Narrative) Details http://smxpublicltd.com/role/GovernmentGrantsTables 87 false false R88.htm 995593 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) Sheet http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) Details http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities 88 false false R89.htm 995594 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) Details 89 false false R90.htm 995595 - Disclosure - SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details) Details 90 false false R91.htm 995596 - Disclosure - SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details) Details 91 false false R92.htm 995597 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) Details 92 false false R93.htm 995598 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) Sheet http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) Details http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables 93 false false R94.htm 995599 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) Sheet http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) Details 94 false false R95.htm 995600 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://smxpublicltd.com/role/SubsequentEvents 95 false false All Reports Book All Reports form20-f.htm smx-20231231.xsd smx-20231231_cal.xml smx-20231231_def.xml smx-20231231_lab.xml smx-20231231_pre.xml fin_001.jpg form20-f_001.jpg form20-f_002.jpg form20-f_003.jpg form20-f_004.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 120 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form20-f.htm": { "nsprefix": "SMX", "nsuri": "http://smxpublicltd.com/20231231", "dts": { "inline": { "local": [ "form20-f.htm" ] }, "schema": { "local": [ "smx-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "smx-20231231_cal.xml" ] }, "definitionLink": { "local": [ "smx-20231231_def.xml" ] }, "labelLink": { "local": [ "smx-20231231_lab.xml" ] }, "presentationLink": { "local": [ "smx-20231231_pre.xml" ] } }, "keyStandard": 288, "keyCustom": 182, "axisStandard": 28, "axisCustom": 0, "memberStandard": 34, "memberCustom": 100, "hidden": { "total": 283, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 183, "http://smxpublicltd.com/20231231": 97, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 520, "entityCount": 1, "segmentCount": 151, "elementCount": 820, "unitCount": 11, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1124, "http://xbrl.sec.gov/dei/2023": 52 }, "report": { "R1": { "role": "http://smxpublicltd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R2": { "role": "http://smxpublicltd.com/role/StatementsOfFinancialPosition", "longName": "00000002 - Statement - Consolidated Statements of Financial Position", "shortName": "Consolidated Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R3": { "role": "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss", "longName": "00000003 - Statement - Consolidated Statements of Comprehensive Loss", "shortName": "Consolidated Statements of Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:SalesAndMarketingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R4": { "role": "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "longName": "00000004 - Statement - Consolidated Statements of Changes In Equity", "shortName": "Consolidated Statements of Changes In Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2020-12-31_custom_IssuedAndAdditionalPaidInCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_IssuedAndAdditionalPaidInCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R5": { "role": "http://smxpublicltd.com/role/StatementsOfCashFlows", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:IncomeLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:IncomeLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R6": { "role": "http://smxpublicltd.com/role/General", "longName": "995511 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R7": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptions", "longName": "995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:", "shortName": "SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R8": { "role": "http://smxpublicltd.com/role/TrueGoldBusinessCombination", "longName": "995513 - Disclosure - TRUE GOLD BUSINESS COMBINATION", "shortName": "TRUE GOLD BUSINESS COMBINATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R9": { "role": "http://smxpublicltd.com/role/OtherCurrentAssets", "longName": "995514 - Disclosure - OTHER CURRENT ASSETS", "shortName": "OTHER CURRENT ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R10": { "role": "http://smxpublicltd.com/role/PropertyPlantAndEquipmentNet", "longName": "995515 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET:", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R11": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "longName": "995516 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R12": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNet", "longName": "995517 - Disclosure - INTANGIBLE ASSETS, NET", "shortName": "INTANGIBLE ASSETS, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R13": { "role": "http://smxpublicltd.com/role/ConvertibleNotes", "longName": "995518 - Disclosure - CONVERTIBLE NOTES", "shortName": "CONVERTIBLE NOTES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R14": { "role": "http://smxpublicltd.com/role/BridgeLoansLiabilities", "longName": "995519 - Disclosure - BRIDGE LOANS LIABILITIES", "shortName": "BRIDGE LOANS LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R15": { "role": "http://smxpublicltd.com/role/Pre-paidAdvance", "longName": "995520 - Disclosure - PRE-PAID ADVANCE", "shortName": "PRE-PAID ADVANCE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R16": { "role": "http://smxpublicltd.com/role/Leases", "longName": "995521 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R17": { "role": "http://smxpublicltd.com/role/OtherPayables", "longName": "995522 - Disclosure - OTHER PAYABLES", "shortName": "OTHER PAYABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R18": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "longName": "995523 - Disclosure - BORROWINGS FROM RELATED PARTIES", "shortName": "BORROWINGS FROM RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R19": { "role": "http://smxpublicltd.com/role/ShareholdersEquity", "longName": "995524 - Disclosure - SHAREHOLDERS\u2019 EQUITY", "shortName": "SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R20": { "role": "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "longName": "995525 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET", "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R21": { "role": "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "longName": "995526 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R22": { "role": "http://smxpublicltd.com/role/TaxesOnIncome", "longName": "995527 - Disclosure - TAXES ON INCOME", "shortName": "TAXES ON INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R23": { "role": "http://smxpublicltd.com/role/LossPerShare", "longName": "995528 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R24": { "role": "http://smxpublicltd.com/role/RelatedParties", "longName": "995529 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R25": { "role": "http://smxpublicltd.com/role/GovernmentGrants", "longName": "995530 - Disclosure - GOVERNMENT GRANTS", "shortName": "GOVERNMENT GRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R26": { "role": "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "longName": "995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R27": { "role": "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "longName": "995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R28": { "role": "http://smxpublicltd.com/role/FairValueMeasurement", "longName": "995533 - Disclosure - FAIR VALUE MEASUREMENT", "shortName": "FAIR VALUE MEASUREMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R29": { "role": "http://smxpublicltd.com/role/SubsequentEvents", "longName": "995534 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R30": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies", "longName": "995535 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R31": { "role": "http://smxpublicltd.com/role/GeneralTables", "longName": "995536 - Disclosure - GENERAL (Tables)", "shortName": "GENERAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R32": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsTables", "longName": "995537 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R33": { "role": "http://smxpublicltd.com/role/TrueGoldBusinessCombinationTables", "longName": "995538 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Tables)", "shortName": "TRUE GOLD BUSINESS COMBINATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R34": { "role": "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "longName": "995539 - Disclosure - OTHER CURRENT ASSETS (Tables)", "shortName": "OTHER CURRENT ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R35": { "role": "http://smxpublicltd.com/role/PropertyPlantAndEquipmentNetTables", "longName": "995540 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET: (Tables)", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R36": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "longName": "995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables)", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R37": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "longName": "995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R38": { "role": "http://smxpublicltd.com/role/LeasesTables", "longName": "995543 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R39": { "role": "http://smxpublicltd.com/role/OtherPayablesTables", "longName": "995544 - Disclosure - OTHER PAYABLES (Tables)", "shortName": "OTHER PAYABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R40": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "longName": "995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables)", "shortName": "BORROWINGS FROM RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R41": { "role": "http://smxpublicltd.com/role/ShareholdersEquityTables", "longName": "995546 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Tables)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R42": { "role": "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "longName": "995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)", "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R43": { "role": "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "longName": "995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R44": { "role": "http://smxpublicltd.com/role/TaxesOnIncomeTables", "longName": "995549 - Disclosure - TAXES ON INCOME (Tables)", "shortName": "TAXES ON INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R45": { "role": "http://smxpublicltd.com/role/LossPerShareTables", "longName": "995550 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R46": { "role": "http://smxpublicltd.com/role/RelatedPartiesTables", "longName": "995551 - Disclosure - RELATED PARTIES (Tables)", "shortName": "RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R47": { "role": "http://smxpublicltd.com/role/GovernmentGrantsTables", "longName": "995552 - Disclosure - GOVERNMENT GRANTS (Tables)", "shortName": "GOVERNMENT GRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R48": { "role": "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "longName": "995553 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCreditRiskExposureExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCreditRiskExposureExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R49": { "role": "http://smxpublicltd.com/role/FairValueMeasurementTables", "longName": "995554 - Disclosure - FAIR VALUE MEASUREMENT (Tables)", "shortName": "FAIR VALUE MEASUREMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R50": { "role": "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "longName": "995555 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "shortName": "SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_SecurityMattersSmxPlcMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_SecurityMattersSmxPlcMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R51": { "role": "http://smxpublicltd.com/role/GeneralDetailsNarrative", "longName": "995556 - Disclosure - GENERAL (Details Narrative)", "shortName": "GENERAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R52": { "role": "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "longName": "995557 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R53": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative", "longName": "995558 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:FairValueBasedOnQuotedOpeningSharePrice", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:FairValueBasedOnQuotedOpeningSharePrice", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R54": { "role": "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "longName": "995559 - Disclosure - SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2023-10-03_custom_TrueGoldConsortiumPtyLtdMember67906390", "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-03_custom_TrueGoldConsortiumPtyLtdMember67906390", "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R55": { "role": "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative", "longName": "995560 - Disclosure - TRUE GOLD BUSINESS COMBINATION (Details Narrative)", "shortName": "TRUE GOLD BUSINESS COMBINATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2015-01-31", "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-03_custom_TrueGoldConsortiumPtyLtdMember67906390", "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R56": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "longName": "995561 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details)", "shortName": "SCHEDULE OF OTHER CURRENT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R57": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "longName": "995562 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)", "shortName": "SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SpecialPurposeAcquisitionCompanyMember", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SpecialPurposeAcquisitionCompanyMember", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R58": { "role": "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "995563 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R59": { "role": "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails", "longName": "995564 - Disclosure - SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details)", "shortName": "SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_YahalomaTechnologiesIncMember67909312", "name": "ifrs-full:CountryOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_YahalomaTechnologiesIncMember67909312", "name": "ifrs-full:CountryOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R60": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "longName": "995565 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-292023-01-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2021-12-232021-12-24_custom_TrueGoldConsortiumPtyLtdMember", "name": "ifrs-full:ProportionOfOwnershipInterestInJointVenture", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R61": { "role": "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "longName": "995566 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details)", "shortName": "SUMMARY OF INTANGIBLE ASSETS NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R62": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "longName": "995567 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)", "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_OtherIntangibleAssetsMember_custom_SMXBeveragesPtyLtdMember", "name": "ifrs-full:IntangibleAssetsUnderDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R63": { "role": "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "longName": "995568 - Disclosure - CONVERTIBLE NOTES (Details Narrative)", "shortName": "CONVERTIBLE NOTES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2022-05-012022-05-31", "name": "ifrs-full:IssueOfConvertibleInstruments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "SMX:FairValueOfConvertibleNotes", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R64": { "role": "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "longName": "995569 - Disclosure - BRIDGE LOANS LIABILITIES (Details Narrative)", "shortName": "BRIDGE LOANS LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:BorrowingsInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:ProceedsFromWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R65": { "role": "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "longName": "995570 - Disclosure - PRE-PAID ADVANCE (Details Narrative)", "shortName": "PRE-PAID ADVANCE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-07-27", "name": "SMX:FloorPricePricePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R66": { "role": "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "longName": "995571 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details)", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R67": { "role": "http://smxpublicltd.com/role/ScheduleOfInformationOnLeaseDetails", "longName": "995572 - Disclosure - SCHEDULE OF INFORMATION ON LEASE (Details)", "shortName": "SCHEDULE OF INFORMATION ON LEASE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R68": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "longName": "995573 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details)", "shortName": "SCHEDULE OF OTHER PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R69": { "role": "http://smxpublicltd.com/role/LeasesDetailsNarrative", "longName": "995574 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_OfficeEquipmentMember", "name": "SMX:LeaseExpiration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_OfficeEquipmentMember", "name": "SMX:LeaseExpiration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R70": { "role": "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "longName": "995575 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details)", "shortName": "SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:PaymentOfBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R71": { "role": "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "longName": "995576 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_PreferenceSharesMember", "name": "ifrs-full:ParValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R72": { "role": "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "longName": "995577 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_OrdinarySharesMember", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_OrdinarySharesMember", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R73": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "longName": "995578 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative)", "shortName": "BORROWINGS FROM RELATED PARTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2015-01-012015-12-31", "name": "ifrs-full:CashAdvancesAndLoansFromRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2015-01-012015-12-31", "name": "ifrs-full:CashAdvancesAndLoansFromRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R74": { "role": "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "longName": "995579 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details)", "shortName": "SCHEDULE OF RESTRICTED STOCK UNIT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2023-03-07", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_EmployeesDirectorsAndServiceMember_ifrs-full_RestrictedShareUnitsMember", "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "SMX:DisclosureOfWeightedAverageLossPerShareExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R75": { "role": "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "longName": "995580 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details)", "shortName": "SCHEDULE OF SHARE OPTION GRANTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "unitRef": "AUDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R76": { "role": "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "longName": "995581 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)", "shortName": "SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_OptionsOutstandingTwoMember", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R77": { "role": "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "longName": "995582 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details)", "shortName": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdjustmentsForSharebasedPayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ResearchAndDevelopmentExpensesMember", "name": "ifrs-full:EmployeeBenefitsExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R78": { "role": "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "longName": "995583 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "shortName": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:GeneralAndAdministrativeExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GeneralAndAdministrativeExpensesMember", "name": "SMX:TransactionCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R79": { "role": "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "longName": "995584 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "SMX:ParValuePerSharePostReverseSplit", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "SMX:ParValuePerSharePostReverseSplit", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R80": { "role": "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "longName": "995585 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R81": { "role": "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "longName": "995586 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R82": { "role": "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "longName": "995587 - Disclosure - TAXES ON INCOME (Details Narrative)", "shortName": "TAXES ON INCOME (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:TaxEffectOfTaxLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R83": { "role": "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "longName": "995588 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details)", "shortName": "SCHEDULE OF LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:NetIncomeLossAttributableToOwners", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:NetIncomeLossAttributableToOwners", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R84": { "role": "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "longName": "995589 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details)", "shortName": "SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "SMX:KeyManagementIssuanceOfOptionsToRelatedParty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "SMX:KeyManagementIssuanceOfOptionsToRelatedParty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R85": { "role": "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "longName": "995590 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "shortName": "SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:OtherPayables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R86": { "role": "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "longName": "995591 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details)", "shortName": "SCHEDULE OF GOVERNMENT GRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentGovernmentGrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentGovernmentGrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R87": { "role": "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "longName": "995592 - Disclosure - GOVERNMENT GRANTS (Details Narrative)", "shortName": "GOVERNMENT GRANTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:ProceedsFromGovernmentGrantsReceived", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "SMX:ProceedsFromGovernmentGrantsReceived", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R88": { "role": "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "longName": "995593 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "AsOf2015-01-31", "name": "SMX:PercentageOfRoyalty", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2015-01-31", "name": "SMX:PercentageOfRoyalty", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R89": { "role": "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "longName": "995594 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details)", "shortName": "SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_CreditRiskMember", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCreditRiskExposureExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R90": { "role": "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "longName": "995595 - Disclosure - SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details)", "shortName": "SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfFinancialLiabilitiesRiskManagementExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfFinancialLiabilitiesRiskManagementExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R91": { "role": "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails", "longName": "995596 - Disclosure - SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details)", "shortName": "SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:NetForeignExchangeLoss", "unitRef": "AUD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:NetForeignExchangeLoss", "unitRef": "AUD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R92": { "role": "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "longName": "995597 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details)", "shortName": "SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfFinancialLiabilitiesRiskManagementExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember", "name": "ifrs-full:FinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R93": { "role": "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative", "longName": "995598 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative)", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseInFinancialAssets", "unitRef": "AUD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseInFinancialAssets", "unitRef": "AUD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R94": { "role": "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "longName": "995599 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details)", "shortName": "SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R95": { "role": "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "longName": "995600 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-01-31_custom_NonadjustingEventMember", "name": "SMX:NumberOfWarrants", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } } }, "tag": { "SMX_AUDMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AUDMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "AUD [member]", "documentation": "AUD [member]" } } }, "auth_ref": [] }, "SMX_AccumulatedDepreciationAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AccumulatedDepreciationAmortisationMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation Amortisation [Member]", "documentation": "Accumulated Depreciation Amortisation [Member]" } } }, "auth_ref": [] }, "SMX_AccumulatedDepreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AccumulatedDepreciationMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation [member]", "documentation": "Accumulated depreciation [member]" } } }, "auth_ref": [] }, "SMX_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated amortization, beginning balance", "periodEndLabel": "Accumulated amortization, ending balance", "documentation": "Accumulated depreciation of intangible assets other than goodwill.", "label": "AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" } } }, "auth_ref": [] }, "SMX_AccumulatedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AccumulatedInterest", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated interest", "documentation": "Accumulated interest" } } }, "auth_ref": [] }, "ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of previous investment", "verboseLabel": "Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date" } }, "en": { "role": { "documentation": "The acquisition-date fair value of equity interest in the acquiree held by the acquirer immediately before the acquisition date in a business combination achieved in stages. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r175" ] }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of identifiable assets and liabilities", "verboseLabel": "Consideration transferred, acquisition-date fair value" } }, "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r171" ] }, "ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Total purchase cost" } }, "en": { "role": { "documentation": "The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r173" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r306" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Capitalized development cost" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r81" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r44" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "label": "Additions to right-of-use assets" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r140" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "SMX_AddtionalEquityFundOfConvertiblePercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AddtionalEquityFundOfConvertiblePercent", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Addtional equity fund of convertible percent", "documentation": "Addtional equity fund of convertible percent." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r312" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r312" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r312" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r312" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r75" ] }, "SMX_AdjustmentsForDecreaseIncreaseInExpensesAndCapitalize": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInExpensesAndCapitalize", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Decrease increase in expenses snd capitalize", "documentation": "Adjustments for decrease increase in expenses and capitalize" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease (increase) in other current receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r369" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Revaluation of financial liabilities at fair value" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in derivative financial liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Derivative financial liabilities; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "SMX_AdjustmentsForIncreaseDecreaseInInterestExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AdjustmentsForIncreaseDecreaseInInterestExpenses", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest expenses", "documentation": "Adjustments for increase decrease in interest expenses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in other liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other operating payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in trade payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share based compensation" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r369" ] }, "SMX_AdvancePaymentForEquityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AdvancePaymentForEquityNet", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advance payment for equity, net (see note 10)", "documentation": "Advance payment for equity net" } } }, "auth_ref": [] }, "SMX_AggregateOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "AggregateOrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate ordinary shares" } } }, "auth_ref": [] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r88", "r92", "r127" ] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r17", "r134", "r143", "r144", "r147", "r148", "r150", "r155", "r184", "r222", "r251", "r253" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r279", "r291", "r301", "r327" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r312" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r319" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r283", "r292", "r302", "r319", "r328", "r332", "r340" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r51", "r128" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r338" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Amortization", "verboseLabel": "Amortisation, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r82" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Salary and related", "label": "Amounts payable, related party transactions" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r59", "r63" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r284" ] }, "ifrs-full_AntidilutiveInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AntidilutiveInstrumentsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Applicable tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r40" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r15", "r127", "r128", "r129", "r202", "r204" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r350", "r353" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r284" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r269", "r271", "r284" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r269", "r271", "r284" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r269", "r271", "r284" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r335" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r336" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r331" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r331" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r331" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r331" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r331" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r331" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r334" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r333" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r332" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r332" ] }, "SMX_BalanceWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BalanceWithRelatedParties", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Balance with related parties." } } }, "auth_ref": [] }, "SMX_BlackScholesPricingModelMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BlackScholesPricingModelMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Black scholes pricing model [member]", "documentation": "Black scholes pricing model [member]" } } }, "auth_ref": [] }, "SMX_BoardOfDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BoardOfDirectorMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board of director [member]", "documentation": "Board of director [member]" } } }, "auth_ref": [] }, "SMX_BonusPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BonusPayments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bonus payments", "documentation": "Bonus payments." } } }, "auth_ref": [] }, "SMX_BonusWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BonusWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bonus warrants [member]", "documentation": "Bonus warrants [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingCostsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingCostsIncurred", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowing costs incurred" } }, "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds." } } }, "auth_ref": [ "r353" ] }, "SMX_BorrowingFromRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BorrowingFromRelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Borrowing from related parties [member]", "documentation": "Borrowing from related parties [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r373" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r373" ] }, "SMX_BorrowingsFromRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BorrowingsFromRelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings from related parties [member]", "documentation": "Borrowings from related parties [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r373" ] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings, maturity" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r373" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r132", "r150", "r164", "r236", "r238", "r373" ] }, "SMX_BridgeLoanAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BridgeLoanAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge loan agreements [member]", "documentation": "Bridge loan agreements [member]" } } }, "auth_ref": [] }, "SMX_BridgeLoansLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BridgeLoansLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Bridge loans liabilities", "documentation": "Bridge loans liabilities." } } }, "auth_ref": [] }, "SMX_BridgeLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BridgeLoansMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge loans [member]", "documentation": "Bridge loans [member]" } } }, "auth_ref": [] }, "SMX_BridgeLoanslLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BridgeLoanslLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Bridge loans liabilities", "documentation": "Bridge loans l liabilities current", "label": "Bridge loans l liabilities current" } } }, "auth_ref": [] }, "SMX_BusinessCombinationAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "BusinessCombinationAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Combination Agreement [Member]", "documentation": "Business Combination Agreement [Member]" } } }, "auth_ref": [] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r178" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r271", "r284" ] }, "SMX_CapitalRaiseFee": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "CapitalRaiseFee", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Capital raise fee", "documentation": "Capital raise fee." } } }, "auth_ref": [] }, "ifrs-full_CapitalisedDevelopmentExpenditureMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalisedDevelopmentExpenditureMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Capitalised development expenditure [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets arising from development expenditure capitalised before the start of commercial production or use. An intangible asset shall only be recognised if the entity can demonstrate all of the following: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) its intention to complete the intangible asset and use or sell it; (c) its ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) its ability to measure reliably the expenditure attributable to the intangible asset during its development." } } }, "auth_ref": [ "r366" ] }, "SMX_CapitalizedDevelopmentCostClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "CapitalizedDevelopmentCostClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized development cost", "documentation": "Capitalized development cost classified as investing activities.", "label": "CapitalizedDevelopmentCostClassifiedAsInvestingActivities" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r43", "r47", "r80", "r84", "r89", "r90", "r91", "r92", "r93", "r179", "r188", "r189" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r47", "r84", "r89", "r91", "r92", "r179", "r188", "r189" ] }, "ifrs-full_CashAdvancesAndLoansFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAdvancesAndLoansFromRelatedParties", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash advances and loans from related parties" } }, "en": { "role": { "documentation": "The cash inflow from advances and loans from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r367" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/StatementsOfCashFlows", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of year" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r11", "r99", "r121" ] }, "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and cash equivalents recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow from financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r94", "r100" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r94", "r100" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r94", "r100" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "ifrs-full_CashOutflowForLeases": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashOutflowForLeases", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationOnLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Total cash outflow for leases" } }, "en": { "role": { "documentation": "The cash outflow for leases." } } }, "auth_ref": [ "r139" ] }, "ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashRepaymentsOfAdvancesAndLoansFromRelatedParties", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of borrowings to related parties", "label": "Cash repayments of advances and loans from related parties" } }, "en": { "role": { "documentation": "The cash outflow for repayments of advances and loans from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r367" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r62" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r310" ] }, "ifrs-full_ChangesInInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ChangesInInvestmentProperty", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in investment property" } }, "en": { "role": { "documentation": "The increase (decrease) in investment property. [Refer: Investment property]" } } }, "auth_ref": [ "r89", "r91" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r192", "r193", "r207", "r208" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r48" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/Cover", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r24" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/Cover", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r24" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r311" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r311" ] }, "SMX_CommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "CommitmentFeePercentage", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Commitment fee, percentage" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r316" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r315" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r317" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r314" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will or may be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will not be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Total comprehensive loss for the year" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r28", "r105", "r107", "r119", "r234" ] }, "SMX_ComprehensiveIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ComprehensiveIncomeLoss", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "label": "ComprehensiveIncomeLoss" } } }, "auth_ref": [] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_ConsiderationPaidReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConsiderationPaidReceived", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration paid (received)" } }, "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r98" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "auth_ref": [] }, "SMX_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConsultingAgreementMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting agreement [member]", "documentation": "Consulting agreement [member]" } } }, "auth_ref": [] }, "SMX_ConsultingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConsultingFees", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting fees", "documentation": "Consulting fees." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "SMX_ContingentOfConsiderationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ContingentOfConsiderationPercentage", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contingent of consideration percentage", "documentation": "Contingent of consideration percentage." } } }, "auth_ref": [] }, "ifrs-full_ContractualCapitalCommitments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContractualCapitalCommitments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contractual capital commitments" } }, "en": { "role": { "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]" } } }, "auth_ref": [ "r353" ] }, "SMX_ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of bridge loans and derivative financial liability to ordinary shares", "documentation": "Conversion of bridge loans and derivative financial liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfConvertibleNotesToOrdinaryShare": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfConvertibleNotesToOrdinaryShare", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to ordinary shares", "documentation": "Conversion of convertible notes to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of liability to ordinary shares (see note 10)", "documentation": "Conversion of liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfLiabilityToOrdinarySharesOne": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfLiabilityToOrdinarySharesOne", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of liability to ordinary shares (see note 14)", "documentation": "Conversion of liability to ordinary shares one." } } }, "auth_ref": [] }, "SMX_ConversionOfLoanToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfLoanToOrdinaryShares", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of loan to ordinary shares", "documentation": "Conversion of loan to ordinary shares" } } }, "auth_ref": [] }, "SMX_ConversionOfWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionOfWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows", "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Conversion of warrants A to ordinary shares (See note 14.B.3)", "verboseLabel": "Conversion of warrants A to ordinary shares (see note 14.B.3)", "documentation": "Conversion of warrants to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConversionPrice", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion price", "documentation": "Conversion price." } } }, "auth_ref": [] }, "SMX_ConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNote", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Convertible notes", "verboseLabel": "Convertible note", "documentation": "Convertible note." } } }, "auth_ref": [] }, "SMX_ConvertibleNoteAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNoteAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Note Agreements [Member]", "documentation": "Convertible Note Agreements [Member]" } } }, "auth_ref": [] }, "SMX_ConvertibleNoteConversionPriceDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNoteConversionPriceDescription", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible note conversion price description", "documentation": "Convertible note conversion price description." } } }, "auth_ref": [] }, "SMX_ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNoteMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Note [Member]", "documentation": "Convertible Note [Member]" } } }, "auth_ref": [] }, "SMX_ConvertibleNotesAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNotesAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Agreements [Member]", "documentation": "Convertible Notes Agreements [Member]" } } }, "auth_ref": [] }, "SMX_ConvertibleNotesConveredIntoOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNotesConveredIntoOrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes convered into ordinary shares", "documentation": "Convertible notes convered into ordinary shares." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesMaturityPeriod": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNotesMaturityPeriod", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes maturity period", "documentation": "Convertible notes maturity period." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleNotesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes [member]", "documentation": "Convertible notes [member]" } } }, "auth_ref": [] }, "SMX_ConvertiblePromissoryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertiblePromissoryMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory [Member]", "documentation": "Convertible Promissory [Member]" } } }, "auth_ref": [] }, "SMX_ConvertiblePromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertiblePromissoryNote", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Convertible promissory note", "documentation": "Convertible promissory note" } } }, "auth_ref": [] }, "SMX_ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertiblePromissoryNoteMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible promissory note [member]", "documentation": "Convertible promissory note [member]" } } }, "auth_ref": [] }, "SMX_ConvertibleSecurityToInvestorDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ConvertibleSecurityToInvestorDescription", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible security to investor, description", "documentation": "Convertible security to an investor description." } } }, "auth_ref": [] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r197" ] }, "ifrs-full_CounterpartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r197" ] }, "ifrs-full_CountryOfIncorporation": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporation", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en-us": { "role": { "label": "Country of incorporation" } }, "en": { "role": { "documentation": "The country in which the entity is incorporated." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Country of incorporation of subsidiary" } }, "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r67", "r70", "r109", "r112" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CreationDateAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CreationDateAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Creation date [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r101", "r102", "r103" ] }, "ifrs-full_CreditRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CreditRiskMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "label": "Credit risk [member]" } }, "en": { "role": { "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r151", "r152", "r153", "r248" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r18", "r115", "r234" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current receivables", "label": "Current assets recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Current assets; Business combinations [member]]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_CurrentExciseTaxPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentExciseTaxPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Excise Tax" } }, "en": { "role": { "documentation": "The amount of current excise tax payables. [Refer: Excise tax payables]" } } }, "auth_ref": [ "r359" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": "ifrs-full_GovernmentGrants", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "label": "Short term liability at year end" } }, "en": { "role": { "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r136" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r19", "r117", "r234" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Anticipated transaction costs" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Current prepayments and other current assets" } }, "en": { "role": { "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_CurrentValueAddedTaxReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentValueAddedTaxReceivables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Tax authorities" } }, "en": { "role": { "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrants - derivative financial liability" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DebtInstrumentsHeld": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtInstrumentsHeld", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instruments held" } }, "en": { "role": { "documentation": "The amount of instruments representing indebtedness held by the entity." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtSecurities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Debt instruments issued" } }, "en": { "role": { "documentation": "The amount of instruments issued by the entity that represent indebtedness." } } }, "auth_ref": [ "r356" ] }, "SMX_DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Deductions", "documentation": "Deductions other than through business combinations property plant and equipment." } } }, "auth_ref": [] }, "SMX_DeductionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DeductionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deductions", "documentation": "Deductions to right of use assets.", "label": "DeductionsToRightofuseAssets" } } }, "auth_ref": [] }, "ifrs-full_DefaultFinancialStatementsDateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DefaultFinancialStatementsDateMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used." } } }, "auth_ref": [ "r101", "r102", "r103" ] }, "SMX_DeferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DeferredSharesMember", "presentation": [ "http://smxpublicltd.com/role/Cover", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Shares [Member]", "documentation": "Deferred Shares [Member]" } } }, "auth_ref": [] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r0", "r35", "r122", "r199", "r206", "r210" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r45", "r49" ] }, "ifrs-full_DepreciationRatePropertyPlantAndEquipment": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRatePropertyPlantAndEquipment", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation rate, property, plant and equipment" } }, "en": { "role": { "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r42" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation expense", "label": "Depreciation, right-of-use assets" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r137" ] }, "ifrs-full_DerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialLiabilities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r356" ] }, "SMX_Derivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "Derivatives", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Derivatives", "documentation": "Derivatives" } } }, "auth_ref": [] }, "ifrs-full_DerivativesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivatives [member]" } }, "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r235", "r237", "r250", "r255" ] }, "SMX_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of preparation", "documentation": "Description of accounting policy for basis of preparation explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombination" ], "lang": { "en-us": { "role": { "label": "TRUE GOLD BUSINESS COMBINATION" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value measurement" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Classification of financial instruments by fair value hierarchy" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Issue of a unit of financial instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r354" ] }, "SMX_DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Financial liability at fair value", "documentation": "Description of accounting policy for financial liabilities at fair value explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Governmental grants" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r52" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of non-financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Capitalized technology development costs" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Investments in associated companies" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for investments in associates. [Refer: Associates [member]]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Description of accounting policy for leases [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse acquisition transaction" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for repurchase and reverse repurchase agreements." } } }, "auth_ref": [ "r354" ] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Reimbursement of research and development expenses" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r354" ] }, "SMX_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "documentation": "Description of accounting policy for right of use assets explanatory." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share based compensation", "documentation": "Description of accounting policy for share based compensation explanatory", "label": "DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r354" ] }, "SMX_DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "New standards, interpretations and amendments adopted from January 1, 2023", "documentation": "Description of accounting policy new standards interpretations and amendments adopted explanatory." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "New standards, interpretations and amendments not yet effective", "documentation": "Description of accounting policy new standards interpretations and amendments not yet effective [Explanatory]" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfApproachUsedToDetermineDiscountRates": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfApproachUsedToDetermineDiscountRates", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of approach used to determine discount rates" } }, "en": { "role": { "documentation": "The description of the approach used to determine discount rates when applying IFRS 17." } } }, "auth_ref": [ "r149" ] }, "ifrs-full_DescriptionOfConversionOfDebtToEquity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfConversionOfDebtToEquity", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of conversion of debt to equity" } }, "en": { "role": { "documentation": "The description of the non-cash conversion of debt to equity." } } }, "auth_ref": [ "r231" ] }, "SMX_DescriptionOfExpectedExpectedTermOptionsGranted": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfExpectedExpectedTermOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected term", "documentation": "Description of expected expected term options granted." } } }, "auth_ref": [] }, "SMX_DescriptionOfExpectedTermWarrants": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptionOfExpectedTermWarrants", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected term of warrants", "verboseLabel": "Expected term", "documentation": "Description of expected term warrants." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected volatility, share options granted", "verboseLabel": "Expected volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfOptionLifeShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Option life, share options granted" } }, "en": { "role": { "documentation": "The option life of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate, share options granted", "verboseLabel": "Risk-free interest rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r165" ] }, "SMX_DescriptiontOfGovernmentGrants": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DescriptiontOfGovernmentGrants", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Descriptiont of government grants", "documentation": "Descriptiont of government grants." } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r73", "r74" ] }, "SMX_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DirectorsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Directors [member]", "documentation": "Directors [member]" } } }, "auth_ref": [] }, "SMX_DisclosureFinancialInstrumentsAndRiskManagementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureFinancialInstrumentsAndRiskManagementAbstract", "lang": { "en-us": { "role": { "label": "Financial Instruments And Risk Management" } } }, "auth_ref": [] }, "SMX_DisclosureInvestmentsInAssociatedCompaniesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureInvestmentsInAssociatedCompaniesAbstract", "lang": { "en-us": { "role": { "label": "Investments In Associated Companies" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "presentation": [ "http://smxpublicltd.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INFORMATION ON LEASE" } }, "en": { "role": { "documentation": "The disclosure of additional information about leasing activities of a lessee." } } }, "auth_ref": [ "r142" ] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r17" ] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss." } } }, "auth_ref": [ "r350", "r353" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://smxpublicltd.com/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties" ], "lang": { "en-us": { "role": { "label": "BORROWINGS FROM RELATED PARTIES" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r178" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE CAPITAL" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } } }, "auth_ref": [ "r24" ] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENT LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfCreditRiskExposureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCreditRiskExposureExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE" } }, "en": { "role": { "documentation": "The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity\u2019s financial assets and commitments to extend credit." } } }, "auth_ref": [ "r190" ] }, "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilities" ], "lang": { "en-us": { "role": { "label": "BRIDGE LOANS LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r349" ] }, "SMX_DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BALANCE WITH RELATED PARTIES", "documentation": "Disclosure of detailed information about balance with related parties explanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BORROWINGS FROM RELATED PARTIES" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r373" ] }, "SMX_DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE", "documentation": "Disclosure of detailed information about components of income tax expense explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES", "documentation": "Disclosure of detailed information about general and administrative expense explanatory" } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GOVERNMENT GRANTS", "documentation": "Disclosure of detailed information about government grants explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF INTANGIBLE ASSETS NET" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r85" ] }, "SMX_DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER CURRENT ASSETS", "documentation": "Disclosure of detailed information about other current assets explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT", "documentation": "Disclosure of detailed information about property plant and equipment depreciation rate explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/PropertyPlantAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r48" ] }, "SMX_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE", "documentation": "Disclosure of detailed information about research and development expense explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "presentation": [ "http://smxpublicltd.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE ASSETS", "documentation": "Disclosure of detailed information about right of use assets text block." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherPayablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER PAYABLES", "documentation": "Disclosure of detailed information about trade and other payables explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r133" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOSS PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r77" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r37" ] }, "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementExplanatory", "presentation": [ "http://smxpublicltd.com/role/FairValueMeasurement" ], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENT" } }, "en": { "role": { "documentation": "The entire disclosure for fair value measurement." } } }, "auth_ref": [ "r131" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/FairValueMeasurementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY" } }, "en": { "role": { "documentation": "The disclosure of the fair value measurement of liabilities." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_DisclosureOfFinancialAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at amortized cost:" } } }, "auth_ref": [] }, "SMX_DisclosureOfFinancialInstrumentAndRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "documentation": "Disclosure of financial instrument and risk management explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "CONVERTIBLE NOTES" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r198" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r194" ] }, "SMX_DisclosureOfFinancialLiabilitiesRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfFinancialLiabilitiesRiskManagementExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS", "documentation": "Disclosure of Financial Liabilities Risk Management Explanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r194" ] }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses" ], "lang": { "en-us": { "role": { "label": "GENERAL AND ADMINISTRATIVE EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGovernmentGrantsExplanatory", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrants" ], "lang": { "en-us": { "role": { "label": "GOVERNMENT GRANTS" } }, "en": { "role": { "documentation": "The entire disclosure for government grants." } } }, "auth_ref": [ "r53" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncome" ], "lang": { "en-us": { "role": { "label": "TAXES ON INCOME" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r41" ] }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNet" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS, NET" } }, "en": { "role": { "documentation": "The entire disclosure for intangible assets." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r85" ] }, "SMX_DisclosureOfInvestmentInAssociatedCompaniesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies" ], "lang": { "en-us": { "role": { "label": "INVESTMENTS IN ASSOCIATED COMPANIES", "documentation": "Disclosure O fInvestment In Associated Companies Explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfJointVenturesTable", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to joint ventures." } } }, "auth_ref": [ "r69", "r72", "r125" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://smxpublicltd.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r145", "r146" ] }, "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of material accounting policy information [text block]" } }, "en": { "role": { "documentation": "The entire disclosure of material accounting policy information applied by the entity." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "presentation": [ "http://smxpublicltd.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]" } } }, "auth_ref": [ "r36" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } } }, "auth_ref": [ "r36" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE OPTION GRANTED" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r163" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherCurrentAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "OTHER CURRENT ASSETS" } }, "en": { "role": { "documentation": "The disclosure of other current assets. [Refer: Other current assets]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvance" ], "lang": { "en-us": { "role": { "label": "PRE-PAID ADVANCE" } }, "en": { "role": { "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/PropertyPlantAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT AND EQUIPMENT, NET:" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r50" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r48" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r64" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet" ], "lang": { "en-us": { "role": { "label": "RESEARCH AND DEVELOPMENT EXPENSES, NET" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r349" ] }, "SMX_DisclosureOfRestrictedStockUnitExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfRestrictedStockUnitExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "verboseLabel": "SCHEDULE OF RESTRICTED STOCK UNIT", "documentation": "Disclosure of restricted stock unit explanatory.", "label": "DisclosureOfRestrictedStockUnitExplanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of risk management strategy related to hedge accounting [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting." } } }, "auth_ref": [ "r183", "r209" ] }, "SMX_DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS", "documentation": "Disclosure of sensitivity analysis for actuarial assumption explanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r25" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES" } }, "en": { "role": { "documentation": "The disclosure of associates. [Refer: Associates [member]]" } } }, "auth_ref": [ "r69", "r72", "r126" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of associates [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to associates." } } }, "auth_ref": [ "r69", "r72", "r126" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPANIES SUBSIDIARIES" } }, "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r69", "r72", "r124" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r69", "r72", "r124" ] }, "SMX_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptions" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:", "documentation": "Disclosure of summary of significant accounting policies explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherPayables" ], "lang": { "en-us": { "role": { "label": "OTHER PAYABLES" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF KEY MANAGEMENT PERSONNEL" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r60" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r62" ] }, "ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r172" ] }, "SMX_DisclosureOfWeightedAverageLossPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureOfWeightedAverageLossPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RESTRICTED STOCK UNIT", "documentation": "Disclosure of weighted average loss per share explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureSignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DisclosureSignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies Accounting Judgments Estimates And Assumptions" } } }, "auth_ref": [] }, "SMX_DiscountForLackOfMarketabilityPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DiscountForLackOfMarketabilityPercentage", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount for lack of marketability percentage", "documentation": "Discount for lack of marketability percentage" } } }, "auth_ref": [] }, "SMX_DiscountForLackOfMarketabilityValue": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DiscountForLackOfMarketabilityValue", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount for lack of marketability value", "documentation": "Discount for lack of marketability value" } } }, "auth_ref": [] }, "SMX_DiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "DiscountRate", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Discount rate." } } }, "auth_ref": [] }, "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests arising from initially consolidated companies" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]" } } }, "auth_ref": [ "r351" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r271" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r269", "r271", "r284" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r269", "r271", "r284", "r320" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r270" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r258" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r271" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r271" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r305" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r261" ] }, "SMX_EFHuttonLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EFHuttonLLCMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "EF hutton llc [member]", "documentation": "EF hutton llc [member]" } } }, "auth_ref": [] }, "SMX_EURMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EURMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "EUR [member]", "documentation": "EUR [member]" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences on cash and cash equivalent" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r96", "r97" ] }, "SMX_ElevenLendersMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ElevenLendersMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Eleven lenders [member]", "documentation": "Eleven lenders [member]" } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and related expenses" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r0", "r35", "r210" ] }, "SMX_EmployeesDirectorsAndServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EmployeesDirectorsAndServiceMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Employees directors and service [member]", "documentation": "Employees directors and service [member]" } } }, "auth_ref": [] }, "SMX_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EmployeesMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees [member]", "documentation": "Employees [member]" } } }, "auth_ref": [] }, "ifrs-full_EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Entering into significant commitments or contingent liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for entering into significant commitments or contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r218" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r260" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r264" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r260" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r260" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r348" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r260" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r345" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r284" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r260" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r260" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r260" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r260" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r346" ] }, "ifrs-full_EntitysTotalForAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForAssociatesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "auth_ref": [ "r69", "r72", "r126" ] }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForBusinessCombinationsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r178", "r180" ] }, "ifrs-full_EntitysTotalForJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForJointVenturesMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } } }, "auth_ref": [ "r69", "r72", "r125" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r62" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r69", "r72", "r124" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity [Default Label]" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r15", "r21", "r104", "r106", "r127", "r128", "r129" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r15" ] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity attributable to owners of the parent", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r14" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r5" ] }, "SMX_EquityLineAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EquityLineAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity line agreement [member]", "documentation": "Equity line agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r5" ] }, "SMX_EquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "EquityPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Purchase Agreement [Member]" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r313" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r273", "r285", "r295", "r321" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r319" ] }, "SMX_ExerciseOfOptionsAndWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ExerciseOfOptionsAndWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exercise of options and warrants into ordinary shares", "documentation": "Exercise of options and warrants to ordinary shares." } } }, "auth_ref": [] }, "SMX_ExerciseOfWarrantsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ExerciseOfWarrantsNet", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants B, net (See note 14 B.3)", "documentation": "Exercise of warrants net" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price of outstanding share options" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r164" ] }, "SMX_ExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ExercisePriceOfWarrants", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price of warrants", "documentation": "Exercise price of warrants." } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price, share options granted", "verboseLabel": "Exercise price of share" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "verboseLabel": "Expected dividend yield" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expense from share-based payment transactions", "verboseLabel": "Share based compensation" } }, "en": { "role": { "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExplanationOfShareOptionsInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of share-based payment arrangement" } }, "en": { "role": { "documentation": "The description of a share-based payment arrangement that existed at any time during the reporting period. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r156" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "SMX_FaceValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FaceValueOfConvertibleNotes", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Face value of convertible notes", "documentation": "Face value of convertible notes." } } }, "auth_ref": [] }, "SMX_FairValueBasedOnQuotedOpeningSharePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueBasedOnQuotedOpeningSharePrice", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value based on quoted opening share price", "documentation": "Fair value based on quoted opening share price." } } }, "auth_ref": [] }, "SMX_FairValueOfBonusWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueOfBonusWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of bonus warrants", "documentation": "Fair value of bonus warrants." } } }, "auth_ref": [] }, "SMX_FairValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueOfConvertibleNotes", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of convertible notes", "documentation": "Fair value of convertible notes." } } }, "auth_ref": [] }, "SMX_FairValueOfEquityTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueOfEquityTransaction", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of equity transaction", "documentation": "Fair value of equity transaction." } } }, "auth_ref": [] }, "SMX_FairValueOfRedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueOfRedeemableWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of redeemable warrants", "documentation": "Fair value of redeemable warrants." } } }, "auth_ref": [] }, "SMX_FairValueOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FairValueOfWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants", "documentation": "Fair value of warrants." } } }, "auth_ref": [] }, "ifrs-full_FeeAndCommissionIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FeeAndCommissionIncome", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fee and commission income" } }, "en": { "role": { "documentation": "The amount of income relating to fees and commissions." } } }, "auth_ref": [ "r361" ] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance expenses" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r31" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r361" ] }, "SMX_FinancialDerivativesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FinancialDerivativesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Financial Derivatives [Member]", "documentation": "Financial Derivatives [Member]" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Total financial liabilities", "verboseLabel": "Financial liabilities at amortized cost" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r185" ] }, "SMX_FinancialLiabilitiesAmortisedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FinancialLiabilitiesAmortisedCostAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at amortized cost:", "documentation": "Financial liabilities amortised cost abstract" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCost", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Total financial liabilities at amortized cost" } }, "en": { "role": { "documentation": "The amount of financial liabilities at amortised cost. The amortised cost is the amount at which financial liabilities are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r196" ] }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLoss", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Total financial liabilities at fair value through profit or loss" } }, "en": { "role": { "documentation": "The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as \u2018an accounting mismatch\u2019) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity\u2019s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r195" ] }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at fair value through profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r192", "r193", "r207", "r208" ] }, "SMX_FirstAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FirstAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First anniversary [member]", "documentation": "First anniversary [member]" } } }, "auth_ref": [] }, "SMX_FirstInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FirstInstallmentMember", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First installment [member]", "documentation": "First installment [member]" } } }, "auth_ref": [] }, "SMX_FixedConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FixedConversionPrice", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed conversion price", "documentation": "Fixed conversion price." } } }, "auth_ref": [] }, "SMX_FloorPricePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FloorPricePricePerShare", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Floor price", "documentation": "Floor price per share." } } }, "auth_ref": [] }, "SMX_ForeignCurrencyTranslationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ForeignCurrencyTranslationMember", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Translation [Member]", "documentation": "Foreign Currency Translation [Member]" } } }, "auth_ref": [] }, "SMX_ForgivenessOfOutstandingPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ForgivenessOfOutstandingPayables", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Forgiveness of outstanding payables", "documentation": "Forgiveness of outstanding payables" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r280", "r292", "r302", "r328" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r280", "r292", "r302", "r328" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r280", "r292", "r302", "r328" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r280", "r292", "r302", "r328" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r280", "r292", "r302", "r328" ] }, "SMX_FourthAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FourthAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fourth anniversary [member]", "documentation": "Fourth anniversary [member]" } } }, "auth_ref": [] }, "SMX_FreightExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FreightExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Freight", "documentation": "Freight expense." } } }, "auth_ref": [] }, "SMX_FurnitureAndOfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "FurnitureAndOfficeEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and office equipment [member]", "documentation": "Furniture and office equipment [member]" } } }, "auth_ref": [] }, "ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination" } }, "en": { "role": { "documentation": "The gain (loss) recognised as result of remeasuring to fair value the equity interest in the acquiree held by the acquirer before the business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r176" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r34" ] }, "ifrs-full_GainsOnDisposalsOfInvestmentProperties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsOnDisposalsOfInvestmentProperties", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Gain from remeasurement of investment in associated company" } }, "en": { "role": { "documentation": "The gain on disposals of investment properties. [Refer: Investment property]" } } }, "auth_ref": [ "r353" ] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } } }, "auth_ref": [ "r353" ] }, "SMX_GeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "GeneralAndAdministrativeExpensesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses [member]", "documentation": "General and administrative expenses [member]" } } }, "auth_ref": [] }, "SMX_GlobalBevCoPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "GlobalBevCoPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Global BevCo Pty Ltd. [member]", "documentation": "Global BevCo Pty Ltd. [member]" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r9", "r78", "r79", "r179" ] }, "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GoodwillRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Goodwill recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]" } } }, "auth_ref": [ "r246", "r247" ] }, "ifrs-full_GovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Government grants" } }, "en": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]" } } }, "auth_ref": [ "r356" ] }, "SMX_GovernmentGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "GovernmentGrantsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Government grants [member]", "documentation": "Government grants [member]" } } }, "auth_ref": [] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r43", "r80", "r90", "r93", "r179", "r189", "r190", "r249" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r269", "r271", "r284" ] }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Net identifiable assets" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r245", "r247" ] }, "SMX_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IfrsStatementLineItems", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "SMX_IncentiveEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IncentiveEquityPlanMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Incentive equity plan [member]", "documentation": "Incentive equity plan [member]" } } }, "auth_ref": [] }, "SMX_IncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss before tax for the year" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income tax", "totalLabel": "Income tax / (benefit)" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r33", "r38", "r39", "r40", "r65", "r123", "r201" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r99" ] }, "ifrs-full_IncreaseDecreaseInFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInFinancialAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in financial assets" } }, "en": { "role": { "documentation": "The increase (decrease) in financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r188", "r189" ] }, "SMX_IncreaseDecreaseIssuanceOfSharesAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IncreaseDecreaseIssuanceOfSharesAndWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares and warrants B, net (See note 14.B.3)", "documentation": "Increase decrease issuance of shares and warrants" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Conversion of financial liabilities to shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments." } } }, "auth_ref": [ "r351" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfOptions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of options into shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } } }, "auth_ref": [ "r351" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } } }, "auth_ref": [ "r351" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency translation adjustments", "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r83" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Currency translation adjustments" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r4" ] }, "SMX_IncreaseInCarryingAmountOfLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IncreaseInCarryingAmountOfLiability", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in the carrying amount of the liability", "documentation": "Increase in carrying amount of liability." } } }, "auth_ref": [] }, "ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incremental fair value granted, modified share-based payment arrangements" } }, "en": { "role": { "documentation": "The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r168" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r283", "r292", "r302", "r319", "r328", "r332", "r340" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r338" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r272", "r344" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r272", "r344" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r272", "r344" ] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r353" ] }, "SMX_IntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Cost, ending balance", "label": "IntangibleAssetsGross" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "periodEndLabel": "Net book value" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r9", "r84" ] }, "SMX_IntangibleAssetsOtherThanGoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IntangibleAssetsOtherThanGoodwillGross", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cost, beginning balance", "periodEndLabel": "Cost, ending balance", "documentation": "Intangible assets other than goodwill, gross.", "label": "IntangibleAssetsOtherThanGoodwillGross" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r85", "r224", "r240" ] }, "ifrs-full_IntangibleAssetsUnderDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsUnderDevelopment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets under development" } }, "en": { "role": { "documentation": "The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r225" ] }, "SMX_InterestAccruedPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "InterestAccruedPercent", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest accrued percent", "documentation": "Interest accrued percent." } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationOnLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on lease liabilities" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r138" ] }, "ifrs-full_InvestmentsInSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInSubsidiaries", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment in subsidiary" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r66" ] }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investment in associated companies" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } } }, "auth_ref": [ "r66" ] }, "SMX_IssuanceOfOptionsToAcquireIntangibleAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IssuanceOfOptionsToAcquireIntangibleAsset", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of options to acquire intangible asset", "documentation": "Issuance of options to acquire intangible asset." } } }, "auth_ref": [] }, "SMX_IssuanceOfOptionsToUnderwriters": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IssuanceOfOptionsToUnderwriters", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of options to underwriters", "documentation": "Issuance of options to underwriters" } } }, "auth_ref": [] }, "SMX_IssuanceOfWarrantsAfterReset": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IssuanceOfWarrantsAfterReset", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of warrants B after reset (See note 14 B.3)", "documentation": "Issuance of warrants A after reset." } } }, "auth_ref": [] }, "ifrs-full_IssueOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issue of convertible instruments", "verboseLabel": "Aggregate amount of convertible instruments issued" } }, "en": { "role": { "documentation": "The change in equity resulting from the issuing of convertible instruments." } } }, "auth_ref": [ "r351" ] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares, net" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r4" ] }, "SMX_IssuedAndAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IssuedAndAdditionalPaidInCapitalMember", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued and Additional paid in capital [member]", "documentation": "Issued and Additional paid in capital [member]" } } }, "auth_ref": [] }, "SMX_IssuedCapitalAndAdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "IssuedCapitalAndAdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Issued capital and additional paid-in capital", "documentation": "Issued capital and additional paid in capital." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issued capital, ordinary shares" } }, "en": { "role": { "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_JointVenturesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesAxis", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Joint ventures [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r69", "r72", "r125" ] }, "ifrs-full_JointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [member]" } }, "en": { "role": { "documentation": "This member stands for joint arrangements whereby the parties that have joint control of the arrangement have rights to the net assets of the arrangement." } } }, "auth_ref": [ "r69", "r72", "r125" ] }, "SMX_KeyManagementIssuanceOfOptionsToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementIssuanceOfOptionsToRelatedParty", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of options to related party", "documentation": "Issuance of options to related party." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Key management personnel compensation", "label": "Key management personnel compensation" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r58" ] }, "SMX_KeyManagementPersonnelCompensationLoanRepayment": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementPersonnelCompensationLoanRepayment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Loan repayment", "documentation": "Key management personnel compensation loan repayment." } } }, "auth_ref": [] }, "SMX_KeyManagementPersonnelCompensationNonmonetaryBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementPersonnelCompensationNonmonetaryBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Non-monetary benefits", "documentation": "Key management personnel compensation non monetary benefits." } } }, "auth_ref": [] }, "SMX_KeyManagementPersonnelCompensationPaymentForAdministrativeServices": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementPersonnelCompensationPaymentForAdministrativeServices", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Payment for Administrative services", "documentation": "Key management personnel compensation payment for administrative services." } } }, "auth_ref": [] }, "SMX_KeyManagementPersonnelCompensationPaymentsForLegalServices": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementPersonnelCompensationPaymentsForLegalServices", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Payments for legal services", "documentation": "Key management personnel compensation payments for legal services." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Post-employment retirement benefits" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Share based payments" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r57" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Short-term salary and fees" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r55" ] }, "SMX_KeyManagementPersonnelCompensationShorttermEmployeeBenefitsDeletion": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefitsDeletion", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Short-term salary until deletion", "documentation": "Key management personnel compensation short term employee benefits deletion." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel of entity or parent [member]" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r61" ] }, "ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFiveYearsAndNotLaterThanSevenYearsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than five years and not later than seven years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years and not later than seven years." } } }, "auth_ref": [ "r251", "r254" ] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r143", "r144", "r155", "r251", "r252", "r254" ] }, "SMX_LeaseExpiration": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LeaseExpiration", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease expiration", "documentation": "Lease expiration." } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r232", "r233" ] }, "ifrs-full_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } } }, "auth_ref": [ "r362" ] }, "SMX_LenderTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LenderTwoMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lender two [member]", "documentation": "Lender two [member]" } } }, "auth_ref": [] }, "SMX_LetterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LetterAgreementMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Letter Agreement [member]", "documentation": "Letter Agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r51", "r128" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r128" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r128" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r51", "r128" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r15", "r127", "r128", "r129", "r202", "r205" ] }, "SMX_LiabilitiesForGrantsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LiabilitiesForGrantsReceived", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities for grants received (see also note 20)", "documentation": "Liabilities for grants received." } } }, "auth_ref": [] }, "ifrs-full_LiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r130" ] }, "ifrs-full_LicencesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LicencesMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Licences [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r366" ] }, "SMX_LicenseIntellectualProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LicenseIntellectualProperty", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "License intellectual property", "documentation": "License intellectual property" } } }, "auth_ref": [] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r350", "r353" ] }, "SMX_LionheartIIICorpMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LionheartIIICorpMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Lion heart III corp [member]", "documentation": "Lion heart III corp [member]" } } }, "auth_ref": [] }, "SMX_LionheartMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LionheartMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lionheart [Member]", "documentation": "Lionheart [Member]" } } }, "auth_ref": [] }, "SMX_ListingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ListingCosts", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SPAC transaction - listing costs", "documentation": "Listing costs." } } }, "auth_ref": [] }, "SMX_ListingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ListingExpenses", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Listing expenses", "documentation": "Listing expenses." } } }, "auth_ref": [] }, "SMX_LoanAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LoanAgreementMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Loan agreement [member]", "documentation": "Loan agreement [member]" } } }, "auth_ref": [] }, "SMX_LoanAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "LoanAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Loan agreements [member]", "documentation": "Loan agreements [member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Machinery [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r219" ] }, "ifrs-full_MajorOrdinaryShareTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorOrdinaryShareTransactionsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Major ordinary share transactions [member]" } }, "en": { "role": { "documentation": "This member stands for major ordinary share transactions. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r217" ] }, "SMX_MarketableSecuritiesHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "MarketableSecuritiesHeldInTrustAccount", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Marketable securities held in trust account", "documentation": "Marketable securities held in trust account." } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r17", "r134", "r143", "r144", "r147", "r148", "r150", "r155", "r184", "r191", "r222", "r251" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r311" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r311" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r88", "r92", "r127" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r331" ] }, "SMX_MonteCarloSimulationModelMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "MonteCarloSimulationModelMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Monte carlo simulation model [member]", "documentation": "Monte carlo simulation model [member]" } } }, "auth_ref": [] }, "ifrs-full_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MotorVehiclesMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Motor vehicles [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r220" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r339" ] }, "SMX_NISMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NISMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "NIS [member]", "documentation": "NIS [member]" } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r312" ] }, "SMX_NatoAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NatoAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nato Agreement [Member]", "documentation": "Nato Agreement [Member]" } } }, "auth_ref": [] }, "ifrs-full_NetDebt": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDebt", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net debt" } }, "en": { "role": { "documentation": "The amount of net debt of the entity." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_NetForeignExchangeLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetForeignExchangeLoss", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Net foreign exchange loss" } }, "en": { "role": { "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]" } } }, "auth_ref": [ "r355", "r364" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent" } } }, "auth_ref": [] }, "SMX_NetIncomeLossAttributableToOwners": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NetIncomeLossAttributableToOwners", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net loss attributable to the owners of the company" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r311" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r309" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r308" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r339" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r339" ] }, "SMX_NonadjustingEventMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NonadjustingEventMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nonadjusting event [member]", "documentation": "Nonadjusting event [member]" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r36" ] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r36" ] }, "SMX_NoncashTransactionsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NoncashTransactionsDuringPeriodAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Appendix A \u2013 Non-cash transactions during the year:", "documentation": "Non cash transactions during period abstract." } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Non-controlling interests", "label": "Non-controlling interest in acquiree recognised at acquisition date" } }, "en": { "role": { "documentation": "The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r174" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non- controlling interest" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r13", "r108", "r111" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r18", "r116", "r234" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": "ifrs-full_GovernmentGrants", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "label": "Long term liability at year end" } }, "en": { "role": { "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Non-current lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r136" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r19", "r118", "r234" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Long term payables" } }, "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } } }, "auth_ref": [ "r12" ] }, "SMX_NotLaterThanFourToFiveYearMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NotLaterThanFourToFiveYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not Later Than Four To Five Year [Member]", "documentation": "Not Later Than Four To Five Year [Member]" } } }, "auth_ref": [] }, "SMX_NotLaterThanOneToTwoYearMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NotLaterThanOneToTwoYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not Later Than One To Two Year [Member]", "documentation": "Not Later Than One To Two Year [Member]" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r16", "r143", "r144", "r155", "r251", "r254" ] }, "SMX_NotLaterThanThreeToFourYearMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NotLaterThanThreeToFourYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not Later Than Three To Four Year [Member]", "documentation": "Not Later Than Three To Four Year [Member]" } } }, "auth_ref": [] }, "SMX_NotLaterThanTwoToThreeYearMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NotLaterThanTwoToThreeYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not Later Than Two To Three Year [Member]", "documentation": "Not Later Than Two To Three Year [Member]" } } }, "auth_ref": [] }, "ifrs-full_NotesAndDebenturesIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndDebenturesIssued", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes and debentures issued" } }, "en": { "role": { "documentation": "The amount of notes and debentures issued by the entity." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notional amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r353" ] }, "SMX_NumberOfConvertibleNotesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfConvertibleNotesIssued", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of convertible notes issued", "documentation": "Number of convertible notes issued." } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of instruments granted in share-based payment arrangement." } } }, "auth_ref": [ "r243", "r244" ] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Number of outstanding, Granted" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r167", "r371" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of outstanding, Vested", "label": "Number of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r371" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of outstanding, Forfeited", "label": "Number of other equity instruments forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r371" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of outstanding, Beginning", "periodEndLabel": "Number of outstanding, Ending", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r371" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of options outstanding Beginning balance", "periodEndLabel": "Number of options outstanding Ending balance", "label": "Number of outstanding shares" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r157", "r161", "r164" ] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of options, Exercisable", "label": "Number of exercisable shares" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, Expired", "label": "Number of share options expired in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } } }, "auth_ref": [ "r160" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r159" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Number of issue of options" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized", "verboseLabel": "Number of shares authorised" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r22" ] }, "SMX_NumberOfSharesCommitmentFees": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfSharesCommitmentFees", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares commitment fees", "documentation": "Number of shares commitment fees." } } }, "auth_ref": [] }, "SMX_NumberOfSharesExercisedWarrantsClassA": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfSharesExercisedWarrantsClassA", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercised the warrant" } } }, "auth_ref": [] }, "SMX_NumberOfSharesExercisedWarrantsClassB": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfSharesExercisedWarrantsClassB", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercised the warrant", "label": "NumberOfSharesExercisedWarrantsClassB" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r351" ] }, "SMX_NumberOfSharesIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfSharesIssuedAndOutstanding", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued and outstanding", "documentation": "Number of shares issued and outstanding." } } }, "auth_ref": [] }, "SMX_NumberOfValueConverted": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfValueConverted", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of value converted", "documentation": "Number of value converted." } } }, "auth_ref": [] }, "SMX_NumberOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "NumberOfWarrants", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants" } } }, "auth_ref": [] }, "SMX_OfferingExpensesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OfferingExpensesPayable", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offering expenses payable", "documentation": "Offering expenses payable" } } }, "auth_ref": [] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r221" ] }, "SMX_OptionsExpectedLife": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsExpectedLife", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options expected life", "documentation": "Options expected life." } } }, "auth_ref": [] }, "SMX_OptionsOutstandingFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingFiveMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price five [member]", "documentation": "Exercise price five [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingFourMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingFourMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price four [member]", "documentation": "Exercise price four [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingSevenMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Seven [Member]", "documentation": "Options Outstanding Seven [Member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingSixMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingSixMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Six [Member]", "documentation": "Options Outstanding Six [Member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingThreeMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price three [member]", "documentation": "Exercise price three [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OptionsOutstandingTwoMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price two [member]", "documentation": "Exercise price two [member]" } } }, "auth_ref": [] }, "SMX_OrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/Cover", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r73", "r360" ] }, "SMX_OrdinarySharesTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OrdinarySharesTwoMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares Two [Member]", "documentation": "Ordinary shares two [member]" } } }, "auth_ref": [] }, "SMX_OrdinarySharesWithNominalValueOf0.0022PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OrdinarySharesWithNominalValueOf0.0022PerShareMember", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares With Nominal Value Of 0. 0022 Per Share [Member]" } } }, "auth_ref": [] }, "SMX_OriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OriginalIssueDiscount", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Original issue discount", "documentation": "Original issue discount." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss for the year" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r3", "r27", "r34", "r120" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss:" } } }, "auth_ref": [] }, "SMX_OtherComprehensiveIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "OtherComprehensiveIncomeLoss", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "SMX_ComprehensiveIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive loss", "label": "OtherComprehensiveIncomeLoss" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "SMX_OtherComprehensiveIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Exchange losses arising on translation of foreign operations" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r20", "r34" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "SMX_OtherComprehensiveIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Adjustments arising from translating financial statements from functional currency to presentation currency" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r34" ] }, "ifrs-full_OtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r10" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other payables", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_OtherExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherExpenseByNature", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other expenses, by nature" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r35", "r210" ] }, "ifrs-full_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r366" ] }, "ifrs-full_OtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "negatedLabel": "Other accounts payable", "label": "Other payables [Default Label]" } }, "en": { "role": { "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r356" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r311" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r214" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r271" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r278", "r290", "r300", "r326" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r281", "r293", "r303", "r329" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r281", "r293", "r303", "r329" ] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r23" ] }, "SMX_ParValuePerSharePostReverseSplit": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ParValuePerSharePostReverseSplit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Par value per share post reverse split.", "documentation": "Par value per share post reverse split." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r307" ] }, "SMX_PaymentForFee": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PaymentForFee", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment for fee", "documentation": "Payment for fee" } } }, "auth_ref": [] }, "SMX_PaymentForService": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PaymentForService", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Payment for service", "documentation": "Payment for service" } } }, "auth_ref": [] }, "SMX_PaymentOfBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PaymentOfBorrowings", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of borrowings", "documentation": "Payment of borrowings", "label": "Payment of borrowings" } } }, "auth_ref": [] }, "SMX_PaymentOfCashPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PaymentOfCashPercent", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of cash percent", "documentation": "Payment of cash percent." } } }, "auth_ref": [] }, "SMX_PaymentsForGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PaymentsForGovernmentGrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for government grants", "documentation": "Payments for government grants." } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r230" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r310" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r310" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r309" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r312" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r308" ] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of entity's revenue" } }, "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r374" ] }, "SMX_PercentageOfRevenue": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PercentageOfRevenue", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of revenue", "documentation": "Percentage of revenue." } } }, "auth_ref": [] }, "SMX_PercentageOfRoyalty": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PercentageOfRoyalty", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of royalty", "documentation": "Percentage of royalty." } } }, "auth_ref": [] }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PercentageOfVotingEquityInterestsAcquired", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of voting equity interests acquired" } }, "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r170" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r265" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r266" ] }, "SMX_PreFundedWarrantsConvertibleDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PreFundedWarrantsConvertibleDescription", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Pre funded warrants convertible description", "documentation": "Prefunded warrants convertible description." } } }, "auth_ref": [] }, "SMX_PrePaidAdvanceMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrePaidAdvanceMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Pre paid Advance [member]", "documentation": "Pre paid Advance [member]" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r360" ] }, "SMX_PrefundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrefundedWarrantMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prefunded warrant [member]", "documentation": "Prefunded warrant [member]" } } }, "auth_ref": [] }, "SMX_PrepaidAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrepaidAdvance", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Pre-paid advance", "documentation": "Prepaid advance" } } }, "auth_ref": [] }, "SMX_PrepaidAdvancePercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrepaidAdvancePercentage", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid advance percentage", "documentation": "Prepaid advance percentage." } } }, "auth_ref": [] }, "SMX_PrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrincipalAmount", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Principal amount", "documentation": "Principal amount" } } }, "auth_ref": [] }, "SMX_PrinciplesOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrinciplesOfConsolidationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of consolidation", "documentation": "Principles of consolidation explanatory." } } }, "auth_ref": [] }, "SMX_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PrivateWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private warrants [member]", "documentation": "Private warrants [member]" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_ProceedsFromExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfOptions", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from offering" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of options." } } }, "auth_ref": [ "r367" ] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants B (see note 14 B.3)" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r367" ] }, "SMX_ProceedsFromGovernmentGrantsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromGovernmentGrantsReceived", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from government grants received", "documentation": "Proceeds from government grants received." } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfBridgeLoansAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromIssuanceOfBridgeLoansAndWarrants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of bridge loans and warrants (see note 9)", "documentation": "Proceeds from issuance of bridge loans and warrants" } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromIssuanceOfPromissoryNote", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of promissory note (see note 8.C)", "documentation": "Proceeds from issuance of promissory note" } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromIssuanceOfShares", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of shares, warrants A and B, net (see note 14 B.3)", "documentation": "Proceeds from issuance of shares." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfBondsNotesAndDebentures", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of convertible notes (see note 8.A)" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of bonds, notes and debentures." } } }, "auth_ref": [ "r367" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issue of ordinary shares" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r367" ] }, "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingOtherEquityInstruments", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of shares in the SPAC transaction, net" } }, "en": { "role": { "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r227" ] }, "ifrs-full_ProceedsFromIssuingShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingShares", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfCashFlows", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of shares, net", "verboseLabel": "Proceeds from issuing shares", "terseLabel": "Gross proceeds of warrants" } }, "en": { "role": { "documentation": "The cash inflow from issuing shares." } } }, "auth_ref": [ "r227" ] }, "SMX_ProceedsFromLoansAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromLoansAndWarrants", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from loans and warrants", "documentation": "Proceeds from loans and warrants." } } }, "auth_ref": [] }, "SMX_ProceedsFromWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProceedsFromWarrants", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from warrants", "documentation": "Proceeds from warrants" } } }, "auth_ref": [] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Professional services" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "SMX_ComprehensiveIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Loss after income tax for the year" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r2", "r26", "r95", "r105", "r107", "r202", "r203", "r234", "r241" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net loss attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Non- controlling interest", "label": "Profit (loss), attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r29", "r110" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Equity holders of the Company" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r30" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax", "label": "Loss before income tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r181", "r210", "r211", "r256", "r257" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Operating loss", "label": "Profit (loss) from operating activities" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r223", "r361" ] }, "ifrs-full_ProfitLossOfAcquiree": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossOfAcquiree", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Profit (loss) of acquiree since acquisition date" } }, "en": { "role": { "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r177" ] }, "SMX_PromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PromissoryNote", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Promissory note", "documentation": "Promissory note." } } }, "auth_ref": [] }, "SMX_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PromissoryNoteMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]", "documentation": "Promissory Note [Member]" } } }, "auth_ref": [] }, "SMX_ProofOfConceptProjectsPaidByAffiliatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProofOfConceptProjectsPaidByAffiliatedCompanies", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Proof of Concept projects paid by affiliated companies", "documentation": "Proof of concept projects paid by affiliated companies." } } }, "auth_ref": [] }, "SMX_ProofOfConceptReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProofOfConceptReceivablesCurrent", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Proof of concept receivables", "documentation": "Proof of concept receivables current." } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, net", "periodStartLabel": "Property and equipment, beginning balance", "periodEndLabel": "Property and equipment, ending balance" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r8", "r47" ] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r48", "r224", "r240" ] }, "ifrs-full_ProportionOfOwnershipInterestInAssociate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInAssociate", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in associate" } }, "en": { "role": { "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]" } } }, "auth_ref": [ "r68", "r71", "r114" ] }, "ifrs-full_ProportionOfOwnershipInterestInJointVenture": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInJointVenture", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in joint venture" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r68", "r71", "r114" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r68", "r71", "r113" ] }, "SMX_ProvisionOfBorrowingToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ProvisionOfBorrowingToRelatedParties", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision of borrowing to related parties", "verboseLabel": "Provision for bonus (include interest)", "documentation": "Provision of borrowing to related parties." } } }, "auth_ref": [] }, "SMX_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PublicOfferingMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public offering [member]", "documentation": "Public offering [member]" } } }, "auth_ref": [] }, "SMX_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PublicWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/Cover", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public Warrants [member]", "documentation": "Public Warrants [member]" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r226" ] }, "SMX_PurchasePriceOfPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PurchasePriceOfPerShare", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price", "documentation": "Purchase price of per share." } } }, "auth_ref": [] }, "SMX_PurchasePricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "PurchasePricePercentage", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price, percentage" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r307" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r307" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r132", "r150", "r164", "r236", "r238", "r373" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "auth_ref": [] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r132", "r150", "r164", "r236", "r238", "r373" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "auth_ref": [ "r164" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r273", "r285", "r295", "r321" ] }, "SMX_RedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RedeemableWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants", "documentation": "Redeemable warrants." } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RedeemableWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants [member]", "documentation": "Redeemable warrants [member]" } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsTypeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RedeemableWarrantsTypeOneMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants type 1 [member]", "documentation": "Redeemable warrants type 1 [member]" } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsTypeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RedeemableWarrantsTypeTwoMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants type 2 [member]", "documentation": "Redeemable warrants type 2 [member]" } } }, "auth_ref": [] }, "SMX_RedemptionPercentageOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RedemptionPercentageOfBusinessCombination", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redemption percentage of business combination", "documentation": "Redemption percentage of business combination." } } }, "auth_ref": [] }, "SMX_ReimbursementFromPaidPilotsAndProofOfConceptProjects": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ReimbursementFromPaidPilotsAndProofOfConceptProjects", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Reimbursement from paid pilots and proof of concept projects", "documentation": "Reimbursement from paid pilots and proof of concept projects." } } }, "auth_ref": [] }, "ifrs-full_RelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related parties [member]" } }, "en": { "role": { "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r62" ] }, "SMX_RemainingFundsInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RemainingFundsInTrustAccount", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remaining funds in trust account", "documentation": "Remaining funds in trust account." } } }, "auth_ref": [] }, "SMX_RemeasurementOfInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RemeasurementOfInvestment", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Remeasurement of investment in associated company (see note 3)", "documentation": "Remeasurement of investment." } } }, "auth_ref": [] }, "SMX_RemeasurementOfInvestmentInAssociatedCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RemeasurementOfInvestmentInAssociatedCompany", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Remeasurement of investment in associated company", "documentation": "Remeasurement of investment in associated company", "label": "RemeasurementOfInvestmentInAssociatedCompany" } } }, "auth_ref": [] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Office and maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r361" ] }, "SMX_RepaymentOfBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RepaymentOfBridgeLoans", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of bridge loans (see note 9)", "documentation": "Repayment of bridge loans.", "label": "RepaymentOfBridgeLoans" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Research and development expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r86" ] }, "SMX_ResearchAndDevelopmentExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ResearchAndDevelopmentExpensesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Research and development expenses [member]", "documentation": "Research and development expenses [member]" } } }, "auth_ref": [] }, "SMX_ResearchExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ResearchExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Materials and laboratory expenses", "documentation": "Research expense." } } }, "auth_ref": [] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r54" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r274", "r286", "r296", "r322" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r275", "r287", "r297", "r323" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r282", "r294", "r304", "r330" ] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing restricted share units." } } }, "auth_ref": [ "r365" ] }, "SMX_RestrictedStockUnitShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RestrictedStockUnitShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock unit shares", "documentation": "Restricted stock unit shares" } } }, "auth_ref": [] }, "SMX_RestrictedStockUnitVestedShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RestrictedStockUnitVestedShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock unit vested shares", "documentation": "Restricted stock unit vested shares." } } }, "auth_ref": [] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated losses" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r215", "r216" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r5", "r212" ] }, "SMX_RevaluationOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RevaluationOfConvertibleNotes", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Revaluation of convertible notes", "documentation": "Revaluation of convertible notes.", "label": "RevaluationOfConvertibleNotes" } } }, "auth_ref": [] }, "SMX_RevaluationOfFinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RevaluationOfFinancialLiabilitiesAtFairValue", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revaluation of financial liabilities at fair value", "documentation": "Revaluation of financial liabilities at fair value.", "label": "Revaluation of financial liabilities at fair value [Default Label]" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right of use assets", "periodStartLabel": "Right-of-use assets, beginning balance", "periodEndLabel": "Right-of-use assets, ending balance" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r135", "r141" ] }, "SMX_RightofuseAssetsEffectofForeignExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "RightofuseAssetsEffectofForeignExchange", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign currency translation", "documentation": "Right-of-use assets effect of foreign exchange.", "label": "RightofuseAssetsEffectofForeignExchange" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r339" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r339" ] }, "SMX_SGDMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SGDMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "SGD [member]", "documentation": "SGD [member]" } } }, "auth_ref": [] }, "SMX_SMXBeveragesPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SMXBeveragesPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX beverages pty ltd [member]", "documentation": "SMX beverages pty ltd [member]" } } }, "auth_ref": [] }, "SMX_SMXCircularEconomyPlatformPTELtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SMXCircularEconomyPlatformPTELtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX circular economy platform pte ltd [member]", "documentation": "SMX circular economy platform pte ltd [member]" } } }, "auth_ref": [] }, "SMX_SMXFashionAndLuxuryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SMXFashionAndLuxuryMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "S M X Fashion And Luxury [Member]", "documentation": "SMX Fashion And Luxury [Member]" } } }, "auth_ref": [] }, "SMX_SMXIrelandLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SMXIrelandLimitedMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX ireland limited [member]", "documentation": "SMX ireland limited [member]" } } }, "auth_ref": [] }, "SMX_SMXIsraelLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SMXIsraelLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX israel ltd [member]", "documentation": "SMX israel ltd [member]" } } }, "auth_ref": [] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Selling and marketing expenses" } }, "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } } }, "auth_ref": [ "r361" ] }, "SMX_SecondAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecondAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second anniversary [member]", "documentation": "Second anniversary [member]" } } }, "auth_ref": [] }, "SMX_SecondInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecondInstallmentMember", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second installment [member]", "documentation": "Second installment [member]" } } }, "auth_ref": [] }, "SMX_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities purchase agreement [member]", "documentation": "Securities purchase agreement [member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r259" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r263" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r262" ] }, "SMX_SecurityMattersCanadaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecurityMattersCanadaLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security matters canada ltd [member]", "documentation": "Security matters canada ltd [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersPTYLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecurityMattersPTYLtdMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security matters pty ltd [member]", "documentation": "Security matters pty ltd [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersSmxPlcMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SecurityMattersSmxPlcMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security Matters Smx Plc [Member]", "documentation": "Security Matters Smx Plc [Member]" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r267" ] }, "SMX_ServiceProviderAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ServiceProviderAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Service Provider Agreements [Member]", "documentation": "Service Provider Agreements [Member]" } } }, "auth_ref": [] }, "ifrs-full_ServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ServicesExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Public company expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from services." } } }, "auth_ref": [ "r361" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "auth_ref": [] }, "ifrs-full_ShareIssueRelatedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareIssueRelatedCost", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Recapitalization due to issuance of shares following the SPAC transaction, net", "verboseLabel": "Share issue related cost" } }, "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } } }, "auth_ref": [ "r351" ] }, "SMX_ShareIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ShareIssued", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares", "label": "ShareIssued" } } }, "auth_ref": [] }, "SMX_ShareIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ShareIssuedPricePerShare", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Share issued price per share." } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 5.0 }, "http://smxpublicltd.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfCashFlows", "http://smxpublicltd.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share of net profit (loss) of associated companies", "negatedLabel": "Share in (earnings) losses of associated companies, net" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r32", "r200", "r206" ] }, "SMX_SharePurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SharePurchasePrice", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share purchase price", "documentation": "Share purchase price." } } }, "auth_ref": [] }, "SMX_ShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ShareholdersMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Shareholders [member]", "documentation": "Shareholders [member]" } } }, "auth_ref": [] }, "SMX_SharesIssuedAndOutstandingPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SharesIssuedAndOutstandingPercent", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Number of ordinary shares, percentage", "documentation": "Shares issued and outstanding period." } } }, "auth_ref": [] }, "SMX_SharesIssuedForExerciseOfStockOptionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SharesIssuedForExerciseOfStockOptionsShares", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued for exercise of stock options, shares", "documentation": "Shares issued for exercise of stock options, shares." } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Borrowings from related parties", "periodStartLabel": "Borrowings from related parties, beginning balance", "periodEndLabel": "Borrowings from related parties, ending balance" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermEmployeeBenefitsAccruals", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Employees, salaries and related liabilities" } }, "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInAssociatesAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en-us": { "role": { "label": "Associates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r69", "r72", "r126" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r69", "r72", "r124" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r268" ] }, "SMX_SpecialPurposeAcquisitionCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SpecialPurposeAcquisitionCompanyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "SPAC [member]", "documentation": "SPAC [member]" } } }, "auth_ref": [] }, "SMX_StandbyEquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "StandbyEquityPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Standby equity purchase agreement [member]", "documentation": "Standby equity purchase agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r277", "r289", "r299", "r325" ] }, "SMX_StockHoldersEquityDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "StockHoldersEquityDescription", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock purchase agreement description" } } }, "auth_ref": [] }, "SMX_StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares", "documentation": "Stock issued during period value consideration of issuance of common stock." } } }, "auth_ref": [] }, "SMX_StockOptionVestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "StockOptionVestingPeriod", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option vesting period", "documentation": "Stock option vesting period." } } }, "auth_ref": [] }, "SMX_StockPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "StockPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Purchase Agreement [Member]" } } }, "auth_ref": [] }, "SMX_SubcontractorsAndConsultants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "SubcontractorsAndConsultants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Subcontractors and consultants", "documentation": "Subcontractors and consultants." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r318" ] }, "SMX_TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect amounts which are not deductible/(taxable) in calculating taxable income:", "documentation": "Tax effect amounts which are not deductible taxable in calculating taxable income [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Non-deductible expenditure and others" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_TaxEffectOfTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfTaxLosses", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax effect of tax losses" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "SMX_TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized temporary differences and tax losses for which deferred tax weren\u2019t recognized", "documentation": "Tax expense benefit arising from previously unrecognised tax loss tax credit or temporary difference of prior period used to reduce current tax expense." } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Theoretical tax rate of 12.5%" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_TaxRateEffectFromChangeInTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxRateEffectFromChangeInTaxRate", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Tax rate effect from change in tax rate" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r40" ] }, "SMX_TechnologyLicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TechnologyLicenseMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Technology License [Member]", "documentation": "Technology License [Member]" } } }, "auth_ref": [] }, "ifrs-full_TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible asset (core technology license)" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for technology-based intangible assets acquired in a business combination. [Refer: Technology-based intangible assets [member]; Business combinations [member]]" } } }, "auth_ref": [ "r372" ] }, "SMX_TerminalGrowthRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TerminalGrowthRatePercentage", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Terminal growth rate percentage", "documentation": "Terminal growth rate percentage." } } }, "auth_ref": [] }, "SMX_TerminalPerShares": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TerminalPerShares", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Terminal per shares", "documentation": "Terminal per shares." } } }, "auth_ref": [] }, "SMX_ThirdAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ThirdAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third anniversary [member]", "documentation": "Third anniversary [member]" } } }, "auth_ref": [] }, "SMX_ThreeValuationModelsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "ThreeValuationModelsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three valuation models [member]", "documentation": "Three valuation models [member]" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r132", "r150", "r164", "r236", "r238", "r373" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r310" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r317" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Related party" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r213", "r359" ] }, "SMX_TradeAndOtherPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TradeAndOtherPayableMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade And Other Payable [Member]", "documentation": "Trade And Other Payable [Member]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/SignificantAccountingPoliciesAccountingJudgmentsEstimatesAndAssumptionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade and other payables", "negatedLabel": "Trade payables", "verboseLabel": "Trade payables" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r12" ] }, "SMX_TradeAndOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TradeAndOtherPayablesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialLiabilitiesFairValueThroughProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other payables [member]", "documentation": "Trade and other payables [member]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade payables", "label": "Trade and other payables recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherReceivablesDueFromRelatedParties", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Borrowings from related parties", "label": "Receivables due from related parties" } }, "en": { "role": { "documentation": "The amount of receivables due from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r214" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r338" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r340" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "SMX_TransactionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TransactionCost", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "BCA transaction cost", "documentation": "Transaction cost." } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 5.0 }, "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Travel expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r353" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r341" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r342" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r340" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r340" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r343" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r341" ] }, "SMX_TrueGoldConsortiumPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TrueGoldConsortiumPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/ScheduleOfFairValueOfIdentifiableAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails", "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "True gold consortium pty ltd [member]", "documentation": "True gold consortium pty ltd [member]" } } }, "auth_ref": [] }, "SMX_TrueSilverSMXPlatformLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "TrueSilverSMXPlatformLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "True Silver SMX Platform Ltd [Member]", "documentation": "True Silver SMX Platform Ltd [Member]" } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_TypesOfContractsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsAxis", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of contracts [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r239", "r242" ] }, "ifrs-full_TypesOfContractsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/Pre-paidAdvanceDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "auth_ref": [ "r239", "r242" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r151", "r152", "r153", "r154", "r182", "r186", "r187" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencySensitivityAnalysisDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r151", "r152", "r153", "r154", "r182", "r186", "r187" ] }, "SMX_UnderwriterWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "UnderwriterWarrantMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter warrant [member]", "documentation": "Underwriter warrant [member]" } } }, "auth_ref": [] }, "SMX_UnderwritingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "UnderwritingAgreementMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriting agreement [member]", "documentation": "Underwriting agreement [member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r337" ] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Wages and salaries related" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r363" ] }, "SMX_WarrantAMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantAMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant A [member]", "documentation": "Warrant A [member]" } } }, "auth_ref": [] }, "SMX_WarrantBMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantBMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant B [member]", "documentation": "Warrant B [member]" } } }, "auth_ref": [] }, "SMX_WarrantCashExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantCashExercisePrice", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant cash exercise price", "documentation": "Warrant cash exercise price." } } }, "auth_ref": [] }, "SMX_WarrantCashlessExercised": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantCashlessExercised", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant cashless exercised", "documentation": "Warrant cashless exercised." } } }, "auth_ref": [] }, "SMX_WarrantExerciseDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantExerciseDescription", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise description", "documentation": "Warrant exercise description." } } }, "auth_ref": [] }, "SMX_WarrantExercisePriceShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantExercisePriceShare", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise price share", "documentation": "Warrant exercise price share" } } }, "auth_ref": [] }, "SMX_WarrantPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantPerShare", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant per share", "documentation": "Warrant per share" } } }, "auth_ref": [] }, "SMX_WarrantPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantPricePerShare", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant price per share", "documentation": "Warrant price per share." } } }, "auth_ref": [] }, "ifrs-full_WarrantReserveMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WarrantReserveMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant reserve [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]" } } }, "auth_ref": [ "r352" ] }, "SMX_WarrantShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant shares", "documentation": "Warrant shares." } } }, "auth_ref": [] }, "SMX_WarrantTerm": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantTerm", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant term" } } }, "auth_ref": [] }, "SMX_WarrantTermDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantTermDescription", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant term description", "documentation": "Warrant term description." } } }, "auth_ref": [] }, "SMX_WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf253.00PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf253.00PerShareMember", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants Each Exercisable For One Ordinary Share At Exercise Price Of 253. 00 Per Share [Member]" } } }, "auth_ref": [] }, "SMX_WarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsExercisePrice", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise price", "documentation": "Warrants exercise price." } } }, "auth_ref": [] }, "SMX_WarrantsExercisePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsExercisePricePerShare", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercise price per share", "documentation": "Warrants exercise price per share." } } }, "auth_ref": [] }, "SMX_WarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsExercised", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercised" } } }, "auth_ref": [] }, "SMX_WarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsIssued", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued", "documentation": "Warrants issued." } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing warrants." } } }, "auth_ref": [ "r365" ] }, "SMX_WarrantsPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsPricePerShare", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants price per share", "documentation": "Warrants price per share." } } }, "auth_ref": [] }, "SMX_WarrantsTerm": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsTerm", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants term", "documentation": "Warrants term." } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseOrdinaryAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsToPurchaseOrdinaryAmount", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase ordinary amount", "documentation": "Warrants to purchase ordinary amount" } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsToPurchaseOrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase ordinary shares", "documentation": "Warrants to purchase ordinary shares." } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WarrantsToPurchaseShares", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase shares", "documentation": "Warrants to purchase shares." } } }, "auth_ref": [] }, "SMX_WeightedAverageCostOfCapitalPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WeightedAverageCostOfCapitalPercentage", "presentation": [ "http://smxpublicltd.com/role/TrueGoldBusinessCombinationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average cost of capital percentage", "documentation": "Weighted average cost of capital percentage" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, Exercisable", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r162" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Expired" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r160" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, issued of options" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r158" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, outstanding beginning balance", "periodEndLabel": "Weighted average exercise price, outstanding beginning balance", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r157", "r161" ] }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average fair value at measurement date, share options granted" } }, "en": { "role": { "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r166" ] }, "SMX_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of exercisable share options", "documentation": "Weighted average remaining contractual life of exercisable share options 2019." } } }, "auth_ref": [] }, "SMX_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions": { "xbrltype": "dateItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options", "documentation": "Weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average remaining contractual life of outstanding share options", "label": "Weighted average remaining contractual life of outstanding share options [Default Label]" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r164" ] }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average share price, share options granted" } }, "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } } }, "auth_ref": [ "r165" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r347" ] }, "SMX_YahalomaTechnologiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20231231", "localname": "YahalomaTechnologiesIncMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/ScheduleOfInvestmentsInAssociatedCompaniesDetails" ], "lang": { "en-us": { "role": { "label": "Yahaloma technologies inc [member]", "documentation": "Yahaloma technologies inc [member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "29", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "49", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "59", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_59&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "117", "Subparagraph": "c", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_117_c_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "51", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_l&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "m", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "o", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_o_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "p", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_p_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "p", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_p_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "q", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "22A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_22A&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_e&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_g&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22_f&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22_i&doctype=Standard", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_f&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_g&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44_c&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "IG23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_IG23&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "IE72", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG40B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r310": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r314": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r315": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r316": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r317": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r318": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r319": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r320": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r321": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r322": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r323": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r324": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r325": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r326": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r327": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r328": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r329": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r330": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r331": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r332": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r333": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r334": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r335": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r336": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r337": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r338": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r339": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r340": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r341": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r342": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r343": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r344": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r345": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r346": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r347": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r348": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2023-03-23" }, "r365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 121 0001493152-24-017279-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-017279-xbrl.zip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�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
=+H]Y%7]HXK%EG@]&SG^KW 'ZJEP_/6!%%Z&OW MEN+"0.^0_JM,U7(=WQ2'?W7K+*HKU^=\7-I#J$,Q9O=6];Q,3,E6?24CL/M: MKS6MR](([V>UZJCE%>..UQ()UD4-@RCX)K9@?@] LK^)&%:XB)$B-SP9(=ZN M,65NR=A'2!Z>IG]=JOF(JQ1 W@P]!1&.@MCLKG0W2Y(3-!R[N&6"44DY+R7/ M8JFQIPXMS./5F^B#7"M$4T2CPDD/Z&S4[AY <-I,/;.+.EB::U)P(HP=]$ N M-A(?4?N]94..V:@@[1.MJP;. M7U^TWVZR:.39R8N\OOZ>:#Y-HZWQ?<"2(*5_CEIPX/:J KFWF)MCJX'1J9&9 M!TJ!#+[)>2E#;R:QC65A&LZ M-#B&]T2C,UE;@04UL&EL[+>IWEL_-P)%5 AJG^Z=VX]JM]\#\#P?_8P>(DS[ M1] .OC#%@#+?+\?W #7/+S."WRM567T)BFA6LW#N ?8'(OKHP[CEDB$"W5!S MQR=T)13',U>;C84K$TU<7GR4;^Z4^5DZWU0>[)V0&V;T-]=('7 RE8E?W:WV MGU'NNI.,R_CI]?PZ,)$+N?G8L#%1(T%Q"?YPRN-KOF>J"^S$KX]>0X#\HZ(< MV38;6D,SF2:-].ZF&A6<:.?KNZ6U&A]JJ:((M.Q) M)/QMHN?7:,("5B'Z#)I::@F9[V0^&XH;YB$P#[@_.WH W5[1B:BI Y-E=R8 MFHK4_X=I^73Q2V +<==&YLCOWG(FW@-,_Y7?K^&248$K_J=PY=L_]X#UW_9F M9YMRISPG*?> "?B*48\E7?U6%K/GB=M*G8".LUTN41#KV7J#<3R?,,WQFJ/+KRBA/NW$X+NN MAD:^:+YC)P[X8!#CT3#NXU\)4<%I*W=DNYJ[(&"C'16QRW-<#,V\\_%?5^%^ MD.[9D!HW6:@(1\0O.ILGK\RTP8%L,*%)&![<_JHP!1&:Y]AB(;1A3)92GK5B M%JIUK9.@4^=: _TH05)V\\8=SVV)&L07!/&-8?!2C4"I#*W'KF@XV!'%*UWG MHK")/UAR\OSN 5T#]*C%]ELE1@F*FD5(WCW@Z[]0>_;#U-.RSJ;A7P3N:8^V M<-ZHF%!>O%PX M^1+/+!BL,((G?XW-MC1[ MZ>N,@;TD9M)7*"&=<>Y&G-X#J$8*L D:$TX9OV>?-A[(6,I,5'T+#/;A72>,KJ,I)>> CMY4(W'/C]*T-W*W/K1A*Y3VV0WD"!-EDO7 M6O"<[AZ@MS4*[F %83U6@2$HY$XF.]*VHE'OTO0-R,B_:"?BMNQQS5K26J'L M7@9FNL.,[$9ES HI(Y_?5FC4^^)=N 295/!4M5:% '=6U#DKWX0G]@T^K+U MUN.,H7RKO2$_U>^1'4?L 0=L[FJS>6LM[(;J2!-]X[&;B9M^D#3V94V=:U-S M8DT6LDY\+7U$OAMOM# 'RO"GLE#9>!W&CI2%6"&%-^RN1-I8I>O_K?"Y6*,U M.(,.;^E*EYP5]FX"Q(%-@]3EV%NG;.1]QP#'FR :&,OJL;R;6-GZT^6(4R>! M\XX/"&WK%\_#Y 1)L9/Z8%F-3YHN@>L!'5+P[_2@:?C.)QKW>@91A9Q)\"$ MJR-T$)#T1+ESFJV7+8?INR!?NG(\&X-M5CSL0@E,;-0KFNM==)[_Y]0'Y591 M5U'@U'GQ[%7>SW[P,ZY8(%R/>6;-_ MEOD/(.5[WD,VEACVQ*$%40BGU\.2^RLGZ?::7]EE"W'W29G^9E)AZ=!?3,#J M2"=3GS\G&_';N.SQ30?<@W91[9$$O][?.IAY6?>N[\)9X50_8*#_[QFXHU6,X+''5' M,[*XIV52@B>MXV5]QUA"55064&*$*EGSJ&>G7[\'7)40?)@L=V9(3,8%BB./ MUV[L/4WHM#"DJW,[22>FPS>XC_KDM%$M\5C-ZZ=51G.[@4*I.7?/3[$: M]ZK4<= \'LEEB8 +WG MZB^K07RD0-4F6WNSO&\:9V^4'\M1NO/2,K7]-GC MP(\J[/0]8A8,J(5[@(_ 6M0:0F--W6;JZBI X5VE75ER**5? M$;B82%91_J_T,!GHG$E5THR5UT@4,F$M6P-&T:+4$1V*;(K;$JS*XTU6F:8 LW)6"#$^/9K_S+=%8>)%M2OOABH,^N(TWU;:984Q\Y]ZCIU*! M*2>JUY?L6X^D?DXO9!)BW7YC\=LLD&43:C<><2<51T.V'W*]/AT"8G[L.JSH MN$48]E;\%WQMP@7*_KNF,[ MWI_\0[C*H/R9%7Z_%XA+B(,A+V6X+4-9ZW9,:S'LRUFA=YR&CA-.+2/>37D' M?PB?RVE.-4$[EL&QHAEOU9D=7!=WN&Y-3G\=1DL+3E4W=UE.-1%CW@(?[[;. M)/MKZ^HL>KO3DYUMUP,-EP-9;]B1,"H>T]HKO5(P9 &X2C#>>!7Z8FEOXR4<^DC!I>\@#PR&R4\95#'UNH\/ KW?5X2!0&W%G"3RFNLJ&7 (3^ MD=$M=FB(2?8YY^+T!O*].C$3QT9V&C;Y"!OLTA[+2]T#J#\MWXFIXDK? YAN M##,Q*,E-B^@)?C^GNV:W(HWJM[V9B;JI=WI^A+*WW*4=KCT/L]Y./F78;@%8 M5.Q:7D]%B2PU^[7?%,2\IB0+1&RWDH,OH#'ZA]2>E8M9+ M'7161^R>*1R]>"MX*%-:W;8L>/:': :F(SZ^#>$V4NVDJ*[Y6]XN3H669 P?HLD M*=W?A@8\RWQ>01LQK\>B$O9>Q<"5)ST;LUJM75P$W#K?BER!51[43&D]8NEY M>T)ZGM(C!;G3S?_M*,Q4?1!FSF'H_D/ MSS@'4_V?XQEM2B_H6HM^$:<%A9?S8UBP),UX_YEIN7UPR%X?+N-.J'P1XD[) MYTZ:K9&\H &ULI?-.N*S/JZ8>OF2&F<.LQ-A"B%0QXBZ5W9Y1I.D7&\=ILU3 MXIOT*Y#-_++P+7\/Q#T MRM6PR:'_B/XFN@?T_/K':\VF_ODH]4!:7FL;V3YFHBNZU8N.!8F>>\!C/A<7 M#I<*14>:7!9A,C<=A$O(:(^-F8*779Q?- A3EC#:5Z:!A[%&9&:L+.@1ILPO M]#E>6[R/<)MJDE[)F!K!P[8,?N9*"[[#^6Q:A3%JAUZ5UIRGEV8J(-:_ QN@ MT[C%OIQK'8M,XH8<3K(+[7=W[]#=\&Q:\2";Q@&U '+]JH:O56HO>+F<$_? MB_2\-6KVN"7@-)@TNFPX,F?.(.0?M25O_O@\>@M9[ DY8Z%3J*FOJXESR@64 MUO466;-_0]XHN&7O^%Q9Q=4,M":[PNFPO8WI[R*O"SA;PIO&?TT YO/<>D&( M-2!#$T$1L,IDAB/9C8N/G8%-ES/,LFN 4&:ZS?++@^FQUG^Y?IB+#3;:IT3Y MLZVES9W+1+"93',3II]2_UF42\]S^2MP!>P1IO8;"-A1J&R;/U^6E).2N:G2 M#Y"CT#E_QHHX[Q,\&RCY]MX$[H%U@5=[)C2J(]@+?K3VMSP9=1]_LW[HG>&^ MI >O]=^ MVF)/S,Q4YBQM<#E(IMM9N:KJL-\PD1^^X;Z=IB-EI9L!HLN>U%,VQ^#R)UF\ M8$*0@+2"HSL8BN#\'$AXN>/FRWBZYQU(_'0(E;%Q%[6EOS0>[D3F9'7I5*A0 M\TB=G&VSKV_PBG,B>YUM[2 !@ M>*;UP812<"C.]S;AAPL3\+:_-YS$[ M>")&;$W,DSE_ =>Q)JEC?YI@6__@*XKBT@@S<"Z$"6OW3COO%\<(1'_1LJ,^ M"O>/-8.B9>6TFI$"50\W>7/O 0;$)'(L*=.'5M][.#2H(UB8S1-#Y5G/3K)Z M-&:JVEJIL^.WU+[)R,(?O]5PKHL>N5:[A=B-U/_X'>BU#7J.:*Z70WU,C95D MX1U]$L\[H"O>1?+6!Y9?+Q>9!8!9HFTUCQ%#PAI5SY\)\BNG,@=/_+EN?;MR MNN!PV*41)TW!UA;F+6.I M1HA8CB\I4K;Z;VOL-OWZ#@.XKM)2+'KOST/&5\24B8R>#6 M1.;9*.8BQ>6CK]7NS^.HB;\KYV\_(T8A-KUBBC'PUI8OC(5O_J,TLCI.: M]&Z_/52&&W72L87^3<6NHDB(Z3ZYVZM/%3(TI'JBUR61!N2SZ\@ZJA,#VIGZAB1O7=DJ3+^$$N;HR+@LTEHUNH5.!I;TD67^6*"6)V=S[S" MZ=%UJ>RN',,>$-50\+TG -$B%*MI(M%Q#R"^[#1;Y#PS-3=V4\=Q:0LB7U,T M.E 49GGQ1/;1%3@$9HPNS<3#.,8"W%P\?;K'3C4*S%')>YM=8\;>Y;':33$7'=.A#&-(-(M6:+WM%NI;+6$E'6& M/?K8Z24K8HOQ(@HN5MII-O 9GSWTR0#CWAT]C!PCT96ATANG!LF'"_JX(9=H MSJ;__*7A.UQ]9L2!MZDU .U"Z5 %ZB7ZQTI-MUV5>'F63NZ(.>6 MMTJ/]\G#PY$=@S0JS?_9#DRHR/_D%VZ:_?7"K1 J.7,^ NX70!IEG>O:?'XA MBO/1M2=3EBT+-\O7%* G=)+R>7^U M,S[8L>-X.& M?_!\>D3)\6>7]ML+\^C^EZR79']?^L-B'H\WH88R3,J!W M#9K7 0D>YX&E!'E^^]KX]11WQPPBB!RW]CA4R_#XC;2/[USOBX)6;5T9$[1< M1PM/U?/1VYC]&*ZO'YW/V)N9VRO^42:YY0-9]:JX8O@"-X!I(_^&Y+"1IHMJH&;1G%;=,]I)9S,77I[U6 MG6QGKO=;S&MHA AH[9#PJXZB9L2VOSG'9H3FF[Y(416WX M\+D>I[R93^2S*U'W .!B4)[1J&@SN&M:)4TQ.%PDK#YA0_/H2"VEA.XTB-4, MRV I] [9N8YCU^-AT7RA,,ED..YT1,)/F"@\)O$0S+2\%-P0%,9)ESQR6U1( M%7],GACXI?F1<@B.TJ!GZ49=/QBE6)Y'-OW.ZJ/P6;F9+OJ@.U.$X,BB9^BT M?$-'4#[F-"K[1Q$@>&8BZO@H[B^?$\'O8 X]=,]GOC2YT4]8))N0 :1/RE*0VP4#O!7M]^.U7"(CFLZ.'8I2_\$^C0 M""E*E'0[OAK%;QV/%[^>'79X[FR9ZL%0 A3'>?")Z5F3"W#D1##(T$BMI%FH MUFA@$^43W7+&U.+\(Y6IUI)T[Q4+63+SZ#.^\S47$?9Z[,'Z,IY8TY,[TL'AD(3<>- MVA\C!8,??P1L9V67R,=^<+4SKG*R'KD5+>;HF\@9OU%G,H30?I'8V<3;,PU: M!7X5VLF=US<**)XY"9$MF;2J58M-/.^;X8EQ.,Q:"=":9+0S$U^W[0O2&2'UUMF"@K70GN]^,DW'BQY>)AIKDP,S.##>JM^\8Z_*AE+^ISEU]+Q8J_ MT=Y,[L)M:M&;7&6!%_5#EKZ-G:R<8>VU#?SC#/$K,A4!0/18G6$/05EX_D2Y M380B=U/X)-2B!-6WL?C7)(EF'F#LO'!6&B A'_'W39D/Q_@;Z4S"0B]R6L7\ M1?F'%"YUE-8__X4=X@-"EGR5+M13M;1Z+VS<*>V TQ22(T$\9O(%_JRJU,\ MUXG0!2C3?\!_6=H::;BQF67Y6YWH4V4WPTW;R(H2HD0*)C[^K,4LR>"/DJ18 MP6OH3\$P^H-/ZTYTQ G8Z;F&=T7BR0Z][C*(.UU,:=*H,N+@%>WP2@W<\*(5 M']O^DL^II<_U742V(3>Y8;=2X1F*E^H=1E3BK_*38]M#ICQ'_$N/3%D'?,7 MP1H)O/=3QW,$:'A*"^&,T8+O@-'$>J0E2E'TSOSN7&4HX&6A8*JE>T%V=&L< M//E&VN\>\.@>T''$M/>2N%KV#TL?G\.JF@RYW@3')()IX/<#F2IIJKT3QN3V M:4+[577.5<7+IPW1Z;*28EF,WRCT,YN6KY$Y3E&$DFV]+\OTNI4G6G@000"8 MROB-!N1SG@.3VO[VK]O=*\HIJX;:&+LY3_?GUNRC41'8$07L6 &V%Z;23_] ML?J/.%$9Z2):.$*N+( !#=9L;4)[-9@,L/0K"9%@:GS*K,:*94GM)PE2YJT\ M8A)?[ S)O_Z_R4!(3_!8/W;[ZXJ'>:BL.KZX$SR\!H_< QB#G&-#EO 0^,@C M+T*O(3WF;_R>?SCL1G*\J4FN)+S8/G:P8

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

  •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�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�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

  •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�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form20-f_htm.xml IDEA: XBRL DOCUMENT 0001940674 2023-01-01 2023-12-31 0001940674 dei:BusinessContactMember 2023-01-01 2023-12-31 0001940674 SMX:OrdinarySharesWithNominalValueOf0.0022PerShareMember 2023-01-01 2023-12-31 0001940674 SMX:WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf253.00PerShareMember 2023-01-01 2023-12-31 0001940674 ifrs-full:OrdinarySharesMember 2023-12-31 0001940674 SMX:PublicWarrantsMember 2023-12-31 0001940674 SMX:DeferredSharesMember 2023-12-31 0001940674 2023-12-31 0001940674 2022-12-31 0001940674 2022-01-01 2022-12-31 0001940674 2021-01-01 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2020-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2020-12-31 0001940674 ifrs-full:RetainedEarningsMember 2020-12-31 0001940674 2020-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-12-31 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-01-01 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2023-12-31 0001940674 ifrs-full:RetainedEarningsMember 2023-12-31 0001940674 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001940674 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001940674 SMX:SecurityMattersPTYLtdMember ifrs-full:OrdinarySharesMember 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-10-03 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-12-31 0001940674 ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember SMX:EquityPurchaseAgreementMember 2024-04-01 0001940674 SMX:EquityLineAgreementMember 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001940674 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:NatoAgreementMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersSmxPlcMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-12-31 0001940674 SMX:SMXFashionAndLuxuryMember 2023-01-01 2023-12-31 0001940674 SMX:TrueSilverSMXPlatformLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MachineryMember 2023-01-01 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-02 2023-10-02 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-10-03 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-10-02 0001940674 SMX:SpecialPurposeAcquisitionCompanyMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationMember 2023-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001940674 ifrs-full:MachineryMember 2023-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2023-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2021-12-23 2021-12-24 0001940674 SMX:SMXBeveragesPtyLtdMember 2021-12-23 2021-12-24 0001940674 SMX:SMXBeveragesPtyLtdMember 2021-12-24 0001940674 SMX:GlobalBevCoPtyLtdMember SMX:ConsultingAgreementMember 2021-12-23 2021-12-24 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2023-01-01 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:TechnologyLicenseMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2023-01-01 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:TechnologyLicenseMember 2023-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2023-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember 2023-12-31 0001940674 ifrs-full:LicencesMember 2023-12-31 0001940674 SMX:TechnologyLicenseMember 2023-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember 2022-01-01 2022-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 ifrs-full:LicencesMember 2022-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2023-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-12-31 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 ifrs-full:OrdinarySharesMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember ifrs-full:OrdinarySharesMember 2023-01-24 2023-01-25 0001940674 SMX:BonusWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-25 0001940674 SMX:RedeemableWarrantsMember 2023-01-24 2023-01-25 0001940674 2022-05-01 2022-05-31 0001940674 2022-05-31 0001940674 SMX:ConvertibleNotesAgreementsMember 2022-07-31 0001940674 ifrs-full:MajorOrdinaryShareTransactionsMember 2023-03-07 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-09-06 2023-09-06 0001940674 SMX:WarrantAMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:WarrantBMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 ifrs-full:OrdinarySharesMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 ifrs-full:OrdinarySharesMember SMX:WarrantAMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:PromissoryNoteMember SMX:SecuritiesPurchaseAgreementMember 2023-12-31 0001940674 SMX:SecuritiesPurchaseAgreementMember 2023-12-31 0001940674 SMX:ElevenLendersMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:BonusWarrantsMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:ThreeValuationModelsMember 2023-01-01 2023-12-31 0001940674 SMX:ThreeValuationModelsMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-12-31 2023-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:FirstInstallmentMember SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:SecondInstallmentMember SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-01 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-12-31 2023-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 0001940674 SMX:NonadjustingEventMember SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 2023-07-31 0001940674 ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember SMX:EquityPurchaseAgreementMember 2024-04-19 0001940674 ifrs-full:OfficeEquipmentMember 2023-01-01 2023-12-31 0001940674 ifrs-full:MotorVehiclesMember 2023-01-01 2023-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2021-12-31 0001940674 ifrs-full:MotorVehiclesMember 2021-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember 2022-01-01 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember 2023-12-31 0001940674 ifrs-full:MotorVehiclesMember 2023-12-31 0001940674 2015-01-01 2015-12-31 0001940674 SMX:LenderTwoMember 2023-01-01 2023-12-31 0001940674 2022-08-01 2022-08-31 0001940674 SMX:LoanAgreementMember 2023-09-19 0001940674 SMX:LoanAgreementsMember 2023-09-19 0001940674 ifrs-full:PreferenceSharesMember 2023-12-31 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 2023-03-07 0001940674 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:PrivateWarrantsMember 2023-03-07 0001940674 SMX:PublicWarrantsMember 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 2023-03-07 0001940674 SMX:BridgeLoansMember 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantAMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:PrefundedWarrantMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantAMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember 2022-06-27 0001940674 SMX:WarrantBMember 2023-12-08 0001940674 SMX:WarrantBMember 2023-12-08 2023-12-08 0001940674 2023-12-08 2023-12-08 0001940674 SMX:WarrantBMember 2023-12-31 0001940674 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001940674 SMX:UnderwriterWarrantMember 2023-12-31 0001940674 SMX:UnderwriterWarrantMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesMember ifrs-full:BottomOfRangeMember 2023-12-31 0001940674 SMX:EmployeesMember ifrs-full:TopOfRangeMember 2023-12-31 0001940674 SMX:EmployeesMember 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember 2023-01-01 2023-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:BlackScholesPricingModelMember 2022-01-01 2022-12-31 0001940674 SMX:ServiceProviderAgreementsMember 2023-12-31 0001940674 SMX:IncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:BottomOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:TopOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2022-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2021-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2022-01-01 2022-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingTwoMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingTwoMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember 2023-12-31 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingThreeMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingThreeMember 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember 2023-12-31 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingFourMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingFourMember 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember 2023-12-31 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingFiveMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingFiveMember 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember 2023-12-31 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingSixMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingSixMember 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember 2023-12-31 0001940674 SMX:OptionsOutstandingSixMember 2023-01-01 2023-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingSevenMember 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingSevenMember 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember 2023-12-31 0001940674 SMX:OptionsOutstandingSevenMember 2023-01-01 2023-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2023-01-01 2023-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:ResearchAndDevelopmentExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-12-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-12-31 0001940674 SMX:DirectorsMember 2023-12-31 0001940674 SMX:DirectorsMember 2022-12-31 0001940674 SMX:ShareholdersMember 2023-12-31 0001940674 SMX:ShareholdersMember 2022-12-31 0001940674 ifrs-full:JointVenturesMember 2023-12-31 0001940674 ifrs-full:JointVenturesMember 2022-12-31 0001940674 ifrs-full:RelatedPartiesMember 2023-12-31 0001940674 ifrs-full:RelatedPartiesMember 2022-12-31 0001940674 2023-10-25 2023-10-25 0001940674 2015-01-31 0001940674 2023-01-31 0001940674 2023-01-29 2023-01-31 0001940674 ifrs-full:CreditRiskMember 2023-12-31 0001940674 ifrs-full:CreditRiskMember 2022-12-31 0001940674 SMX:ConvertibleNotesMember 2023-12-31 0001940674 SMX:ConvertibleNotesMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember 2022-12-31 0001940674 SMX:BridgeLoansMember 2023-12-31 0001940674 SMX:BridgeLoansMember 2022-12-31 0001940674 SMX:PrePaidAdvanceMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember 2022-12-31 0001940674 ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:DerivativesMember 2022-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember 2022-12-31 0001940674 SMX:BorrowingFromRelatedPartiesMember 2023-12-31 0001940674 SMX:BorrowingFromRelatedPartiesMember 2022-12-31 0001940674 SMX:NISMember 2023-01-01 2023-12-31 0001940674 SMX:NISMember 2022-01-01 2022-12-31 0001940674 SMX:AUDMember 2023-01-01 2023-12-31 0001940674 SMX:AUDMember 2022-01-01 2022-12-31 0001940674 SMX:SGDMember 2023-01-01 2023-12-31 0001940674 SMX:SGDMember 2022-01-01 2022-12-31 0001940674 SMX:EURMember 2023-01-01 2023-12-31 0001940674 SMX:EURMember 2022-01-01 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:TradeAndOtherPayableMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryNoteMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:ConvertiblePromissoryMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:PrePaidAdvanceMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:ConvertibleNoteMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 SMX:FinancialDerivativesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember 2023-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember 2023-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember 2023-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001940674 ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2023-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:TradeAndOtherPayableMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:BridgeLoansMember SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:BorrowingsFromRelatedPartiesMember ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:NotLaterThanOneToTwoYearMember 2022-12-31 0001940674 SMX:NotLaterThanTwoToThreeYearMember 2022-12-31 0001940674 SMX:NotLaterThanThreeToFourYearMember 2022-12-31 0001940674 SMX:NotLaterThanFourToFiveYearMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember 2022-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:DerivativesMember 2023-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:DerivativesMember 2022-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:NonadjustingEventMember SMX:UnderwritingAgreementMember 2024-01-12 0001940674 SMX:NonadjustingEventMember 2024-01-01 2024-01-31 0001940674 SMX:NonadjustingEventMember SMX:LetterAgreementMember 2024-02-29 0001940674 SMX:NonadjustingEventMember SMX:LetterAgreementMember 2024-02-01 2024-02-29 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember SMX:UnderwritingAgreementMember 2024-02-20 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember SMX:UnderwritingAgreementMember 2024-02-20 2024-02-20 0001940674 SMX:NonadjustingEventMember 2024-02-20 2024-02-20 0001940674 SMX:NonadjustingEventMember 2024-02-01 2024-02-29 0001940674 SMX:NonadjustingEventMember 2024-02-29 2024-02-29 0001940674 SMX:BoardOfDirectorMember ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember 2024-03-04 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2024-04-11 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2024-04-11 2024-04-11 0001940674 ifrs-full:WarrantsMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember SMX:StockPurchaseAgreementMember 2024-04-19 0001940674 ifrs-full:EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember SMX:StockPurchaseAgreementMember 2024-04-19 2024-04-19 0001940674 SMX:NonadjustingEventMember 2024-04-19 0001940674 ifrs-full:OrdinarySharesMember ifrs-full:WarrantReserveMember SMX:NonadjustingEventMember 2024-01-12 0001940674 ifrs-full:OrdinarySharesMember SMX:NonadjustingEventMember 2024-01-12 0001940674 SMX:WarrantBMember SMX:NonadjustingEventMember 2024-01-12 iso4217:USD shares iso4217:USD shares pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD shares iso4217:EUR iso4217:EUR shares iso4217:SGD false FY 0001940674 20-F false true 2023-12-31 --12-31 2023 false false 001-41639 SMX (Security Matters) Public Limited Company L2 Mespil Business Centre Mespil House Sussex Road Dublin 4 IE D04 T4A6 Haggai Alon Mespil Business Centre Mespil House Sussex Road Dublin 4 IE D04 T4A6 +353-1 920-1000 Ordinary Shares, with a nominal value of $0.0022 per share SMX NASDAQ Warrants, each exercisable for one Ordinary Share at an exercise price of $253.00 per share SMXWW NASDAQ 10242706 284091 25000 No No Yes Yes Non-accelerated Filer true false false false International Financial Reporting Standards false 1185 Tel-Aviv, Israel Ziv Haft 168000 1398000 634000 3673000 802000 5071000 16486000 5027000 32957000 411000 555000 389000 414000 115000 221000 50358000 6217000 51160000 11288000 10515000 2972000 2483000 650000 377000 563000 1143000 700000 1750000 1013000 710000 41000 30000 18022000 4925000 411000 440000 483000 3682000 85000 894000 4207000 18916000 9132000 62901000 32713000 -491000 -537000 -50934000 -30020000 11476000 2156000 20768000 32244000 2156000 51160000 11288000 2711000 1898000 2039000 661000 569000 453000 16567000 2723000 2482000 16802000 -36741000 -5190000 -4974000 7891000 1128000 101000 1580000 28000 237000 22164000 -101000 106000 -101000 -20989000 -6184000 -4939000 -20989000 -6184000 -4939000 -224000 -522000 -7000 -59000 -238000 -375000 -283000 -760000 -382000 -21272000 -6944000 -5321000 -20914000 -75000 -7.82 -8.47 -7.41 32713000 -537000 -30020000 2156000 2156000 -20914000 -20914000 -75000 -20989000 46000 46000 17000 63000 46000 -20914000 -20868000 -58000 -20926000 4896000 4896000 4896000 11460000 11460000 11460000 3269000 3269000 3269000 5955000 5955000 5955000 10000 10000 10000 1837000 1837000 1837000 1008000 1008000 1008000 888000 888000 888000 865000 865000 865000 20826000 20826000 62901000 -491000 -50934000 11476000 20768000 32244000 31504000 223000 -23836000 7891000 -6184000 -6184000 -760000 -760000 -760000 -6184000 -6944000 182000 182000 306000 306000 721000 721000 32713000 -537000 -30020000 2156000 24733000 605000 -18897000 6441000 -4939000 -4939000 -382000 -382000 -382000 -4939000 -5321000 5892000 5892000 395000 395000 484000 484000 31504000 223000 -23836000 7891000 -20914000 -6184000 -4939000 3269000 306000 484000 225000 290000 315000 2938000 -2936000 -463000 2074000 2217000 401000 -235000 114000 60000 19000 17000 -3000 1496000 387000 4281000 51000 47000 382000 22164000 621000 89000 -101000 106000 -101000 11000 16802000 -12479000 -5223000 -3908000 60000 152000 297000 976000 975000 1468000 -1036000 -1127000 -1765000 172000 103000 42000 55000 98000 2630000 642000 395000 250000 581000 2679000 30000 182000 5892000 550000 3310000 32000 2356000 2919000 11954000 3846000 6118000 -1561000 -2504000 445000 1398000 4171000 4341000 331000 -269000 -615000 168000 1398000 4171000 2300000 1008000 5192000 2925000 175000 3030000 -22164000 <p id="xdx_808_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_z5HuYrxCmLme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_82B_zl271IUatGZd">GENERAL</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, SMX’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. One reader can detect embedded data in various materials, from metals to fabrics to food and plastics, with all data logged onto the same digital platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SPAC transaction:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”) the Company completed its SPAC transaction (the “Business Combination”) with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd. were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_zMiXOJ0oH1Il">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary share per <span id="xdx_906_ecustom--ShareIssuedPricePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_z5k942CscZU1" title="Share price">10.3624 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. shares, having an implied value of $<span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_zY2QuUlK5Su7">10.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange. The Business Combination resulted in <span id="xdx_903_ecustom--RedemptionPercentageOfBusinessCombination_pid_dp_uPure_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zhwoZopWKLFi">97.58</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% redemption by Lionheart’s public shareholders which resulted in leaving $<span id="xdx_90A_ecustom--RemainingFundsInTrustAccount_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zqrZUXD7Gwbe">3,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of funds remaining in the trust account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd.’s (“TrueGold”) shareholders to acquire an additional <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zGWUDJFlwzUf">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% which will increase the Company’s holdings to <span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20231003__20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zuoDqvLbE2Ub">51.9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% in TrueGold and result in the Company’s gain control over TrueGold, See also Note 3.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the 12 months ended December 31, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 10, the Company executed an equity line agreement to raise up to $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock_pn3n3_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_zNFkSmAZhsN4" title="Number of shares">25,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). Furthermore, and as described in note 10 and note 24(10), in April 2024, the Company terminated the equity line agreement with Yorkville and entered into a similar agreement for $<span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20240401__ifrs-full--TypesOfContractsAxis__custom--EquityPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zEudNm1Y9Fxk">30,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with an institutional investor. The Company is continuing with additional capital raising and as described in note 24(5), post balance sheet date it received an additional $<span id="xdx_903_eifrs-full--OtherReceivables_iI_pn5n6_c20231231__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_z8djcFrhyjkf">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in funding. The Company also plans to secure a convertible note between $<span id="xdx_908_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230101__20231231__srt--RangeAxis__ifrs-full--BottomOfRangeMember_zDglqhmneISf">500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230101__20231231__srt--RangeAxis__ifrs-full--TopOfRangeMember_zeFAHtAnaI5k">1,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in addition to second round funding to raise approximately $<span id="xdx_90C_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230101__20231231_zLpMV9WKiST7">5,800 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after balance sheet date. The Company has also the ability to decrease its expenses and capitalize debt in order to meet its existing cash flow streams. Furthermore, the Company expect that the $<span id="xdx_905_ecustom--AdjustmentsForDecreaseIncreaseInExpensesAndCapitalize_pn3n3_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--NatoAgreementMember_zpKJJoMJli3f" title="Decrease increase in expenses snd capitalize">5,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NATO government agreement describe in note 24 (2), shall continue in the second half of 2024. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - GENERAL (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates primarily through 9 wholly owned subsidiaries and one majority owned all of which have been consolidated in these consolidated financial statements.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_895_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zeiKBUZdNVb3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BF_zI50ZQUhB5Pd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPANIES SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Controlled entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters (SMX) PLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_fKg_____z3auCKkm4bT" style="font-family: Times New Roman, Times, Serif">Ireland</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_fKg_____zWlAZ6udYJY5" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zATOKsFaw8C" style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters PTY Ltd. <br/>(Formerly - Security Matters Limited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zPX3TOhuE0Nb" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zH5ZoNoze026" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lionheart III Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___z3PAh3MlSWjd" style="font-family: Times New Roman, Times, Serif">USA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zjiQRAektlve" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Circular Economy Platform PTE, Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zzSP0So3sOWd" style="font-family: Times New Roman, Times, Serif">Singapore</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zsWWZwdXbkmd" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Ireland Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zDJLuEdXKvch" style="font-family: Times New Roman, Times, Serif">Ireland</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zeJL0daMxIv6" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Fashion and Luxury <br/></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zbKMF4142c3f" style="font-family: Times New Roman, Times, Serif">France</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zDUDoXwSVuok" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TrueSilver SMX Platform Ltd. <br/></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zZMGwdMJCBy5" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_z544kve5uNea" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Israel Ltd. <br/>(Formerly - Security Matters Ltd.)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_z6joc30UlIc4" style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zX64DF5n0tcg" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_zTRnvDiTXsO7" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters Canada Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_z7hlF3N9bhQl" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zW592XSVWeD7" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_zkCoqKPmFTla" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Beverages Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zUTqh0Lmn162" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zlZhE1pkZjcb" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_z7liput8Fta3" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">True Gold Consortium Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z9aioUiTb7O7" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zrL1HlLpRwG6" style="font-family: Times New Roman, Times, Serif">51.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See note 6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Entity</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Yahaloma Technologies Inc.</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zwiBNeTvveId" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zvMeelolicXl" style="font-family: Times New Roman, Times, Serif">50</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zHUTsU1Yqo5l" style="font-family: Times New Roman, Times, Serif">50</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span id="xdx_F0D_z4djdngUIHxi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zstaJiI7mr8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td> </tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_F03_zqqN49aA9dbh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_z4LGTFwtHpK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023 as part of the Business Combination.</span></td> </tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_F08_zZ4xlpaGKCN8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_z1DGbgBlDnjj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.</span></td> </tr></table> <p id="xdx_8A0_zmxuVLbaula8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 10.3624 10.00 0.9758 3061000 0.075 0.519 25000000 30000000 3000000 500000 1000000 5800000 5000000 <p id="xdx_895_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zeiKBUZdNVb3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BF_zI50ZQUhB5Pd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPANIES SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Controlled entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters (SMX) PLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_fKg_____z3auCKkm4bT" style="font-family: Times New Roman, Times, Serif">Ireland</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersSmxPlcMember_fKg_____zWlAZ6udYJY5" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zATOKsFaw8C" style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters PTY Ltd. <br/>(Formerly - Security Matters Limited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zPX3TOhuE0Nb" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zH5ZoNoze026" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lionheart III Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___z3PAh3MlSWjd" style="font-family: Times New Roman, Times, Serif">USA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zjiQRAektlve" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Circular Economy Platform PTE, Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zzSP0So3sOWd" style="font-family: Times New Roman, Times, Serif">Singapore</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zsWWZwdXbkmd" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Ireland Limited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zDJLuEdXKvch" style="font-family: Times New Roman, Times, Serif">Ireland</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zeJL0daMxIv6" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Fashion and Luxury <br/></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zbKMF4142c3f" style="font-family: Times New Roman, Times, Serif">France</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXFashionAndLuxuryMember_zDUDoXwSVuok" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TrueSilver SMX Platform Ltd. <br/></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_zZMGwdMJCBy5" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueSilverSMXPlatformLtdMember_z544kve5uNea" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Israel Ltd. <br/>(Formerly - Security Matters Ltd.)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_z6joc30UlIc4" style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zX64DF5n0tcg" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_zTRnvDiTXsO7" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters Canada Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_z7hlF3N9bhQl" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zW592XSVWeD7" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_zkCoqKPmFTla" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Beverages Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zUTqh0Lmn162" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zlZhE1pkZjcb" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_z7liput8Fta3" style="font-family: Times New Roman, Times, Serif">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">True Gold Consortium Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z9aioUiTb7O7" style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zrL1HlLpRwG6" style="font-family: Times New Roman, Times, Serif">51.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See note 6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Entity</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Yahaloma Technologies Inc.</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zwiBNeTvveId" style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zvMeelolicXl" style="font-family: Times New Roman, Times, Serif">50</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zHUTsU1Yqo5l" style="font-family: Times New Roman, Times, Serif">50</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span id="xdx_F0D_z4djdngUIHxi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zstaJiI7mr8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td> </tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_F03_zqqN49aA9dbh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_z4LGTFwtHpK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023 as part of the Business Combination.</span></td> </tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span id="xdx_F08_zZ4xlpaGKCN8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_z1DGbgBlDnjj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023.</span></td> </tr></table> Ireland 1 Australia 1 USA 1 Singapore 1 Ireland 1 France 1 Canada 1 Israel 1 1 Canada 1 1 Australia 1 1 Australia 0.519 Canada 0.50 0.50 <p id="xdx_80D_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zK5VqN1Vunwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_82B_zY7Sij8GHCDk">SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zTWTZQu4YK3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zPjBGrsKi03b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--PrinciplesOfConsolidationExplanatory_zDe8SfLaRmT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_zOtba1wA91Ve" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of SMX (Security Matters) Public Limited Company as of December 31, 2023 and 2022 and the results of all subsidiaries for the three years in the period then ended. SMX (Security Matters) Public Limited Company, a public limited company and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_zgwoSpm7RBM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_864_zR4T9tGqrwI8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments in associated companies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory_z51h7th5Odah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zZxotMvX6Uae" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_90D_ecustom--FairValueBasedOnQuotedOpeningSharePrice_c20230101__20231231_znploN9xQNod" title="Fair value based on quoted opening share price">11,599</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_90D_ecustom--FairValueOfEquityTransaction_c20230101__20231231_zrdehcJbEp0d" title="Fair value of equity transaction">16,802</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_900_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_c20231231_zheU2DVoHxhj" title="Marketable securities held in trust account">4,921</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and trade and other payables and warrants ($<span id="xdx_906_eifrs-full--TradeAndOtherPayables_iI_c20231231_z5czFH63kia9">10,127</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr></table> <p id="xdx_85C_zehzMIw767yg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zR9J0veDnDFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_zj5Gd1yy5d83" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True Gold consortium PYT LTD. is Australian Dollar.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities – at the rate of exchange applicable at the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense items – at annual average rate at the statements of financial position date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.7pt; text-align: justify; text-indent: -14.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zGUyDZVsKhNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86E_zIPFM8mizdHb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issue of a unit of financial instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p id="xdx_859_zRtOERVKebfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zcDBQgNNg834" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_869_zuSNbZwdztDk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zYRE2c7C74T" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_860_z5t4eWS6wFkc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the principal market for the asset or liability; or</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the absence of a principal market, in the most advantageous market for the asset or liability.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal or the most advantageous market must be accessible to the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zUj6dSEC9HNe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_z6CRlCZA9IVi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification of financial instruments by fair value hierarchy</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_znxbMajXKVyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zqC6KG6dOCfa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has no financial assets classified at fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zG7bBmUyFg7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86A_zKp41SrRw78" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>financial liabilities measured at amortized cost:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for financial liabilities which are measured at fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>measured at fair value through profit or loss:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z90QkzxLtOe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_868_zbwouNA5xcw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of non-financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zmQTgd2PaNrc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_zWeGJjI5XHJa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property, plant and equipment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:</span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zIjfPd6SvuC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B4_zyOr7GTKMG88" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%; margin-left: 0.25in"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zl02PdJ3egZk" style="font-family: Times New Roman, Times, Serif">33</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Machines and equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z6KcM4RYus9h" style="font-family: Times New Roman, Times, Serif">20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zC6JiLAxGP81" style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWx1KDDkqv6d" style="font-family: Times New Roman, Times, Serif">8</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zvpuXBhIncte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zVKEBndKEqol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_865_zXnfwmhd68l6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reimbursement of research and development expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be successful, are offset in profit or loss against the related expenses (research and development expenses). Any intellectual property generated from this activity remains at the ownership of the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zw5NTPcDadk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_863_zUNceoq8Xslk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Right-of-use assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p> <p id="xdx_855_z1H2OVhuKBz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zarCEXN9HEB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86D_z3VAIktHl7Li" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On initial recognition, the carrying value of the lease liability also includes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amounts expected to be payable under any residual value guarantee;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOes4nMIOCK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zJDPkhts0rF2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capitalized technology development costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The technical feasibility of completing the intangible asset so that it will be available for use or sale.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intention to complete the intangible asset and use or sell it.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to measure reliably the expenditures attributable to the intangible asset during its development.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The technical feasibility criteria is determined to be met when a milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.</span></p> <p id="xdx_852_z6kKQk6l6IFd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Capitalized technology development costs (Cont.) </b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Currently, the Group’s capitalized development activities focus on:</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">2.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Semi Industrial scale – technology implementation in semi-industrial production.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">3.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.</span></td></tr> </table> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent measurement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>Capitalized technology development costs (Cont.) </b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zFpcV7aGMCUi" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_z4IvE3WnQXPk" style="font: normal 10pt Times New Roman, Times, Serif"><b>Share-based compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory_zX0jMHnorLuh" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zDYO2vuw0fmc" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments adopted from January 1, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of Accounting Policies (Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements);</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">In February 2021, the IASB issued amendments to IAS 1 and IFRS Practice Statement 2. The amendments aim to make accounting policy disclosures more informative by replacing the requirement to disclose ‘significant accounting policies’ with ‘material accounting policy information’. The amendments also provide guidance under what circumstance, the accounting policy information is likely to be considered material and therefore requiring disclosure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">These amendments have no effect on the measurement or presentation of any items in the consolidated financial statements of the Group but affect the disclosure of accounting policies of the Group.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definition of Accounting Estimates (Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors);</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The amendments to IAS 8, which added the definition of accounting estimates, clarify that the effects of a change in an input or measurement technique are changes in accounting estimates</span><span style="font: normal 10pt Times New Roman, Times, Serif"><b>, </b><span style="font-weight: normal">unless resulting from the correction of prior period errors. These amendments clarify how entities make the distinction between changes in accounting estimate, changes in accounting policy and prior period errors. These amendments had no effect on the consolidated financial statements of the Group.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory_zW5RZcaUXnIg" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_863_zRvcsHdEwcjc" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments not yet effective</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The following amendments are effective for the period beginning January 1, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Non-current Liabilities with Covenants (Amendments to IAS 1 Presentation of Financial Statements); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Supplier Finance Arrangements (Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The following amendments are effective for the period beginning January 1, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Lack of Exchangeability (Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates).</span></td></tr></table> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group is currently assessing the impact of these new accounting standards and amendments. The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent basis, are:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory_zqhlqz9ip6Kc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86D_zSfskGpC0izf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zBWGO49Nyj4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86A_z7NPtkNG1Uil" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory_z8NDAtgTwAGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zoXTDzzTlfR1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liability at fair value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions of the financial liability, which are described in Note 22 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.</span></p> <p id="xdx_851_z0GPcB5twird" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zTWTZQu4YK3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zPjBGrsKi03b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--PrinciplesOfConsolidationExplanatory_zDe8SfLaRmT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_zOtba1wA91Ve" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of SMX (Security Matters) Public Limited Company as of December 31, 2023 and 2022 and the results of all subsidiaries for the three years in the period then ended. SMX (Security Matters) Public Limited Company, a public limited company and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_zgwoSpm7RBM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_864_zR4T9tGqrwI8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments in associated companies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForRepurchaseAndReverseRepurchaseAgreementsExplanatory_z51h7th5Odah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zZxotMvX6Uae" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1.B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_90D_ecustom--FairValueBasedOnQuotedOpeningSharePrice_c20230101__20231231_znploN9xQNod" title="Fair value based on quoted opening share price">11,599</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_90D_ecustom--FairValueOfEquityTransaction_c20230101__20231231_zrdehcJbEp0d" title="Fair value of equity transaction">16,802</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the closing date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_900_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_c20231231_zheU2DVoHxhj" title="Marketable securities held in trust account">4,921</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and trade and other payables and warrants ($<span id="xdx_906_eifrs-full--TradeAndOtherPayables_iI_c20231231_z5czFH63kia9">10,127</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr></table> 11599 16802 4921 10127 <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zR9J0veDnDFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_zj5Gd1yy5d83" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars which is the functional and presentation currency of the Company. Security Matters (SMX) PLC functional currency is US Dollar. The functional currency of Lionheart III Corp is US Dollar. The functional currency of SMX Fashion and Luxury is EURO. The functional currency of True Silver SMX Platform is Canadian Dollars. The functional currency of SMX (Security Matters) Ireland Limited is US Dollar. The functional currency of SMX Circular Economy Platform PTE, Ltd. is Singapore Dollar. Security Matters Pty Ltd.’s functional currency is Australian Dollars. The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. is Canadian Dollars. The functional currency of SMX Beverages Pty Ltd. is Australian Dollar. The functional currency of True Gold consortium PYT LTD. is Australian Dollar.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities – at the rate of exchange applicable at the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense items – at annual average rate at the statements of financial position date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 14.7pt; text-align: justify; text-indent: -14.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zGUyDZVsKhNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86E_zIPFM8mizdHb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issue of a unit of financial instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zcDBQgNNg834" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_869_zuSNbZwdztDk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zYRE2c7C74T" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_860_z5t4eWS6wFkc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the principal market for the asset or liability; or</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the absence of a principal market, in the most advantageous market for the asset or liability.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal or the most advantageous market must be accessible to the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zUj6dSEC9HNe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_z6CRlCZA9IVi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification of financial instruments by fair value hierarchy</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_znxbMajXKVyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zqC6KG6dOCfa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has no financial assets classified at fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zG7bBmUyFg7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86A_zKp41SrRw78" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>financial liabilities measured at amortized cost:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of financial liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for financial liabilities which are measured at fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>measured at fair value through profit or loss:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instruments. The Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z90QkzxLtOe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_868_zbwouNA5xcw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of non-financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets and goodwill that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zmQTgd2PaNrc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_zWeGJjI5XHJa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property, plant and equipment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:</span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zIjfPd6SvuC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B4_zyOr7GTKMG88" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%; margin-left: 0.25in"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zl02PdJ3egZk" style="font-family: Times New Roman, Times, Serif">33</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Machines and equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z6KcM4RYus9h" style="font-family: Times New Roman, Times, Serif">20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zC6JiLAxGP81" style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWx1KDDkqv6d" style="font-family: Times New Roman, Times, Serif">8</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zvpuXBhIncte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zIjfPd6SvuC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B4_zyOr7GTKMG88" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%; margin-left: 0.25in"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zl02PdJ3egZk" style="font-family: Times New Roman, Times, Serif">33</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Machines and equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z6KcM4RYus9h" style="font-family: Times New Roman, Times, Serif">20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and office equipment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zC6JiLAxGP81" style="font-family: Times New Roman, Times, Serif">10</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWx1KDDkqv6d" style="font-family: Times New Roman, Times, Serif">8</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.33 0.20 0.10 0.08 <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zVKEBndKEqol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_865_zXnfwmhd68l6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reimbursement of research and development expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be successful, are offset in profit or loss against the related expenses (research and development expenses). Any intellectual property generated from this activity remains at the ownership of the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zw5NTPcDadk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_863_zUNceoq8Xslk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Right-of-use assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term. A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zarCEXN9HEB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86D_z3VAIktHl7Li" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On initial recognition, the carrying value of the lease liability also includes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amounts expected to be payable under any residual value guarantee;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOes4nMIOCK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86F_zJDPkhts0rF2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capitalized technology development costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The technical feasibility of completing the intangible asset so that it will be available for use or sale.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intention to complete the intangible asset and use or sell it.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to measure reliably the expenditures attributable to the intangible asset during its development.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The technical feasibility criteria is determined to be met when a milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.</span></p> <p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zFpcV7aGMCUi" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_z4IvE3WnQXPk" style="font: normal 10pt Times New Roman, Times, Serif"><b>Share-based compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsAdoptedExplanatory_zX0jMHnorLuh" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zDYO2vuw0fmc" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments adopted from January 1, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of Accounting Policies (Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements);</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">In February 2021, the IASB issued amendments to IAS 1 and IFRS Practice Statement 2. The amendments aim to make accounting policy disclosures more informative by replacing the requirement to disclose ‘significant accounting policies’ with ‘material accounting policy information’. The amendments also provide guidance under what circumstance, the accounting policy information is likely to be considered material and therefore requiring disclosure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">These amendments have no effect on the measurement or presentation of any items in the consolidated financial statements of the Group but affect the disclosure of accounting policies of the Group.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definition of Accounting Estimates (Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors);</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The amendments to IAS 8, which added the definition of accounting estimates, clarify that the effects of a change in an input or measurement technique are changes in accounting estimates</span><span style="font: normal 10pt Times New Roman, Times, Serif"><b>, </b><span style="font-weight: normal">unless resulting from the correction of prior period errors. These amendments clarify how entities make the distinction between changes in accounting estimate, changes in accounting policy and prior period errors. These amendments had no effect on the consolidated financial statements of the Group.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory_zW5RZcaUXnIg" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_863_zRvcsHdEwcjc" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments not yet effective</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The following amendments are effective for the period beginning January 1, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Non-current Liabilities with Covenants (Amendments to IAS 1 Presentation of Financial Statements); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Supplier Finance Arrangements (Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The following amendments are effective for the period beginning January 1, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Lack of Exchangeability (Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates).</span></td></tr></table> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group is currently assessing the impact of these new accounting standards and amendments. The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The significant accounting judgments, estimates and assumptions followed in the preparation of the financial statements, on a consistent basis, are:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--DescriptionOfAccountingPolicyForShareBasedCompensationExplanatory_zqhlqz9ip6Kc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86D_zSfskGpC0izf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zBWGO49Nyj4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86A_z7NPtkNG1Uil" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES, ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForFinancialLiabilitiesAtFairValueExplanatory_z8NDAtgTwAGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zoXTDzzTlfR1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liability at fair value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions of the financial liability, which are described in Note 22 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.</span></p> <p id="xdx_80C_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zrx3K6YwWla8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_82F_zQMDoUXRPpag">TRUE GOLD BUSINESS COMBINATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 3, 2023 (acquisition date), the Company signed an agreement with True Gold Consortium Pty Ltd. (“TrueGold”) shareholders to acquire an additional <span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zVlj0ZdhevGh">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% which will increase the Company’s holdings to <span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zeJSdWnjAtO8">51.9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% in TrueGold and result in the Company’s gain control over TrueGold. TrueGold uses the Company’s advanced next-generation technology to invisibly mark and store multiple data types at a molecular level as well as its blockchain digital platform. This strategic transaction through gaining control of TrueGold diversifies the Company’s operations into TrueGold’s pioneering ventures in research and development and revenue commercialization.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company previously held <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20231002__20231002__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zMFw8ZWXPaSd">44.4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the shares of TrueGold which, up to the acquisition date and the beginning of consolidation, were treated as an investment in a joint venture which accounted for under the equity method. At the time the transaction was completed and control was obtained, the balance of the investment was remeasured at fair value of $<span id="xdx_905_eifrs-full--AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_iI_pn3n3_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_z8HZMDZ3nS82">22,164 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a gain was recognized in the amount of $<span id="xdx_900_eifrs-full--GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination_pn3n3_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zyyFwE2t7DIi">22,164</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which was recorded in the statement of comprehensive loss (the carrying amount of the previous investment in TrueGold was approximately nil). This fair value amount was added to the consideration transferred for the calculation of goodwill, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to measure the non-controlling interests in TrueGold at full fair value which includes also the non-controlling interests’ share in the entire goodwill of TrueGold. The fair value of the non-controlling interests in TrueGold was based on the fair value of TrueGold as a whole, as described above, and was estimated using the discounted cash flow method of the income approach, as TrueGold is a private company and therefore quoted market prices of its share were unavailable. The fair value has been determined by management with the assistance of a valuation performed by an external and independent valuation specialist using valuation techniques and assumptions as to estimates of projected net future cash flows of TrueGold and estimate of the suitable discount rate for these cash flows. The significant assumptions used in estimating the fair value of TrueGold are:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After-tax net cash flow discount rate (weighted average cost of capital) of <span id="xdx_90B_ecustom--WeightedAverageCostOfCapitalPercentage_iI_pid_dp_uPure_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zHh5VeTeX4T9" title="Weighted average cost of capital percentage">24.8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terminal value cash flow multiple of <span id="xdx_906_ecustom--TerminalPerShares_iI_pid_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zF6JYoZsEGul" title="Terminal per shares">4.59 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and terminal growth rate of <span id="xdx_90F_ecustom--TerminalGrowthRatePercentage_iI_pid_dp_uPure_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zDrDNik6jC81" title="Terminal growth rate percentage">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount for lack of marketability of <span id="xdx_900_ecustom--DiscountForLackOfMarketabilityPercentage_iI_pid_dp_uPure_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zUsb9CKrYsue" title="Discount for lack of marketability percentage">25.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% (or $<span id="xdx_908_ecustom--DiscountForLackOfMarketabilityValue_iI_pid_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zTb1rdRQQOOk" title="Discount for lack of marketability value">11.17</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), resulting in a fair value of $<span id="xdx_907_eifrs-full--ParValuePerShare_iI_pid_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zR8zB6cTtpIc">33.12 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per ordinary share of TrueGold).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total cost of the business combination comprised a full forgiveness of the outstanding payables from TrueGold to the Company which amounted to AUD <span id="xdx_90A_ecustom--ForgivenessOfOutstandingPayables_uAUD_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zvKT73RZNDe2" title="Forgiveness of outstanding payables">475 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(approximately $<span id="xdx_903_ecustom--ForgivenessOfOutstandingPayables_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_z4cl9ZkfdSVh" title="Forgiveness of outstanding payables">307</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) at acquisition date. The calculating of any goodwill upon acquisition included also the fair value of the previous investment in TrueGold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – TRUE GOLD BUSINESS COMBINATION (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_z3pvk6Cafhaf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the identifiable assets and liabilities of TrueGold on the acquisition date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BF_zLkMYO4jfJf5" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 0.3in"> <tr style="font-family: Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_490_20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zujgfjoEQQXa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_zU2Xqv6IjTl8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_zNMt75TCF5w6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other current receivables</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">155</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_zvGtGmXcFbQg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible asset (core technology license)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,449</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_zjKDqj27gEPa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade payables</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">277</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--IdentifiableAssetsAcquiredLiabilitiesAssumed_iI_pn3n3_zu2dUCicp8Ck" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net identifiable assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,340</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_iNI_pn3n3_di_zuHhWj09JS7c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-controlling interests</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,826</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_401_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_zHYhr73CAqU3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,957</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loan to TrueGold</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zScwOOBAmeZb" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total purchase cost"><span style="font-family: Times New Roman, Times, Serif">307</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of previous investment</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_iI_pn3n3_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_z0w3ndDKAhU3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Fair value of previous investment"><span style="font-family: Times New Roman, Times, Serif">22,164</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_zW7wkUy1uWGb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of identifiable assets and liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,471</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zdbzFn6A9wD7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The only intangible asset identified in the purchase price allocation, and recognized as shown in the table above, represents a core technology license that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). As mentioned above, this licensee represents the current right of TrueGold to use the Company’s intellectual property of technology under a license agreement signed in 2020. For the purpose of the purchase price allocation, this right was treated as a reacquired right and accordingly was recognized separately from goodwill and valued on the basis of the remaining contractual term of the related contract, regardless of whether market participants would consider potential contractual renewals. After acquisition, this intangible asset should be amortized in according to its economic useful life. The Company has not yet began amortizing the asset and is assessing the economic useful life of it. See also Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The goodwill arising from acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Company and TrueGold. The goodwill recognized is not expected to be deductible for income tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the acquisition date, TrueGold has contributed $<span id="xdx_902_eifrs-full--ProfitLossOfAcquiree_c20231003__20231231__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zYbg9A3Wqw8i">155 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the consolidated net loss. If the business combination had taken place at the beginning of the year 2023, the consolidated net loss would have been increased by $<span id="xdx_90B_eifrs-full--ProfitLossOfAcquiree_c20230101__20231002__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zRSgEbzbBoY3">692 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after elimination the Company’s’ share of TrueGold’s net loss until acquisition date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.075 0.519 0.444 22164000 22164000 0.248 4.59 0.03 0.252 11.17 33.12 475 307 <p id="xdx_891_eifrs-full--DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_z3pvk6Cafhaf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the identifiable assets and liabilities of TrueGold on the acquisition date:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BF_zLkMYO4jfJf5" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF FAIR VALUE OF THE IDENTIFIABLE ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 0.3in"> <tr style="font-family: Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_490_20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zujgfjoEQQXa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_zU2Xqv6IjTl8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_zNMt75TCF5w6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other current receivables</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">155</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_zvGtGmXcFbQg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible asset (core technology license)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,449</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_zjKDqj27gEPa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade payables</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">277</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--IdentifiableAssetsAcquiredLiabilitiesAssumed_iI_pn3n3_zu2dUCicp8Ck" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net identifiable assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,340</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_iNI_pn3n3_di_zuHhWj09JS7c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-controlling interests</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,826</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_401_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_zHYhr73CAqU3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,957</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loan to TrueGold</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20231003__20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_zScwOOBAmeZb" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total purchase cost"><span style="font-family: Times New Roman, Times, Serif">307</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of previous investment</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_iI_pn3n3_c20231003__ifrs-full--BusinessCombinationsAxis__custom--TrueGoldConsortiumPtyLtdMember_z0w3ndDKAhU3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Fair value of previous investment"><span style="font-family: Times New Roman, Times, Serif">22,164</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_zW7wkUy1uWGb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of identifiable assets and liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,471</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 13000 155000 10449000 277000 10340000 20826000 32957000 307000 22164000 22471000 155 692 <p id="xdx_806_eifrs-full--DisclosureOfOtherCurrentAssetsExplanatory_z6CkBTBi8Tfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 - <span id="xdx_827_z5wD7l0WpPik">OTHER CURRENT ASSETS</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_z0wYPsSuLhZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_8BB_zdigpUmxJtA4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF OTHER CURRENT ASSETS</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20231231_zHgqXo5BcnTd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20221231_zKbWhKtiWvbi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_909_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_c20231231_zwBihGSEEDdf" style="font-family: Times New Roman, Times, Serif">142</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span><span id="xdx_902_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_c20221231_fKg_____zlxzvaZNjaKj" style="font-family: Times New Roman, Times, Serif">3,157</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr> <tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zW1dMFff1ET2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tax authorities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">257</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">358</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zxAxXZlFez0f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proof of concept receivables</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">148</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_zxA96I4UILfa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">87</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zEy1IYOjEr7f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">634</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,673</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td id="xdx_F06_zfmtFxcYwtn3" style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zYNGsU8NOASd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9USEVSIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eifrs-full--CurrentPrepaidExpenses_iI_c20221231__ifrs-full--BusinessCombinationsAxis__custom--SpecialPurposeAcquisitionCompanyMember_zVqGvBUFRc9j" title="Anticipated transaction costs">3,123</span> for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).</span></td> </tr></table> <p id="xdx_8A4_z8faoc0PDFWl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_z0wYPsSuLhZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_8BB_zdigpUmxJtA4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF OTHER CURRENT ASSETS</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20231231_zHgqXo5BcnTd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20221231_zKbWhKtiWvbi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_909_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_c20231231_zwBihGSEEDdf" style="font-family: Times New Roman, Times, Serif">142</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span><span id="xdx_902_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_c20221231_fKg_____zlxzvaZNjaKj" style="font-family: Times New Roman, Times, Serif">3,157</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr> <tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zW1dMFff1ET2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tax authorities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">257</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">358</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zxAxXZlFez0f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Proof of concept receivables</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">148</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_zxA96I4UILfa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">87</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zEy1IYOjEr7f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">634</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,673</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td id="xdx_F06_zfmtFxcYwtn3" style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zYNGsU8NOASd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9USEVSIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eifrs-full--CurrentPrepaidExpenses_iI_c20221231__ifrs-full--BusinessCombinationsAxis__custom--SpecialPurposeAcquisitionCompanyMember_zVqGvBUFRc9j" title="Anticipated transaction costs">3,123</span> for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B).</span></td> </tr></table> 142000 3157000 257000 358000 148000 86000 87000 72000 634000 3673000 3123000 <p id="xdx_80B_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zMnLWpiCwS9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 - <span id="xdx_82F_zFTCT93uQqy5">PROPERTY, PLANT AND EQUIPMENT, NET:</span></b></span></p> <p id="xdx_894_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z1cGD4QoUARe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8BE_zqoutNO4j7Yf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNr5qw5P18Hb" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjUpyzLXSGwd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSD0KPdGsERf" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4ulvZ1VcUkg" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaJarxC9krbd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,377</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlRLpAiqlMm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKCF32iIIO7i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrzC7TJbYEY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zU1Nl5BZ1Yy5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoJu5GFU5hE5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7cE7HxlRT53" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdXVkOAFMrMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPPzOeW8ARxc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB1tDwdqBNv9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkD2sPbOacSi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3hbQ1FG39a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwVL8EVNTvDk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxcpxKQgYbse" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAGIOmAvvU3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znpgitXcPIZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK0gsqCX5cT6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMvK9LjM4L39" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKjMey37xKd1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPZUKMi9sJ2k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9Asb6iUCWNl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znxojZArLoUd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zL79CcNKYOqc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,146</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8H5oxfO3Ig3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9tDJ50W8kbb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztRygyANIVMf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zr6EuxW86SIb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z7SrJ8X9GLXf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zi0VRrBN41Xk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zWqYsA368Cs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0w4wMaIezM8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zRK1WBu9GOOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJ8F6cAU3K94" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ze40CjW2LoYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdYYO8dIGH5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zV65IZODdcSh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z793LJuBSiOa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBZMKirziod1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z79E4GGCCMsg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zA41IkGR8t9d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z7rmUMKojv15" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zyWZGirNIObf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbBj6RfKWipc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBtYUREjs1r3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3xh4aZUBwSc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zEzAO6QQlNSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">981</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zugjyJarBal" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zyWpr34eeeWh" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zhRmk64qVCH4" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4FYCc34Jwn9" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231_zX8XBNPgjWJa" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">411</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbD78op2MNAl" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfEcpB013Nua" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znzRSwuQtRLf" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zo7mrhrWMDi2" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIButjYFqcTa" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaog4GSSqku5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztiCAgXdWF75" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfNlSgL1Z5ch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHMUQCrGsQt3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdbHNLbAnP1f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG7Wm3fGV1Fi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMKLtYOAuiZ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z02UqXINtIg9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z60jHMiway89" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYZO4AdZDskb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMqL5rQWJn67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVMpg5a05Kmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFwS3t5RYPA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwBHwZelbRBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzbvPzHNcQLh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3UXuiU6d9k6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTStZ4EtVTm8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(221</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvnU6eKwyOc1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z734ioEwapDc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWbnR4pwTfYj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(271</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0caNwMicBya" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgXA0TJvYQag" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSdelfjPUfd8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSKWkmmPt6J5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzUzb37UFABd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,377</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zZsNc0G9MFw" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z8aN4qcN5SSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zLAuoqEEoUEl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zc6UCIEuFx7j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQuSxZugL1hb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">770</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z73euki207fj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFy8wFQn7pmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zozctPX6pYX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zoHy9TMZr0Nj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgo4Ow5PsuJa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zV7ALPkmEAbc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zp1hvn8NjcS" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(148</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJsahUiiqct7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zluFOw9XDa34" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zD6kLiNqrxHa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(180</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zPkVfvBpdTL2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3cXMGGL14m" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqSSEjLaOsek" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBBGoqXy8bZd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJCvZ60kDoK7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">822</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_z4muu8a8VlR6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zSnPYyzhvMWb" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zGJgaMgnvWId" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zFIna7n8UYT2" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231_zqD2C7hmgIv9" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">555</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z1cGD4QoUARe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8BE_zqoutNO4j7Yf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNr5qw5P18Hb" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjUpyzLXSGwd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSD0KPdGsERf" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4ulvZ1VcUkg" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaJarxC9krbd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,377</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlRLpAiqlMm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKCF32iIIO7i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrzC7TJbYEY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zU1Nl5BZ1Yy5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoJu5GFU5hE5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7cE7HxlRT53" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdXVkOAFMrMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPPzOeW8ARxc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB1tDwdqBNv9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkD2sPbOacSi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3hbQ1FG39a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwVL8EVNTvDk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxcpxKQgYbse" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAGIOmAvvU3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znpgitXcPIZd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK0gsqCX5cT6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMvK9LjM4L39" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKjMey37xKd1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPZUKMi9sJ2k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9Asb6iUCWNl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znxojZArLoUd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zL79CcNKYOqc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,146</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8H5oxfO3Ig3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9tDJ50W8kbb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztRygyANIVMf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zr6EuxW86SIb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z7SrJ8X9GLXf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zi0VRrBN41Xk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zWqYsA368Cs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0w4wMaIezM8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zRK1WBu9GOOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJ8F6cAU3K94" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ze40CjW2LoYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdYYO8dIGH5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zV65IZODdcSh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z793LJuBSiOa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBZMKirziod1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z79E4GGCCMsg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zA41IkGR8t9d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z7rmUMKojv15" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zyWZGirNIObf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbBj6RfKWipc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBtYUREjs1r3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3xh4aZUBwSc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zEzAO6QQlNSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">981</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zugjyJarBal" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zyWpr34eeeWh" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zhRmk64qVCH4" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4FYCc34Jwn9" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20230101__20231231_zX8XBNPgjWJa" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">411</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbD78op2MNAl" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfEcpB013Nua" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znzRSwuQtRLf" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zo7mrhrWMDi2" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIButjYFqcTa" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaog4GSSqku5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztiCAgXdWF75" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfNlSgL1Z5ch" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHMUQCrGsQt3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdbHNLbAnP1f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG7Wm3fGV1Fi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMKLtYOAuiZ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z02UqXINtIg9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z60jHMiway89" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYZO4AdZDskb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMqL5rQWJn67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVMpg5a05Kmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFwS3t5RYPA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwBHwZelbRBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzbvPzHNcQLh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3UXuiU6d9k6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTStZ4EtVTm8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(221</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvnU6eKwyOc1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z734ioEwapDc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWbnR4pwTfYj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(271</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0caNwMicBya" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgXA0TJvYQag" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSdelfjPUfd8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSKWkmmPt6J5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzUzb37UFABd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,377</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zZsNc0G9MFw" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z8aN4qcN5SSb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zLAuoqEEoUEl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zc6UCIEuFx7j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQuSxZugL1hb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">770</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z73euki207fj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFy8wFQn7pmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zozctPX6pYX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zoHy9TMZr0Nj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgo4Ow5PsuJa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zV7ALPkmEAbc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zp1hvn8NjcS" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(148</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJsahUiiqct7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zluFOw9XDa34" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zD6kLiNqrxHa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(180</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zPkVfvBpdTL2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z3cXMGGL14m" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqSSEjLaOsek" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zBBGoqXy8bZd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zJCvZ60kDoK7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">822</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_z4muu8a8VlR6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zSnPYyzhvMWb" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zGJgaMgnvWId" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zFIna7n8UYT2" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231_zqD2C7hmgIv9" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">555</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 63000 1147000 65000 102000 1377000 15000 5000 7000 4000 31000 -3000 -6000 -3000 -4000 -16000 75000 1146000 69000 102000 1392000 18000 699000 31000 74000 822000 6000 151000 7000 16000 180000 -18000 -1000 -2000 -21000 24000 832000 37000 88000 981000 51000 314000 32000 14000 411000 81000 1233000 83000 99000 1496000 135000 17000 152000 -18000 -221000 -18000 -14000 -271000 63000 1147000 65000 102000 1377000 20000 645000 33000 72000 770000 4000 202000 7000 19000 232000 -6000 -148000 -9000 -17000 -180000 18000 699000 31000 74000 822000 45000 448000 34000 28000 555000 <p id="xdx_80C_ecustom--DisclosureOfInvestmentInAssociatedCompaniesExplanatory_zoah7Z50uBt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - <span id="xdx_824_z4cOFGKvqiy5">INVESTMENTS IN ASSOCIATED COMPANIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eifrs-full--DisclosureOfSignificantInvestmentsInAssociatesExplanatory_z4UTwGOvX4e6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B4_zwCvyA5mgnY6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma Technologies Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: left"><span id="xdx_900_eifrs-full--CountryOfIncorporation_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zWQC6HE3pv94" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zQKtE1x0uif5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zhvNmAXR1JO6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">True Gold Consortium Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_eifrs-full--CountryOfIncorporation_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_z7WvwjhpG5hi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zHiM209xpsO9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zbfcNoe9Hmel" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8AA_zMnDOTIwmXi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yahaloma Technologies Inc</span><b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2019, Security Matters Ltd. signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the agreement, Security Matters Ltd. and Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">True Gold Consortium Pty Ltd</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. and TrueGold. The purpose of the agreement is to set the framework for TrueGold’s activity. TrueGold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, TrueGold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting. During 2023 the Company acquired an additional <span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--TrueGoldConsortiumPtyLtdMember_zOWq0DXvSqve">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and gained control in TrueGold. See also note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">SMX Beverages Pty Ltd</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_z8UvXHjv2GSe">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% shares in SMX-B in exchange for <span id="xdx_90F_ecustom--SharesIssuedForExerciseOfStockOptionsShares_pid_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zlI4stzMlwCk" title="Shares issued for exercise of stock options, shares">8,000,001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options of the Company at exercise price of AUD <span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uAUDPShares_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zUGhwBDPOmq6">0.4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with an expiration date of <span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zUTXorzga9h" title="Weighted average remaining contractual life of outstanding share options">March 25, 2027</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Total fair value is AUD <span id="xdx_90E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zn1BjLwSO5S8">960,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD <span id="xdx_906_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uUSD_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zFStq44Rwqb8">721,424</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black-Scholes model, free rate interest of <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zBZWBjh4lR66">2.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, expected life <span id="xdx_900_ecustom--OptionsExpectedLife_dtY_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zb5bqejB3W69" title="Options expected life">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD <span id="xdx_90B_ecustom--ConsultingFees_uAUD_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--GlobalBevCoPtyLtdMember__ifrs-full--TypesOfContractsAxis__custom--ConsultingAgreementMember_zhcjnc4zmuDj" title="Consulting fees">13,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month and a <span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--GlobalBevCoPtyLtdMember__ifrs-full--TypesOfContractsAxis__custom--ConsultingAgreementMember_zNAQW35fsOs1">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% revenue share for referred clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eifrs-full--DisclosureOfSignificantInvestmentsInAssociatesExplanatory_z4UTwGOvX4e6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B4_zwCvyA5mgnY6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma Technologies Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: left"><span id="xdx_900_eifrs-full--CountryOfIncorporation_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zWQC6HE3pv94" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zQKtE1x0uif5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zhvNmAXR1JO6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">True Gold Consortium Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_904_eifrs-full--CountryOfIncorporation_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_z7WvwjhpG5hi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20230101__20231231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zHiM209xpsO9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zbfcNoe9Hmel" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> Canada 0.50 0.50 Australia 0.519 0.444 0.075 0.50 8000001 0.4 2027-03-25 960000 721424 0.025 P5Y 13500 0.05 <p id="xdx_806_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zCcyG78sShpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 - <span id="xdx_820_zQJwllN7oCKc" style="text-transform: uppercase">INTANGIBLE ASSETS, NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zyE6zf8i20la" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8B8_zd6UxWkfXnn1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SUMMARY OF INTANGIBLE ASSETS NET</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zJg5BnEBjsp3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zAKZYm0vW2A" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased license</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_custom--TechnologyLicenseMember_zEYbk5d9F6Jj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core Technology License</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_z6VvYRvVTPLj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zRrQJnKerc5j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zaW0dTp8XTOk" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znfW7J4EeCjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">977</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">157</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOZ7Bs3MRvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zv4srPbePujc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,610</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zfE8Ef9lizH9" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,610</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zAOwS3JvhYyb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1106">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zCgoLcfYID69" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zEUzgvmphBP9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zsvpOuWYpnHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z6CnWo0cZD9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1126">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1127">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zCNnD3cVz5Eg" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balances</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1132">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20230101__20231231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zYNEvPCo9HFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,218</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,486</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_432_c20230101__20231231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zfDvUvduiok7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,218</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,486</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 - <span style="text-transform: uppercase">Intangible assets, NET</span> (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_ztGwzUDBEOa5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zqEgmla4bO32" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased license</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_zifxiVGFlmil" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zsj0rWORb2O1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_ztmuZzUfPSr1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHcsjuGkJwFb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrxBW3sOD2n5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(500</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(566</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsGross_iE_pn3n3_zay3r18XKxPk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsGross_iE_pn3n3_znzNh1QZ5Ii7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_ztbIwM8VBnq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zGzATVTWsto6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zsHRBqp6ScYh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zpbgXCapfN6j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJDSi47VHIm6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zToTmniBsVgd" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zVzh6qkTwb3h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zGawrtSqYZw9" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_ztAalUe0avDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset at the amount of <span id="xdx_90B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231_z2vSjMq8zU41">145 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is being amortized. The rest of the intangible assets have not yet commenced amortization.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets as of December 31, 2023, consist of capitalized development costs of the Group’s technology as well as the cost of the exclusive license intellectual property (<span id="xdx_903_eifrs-full--IntangibleAssetsUnderDevelopment_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zwT9j7VyPXg3">662</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) which includes the addition amount as a result of the acquisition of additional <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zLAL6UEXnlQl">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% interest in SMX Beverages Pty Ltd. The acquired rights have not yet commenced amortization as the license was not yet commenced usage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, intangible asset as of December 31, 2023, consist also of core technology license raised from the TrueGold business combination that reflects the existence of underlying technology that has value through its continued use or re-use in many products or many generations of a singular product (that is, a product family). See also Note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zyE6zf8i20la" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8B8_zd6UxWkfXnn1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SUMMARY OF INTANGIBLE ASSETS NET</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zJg5BnEBjsp3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zAKZYm0vW2A" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased license</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_custom--TechnologyLicenseMember_zEYbk5d9F6Jj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core Technology License</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_z6VvYRvVTPLj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zRrQJnKerc5j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zaW0dTp8XTOk" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znfW7J4EeCjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">977</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">157</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOZ7Bs3MRvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zv4srPbePujc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,610</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zfE8Ef9lizH9" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,610</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zAOwS3JvhYyb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1106">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zCgoLcfYID69" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zEUzgvmphBP9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zsvpOuWYpnHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z6CnWo0cZD9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1126">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1127">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zCNnD3cVz5Eg" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balances</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1132">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20230101__20231231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zYNEvPCo9HFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,218</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,486</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_432_c20230101__20231231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zfDvUvduiok7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,218</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,449</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,486</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 - <span style="text-transform: uppercase">Intangible assets, NET</span> (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_ztGwzUDBEOa5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zqEgmla4bO32" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased license</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_zifxiVGFlmil" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zsj0rWORb2O1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_ztmuZzUfPSr1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHcsjuGkJwFb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrxBW3sOD2n5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(500</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(566</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsGross_iE_pn3n3_zay3r18XKxPk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsGross_iE_pn3n3_znzNh1QZ5Ii7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_ztbIwM8VBnq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zGzATVTWsto6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zsHRBqp6ScYh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zpbgXCapfN6j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJDSi47VHIm6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zToTmniBsVgd" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zVzh6qkTwb3h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zGawrtSqYZw9" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 4372000 655000 5027000 4372000 655000 5027000 977000 157000 10449000 11583000 7000 -7000 5342000 819000 10449000 16610000 5342000 819000 10449000 16610000 127000 127000 127000 127000 3000 3000 124000 124000 124000 124000 5218000 819000 10449000 16486000 5218000 819000 10449000 16486000 4024000 4024000 4024000 4024000 975000 721000 1696000 500000 66000 566000 4499000 655000 5154000 4499000 655000 5154000 116000 116000 116000 116000 14000 14000 3000 3000 127000 127000 127000 127000 4372000 655000 5027000 4372000 655000 5027000 145000 662000 0.50 <p id="xdx_80E_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zELrqSv4wjol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_822_zoCWbPaFUyM6">CONVERTIBLE NOTES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company received an amount of $<span id="xdx_909_eifrs-full--IssueOfConvertibleInstruments_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zxFSFapZr3Oh">250 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $<span id="xdx_907_eifrs-full--NotionalAmount_iI_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_z3p78UZCpGub">250 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and maturity date is the earlier between <span id="xdx_90B_eifrs-full--BorrowingsMaturity_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zALCBazi7rL1">December 31, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of <span id="xdx_909_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zZB2szdymAbk">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD <span id="xdx_90B_ecustom--FixedConversionPrice_iI_pid_c20230125__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zX82alsoAPj" title="Fixed conversion price">10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per ordinary share, or (2) through issuance of the Company’s ordinary shares at a <span id="xdx_90B_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKq2JS0hqO54">20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Convertible Note agreements, the investor was granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Bonus Warrants - <span id="xdx_90B_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zHXj3Rw44wPe" title="Warrants to purchase ordinary shares">12,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_904_ecustom--ExercisePriceOfWarrants_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zOQFNxCJvWh8" title="Exercise price of warrants">11.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Bonus Warrants have a term of <span id="xdx_902_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_ztMQgZqe4iMd" title="Warrants term">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the closing of the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Redeemable Warrants – <span id="xdx_900_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z7J7N3iPhTQa" title="Warrants to purchase ordinary shares">12,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_90E_ecustom--SharePurchasePrice_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zXl4NrX403ci" title="Share purchase price">11.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Redeemable Warrants have a term of <span id="xdx_905_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zNaeHj5qkQ62" title="Warrants term">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the closing of the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_c20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zZNqo0bln2G9">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant. <span id="xdx_904_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zUH3N5dA0MH7" title="Description of approach used to determine discount rates">The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a <span id="xdx_90E_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z9rmwi1mFtv8" title="Discount rate">20</span>% discount to the 20-trading day VWAP preceding each such anniversary</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_822_zQnGUNy2LQfk">CONVERTIBLE NOTES</span></b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(CONT.):</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of <span id="xdx_90B_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zIgasvlvhUf4">32.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230124__20230125__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_ziGpAMmsc09h">73.74</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and the risk-free interest rate used is <span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230124__20230125__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zejgt94hA4gl">3.91</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. As of December 31, 2023, the fair value of the Convertible Notes was $<span id="xdx_90F_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20231231_zIPMZUzLSYH2" title="Fair value of convertible notes">304 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the fair value of the Redeemable Warrants was $<span id="xdx_90A_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20231231_z2b9iGz56bRh" title="Fair value of redeemable warrants">73</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, Security Matters PTY Ltd. issued <span id="xdx_908_ecustom--NumberOfConvertibleNotesIssued_pid_c20220501__20220531_zh4A4xSxSkth">828,240 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">convertible notes (the “2022 Convertible Notes”), with a face value of AUD <span id="xdx_901_ecustom--FaceValueOfConvertibleNotes_iI_pn3n3_uAUD_c20220531_zziHRXlMucMg">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD <span id="xdx_90C_ecustom--FaceValueOfConvertibleNotes_iI_pn2n3_c20220531_zWXzdq0DDVx2">0.7</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) per each 2022 Convertible Note, for an aggregate amount of AUD <span id="xdx_909_eifrs-full--IssueOfConvertibleInstruments_pn3n3_uAUD_c20220501__20220531_z8hhKZvrrW3f">828 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand (USD <span id="xdx_906_eifrs-full--IssueOfConvertibleInstruments_pn3n3_uUSD_c20220501__20220531_zFrmgbFCa818">569</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The 2022 Convertible Notes have a maturity date of <span id="xdx_907_ecustom--ConvertibleNotesMaturityPeriod_dc_c20220501__20220531_zeJQQZCblMCc">six months</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from issuance date. The conversion price is as follows: <span id="xdx_906_ecustom--ConvertibleNoteConversionPriceDescription_c20220501__20220531_zVL5lrokmR51">(i) if Security Matters PTY Ltd. executes a binding agreement for an M&amp;A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.. As of December 31, 2022, the 2022 Convertible Note amounted to <span id="xdx_902_ecustom--ConvertibleNote_iI_pn3n3_uUSD_c20221231_zl4iknZRV05a" title="Convertible note">563</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In July 2022, an amendment to the 2022 Convertible Notes agreements was signed between Security Matters PTY Ltd. and the investors which prescribes a cancellation of the 2022 Convertible Notes and replacing them with the issuance of <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20220731__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNotesAgreementsMember_zfk5wNgJsgue">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of Security Matters PTY Ltd. (with the occurrence of the Business Combination as described in Note 1.B). On March 7, 2023, the 2022 Convertible Notes were converted to <span id="xdx_90B_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20230307__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--MajorOrdinaryShareTransactionsMember_zhuoEZxPmVhe">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of Security Matters PTY Ltd.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a convertible promissory note with a fixed conversion price of $<span id="xdx_909_ecustom--ConversionPrice_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zamY2qn4j92i" title="Conversion price">1.6378</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zizBwggNiTEj">3,929,051 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrant As and <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zbqS15uVk4v8">2,619,367 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrant Bs, for gross proceeds to SMX of approximately $<span id="xdx_90C_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zMlCzCnllPid">2,358</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, before deducting fees and other offering expenses payable by the Company to their service providers. The warrant As are exercisable into <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zonNEqAzIp0l">3,929,051 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares at an exercise price of $<span id="xdx_90B_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zrG2300c2vLi" title="Warrants exercise price per share">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per, share subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant As. The warrant Bs are exercisable into <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zyp5R93NZEnd">2,619,367 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares at an exercise price of $<span id="xdx_90A_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zRKdwR9JBrlf" title="Warrants exercise price per share">1.6378 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to customary adjustments and may be exercised at any time until the five year anniversary of the warrant Bs. The warrant As and the warrant Bs meet the fixed-for-fixed criterion of IAS 32, resulting in being classified as equity. The note is in the principal amount of $<span id="xdx_903_eifrs-full--NetDebt_iI_pn3n3_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zoylES9Jy7xh">4,290</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The actual amount loaned by the investor pursuant to the Note is $<span id="xdx_90E_eifrs-full--BorrowingCostsIncurred_pn3n3_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z5Ofas9RKx66">2,574 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after a <span id="xdx_90F_ecustom--OriginalIssueDiscount_iI_pid_dp_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z8mmUg3Zfz69" title="Original issue discount">40</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of <span id="xdx_902_ecustom--InterestAccruedPercent_iI_pid_dp_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zmMwMez2y8Qc" title="Interest accrued percent">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $<span id="xdx_90D_ecustom--ConversionPrice_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z1vSAwJFd2K6" title="Conversion price">1.6378 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. <span id="xdx_909_eifrs-full--DescriptionOfConversionOfDebtToEquity_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zI3nmUnDNO54">Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - CONVERTIBLE NOTES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The promissory note was recognized base on the amortized cost method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the note principle amounted to $<span id="xdx_903_eifrs-full--NotionalAmount_iI_pn6n6_c20231231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PromissoryNoteMember_z4F8N2XC5iAe">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and during the period $<span id="xdx_90D_ecustom--NumberOfValueConverted_iI_pn5n6_c20231231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PromissoryNoteMember_zBZg9OhBboUk" title="Number of value converted">2.1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of promissory note was converted to shares. As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zMvbwN6AHOo8">2,619,377 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares and exercised the Warrant A and Warrant B for <span id="xdx_908_ecustom--NumberOfSharesExercisedWarrantsClassA_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zxDtaeI5zIEh" title="Exercised the warrant">3,789,264 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_908_ecustom--NumberOfSharesExercisedWarrantsClassB_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zV50cRwHs3G4" title="Exercised the warrant">2,619,367 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, respectively. See note 24(11).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 250000 December 31, 2024 0.15 10 0.20 12500 11.50 P5Y 12500 11.50 P5Y 5.00 The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary 0.20 0.322 0.7374 0.0391 304000 73000 828240 1000 700 828000 569000 P6M (i) if Security Matters PTY Ltd. executes a binding agreement for an M&A transaction or receives USD 20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each 2022 Convertible Note will automatically be converted into shares in Security Matters PTY Ltd. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the 2022 Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, Security Matters PTY Ltd. entered into the Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if Security Matters PTY Ltd. has not executed a binding agreement for a qualified transaction until December 31, 2022, the 2022 Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share 563000 1000000 1000000 1.6378 3929051 2619367 2358000 3929051 0.0022 2619367 1.6378 4290000 2574000 0.40 0.12 1.6378 Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99% 1000000 2100000 2619377 3789264 2619367 <p id="xdx_806_eifrs-full--DisclosureOfDerivativeFinancialInstrumentsExplanatory_zkNGMlJlXT96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 - <span id="xdx_826_zW2hWlQc20Z4">BRIDGE LOANS LIABILITIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $<span id="xdx_901_ecustom--ProceedsFromLoansAndWarrants_pn3n3_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ElevenLendersMember_zivl2ChPDZTa" title="Proceeds from loans and warrants">3,860</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Bridge Loans have a maturity date of up to <span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zkEzq8DP4Bu7">two years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and bear an interest rate of <span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zSK4prorpDe6">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2023, the principal and the accumulated interest of the bridge loans were $<span id="xdx_906_ecustom--AccumulatedInterest_pn3n3_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zpzJplMN8Aak" title="Accumulated interest">1,739</span></span><span style="font-family: Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Bridge Loans agreements, some of the lenders were granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus Warrants - <span id="xdx_90B_ecustom--WarrantsToPurchaseShares_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_z62ynVI5j5C3">11,045 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(after reverse stock split) warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zOxcmGaPF19b">253 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a first priority security interest in the shares of Security Matters PTY’s interest in trueGold Consortium Pty Ltd.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Bonus Warrants term is <span id="xdx_904_eifrs-full--BorrowingsMaturity_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsMember_zHj3eivN7wDh">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the closing of the Business Combination.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants The fair value of the Bonus Warrants was calculated using the Black and Scholes model.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and as of December 31, 2022, the fair value of the Bonus Warrants was <span id="xdx_902_ecustom--FairValueOfBonusWarrants_iI_dxL_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zzWyapnD0SF4" title="Fair value of bonus warrants::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1287">nil </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_ecustom--FairValueOfBonusWarrants_iI_pn3n3_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zb2lVorPvlR8">24 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants Type 1 - <span id="xdx_90C_ecustom--WarrantsToPurchaseShares_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zE1NekaRh0Tl">15,545 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD <span id="xdx_90D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_znyFUADxSk81">253 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Redeemable Warrants Type 1 term is <span id="xdx_906_eifrs-full--BorrowingsMaturity_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zxeceeulPQ77">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the BCA (see to Note 1B<b>)</b>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zgkUnE3zhvx9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD <span id="xdx_90D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_z6pBCvTwH6x2">110 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember_zVjTzl1UhJt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_zp9m3NSnyFT4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD <span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_ztkaGdiQVeAc">110 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was $<span id="xdx_90C_ecustom--FairValueOfWarrants_pn3n3_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zskh3q73vkZj">72 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_ecustom--FairValueOfWarrants_pn3n3_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zaQXxEcqX6x1">1,973 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 - BRIDGE LOANS LIABILITIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants Type 2 – <span id="xdx_904_ecustom--WarrantsToPurchaseShares_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zO3gKOwELAY3" title="Warrants to purchase shares">10,454 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(after reverse stock split) warrants to purchase ordinary shares of SMX at a purchase price of USD <span id="xdx_90B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zo4or8PSzOUf">253 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Redeemable Warrants Type 2 term is <span id="xdx_906_eifrs-full--BorrowingsMaturity_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zB2QjkO0nxN3">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the SPAC transaction (see also Note 1B<b>)</b>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_903_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_zJSXyY8zJOVc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD <span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_zAfmESmzGl9d">110 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_zPYebmG370Dj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD <span id="xdx_90B_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_zgyKzXA2pkha">110 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and as of December 31, 2022, the fair value of the Redeemable Warrants Type 2 was <span id="xdx_90E_ecustom--FairValueOfWarrants_pn3n3_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zY5wfbQkJP07">$421 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_ecustom--FairValueOfWarrants_pn3n3_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zkTq7zNshMhi" title="Fair value of warrants">696 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span id="xdx_90C_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zCtiWWx9lj9g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The main assumptions used in the three valuation models as of December 31, 2023 described above were: (1) risk free rate <span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zTyaA1WYhRBe">3.91</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) volatility of assets <span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zezrRf4Lwre5">73.74</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; and (3) excepted terms of the warrants <span id="xdx_901_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20230101__20231231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zO3ER3HBKoDb" title="Description of expected term warrants">4.18 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The main assumptions used in the three valuation models as of December 31, 2022 described above were: (1) risk free rate <span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zNsAiWAHqh8h">3.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) volatility of assets <span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zIvIqnVzLRxj">81.03</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; and (3) excepted terms of the warrants -<span id="xdx_906_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zxmu3BrfFxUg" title="Description of expected term warrants">5.18 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $<span id="xdx_900_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230301__20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zZ80CyQxceee">1,350 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and redeemable warrants at the amount of $<span id="xdx_901_ecustom--RedeemableWarrants_iI_pn3n3_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z1Gs9VO7mgli">1,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zQEE4XZ59Lm7">872,418 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares</span><span style="font-family: Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $<span id="xdx_903_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20231231__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zCMTb5Sskm92">750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and redeemable warrants at the amount of $<span id="xdx_905_ecustom--RedeemableWarrants_iI_pn3n3_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z9OBN43EH9s9" title="Redeemable warrants">1,450 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z9E0Mphakukb">4,032,256 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares. According to the addendum the company has issued to the lenders an aggregate of fully paid <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zMGEF0LXdGs8">4,032,256 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase up to an aggregate of <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_c20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zVifospg0cH9">4,032,256 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares at an exercise price of $<span id="xdx_906_ecustom--SharePurchasePrice_pid_c20231231__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z4Fln6RjZmDj" title="Share purchase price">1.17 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Warrants were exercisable immediately upon issuance and will expire three years following their issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants include a cashless exercise mechanism, according to the terms specified in the addendum and it’s according to the lender election (the “Cashless Warrants”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore, the Company accounts for the Cashless Warrants as financial liability instruments that measured at fair value and recognized financial expenses or income through profit and loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company valued each Cashless Warrants at $<span id="xdx_904_ecustom--WarrantPerShare_iI_pid_c20231231_zPmz8tDOyJRe">0.25</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant by using the Black-Scholes option-pricing model The key inputs that were used in the Cashless Warrants fair value as of December 31, 2023 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk-free interest rate <span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zIOs4kpCu84c">4.13</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expected volatility <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zcofCpF5ND2">70.39</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expected dividend yield of <span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zbYFbbVivIRd">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expected term of warrants – <span id="xdx_90A_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20230101__20231231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zg9WnnK5wY7f" title="Expected term of warrants">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 the Cashless Warrants fair value was $<span id="xdx_902_ecustom--ProceedsFromWarrants_c20230101__20231231_zlZ8c9DOoxVf">1,023</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3860000 two years 0.10 1739000 11045 253 five years 24000 15545 253 five years 0.5000 110 0.2500 0.2500 110 72000 1973000 10454 253 five years 0.5000 110 0.5000 110 421000 696000 Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary 0.0391 0.7374 P4Y2M4D 0.0399 0.8103 P5Y2M4D 1350000 1000000 872418 750000 1450000 4032256 4032256 4032256 1.17 0.25 0.0413 0.7039 0 P3Y 1023 <p id="xdx_804_eifrs-full--DisclosureOfPrepaymentsAndOtherAssetsExplanatory_zWpTSMPcjhZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 - <span id="xdx_825_znHDaPhW7VFb">PRE-PAID ADVANCE</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, the Company entered into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $<span id="xdx_90D_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zFMHpfzeY2nb">25,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville ordinary shares at a purchase price as one of two options <span id="xdx_902_eifrs-full--ExplanationOfShareOptionsInSharebasedPaymentArrangement_c20230201__20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zeX0FWIXSB44">(i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period or (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville advanced to the Company an aggregate principal amount of $<span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zJTANj47PXXc">3,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $<span id="xdx_90C_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--FirstInstallmentMember_zrrlvD3ZIUBd">1,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at the closing of the Business Combination, and the second, as subsequently amended, for $<span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--SecondInstallmentMember_zB68aubADJQc">2,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon the effectiveness of a registration statement. The purchase price for the Pre-Paid Advance is <span id="xdx_90A_ecustom--PrepaidAdvancePercentage_iI_pid_dp_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--SecondInstallmentMember_zGdfxi3PKEfb" title="Prepaid advance percentage">92.0% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the ordinary shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $<span id="xdx_909_eifrs-full--ParValuePerShare_iI_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zwBCvwuu5Q5d">3.65</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $<span id="xdx_903_ecustom--PurchasePriceOfPerShare_c20230201__20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zXGKMDKOgnO6" title="Purchase price">1.10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $<span id="xdx_902_ecustom--FloorPricePricePerShare_iI_pid_c20230727_zEcVF98exVs8" title="Floor price">1.10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 14.4), after the Company was required to repay in cash $<span id="xdx_909_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230727__20230727__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_z4tET1j2rM7a">500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of principal amount as a result of the Company’s share price being below the original Floor Price. The Company made additional change to the Yorkville agreement which effectively eliminates the floor price - see also note 24(4). The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $<span id="xdx_90E_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230701__20230731__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zQLm4r1DDCF9">1,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and as of December 31, 2023 the Company repaid the second Pre-Paid Advance in the amount of $<span id="xdx_90B_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20231231__20231231__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zH203uycJc1l">1,300</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In the period, the Company issued ordinary shares in net consideration of $<span id="xdx_90C_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230731__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zRCVAd4EPeAf">1,979 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $<span id="xdx_900_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230731__20230731__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zK4m0tnr8v6h">377 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of the date of the authorization of these financial statements. <span style="background-color: white">On April 13, 2024, the Company exercised its right of termination under the SEPA and sent Yorkville a written termination letter, which is effective </span>upon five trading days thereafter. On April 19, 2024, the Company entered into a similar agreement with an institutional investor, which will enable the Company to raise up to $<span id="xdx_900_eifrs-full--NotionalAmount_iI_pn3n3_c20240419__ifrs-full--TypesOfContractsAxis__custom--EquityPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zB1VvP1UdXU3">30,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. See also note 24(10).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 25000000 (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period or (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. 3500000 1500000 2000000 0.920 3.65 1.10 1.10 500000 1500000 1300000 1979000 377000 30000000 <p id="xdx_805_eifrs-full--DisclosureOfLeasesExplanatory_zH3uz8upOoog" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 - <span id="xdx_82D_zi4oBSvwFxTi">LEASES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of <span id="xdx_909_ecustom--LeaseExpiration_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zkHNnqhN5fAd" title="Lease expiration">12 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years, motor vehicles generally have lease terms of <span id="xdx_904_ecustom--LeaseExpiration_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zQcoiix00QFg" title="Lease expiration">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock_zkZjs0w2f92f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zojtf7h2aT6k" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zrxKBUh120ma" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office and lab</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>facilities</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zo4DcHrh92G1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_z2jM9aapXUE" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zNvWW9Lf4eIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AdditionsToRightofuseAssets_zSQIoxIJO1yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zjrgNxbD0mFh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--DeductionsToRightofuseAssets_iN_di_zElwj1PBs1X2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_zlzJOSXWVnW9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_432_c20230101__20231231_eifrs-full--RightofuseAssets_iS_zoTJHoDyvgTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--RightofuseAssets_iS_zmLSU8Eg77qb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1391">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdditionsToRightofuseAssets_zmm4dPabcf4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zYkmQ0NEJzU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_ecustom--DeductionsToRightofuseAssets_iN_di_z28Vav1pkNui" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1402">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1403">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1404">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_zpWw5HrVNCMe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43F_c20230101__20231231_eifrs-full--RightofuseAssets_iE_zVZ9zJpMnoLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--RightofuseAssets_iE_zAcbrLFFxb0j" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zk4vM7Ojbgu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 - LEASES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zWIRFbEnPOLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information on leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B9_z25BV3GhkQ51" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INFORMATION ON LEASE </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231_zxBFhRSj704g" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_zlFuzrmXvKra" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_z3MdNLs3ZvDa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashOutflowForLeases_pn3n3_zZ2fxuIyhUe9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash outflow for leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zIP8rZkBKR94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For an analysis of maturity dates of lease liabilities, see Note 22 on liquidity risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P12Y P3Y <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock_zkZjs0w2f92f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zojtf7h2aT6k" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zrxKBUh120ma" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office and lab</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>facilities</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zo4DcHrh92G1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BC_z2jM9aapXUE" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zNvWW9Lf4eIb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AdditionsToRightofuseAssets_zSQIoxIJO1yk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zjrgNxbD0mFh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--DeductionsToRightofuseAssets_iN_di_zElwj1PBs1X2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_zlzJOSXWVnW9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_432_c20230101__20231231_eifrs-full--RightofuseAssets_iS_zoTJHoDyvgTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--RightofuseAssets_iS_zmLSU8Eg77qb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1391">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdditionsToRightofuseAssets_zmm4dPabcf4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zYkmQ0NEJzU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_ecustom--DeductionsToRightofuseAssets_iN_di_z28Vav1pkNui" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1402">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1403">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1404">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_zpWw5HrVNCMe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43F_c20230101__20231231_eifrs-full--RightofuseAssets_iE_zVZ9zJpMnoLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--RightofuseAssets_iE_zAcbrLFFxb0j" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 446000 20000 466000 49000 49000 35000 6000 41000 7000 14000 21000 39000 39000 414000 414000 414000 414000 26000 26000 6000 6000 42000 3000 45000 366000 23000 389000 366000 23000 389000 <p id="xdx_89F_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zWIRFbEnPOLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information on leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B9_z25BV3GhkQ51" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INFORMATION ON LEASE </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231_zxBFhRSj704g" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_zlFuzrmXvKra" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_z3MdNLs3ZvDa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashOutflowForLeases_pn3n3_zZ2fxuIyhUe9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash outflow for leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 32000 51000 45000 39000 <p id="xdx_80B_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zyVkmfXqQqtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 - <span id="xdx_822_zDJSip0Ikxz2">OTHER PAYABLES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zz1Frt6yOa32" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BC_z30HRTUyqwij" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF OTHER PAYABLES</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20231231_zPeqZlo6aZwk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zJDqS7nZEcl9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_pn3n3_maTAOPzSMC_zoiXH3zmZzok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees, salaries and related liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">726</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn3n3_maTAOPzSMC_zkflCC3jfsvb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zhLLC7POyCSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities for grants received (see also note 20)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--CurrentExciseTaxPayables_iI_pn3n3_maTAOPzSMC_z5uZ2rs8ANcg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excise Tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,569</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1440">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--OtherPayables_iI_pn3n3_maTAOPzSMC_z3LQv86RdAbi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherCurrentPayables_iTI_pn3n3_mtTAOPzSMC_zuhkpBXIU5Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,483</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zhu1sD1Sa0Cd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zz1Frt6yOa32" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BC_z30HRTUyqwij" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF OTHER PAYABLES</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20231231_zPeqZlo6aZwk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zJDqS7nZEcl9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_pn3n3_maTAOPzSMC_zoiXH3zmZzok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees, salaries and related liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">726</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn3n3_maTAOPzSMC_zkflCC3jfsvb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zhLLC7POyCSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities for grants received (see also note 20)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--CurrentExciseTaxPayables_iI_pn3n3_maTAOPzSMC_z5uZ2rs8ANcg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excise Tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,569</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1440">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--OtherPayables_iI_pn3n3_maTAOPzSMC_z3LQv86RdAbi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherCurrentPayables_iTI_pn3n3_mtTAOPzSMC_zuhkpBXIU5Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,483</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 726000 392000 4000 56000 153000 50000 1569000 31000 152000 2483000 650000 <p id="xdx_808_eifrs-full--DisclosureOfBorrowingsExplanatory_z8T1HCC8OPeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 - <span id="xdx_821_z8hp55L0MqNd">BORROWINGS FROM RELATED PARTIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">In 2015, the Group signed an agreement to receive a loan of ILS <span id="xdx_901_eifrs-full--CashAdvancesAndLoansFromRelatedParties_pn6n6_uILS_c20150101__20151231_z2U9e2Pm0GN3">2 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">million (approximately <span id="xdx_90B_eifrs-full--CashAdvancesAndLoansFromRelatedParties_pn3n3_c20150101__20151231_zgRanQKI9VQ1">513</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">) from its shareholders. These loan bears interest at an annual rate of <span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_dp_uPure_c20231231_zUUitfseuxDi">4%</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zInb3jrwSmU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B0_zjl1yJbreOub" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BORROWINGS FROM RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20230101__20231231_zDOmNVWZrPu1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20220101__20221231_zVY3oSoXujub" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ShorttermBorrowings_iS_pn3n3_z9Puc0C4Mcza" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ShorttermBorrowings_iS_pn3n3_zdhxO2M1DTh5" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, beginning balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--PaymentOfBorrowings_iN_pn3n3_di_zgKYMsqgkmW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_ecustom--ProvisionOfBorrowingToRelatedParties_pn3n3_zRb9Ll1K2qIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for bonus (include interest)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">621</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_pn3n3_zynSJrxWwCE2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange rate differences</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--ShorttermBorrowings_iE_pn3n3_zJMdQoXdk7Al" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--ShorttermBorrowings_iE_pn3n3_ztte6n8JXDQ7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zQb6nYVsmsI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS <span id="xdx_903_ecustom--BonusPayments_pn6n6_uILS_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_zyAJZTUj1s6a">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (approximately <span id="xdx_905_ecustom--BonusPayments_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_z4bqONBmo6Gh">965</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) per each of the two lenders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Bonus Payments are intended to operate in one of the two trigger events:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dividend distributions paid by the Company; or</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 - BORROWINGS FROM RELATED PARTIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS <span id="xdx_90E_ecustom--BonusPayments_pn6n6_uILS_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_zn7Od93rkyNf">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of <span id="xdx_907_ecustom--IncreaseInCarryingAmountOfLiability_pn3n3_c20210101__20211231_zecmY9VGQclc" title="Increase in the carrying amount of the liability">87 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to profit and loss in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022 the loan from related party has been fully repaid and the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS <span id="xdx_90C_ecustom--BonusPayments_pn5n6_uILS_c20220801__20220831_znKCyx2qoEMc">2.5</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (approximately <span id="xdx_90B_ecustom--BonusPayments_pn3n3_c20220801__20220831_z62gRqx2433">710</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), to be paid upon the completion of the business combination. As of December 31, 2022, the liability was <span id="xdx_90B_ecustom--BonusPayments_pn3n3_c20220801__20220831_z3PYSbvmW0aa" title="Bonus payments">710</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $<span id="xdx_90A_eifrs-full--DebtSecurities_iI_pn3n3_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zcLJX945stnh">657 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementsMember_z4S0xwOnwMO1">487,281 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount. In accordance with management estimation the FV of this Indebtedness is immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2000000 513000 0.04 <p id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zInb3jrwSmU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B0_zjl1yJbreOub" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BORROWINGS FROM RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20230101__20231231_zDOmNVWZrPu1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20220101__20221231_zVY3oSoXujub" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ShorttermBorrowings_iS_pn3n3_z9Puc0C4Mcza" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ShorttermBorrowings_iS_pn3n3_zdhxO2M1DTh5" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, beginning balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--PaymentOfBorrowings_iN_pn3n3_di_zgKYMsqgkmW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_ecustom--ProvisionOfBorrowingToRelatedParties_pn3n3_zRb9Ll1K2qIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for bonus (include interest)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">621</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_pn3n3_zynSJrxWwCE2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange rate differences</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--ShorttermBorrowings_iE_pn3n3_zJMdQoXdk7Al" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--ShorttermBorrowings_iE_pn3n3_ztte6n8JXDQ7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 710000 270000 710000 270000 657000 172000 621000 -53000 -9000 710000 710000 3000000 965000 3000000 87000 2500000 710000 710000 657000 487281 <p id="xdx_802_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zK5L2HiXTHVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - <span id="xdx_82E_z1eHl0MiaH24">SHAREHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share capital:</b></span></td></tr></table> <p id="xdx_89C_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z5fhXQl6uCok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zBKnyP9YYY5e"><i style="display: none">SCHEDULE OF SHARE CAPITAL</i></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eifrs-full--ParValuePerShare_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zS8ADYt9HQOk">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zK9Pj1fuM6hi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,363,636,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zW3ygCWtZod9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,185,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKS5MJjcgtE8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,727,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJzz0KYxrj76" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_z5G5qK6g8LGe">0.0001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zh5FfsVglOP9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zpyUSJQAxnBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_z9U0kW7diYBi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zkwg9oyqnmbi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred shares <br/>Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20231231_ziOF934WEim7">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_z3YSTiZVA4xj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zGIOLJAMB3C" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zepfvoWkz0xc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zA7KaRCT4PD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zZVtRxzYsgWh" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $<span id="xdx_90F_ecustom--ParValuePerSharePostReverseSplit_iI_c20231231_zYiC5IuyGjQ3" title="Par value per share post reverse split.">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the Company does not have a limited amount of authorised capital.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Preferred shares</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferred shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes in Share capital</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination as described in Note 1B. Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The AUD <span id="xdx_90C_eifrs-full--NotesAndDebenturesIssued_iI_uAUD_c20230307_zEU1qDP0Hq9b">828,240</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the 2022 Convertible Notes have been cancelled in consideration for the issuance of <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307_z8GJhtJ6bena">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares in Security Matters PTY Ltd.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $<span id="xdx_90E_eifrs-full--ShareIssueRelatedCost_pn3n3_c20230307__20230307_z4Q1WeD3Hmr4">186</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_901_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zrpoANNsO605" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,211,716 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants and options have been exercised on cashless basis to <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zCzFSAkiFqhe">24,568,773 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in Security Matters PTY Ltd.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90E_eifrs-full--NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307_zsJ3CkrzQUCj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">848,784 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(post reverse stock split) ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their <span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307_zSlUcpPY1Enf">193,500,379 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s <span id="xdx_909_eifrs-full--DescriptionOfConversionOfDebtToEquity_uShares_c20230307__20230307_z9tE1anljiw2">shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z5DpGWBv9fhc">160,227 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares, <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrivateWarrantsMember_zGgWHYiV3gma">2,200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">private warrants and <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PublicWarrantsMember_zJdruGnKmAr9">6,250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $<span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zSArklMeLXN4">11.5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $<span id="xdx_903_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230307__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zwh2c04r4cA5" title="Warrants exercise price per share">0.0204 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_z3T9LCI0CV86">303,053 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares for an aggregate of $<span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn3n3_c20230307__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zFF73KW56fwe">3,110 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net proceeds.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20230307__ifrs-full--TypesOfContractsAxis__custom--BridgeLoansMember_z3BugdzOMJeh">872,418 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares for the conversion of bridge loan at principal amount of $<span id="xdx_90F_eifrs-full--DebtInstrumentsHeld_iI_pn3n3_c20230307__ifrs-full--TypesOfContractsAxis__custom--BridgeLoansMember_zsyTrH3ahpsd">1,350 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_909_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z5TCSosyT5Y7">200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redeemable warrants ($<span id="xdx_906_ecustom--WarrantPricePerShare_iI_pid_c20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zhTDU80fGque" title="Warrant price per share">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant, <span id="xdx_90C_ecustom--WarrantsTerm_pid_dtY_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zSU3IeL6nsc6" title="Warrants term">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years, exercise price of $<span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zl3uotPDACz5">11.5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, the Company issued <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231_zrNNDa4V0Vx3">1,237,751 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares (<span id="xdx_909_ecustom--NumberOfSharesCommitmentFees_iI_pid_c20231231_zRHOSrfB8ofb">4,196 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares as commitment fees) to Yorkville post reverse stock split, for an aggregate of $<span id="xdx_903_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn3n3_c20230101__20231231_zvnQbvG778Vd">1,979 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net proceeds (see also Note 10).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zcEyKBSBBFS2">606,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company, at a subscription price per share of $<span id="xdx_90A_eifrs-full--ParValuePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zWA4MRNlubM5">0.24 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the “Firm Shares”), (ii) <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_z0b7Znp2AEtf">606,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants in the form of Warrant A to subscribe for <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zU5tIpQWdXMi">606,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares, at an exercise price of $<span id="xdx_90F_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zqP42bjPwnH8" title="Warrants exercise price per share">0.24 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (“Warrant A”), and (iii) <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zhko6nX2dRDl">606,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants in the form of Warrant B to subscribe for <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z95kaHh21Q9e">606,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares, at an exercise price of $<span id="xdx_90C_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zK2ITyIhc9a" title="Warrants exercise price per share">0.24 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, <span id="xdx_900_eifrs-full--ExplanationOfShareOptionsInSharebasedPaymentArrangement_pp0d_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z5JbMTTwQTJg" title="Description of share-based payment arrangement">(a) up to <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zPUgsrHBEnT4" title="Number of shares issued">90,909</span> additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $<span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zCYfaaR3Tagb" title="Par value per share">0.24</span> (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z0j07cCvw4L1" title="Number of shares issued">90,909</span> ordinary shares at a price per share of $<span id="xdx_907_ecustom--WarrantsPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zAeaWG5mvqPl" title="Warrants price per share">0.2399</span> (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $<span id="xdx_901_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z4tLC4VAjzA8" title="Warrants exercise price per share">0.0 001</span> per share, and/or (b) <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z6wolaluiUn6" title="Number of shares issued">90,909</span> warrants in the form of Warrant A to subscribe for an aggregate of <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zVDMICw3Kyw" title="Number of shares issued">90,909</span> ordinary shares (15% of the Firm Warrants) at an exercise price of $<span id="xdx_90C_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z2nGinkZVxwd" title="Warrants exercise price per share">0.24</span> per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) <span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zvojrBX9Rlmg" title="Number of shares issued">90,909</span> warrants in the form of Warrant B to purchase an aggregate of <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zvEYXq4IKEHd" title="Number of shares issued">90,909</span> ordinary shares (15% of the Firm Warrants) at a purchase price of $<span id="xdx_907_ecustom--WarrantsPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zJr19Y0ffhB4" title="Warrants price per share">0.24</span> per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants</span>. The Option Shares and the Option Warrants are referred to as the “Option Securities”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of <span id="xdx_90E_ecustom--WarrantTermDescription_pp0d_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zGHWd032Cxej" title="Warrant term description">(i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 681,818 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of the authorization of these financial statements, an aggregate of <span id="xdx_90D_ecustom--WarrantCashlessExercised_pid_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember_zgDGaIf5nrWc" title="Warrant cashless exercised">690,096</span> Warrant A warrants were cashless exercised into an aggregate of <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z300hEa3m77g" title="Warrant cashless exercised">345,349</span> ordinary shares.</span> The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 8, 2023, the Company consummated an inducement offer letter agreement with certain holders of the Company’s outstanding Warrant Bs to purchase Ordinary Shares of the Company. The Warrant Bs were issued on June 27, 2022 and had an exercise price of $<span id="xdx_903_ecustom--WarrantsExercisePricePerShare_iI_pid_c20220627__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_z2yGlT7oZbE7" title="Warrants exercise price per share">5.28 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (after taking into account the Company’s 1:22 reverse share split).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the inducement letter, the holders agreed to exercise for cash their Warrant Bs to purchase an aggregate of <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_znaRQB0LsVTd" title="Number of shares issued">606,060</span> shares of the Company’s Ordinary Shares at a reduced exercise price of $<span id="xdx_90D_ecustom--WarrantsExercisePricePerShare_iI_pid_c20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zZQ7A4wGQCNl" title="Warrants exercise price per share">1.15</span> per share in consideration for the Company’s agreement to issue new warrants to purchase, in the aggregate, up to <span id="xdx_906_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20231208__20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zey5EathMCtg" title="Warrants to purchase ordinary shares">909,090</span> of the Company’s Ordinary Shares at an exercise price of either <span id="xdx_905_ecustom--WarrantTermDescription_pp0d_c20231208__20231208_zmUeqk29YUGg" title="Warrant term description">(i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrant holders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of $<span id="xdx_906_eifrs-full--ProceedsFromIssuingShares_pid_c20231208__20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zsJVA24i64B5" title="Gross proceeds of warrants">697</span> from the exercise of the Warrant Bs by the holders, and the carrying amount of those warrants, was classified to ordinary shares and premium together with the proceeds the Company received from the exercise price</span>. See also note 24(3).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with IAS 32, the Company measured the difference between the fair value of the consideration the holder receives on conversion of the instrument under the revised terms and the fair value of the consideration the holder would have received under the original terms, was recognized as a loss in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilized Black-Scholes valuation model to calculate the fair values of the repriced warrants both before and after the repricing and recognized the incremental fair value of $<span id="xdx_90D_eifrs-full--IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements_c20231208__20231208_zIR0rM2ydx2k">209 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as finance expense in the statement of comprehensive income against an increase in the carrying amount of the warrants (presented within issued capital and additional paid-in capital). In addition, fair value was also calculated for the new <span id="xdx_907_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20231208__20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zlv6zaieVQuf" title="Warrants to purchase ordinary shares">909,090 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued warrants at the amount of $<span id="xdx_90A_ecustom--WarrantsToPurchaseOrdinaryAmount_pid_c20231208__20231208__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_z8HCuBhlI6e4" title="Warrants to purchase ordinary amount">865</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which was recognized as finance expense against an increase in equity. Warrant Bs are classified as equity instruments according to IAS 32.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantExerciseDescription_c20230101__20231231_zKuxVRm6Y8G9" title="Warrant exercise description">Warrant A was valued at $0.067 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of the Warrant Bs specify that each warrant has a cash exercise price of $<span id="xdx_90F_ecustom--WarrantCashExercisePrice_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember_z8r9eE1bcNSk" title="Warrant cash exercise price">0.24</span>. The Warrant Bs were valued at $<span id="xdx_907_ecustom--WarrantsExercisePrice_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember_zoShRH6K5zok" title="Warrant exercise price">0.0602</span> by using the Black-Scholes option-pricing</span> model, with expected volatility of <span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zCJ5H10QbZgb" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_znjZtU9SSNl9" title="Risk-free interest rate">4.13</span>%. Warrant As and Bs expire in June 2028. The net proceeds to the Company upon the closing of this offering were approximately $<span id="xdx_90E_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20230101__20231231_z3UJGSU7UETd" title="Net proceeds from offering">2,580</span>. The capital raise fee amounted to $<span id="xdx_909_ecustom--CapitalRaiseFee_iI_pn3n3_c20231231_zkFfW3aegIne" title="Capital raise fee">660</span>. The Company also granted to the Underwriter, <span id="xdx_902_ecustom--WarrantsIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zpaKqkxwLAQk" title="Warrants issued">666,667</span> warrants at an exercise price of $<span id="xdx_90E_ecustom--WarrantsExercisePrice_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zoGUBnANeFLl" title="Warrant exercise price">0.264</span> per share, which expires after 5 years. The Underwriter’s warrants were valued at $<span id="xdx_906_ecustom--WarrantsPricePerShare_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zDiA8fZZC1tf" title="Warrants price per share">0.0575</span> per option by using the Black &amp; Scholes option-pricing, with expected volatility of <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_z7BiNIFkvzp2" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zxyvqxQUOfck" title="Risk-free interest rate">4.13</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.</span></p> <p id="xdx_89D_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zIkTxjVoKP0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $<span id="xdx_90D_eifrs-full--DebtSecurities_iI_pn3n3_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zxtmzav4k9T2">657 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementsMember_z5A7Bs6UAU02">487,281 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount (see also note 13).</span></td></tr> </table> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31,2023 The Company also issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember_zYh2fPDZPlXh">457,682 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares to a service provider as payment in full for $<span id="xdx_90A_ecustom--PaymentForService_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember_zswk8OOSVt9i" title="Payment for service">260 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">worth of legal services which previously provided to the Company.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers:</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2018, Security Matters PTY Ltd. has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Plan include employees, directors and consultants of Security Matters PTY Ltd. or any subsidiary. On March 7, 2023 as part of the SPAC transaction. These options were exercised on a cashless basis and then after replaced to the Company’s shares. See also note 14B1(c-d).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March 7, 2023 Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $<span id="xdx_90F_eifrs-full--ShareIssueRelatedCost_pn3n3_c20230307__20230307_zkhYyh5KaHMc">186</span></span><span style="font-family: Times New Roman, Times, Serif">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to <span id="xdx_905_ecustom--SharesIssuedAndOutstandingPercent_iI_pid_dp_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_z6hNSW7GU3Ui" title="Number of ordinary shares, percentage">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or <span id="xdx_908_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_zMHawKrmaQ96">5,082,417 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorized ordinary shares.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2023, the Company granted <span id="xdx_906_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zqhOu1KtvnZb">197,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $<span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8OIU4pdub0f">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-$<span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zP9xOHtii1Ge">1.09</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Related share-based expenses recognized for the period totaled $<span id="xdx_904_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zjWZ80M3vlcc">2,820</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RSUs granted to employees, directors and service providers:</b></span></p> <p id="xdx_890_ecustom--DisclosureOfRestrictedStockUnitExplanatory_zBdtEJUfrElh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B5_ziUpn9ViFbn6" style="display: none">SCHEDULE OF RESTRICTED STOCK UNIT</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zQ1UTZZ5LU68" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1645">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTkhDYVkDj1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zbJcVOJ4kEq2" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLLfJ9jsNC0i" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zvPiOrjegm5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTteSVJfEza7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLGKVIXM2die" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z0p45J5OJTn8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at <b>December 31, 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zZVPqKlB47A3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z9TJpjDSLx81" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_z9AdQB04SB49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company granted <span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zK73V1REFgS1">38,656 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to employees and service providers. These grants carry an exercise price of between $<span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zr6wmPD70GA2">22.71 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- $<span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_z8Z7X39FgON2">88</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, vesting period up to <span id="xdx_90A_ecustom--StockOptionVestingPeriod_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zsrniTfs9Dbg" title="Stock option vesting period">4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years from the grant date, contractual life of the options under the plan is <span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231_zskmN7tAW7l4">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. The fair value of the grant at grant date is $<span id="xdx_90B_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zIrGaeDQpbjl">219</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The related share-based expenses that were recognized in the year ended December 31, 2023, amounted to $<span id="xdx_90F_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zWyCGAJ4M4hf">184</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><br/> <span style="font-size: 10pt">A summary of the status of the Company’s Share Option Plan granted to employees and service providers (including performance-based awards) and changes during the relevant period ended on that date is presented below:</span></span></p></td></tr></table> <p id="xdx_895_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zkqznwgGHG05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zaPXBaHdpPMd" style="display: none">SCHEDULE OF SHARE OPTION GRANTED</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended <br/> December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended <br/> December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (USD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (USD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20231231_zA4kKaVE4xci" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_zcbju1BkWS6l" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20221231_zvLoLUwg23bj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20220101__20221231_zq5RVHFd5QR6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20231231_z1d3vIsFYgKj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231_zL0LZG9AiFBa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.04</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20221231_zQheINC4Ojra" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zlx8l6FJlQAa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231_zrXgULh9D7D3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231_zA9n5p0KLSdj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.02</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231_zXgCEheGT3Lk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zBKkaBRiyJn9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20231231_zp9hzBYAFJM6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">65<span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zahDZlLg4xOe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">69.92<span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20221231_zPz6eFDSz6G7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zjL0fP2hES8c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20231231_zVTtDVydrL9f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zF7K7vxjD5Qc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231_zM0Rhj3eTO22" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zDh9fnAWBnJd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_z3Z9OsUuaUAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zJk8IrnleQ1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of December 31, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span id="xdx_8BF_zPqOMwKjPmaf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (USD)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 44%"><span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcm1l3oZa4if" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.70</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUHPTVU1mMjc">23.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zrB5E6BHkJdb" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zOOJve9XQZr7" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z8wG1M70AeJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zRz03KRjEosh" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEL9xWdTPBH" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.48</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zIyL2KRQECpi">31.02</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zl6ueF2F2Lzk" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zAlYx8LM2VL1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zLqFxrgDtS6d" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zCrY0FoMPbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGkLBr0HxO19" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.48</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zie7L5bAUtu2">48.18</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zUjFXcGfbO2f" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zpf53tUQh2B5" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zPdIkmcd7mhf" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zwAG71jEBFm8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zMN3MjjwEtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.80</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zyuctYzrKt5g">56.10</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zdpdbuqSWLE1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zf3wtXhzXChg" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zzKa9YwvAwDh" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zqIy0ipsbl58" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzfJwE1SjEX7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78.54</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zS7cprvJJV6a">88.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_ztWb2iimLSte" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zs6HnipnU6l1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zmuOC3HcP4qa" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zEKacACnTG5l" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXRyl23et2Ul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.28</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_907_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zY2imYzdjz2e">108.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_za1dkp81moh9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_zHlNQSStJxDk" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_zcY5wJoVQjFl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_z2P7CUv8VfT8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231_zMU3RwANv00k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231_z2G5XQSlbQVe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zzd146N2Nfi2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options issued in 2023, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: <span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdaIBnyVvnqd">3.58</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxgBuHbgR6pe">3.42</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) expected volatility: <span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zOHsPiUwGKx8">78.35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwhNn8S4Gt8d">73.01</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%: (3) expected term: up to <span id="xdx_90D_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zIj4AATCo3x6" title="Expected term">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; and (4) expected dividend yield: <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zZl3SUaWaJZ">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options issued in 2022, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: <span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zzsse4VtfLi6">3.09</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwrhecUsMP69">4.68</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) expected volatility: <span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhiOQGJoKTl8">62.06</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkkykAwHYz6e">85.03</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%: (3) expected term: up to <span id="xdx_903_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zpmStCky8PU9" title="Expected term">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; and (4) expected dividend yield: <span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zueSbN1qAg0l">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></td></tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_89C_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z5fhXQl6uCok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zBKnyP9YYY5e"><i style="display: none">SCHEDULE OF SHARE CAPITAL</i></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eifrs-full--ParValuePerShare_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zS8ADYt9HQOk">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zK9Pj1fuM6hi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,363,636,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zW3ygCWtZod9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,185,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zKS5MJjcgtE8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,727,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJzz0KYxrj76" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_z5G5qK6g8LGe">0.0001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zh5FfsVglOP9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zpyUSJQAxnBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_z9U0kW7diYBi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zkwg9oyqnmbi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred shares <br/>Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20231231_ziOF934WEim7">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_z3YSTiZVA4xj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zGIOLJAMB3C" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zepfvoWkz0xc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zA7KaRCT4PD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.0022 36363636364 10185909 22727272 0.0001 200000000000 1 25000 25000 25000 25000 0.0022 828240000 1000000 186000 32211716 24568773 848784 193500379 shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares 160227 2200000 6250000 11.5 0.0204 303053 3110000 872418 1350000 200000 5 P5Y 11.5 1237751 4196 1979000 606061 0.24 606061 606061 0.24 606061 606061 0.24 (a) up to 90,909 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 90,909 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0 001 per share, and/or (b) 90,909 warrants in the form of Warrant A to subscribe for an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 90,909 warrants in the form of Warrant B to purchase an aggregate of 90,909 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants 90909 0.24 90909 0.2399 0.0 90909 90909 0.24 90909 90909 0.24 (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 681,818 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of the authorization of these financial statements, an aggregate of 690,096 Warrant A warrants were cashless exercised into an aggregate of 345,349 ordinary shares. 690096 345349 5.28 606060 1.15 909090 (i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrant holders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of $697 from the exercise of the Warrant Bs by the holders, and the carrying amount of those warrants, was classified to ordinary shares and premium together with the proceeds the Company received from the exercise price 697 209 909090 865 Warrant A was valued at $0.067 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of the Warrant Bs specify that each warrant has a cash exercise price of $0.24. The Warrant Bs were valued at $0.0602 by using the Black-Scholes option-pricing 0.24 0.0602 0.7039 0.0413 2580000 660000 666667 0.264 0.0575 0.7039 0.0413 <p id="xdx_89D_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zIkTxjVoKP0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $<span id="xdx_90D_eifrs-full--DebtSecurities_iI_pn3n3_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zxtmzav4k9T2">657 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230919__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementsMember_z5A7Bs6UAU02">487,281 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount (see also note 13).</span></td></tr> </table> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31,2023 The Company also issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember_zYh2fPDZPlXh">457,682 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares to a service provider as payment in full for $<span id="xdx_90A_ecustom--PaymentForService_iI_pid_c20231231__ifrs-full--TypesOfContractsAxis__custom--ServiceProviderAgreementsMember_zswk8OOSVt9i" title="Payment for service">260 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">worth of legal services which previously provided to the Company.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers:</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2018, Security Matters PTY Ltd. has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Group and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Plan include employees, directors and consultants of Security Matters PTY Ltd. or any subsidiary. On March 7, 2023 as part of the SPAC transaction. These options were exercised on a cashless basis and then after replaced to the Company’s shares. See also note 14B1(c-d).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March 7, 2023 Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $<span id="xdx_90F_eifrs-full--ShareIssueRelatedCost_pn3n3_c20230307__20230307_zkhYyh5KaHMc">186</span></span><span style="font-family: Times New Roman, Times, Serif">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to <span id="xdx_905_ecustom--SharesIssuedAndOutstandingPercent_iI_pid_dp_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_z6hNSW7GU3Ui" title="Number of ordinary shares, percentage">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or <span id="xdx_908_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_zMHawKrmaQ96">5,082,417 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorized ordinary shares.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2023, the Company granted <span id="xdx_906_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zqhOu1KtvnZb">197,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $<span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8OIU4pdub0f">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-$<span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zP9xOHtii1Ge">1.09</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Related share-based expenses recognized for the period totaled $<span id="xdx_904_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zjWZ80M3vlcc">2,820</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RSUs granted to employees, directors and service providers:</b></span></p> <p id="xdx_890_ecustom--DisclosureOfRestrictedStockUnitExplanatory_zBdtEJUfrElh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B5_ziUpn9ViFbn6" style="display: none">SCHEDULE OF RESTRICTED STOCK UNIT</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zQ1UTZZ5LU68" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1645">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTkhDYVkDj1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zbJcVOJ4kEq2" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLLfJ9jsNC0i" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zvPiOrjegm5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTteSVJfEza7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLGKVIXM2die" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z0p45J5OJTn8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at <b>December 31, 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zZVPqKlB47A3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z9TJpjDSLx81" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 657000 487281 457682 260 186000 0.15 5082417 197000 1 1.09 2820000 <p id="xdx_890_ecustom--DisclosureOfRestrictedStockUnitExplanatory_zBdtEJUfrElh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B5_ziUpn9ViFbn6" style="display: none">SCHEDULE OF RESTRICTED STOCK UNIT</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022 (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zQ1UTZZ5LU68" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1645">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTkhDYVkDj1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zbJcVOJ4kEq2" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLLfJ9jsNC0i" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zvPiOrjegm5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTteSVJfEza7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zLGKVIXM2die" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z0p45J5OJTn8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at <b>December 31, 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zZVPqKlB47A3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z9TJpjDSLx81" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 197000 57000 4000 136000 38656 22.71 88 P4Y P5Y 219000 184000 <p id="xdx_895_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zkqznwgGHG05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zaPXBaHdpPMd" style="display: none">SCHEDULE OF SHARE OPTION GRANTED</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended <br/> December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended <br/> December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (USD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (USD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20231231_zA4kKaVE4xci" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_zcbju1BkWS6l" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20221231_zvLoLUwg23bj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20220101__20221231_zq5RVHFd5QR6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20231231_z1d3vIsFYgKj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231_zL0LZG9AiFBa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.04</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20221231_zQheINC4Ojra" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zlx8l6FJlQAa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20231231_zrXgULh9D7D3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231_zA9n5p0KLSdj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.02</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231_zXgCEheGT3Lk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zBKkaBRiyJn9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20231231_zp9hzBYAFJM6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">65<span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zahDZlLg4xOe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">69.92<span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20221231_zPz6eFDSz6G7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zjL0fP2hES8c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20231231_zVTtDVydrL9f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zF7K7vxjD5Qc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231_zM0Rhj3eTO22" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zDh9fnAWBnJd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 57000 44.22 73000 41.85 38000 82.04 17000 41.85 30000 31.02 33000 34.10 65000 69.92 57000 54.25 58000 68.67 38000 43.40 <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zJk8IrnleQ1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of December 31, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span id="xdx_8BF_zPqOMwKjPmaf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (USD)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 44%"><span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcm1l3oZa4if" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.70</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUHPTVU1mMjc">23.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zrB5E6BHkJdb" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zOOJve9XQZr7" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z8wG1M70AeJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zRz03KRjEosh" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEL9xWdTPBH" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.48</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zIyL2KRQECpi">31.02</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zl6ueF2F2Lzk" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zAlYx8LM2VL1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zLqFxrgDtS6d" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zCrY0FoMPbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGkLBr0HxO19" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.48</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zie7L5bAUtu2">48.18</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zUjFXcGfbO2f" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zpf53tUQh2B5" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zPdIkmcd7mhf" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zwAG71jEBFm8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zMN3MjjwEtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.80</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zyuctYzrKt5g">56.10</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zdpdbuqSWLE1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zf3wtXhzXChg" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zzKa9YwvAwDh" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zqIy0ipsbl58" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzfJwE1SjEX7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78.54</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zS7cprvJJV6a">88.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_ztWb2iimLSte" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zs6HnipnU6l1" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zmuOC3HcP4qa" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSixMember_zEKacACnTG5l" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXRyl23et2Ul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.28</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_907_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zY2imYzdjz2e">108.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_za1dkp81moh9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_zHlNQSStJxDk" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_zcY5wJoVQjFl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingSevenMember_z2P7CUv8VfT8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231_zMU3RwANv00k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20231231_z2G5XQSlbQVe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 18.70 23.32 5000 P2Y5M15D 5000 P2Y5M15D 29.48 31.02 3000 P3Y2M15D 3000 P3Y2M15D 40.48 48.18 6000 P1Y4M28D 6000 P1Y4M28D 52.80 56.10 9000 P2Y3M3D 9000 P2Y3M3D 78.54 88.00 35000 P4Y4M24D 28000 P4Y4M17D 93.28 108.90 7000 P3Y10D 7000 P3Y10D 65000 58000 0.0358 0.0342 0.7835 0.7301 P5Y 0 0.0309 0.0468 0.6206 0.8503 P5Y 0 <p id="xdx_800_eifrs-full--DisclosureOfResearchAndDevelopmentExpenseExplanatory_zWatlg7MpBK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 - <span id="xdx_829_zp0iVzW9tkFf">RESEARCH AND DEVELOPMENT EXPENSES, NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zfEsdwQZUrU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zlMLokING7R2" style="display: none">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20230101__20231231_zaacwS6LNc8c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zPnvXQifFgka" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20210101__20211231_zvDKDk6jLOX6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zDDLqjB2dfKk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries and related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zd8GjhQFYwRa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subcontractors and consultants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">374</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zWV3eBNextog" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Materials and laboratory expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z4BppqBkTyBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zclzEIvcYHZg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zLViYtNLNim4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zoZPRxCQp0Pe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freight</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zaL513ahZZFd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zT6lvmtgtqr1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursement from paid pilots and proof of concept projects</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(858</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzLMx_zhMLIKSz15da" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,711</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,898</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,039</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zwAL69GGR0ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zfEsdwQZUrU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zlMLokING7R2" style="display: none">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20230101__20231231_zaacwS6LNc8c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zPnvXQifFgka" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20210101__20211231_zvDKDk6jLOX6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zDDLqjB2dfKk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries and related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,228</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zd8GjhQFYwRa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subcontractors and consultants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">374</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zWV3eBNextog" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Materials and laboratory expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z4BppqBkTyBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zclzEIvcYHZg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zLViYtNLNim4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zoZPRxCQp0Pe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freight</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zaL513ahZZFd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zT6lvmtgtqr1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursement from paid pilots and proof of concept projects</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(858</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzLMx_zhMLIKSz15da" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,711</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,898</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,039</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2228000 2166000 1795000 344000 374000 631000 223000 316000 252000 197000 255000 287000 447000 127000 100000 87000 50000 42000 33000 30000 23000 10000 6000 -858000 -1426000 -1091000 2711000 1898000 2039000 <p id="xdx_80E_eifrs-full--DisclosureOfGeneralAndAdministrativeExpenseExplanatory_zb95mhHYgN03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 - <span id="xdx_82B_zjXxEpAKU6n5">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_z1rsHMzH9bp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BC_z1OV6kQPSMQh" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_z2LUtxXWQjsh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231_zpSSAMNmR4zc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zkuAA8jAdj53" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TransactionCost_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zukpTYIQP8I6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BCA transaction cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,278</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1844">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zmFIouazIsN7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">667</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,089</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--ServicesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLSq2FBF24D7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,128</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z9iE5Giy2uSc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zuv1BMPforBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">611</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zFaT5XtVTu4i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zGumDJ1WPbpi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zYzwgXtN7Lw5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsajDRrRWX07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z8JQPmrjGal9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zEYHchAmh0mc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,567</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,723</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_z1rsHMzH9bp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BC_z1OV6kQPSMQh" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_z2LUtxXWQjsh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231_zpSSAMNmR4zc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zkuAA8jAdj53" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TransactionCost_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zukpTYIQP8I6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BCA transaction cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,278</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1844">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zmFIouazIsN7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">667</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,089</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--ServicesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLSq2FBF24D7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,128</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z9iE5Giy2uSc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zuv1BMPforBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">611</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zFaT5XtVTu4i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zGumDJ1WPbpi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zYzwgXtN7Lw5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsajDRrRWX07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z8JQPmrjGal9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zEYHchAmh0mc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,567</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,723</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7278000 667000 1105000 1089000 5128000 1348000 935000 752000 611000 223000 170000 145000 116000 1222000 137000 331000 50000 60000 102000 30000 35000 28000 63000 83000 64000 16567000 2723000 2482000 <p id="xdx_801_eifrs-full--DisclosureOfIncomeTaxExplanatory_zJWzgzwpREh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 - <span id="xdx_82E_zzylPHN6ijV5">TAXES ON INCOME</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Company is incorporated and domiciled in Ireland where the applicable tax rate is <span id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_uPure_c20230101__20231231_z1o2iTtNNTdb">12.5%</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Theoretical tax:</span></td></tr></table> <p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_zQGoFuZUwTlf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_z7hNNfGC87vd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231_zSm2GPnJD5Ub" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220101__20221231_zmzzn5tx2Mb9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20210101__20211231_zF3yX29o4kri" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation of income tax at the statutory rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zd1mt4OYNu84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income tax</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,989</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zURBdejPy7g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Theoretical tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eifrs-full--ApplicableTaxRate_pid_dp_c20230101__20231231_z027mOvLZwnf">12.5%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,624</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,701</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,358</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract_iB_zyKdRSfyAXHj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax effect amounts which are not deductible/(taxable) in calculating taxable income:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_zJghOtz3LMZ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenditure and others</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3254</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_maITECOzgxM_zV1FQFpEOGo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(630</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,240</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_pn3n3_mtITECOzgxM_zfceZHy1fpP7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax / (benefit)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1913">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1914">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1915">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zjfbZcrk7IJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">As of December 31, 2023, the Group has estimated carry forward tax losses of approximately <span id="xdx_90C_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20230101__20231231_z1J2eQnMclRb">$45,095 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">(2022: <span id="xdx_901_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20220101__20221231_zdXc4emPw7e">$24,106 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">2021<span id="xdx_901_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20210101__20211231_zJlCtaCLBd27">:$17,659</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.125 <p id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_zQGoFuZUwTlf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_z7hNNfGC87vd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230101__20231231_zSm2GPnJD5Ub" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220101__20221231_zmzzn5tx2Mb9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20210101__20211231_zF3yX29o4kri" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation of income tax at the statutory rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zd1mt4OYNu84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income tax</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,989</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zURBdejPy7g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Theoretical tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eifrs-full--ApplicableTaxRate_pid_dp_c20230101__20231231_z027mOvLZwnf">12.5%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,624</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,701</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,358</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract_iB_zyKdRSfyAXHj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax effect amounts which are not deductible/(taxable) in calculating taxable income:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_zJghOtz3LMZ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenditure and others</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3254</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--TaxExpenseBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_maITECOzgxM_zV1FQFpEOGo4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(630</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,240</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_pn3n3_mtITECOzgxM_zfceZHy1fpP7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax / (benefit)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1913">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1914">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1915">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> -20989000 -6184000 -4939000 0.125 -2624000 -1701000 -1358000 3254000 335000 118000 -630000 1366000 1240000 45095000 24106000 17659000 <p id="xdx_802_eifrs-full--EarningsPerShareExplanatory_z518OkTWZ7S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 - <span id="xdx_821_zvJK5Qc3Anya">LOSS PER SHARE</span></b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfEarningsPerShareExplanatory_ztyoJuw2W8R9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zyNkd3gAGvS7" style="display: none">SCHEDULE OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zBp3TU5vOBf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_zmgynDSvdru1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zoX7HcgsrG99" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--NetIncomeLossAttributableToOwners_pn3n3_zVCFkXUroeO7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,914</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_zssffIJcbIkd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7.82</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span id="xdx_90B_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20221231_fKg_____zsb19CiE72wb">(8.47</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span id="xdx_90D_eifrs-full--DilutedEarningsLossPerShare_pid_c20210101__20211231_fKg_____zEfoBK3Mjzwg">(7.41</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20231231_zjNCOYue9nNl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,676</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20221231_zDZWzRoq1Yl8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">730</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--AdjustedWeightedAverageShares_pid_c20210101__20211231_zzjhWKfkmQD2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">666</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td id="xdx_F0B_zKThmTiLt2se" style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zB4hM0OmEqN4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></td> </tr></table> <p id="xdx_8A9_z2zavQqoQYs2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfEarningsPerShareExplanatory_ztyoJuw2W8R9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zyNkd3gAGvS7" style="display: none">SCHEDULE OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zBp3TU5vOBf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_zmgynDSvdru1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zoX7HcgsrG99" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--NetIncomeLossAttributableToOwners_pn3n3_zVCFkXUroeO7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,914</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20231231_zssffIJcbIkd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7.82</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span id="xdx_90B_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20221231_fKg_____zsb19CiE72wb">(8.47</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span id="xdx_90D_eifrs-full--DilutedEarningsLossPerShare_pid_c20210101__20211231_fKg_____zEfoBK3Mjzwg">(7.41</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20231231_zjNCOYue9nNl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,676</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20221231_zDZWzRoq1Yl8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">730</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--AdjustedWeightedAverageShares_pid_c20210101__20211231_zzjhWKfkmQD2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">666</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td id="xdx_F0B_zKThmTiLt2se" style="font-family: Times New Roman, Times, Serif; width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zB4hM0OmEqN4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></td> </tr></table> -20914000 -6184000 -4939000 -7.82 -8.47 -7.41 2676 730 666 <p id="xdx_80B_eifrs-full--DisclosureOfRelatedPartyExplanatory_zwOj6IoBOOmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 - <span id="xdx_829_zPseOlkI5fa6">RELATED PARTIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Management Personnel Compensation and other related party transactions and balances:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key management personnel, among others includes board members, CEO and CFO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zUBJXzmauMP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows<b>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zjk3AwZUz5pl" style="display: none">SCHEDULE OF KEY MANAGEMENT PERSONNEL</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Transactions with related parties:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_zNCP3cPYTX5h" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_z7nJlBZ9rQI3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementIssuanceOfOptionsToRelatedParty_maKMPCzriq_zlZBf9P4unc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of options to related party</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1939">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzriq_zAAIgA1OU4K2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary and fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">803</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">508</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--KeyManagementPersonnelCompensationShorttermEmployeeBenefitsDeletion_pn3n3_maKMPCzriq_zirDUgTyDZOk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary until deletion</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationLoanRepayment_pn3n3_maKMPCzriq_zXSYaacxFmB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan repayment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1948">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--ConversionOfLoanToOrdinaryShares_iI_pn3n3_maKMPCzriq_zAor4f4orRJh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion of loan to ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzriq_zoQNwqTPkwK" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzriq_z1iJUiyInkk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment retirement benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--KeyManagementPersonnelCompensationPaymentForAdministrativeServices_pn3n3_maKMPCzriq_zEJlOonxrdOd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Administrative services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzriq_z9XHcm28j02h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-monetary benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--KeyManagementPersonnelCompensationPaymentsForLegalServices_pn3n3_maKMPCzriq_zVecM4K8VEa3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments for legal services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl1967">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RevaluationOfFinancialLiabilitiesAtFairValue_pn3n3_maKMPCzriq_zoUEBc1DpYr6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revaluation of financial liabilities at fair value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ProofOfConceptProjectsPaidByAffiliatedCompanies_pn3n3_maKMPCzriq_zy471xnx1pu7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of Concept projects paid by affiliated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_pn3n3_mtKMPCzriq_zaTGP47YHVrj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel compensation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,238</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">594</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zlA7Xa1CC268" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_zQzOApmqTCo" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BB_zP4OtwEVofn9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BALANCE WITH RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Balance with related parties:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zTMyWPXPKni4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(219</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zzuBs7Onv4le" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zfDgoGHPBAE6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zeU0TUcytGm2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zgHeGeMvhxE1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zWWbNTpn7Ejf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--OtherPayables_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zopgnNyxgsp5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--OtherPayables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zGdUYA9c37G2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--TradeAndOtherPayables_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zV0v0EvEUgHb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Trade payables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zVlZjIZUQhn8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Trade payables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1998">-</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--Derivatives_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zOaOemuCI9Dj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivatives"><span style="font-family: Times New Roman, Times, Serif">(476</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--Derivatives_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zq5fIZa4Ob17" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivatives"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--OtherReceivables_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zNrNQXl6vD9l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--OtherReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zXp6b6VRUbH2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zcl74EkJWzle" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z0KjU5xqjWx6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zUT6YMOuoZD1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zrennOUHvylf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8A5_ziyWylh612Sb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zUBJXzmauMP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows<b>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zjk3AwZUz5pl" style="display: none">SCHEDULE OF KEY MANAGEMENT PERSONNEL</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Transactions with related parties:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20231231_zNCP3cPYTX5h" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_z7nJlBZ9rQI3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementIssuanceOfOptionsToRelatedParty_maKMPCzriq_zlZBf9P4unc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of options to related party</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1939">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzriq_zAAIgA1OU4K2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary and fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">803</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">508</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--KeyManagementPersonnelCompensationShorttermEmployeeBenefitsDeletion_pn3n3_maKMPCzriq_zirDUgTyDZOk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary until deletion</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationLoanRepayment_pn3n3_maKMPCzriq_zXSYaacxFmB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan repayment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1948">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--ConversionOfLoanToOrdinaryShares_iI_pn3n3_maKMPCzriq_zAor4f4orRJh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion of loan to ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzriq_zoQNwqTPkwK" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzriq_z1iJUiyInkk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment retirement benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--KeyManagementPersonnelCompensationPaymentForAdministrativeServices_pn3n3_maKMPCzriq_zEJlOonxrdOd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Administrative services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzriq_z9XHcm28j02h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-monetary benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--KeyManagementPersonnelCompensationPaymentsForLegalServices_pn3n3_maKMPCzriq_zVecM4K8VEa3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments for legal services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl1967">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RevaluationOfFinancialLiabilitiesAtFairValue_pn3n3_maKMPCzriq_zoUEBc1DpYr6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revaluation of financial liabilities at fair value</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ProofOfConceptProjectsPaidByAffiliatedCompanies_pn3n3_maKMPCzriq_zy471xnx1pu7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of Concept projects paid by affiliated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_pn3n3_mtKMPCzriq_zaTGP47YHVrj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel compensation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,238</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">594</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 721000 803000 508000 22000 172000 657000 2084000 98000 98000 94000 34000 36000 49000 29000 287000 1204000 -1064000 5238000 594000 <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_zQzOApmqTCo" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BB_zP4OtwEVofn9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BALANCE WITH RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Balance with related parties:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zTMyWPXPKni4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(219</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zzuBs7Onv4le" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zfDgoGHPBAE6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zeU0TUcytGm2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zgHeGeMvhxE1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zWWbNTpn7Ejf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--OtherPayables_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zopgnNyxgsp5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--OtherPayables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zGdUYA9c37G2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--TradeAndOtherPayables_iNI_pn3n3_di_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zV0v0EvEUgHb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Trade payables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zVlZjIZUQhn8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Trade payables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1998">-</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--Derivatives_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zOaOemuCI9Dj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivatives"><span style="font-family: Times New Roman, Times, Serif">(476</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--Derivatives_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zq5fIZa4Ob17" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivatives"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--OtherReceivables_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zNrNQXl6vD9l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--OtherReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zXp6b6VRUbH2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zcl74EkJWzle" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z0KjU5xqjWx6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zUT6YMOuoZD1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(626</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zrennOUHvylf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 219000 99000 82000 710000 3000 56000 58000 -476000 15000 59000 115000 221000 -626000 -667000 <p id="xdx_804_eifrs-full--DisclosureOfGovernmentGrantsExplanatory_zRPomJJxZeSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 - <span id="xdx_823_zIEV3lGiu6t4">GOVERNMENT GRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS). The Group has an approved project with the IIA under which it received a total of $<span id="xdx_900_ecustom--ProceedsFromGovernmentGrantsReceived_pn3n3_c20230101__20231231_zqf2WOxU8Uz8" title="Proceeds from government grants received">162 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">in prior years. The Group is subject to paying <span id="xdx_909_ecustom--PercentageOfRevenue_pid_dp_c20230101__20231231_zzFG4RgHkdn5" title="Percentage of revenue">3% </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">of its relevant revenues until repayment of the entire grant. As of December 31, 2023, the Group paid an amount of <span id="xdx_90B_ecustom--PaymentsForGovernmentGrants_pn3n3_c20230101__20231231_zESJ2hcxpRG1" title="Payments for government grants">0</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">. The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">Until October 25, 2023, the interest was calculated at a rate based on 12-month London Interbank Offered Rate, or LIBOR applicable to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such directive, regarding <span id="xdx_90B_ecustom--DescriptiontOfGovernmentGrants_c20231025__20231025_z0kxG1yOEgV8">IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual interest will be calculated at a rate based on 12-month Secured Overnight Financing Rate, the SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest will be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">.</span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zuWAiV6p2nih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zQ1eYWQa99Yg" style="display: none">SCHEDULE OF GOVERNMENT GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20231231_zLqQ39eXg4y3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zlgEAW3yB7bk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zYOVhXDSpmDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zyW4KnJorlfa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzTVv_zmF5zFbNpLIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zhvaDM1ozLv7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 162000 0.03 0 IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual interest will be calculated at a rate based on 12-month Secured Overnight Financing Rate, the SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest will be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4% <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zuWAiV6p2nih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zQ1eYWQa99Yg" style="display: none">SCHEDULE OF GOVERNMENT GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20231231_zLqQ39eXg4y3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zlgEAW3yB7bk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zYOVhXDSpmDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zyW4KnJorlfa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzTVv_zmF5zFbNpLIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 153000 50000 85000 153000 135000 <p id="xdx_80F_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_zV6osFHKt9V4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 - <span id="xdx_820_zA3ttKARieq8">COMMITMENTS AND CONTINGENT LIABILITIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on <span id="xdx_909_ecustom--PercentageOfRoyalty_iI_pid_dp_c20150131_zAiTPVoSIp9a" title="Percentage of royalty">2.2% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&amp;A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&amp;A event, the Company is to pay a consideration equal to <span id="xdx_90B_ecustom--ContingentOfConsiderationPercentage_iI_pid_dp_c20150131_znMKa7AdHcej" title="Contingent of consideration percentage">1% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the amount received or transferred and in the second M&amp;A event, a consideration equal to <span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20150131_zc2YCSxLpi1c">2% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">On January 2023, the Company signed an amendment to the agreement that determine the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">(1) for the BCA with Lionheart, Isorad was issued (a) <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230131_zDm8IJMWXPyb">864,000 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main assumptions which were used are: (1) risk-free rate: <span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230129__20230131_zUjkdIceSQLi">3.42%</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">; (2) expected volatility: <span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230129__20230131_zmcjkq1q6Th3">81.92%</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">: (3) expected term: up to <span id="xdx_901_ecustom--DescriptionOfExpectedExpectedTermOptionsGranted_dtY_c20230129__20230131_zpMxKUpeaYWe" title="Expected term">3 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">years; and (4) expected dividend yield: <span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230129__20230131_zbsYgALGc2Hl" title="Expected dividend yield">0</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">%;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The fair value of these options was $<span id="xdx_900_ecustom--LicenseIntellectualProperty_iI_pn3n3_c20231231_zZP2wZGzksq7">33</span></span> <span style="font: normal 10pt Times New Roman, Times, Serif">and recognized as a technology license intellectual property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 - COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">(2) Additionally, Isorad will be entitled to <span id="xdx_902_ecustom--AddtionalEquityFundOfConvertiblePercent_iI_pid_dp_uPure_c20230131_zo9w0ImIPAa4" title="Addtional equity fund of convertible percent">1% </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of <span id="xdx_906_eifrs-full--ConsiderationPaidReceived_pn6n6_c20230129__20230131_z3SObQUiDIb1">27 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">million, or at the end of such 13 months, the earlier thereof).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">As of December 31, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $<span id="xdx_907_eifrs-full--ChangesInInvestmentProperty_pn3n3_c20230101__20231231_z4KdxlaNkGD2">123</span></span> <span style="font: normal 10pt Times New Roman, Times, Serif">against a liability that reflects the due amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">(3) Exit fee - in the occurrence of the first M&amp;A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to <span id="xdx_900_ecustom--PaymentOfCashPercent_iI_pid_dp_uPure_c20230131_z1R3TW5Rdw0j" title="Payment of cash percent">1.5% </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.022 0.01 0.02 864000 0.0342 0.8192 P3Y 0 33000 0.01 27000000 123000 0.015 <p id="xdx_807_ecustom--DisclosureOfFinancialInstrumentAndRiskManagementExplanatory_zrXbW14iD5dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - <span id="xdx_823_zkO19FT5dxwl">FINANCIAL INSTRUMENTS AND RISK MANAGEMENT</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zyZbkSitVu2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of the Group’s financial assets and financial liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zAPRatsovFbc" style="display: none">SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20231231_zlX7DrkFLFlg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20221231_zZarTVYQvJQ" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--DisclosureOfFinancialAssetsAbstract_iB_zoXoY72cLDyi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--CashAndCashEquivalents_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zxCBY20Igw4j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherCurrentAssets_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zbRr19PhBXO5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">424</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,673</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CurrentAssets_i01TI_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zSGZBEwfV1V6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,071</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_z3hhYTdgO018" style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_ecustom--DisclosureOfFinancialLiabilitiesRiskManagementExplanatory_za3bYm8kCssi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zFvOw4OKDovc" style="display: none">SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20231231_zVUAyIcMYCR1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zMsVVndM94ad" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract_iB_zqxmAmWVOG08" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at fair value through profit or loss:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zB3gWIcnEZc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">563</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zcOn88yIGer4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zgdDEQ3GnHU5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,682</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zN8eatBbtjM6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pre-paid advance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--DerivativesMember_zsqJsLeb0iL3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_zeeJNaT1pof4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities at fair value through profit or loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,940</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,867</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--FinancialLiabilitiesAmortisedCostAbstract_iB_zwN90By03lDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zlgWdJ1Azk3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible promissory note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zTi6011Mt8o9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">649</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2103">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zl2x2tii84a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingFromRelatedPartiesMember_z935Eei8CHTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Borrowing from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2108">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2109">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_znGDODESmNsa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,815</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_i01I_z3tsRlFeK7Od" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,755</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,867</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zC2irQ3ZiVp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial risk management objectives</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group’s activities expose it to a variety of financial risks such as market risks (foreign currency risk), credit risk and liquidity risk. The Company’s management oversees the management of these risks, focusing on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to monitor different types of risk to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange, ageing analysis for credit risk and maturity analysis in respect of liquidity risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices, which in the group’s case refers only to foreign currency risk. Financial instruments affected by this risk include, loans and borrowings and short-term payables and receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the NIS and Euro.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Group has excess financial liabilities over financial assets in foreign currencies in relation to the NIS , AUD ,SGD and EUR totaling approximately $<span id="xdx_904_eifrs-full--IncreaseDecreaseInFinancialAssets_uILS_c20230101__20231231_zpCzTGFjeXyg">1,651</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, $<span id="xdx_90E_eifrs-full--IncreaseDecreaseInFinancialAssets_uAUD_c20230101__20231231_z9Z5so2lVV6f">185</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eifrs-full--IncreaseDecreaseInFinancialAssets_uSGD_c20230101__20231231_zECQcfzRqgG6">142 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eifrs-full--IncreaseDecreaseInFinancialAssets_uEuro_c20230101__20231231_zULkMe7fQql5">101</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively (December 31, 2022: approximately $<span id="xdx_901_eifrs-full--IncreaseDecreaseInFinancialAssets_uILS_c20220101__20221231_zCSbuoVIKUad">729 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,$<span id="xdx_90A_eifrs-full--IncreaseDecreaseInFinancialAssets_uAUD_c20220101__20221231_z30Gw3OPAMmd">1265 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_900_eifrs-full--IncreaseDecreaseInFinancialAssets_uSGD_c20220101__20221231_zFSxzD9jQBDd">0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eifrs-full--IncreaseDecreaseInFinancialAssets_uEuro_c20220101__20221231_zDYtJeI6frj">34</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign currency sensitivity analysis</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table demonstrates the sensitivity test to a reasonably possible change of 10% in EUR and NIS exchange rates against the USD, with all other variables held constant. The impact on the Group’s net loss (tax effect is not relevant) and equity is due to changes in the fair value of monetary assets and liabilities including non-designated foreign currency derivatives and embedded derivatives. The Company’s exposure to foreign currency changes for all other currencies is immaterial<i>.</i></span></p> <p id="xdx_89C_ecustom--DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory_zD6Fgrvgf9u2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><i> <span id="xdx_8B3_ziCUc3gkeFh7" style="display: none">SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS</span></i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in NIS rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90D_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--NISMember_zuUOXsU2BwZd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_uILS_c20230101__20231231_zkcXelbu02q2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--NISMember_zx8VLVt4b7R5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eifrs-full--NetForeignExchangeLoss_uILS_c20220101__20221231_zJZmWKOgUlbc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in AUD rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--AUDMember_zpvQsnoDaRk3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--NetForeignExchangeLoss_uAUD_c20230101__20231231_zYR521u40EQi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--AUDMember_z2NmkPTeBDc3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--NetForeignExchangeLoss_uAUD_c20220101__20221231_zbHqFBOZiwR1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in SGD rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_903_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--SGDMember_zBDBqvmcLkI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_903_eifrs-full--NetForeignExchangeLoss_uSGD_c20230101__20231231_zOPnkhTtJh1j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--SGDMember_zzuejg281a91" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--NetForeignExchangeLoss_uSGD_c20220101__20221231_z3MYzkcI0zRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in EUR rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EURMember_z0fmWAjNu5xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_eifrs-full--NetForeignExchangeLoss_uEuro_c20230101__20231231_z3QtYEnCef85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EURMember_zSZjGDyTxgpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--NetForeignExchangeLoss_uEuro_c20220101__20221231_zSU9HoQO4ROl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zwyYWxUgMdJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Credit risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk that a counterparty will not meet its obligations as a customer or under a financial instrument leading to a loss to the Group. The Group is exposed to credit risk from its operating activity (other receivables and cash balances). The Group’s main financial assets are cash and cash equivalents as well as other receivables and their carrying amounts represent the Group’s maximum exposure to credit risk. Credit risk from balances with banks and financial institutions is managed by the Group’s management in accordance with the Group’s policy. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia which the Company’s management regards as financially solid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2023</b></span></p> <p id="xdx_898_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_za2bUTfqdp8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyZtL2dKAnQ" style="display: none">SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 2 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2 to 3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 4 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4 to 5 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&gt;5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zBbKxl484nYj" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zhuRoTSHZGF2" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2147">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zIZKfbPC98A3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zpmcaMDrzrQ" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zg66xI4Vaxf7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2153">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zLdgHDhosylc" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2155">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayableMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_z49GuLqeyxm8" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z5jahzJrLZL8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zb9G09v6SeM7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zEZmIf2lapv1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zNdO1A5OVbrg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zuvVOCfIbTn4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2167">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z2MRnVCLYwj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zo97n1hXCGf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zvPvKn3MnJQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zL4M2kROnMu" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zhQqSUguc765" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zUq71vAXrsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2179">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zEfQPgqtpiud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zNguUSu0Jgcj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zZJ3HWEOSbPl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGlaoT8Pjhi5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zFsLpkDIFMi8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zQaD2Lu5Bkzg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_ztFKggfsFa7j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3qWvp2EeaWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrEuJ1H5FH7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zteFHuzfKqX1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">649</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible promissory note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zJMr1sDGYND6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zwitlYct1Rk5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zWuCQrbLVgn1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zUXlCjSVEhM5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2207">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zck0lQxpdzpi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_z55yomIhQFni" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zjL5mzNi6mt7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pre-paid advance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zSfKwOdWLg4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zqL7C8Sqvku2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2217">-</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zqM0VbFodLT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2219">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zbtA26SJ2W9f" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2221">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zH0BgSxf6O3d" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2223">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_z7vGyoNEDqcd" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zMsmofok1Hh4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zAm5jZ9iAOB1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zqwmJ6x5spwl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z0ZiUbo6NXl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z434ylWSMqA" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2235">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zXXdKR7IA5yh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2237">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z7GzyWXGHmRj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zrldGOaN5DXf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zLA3PlqSZITj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zKczfkYjayx7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2245">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zQR4HR3CBsBc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zTve40Wifj33" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2249">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_z8vMpsv2ZBS7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2251">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_z7DFAHVNd4Cj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2253">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zjupGLuZzc5l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNZfPUyipWl2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,704</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember_za0fRs5cVcCb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">534</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember_z2LBPpuQoM85" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember_zEXDGIQzOeTc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember_zgAZ7Mwf3Y84" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z2BTQhtS3YVh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zGaaNi4NUHHk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,755</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 2 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2 to 3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 4 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4 to 5 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&gt;5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zc6hCsSeTUr2" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zjmLBTo4cS11" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2273">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zUjRQbmuZbz1" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2275">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zh9bJ45DCWd7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2277">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zv70yBC0oajl" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zU9Xu2oIedZ2" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayableMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zTjbTc2n6ABg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zSmspqRAdJk8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2285">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zrUuZsUGNaqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zj9anj2OmwIi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zb9F5eELN0ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z4gprrudczMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z1whbUksHR5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2295">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztZxJ2Alxuvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zTrJzIUeqzY1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zojfiLhZeJLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zKmo9d956qFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_z3kCXEqSUf01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2305">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zjR7zVJhRzxc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2307">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zlwN2uIkUGjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2309">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zi5cyAADn6zj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z35xFLDIS5J2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwzFLQueWU0h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_ztaVoIsF5mKg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhpmdwtnpYR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWPo41N78sn7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrKC4Sa4BMJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztMmyKE0GRYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">713</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z6VypeIrGO7l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z7Ke6pjVlnO9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z2wLQOf1XMeh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zY0vjSlnvGB2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2333">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zm9L2QFSObZj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2335">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zS4KoulodbO" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2337">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zG0hNCDonHql" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zKptnYM0Xjvl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,479</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember_z3pQWu4ory3f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,187</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember_zRGjoMR3ZU8a" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember_zrvpNMVRu3Y1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember_zNTFWpFI3Fnb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zgeoD8scfAW6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztXtsKUPcO85" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,235</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p id="xdx_8A4_zteGkcT8rpy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zyZbkSitVu2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of the Group’s financial assets and financial liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zAPRatsovFbc" style="display: none">SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20231231_zlX7DrkFLFlg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20221231_zZarTVYQvJQ" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--DisclosureOfFinancialAssetsAbstract_iB_zoXoY72cLDyi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--CashAndCashEquivalents_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zxCBY20Igw4j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherCurrentAssets_i01I_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zbRr19PhBXO5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">424</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,673</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CurrentAssets_i01TI_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_zSGZBEwfV1V6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,071</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 168000 1398000 424000 3673000 592000 5071000 <p id="xdx_895_ecustom--DisclosureOfFinancialLiabilitiesRiskManagementExplanatory_za3bYm8kCssi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zFvOw4OKDovc" style="display: none">SCHEDULE OF FINANCIAL LIABILITIES FAIR VALUE THROUGH PROFIT OR LOSS</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20231231_zVUAyIcMYCR1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zMsVVndM94ad" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossAbstract_iB_zqxmAmWVOG08" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at fair value through profit or loss:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zB3gWIcnEZc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">563</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zcOn88yIGer4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zgdDEQ3GnHU5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,682</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zN8eatBbtjM6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pre-paid advance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--DerivativesMember_zsqJsLeb0iL3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_i01I_zeeJNaT1pof4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities at fair value through profit or loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,940</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,867</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--FinancialLiabilitiesAmortisedCostAbstract_iB_zwN90By03lDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zlgWdJ1Azk3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible promissory note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zTi6011Mt8o9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">649</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2103">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zl2x2tii84a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--FinancialLiabilities_i01I_hifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingFromRelatedPartiesMember_z935Eei8CHTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Borrowing from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2108">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2109">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--FinancialLiabilitiesAtAmortisedCost_i01I_znGDODESmNsa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,815</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_i01I_z3tsRlFeK7Od" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,755</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,867</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 377000 563000 12487000 3622000 2233000 3682000 700000 1143000 16940000 7867000 1013000 649000 153000 1815000 18755000 7867000 1651 185 142 101 729 1265 0 34 <p id="xdx_89C_ecustom--DisclosureOfSensitivityAnalysisForActuarialAssumptionExplanatory_zD6Fgrvgf9u2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><i> <span id="xdx_8B3_ziCUc3gkeFh7" style="display: none">SCHEDULE OF FOREIGN CURRENCY SENSITIVITY ANALYSIS</span></i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in NIS rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90D_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--NISMember_zuUOXsU2BwZd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90A_eifrs-full--NetForeignExchangeLoss_uILS_c20230101__20231231_zkcXelbu02q2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--NISMember_zx8VLVt4b7R5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eifrs-full--NetForeignExchangeLoss_uILS_c20220101__20221231_zJZmWKOgUlbc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in AUD rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--AUDMember_zpvQsnoDaRk3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_902_eifrs-full--NetForeignExchangeLoss_uAUD_c20230101__20231231_zYR521u40EQi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--AUDMember_z2NmkPTeBDc3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--NetForeignExchangeLoss_uAUD_c20220101__20221231_zbHqFBOZiwR1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in SGD rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_903_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--SGDMember_zBDBqvmcLkI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_903_eifrs-full--NetForeignExchangeLoss_uSGD_c20230101__20231231_zOPnkhTtJh1j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--SGDMember_zzuejg281a91" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eifrs-full--NetForeignExchangeLoss_uSGD_c20220101__20221231_z3MYzkcI0zRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in EUR rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EURMember_z0fmWAjNu5xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_900_eifrs-full--NetForeignExchangeLoss_uEuro_c20230101__20231231_z3QtYEnCef85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_uPure_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EURMember_zSZjGDyTxgpf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--NetForeignExchangeLoss_uEuro_c20220101__20221231_zSU9HoQO4ROl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.10 165000 0.10 73000 0.10 19000 0.10 127000 0.10 14000 0.10 0.10 10000 0.10 3000 <p id="xdx_898_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_za2bUTfqdp8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyZtL2dKAnQ" style="display: none">SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 2 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2 to 3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 4 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4 to 5 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&gt;5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zBbKxl484nYj" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zhuRoTSHZGF2" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2147">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zIZKfbPC98A3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zpmcaMDrzrQ" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zg66xI4Vaxf7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2153">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zLdgHDhosylc" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2155">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayableMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_z49GuLqeyxm8" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z5jahzJrLZL8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zb9G09v6SeM7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zEZmIf2lapv1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zNdO1A5OVbrg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zuvVOCfIbTn4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2167">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z2MRnVCLYwj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zo97n1hXCGf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zvPvKn3MnJQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zL4M2kROnMu" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zhQqSUguc765" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zUq71vAXrsd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2179">-</span><span style="font-size: 10pt"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zEfQPgqtpiud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zNguUSu0Jgcj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zZJ3HWEOSbPl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGlaoT8Pjhi5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zFsLpkDIFMi8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zQaD2Lu5Bkzg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_ztFKggfsFa7j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3qWvp2EeaWc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrEuJ1H5FH7e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zteFHuzfKqX1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">649</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible promissory note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zJMr1sDGYND6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zwitlYct1Rk5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zWuCQrbLVgn1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zUXlCjSVEhM5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2207">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_zck0lQxpdzpi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryNoteMember_z55yomIhQFni" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertiblePromissoryMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zjL5mzNi6mt7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pre-paid advance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zSfKwOdWLg4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zqL7C8Sqvku2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2217">-</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zqM0VbFodLT2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2219">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zbtA26SJ2W9f" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2221">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_zH0BgSxf6O3d" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2223">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><p id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember_z7vGyoNEDqcd" style="margin: 0; font-family: Times New Roman, Times, Serif" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PrePaidAdvanceMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zMsmofok1Hh4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif">700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zAm5jZ9iAOB1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zqwmJ6x5spwl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z0ZiUbo6NXl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z434ylWSMqA" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2235">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_zXXdKR7IA5yh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2237">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember_z7GzyWXGHmRj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNoteMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zrldGOaN5DXf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial derivatives</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zLA3PlqSZITj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zKczfkYjayx7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2245">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zQR4HR3CBsBc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_zTve40Wifj33" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2249">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_z8vMpsv2ZBS7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2251">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember_z7DFAHVNd4Cj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2253">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--FinancialDerivativesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zjupGLuZzc5l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNZfPUyipWl2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,704</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember_za0fRs5cVcCb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">534</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember_z2LBPpuQoM85" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember_zEXDGIQzOeTc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember_zgAZ7Mwf3Y84" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z2BTQhtS3YVh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zGaaNi4NUHHk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,755</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 2 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2 to 3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 4 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4 to 5 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&gt;5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>years</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zc6hCsSeTUr2" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zjmLBTo4cS11" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2273">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zUjRQbmuZbz1" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2275">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zh9bJ45DCWd7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2277">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zv70yBC0oajl" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember_zU9Xu2oIedZ2" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayableMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zTjbTc2n6ABg" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zSmspqRAdJk8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2285">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zrUuZsUGNaqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zj9anj2OmwIi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_zb9F5eELN0ja" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z4gprrudczMb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember_z1whbUksHR5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2295">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztZxJ2Alxuvd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zTrJzIUeqzY1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zojfiLhZeJLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zKmo9d956qFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_z3kCXEqSUf01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2305">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zjR7zVJhRzxc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2307">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember_zlwN2uIkUGjj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2309">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zi5cyAADn6zj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z35xFLDIS5J2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwzFLQueWU0h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_ztaVoIsF5mKg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhpmdwtnpYR3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWPo41N78sn7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrKC4Sa4BMJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztMmyKE0GRYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">713</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z6VypeIrGO7l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z7Ke6pjVlnO9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_z2wLQOf1XMeh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zY0vjSlnvGB2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2333">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zm9L2QFSObZj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2335">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember_zS4KoulodbO" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl2337">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingsFromRelatedPartiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_zG0hNCDonHql" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zKptnYM0Xjvl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,479</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanOneToTwoYearMember_z3pQWu4ory3f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,187</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanTwoToThreeYearMember_zRGjoMR3ZU8a" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanThreeToFourYearMember_zrvpNMVRu3Y1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--NotLaterThanFourToFiveYearMember_zNTFWpFI3Fnb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zgeoD8scfAW6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsAndNotLaterThanSevenYearsMember_ztXtsKUPcO85" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,235</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 90%"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands)</b></span></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> 12487000 12487000 1750000 453000 15000 15000 2233000 153000 153000 81000 81000 74000 74000 74000 265000 649000 1013000 1013000 700000 700000 377000 377000 1143000 1143000 17704000 534000 89000 89000 74000 265000 18755000 3622000 3622000 1031000 1031000 75000 84000 159000 72000 72000 72000 72000 72000 353000 713000 710000 710000 4479000 1187000 72000 72000 72000 353000 6235000 <p id="xdx_802_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zDXb600wXHSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 23 - <span id="xdx_82B_zUulvUbnl8L5">FAIR VALUE MEASUREMENT</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair value hierarchy</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs for the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_zQpibflnrFMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_z7OdxCIc4015" style="display: none">SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zF1H4m36VH1d" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2359">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zB4GVjsa1x8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2361">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zLf9hSSzkMXe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z7qWbGfWngs5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradable warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ConvertiblePromissoryNote_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zLeakSlKjT9k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ConvertiblePromissoryNote_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zHdtffg0HRE2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ConvertiblePromissoryNote_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zkhqtsCEYGw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2371">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ConvertiblePromissoryNote_iI_pn3n3_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zJaDL1Fln2ld" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zCbUvKh4hgd3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zjQSjk438Yd2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0RrDUwKNSU5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231_zob6GekGBYW3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,709</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zCp8Fh7ln6Ld" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z5jfwoUJMK5a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2385">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zn5saTAsvVMb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zGynPthVCgi2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zyddWTz72NU" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2391">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zr7Z2pas8VBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2393">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zNrGuubIVqFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231_zKZzpKu3cgDc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zUdeO9gOw0F3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_zQpibflnrFMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_z7OdxCIc4015" style="display: none">SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zF1H4m36VH1d" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2359">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zB4GVjsa1x8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2361">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zLf9hSSzkMXe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z7qWbGfWngs5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradable warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ConvertiblePromissoryNote_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zLeakSlKjT9k" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ConvertiblePromissoryNote_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zHdtffg0HRE2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ConvertiblePromissoryNote_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zkhqtsCEYGw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2371">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ConvertiblePromissoryNote_iI_pn3n3_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zJaDL1Fln2ld" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zCbUvKh4hgd3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zjQSjk438Yd2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0RrDUwKNSU5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_c20231231_zob6GekGBYW3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,709</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zCp8Fh7ln6Ld" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z5jfwoUJMK5a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2385">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zn5saTAsvVMb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zGynPthVCgi2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zyddWTz72NU" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2391">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zr7Z2pas8VBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2393">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zNrGuubIVqFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231_zKZzpKu3cgDc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1707000 1707000 2000 2000 2000 1707000 1709000 1031000 1031000 1031000 1031000 <p id="xdx_806_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_zhz231e8gfAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 24 - <span id="xdx_820_z6cK2qdG4cM3">SUBSEQUENT EVENTS</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the reporting date the following significant events have occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements were authorized for issuance on April 19, 2024.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 12, 2024, the Company announced that it entered into a $<span id="xdx_90C_eifrs-full--ContractualCapitalCommitments_iI_pn6n6_c20240112__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zXQdU4MagpO2">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million contract with R&amp;I Trading of New York. This project, spearheaded by the SMX team, will deploy SMX’s technology to enhance supply chain transparency with respect to a NATO government member state and with the expectation of expanding to further NATO government member states.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2024, pursuant to the inducement letter described in note 14(3), the holders of the new <span id="xdx_90A_ecustom--NumberOfWarrants_c20240101__20240131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zlEjTuurMaIb" title="Number of warrants">909,090 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants exercised <span id="xdx_900_ecustom--WarrantsExercised_c20240101__20240131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zbmxNvUQdIhb" title="Warrants exercised">454,544 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants for an aggregate of <span id="xdx_902_ecustom--AggregateOrdinaryShares_c20240101__20240131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8GlMXYAqlt2" title="Aggregate ordinary shares">454,544 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In February 2024, the Company entered into a Letter Agreement with Yorkville dated February 1, 2024 (the “Letter Agreement”), which amends the SEPA. Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances under the SEPA, to repay the amounts outstanding under the Pre-Paid Advance plus payment premium. The Company agreed to pay a fee to Yorkville equal to $<span id="xdx_907_ecustom--PaymentForFee_iI_pn6n6_c20240229__ifrs-full--TypesOfContractsAxis__custom--LetterAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zzDpPOUISX5i">200</span></span><span style="font-family: Times New Roman, Times, Serif">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company further agreed to issue to Yorkville a 5-year warrant to purchase <span id="xdx_902_ecustom--WarrantShares_iI_pid_c20240229__ifrs-full--TypesOfContractsAxis__custom--LetterAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zRG5P8BY2MMj">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif">ordinary shares of the Company at an exercise price of $<span id="xdx_906_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240201__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--LetterAgreementMember_zVnYyKbwLls8">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif">per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 20, 2024, the Company closed an underwritten public offering of <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_ziy0ZHiqz448">12,124,666 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares at a subscription price per share of $<span id="xdx_90A_eifrs-full--ParValuePerShare_iI_pid_c20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zgjPIFJzXEll">0.24 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Pre-Funded Warrants convertible on a <span id="xdx_909_ecustom--PreFundedWarrantsConvertibleDescription_pid_c20240220__20240220__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zmSXarutWCXe" title="Pre funded warrants convertible description">1-for-1 basis</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into Ordinary Shares, at a price per Pre-Funded Warrant of $<span id="xdx_901_ecustom--WarrantExercisePriceShare_pid_c20240220__20240220__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zzs7hqjq7Gri" title="Warrant exercise price share">0.2378</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The gross proceeds was approximately $<span id="xdx_908_eifrs-full--FeeAndCommissionIncome_pn5n6_c20240220__20240220__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zAbNfRtlUOVe">2.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The net proceeds to the Company upon the closing of the offering, after deducting the underwriting commissions and estimated offering expenses payable by the Company, were approximately $<span id="xdx_906_ecustom--OfferingExpensesPayable_pn4n6_c20240220__20240220__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zx9A8j9rdaNb" title="Offering expenses payable">2.66 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2024, in connection with a private placement binding term sheet, the Company issued <span id="xdx_900_ecustom--ConvertibleSecurityToInvestorDescription_c20240201__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z0yknxZNPu0f" title="Convertible security to investor, description">(i) a convertible security to an investor relating to a loan in the principal amount of $<span id="xdx_90B_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20240201__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zOzGSddEGHhl" title="Aggregate amount of convertible instruments issued">407</span> and (ii) 100,000 warrants to the investor.</span> The warrants have an exercise price of $<span id="xdx_902_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20240201__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zj0C02kdbp7j" title="Exercise price of share">0.5</span> per share. The net proceeds to the Company upon the closing of the private placement was $<span id="xdx_90A_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20240201__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zicaYugBMPI5" title="Net proceeds from private placement">350</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">7.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 29, 2024, the Company’s Board of Directors approved a grant of <span id="xdx_90F_ecustom--RestrictedStockUnitShares_pid_c20240229__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zILmckgf48Cc">1,500,000 </span></span><span style="font-family: Times New Roman, Times, Serif">RSUs to an officer, directors and service providers under the 2022 Incentive Equity Plan. As of the date of these Financial Statements <span id="xdx_900_ecustom--RestrictedStockUnitVestedShares_pid_c20240229__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zDpJ6791iO1j">166,667 </span></span><span style="font-family: Times New Roman, Times, Serif">of the RSUs are vested.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">8.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On March 4, 2024, the Company’s Board of Directors approved the issuance of <span id="xdx_906_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20240304__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardOfDirectorMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_za72vkwMGyIl">100,000 </span></span><span style="font-family: Times New Roman, Times, Serif">ordinary shares to a service provider in connection with certain investor relations services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">9.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On April 11, 2024 the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor a promissory note and warrants, for gross proceeds of approximately US$<span id="xdx_902_ecustom--PromissoryNote_iI_pn5n6_c20240411__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z0ae4xhnoUJf">2.0 </span></span><span style="font-family: Times New Roman, Times, Serif">million, before deducting fees and other offering expenses payable by the Company. The Note is in the principal amount of $<span id="xdx_902_ecustom--PrincipalAmount_iI_c20240411__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8FpUAtep8Ih">2,250</span></span><span style="font-family: Times New Roman, Times, Serif">. The actual amount loaned by the Investor pursuant to the Note is approximately $<span id="xdx_90B_eifrs-full--BorrowingCostsIncurred_pn3n3_c20240411__20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zF8aNgKoRIqa">2.0 </span></span><span style="font-family: Times New Roman, Times, Serif">million after a <span id="xdx_903_ecustom--OriginalIssueDiscount_iI_pid_dp_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zkyFfE6hc7th" title="Original issue discount">10% </span></span><span style="font-family: Times New Roman, Times, Serif">original issue discount. The maturity date of the Note is the 12-month anniversary of the Effective Date, and is the date upon which the Principal Amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of <span id="xdx_908_ecustom--InterestAccruedPercent_iI_pid_dp_c20240411__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z5ngU9mOBBC3" title="Interest accrued percent">12% </span></span><span style="font-family: Times New Roman, Times, Serif">per year. In addition, the Warrant, for <span id="xdx_90D_ecustom--WarrantTerm_iI_c20240411__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zGT8be6VDr7b" title="Warrant term">5 years</span> period and for <span id="xdx_903_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20240411__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zRa6VyU153z1">11,825,508 </span></span><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares, has an exercise price of $$<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20240411__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zIN7qO4w2Hn7">0.157 </span></span><span style="font-family: Times New Roman, Times, Serif">per share, subject to customary adjustments and limitations as described in the agreement. Furthermore, as a further inducement of the Company for the Investor to enter into the transaction, the Company entered into a Warrant Amendment and Inducement Letter with the Investor, with respect to its outstanding “B” warrants of the Company (the “Existing Warrant”) to purchase <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zjIKSZXlu2Q8">2,619,367 </span></span><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares. The Existing Warrant was issued to the Investor as of September 6, 2023 and had a fixed exercise price of $<span id="xdx_90C_ecustom--ConversionPrice_pid_c20230906__20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z7dnAMvWcw0f" title="Conversion price">1.6378 </span></span><span style="font-family: Times New Roman, Times, Serif">per share. Pursuant to the Inducement Letter, the Investor agreed to exercise for cash the Existing Warrant in full at a reduced exercise price of $<span id="xdx_902_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zUkt5hQqHaN" title="Warrants exercise price per share">0.0022 </span></span><span style="font-family: Times New Roman, Times, Serif">per share, or approximately $<span id="xdx_905_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230906__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zKuKgOAXt2ze" title="Warrants exercise price per share">6</span></span><span style="font-family: Times New Roman, Times, Serif">, see also note 8(c).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 19, 2024, the Company entered into a Stock Purchase Agreement (the “SPA”) with an institutional investor, pursuant to which the investor has committed to purchase from time to time from the Company, up to $<span id="xdx_909_eifrs-full--NotionalAmount_iI_pn3n3_c20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zuXMOkJEHvS">30,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Company’s ordinary shares, subject to the terms and conditions specified in the SPA. Subject to the terms and conditions of the SPA, the Company has the right from time to time at its discretion, any time after the three month anniversary of the shares underlying the SPA being registered for resale pursuant to the Registration Rights Agreement referred to below, to direct Alpha to purchase a specified amount of the Company’s ordinary shares (each such sale, a “Put”) by delivering written notice to Alpha (each, a “Put Notice”). <span id="xdx_904_ecustom--StockHoldersEquityDescription_c20240419__20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_z6kwODN0xZqd" title="Stock purchase agreement description">There is a $20 mandatory minimum amount for any Put and it may not exceed $500 in any consecutive 30-day period, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The obligations of the investor to accept any Put pursuant to a Put Notice is subject to customary conditions, including that it is not required to purchase any ordinary shares pursuant to a Put if it would result in it beneficially owning in excess of <span id="xdx_905_ecustom--PurchasePricePercentage_iI_pid_dp_uPure_c20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zXYHuGWqUXf7" title="Purchase price, percentage">4.99</span>% of the Company’s ordinary shares, and that the ordinary shares subject to the Put be registered for resale. The Company agreed to pay a commitment fee to the investor equal to <span id="xdx_90B_ecustom--CommitmentFeePercentage_iI_pid_dp_uPure_c20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zN6oDoOCbSih" title="Commitment fee, percentage">1.5</span>% of the commitment amount, payable in shares, or <span id="xdx_905_ecustom--ShareIssued_iI_c20240419__ifrs-full--TypesOfContractsAxis__custom--StockPurchaseAgreementMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--EnteringIntoSignificantCommitmentsOrContingentLiabilitiesMember_zysG9dg0aHa5" title="Number of shares">2,725,621</span> ordinary shares (the “Commitment Shares”) and which are subject to a three month lock-up.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SPA will automatically terminate on the earliest to occur of (a) the first day of the month next following the 36-month anniversary of the date of the SPA or (ii) the date on which the investor shall have made payment of Puts pursuant to the SPA for ordinary shares equal to $<span id="xdx_90C_ecustom--OrdinaryShares_iI_pid_c20240419__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zd9jLltGLN4b" title="Ordinary shares">30,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company has the right to terminate the SPA at no cost or penalty upon five (5) trading days’ prior written notice to the investor, provided that there are no outstanding Put Notices for which ordinary shares need to be issued and the Company has paid all amounts owed to the investor pursuant to the SPA and any indebtedness the Company otherwise owes to the investor or its affiliates. The Company and the investor may also agree to terminate the SPA by mutual written consent.</span></p> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of publication of these financial statements, the Company’s institutional investor has converted all of the principal of the convertible promissory note into an aggregate of <span id="xdx_908_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20240112__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zyhGAPJ4LQsh">2,619,377 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares and exercised the Warrant A and Warrant B for <span id="xdx_901_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20240112__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zLBztBnLp6Ma">3,789,264 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_900_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20240112__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zH3hHoIimcZ9">2,619,367 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, respectively, see also note 8(c).</span></td></tr></table> 5000000 909090000 454544000 454544000 200000000 250000 0.0022 12124666 0.24 1-for-1 basis 0.2378 2900000 2660000 (i) a convertible security to an investor relating to a loan in the principal amount of $407 and (ii) 100,000 warrants to the investor. 407000 0.5 350000 1500000 166667 100000 2000000.0 2250000 2000.0 0.10 0.12 P5Y 11825508 0.157 2619367 1.6378 0.0022 6 30000000 There is a $20 mandatory minimum amount for any Put and it may not exceed $500 in any consecutive 30-day period, subject to a volume threshold equal to the quotient of (a) the number of ordinary shares requested by the Company in a Put Notice divided by (b) 0.30. The ordinary shares will be purchased at a price equal to: (a) 95% of the lowest daily traded price of the Company’s ordinary shares during the five trading day valuation period (provided that it shall not be less than a Company-specified minimum acceptable price) (“Market Price”), if the market price of the ordinary shares is over $1.00; (b) 90% of the Market Price, if the market price of the ordinary shares is between $0.80 and $1.00: (c) 85% of the Market Price, if the market price of the ordinary shares is between $0.60 and $0.80; (d) 80% of the Market Price, if the market price of the ordinary shares is between $0.40 and $0.60; (e) 75% of the Market Price, if the market price of the ordinary shares is between $0.20 and $0.40; and (f) 50% of the Market Price, if the market price of the ordinary shares is below $0.20. The SPA contains restrictions on the Company’s ability to enter into any Variable Rate Transaction (as defined in the SPA), as described in the SPA. 0.0499 0.015 2725621000 30000 2619377 3789264 2619367 Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1.B) Incorporated in 2023. Merger occurred in March 2023 as part of the Business Combination. Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2023. Includes $3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1.B). Restated as a result of the SPAC transaction and the reverse share split described in Note 14B(4), the calculation of the basic and diluted loss per share for all past periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

  •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